Citrus Sinensis ID: 014623
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 421 | 2.2.26 [Sep-21-2011] | |||||||
| O49840 | 426 | Protein kinase 2B, chloro | yes | no | 0.990 | 0.978 | 0.739 | 1e-178 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.997 | 0.985 | 0.721 | 1e-169 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.850 | 0.868 | 0.639 | 1e-136 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.836 | 0.858 | 0.637 | 1e-135 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.876 | 0.948 | 0.605 | 1e-131 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.774 | 0.825 | 0.639 | 1e-124 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.812 | 0.879 | 0.603 | 1e-122 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.798 | 0.685 | 0.604 | 1e-119 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.755 | 0.645 | 0.625 | 1e-118 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.833 | 0.856 | 0.571 | 1e-112 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 624 bits (1609), Expect = e-178, Method: Compositional matrix adjust.
Identities = 318/430 (73%), Positives = 361/430 (83%), Gaps = 13/430 (3%)
Query: 1 MGNCLQHSSARVDST-QSPRATSGASRIST--RSSHSSAPSTLPIPPSKEKGNSESLPTP 57
MGNCL SSA+VDS+ SP A S + ++S S+ PS+L + ESLPTP
Sbjct: 1 MGNCLD-SSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLS---INSYSSVESLPTP 56
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
++EGEILSS NLKAFTFNELK ATRNFRPDSLLGEGGFG+V+KGWID +L+ +KPGSG+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
VVAVKKLK EG+QGHKEWLTEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
HLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFG
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297
LAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+
Sbjct: 237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296
Query: 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+M
Sbjct: 297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356
Query: 358 SEVLAILERLEAPKNSAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPL 411
SEVLA L++LE+ K + +Q + R + V+KSP R R L++TP ASPL
Sbjct: 357 SEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRRYSYDRPLLHITPGASPL 416
Query: 412 PSHRQSPRVR 421
P+H SPRVR
Sbjct: 417 PTHNHSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 308/427 (72%), Positives = 345/427 (80%), Gaps = 7/427 (1%)
Query: 1 MGNCLQHSSARVD-STQSPRATSGASRISTRSS--HSSAPSTLPIPPSKEKGNSESLPTP 57
MGNCL SSA+VD S SP A S +S S S+ PS L + LPT
Sbjct: 1 MGNCLD-SSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTL 59
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
++EGEILSS NLKAFTFNELK AT+NFR D+LLGEGGFG V+KGWIDQ SL+ ++PGSG+
Sbjct: 60 RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
VVAVK+LKPEGFQGHKEWLTEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
HLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFG
Sbjct: 180 HLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297
LAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 358 SEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSH 414
SEVL LE+LE+ K K +Q E R ++KSP+R R L+MTP ASPLPS+
Sbjct: 360 SEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSY 419
Query: 415 RQSPRVR 421
QSPRVR
Sbjct: 420 TQSPRVR 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 234/366 (63%), Positives = 291/366 (79%), Gaps = 8/366 (2%)
Query: 56 TPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGS 115
P++EGEIL S NLK+FTF ELK ATRNFRPDS+LGEGGFG V+KGWID+ +L+ +KPG+
Sbjct: 41 NPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGT 100
Query: 116 GMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 175
G+V+AVKKL +G+QGH+EWL EVNYLGQ HPNLVKLIGYCLE E+RLLVYEFMP+GSL
Sbjct: 101 GVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSL 160
Query: 176 ENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233
ENHLFRRG QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNILLD+E+NAKL
Sbjct: 161 ENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKL 220
Query: 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 293
SDFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVLLE+LSGR A
Sbjct: 221 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 280
Query: 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 353
VDK + EQ LV+WA+P L++KRKLFR++D +L QY + A ATLAL+CL E KL
Sbjct: 281 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 340
Query: 354 RPRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPT 407
RP M+EV++ LE + EA + + Q R++ V + + P +++ + + T
Sbjct: 341 RPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFARQTAVGVIAT 400
Query: 408 ASPLPS 413
A P PS
Sbjct: 401 AYPRPS 406
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1237), Expect = e-135, Method: Compositional matrix adjust.
Identities = 237/372 (63%), Positives = 293/372 (78%), Gaps = 20/372 (5%)
Query: 1 MGNCLQHSSARVDSTQSPRATS-GASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKS 59
MG CL SA+V + S +T A I + S +S+ S P +P++
Sbjct: 1 MGICL---SAQVKAESSGASTKYDAKDIGSLGSKASSVSVRP--------------SPRT 43
Query: 60 EGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
EGEIL S NLK+F+F ELK+ATRNFRPDS+LGEGGFG V+KGWID+ SL+ ++PG+G+V+
Sbjct: 44 EGEILQSPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVI 103
Query: 120 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 179
AVKKL +G+QGH+EWL EVNYLGQ H +LVKLIGYCLE E+RLLVYEFMP+GSLENHL
Sbjct: 104 AVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHL 163
Query: 180 FRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
FRRG QPLSW +R+KVA+GAAKGL FLH +E++VIYRDFK SNILLD+E+NAKLSDFG
Sbjct: 164 FRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFG 223
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297
LAK GP GD++HVST+VMGTHGYAAPEY+ATG LTTKSDVYSFGVVLLELLSGR AVDK
Sbjct: 224 LAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKN 283
Query: 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
+ E++LV+WAKPYL +KRK+FR++D +L QY + A ATL+L+CL E KLRP M
Sbjct: 284 RPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNM 343
Query: 358 SEVLAILERLEA 369
SEV++ LE +++
Sbjct: 344 SEVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 468 bits (1203), Expect = e-131, Method: Compositional matrix adjust.
Identities = 227/375 (60%), Positives = 291/375 (77%), Gaps = 6/375 (1%)
Query: 24 ASRISTRSSHSSAPSTLPIPPSKEKGNSESLPT--PKSEGEILSSSNLKAFTFNELKTAT 81
++RI T + S+ S+ + KG+S + + P++EGEIL ++NLK F+ +ELK+AT
Sbjct: 6 SNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSAT 65
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
RNFRPDS++GEGGFG V+KGWID+ SL+P+KPG+G+V+AVK+L EGFQGH+EWL E+NY
Sbjct: 66 RNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINY 125
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGA 199
LGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLENHLFRRG QPLSW R+++A+GA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
A+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLSDFGLA+ GP GD +HVST+VMGT G
Sbjct: 186 ARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQG 245
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
YAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+DK + E +LVDWA+PYL++KR+L
Sbjct: 246 YAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRL 305
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS 379
R+MD +L GQY A A LAL C++ + K RP M+E++ +E L K ++K Q
Sbjct: 306 LRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASK-EQQ 364
Query: 380 EPHRQTGPVTVRKSP 394
P + + KSP
Sbjct: 365 NPQISIDNI-INKSP 378
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1142), Expect = e-124, Method: Compositional matrix adjust.
Identities = 211/330 (63%), Positives = 268/330 (81%), Gaps = 4/330 (1%)
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
K+EGEILSS+ +K+FTFNELK ATRNFRPDS++GEGGFG V+KGW+D+ +L+P KPG+G+
Sbjct: 41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
V+AVKKL EGFQGH+EWLTE+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM KGSLEN
Sbjct: 101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160
Query: 178 HLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235
HLFRRG +PL W +R+ VA+ AAKGL FLH +VIYRD KASNILLDA++NAKLSD
Sbjct: 161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSD 220
Query: 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295
FGLA+ GP GD ++VST+VMGT+GYAAPEY+++G L +SDVYSFGV+LLE+LSG+ A+D
Sbjct: 221 FGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALD 280
Query: 296 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
+ E++LVDWA+PYL+ KRK+ I+D +L QY + A A++A+QCL+ EPK RP
Sbjct: 281 HNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRP 340
Query: 356 RMSEVLAILERLEAPKNSAKLSQSEPHRQT 385
M +V+ L++L+ N K SQ+ P + T
Sbjct: 341 TMDQVVRALQQLQ--DNLGKPSQTNPVKDT 368
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 213/353 (60%), Positives = 270/353 (76%), Gaps = 11/353 (3%)
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
K+EGEILSS+ +K+F+FNELK ATRNFR DS++GEGGFG V++GW+D+ +L+P K SG+
Sbjct: 35 KTEGEILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGL 94
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
V+AVK+L P+GFQGH+EWLTE+NYLGQL HPNLVKLIGYCLE E RLLVYEFM KGSLEN
Sbjct: 95 VIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLEN 154
Query: 178 HLFRRGPQ---PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234
HLF G + PLSW +R+KVA+ AAKGL FLH +VIYRD KASNILLD++FNAKLS
Sbjct: 155 HLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLS 214
Query: 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 294
DFGLA+ GP G++++VST+VMGT GYAAPEYV+TG L +SDVYSFGVVLLELL GR A+
Sbjct: 215 DFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQAL 274
Query: 295 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D + EQ+LVDWA+PYL+ +RK+ I+DT+L QY + A A++A+QCL+ EPK R
Sbjct: 275 DHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSR 334
Query: 355 PRMSEVLAILERLE----APKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 403
P M +V+ L +L+ P N L + + G K+ + QR+ LN
Sbjct: 335 PTMDQVVRALVQLQDSVVKPANVDPLKVKDTKKLVG----LKTEDKYQRNGLN 383
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 205/339 (60%), Positives = 261/339 (76%), Gaps = 3/339 (0%)
Query: 41 PIPPSKEKGNSES-LPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVY 99
P+ + N+ES L TP E+ S+LK F+F +LK ATRNFRP+SLLGEGGFG V+
Sbjct: 92 PVSSTTTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVF 151
Query: 100 KGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159
KGW++++ +P KPG+G+ VAVK L P+G QGHKEWL E+NYLG L HPNLVKL+GYC+E
Sbjct: 152 KGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIE 211
Query: 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDF 218
+ RLLVYEFMP+GSLENHLFRR PL W++RMK+A+GAAKGL+FLH+ A VIYRDF
Sbjct: 212 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDF 270
Query: 219 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 278
K SNILLD E+NAKLSDFGLAK P +THVST+VMGT+GYAAPEYV TG LT+KSDVY
Sbjct: 271 KTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 330
Query: 279 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 338
SFGVVLLE+L+GR ++DK + E +LV+WA+P+L DKR+ +R++D +L G + K A
Sbjct: 331 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQK 390
Query: 339 AATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 377
LA QCL+ + K+RP+MSEV+ +L+ L K+ A S
Sbjct: 391 VTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASAS 429
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 426 bits (1096), Expect = e-118, Method: Compositional matrix adjust.
Identities = 200/320 (62%), Positives = 255/320 (79%), Gaps = 2/320 (0%)
Query: 56 TPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGS 115
TP E+ SS+L+ FTFN+LK +TRNFRP+SLLGEGGFG V+KGWI+++ +P KPG+
Sbjct: 114 TPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 173
Query: 116 GMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 175
G+ VAVK L P+G QGHKEWL E+N+LG L HPNLVKL+GYC+E + RLLVYEFMP+GSL
Sbjct: 174 GLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 233
Query: 176 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEFNAKLS 234
ENHLFRR PL W++RMK+A+GAAKGL+FLH+ A VIYRDFK SNILLDA++NAKLS
Sbjct: 234 ENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLS 292
Query: 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 294
DFGLAK P +THVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GR ++
Sbjct: 293 DFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 352
Query: 295 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
DK + E +LV+WA+P+L DKR+ +R++D +L G + K A LA QCL+ +PK+R
Sbjct: 353 DKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIR 412
Query: 355 PRMSEVLAILERLEAPKNSA 374
P+MS+V+ L+ L K+ A
Sbjct: 413 PKMSDVVEALKPLPHLKDMA 432
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 211/369 (57%), Positives = 257/369 (69%), Gaps = 18/369 (4%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNC A V T A + HS + S L P + + P
Sbjct: 1 MGNCGTRDEAAV-------FTPQAQAQQLQKKHSRSVSDLSDPSTPRFRDDSRTP----- 48
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
+S + + FT EL+T T++FRPD +LGEGGFG VYKG+ID + K + VA
Sbjct: 49 ---ISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVA 102
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VK L EG QGH+EWLTEVN+LGQL HPNLVKLIGYC E ++RLLVYEFM +GSLENHLF
Sbjct: 103 VKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF 162
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
R+ PLSW+ RM +A+GAAKGL FLH+AE VIYRDFK SNILLD+++ AKLSDFGLAK
Sbjct: 163 RKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 222
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
AGP GD THVST+VMGT+GYAAPEYV TG LT +SDVYSFGVVLLE+L+GR +VDKT+
Sbjct: 223 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS 282
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
EQ+LVDWA+P L+DKRKL +I+D +L QY +AA A +LA CL+ PK RP MS+V
Sbjct: 283 KEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 342
Query: 361 LAILERLEA 369
+ LE L+
Sbjct: 343 VETLEPLQC 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 421 | ||||||
| 225425762 | 420 | PREDICTED: protein kinase 2B, chloroplas | 0.992 | 0.995 | 0.813 | 0.0 | |
| 255558180 | 419 | Protein kinase APK1A, chloroplast precur | 0.992 | 0.997 | 0.829 | 0.0 | |
| 224111270 | 417 | predicted protein [Populus trichocarpa] | 0.990 | 1.0 | 0.814 | 0.0 | |
| 224099729 | 418 | predicted protein [Populus trichocarpa] | 0.992 | 1.0 | 0.809 | 0.0 | |
| 356500447 | 414 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.957 | 0.973 | 0.806 | 0.0 | |
| 356498210 | 422 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.957 | 0.954 | 0.803 | 0.0 | |
| 357486685 | 410 | Protein kinase 2B [Medicago truncatula] | 0.966 | 0.992 | 0.778 | 0.0 | |
| 217071950 | 410 | unknown [Medicago truncatula] | 0.952 | 0.978 | 0.777 | 0.0 | |
| 48209875 | 420 | putative protein kinase [Solanum demissu | 0.992 | 0.995 | 0.761 | 0.0 | |
| 297817892 | 426 | hypothetical protein ARALYDRAFT_484186 [ | 0.990 | 0.978 | 0.744 | 1e-177 |
| >gi|225425762|ref|XP_002277256.1| PREDICTED: protein kinase 2B, chloroplastic [Vitis vinifera] gi|296086406|emb|CBI31995.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 713 bits (1841), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/423 (81%), Positives = 382/423 (90%), Gaps = 5/423 (1%)
Query: 1 MGNCLQHSSARVDSTQSPRATS--GASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPK 58
MGNCL SSARVDSTQS TS GAS++ +++S+SSAPSTL +P E+ +ES PTP+
Sbjct: 1 MGNCLD-SSARVDSTQSSHTTSASGASKVVSKTSNSSAPSTLTVPSYSERSTAESFPTPR 59
Query: 59 SEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV 118
SEGEIL S +LKAF+FN+LK ATRNFRPDSLLGEGGFG+V+KGWID+ +L+ KPGSGMV
Sbjct: 60 SEGEILPSPSLKAFSFNDLKNATRNFRPDSLLGEGGFGYVFKGWIDEQTLAAVKPGSGMV 119
Query: 119 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 178
+AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH
Sbjct: 120 IAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 179
Query: 179 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238
LFRRGPQPLSWAVR++VAIGAA+GL+FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL
Sbjct: 180 LFRRGPQPLSWAVRIRVAIGAARGLSFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 239
Query: 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298
AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTK
Sbjct: 240 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTK 299
Query: 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358
+G+EQ+LVDWAKPYL DKR+LFRIMDTKL GQYPQK A AATLALQCLN E K+RPRMS
Sbjct: 300 IGVEQNLVDWAKPYLGDKRRLFRIMDTKLEGQYPQKGAFMAATLALQCLNTEAKVRPRMS 359
Query: 359 EVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 418
EVLA LE++++PKN+AK QSE H T + V+KSP+RQQ SPLN+TP ASPLPS+RQSP
Sbjct: 360 EVLATLEQIQSPKNAAKHIQSEQH--TVSIPVQKSPLRQQHSPLNLTPRASPLPSYRQSP 417
Query: 419 RVR 421
RVR
Sbjct: 418 RVR 420
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558180|ref|XP_002520117.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223540609|gb|EEF42172.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/422 (82%), Positives = 381/422 (90%), Gaps = 4/422 (0%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNCL S+A+VD+TQ SGASRIS+R+S SS PS+L IP E+ +SE LPTP++E
Sbjct: 1 MGNCLDSSAAKVDTTQGSHTPSGASRISSRTSRSSVPSSLTIPSYSERSSSECLPTPRTE 60
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GEILSS NLKAF FNELK ATRNFRPDSLLGEGGFG+V+KGWID+H+LS A+PGSGMVVA
Sbjct: 61 GEILSSPNLKAFCFNELKNATRNFRPDSLLGEGGFGYVFKGWIDEHTLSAARPGSGMVVA 120
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VKKLKPEGFQGHKEWLTEV YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF
Sbjct: 121 VKKLKPEGFQGHKEWLTEVRYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
RRGPQPLSWAVR+KVA+GAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAK
Sbjct: 181 RRGPQPLSWAVRIKVAVGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
GPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVG
Sbjct: 241 EGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVG 300
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
IEQ+LVDWAKPYLSDKRKLFRIMDTKLGGQYPQK+AH AA LALQCL+ E K RPRMSEV
Sbjct: 301 IEQNLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKSAHMAANLALQCLSTEAKARPRMSEV 360
Query: 361 LAILERLEAPKNSAKLSQSE-PHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 419
LA LE++E+PK + +LS SE P Q + VRKSPMRQ SPLN+TP+ASPLPSHRQSPR
Sbjct: 361 LATLEQIESPKTAGRLSHSEHPSIQ---IPVRKSPMRQHHSPLNLTPSASPLPSHRQSPR 417
Query: 420 VR 421
VR
Sbjct: 418 VR 419
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111270|ref|XP_002315799.1| predicted protein [Populus trichocarpa] gi|222864839|gb|EEF01970.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/421 (81%), Positives = 373/421 (88%), Gaps = 4/421 (0%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNCL SSA+VDSTQS GASRIS+R+SHSS PS+L IP S +SE LPTP+SE
Sbjct: 1 MGNCLDSSSAKVDSTQSSH-NPGASRISSRTSHSSVPSSLTIP-SYSGRSSECLPTPRSE 58
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GEILSS NLKAF+FNELK ATRNFRPDSLLGEGGFG+V+KGWID+H+L+ AKPGSGMVVA
Sbjct: 59 GEILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGYVFKGWIDEHTLTAAKPGSGMVVA 118
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF
Sbjct: 119 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 178
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
RRGPQPLSWA+R+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAK
Sbjct: 179 RRGPQPLSWAIRIKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAK 238
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLE LSGR AVDK+KVG
Sbjct: 239 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLEFLSGRRAVDKSKVG 298
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
+EQ+LVDW KPYL DKRKLFRIMDTKLGGQYPQK A AA LALQCL+ E K+RPRMSEV
Sbjct: 299 VEQNLVDWVKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSTEAKVRPRMSEV 358
Query: 361 LAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRV 420
LA LE++E+PK + K Q E QT VR+SPMR RSP+ T +ASPLPSH QSPR+
Sbjct: 359 LATLEQIESPKGAVKNIQLE--HQTVQTPVRQSPMRHHRSPVIPTASASPLPSHHQSPRL 416
Query: 421 R 421
R
Sbjct: 417 R 417
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099729|ref|XP_002311595.1| predicted protein [Populus trichocarpa] gi|222851415|gb|EEE88962.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 672 bits (1734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/421 (80%), Positives = 374/421 (88%), Gaps = 3/421 (0%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNCL S+ARVDSTQS T GASRIS+R+S SS PS+L IP K +S+ PTP+SE
Sbjct: 1 MGNCLDSSAARVDSTQSSH-TPGASRISSRTSRSSVPSSLTIPSYSGKSSSDCFPTPRSE 59
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GEILSS NLKAF+FNELK+ATRNFRPDSLLGEGGFG V+KGWID+++L+ +KPGSGMVVA
Sbjct: 60 GEILSSPNLKAFSFNELKSATRNFRPDSLLGEGGFGCVFKGWIDENTLTASKPGSGMVVA 119
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC+EGENRLLVYEFMPKGSLENHLF
Sbjct: 120 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCVEGENRLLVYEFMPKGSLENHLF 179
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
RRGPQPLSWAVR+KVAIGAA+GL+FLHDA+SQVIYRDFKASNILLDAEFNAKLSDFGLAK
Sbjct: 180 RRGPQPLSWAVRVKVAIGAARGLSFLHDAKSQVIYRDFKASNILLDAEFNAKLSDFGLAK 239
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKTKVG
Sbjct: 240 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTKVG 299
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
+EQ+L DWAKPYL DKRKLFRIMDTKLGGQYPQK A AA LALQCL+NE K+RPRMSEV
Sbjct: 300 VEQNLADWAKPYLGDKRKLFRIMDTKLGGQYPQKGAFMAANLALQCLSNEAKVRPRMSEV 359
Query: 361 LAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPRV 420
LA LE +E+PK +AK S+SE +QT VR+SPMR +P +ASPLPSH QSPR+
Sbjct: 360 LATLENIESPKGAAKNSRSE--QQTVQTPVRQSPMRHHHAPGTPPASASPLPSHHQSPRL 417
Query: 421 R 421
R
Sbjct: 418 R 418
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500447|ref|XP_003519043.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1731), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/413 (80%), Positives = 364/413 (88%), Gaps = 10/413 (2%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNCL SSA+VD+ QS R+TS AS IS + PS+L IP EK N+ SLPTP+SE
Sbjct: 1 MGNCLD-SSAKVDAAQSSRSTS-ASGIS-----KTTPSSLSIPSYSEKSNASSLPTPRSE 53
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GEILSS NLK FTFNELK ATRNFRPDSLLGEGGFG+VYKGWID+H+ + +KPGSGMVVA
Sbjct: 54 GEILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFGYVYKGWIDEHTFTASKPGSGMVVA 113
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VK+LKPEGFQGHKEWLTEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF
Sbjct: 114 VKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 173
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
RRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAK
Sbjct: 174 RRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 233
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
AGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT G
Sbjct: 234 AGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITG 293
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EV
Sbjct: 294 MEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEV 353
Query: 361 LAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 413
LA LE++EAPK + + S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 354 LATLEQIEAPKTAGRNSHSEHHRLQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498210|ref|XP_003517946.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase 2B, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 670 bits (1728), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/413 (80%), Positives = 364/413 (88%), Gaps = 10/413 (2%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSE 60
MGNCL SSA+VD+ QS ++TS AS IS + PS+L IP EK N+ SLPTP+SE
Sbjct: 1 MGNCLD-SSAKVDAAQSSKSTS-ASGIS-----KTTPSSLSIPSYSEKSNASSLPTPRSE 53
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GEILSS NLK FTFNELK ATRNFRPDSLLGEGGFG+VYKGWID+H+ + +KPGSGMVVA
Sbjct: 54 GEILSSPNLKPFTFNELKNATRNFRPDSLLGEGGFGYVYKGWIDEHTFTASKPGSGMVVA 113
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 180
VK+LKPEGFQGHKEWLTEVNYLGQL+HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF
Sbjct: 114 VKRLKPEGFQGHKEWLTEVNYLGQLYHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF 173
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
RRGPQPLSW+VRMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLAK
Sbjct: 174 RRGPQPLSWSVRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLAK 233
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
AGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDKT G
Sbjct: 234 AGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKTITG 293
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
+EQ+LVDWAKPYLSDKR+LFRIMDTKL GQYPQK A TAATLALQCLN+E K RP M+EV
Sbjct: 294 MEQNLVDWAKPYLSDKRRLFRIMDTKLEGQYPQKGAFTAATLALQCLNSEAKARPPMTEV 353
Query: 361 LAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 413
LA LE++EAPK + + S SE HR P VRKSP R RSPLN+TPTASPLP+
Sbjct: 354 LATLEQIEAPKTAGRNSHSEHHRVQTP--VRKSPAR-NRSPLNLTPTASPLPA 403
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357486685|ref|XP_003613630.1| Protein kinase 2B [Medicago truncatula] gi|87241133|gb|ABD32991.1| Protein kinase [Medicago truncatula] gi|355514965|gb|AES96588.1| Protein kinase 2B [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 327/420 (77%), Positives = 365/420 (86%), Gaps = 13/420 (3%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESL-PTPKS 59
MGNCL SSA+VD+ QS R+TSG S+ + PS+L IP +K NS SL PTP+S
Sbjct: 1 MGNCLD-SSAKVDAAQSSRSTSGTSK--------TTPSSLTIPSYSDKSNSSSLLPTPRS 51
Query: 60 EGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
EGEILSS NLKAF+FNELK ATRNFRPDSLLGEGGFG VYKGWID+H+ + AKPGSGMVV
Sbjct: 52 EGEILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAKPGSGMVV 111
Query: 120 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 179
AVK+LKPEG+QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL
Sbjct: 112 AVKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 171
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
FRRGPQPLSW++RMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLA
Sbjct: 172 FRRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLA 231
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
KAGPTGDRTHVSTQV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDKT
Sbjct: 232 KAGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIA 291
Query: 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
G++Q+LVDWAKPYL DKR+LFRIMD+KL GQYPQK A AATLALQCLN E K RP M+E
Sbjct: 292 GVDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTE 351
Query: 360 VLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 419
VLA LE++EAPK++++ S SE HR P VR+SP R R+P +TPTASPLPS RQSPR
Sbjct: 352 VLATLEQIEAPKHASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPSVRQSPR 408
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217071950|gb|ACJ84335.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/414 (77%), Positives = 360/414 (86%), Gaps = 13/414 (3%)
Query: 1 MGNCLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESL-PTPKS 59
MGNCL SSA+VD+ QS R+TSG S+ + PS+L IP +K NS SL PTP+S
Sbjct: 1 MGNCLD-SSAKVDAAQSSRSTSGTSK--------TTPSSLTIPSYSDKSNSSSLLPTPRS 51
Query: 60 EGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
EGEILSS NLKAF+FNELK ATRNFRPDSLLGEGGFG VYKGWID+H+ + AKPGSGMVV
Sbjct: 52 EGEILSSPNLKAFSFNELKNATRNFRPDSLLGEGGFGHVYKGWIDEHTFTAAKPGSGMVV 111
Query: 120 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 179
AVK+LKPEG+QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL
Sbjct: 112 AVKRLKPEGYQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 171
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
FRRGPQPLSW++RMKVAIGAA+GL+FLH+A+SQVIYRDFKASNILLDAEFN+KLSDFGLA
Sbjct: 172 FRRGPQPLSWSIRMKVAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNSKLSDFGLA 231
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
KAGPTGDRTHVSTQV+GT GYAAPEYVATGRLT KSDVYSFGVV+LELLSGR AVDKT
Sbjct: 232 KAGPTGDRTHVSTQVVGTQGYAAPEYVATGRLTAKSDVYSFGVVMLELLSGRRAVDKTIA 291
Query: 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
G++Q+LVDWAKPYL DKR+LFRIMD+KL GQYPQK A AATLALQCLN E K RP M+E
Sbjct: 292 GVDQNLVDWAKPYLGDKRRLFRIMDSKLEGQYPQKGAFMAATLALQCLNREAKARPSMTE 351
Query: 360 VLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPS 413
VLA LE++EAPK++++ S SE HR P VR+SP R R+P +TPTASPLPS
Sbjct: 352 VLATLEQIEAPKHASRNSLSEHHRVHAP--VRRSPAR-NRTPSYVTPTASPLPS 402
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|48209875|gb|AAT40481.1| putative protein kinase [Solanum demissum] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 322/423 (76%), Positives = 360/423 (85%), Gaps = 5/423 (1%)
Query: 1 MGNCLQHSSARVDSTQSPRATSG--ASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPK 58
MGNC+ SSARV++T S S ASR R S+SS PS+L IP K +SESLPTP+
Sbjct: 1 MGNCVG-SSARVEATLSSTTPSAYEASRFPDRKSNSSVPSSLSIPSYGRKSSSESLPTPR 59
Query: 59 SEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV 118
SE EIL S N+K+F+FNELK ATRNFRPDSLLGEGGFG V+KGWID +L+ +KPGSG+V
Sbjct: 60 SESEILFSPNVKSFSFNELKNATRNFRPDSLLGEGGFGCVFKGWIDAQTLTASKPGSGIV 119
Query: 119 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 178
+AVKKLKPEGFQGHKEWLTEVNYLGQL HPNLVKLIGYC++G+N LLVYEFMPKGSLENH
Sbjct: 120 IAVKKLKPEGFQGHKEWLTEVNYLGQLRHPNLVKLIGYCIDGDNHLLVYEFMPKGSLENH 179
Query: 179 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238
LFRRGPQPL+WA R+KVAIGAA+GL FLHDA+ QVIYRDFKASNILLDAEFN+KLSDFGL
Sbjct: 180 LFRRGPQPLNWATRIKVAIGAARGLAFLHDAKEQVIYRDFKASNILLDAEFNSKLSDFGL 239
Query: 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298
AKAGPTGDRTHVSTQVMGT GYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVD TK
Sbjct: 240 AKAGPTGDRTHVSTQVMGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDNTK 299
Query: 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358
VGIEQ+LVDWAKPYL DKRKLFRIMDTKL GQYPQK A+TAA LA QCL+NEPKLRP+MS
Sbjct: 300 VGIEQNLVDWAKPYLGDKRKLFRIMDTKLEGQYPQKGAYTAANLAWQCLSNEPKLRPKMS 359
Query: 359 EVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 418
EVL LE L++PK +KLS +E PV V SPMR RSPL+MTP+ASP ++++SP
Sbjct: 360 EVLTALEELQSPKGVSKLSHTEHRAIPSPVAV--SPMRHHRSPLHMTPSASPFQAYQKSP 417
Query: 419 RVR 421
R R
Sbjct: 418 RGR 420
|
Source: Solanum demissum Species: Solanum demissum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817892|ref|XP_002876829.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] gi|297322667|gb|EFH53088.1| hypothetical protein ARALYDRAFT_484186 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1615), Expect = e-177, Method: Compositional matrix adjust.
Identities = 320/430 (74%), Positives = 361/430 (83%), Gaps = 13/430 (3%)
Query: 1 MGNCLQHSSARVDST-QSPRATSGASRIST--RSSHSSAPSTLPIPPSKEKGNSESLPTP 57
MGNCL SSA+VDS+ SP A S + ++S S+ PS+L + ESLPTP
Sbjct: 1 MGNCLD-SSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLS---INSYSSVESLPTP 56
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
++EGEILSS NLKAFTFNELK ATRNFRPDSLLGEGGFG+V+KGWID +L+ +KPGSG+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
VVAVKKLK EGFQGHKEWLTEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLEN
Sbjct: 117 VVAVKKLKTEGFQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
HLFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFG
Sbjct: 177 HLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFG 236
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297
LAKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+
Sbjct: 237 LAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKS 296
Query: 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
KVG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+M
Sbjct: 297 KVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKM 356
Query: 358 SEVLAILERLEAPKNSAKL----SQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPL 411
SEVLA L++LE+ K + +Q + R + V+KSP R R L++TP ASPL
Sbjct: 357 SEVLAKLDQLESTKPGTGIGNRQAQIDSPRGSNGSVVQKSPRRYSYDRPLLHITPGASPL 416
Query: 412 PSHRQSPRVR 421
PSH SPRVR
Sbjct: 417 PSHNHSPRVR 426
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 421 | ||||||
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.990 | 0.978 | 0.730 | 2.2e-160 | |
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.997 | 0.985 | 0.704 | 5.8e-153 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.976 | 0.997 | 0.654 | 3.9e-140 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.890 | 0.968 | 0.687 | 9.5e-137 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.869 | 0.865 | 0.634 | 1.7e-123 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.795 | 0.861 | 0.648 | 1.4e-117 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.888 | 0.825 | 0.585 | 6.4e-115 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.805 | 0.858 | 0.623 | 1.5e-113 | |
| TAIR|locus:2019180 | 399 | AT1G74490 [Arabidopsis thalian | 0.878 | 0.927 | 0.593 | 3.6e-112 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.798 | 0.685 | 0.604 | 2.1e-109 |
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1562 (554.9 bits), Expect = 2.2e-160, P = 2.2e-160
Identities = 314/430 (73%), Positives = 352/430 (81%)
Query: 1 MGNCLQHSSARVDSTQ-SPXXXXXXXXXXXXXXXXXXXXXLPIPPSKEKGNS-ESLPTPK 58
MGNCL SSA+VDS+ SP +P S +S ESLPTP+
Sbjct: 1 MGNCLD-SSAKVDSSSHSPHANSASLSSRVSSKTSRST--VPSSLSINSYSSVESLPTPR 57
Query: 59 SEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV 118
+EGEILSS NLKAFTFNELK ATRNFRPDSLLGEGGFG+V+KGWID +L+ +KPGSG+V
Sbjct: 58 TEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIV 117
Query: 119 VAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 178
VAVKKLK EG+QGHKEWLTEVNYLGQL HPNLVKL+GYC+EGENRLLVYEFMPKGSLENH
Sbjct: 118 VAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENH 177
Query: 179 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238
LFRRG QPL+WA+RMKVAIGAAKGLTFLHDA+SQVIYRDFKA+NILLDAEFN+KLSDFGL
Sbjct: 178 LFRRGAQPLTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGL 237
Query: 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298
AKAGPTGD+THVSTQVMGTHGYAAPEYVATGRLT KSDVYSFGVVLLELLSGR AVDK+K
Sbjct: 238 AKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSK 297
Query: 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358
VG+EQSLVDWA PYL DKRKLFRIMDT+LGGQYPQK A+TAA+LALQCLN + KLRP+MS
Sbjct: 298 VGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMS 357
Query: 359 EVLAILERLEAPKNSAKLSQSE-----PHRQTGPVTVRKSPMRQQ--RSPLNMTPTASPL 411
EVLA L++LE+ K + + P G + V+KSP R R L++TP ASPL
Sbjct: 358 EVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSI-VQKSPRRYSYDRPLLHITPGASPL 416
Query: 412 PSHRQSPRVR 421
P+H SPRVR
Sbjct: 417 PTHNHSPRVR 426
|
|
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1492 (530.3 bits), Expect = 5.8e-153, P = 5.8e-153
Identities = 301/427 (70%), Positives = 338/427 (79%)
Query: 1 MGNCLQHSSARVD-STQSPXXXXXXXXXXXXXXXXXXXXXLPIPPSKEKGNSE--SLPTP 57
MGNCL SSA+VD S SP + + +S LPT
Sbjct: 1 MGNCLD-SSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTL 59
Query: 58 KSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGM 117
++EGEILSS NLKAFTFNELK AT+NFR D+LLGEGGFG V+KGWIDQ SL+ ++PGSG+
Sbjct: 60 RTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGI 119
Query: 118 VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
VVAVK+LKPEGFQGHKEWLTEVNYLGQL HPNLV L+GYC EGENRLLVYEFMPKGSLEN
Sbjct: 120 VVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLEN 179
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
HLFRRG QPL+WA+RMKVA+GAAKGLTFLH+A+SQVIYRDFKA+NILLDA+FNAKLSDFG
Sbjct: 180 HLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFG 239
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297
LAKAGPTGD THVST+V+GTHGYAAPEYVATGRLT KSDVYSFGVVLLEL+SGR A+D +
Sbjct: 240 LAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNS 299
Query: 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
G E SLVDWA PYL DKRKLFRIMDTKLGGQYPQK A TAA LALQCLN + KLRP+M
Sbjct: 300 NGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKM 359
Query: 358 SEVLAILERLEA-PKNSAKLSQSEPHRQTGPVTVRKSPMR--QQRSPLNMTPTASPLPSH 414
SEVL LE+LE+ K K +Q E R ++KSP+R R L+MTP ASPLPS+
Sbjct: 360 SEVLVTLEQLESVAKPGTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTPGASPLPSY 419
Query: 415 RQSPRVR 421
QSPRVR
Sbjct: 420 TQSPRVR 426
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1371 (487.7 bits), Expect = 3.9e-140, P = 3.9e-140
Identities = 276/422 (65%), Positives = 318/422 (75%)
Query: 1 MGNCLQHSSARVDSTQSPXXXXXXXXXXXXXXXXXXXXXLPIPPSKEKGNSESLPTPKSE 60
MGNC S A+V + +SP + + + SL TP+SE
Sbjct: 1 MGNCFGFS-AKVGNRESPYRGSSRISAKRSQSSRLSSLTIQSSSYNDDTSVASLQTPRSE 59
Query: 61 GEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
GE+L+S LKAFTFNELKTATRNFRPDS++GEGGFG+VYKGWID+ +LSP+KPGSGMVVA
Sbjct: 60 GELLASPTLKAFTFNELKTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVVA 119
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHL 179
VKKLK EGFQGH++WL EV+ LG+LHH NLVKLIGYC +G++ RLLVYE+MPKGSLENHL
Sbjct: 120 VKKLKEEGFQGHRQWLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHL 179
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
FRRG +P+ W R+KVAIGAA+GL FLH+A QVIYRDFKASNILLD+EFNAKLSDFGLA
Sbjct: 180 FRRGAEPIPWRTRIKVAIGAARGLAFLHEA--QVIYRDFKASNILLDSEFNAKLSDFGLA 237
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
K GPTGDRTHVSTQVMGT GYAAPEYVATGR+T KSDVYSFGVVLLELLSGR VDKTKV
Sbjct: 238 KVGPTGDRTHVSTQVMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKV 297
Query: 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
G+E++LVDWA PYL DKRK+FRIMDTKLGGQYP K A A ALQCLN EPKLRP+MS+
Sbjct: 298 GVERNLVDWAIPYLGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSD 357
Query: 360 VLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 419
VL+ LE LE S +S S + S +QR TP A P+ S R+ R
Sbjct: 358 VLSTLEELEMTLKSGSISNSVMKLTSSS----SSFTAKQRV---RTPVADPVLSSRRCRR 410
Query: 420 VR 421
VR
Sbjct: 411 VR 412
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1339 (476.4 bits), Expect = 9.5e-137, P = 9.5e-137
Identities = 262/381 (68%), Positives = 306/381 (80%)
Query: 1 MGNCLQHSSARVDSTQSPXXXXXXXXXXXXXXXXXXXXXLPIPPSKEKGNSE-SLPTPKS 59
MGNCL SSARV + +S +P + S S TP+S
Sbjct: 1 MGNCLD-SSARVGNRESTFGGSSRISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPRS 59
Query: 60 EGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
EGE+L S LKAFTFNELKTATRNF+P+S++GEGGFG VYKGWI + SLSP+KPGSGMVV
Sbjct: 60 EGELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVV 119
Query: 120 AVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 179
AVKKLK EGFQGHKEWLTEV+YLG+LHH NLVKLIGYCLEGE RLLVYE+MPKGSLENHL
Sbjct: 120 AVKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHL 179
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
FRRG +P+ W RMKVA AA+GL+FLH+A+ VIYRDFKASNILLD +FNAKLSDFGLA
Sbjct: 180 FRRGAEPIPWKTRMKVAFSAARGLSFLHEAK--VIYRDFKASNILLDVDFNAKLSDFGLA 237
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
KAGPTGDRTHV+TQV+GT GYAAPEY+ATGRLT+KSDVYSFGVVLLELLSGR +DK+KV
Sbjct: 238 KAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKV 297
Query: 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
G+E++LVDWA PYL D+RK+FRIMDTKLGGQYP K A AA +AL+CLN EPKLRP M++
Sbjct: 298 GVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMAD 357
Query: 360 VLAILERLEAPKNSAKLSQSE 380
VL+ L++LE +S K+ ++
Sbjct: 358 VLSTLQQLET--SSKKMGSTQ 376
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.7e-123, P = 1.7e-123
Identities = 238/375 (63%), Positives = 297/375 (79%)
Query: 48 KGNSESLPT-PKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQH 106
K +S S+ T P++EGEIL S NLK+FTF ELK ATRNFRPDS+LGEGGFG V+KGWID+
Sbjct: 43 KSSSVSIRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQ 102
Query: 107 SLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166
+L+ +KPG+G+V+AVKKL +G+QGH+EWL EVNYLGQ HPNLVKLIGYCLE E+RLLV
Sbjct: 103 TLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLV 162
Query: 167 YEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224
YEFMP+GSLENHLFRRG QPLSW +R+KVA+GAAKGL FLH+AE+ VIYRDFK SNIL
Sbjct: 163 YEFMPRGSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNIL 222
Query: 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVL 284
LD+E+NAKLSDFGLAK GPTGD++HVST++MGT+GYAAPEY+ATG LTTKSDVYS+GVVL
Sbjct: 223 LDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVL 282
Query: 285 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 344
LE+LSGR AVDK + EQ LV+WA+P L++KRKLFR++D +L QY + A ATLAL
Sbjct: 283 LEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLAL 342
Query: 345 QCLNNEPKLRPRMSEVLAILERL----EAPKNSAKLSQSEPHRQTGPVTVRKSPMR--QQ 398
+CL E KLRP M+EV++ LE + EA + + Q R++ V + + P +
Sbjct: 343 RCLTFEIKLRPNMNEVVSHLEHIQTLNEAGGRNIDMVQRRMRRRSDSVAINQKPNAGFAR 402
Query: 399 RSPLNMTPTASPLPS 413
++ + + TA P PS
Sbjct: 403 QTAVGVIATAYPRPS 417
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.4e-117, P = 1.4e-117
Identities = 221/341 (64%), Positives = 276/341 (80%)
Query: 57 PKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSG 116
P++EGEIL ++NLK F+ +ELK+ATRNFRPDS++GEGGFG V+KGWID+ SL+P+KPG+G
Sbjct: 41 PRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTG 100
Query: 117 MVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLE 176
+V+AVK+L EGFQGH+EWL E+NYLGQL HPNLVKLIGYCLE E+RLLVYEFM +GSLE
Sbjct: 101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160
Query: 177 NHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234
NHLFRRG QPLSW R+++A+GAA+GL FLH+A+ QVIYRDFKASNILLD+ +NAKLS
Sbjct: 161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV 294
DFGLA+ GP GD +HVST+VMGT GYAAPEY+ATG L+ KSDVYSFGVVLLELLSGR A+
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 295 DKTK-VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKL 353
DK + VG E +LVDWA+PYL++KR+L R+MD +L GQY A A LAL C++ + K
Sbjct: 281 DKNQPVG-EHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339
Query: 354 RPRMSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSP 394
RP M+E++ +E L K ++K Q P + + KSP
Sbjct: 340 RPTMNEIVKTMEELHIQKEASK-EQQNPQISIDNI-INKSP 378
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
Identities = 227/388 (58%), Positives = 283/388 (72%)
Query: 44 PSKEKGNSES-LPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGW 102
P+K+ G +ES TP GE+ SS L+ F FN+LK ATRNFRP+SLLGEGGFG V+KGW
Sbjct: 62 PTKDTGCAESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 121
Query: 103 IDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162
I+++ +P KPG+G+ VAVK L P+G QGHKEWL E+N+LG L HP+LVKL+GYC+E +
Sbjct: 122 IEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQ 181
Query: 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKAS 221
RLLVYEFMP+GSLENHLFRR PL W+VRMK+A+GAAKGL FLH+ AE VIYRDFK S
Sbjct: 182 RLLVYEFMPRGSLENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS 240
Query: 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 281
NILLD E+NAKLSDFGLAK P ++HVST+VMGT+GYAAPEYV TG LTTKSDVYSFG
Sbjct: 241 NILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFG 300
Query: 282 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 341
VVLLE+L+GR +VDK++ EQ+LV+W +P+L DK++ +R++D +L G Y K A A
Sbjct: 301 VVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQ 360
Query: 342 LALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQS----EP------HRQTGPVTVR 391
+A QCLN + K RP+MSEV+ L+ L K+ A S S +P Q G R
Sbjct: 361 VAAQCLNRDSKARPKMSEVVEALKPLPNLKDFASSSSSFQTMQPVAKNGVRTQGGGFVSR 420
Query: 392 KSPMRQQRSPLNMTPTASPLPSHRQSPR 419
P + S LN+ P ASP RQSP+
Sbjct: 421 NGPPMRSLSSLNL-PQASPYRYARQSPK 447
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 214/343 (62%), Positives = 272/343 (79%)
Query: 45 SKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWID 104
S K +S K+EGEILSS+ +K+FTFNELK ATRNFRPDS++GEGGFG V+KGW+D
Sbjct: 28 SSRKSSSTVAAAQKTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLD 87
Query: 105 QHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164
+ +L+P KPG+G+V+AVKKL EGFQGH+EWLTE+NYLGQL HPNLVKLIGYCLE E+RL
Sbjct: 88 ESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRL 147
Query: 165 LVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222
LVYEFM KGSLENHLFRRG +PL W +R+ VA+ AAKGL FLH +VIYRD KASN
Sbjct: 148 LVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASN 207
Query: 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 282
ILLDA++NAKLSDFGLA+ GP GD ++VST+VMGT+GYAAPEY+++G L +SDVYSFGV
Sbjct: 208 ILLDADYNAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGV 267
Query: 283 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 342
+LLE+LSG+ A+D + E++LVDWA+PYL+ KRK+ I+D +L QY + A A++
Sbjct: 268 LLLEILSGKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASV 327
Query: 343 ALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQT 385
A+QCL+ EPK RP M +V+ L++L+ N K SQ+ P + T
Sbjct: 328 AVQCLSFEPKSRPTMDQVVRALQQLQ--DNLGKPSQTNPVKDT 368
|
|
| TAIR|locus:2019180 AT1G74490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 229/386 (59%), Positives = 274/386 (70%)
Query: 1 MGNCLQHSSARVD--------STQSPXXXXXXXXXXXXXXXXXXXXXLPIPPSKEKGNSE 52
MGNC + S R D S S P+ K + S
Sbjct: 1 MGNCFESCSKRNDNEDDNLDSSVNSKPFSRANSDTGRSSNLSYPWSLKPLITRKCEAIS- 59
Query: 53 SLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAK 112
+LP P EG+I+ S LK+FT +ELK AT NF P+SL+GEGGFGFV+KG I+
Sbjct: 60 ALPPPHKEGDIMHSQYLKSFTLDELKNATGNFCPESLIGEGGFGFVHKGCIN------GG 113
Query: 113 PGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 172
PG + VAVKKLK EG QGHKEWL EVNYLG+LHHPNLVKLIGY LE E+RLLVYE +P
Sbjct: 114 PGIELAVAVKKLKTEGLQGHKEWLREVNYLGRLHHPNLVKLIGYSLENEHRLLVYEHLPN 173
Query: 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232
GSLENHLF R LSW++RMKVAIGAA+GL FLH+A QVIYRDFKA+NILLD+ FNAK
Sbjct: 174 GSLENHLFERSSSVLSWSLRMKVAIGAARGLCFLHEANDQVIYRDFKAANILLDSGFNAK 233
Query: 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 292
LSDFGLAK GP +R+HV+T+VMGT GYAAPEY+ATG LTTK DVYSFGVVLLE+LSGR
Sbjct: 234 LSDFGLAKEGPKDNRSHVTTEVMGTEGYAAPEYLATGHLTTKCDVYSFGVVLLEILSGRR 293
Query: 293 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPK 352
+DK+K E++LVDWA PYL DKRK+FRIMDTKL GQYPQKAA + LALQC+ + K
Sbjct: 294 VIDKSKSREEENLVDWATPYLRDKRKVFRIMDTKLVGQYPQKAAFMMSFLALQCIG-DVK 352
Query: 353 LRPRMSEVLAILERLEAPKNSAKLSQ 378
+RP M EV+++LE++ P++ S+
Sbjct: 353 VRPSMLEVVSLLEKVPIPRHRKSRSK 378
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 205/339 (60%), Positives = 261/339 (76%)
Query: 41 PIPPSKEKGNSES-LPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVY 99
P+ + N+ES L TP E+ S+LK F+F +LK ATRNFRP+SLLGEGGFG V+
Sbjct: 92 PVSSTTTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVF 151
Query: 100 KGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159
KGW++++ +P KPG+G+ VAVK L P+G QGHKEWL E+NYLG L HPNLVKL+GYC+E
Sbjct: 152 KGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIE 211
Query: 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-AESQVIYRDF 218
+ RLLVYEFMP+GSLENHLFRR PL W++RMK+A+GAAKGL+FLH+ A VIYRDF
Sbjct: 212 DDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDF 270
Query: 219 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 278
K SNILLD E+NAKLSDFGLAK P +THVST+VMGT+GYAAPEYV TG LT+KSDVY
Sbjct: 271 KTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 330
Query: 279 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 338
SFGVVLLE+L+GR ++DK + E +LV+WA+P+L DKR+ +R++D +L G + K A
Sbjct: 331 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQK 390
Query: 339 AATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 377
LA QCL+ + K+RP+MSEV+ +L+ L K+ A S
Sbjct: 391 VTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASAS 429
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49840 | APK2B_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7395 | 0.9904 | 0.9788 | yes | no |
| O49839 | APK2A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7213 | 0.9976 | 0.9859 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 421 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-57 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-51 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-38 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-34 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-28 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-22 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 95/289 (32%), Positives = 138/289 (47%), Gaps = 45/289 (15%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL 145
LGEG FG VYKG L G + VAVK LK + Q +E+L E + +L
Sbjct: 4 GKKLGEGAFGEVYKGT-----LKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
HPN+VKL+G C E E ++V E+MP G L ++L + P+ LS + + A+ A+G+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----Y 260
L I+RD A N L+ K+SDFGL++ D V G +
Sbjct: 119 LESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK------GGKLPIRW 170
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE + G+ T+KSDV+SFGV+L E+ + G +PY +S+
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------EEPYPGMSNAEV 213
Query: 319 LFRIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 364
L + G K + L LQC +P+ RP SE++ IL
Sbjct: 214 LEYLKK----GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 1e-56
Identities = 91/285 (31%), Positives = 138/285 (48%), Gaps = 43/285 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LGEG FG VYKG L G+ VAVK LK + +E+L E + + +L HP
Sbjct: 7 LGEGAFGEVYKGT-----LKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V+L+G C +GE +V E+MP G L + L R+ + L+ +++A+ AKG+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA-----AP 263
++RD A N L+ K+SDFGL++ D G AP
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAP 173
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFR 321
E + G+ T+KSDV+SFGV+L E+ + G +PY +S++ L
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTL---------G--------EQPYPGMSNEEVLEL 216
Query: 322 IMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
+ D G + P+ L LQC +P+ RP SE++ L
Sbjct: 217 LED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 2e-55
Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LGEG FG VYKG L + VAVK LK + Q +E+L E + +L HP
Sbjct: 7 LGEGAFGEVYKGK-----LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+VKL+G C E E +V E+M G L ++L + P+ LS + + A+ A+G+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLES 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAP 263
I+RD A N L+ K+SDFGL++ D G + AP
Sbjct: 121 K--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK------RGGKLPIRWMAP 172
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFR 321
E + G+ T+KSDV+SFGV+L E+ + G +PY +S++ L
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIFTL---------G--------EQPYPGMSNEEVLEY 215
Query: 322 IMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVLAIL 364
+ + G + + L LQC +P+ RP SE++ IL
Sbjct: 216 LKN----GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-52
Identities = 72/201 (35%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHP 148
LGEGGFG VY +G VA+K +K E E L E+ L +L+HP
Sbjct: 1 LGEGGFGTVYLAR---------DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+VKL G + + LV E+ GSL++ L LS +++ + +GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLH- 109
Query: 209 AESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YV 266
+ +I+RD K NILLD+ KL+DFGL+K + ++GT Y APE +
Sbjct: 110 -SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLL 166
Query: 267 ATGRLTTKSDVYSFGVVLLEL 287
G + KSD++S GV+L EL
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 3e-52
Identities = 94/295 (31%), Positives = 132/295 (44%), Gaps = 54/295 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHH 147
LGEG FG VYKG K G VAVK LK + + K++L E + +L H
Sbjct: 3 LGEGAFGEVYKGKLKG-------KDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH 55
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-------FRRGPQPLSWAVRMKVAIGAA 200
PN+V+L+G C E E LV E+M G L ++L LS + AI A
Sbjct: 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG- 259
KG+ +L + ++RD A N L+ + K+SDFGL++ D T G
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGK 168
Query: 260 ----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--L 313
+ APE + G T+KSDV+SFGV+L E+ + G A PY L
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTL---------G--------ATPYPGL 211
Query: 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAILE 365
S++ L + G K + L L C +P+ RP SE++ LE
Sbjct: 212 SNEEVLEYLRK----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 94/284 (33%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNY 141
+ LG G FG VYK +H G+G +VAVK LK + + E+
Sbjct: 1 YELLRKLGSGSFGTVYKA---KH------KGTGKIVAVKILKKRSEKSKKDQTARREIRI 51
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L +L HPN+V+LI + ++ LV E+ G L ++L R G PLS K+A+ +
Sbjct: 52 LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILR 109
Query: 202 GLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
GL +LH S +I+RD K NILLD K++DFGLAK + ++T V GT Y
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWY 164
Query: 261 AAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
APE + G K DV+S GV+L ELL+G+ + L + +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLI 211
Query: 320 FRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVL 361
RI+ L P+ ++ + L +CLN +P RP E+L
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-51
Identities = 79/285 (27%), Positives = 118/285 (41%), Gaps = 41/285 (14%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYL 142
+ LGEG FG VY +G +VA+K +K + + +E L E+ L
Sbjct: 1 YEILEKLGEGSFGKVYLAR---------DKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+L HPN+V+L + + LV E+ G L + L +RG A I
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQI--LSA 109
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +LH +++RD K NILLD + + KL+DFGLA+ G++ T V GT Y A
Sbjct: 110 LEYLHSK--GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMA 164
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + D++S GV+L ELL+G+ P +L +
Sbjct: 165 PEVLLGKGYGKAVDIWSLGVILYELLTGK-------------------PPFPGDDQLLEL 205
Query: 323 MDTKLGGQYPQKAAH-----TAATLALQCLNNEPKLRPRMSEVLA 362
+ P A L + L +P+ R E L
Sbjct: 206 FKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 85/289 (29%), Positives = 138/289 (47%), Gaps = 28/289 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHP 148
LGEG FG V D P +G VAVK L G + H ++ E+ L L H
Sbjct: 12 LGEGHFGKVELCRYD-----PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 149 NLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G C + G + L+ E++P GSL ++L R Q ++ + + KG+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDYL 125
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-----VMGTHGYA 261
+ I+RD A NIL+++E K+SDFGLAK P + + + +
Sbjct: 126 GS--QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WY 179
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
APE + T + ++ SDV+SFGV L EL + D ++ + L + + R
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELFT-YG--DPSQSPPAEFLRMIGIA--QGQMIVTR 234
Query: 322 IMDT-KLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 367
+++ K G + P+ + L C EP+ RP ++++ I++RL
Sbjct: 235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 6e-38
Identities = 85/280 (30%), Positives = 130/280 (46%), Gaps = 44/280 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH 146
L+G G FG VYKG ++ + G VA+K++ E + K + E++ L L
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
HPN+VK IG ++ ++ E+ GSL + + GP P S + +GL +L
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV--LQGLAYL 115
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
H E VI+RD KA+NIL + KL+DFG+ A D + V+GT + APE +
Sbjct: 116 H--EQGVIHRDIKAANILTTKDGVVKLADFGV--ATKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 267 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMD 324
+T SD++S G ++ELL+G PY L+ LFRI+
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN------------------PPYYDLNPMAALFRIVQ 213
Query: 325 TKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVL 361
+P + L +QC +P LRP ++L
Sbjct: 214 D----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLG 143
F +G+GGFG VYK + +G VA+K +K E + ++ + E+ L
Sbjct: 2 FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
+ HPN+VK G L+ + +V EF GSL++ L + Q L+ + V KGL
Sbjct: 53 KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGL 111
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAA 262
+LH + +I+RD KA+NILL ++ KL DFGL+ T R ++GT + A
Sbjct: 112 EYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT----MVGTPYWMA 165
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE + K+D++S G+ +EL G+
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 72/208 (34%), Positives = 110/208 (52%), Gaps = 26/208 (12%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH 147
+ +G+G FG V G G VAVK LK + + +L E + + L H
Sbjct: 12 ATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRH 59
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
PNLV+L+G L+G +V E+M KGSL ++L RG ++ A ++ A+ +G+ +L
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTHGYAAPE 264
E ++RD A N+L+ + AK+SDFGLAK G + V + APE
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPE 169
Query: 265 YVATGRLTTKSDVYSFGVVLLELLS-GR 291
+ + +TKSDV+SFG++L E+ S GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK--LKPEGFQGHKEWLTEVNYLGQLH 146
LLG G FG VY +D+ + G ++AVK L + + + E+ L L
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 147 HPNLVKLIGYCL-EGENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HPN+V+ G E +N L ++ E++ GSL + L + G P +R K +GL
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLA 115
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH +++RD K +NIL+D++ KL+DFG AK + + V GT + APE
Sbjct: 116 YLHSN--GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK----LF 320
+ +D++S G ++E+ +G KP S+ L+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATG-------------------KPPWSELGNPMAALY 214
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+I + + P+ + A +CL +PK RP E+L
Sbjct: 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 8e-34
Identities = 80/293 (27%), Positives = 136/293 (46%), Gaps = 48/293 (16%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW--LTEVNYLGQ 144
+ ++G G FG V +G P K + VA+K LK G + LTE + +GQ
Sbjct: 9 EKVIGGGEFGEVCRG----RLKLPGKKE--IDVAIKTLKA-GSSDKQRLDFLTEASIMGQ 61
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HPN+++L G + +++ E+M GSL+ L R + + + G A G+
Sbjct: 62 FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMK 120
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L +E ++RD A NIL+++ K+SDFGL++ R S T G
Sbjct: 121 YL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPI 172
Query: 260 -YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSD 315
+ APE +A + T+ SDV+SFG+V+ E++S G +PY +S+
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE------------------RPYWDMSN 214
Query: 316 KRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + + D +L P L L C + RP S++++ L+++
Sbjct: 215 QDVIKAVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 88/280 (31%), Positives = 134/280 (47%), Gaps = 16/280 (5%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHHP 148
LGEG FG V + PA G+G +VAVK LK E Q + W E+N L L+H
Sbjct: 12 LGEGHFGKV-----SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 149 NLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G C E + L+ E++P GSL ++L + L+ A + A +G+ +L
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYL 123
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEY 265
H I+RD A N+LLD + K+ DFGLAKA P G + V + A E
Sbjct: 124 H--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325
+ + + SDV+SFGV L ELL+ C ++ + ++ + ++ R L +++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVR-LIELLER 239
Query: 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
+ P+ L C E K RP ++ IL+
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 85/281 (30%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLGQLHH 147
+G+G FG VYKG + VAVK + K +L E L Q H
Sbjct: 2 KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
PN+VKLIG C++ + +V E +P GSL L R+ L+ +++++ AA G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYL- 109
Query: 208 DAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
ES+ I+RD A N L+ K+SDFG+++ G T + APE +
Sbjct: 110 --ESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 267 ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMD 324
GR T++SDV+S+G++L E S PY +S+++ RI +
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLG-----------------DTPYPGMSNQQTRERI-E 209
Query: 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
+ PQ L LQC +P+ RP SE+ L+
Sbjct: 210 SGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPG-SGMVVAVKKLK-PEGFQGHKEWLTEVNYLGQLHH 147
LGEG FG V+ G +P +VAVK LK K++ E L H
Sbjct: 13 LGEGAFGKVFLG-----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ------------PLSWAVRMKV 195
N+VK G C EG+ ++V+E+M G L L GP L+ + +++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
A+ A G+ +L A ++RD N L+ + K+ DFG+++ T D V M
Sbjct: 128 AVQIASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ PE + + TT+SDV+SFGVVL E+ +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 94/291 (32%), Positives = 135/291 (46%), Gaps = 53/291 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHP 148
LG G FG V KG K G + VAVK LK E G KE+L E + + QL HP
Sbjct: 3 LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS----WAVRMKVAIGAAKGLT 204
+V+LIG C GE +LV E P G L +L +R P+S A ++ A G+
Sbjct: 57 CIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMA 109
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L ++RD A N+LL AK+SDFG+++A G + +T T G
Sbjct: 110 YLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLK 163
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318
+ APE + G+ ++KSDV+S+GV L E S G AKPY + K
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPY--GEMK 203
Query: 319 LFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
++ G+ P++ ++ L C P+ RP SE+ + R
Sbjct: 204 GAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHP 148
LGEG FG VYKG P + S VA+K LK + +E+ E + L HP
Sbjct: 13 LGEGAFGKVYKG----ELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 194
N+V L+G C + + +++E++ G L L R P L + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
+AI A G+ +L + ++RD A N L+ K+SDFGL++ + D V ++
Sbjct: 129 IAIQIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ + PE + G+ TT+SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 69/207 (33%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
LG G FG VYKG WI P + VA+K L+ E + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQP-LSWAVRMKVAIGAAKG 202
P++V+L+G CL L+ + MP G L NH G Q L+W V++ AKG
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+++L E ++++RD A N+L+ + K++DFGLAK ++ + + + A
Sbjct: 122 MSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS 289
E + T KSDV+S+GV + EL++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 7e-30
Identities = 95/352 (26%), Positives = 135/352 (38%), Gaps = 37/352 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
++R LGEG FG VY +VA+K L + KE L E+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR------------DRKLVALKVLAKKLESKSKEVERFLREI 48
Query: 140 NYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLE---NHLFRRGPQPLSWAVRMKV 195
L L H PN+VKL + + + LV E++ GSLE + R+GP S A+ +
Sbjct: 49 QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK----AGPTGDRTHV 250
I L +LH +I+RD K NILLD + KL DFGLAK G T +
Sbjct: 109 QI--LSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
Query: 251 STQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
+ +GT GY APE + ++ SD++S G+ L ELL+G + K S
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT- 223
Query: 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI-LER 366
L + + A+ L + L +PK R S L+ L
Sbjct: 224 LKIILELPTPSLASPLSPSNPELISKAASD----LLKKLLAKDPKNRLSSSSDLSHDLLA 279
Query: 367 LEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 418
K S +P + S LN + S
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQLHHP 148
LG+G FG VY+G K VA+K + + E+L E + + + +
Sbjct: 14 LGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHL--------FRRGPQPLSWAVRMKVAIGAA 200
++V+L+G G+ L+V E M KG L+++L G P + +++A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
G+ +L A + ++RD A N ++ + K+ DFG+ + D + + +
Sbjct: 130 DGMAYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE + G TTKSDV+SFGVVL E+ +L +PY LS++
Sbjct: 188 MAPESLKDGVFTTKSDVWSFGVVLWEMA---------------TLA--EQPYQGLSNEEV 230
Query: 319 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
L ++D GG P+ L C PK+RP E+++ L+
Sbjct: 231 LKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 7e-29
Identities = 87/276 (31%), Positives = 129/276 (46%), Gaps = 52/276 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLH 146
LG+G FG V K +G + A+K LK + KE LTE N L +++
Sbjct: 1 LGKGSFGKVLL---------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 147 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WAVRMKVAIGAAK 201
HP +VKL Y + E +L LV E+ P G L +HL + G + + +A + +A+
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE--- 107
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVSTQVMGTHGY 260
+LH +IYRD K NILLDA+ + KL+DFGLAK G RT+ GT Y
Sbjct: 108 ---YLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN---TFCGTPEY 159
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE + D +S GV+L E+L+G+ P+ ++ RK
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRKEI 201
Query: 321 --RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+I+ L ++P+ + A L L +P R
Sbjct: 202 YEKILKDPL--RFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 85/288 (29%), Positives = 123/288 (42%), Gaps = 54/288 (18%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK--KLKPEGFQGH---KEWLTEVNYLG 143
LLG G FG VY+G G AVK L +G G K+ E+ L
Sbjct: 7 LLGSGSFGSVYEGL---------NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS 57
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
+L HPN+V+ +G E +N + E +P GSL L + G P +R+ GL
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTR-QILLGL 115
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-----GTH 258
+LHD ++RD K +NIL+D KL+DFG+AK V G+
Sbjct: 116 EYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 259 GYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317
+ APE +A G +D++S G +LE+ +G KP S
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG-------------------KPPWSQLE 206
Query: 318 K---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+F+I +K P + A L+CL +P LRP +E+L
Sbjct: 207 GVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 50/298 (16%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLH 146
+LGEG FG V +G + Q S K VAVK +K + +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 147 HPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQPLSWAVRM--KVA 196
HPN++KLIG C E + +++ FM G L + L R G P ++ K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQ 253
+ A G+ +L + I+RD A N +L + ++DFGL+K +GD + ++
Sbjct: 120 VDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY 312
+ + A E +A T+KSDV++FGV + E+ + G+ G+E
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP----GVENH-------- 222
Query: 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATL---ALQCLNNEPKLRPRMSEVLAILERL 367
I D G ++ L C +PK RP +++ +LE +
Sbjct: 223 --------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 28/297 (9%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
R+ + LG+G FG V D P + +G VVAVKKL+ + +++ E+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58
Query: 142 LGQLHHPNLVKLIGYCLE-GENRL-LVYEFMPKGSLENHLFRR-----GPQPLSWAVRMK 194
L L H N+VK G C G L LV E++P GSL ++L + + L +A ++
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI- 117
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
KG+ +L + ++RD NIL+++E K+ DFGL K P D+ + +
Sbjct: 118 -----CKGMEYL--GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVRE 169
Query: 255 MGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312
G + APE + + + SDV+SFGVVL EL + + ++ K
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YSDKSCSPPAEFMRMMGNDKQG 228
Query: 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLAILERL 367
L ++ K G+ P A A+ +C NN+P RP SE+ +E +
Sbjct: 229 QMIVYHLIELL--KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 73/210 (34%), Positives = 103/210 (49%), Gaps = 27/210 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG G FG V+ G + + VAVK LKP G + +L E + +L H
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDK 62
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFL 206
LV+L C E E +V E+M KGSL + L + G L V M I A+G+ +L
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQI--AEGMAYL 119
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAP 263
I+RD A NIL+ K++DFGLA+ D + + + G + AP
Sbjct: 120 E--SRNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTARE--GAKFPIKWTAP 173
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GRC 292
E GR T KSDV+SFG++L E+++ GR
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V+ G W + VA+K ++ EG +++ E + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRGKID-----------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
NLV+L G C + +V E+M G L N+L R L + + + + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLE- 117
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEY 265
+ I+RD A N L+ + K+SDFGLA+ D + S+Q GT +A PE
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQ--GTKFPVKWAPPEV 172
Query: 266 VATGRLTTKSDVYSFGVVLLELLSG 290
R ++KSDV+SFGV++ E+ S
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 54/295 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK--LKPEGFQGHKEWLTEVN 140
+ +G+G FG VY + G + +K+ L + ++ L EV
Sbjct: 1 KYEIIKQIGKGSFGKVYLV---RRK------SDGKLYVLKEIDLSNMSEKEREDALNEVK 51
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLSWAVR 192
L +L+HPN++K E +V E+ G L + ++ Q L W V+
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVS 251
+ L +LH ++++RD K NI L + KL DFG++K T D
Sbjct: 112 L------CLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAK 161
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311
T V GT Y +PE KSD++S G VL EL + + + + L
Sbjct: 162 TVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---LELA----- 212
Query: 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLAI 363
+I+ GQYP + ++ L L +P+ RP ++++L
Sbjct: 213 --------LKILK----GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 47/300 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
+G+G FG V++ L P +P + +VAVK LK E ++ E + + HP
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------------------PLS 188
N+VKL+G C G+ L++E+M G L L R P+ PLS
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
++ +A A G+ +L +E + ++RD N L+ K++DFGL++ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 249 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308
S + PE + R TT+SDV+++GVVL E+ S G++
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS---------YGMQ------ 231
Query: 309 AKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
PY ++ + ++ + D + P L C + P RP + + IL+R
Sbjct: 232 --PYYGMAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 93/322 (28%), Positives = 146/322 (45%), Gaps = 43/322 (13%)
Query: 60 EGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
E + S K+ T N++ ++ + ++++ G G YKG +GM
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKG---------KSIKNGMQF 718
Query: 120 AVKKLK-----PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
VK++ P +E+ +G+L HPN+VKLIG C + L++E++ +
Sbjct: 719 VVKEINDVNSIPS---------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769
Query: 175 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNAKL 233
L L + LSW R K+AIG AK L FLH V+ + I++D + L
Sbjct: 770 LSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 293
L T + +S+ Y APE T +T KSD+Y FG++L+ELL+G+
Sbjct: 825 R-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
Query: 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEP 351
D + G+ S+V+WA+ SD L +D + G Q LAL C +P
Sbjct: 878 AD-AEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP 935
Query: 352 KLRPRMSEVLAILERLEAPKNS 373
RP ++VL LE +S
Sbjct: 936 TARPCANDVLKTLESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 74/279 (26%), Positives = 127/279 (45%), Gaps = 31/279 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG G +G VY+G ++SL+ VAVK LK + + E+L E + ++ HPN
Sbjct: 14 LGGGQYGEVYEGVWKKYSLT---------VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPN 63
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
LV+L+G C ++ EFM G+L ++L Q ++ V + +A + + +L
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 121
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 269
+ I+RD A N L+ K++DFGL++ TGD + APE +A
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYN 180
Query: 270 RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMDTKLG 328
+ + KSDV++FGV+L E+ + + PY D +++ +++
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKGYR 223
Query: 329 GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ P+ L C P RP +E+ E +
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 84 FRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
F + LG G FG V++G W + VA+K LK + +++ EV L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKN---RVR--------VAIKILKSDDLLKQQDFQKEVQAL 56
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAA 200
+L H +L+ L C GE ++ E M KGSL F R P Q L A + +A A
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVA 114
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+G+ +L E I+RD A NIL+ + K++DFGLA+ + ++S+ + +
Sbjct: 115 EGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKW 170
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLS 289
APE + G +TKSDV+SFG++L E+ +
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 41/279 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+GEG FG V +G +G VAVK +K + + +L E + +LHH N
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKN 60
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
LV+L+G L +V E M KG+L N L RG +S ++ ++ A+G+ +L
Sbjct: 61 LVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE-- 117
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAPEYVAT 268
++++RD A NIL+ + AK+SDFGLA+ G G D + + + + APE +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKH 171
Query: 269 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 327
+ ++KSDV+S+GV+L E+ S GR K + + V+ K +R M+
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------KGYR-MEP-- 218
Query: 328 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
P+ L C EPK RP ++ LE+
Sbjct: 219 ----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 13/204 (6%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLH 146
LG+G FG V +G W + G + VAVK LK + ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEW-----STSG--GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
H NL++L G L ++V E P GSL + L + + A+ A G+ +L
Sbjct: 55 HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QVMGTHGYAAPEY 265
+ I+RD A NILL ++ K+ DFGL +A P + +V + + APE
Sbjct: 114 E--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 266 VATGRLTTKSDVYSFGVVLLELLS 289
+ T + SDV+ FGV L E+ +
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 75/213 (35%), Positives = 111/213 (52%), Gaps = 18/213 (8%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMV-VAVKKLKPEGF-QGHKEWLTEVNYLGQLH 146
LG G FG VY+G + PGSG + VAVK L+ Q KE+L E + + +
Sbjct: 2 FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-----FRRGPQPLSWAVRMKVAIGAAK 201
HPN+VKL+G CL E + ++ E M G L ++L R GP L+ + + + AK
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 202 GLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
G +L I+RD A N L+ DA+ K+ DFGLA+ D + +
Sbjct: 118 GCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + G+ TT+SDV+SFGV++ E+L+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 32/274 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHH 147
+G+G FG V+K + V A+K++ +E + E L +L
Sbjct: 8 IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
+++ L+ +V E+ G L L + +PL + I GL LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
++++RD K+ N+ LDA N K+ D G+AK D T+ + ++GT Y +PE
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCE 174
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 327
KSDV++ GVVL E +G+ D G +L+ K+ R + +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI----------LKIIRGVFPPV 221
Query: 328 GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
Y Q+ A L QCL + + RP ++L
Sbjct: 222 SQMYSQQLAQ----LIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNYLGQLH 146
+LG+G G VYK +H KP +G + A+KK+ + K+ L E+ L
Sbjct: 7 KVLGQGSSGVVYKV---RH-----KP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 147 HPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
P +VK G + EGE + V E+M GSL + L + G + V +A KGL +
Sbjct: 58 SPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDY 114
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMGTHGYAAPE 264
LH + +I+RD K SN+L++++ K++DFG++K T D+ + T V GT Y +PE
Sbjct: 115 LH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR-KLFRIM 323
+ + +D++S G+ LLE G+ P+L + F +M
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKF------------------PFLPPGQPSFFELM 212
Query: 324 DTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVL 361
G P + + ++ CL +PK RP +E+L
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDFISA-CLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-25
Identities = 69/214 (32%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LGEG FG V+ + ++LSP K M+VAVK LK K++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QP------LSWAVRMKV 195
+VK G C +G+ ++V+E+M G L L GP QP L + + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
A A G+ +L A ++RD N L+ A K+ DFG+++ + D V M
Sbjct: 129 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ PE + + TT+SDV+SFGV+L E+ +
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V++G W + VAVK LKP G K++L E + +L HP
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-----------VAVKTLKP-GTMDPKDFLAEAQIMKKLRHP 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
L++L C E +V E M GSL +L + L + +A A G+ +L
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-- 119
Query: 209 AESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YA 261
E+Q I+RD A N+L+ K++DFGLA R G +
Sbjct: 120 -EAQNYIHRDLAARNVLVGENNICKVADFGLA-------RVIKEDIYEAREGAKFPIKWT 171
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GR 291
APE R + KSDV+SFG++L E+++ GR
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 29/207 (14%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+G G FG V+ G W+++ VA+K ++ EG ++++ E + +L HP
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L G C E LV+EFM G L ++L R S + + + +G+ +L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLE- 117
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAA 262
S VI+RD A N L+ K+SDFG+ R + Q + G +++
Sbjct: 118 -SSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVLDDQYTSSTGTKFPVKWSS 169
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS 289
PE + + ++KSDV+SFGV++ E+ S
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 39/217 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP----EGFQGHKEWLT---EVNYL 142
+GEG +G VYK +G +VA+KK++ EGF +T E+ L
Sbjct: 7 IGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFP-----ITAIREIKLL 52
Query: 143 GQLHHPNLVKLIGYCLEGE--NRLLVYEFMP---KGSLENHLFRRG-PQPLSWAVRMKVA 196
+L HPN+V+L + +V+E+M G L++ + Q + ++
Sbjct: 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL--- 109
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
+GL +LH +++RD K SNIL++ + KL+DFGLA+ T + T +
Sbjct: 110 ---LEGLQYLHSN--GILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVI 163
Query: 257 THGYAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGR 291
T Y PE + AT R + D++S G +L EL G+
Sbjct: 164 TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-25
Identities = 81/309 (26%), Positives = 133/309 (43%), Gaps = 47/309 (15%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNY 141
N LGEG FG V K + + G VAVK LK ++ L+E N
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLK---GRAGY-TTVAVKMLKENASSSELRDLLSEFNL 56
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL---------------------- 179
L Q++HP+++KL G C + LL+ E+ GSL + L
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYL 116
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
+ L+ + A ++G+ +L AE ++++RD A N+L+ K+SDFGL+
Sbjct: 117 DNPDERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
+ D ++ + A E + TT+SDV+SFGV+L E+++ +
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------L 225
Query: 300 GIEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358
G PY +LF ++ T + P+ + L L C EP RP +
Sbjct: 226 G--------GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 359 EVLAILERL 367
++ LE++
Sbjct: 278 DISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 45/283 (15%)
Query: 90 LGEGGFGFV-YKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V Y W Q+ VA+K +K EG E++ E + +L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFL 206
LV+L G C + +V E+M G L N+L + QP + +++ +G+ +L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGMAYL 116
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAP 263
Q I+RD A N L+D + K+SDFGL++ D + S+ +G+ ++ P
Sbjct: 117 E--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPP 170
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
E + + ++KSDV++FGV++ E+ S G+ ++ V+ +S +L+R
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVE----KVSQGLRLYR- 222
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
P A+ + C + + + RP ++L+ +E
Sbjct: 223 ---------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 74/204 (36%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHP 148
LGEG FG V D P +G VAVK LKPE H L E+ L L+H
Sbjct: 12 LGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 149 NLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G C E L+ EF+P GSL+ +L R ++ ++K A+ KG+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEY 265
Q ++RD A N+L+++E K+ DFGL KA T + V + + APE
Sbjct: 126 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183
Query: 266 VATGRLTTKSDVYSFGVVLLELLS 289
+ + SDV+SFGV L ELL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 89/296 (30%), Positives = 140/296 (47%), Gaps = 55/296 (18%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGHKEWLTEVNYLGQLH 146
++G+G FG VY G ID G + AVK L + + +++L E +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 147 HPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQ--PLSWAVRMKVAIG--AAK 201
HPN++ L+G CL E L+V +M G L N F R P V+ + G AK
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP---TVKDLIGFGLQVAK 109
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 259
G+ +L A + ++RD A N +LD F K++DFGLA+ D+ + S T
Sbjct: 110 GMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVH-NHTGAKL 164
Query: 260 ---YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-----VDKTKVGIEQSLVDWAKP 311
+ A E + T + TTKSDV+SFGV+L EL++ R A VD + +
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITV---------- 213
Query: 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
YL R+L + P+ + L C + +P++RP SE+++ +E++
Sbjct: 214 YLLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 77/303 (25%), Positives = 137/303 (45%), Gaps = 41/303 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPA-------KPGSGMVVAVKKLKPEGFQGHK-EWLTEVNY 141
LGEG FG V+ + P + G ++VAVK L+P+ + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR----------------GPQ 185
L +L PN+++L+G C++ + ++ E+M G L L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 186 P-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244
P +S++ + VA+ A G+ +L + ++RD N L+ K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304
GD + + + + A E + G+ TT SDV++FGV L E+L C ++
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM-LCKEQPYGELTDEQ 249
Query: 305 LVDWAKPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+++ A + D+ + LFR P L LQC + + + RP S++
Sbjct: 250 VIENAGEFFRDQGRQVYLFR----------PPPCPQGLYELMLQCWSRDCRERPSFSDIH 299
Query: 362 AIL 364
A L
Sbjct: 300 AFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 82/287 (28%), Positives = 125/287 (43%), Gaps = 60/287 (20%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+GEG G VYK D+ + G VA+KK++ Q + + E+ + HPN
Sbjct: 27 IGEGASGEVYKA-TDRAT--------GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQPLSWAVRMKVAIGAA----- 200
+V L G+ +V E+M GSL + VRM A
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----------FVRMNEPQIAYVCREV 125
Query: 201 -KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+GL +LH VI+RD K+ NILL + + KL+DFG A A T +++ ++ V GT
Sbjct: 126 LQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVV-GTPY 181
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK--R 317
+ APE + K D++S G++ +E+ G PYL + R
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE------------------PPYLREPPLR 223
Query: 318 KLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
LF I T G + P+K + +CL +P+ RP E+L
Sbjct: 224 ALFLI--TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-24
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 19/213 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LGEG FG V+ + H+L P + M+VAVK LK +++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-------------PLSWAVRMKVA 196
+V+ G C EG L+V+E+M G L L GP L+ + +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
A G+ +L A ++RD N L+ K+ DFG+++ + D V + M
Sbjct: 129 SQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ PE + + TT+SD++SFGVVL E+ +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLT 137
+ LGEG + VYK D+ + G +VA+KK+K + K+ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALR 51
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
E+ L +L HPN++ L+ N LV+EFM LE + + L+ A +
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYML 109
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
+GL +LH + +++RD K +N+L+ ++ KL+DFGLA++ + +R ++ QV+ T
Sbjct: 110 MTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV-T 165
Query: 258 HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
Y APE + R D++S G + ELL
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 51/286 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
LG G G V K H +P +G ++AVK ++ E K+ L E++ L + + P
Sbjct: 9 LGAGNSGVVSKV---LH-----RP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+V G + + E+M GSL+ + + + + K+A+ KGLT+LH+
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM--------GTHGY 260
+ ++I+RD K SNIL+++ KL DFG VS Q++ GT Y
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE + + KSD++S G+ L+EL +GR P L
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQ 214
Query: 321 RIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
I++ +L G++ CL +P+ RP E+L
Sbjct: 215 YIVNEPPPRLPSGKFSPDFQD----FVNLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP----EGFQGHKEWLTEVNYLGQL 145
+GEG +G VYK + L+ G +VA+KK+K EG K L E+ L +L
Sbjct: 7 IGEGTYGVVYKA---RDKLT------GEIVAIKKIKLRFESEGIP--KTALREIKLLKEL 55
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
+HPN++KL+ + LV+EFM L L + + L ++ +GL F
Sbjct: 56 NHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIKSYLYQLLQGLAF 113
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
H +++RD K N+L++ E KL+DFGLA++ + R + T + T Y APE
Sbjct: 114 CHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--THYVVTRWYRAPEL 169
Query: 266 VATGRL-TTKSDVYSFGVVLLELLSGR 291
+ + +T D++S G + ELLS R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 2e-23
Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 39/292 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LGEG FG V+ + ++L P + ++VAVK LK K++ E L L H +
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-----------LSWAVRMKVAIG 198
+VK G C+EG+ ++V+E+M G L L GP L+ + + +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
A G+ +L A ++RD N L+ K+ DFG+++ + D V M
Sbjct: 129 IAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSD 315
+ PE + + TT+SDV+S GVVL E+ + G+ +P+ LS+
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------------QPWYQLSN 228
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ I ++ Q P+ L L C EP +R + E+ ++L+ L
Sbjct: 229 NEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 33/274 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHH 147
LLG+G FG V+KG +L P VAVK K + Q K ++L+E L Q H
Sbjct: 2 LLGKGNFGEVFKG-----TLKDKTP-----VAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
PN+VKLIG C + + +V E +P G + L R+ L +K A+ AA G+ +L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
I+RD A N L+ K+SDFG+++ G + + + + APE +
Sbjct: 111 --SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALN 167
Query: 268 TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326
GR +++SDV+S+G++L E S G C + V+ K +R+
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE----------KGYRM---- 213
Query: 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
PQK + +C + +P+ RP+ SE+
Sbjct: 214 ---SCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 83/294 (28%), Positives = 125/294 (42%), Gaps = 44/294 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE--WLTEVNYLGQLHH 147
LG G FG VY+G + + VAVK L PE E +L E + + +H
Sbjct: 14 LGHGAFGEVYEG---LYRGRDGDA-VELQVAVKTL-PESCSEQDESDFLMEALIMSKFNH 68
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP---QPLSWAVR--MKVAIGAAKG 202
N+V+LIG E R ++ E M G L++ L P +P S ++ + A AKG
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+L E+ I+RD A N LL + AK++DFG+A+ + M
Sbjct: 129 CKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318
+ PE G T+K+DV+SFGV+L E+ S G PY +
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM------------------PYPGRTNQ 228
Query: 319 LFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369
+M+ GG P+ + C + P+ RP + ILER++
Sbjct: 229 --EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT---ILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 5e-23
Identities = 68/216 (31%), Positives = 112/216 (51%), Gaps = 22/216 (10%)
Query: 81 TRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTE 138
R LLG G FG V+KG WI P + VA+K ++ G Q +E
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDH 59
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR----GPQPL-SWAVRM 193
+ +G L H +V+L+G C G + LV + P GSL +H+ + PQ L +W V++
Sbjct: 60 MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
AKG+ +L E ++++R+ A NILL ++ +++DFG+A D+ + ++
Sbjct: 119 ------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ A E + GR T +SDV+S+GV + E++S
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 8e-23
Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK-LKPEGFQGHKEWLTEVNYLGQLH 146
S LGEG G V K + +GM+ A+K K+ L E+
Sbjct: 7 SRLGEGAGGSVTKCRL---------KNTGMIFALKTITTDPNPDLQKQILRELEINKSCK 57
Query: 147 HPNLVKLIGYCLEGENRLL--VYEFMPKGSLEN---HLFRRGPQPLSWAVRMKVAIGAAK 201
P +VK G L+ + + E+ GSL++ + +RG + + V K+A K
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLK 116
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGY 260
GL++LH ++I+RD K SNILL + KL DFG++ + + T GT Y
Sbjct: 117 GLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFY 169
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
APE + + SDV+S G+ LLE+ R
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 9e-23
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 90 LGEGGFGFVYKGWID--QHSLSPAKPGSGMV-----VAVKKLKPEGFQ-GHKEWLTEVNY 141
LGEG FG V+ D Q A + VAVK L+P+ +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR---------GPQPLSWAVR 192
L +L PN+ +L+G C ++ E+M G L L + + LS++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ +A A G+ +L ++RD N L+ + K++DFG+++ + D V
Sbjct: 133 LYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ + A E V G+ TTKSDV++FGV L E+L+
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 80/289 (27%), Positives = 145/289 (50%), Gaps = 43/289 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH 146
++G G FG V++G + P + VA+K LKP G+ + +++L+E + +GQ
Sbjct: 12 VIGAGEFGEVFRGILK----MPGRKEV--AVAIKTLKP-GYTEKQRQDFLSEASIMGQFS 64
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
H N+++L G + + +++ E+M G+L+ +L R S + + G A G+ +L
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQVMGTHGYAAP 263
++ ++RD A NIL+++ K+SDFGL++ P G T ++ + AP
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAP 179
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLF 320
E +A + T+ SDV+SFG+V+ E++S G +PY +S+ +
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGE------------------RPYWDMSNHEVMK 221
Query: 321 RIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 367
I D G + P +A L LQC + RPR +++ +L++L
Sbjct: 222 AIND---GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-22
Identities = 81/295 (27%), Positives = 146/295 (49%), Gaps = 49/295 (16%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV-VAVKKLKPEGFQGH--KEWLTEVNYLG 143
+ ++G G FG V +G + PG + VA+K LK G+ +++L+E + +G
Sbjct: 9 EEVIGAGEFGEVCRGRLKL-------PGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMG 60
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAK 201
Q HPN++ L G + +++ EFM G+L++ L + Q + V V + G A
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAA 117
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH- 258
G+ +L +E ++RD A NIL+++ K+SDFGL++ T D T+ S+ +G
Sbjct: 118 GMKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKI 173
Query: 259 --GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--L 313
+ APE +A + T+ SDV+S+G+V+ E++S G +PY +
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE------------------RPYWDM 215
Query: 314 SDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
S++ + I D +L P L L C + RP+ ++++ L+++
Sbjct: 216 SNQDVINAIEQDYRLPP--PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-22
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQLHHP 148
LGE FG +YKG + + A+ +VA+K LK Q E+ E + + +LHHP
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP---------------LSWAVRM 193
N+V L+G + + +++E++ +G L L R P L +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
+AI A G+ +L + +++D A NIL+ + + K+SD GL++ + D V +
Sbjct: 128 HIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ + PE + G+ ++ SD++SFGVVL E+ S G++ PY
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS---------FGLQ--------PYY 228
Query: 314 S-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
+++ ++ + + +L +C P RPR ++
Sbjct: 229 GFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 2e-22
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 40/222 (18%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP----EGFQGHKEWLTEV 139
+ LGEG +G VYK D+ + G +VA+KK++ EG L E+
Sbjct: 1 YEKLEKLGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDNEEEGIP--STALREI 49
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-FRRGPQPLSWAVR--MKVA 196
+ L +L HPN+VKL+ LV+E+ L+ +L R GP + ++ M
Sbjct: 50 SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKSIMYQL 107
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
+ +GL + H ++++RD K NIL++ + KL+DFGLA+A RT+ T +
Sbjct: 108 L---RGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVV 160
Query: 257 THGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
T Y APE Y +T D++S G + E+++G+
Sbjct: 161 TLWYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 41/281 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G+G FG V G G VAVK +K + + +L E + + QL H N
Sbjct: 14 IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 150 LVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L+G +E + L +V E+M KGSL ++L RG L +K ++ + + +L
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+ ++RD A N+L+ + AK+SDFGL K A T D + + + APE +
Sbjct: 120 -ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172
Query: 268 TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326
+ +TKSDV+SFG++L E+ S GR V ++ ++ + K Y D
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGYKMDA---------- 220
Query: 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
P + QC + + RP ++ LE +
Sbjct: 221 -----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 79/284 (27%), Positives = 117/284 (41%), Gaps = 44/284 (15%)
Query: 90 LGEGGFGFVYKGW-IDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+G G FG VY +D L M V +++ + KE E+ L L HP
Sbjct: 8 IGGGTFGKVYTAVNLDTGEL--------MAVKEIRIQDNDPKTIKEIADEMKVLELLKHP 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
NLVK G + E + E+ G+LE L + L V + +GL +LH
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLH- 116
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVM-GTHGYAAPEYV 266
+++RD K +NI LD KL DFG A Q + GT Y APE +
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 267 ATGRLTTK---SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323
G+ +D++S G V+LE+ +G+ W++ D F+IM
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK--------------RPWSE---LDNE--FQIM 216
Query: 324 DTKLG-GQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 361
+G G P + +CL ++PK RP SE+L
Sbjct: 217 -FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 84 FRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
F LGEG +G VYK + +G VVA+K + E +E + E++ L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKE----------TGQVVAIKVVPVEE--DLQEIIKEISIL 52
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
Q P +VK G + + +V E+ GS+ + + + + L+ + KG
Sbjct: 53 KQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +LH ++ I+RD KA NILL+ E AKL+DFG+ +G D V+GT + A
Sbjct: 112 LEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMA 167
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE + K+D++S G+ +E+ G+
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 4e-22
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG G FG V+ G+ + H+ VA+K LK +G + +L E N + QL HP
Sbjct: 14 LGAGQFGEVWMGYYNGHT----------KVAIKSLK-QGSMSPEAFLAEANLMKQLQHPR 62
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
LV+L + E ++ E+M GSL + L L+ + +A A+G+ F+
Sbjct: 63 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAAP 263
I+RD +A+NIL+ K++DFGLA R + G + AP
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLA-------RLIEDNEYTAREGAKFPIKWTAP 172
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GR 291
E + G T KSDV+SFG++L E+++ GR
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 5e-22
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLH 146
LG+GGFG V + +G + A KKL + +G + L E L ++
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 147 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
+V L Y E ++ L LV M G L+ H++ G A + A GL
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
LH + +++YRD K N+LLD N ++SD GLA G + GT GY APE
Sbjct: 111 LH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMAPEV 165
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGR 291
+ D ++ G L E+++GR
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 79/294 (26%), Positives = 119/294 (40%), Gaps = 35/294 (11%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK--PEGFQGHKEWLTEVNYLGQL 145
++GEG +G V K +G +VA+KK K + K L EV L QL
Sbjct: 7 GVVGEGAYGVVLKC---------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
H N+V L + RL LV+E++ + LE L P L + +
Sbjct: 58 RHENIVNLKEAFRR-KGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+ H +I+RD K NIL+ KL DFG A+A + ++ V T Y APE
Sbjct: 115 YCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 265 YVATGRLTTKS-DVYSFGVVLLELLSGR------CAVDKTKVGIEQSL--VDWAKPYLSD 315
+ K DV++ G ++ ELL G +D+ + I++ L + + L
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL-IQKCLGPLPPSHQELFS 230
Query: 316 KRKLFRIMDT-------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
F + L +YP K + A CL +PK R E+L
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-22
Identities = 90/317 (28%), Positives = 144/317 (45%), Gaps = 57/317 (17%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQL 145
+ ++GEG FG V + I K G M A+K LK + H+++ E+ L +L
Sbjct: 7 EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59
Query: 146 -HHPNLVKLIGYCLEGENRLLVY---EFMPKGSLENHL-----------FRR---GPQPL 187
HHPN++ L+G C ENR +Y E+ P G+L + L F + L
Sbjct: 60 GHHPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 188 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247
+ ++ A A G+ +L +E Q I+RD A N+L+ +K++DFGL++ G+
Sbjct: 117 TSQQLLQFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEE 170
Query: 248 THVSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305
+V + MG + A E + TTKSDV+SFGV+L E++S +G
Sbjct: 171 VYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS---------LG----- 215
Query: 306 VDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
PY +L+ + + P+ L QC + P RP +++ L
Sbjct: 216 ---GTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
Query: 365 ER-LEAPKNSAKLSQSE 380
R LEA K ++ E
Sbjct: 273 SRMLEARKAYVNMALFE 289
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 70/209 (33%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTE----VNYLGQL 145
LG G FG V + + LS K + M VAVK LKP +E L +++LG
Sbjct: 43 LGAGAFGKVVEA--TAYGLS--KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN- 97
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
H N+V L+G C G L++ E+ G L N L R+ L+ + + AKG+ F
Sbjct: 98 -HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----Y 260
L A I+RD A N+LL K+ DFGLA+ D + S V+ + +
Sbjct: 157 L--ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKW 209
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLS 289
APE + T +SDV+S+G++L E+ S
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-22
Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 38/295 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL---KPEGFQGHKEWLTEV 139
N + + LG G FG V+ + G +V VK L K E Q E+ E+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAK----GIEEEGGETLVLVKALQKTKDENLQ--SEFRREL 59
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-------RRGPQPLSWAVR 192
+ +L H N+V+L+G C E E ++ E+ G L+ L + P PLS +
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ + A G+ L + ++ ++RD A N L+ ++ K+S L+K + +
Sbjct: 120 VALCTQIALGMDHL--SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312
++ + APE V +TKSDV+SFGV++ E+ + + ++ P+
Sbjct: 178 ALIPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT------QGEL-----------PF 219
Query: 313 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
LSD+ L R+ KL P+ L +C PK RP SE+++ L
Sbjct: 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 7e-22
Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 45/282 (15%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V+ G W Q VA+K + EG ++++ E + +L HP
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-----------VAIKAIN-EGAMSEEDFIEEAKVMMKLSHP 59
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L G C + + +V EFM G L N+L +R + LS + + + +G+ +L
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE- 117
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAA 262
+ I+RD A N L+ + K+SDFG+ R + + + G ++
Sbjct: 118 -RNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVLDDEYTSSSGAKFPVKWSP 169
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + ++KSDV+SFGV++ E+ + + K+ E+ +S +L+R
Sbjct: 170 PEVFNFSKYSSKSDVWSFGVLMWEVFT------EGKMPFEKKSNYEVVEMISRGFRLYR- 222
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
P+ A+ T + C + +P+ RP +E+L +
Sbjct: 223 ---------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 38/292 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLH 146
+LG+G FG V + + GS VAVK LK + F +E+L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 147 HPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQPLSWAVR--MKVA 196
HPN++KLIG L + +++ FM G L L R G +P + ++ ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
I A G+ +L + I+RD A N +L+ ++DFGL+K +GD
Sbjct: 120 IDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315
+ A E +A TT SDV++FGV + E+++ G+ G+E S + YL
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY----AGVENSEI---YNYLIK 230
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+L + P L QC + EPK RP + LE +
Sbjct: 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-21
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 49/282 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LG G G VYK + + ++AVK + + + K+ ++E+ L + P
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 149 NLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
++ G ENR+ + EFM GSL+ ++R+ P+ V ++A+ KGLT+L
Sbjct: 60 YIIGFYGAFFV-ENRISICTEFMDGGSLD--VYRKIPEH----VLGRIAVAVVKGLTYLW 112
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
++++RD K SN+L++ KL DFG++ T ++ +GT+ Y APE ++
Sbjct: 113 SL--KILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERIS 166
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTK--------VGIEQSLVDWAKPYLSDKRKL 319
+ SDV+S G+ +EL GR + + + + Q +VD P L
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV---- 222
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
GQ+ +K H QC+ +PK RP ++
Sbjct: 223 ---------GQFSEKFVHFIT----QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-21
Identities = 72/213 (33%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHH 147
LG G FG V KG K VAVK LK + E L E N + QL +
Sbjct: 3 LGSGNFGTVKKGMY--KMKKSEKT-----VAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLEN------HLFRRGPQPLSWAVRMKVAIGAAK 201
P +V++IG C E E+ +LV E G L H+ + L V M
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM-------- 106
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-- 259
G+ +L E+ ++RD A N+LL + AK+SDFGL+KA D + + THG
Sbjct: 107 GMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAK---THGKW 160
Query: 260 ---YAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + + ++KSDV+SFGV++ E S
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 83/300 (27%), Positives = 118/300 (39%), Gaps = 75/300 (25%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYL 142
F +G+G FG VYK ID+ + VVA+K + E + E + E+ +L
Sbjct: 3 FTLLECIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFL 53
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI---GA 199
Q P + K G L+G ++ E+ GS L + G +A
Sbjct: 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLD-----ETYIAFILREV 107
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV----- 254
GL +LH E I+RD KA+NILL E + KL+DFG VS Q+
Sbjct: 108 LLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFG------------VSGQLTSTMS 153
Query: 255 -----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309
+GT + APE + K+D++S G+ +EL G
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG------------------- 194
Query: 310 KPYLSDK---RKLFRIMDTKLGGQYPQKAAHTAATLAL-----QCLNNEPKLRPRMSEVL 361
+P LSD R LF I P + CLN +PK RP E+L
Sbjct: 195 EPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-21
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL----KPEGFQGHKEWLTEVNYLGQL 145
+GEG G V+K + +G VA+KK+ G + L E+ L
Sbjct: 8 IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
HP +VKL+ G +LV E+MP L L R +PL A KG+ +
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
+H + +++RD K +N+L+ A+ K++DFGLA+ + S QV T Y APE
Sbjct: 115 MH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL 171
Query: 266 VATGRLTTKS-DVYSFGVVLLELLSGR 291
+ R D+++ G + ELL+G
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 6e-21
Identities = 60/183 (32%), Positives = 90/183 (49%), Gaps = 11/183 (6%)
Query: 116 GMVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
VA+K++ E Q E EV + Q +HPN+VK + G+ LV ++ GS
Sbjct: 26 NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85
Query: 175 LEN---HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231
L + + RG + V KGL +LH + I+RD KA NILL + +
Sbjct: 86 LLDIMKSSYPRGGLDEAIIA--TVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSV 141
Query: 232 KLSDFGL-AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELL 288
K++DFG+ A GDRT V +GT + APE + K+D++SFG+ +EL
Sbjct: 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201
Query: 289 SGR 291
+G
Sbjct: 202 TGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 52/160 (32%), Positives = 90/160 (56%), Gaps = 9/160 (5%)
Query: 133 KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 192
K+ L E+ + + P +V G L N + EFM GSL+ + GP P+ +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE--IL 105
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH-VS 251
K+A+ +GLT+L++ ++++RD K SNIL+++ KL DFG+ +G+ + ++
Sbjct: 106 GKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIA 159
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+GT Y +PE + G+ T KSDV+S G+ ++EL G+
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 67/282 (23%), Positives = 128/282 (45%), Gaps = 35/282 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK------PEGFQGHKEWLTEVNYL 142
LG G F Y+ +G ++AVK++ E + + E+ +
Sbjct: 7 QLGTGAFSSCYQA---------RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM 57
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+L+HP++++++G E + L E+M GS+ + L + G AV + +G
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRG 115
Query: 203 LTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLA-KAGPTGDRT-HVSTQVMGTHG 259
L++LH+ +Q+I+RD K +N+L+D+ +++DFG A + G Q++GT
Sbjct: 116 LSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
+ APE + + DV+S G V++E+ + + + K +L +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------------I 220
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
F+I P+ + + L+CL +P+ RP E+L
Sbjct: 221 FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 77/284 (27%), Positives = 119/284 (41%), Gaps = 34/284 (11%)
Query: 86 PDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLG 143
+GEG FG VY+G ++ + VAVK K +E +L E +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMS-------PENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
Q HP++VKLIG E +V E P G L ++L L A + + + L
Sbjct: 63 QFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTAL 120
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
+L + ++RD A N+L+ + KL DFGL++ S + + AP
Sbjct: 121 AYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAP 177
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323
E + R T+ SDV+ FGV + E+L +G+ KP+ K I
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILM---------LGV--------KPFQGVKNNDV-IG 219
Query: 324 DTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
+ G + P T +L +C +P RPR +E+ A L
Sbjct: 220 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL------KPEGFQGHKEWLTEVNYL 142
+LG+G +G VY G +Q G ++AVK++ + +++ EV+ L
Sbjct: 7 VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
L H N+V+ +G CL+ + EF+P GS+ + L R GP P V K G
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLP--EPVFCKYTKQILDG 114
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTHVSTQVMGTH 258
+ +LH+ + V++RD K +N++L KL DFG A+ G G +++ + GT
Sbjct: 115 VAYLHN--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+ APE + KSD++S G + E+ +G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 77/294 (26%), Positives = 139/294 (47%), Gaps = 41/294 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
+ + ++G G FG V G + P K + VA+K LK G+ + +++L+E +
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLK----LPGK--REIPVAIKTLKA-GYTEKQRRDFLSEAS 57
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI--G 198
+GQ HPN++ L G + + ++V E+M GSL+ L + Q + V V + G
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLRG 114
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVSTQVM 255
A G+ +L D ++RD A NIL+++ K+SDFGL++ P T ++
Sbjct: 115 IASGMKYLSDM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI- 171
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLS 314
+ APE +A + T+ SDV+S+G+V+ E++S G +PY
Sbjct: 172 -PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE------------------RPYWE 212
Query: 315 -DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + + ++ P L L C + RP+ ++++IL++L
Sbjct: 213 MSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 71/208 (34%), Positives = 102/208 (49%), Gaps = 21/208 (10%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEW-LTEVNYLGQL 145
+LG+G FG V L+ K G+ + AVK LK + E +TE L
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 146 -HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
HP L +L C + ++RL V E++ G L H+ R G A I GL
Sbjct: 53 GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGL 109
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
FLH E +IYRD K N+LLD+E + K++DFG+ K G G T ++ GT Y AP
Sbjct: 110 QFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAP 165
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGR 291
E ++ D ++ GV+L E+L+G+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 58/216 (26%), Positives = 110/216 (50%), Gaps = 18/216 (8%)
Query: 90 LGEGGFGFVY----KGWIDQHSLSPAK-PGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLG 143
LGEG FG V+ +G + + G ++VAVK L+ + + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP----------LSWAVRM 193
+L +PN+++L+G C+ + ++ E+M G L L +R + +S A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
+A+ A G+ +L A ++RD N L+ + K++DFG+++ +GD + +
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ + A E + G+ TT SDV++FGV L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 3e-20
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 55/241 (22%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT---EV 139
+F+ ++GEG F V ++ + A+K L K L +V
Sbjct: 2 DFKFGKIIGEGSFSTVVLAK-EKET--------NKEYAIKILD-------KRQLIKEKKV 45
Query: 140 NY-------LGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA 190
Y L +L HP ++KL Y + E L V E+ P G L ++ + G S
Sbjct: 46 KYVKIEKEVLTRLNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYG----SLD 100
Query: 191 VRMKVAIGA--AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
+ A L +LH +I+RD K NILLD + + K++DFG AK
Sbjct: 101 EKCTRFYAAEILLALEYLHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158
Query: 249 HVSTQVM------------------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
+ GT Y +PE + SD+++ G ++ ++L+G
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
Query: 291 R 291
+
Sbjct: 219 K 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLT-EVNYLGQLHH 147
+G+G FG V K + + S G ++ K++ K+ L EVN L +L H
Sbjct: 8 IGKGSFGTVRK--VRRKS-------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH 58
Query: 148 PNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL------FRRGPQPLSWAVRMKVAIGA 199
PN+V+ ++ N+ L V E+ G L + + + W + ++ + A
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL-A 117
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
D + V++RD K +NI LDA N KL DFGLAK G + + +GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTPY 175
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
Y +PE + KSD++S G ++ EL +
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 28/210 (13%)
Query: 93 GGFGFVYKGWIDQHSLSPAKPGS-GMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHP 148
G +G V+ AK S G + A+K +K + LTE + L Q P
Sbjct: 4 GAYGRVFL----------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSP 53
Query: 149 NLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
+VKL Y +G+ L LV E++P G L + L G A I A L +LH
Sbjct: 54 YVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA--LEYLH 110
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS------TQVMGTHGYA 261
+ +I+RD K NIL+D+ + KL+DFGL+K G + +++ +++GT Y
Sbjct: 111 --SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 262 APEYVATGRLTTKS-DVYSFGVVLLELLSG 290
APE V G+ +K+ D +S G +L E L G
Sbjct: 169 APE-VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 4e-20
Identities = 85/301 (28%), Positives = 136/301 (45%), Gaps = 56/301 (18%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQL-H 146
++GEG FG V K I K G M A+K++K + H+++ E+ L +L H
Sbjct: 2 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 147 HPNLVKLIGYCLEGENRLLVY---EFMPKGSLENHL-----------FRR---GPQPLSW 189
HPN++ L+G C E+R +Y E+ P G+L + L F LS
Sbjct: 55 HPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111
Query: 190 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTH 249
+ A A+G+ +L ++ Q I+RD A NIL+ + AK++DFGL++ G +
Sbjct: 112 QQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 165
Query: 250 VSTQVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
V + MG + A E + TT SDV+S+GV+L E++S +G
Sbjct: 166 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG------- 208
Query: 308 WAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
PY +L+ + + P L QC +P RP +++L L R
Sbjct: 209 -GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267
Query: 367 L 367
+
Sbjct: 268 M 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 50/298 (16%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQL-H 146
++GEG FG V K I K G M A+K++K + H+++ E+ L +L H
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR--------------RGPQPLSWAVR 192
HPN++ L+G C L E+ P G+L + L + LS
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ A A+G+ +L ++ Q I+RD A NIL+ + AK++DFGL++ G +V
Sbjct: 127 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK- 179
Query: 253 QVMGTHG--YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310
+ MG + A E + TT SDV+S+GV+L E++S +G
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LG--------GT 222
Query: 311 PYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
PY +L+ + + P L QC +P RP +++L L R+
Sbjct: 223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-20
Identities = 81/278 (29%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHP 148
+G+G FG VYKG ID + VVA+K + E + E + E+ L Q P
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+ + G L+G ++ E++ GS + L P PL + KGL +LH
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHS 119
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
I+RD KA+N+LL + + KL+DFG+ AG D +GT + APE +
Sbjct: 120 ERK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 269 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 326
K+D++S G+ +EL G P L R LF I
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE------------------PPNSDLHPMRVLFLIPKNS 217
Query: 327 ---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
L GQY + CLN +P+ RP E+L
Sbjct: 218 PPTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-19
Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 55/295 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGW-IDQHSLSPAKPGSGMVVAVKKLK--PEGFQGHKE---WL 136
N+R LLG+G FG VY + +D +G +AVK++ P+ + KE
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAVKQVPFDPDSPETKKEVNALE 52
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMKV 195
E+ L L H +V+ G CL + L ++ E+MP GS+++ L G L+ V K
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKY 109
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDRTH 249
+G+ +LH +++RD K +NIL D+ N KL DFG +K + TG ++
Sbjct: 110 TRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS- 166
Query: 250 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309
V GT + +PE ++ K+DV+S G ++E+L+
Sbjct: 167 ----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-------------------E 203
Query: 310 KPYLSDKRK---LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
KP ++ +F+I Q P + A + K RP E+L
Sbjct: 204 KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 85/286 (29%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+ R D LG+G FG V+ G W VA+K LKP G + +L E
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTW-----------NGTTKVAIKTLKP-GTMMPEAFLQEAQI 54
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ +L H LV L E E +V EFM KGSL + L + L + +A A
Sbjct: 55 MKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMGTHGY 260
G+ ++ I+RD +A+NIL+ K++DFGLA+ D + + Q +
Sbjct: 114 GMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKW 169
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD-KRKL 319
APE GR T KSDV+SFG++L EL V K +V PY R++
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PYPGMVNREV 212
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
++ PQ + L C +P RP + + LE
Sbjct: 213 LEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 85/290 (29%), Positives = 128/290 (44%), Gaps = 39/290 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE--GFQGHKEWLTEVNYLGQLHH 147
LGEG FG V +G ++Q S + VAVK +K +++L+E + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 148 PNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLF--RRGPQPLSWAVRMKVAIGA 199
PN+++LIG CL+ +++ FM G L + L R G P +M V
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 200 --AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
A G+ +L + I+RD A N +L+ N ++DFGL+K GD
Sbjct: 120 DIASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316
+ A E +A TTKSDV+SFGV + E+ + G+ G+E S + YL
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP----GVENSEI---YDYLRQG 230
Query: 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
+L + D L G Y +L C PK RP + LE+
Sbjct: 231 NRLKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 76/300 (25%), Positives = 137/300 (45%), Gaps = 43/300 (14%)
Query: 90 LGEGGFGFVY-------KGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNY 141
LGEG FG V+ + ++D+ ++VAVK L+ + + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP---------LSWAVR 192
+ +L PN+++L+ C+ + ++ E+M G L L R PQ +S++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ +A A G+ +L + ++RD N L+ + K++DFG+++ +GD +
Sbjct: 133 IFMATQIASGMKYL--SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312
+ + + + E + G+ TT SDV++FGV L E+L+ C EQ PY
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT-LCK--------EQ-------PY 234
Query: 313 --LSDKR------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
LSD++ + FR ++ P + L L C K RP E+ A L
Sbjct: 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLH 146
LG G FG V + +H GSG A+K L K+ L E L +
Sbjct: 9 LGTGSFGRV---MLVRHK------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTF 205
HP LV L G + N LV E++P G L +HL + G P A R A + A L +
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQVVLA--LEY 116
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
LH + ++YRD K N+LLD++ K++DFG AK RT+ + GT Y APE
Sbjct: 117 LHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPE- 168
Query: 266 VATGRLTTKS-DVYSFGVVLLELLSG 290
+ + K+ D ++ G+++ E+L+G
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 80/289 (27%), Positives = 139/289 (48%), Gaps = 44/289 (15%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLH 146
+LG G FG VYKG WI P + VA+K L+ + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF----RRGPQPL-SWAVRMKVAIGAAK 201
P + +L+G CL +L V + MP G L +++ R G Q L +W V++ AK
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AK 120
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
G+++L + ++++RD A N+L+ + + K++DFGLA+ + + + +
Sbjct: 121 GMSYLEEV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLF 320
A E + R T +SDV+S+GV + EL++ G AKPY R++
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMT---------FG--------AKPYDGIPAREIP 221
Query: 321 RIMDTKLGGQYPQKAAHTAAT--LALQCLNNEPKLRPRMSEVLAILERL 367
+++ G + PQ T + ++C + + RPR E++ R+
Sbjct: 222 DLLEK--GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 56/294 (19%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGS-GMVVAVKKLKPEGFQGHKE---WLTE 138
+F+ LG+G +G VYK K S A+K++ G KE + E
Sbjct: 1 DFKVLKKLGKGSYGSVYK----------VKRLSDNQFYALKEVDL-GSMSQKEREDAVNE 49
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------PQPLSWAVR 192
+ L ++HPN++ L+G +V E+ P G L + +R P+ W
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--- 106
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
++ I +GL LH E ++++RD K++NILL A K+ D G++K + T
Sbjct: 107 -RIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKT 160
Query: 253 QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311
Q+ GT Y APE V GR + KSD++S G +L E+ + +
Sbjct: 161 QI-GTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFA--------------PPFEAR 204
Query: 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLA---LQCLNNEPKLRPRMSEVLA 362
+ D R +++ G+YP + L L +PKLRP ++LA
Sbjct: 205 SMQDLR--YKVQ----RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 85/281 (30%), Positives = 125/281 (44%), Gaps = 41/281 (14%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V+ G W VAVK LKP G + +L E + +L H
Sbjct: 14 LGNGQFGEVWMGTW-----------NGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHD 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L E E +V E+M KGSL + L + L + +A A G+ ++
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEY 265
I+RD +++NIL+ K++DFGLA+ D + + Q G + APE
Sbjct: 120 -RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQ--GAKFPIKWTAPEA 174
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-DKRKLFRIMD 324
GR T KSDV+SFG++L EL V K +V PY + R++ ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTEL------VTKGRV-----------PYPGMNNREVLEQVE 217
Query: 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
PQ + L LQC +P+ RP + + LE
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 84 FRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNY 141
F+ +LG G FG VYKG WI P + VA+K+L+ + +KE L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL----ENHLFRRGPQPL-SWAVRMKVA 196
+ + +P++ +L+G CL +L + + MP G L H G Q L +W V++
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
AKG+ +L E ++++RD A N+L+ + K++DFGLAK ++ + +
Sbjct: 119 ---AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ A E + T +SDV+S+GV + EL++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 8e-19
Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 43/285 (15%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH 146
+ LG G FG V+ ++H+ VAVK +KP G + +L E N + L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHT----------KVAVKTMKP-GSMSVEAFLAEANVMKTLQ 59
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLT 204
H LVKL + E ++ EFM KGSL + L QPL + I A+G+
Sbjct: 60 HDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYA 261
F+ + I+RD +A+NIL+ A K++DFGLA+ D + + + G +
Sbjct: 117 FIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWT 170
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE + G T KSDV+SFG++L+E+++ GR P +S+ ++
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY----------------PGMSNP-EVI 213
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
R ++ P+ + ++C N P+ RP + ++L+
Sbjct: 214 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 77/274 (28%), Positives = 106/274 (38%), Gaps = 45/274 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-----PEGFQGHKEWLTEVNYLGQ 144
LG GGFG V L K A+K +K G Q H +E L +
Sbjct: 1 LGVGGFGRVE--------LVKVKS-KNRTFALKCVKKRHIVETGQQEHI--FSEKEILEE 49
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
+HP +VKL + + ++ E+ G L L RG + R +A
Sbjct: 50 CNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVLAFE 107
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH +IYRD K N+LLD+ KL DFG AK +G +T GT Y APE
Sbjct: 108 YLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPE 162
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324
+ D +S G++L ELL+GR P+ D I +
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDEDPMEIYN 204
Query: 325 TKLGG----QYPQKAAHTAATLALQCLNNEPKLR 354
L G ++P A L Q L P+ R
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 64/208 (30%), Positives = 112/208 (53%), Gaps = 22/208 (10%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGHKEWLTEVNYLGQLH 146
+LG G FG VYKG W+ P + VA+K L + G + + E++ E + +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR----GPQPL-SWAVRMKVAIGAAK 201
HP+LV+L+G CL +L V + MP G L +++ G Q L +W V++ AK
Sbjct: 68 HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
G+ +L E ++++RD A N+L+ + + K++DFGLA+ ++ + + +
Sbjct: 121 GMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS 289
A E + + T +SDV+S+GV + EL++
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW--LTEVN 140
+ ++G G FG V+ L K +V+ +K++ E + E
Sbjct: 1 KYEKIRVVGRGAFGIVH--------LCRRKADQKLVI-IKQIPVEQMTKDERLAAQNECQ 51
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L L HPN+++ LE + ++V E+ P G+L ++ +R L + +
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
L +H +++RD K NILLD K+ DFG++K ++ T V+GT
Sbjct: 112 LALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPC 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
Y +PE KSD+++ G VL EL S + A + + P L +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----------PAL-----V 210
Query: 320 FRIMDTK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+IM + +Y L L LN +P RP++S+++A
Sbjct: 211 LKIMSGTFAPISDRYSPDLRQ----LILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 75/302 (24%), Positives = 130/302 (43%), Gaps = 48/302 (15%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK---EWLT 137
NF+ + +G+G F VYK G VVA+KK++ K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQDCLK 51
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRG----PQPLSWAV 191
E++ L QL HPN++K + +E +V E G L + F++ P+ W
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+++ L +H ++++RD K +N+ + A KL D GL + +T +
Sbjct: 112 FVQL----CSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAA 163
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311
++GT Y +PE + KSD++S G +L E+ + + P
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SP 205
Query: 312 YLSDKRKLFRIMDTKLGGQY-PQKAAHTAATL---ALQCLNNEPKLRPRMSEVLAILERL 367
+ DK L+ + Y P A H + L +C+N +P+ RP +S VL + + +
Sbjct: 206 FYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
Query: 368 EA 369
A
Sbjct: 266 HA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG G FG V+ G+ + + VAVK LKP G + +L E N + L H
Sbjct: 14 LGAGQFGEVWMGYYNNST----------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 62
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
LV+L + E ++ E+M KGSL + L + + + A+G+ ++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE-- 120
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 269
I+RD +A+N+L+ K++DFGLA+ + T + APE + G
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFG 179
Query: 270 RLTTKSDVYSFGVVLLELLS 289
T KSDV+SFG++L E+++
Sbjct: 180 SFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 84/292 (28%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+ R + LG+G FG V+ G W VA+K LKP G + +L E
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTW-----------NGTTRVAIKTLKP-GTMSPEAFLQEAQV 54
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL------FRRGPQPLSWAVRMKV 195
+ +L H LV+L E E +V E+M KGSL + L + R PQ + A ++
Sbjct: 55 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-V 254
+ + + ++H RD +A+NIL+ K++DFGLA+ D + + Q
Sbjct: 114 GMAYVERMNYVH--------RDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGA 163
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
+ APE GR T KSDV+SFG++L EL + K +V PY
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGRV-----------PYPG 206
Query: 315 D-KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
R++ ++ P + + L QC EP+ RP + A LE
Sbjct: 207 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 32/220 (14%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-----PEGFQGHKEWLT----E 138
+L+G G FG VY G ++ S G ++AVK+++ + L E
Sbjct: 6 ALIGSGSFGSVYLG---MNASS------GELMAVKQVELPSVSASSKDRKRSMLDALARE 56
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVA 196
+ L +L H N+V+ +G L+ ++ + E++P GS+ L G + L VR V
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VRNFVR 113
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-----AGPTGDRTHVS 251
KGL +LH+ +I+RD K +NIL+D + K+SDFG++K + T
Sbjct: 114 -QILKGLNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA-R 169
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+ G+ + APE V T K+D++S G +++E+L+G+
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 79/305 (25%), Positives = 128/305 (41%), Gaps = 54/305 (17%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL- 145
LGEG FG V K ++ P VAVK LK + + K+ V+ + +
Sbjct: 17 GKPLGEGAFGQVVKA----EAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMK 70
Query: 146 ---HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP--------------LS 188
H N++ L+G C + +V E+ G+L + L R P L+
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
+ A A+G+ FL A + I+RD A N+L+ + K++DFGLA+ D
Sbjct: 131 QKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH 183
Query: 249 HVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303
H+ T+G + APE + T +SDV+SFGV+L E+ + +G
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG--- 231
Query: 304 SLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
PY +LF+++ + PQ L C + P RP +++
Sbjct: 232 -----GSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
Query: 363 ILERL 367
L+R+
Sbjct: 287 DLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK--LKPEGFQGHKEWL--------TE 138
L+G+G +G VY +G ++AVK+ L H +E
Sbjct: 8 LIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVY-EFMPKGSLENHLFRRGP--QPLSWAVRMKV 195
+ L L H N+V+ +G E L ++ E++P GS+ + L G + L +V
Sbjct: 59 IETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV 117
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
+GL +LH +++RD KA N+L+DA+ K+SDFG++K + +
Sbjct: 118 L----EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 256 GTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 291
G+ + APE + + + K D++S G V+LE+ +GR
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 64/212 (30%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
+G G FG V G H S V VK+L+ +L EV +L+HP
Sbjct: 3 IGNGWFGKVLLGEA--HRGM-----SKARVVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHL------FRRGPQPLSWAVRMKVAIGAAKG 202
N+++ +G C+E LLV EF P G L+N+L + Q V ++A A G
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD---VLQRMACEVASG 112
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +LH A+ I+ D N L A+ + K+ D+GLA D + A
Sbjct: 113 LLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA 170
Query: 263 PEYVA-------TGRLTTKSDVYSFGVVLLEL 287
PE V T KS+++S GV + EL
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHP 148
LG G FG V KG + VA+K LK E + E + E + QL +P
Sbjct: 3 LGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLH 207
+V++IG C E E +LV E G L L + + +S V + + + G+ +L
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQV--SMGMKYLE 112
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEY 265
++RD A N+LL + AK+SDFGL+KA D ++ + G + APE
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLKWYAPEC 169
Query: 266 VATGRLTTKSDVYSFGVVLLELLS 289
+ + +++SDV+S+G+ + E S
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 39/286 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LG+G FG VY+G + K VA+K + + E+L E + + + +
Sbjct: 14 LGQGSFGMVYEGI----AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----------RGPQPLSWAVRMKVAIG 198
++V+L+G +G+ L++ E M +G L+++L + P L ++M I
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI- 128
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
A G+ +L+ ++ ++RD A N ++ +F K+ DFG+ + D + +
Sbjct: 129 -ADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 316
+ +PE + G TT SDV+SFGVVL E+ +L + +PY +S++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAE--QPYQGMSNE 228
Query: 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ L +M+ L + P L C PK+RP E+++
Sbjct: 229 QVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 78/282 (27%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK----LKPEGFQGHKEWLTEVNYLGQL 145
+G G FG V+ G + VAVK L P+ ++L E L Q
Sbjct: 3 IGRGNFGEVFSGRLR---------ADNTPVAVKSCRETLPPDL---KAKFLQEARILKQY 50
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
HPN+V+LIG C + + +V E + G L GP+ L +++ AA G+ +
Sbjct: 51 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEY 109
Query: 206 LHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
L ES+ I+RD A N L+ + K+SDFG+++ G + APE
Sbjct: 110 L---ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324
+ GR +++SDV+SFG++L E S +G A PY + + R
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFS---------LG--------AVPYANLSNQQTREAI 209
Query: 325 TKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
+ G + P+ L +C +P RP S V L
Sbjct: 210 EQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G FG VYK QH +G+ A K ++ E + ++++ E++ L + HPN
Sbjct: 13 LGDGAFGKVYKA---QHK------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 150 LVKLI-GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+V L Y E + +L+ EF G+L++ + + L+ V + L FLH
Sbjct: 64 IVGLYEAYFYENKLWILI-EFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS 121
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+VI+RD KA NILL + + KL+DFG+ AK T + +GT + APE VA
Sbjct: 122 --HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVA 176
Query: 268 TGRLTT-----KSDVYSFGVVLLELLSGR 291
K+D++S G+ L+EL
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 74/301 (24%), Positives = 123/301 (40%), Gaps = 41/301 (13%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKE 134
E+ +T F + LGE FG VYKG H A VA+K LK + +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTLKDKAEGPLREE 54
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-------- 186
+ E +L HPN+V L+G + + +++ + L L R P
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 187 ------LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
L A + + A G+ FL + V+++D N+L+ + N K+SD GL +
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
D + + + +PE + G+ + SD++S+GVVL E+ S G
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS---------YG 223
Query: 301 IEQSLVDWAKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
++ PY + + ++ + P TL L+C N P RPR +
Sbjct: 224 LQ--------PYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD 275
Query: 360 V 360
+
Sbjct: 276 I 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLH 146
LG+GGFG V + +G + A KKL + + G K L E L +++
Sbjct: 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51
Query: 147 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
P +V L Y E + L LV M G L+ H++ G + L + + G+
Sbjct: 52 SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
LH ++YRD K N+LLD + N +LSD GLA G TQ GT+GY APE
Sbjct: 111 LH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEI 165
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGR 291
+ + D ++ G + E+++GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 69/205 (33%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLH 146
+G G FG VY + VVAVKK+ G Q +++W + EV +L QL
Sbjct: 29 IGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
HPN ++ G L+ LV E+ GS + L +PL + GA +GL +L
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEY 265
H +I+RD KA NILL KL+DFG A K+ P + +GT + APE
Sbjct: 138 H--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEV 188
Query: 266 VAT---GRLTTKSDVYSFGVVLLEL 287
+ G+ K DV+S G+ +EL
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 70/226 (30%), Positives = 109/226 (48%), Gaps = 28/226 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK--KLKPEGFQGHKEWLTEVNY 141
++ L+G G +G VY+G +H + G VVA+K L EV
Sbjct: 3 YQRLELIGRGAYGAVYRG---KHVPT------GRVVALKIINLDTPDDDVSDIQ-REVAL 52
Query: 142 LGQLHH---PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAI 197
L QL PN+ K G L+G ++ E+ GS+ L + GP +V ++ +
Sbjct: 53 LSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
A L ++H + VI+RD KA+NIL+ N KL DFG+A A + + ST V GT
Sbjct: 112 VA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFV-GT 164
Query: 258 HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR---CAVDKTKV 299
+ APE + G+ TK+D++S G+ + E+ +G VD +
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 82/280 (29%), Positives = 124/280 (44%), Gaps = 48/280 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHP 148
+G+G FG V+KG ID + VVA+K + E + E + E+ L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLH 207
+ K G L+G ++ E++ GS + L R GP A +K + KGL +LH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLH 118
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+ I+RD KA+N+LL + + KL+DFG+ AG D +GT + APE +
Sbjct: 119 SEKK--IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD---KRKLFRIMD 324
+K+D++S G+ +EL G +P SD R LF I
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG-------------------EPPNSDMHPMRVLFLIPK 215
Query: 325 TK---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
L G++ + CLN +P RP E+L
Sbjct: 216 NNPPTLTGEFSK----PFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 68/233 (29%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-------EVNYL 142
LG+G +G V+K ID+ + VVA+KK+ + F+ T E+ +L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKIF-DAFRN----ATDAQRTFREIMFL 60
Query: 143 GQL-HHPNLVKLIGYCLEGENRL---LVYEFMP--------KGSLEN-H-------LFRR 182
+L HPN+VKL+ ++ EN LV+E+M LE+ H L
Sbjct: 61 QELGDHPNIVKLLN-VIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLL-- 117
Query: 183 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242
K L ++H VI+RD K SNILL+++ KL+DFGLA++
Sbjct: 118 ------------------KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSL 157
Query: 243 PTGDRTH---VSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 291
+ V T + T Y APE + + R T D++S G +L E+L G+
Sbjct: 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 68/245 (27%), Positives = 96/245 (39%), Gaps = 57/245 (23%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-----GFQGHKEWLT 137
+F ++G G FG V+ +G V A+K L+ H
Sbjct: 2 DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAH--VRA 50
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA----VR 192
E + L P +VKL Y + E L LV E+MP G L N L R+ P A
Sbjct: 51 ERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE 109
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVS 251
+ +A+ + L F+H RD K NIL+DA+ + KL+DFGL K DR +
Sbjct: 110 LVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161
Query: 252 TQ--------------------------VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 285
+GT Y APE + + D +S GV+L
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221
Query: 286 ELLSG 290
E+L G
Sbjct: 222 EMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 73/246 (29%), Positives = 107/246 (43%), Gaps = 59/246 (23%)
Query: 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL----KPEGFQGHKE 134
+ R++ LGEG FG VYK + + G VVA+KK+ + +GF
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKA---RQIKT------GRVVALKKILMHNEKDGF--PIT 53
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLE-----GENRLLVYEFMP------KGSLENHLFRRG 183
L E+ L +L HPN+V LI +E R VY P G LEN
Sbjct: 54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP----- 108
Query: 184 PQPLSWAVRMKVAIGAAK--------GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235
+K+ K G+ +LH E+ +++RD KA+NIL+D + K++D
Sbjct: 109 --------SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIAD 158
Query: 236 FGLAK---------AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLL 285
FGLA+ G G T T ++ T Y PE + R TT D++ G V
Sbjct: 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218
Query: 286 ELLSGR 291
E+ + R
Sbjct: 219 EMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 70/221 (31%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP---------EGFQGHKE 134
FR ++LG G FG V L+ K + A+K LK E K
Sbjct: 1 FRCLAVLGRGHFGKVL--------LAEYKKTGELY-AIKALKKGDIIARDEVESLMCEKR 51
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RGPQPLSWAVR 192
N HP LV L C + E+ + V E+ G L H+ +P +
Sbjct: 52 IFETAN---SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYA 107
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP-TGDRTHVS 251
V +G L +LH E++++YRD K N+LLD E K++DFGL K G GDRT S
Sbjct: 108 ACVVLG----LQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--S 159
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 292
T GT + APE + T D + GV++ E+L G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 85/293 (29%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL--KPEGFQGHKEWLTEVNYLGQLH 146
L+GEG +G V K +H +G +VA+KK + K + E+ L QL
Sbjct: 8 LVGEGSYGMVMKC---KHK------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
H NLV LI + LV+EF+ L++ + P L + K +G+ F
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPE 264
H +I+RD K NIL+ KL DFG A+ A P G+ V T + T Y APE
Sbjct: 117 HS--HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATRWYRAPE 170
Query: 265 Y-VATGRLTTKSDVYSFGVVLLELLSGR------CAVDKTKVGIEQSLVDWAKPY--LSD 315
V + D+++ G ++ E+L+G +D+ I + L + + +
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNLIPRHQEIFQ 229
Query: 316 KRKLFRIM---DTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
K LF M + K L ++P K + LA QCL +P RP S++L
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLTE 138
NF+ +GEG +G VYK +G VVA+KK++ EG + E
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
++ L +L+HPN+VKL+ + EN+L LV+EF+ + L+ + + +
Sbjct: 50 ISLLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
+GL F H +V++RD K N+L++ E KL+DFGLA+A RT+ V T
Sbjct: 108 QLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 258 HGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
Y APE + + +T D++S G + E+++ R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 27/216 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK---KLKPEGFQGHKEWLTEV 139
+F ++G+G FG V I Q + + A+K K K + L E
Sbjct: 1 HFELLRVIGKGAFGKV---CIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNER 51
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKV 195
L +L+HP LV L + EN LV + + G L HL ++ Q W + +
Sbjct: 52 RILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
A L +LH +I+RD K NILLD + + ++DF +A T T
Sbjct: 112 A------LEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTS 160
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
GT GY APE + + D +S GV E L G+
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 16/192 (8%)
Query: 115 SGMVVAVKKLK---PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL-VYEFM 170
+G VA+K L+ PE + E +L+HPN+V L+ L V+E++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 171 PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DA 227
P +L L G P R+ + + L H+ +++RD K NI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQV--LDALACAHNQ--GIVHRDLKPQNIMVSQTGV 117
Query: 228 EFNAKLSDFGLAKAGP-TGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 282
+AK+ DFG+ P D +T+V+GT Y APE + +T SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 283 VLLELLSGRCAV 294
+ LE L+G+ V
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLTEVNYLGQL 145
+GEG +G VYKG ++ + G +VA+KK++ EG + E++ L +L
Sbjct: 8 IGEGTYGVVYKG---RNKKT------GQIVAMKKIRLESEEEGVPSTA--IREISLLKEL 56
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI-GAAKGL 203
HPN+V L ++ E+RL L++EF+ L+ +L A +K + +G+
Sbjct: 57 QHPNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
F H +V++RD K N+L+D + KL+DFGLA+A G V T + T Y AP
Sbjct: 115 LFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWYRAP 170
Query: 264 E-YVATGRLTTKSDVYSFGVVLLELLSGR 291
E + + R +T D++S G + E+ + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 72/287 (25%), Positives = 130/287 (45%), Gaps = 37/287 (12%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLGQL 145
+ +LG G FG + +G + P+K + VA+ L+ + +L E LGQ
Sbjct: 10 ERILGTGRFGELCRGCLKL----PSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQF 63
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
H N+V+L G G ++V E+M G+L++ L R+ L M + G A G+ +
Sbjct: 64 DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAA 262
L +E +++ A +L++++ K+S F + D++ M +AA
Sbjct: 123 L--SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE----DKSEAIYTTMSGKSPVLWAA 176
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
PE + ++ SDV+SFG+V+ E++S R D + + +++ D F
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-----------F 225
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
R+ P+ + L L C E RPR S++ +IL ++
Sbjct: 226 RL-------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 76/315 (24%), Positives = 137/315 (43%), Gaps = 38/315 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HH 147
LGEG FG V + + + + ++P + VAVK LK + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L L R P + LS+ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A A+G+ +L + I+RD A N+L+ + K++DFGLA+ D ++
Sbjct: 138 SCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ APE + T +SDV+SFG+++ E+ + +G PY
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT---------LG--------GSPYP 238
Query: 314 S-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 372
+LF+++ P H L +C + P RP +++ L+++ A +
Sbjct: 239 GIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 373 SAKLSQSEPHRQTGP 387
L S P Q P
Sbjct: 299 EEYLDLSMPFEQYSP 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 65/184 (35%), Positives = 93/184 (50%), Gaps = 14/184 (7%)
Query: 118 VVAVKKLKPEGFQGHKE--WL-TEVNYLGQL-HHPNLVKLIGYCLEGENRL-LVYEFMPK 172
+ A+K +K E ++ W+ TE + +HP LV L C + E+RL V EF+
Sbjct: 22 IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEFVSG 80
Query: 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232
G L H+ R+ P A I A L FLH E +IYRD K N+LLDAE + K
Sbjct: 81 GDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH--ERGIIYRDLKLDNVLLDAEGHIK 136
Query: 233 LSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
L+D+G+ K G GD T + GT Y APE + D ++ GV++ E+++GR
Sbjct: 137 LTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
Query: 292 CAVD 295
D
Sbjct: 194 SPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGHKEWLTEVNYLGQLHHP 148
LG+G FG VY+G ++ K + VAVK + + + E+L E + +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FR--------RGPQPLSWAVRMKVAIG 198
++V+L+G +G+ L+V E M G L+++L R R P L ++M I
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI- 128
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
A G+ +L+ + ++RD A N ++ +F K+ DFG+ + D + +
Sbjct: 129 -ADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 316
+ APE + G TT SD++SFGVVL E+ SL + +PY LS++
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE--QPYQGLSNE 228
Query: 317 RKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
+ L +MD GG P L C PK+RP E++ +L+
Sbjct: 229 QVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQ 144
+LG+G FG V + + G+ + A+K LK + + + E L
Sbjct: 6 MVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL 56
Query: 145 LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMKVAIGA 199
P + + C + +RL V E++ G L H+ + G P + +A +
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI------ 110
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
A GL FLH +IYRD K N++LDAE + K++DFG+ K G +T + GT
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPD 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295
Y APE +A D ++FGV+L E+L+G+ D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-17
Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVN 140
FR +LG+GGFG V + +G + A KKL+ + + G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52
Query: 141 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L +++ +V L Y E ++ L LV M G L+ H++ G + A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
GL LH +++YRD K NILLD + ++SD GLA P G+ + +V GT G
Sbjct: 112 TCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVG 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
Y APE V R T D + G ++ E++ G+ + K +++ V+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----------- 215
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
R+ + + +Y +K + A ++ Q L +P R
Sbjct: 216 -RVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 76/250 (30%), Positives = 111/250 (44%), Gaps = 41/250 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL--KPEGFQGHKEWLTEVNYLGQLHH 147
+GEG +G V+K ++ +G +VA+KK + K L E+ L QL H
Sbjct: 9 IGEGSYGVVFKC---RNR------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 148 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
PNLV LI + +L LV+E+ L + + P+ + + K+ + + F
Sbjct: 60 PNLVNLI-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAPE 264
H + I+RD K NIL+ + KL DFG A+ GP D T + T Y APE
Sbjct: 117 H--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPE 170
Query: 265 Y-VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323
V + DV++ G V ELL+G Q L W P SD +L+ I
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG------------QPL--W--PGKSDVDQLYLIR 214
Query: 324 DTKLGGQYPQ 333
T LG P+
Sbjct: 215 KT-LGDLIPR 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 115 SGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
+G VAVKK+ Q + EV + HPN+V++ L G+ +V EF+ G+
Sbjct: 43 TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102
Query: 175 LENHLFRRGPQPLSWAVRMK------VAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDA 227
L + + RM V + K L+FLH +Q VI+RD K+ +ILL +
Sbjct: 103 LTD---------IVTHTRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTS 150
Query: 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 287
+ KLSDFG ++GT + APE ++ T+ D++S G++++E+
Sbjct: 151 DGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 288 LSG 290
+ G
Sbjct: 209 VDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 8e-17
Identities = 71/209 (33%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLH 146
+G G FG VY D + VVA+KK+ G Q +++W + EV +L QL
Sbjct: 23 IGHGSFGAVYFAR-DVRT--------NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGS----LENHLFRRGPQPLSWAVRMKVAIGAAKG 202
HPN ++ G L LV E+ GS LE H ++ Q + A + GA +G
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KKPLQEVEIAA---ICHGALQG 127
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYA 261
L +LH E I+RD KA NILL KL+DFG A P + +GT +
Sbjct: 128 LAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWM 178
Query: 262 APEYVAT---GRLTTKSDVYSFGVVLLEL 287
APE + G+ K DV+S G+ +EL
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 56/296 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGW-IDQHSLSPAKPGSGMVVAVKKLK--PEGFQGHKEWLT-- 137
N+R LLG+G FG VY + +D +G +A K+++ PE + KE
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVD----------TGRELAAKQVQFDPESPETSKEVSALE 52
Query: 138 -EVNYLGQLHHPNLVKLIGYCLE--GENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRM 193
E+ L L H +V+ G CL E L ++ E+MP GS+++ L G L+ +V
Sbjct: 53 CEIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTR 109
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------AGPTGDR 247
K +G+++LH + +++RD K +NIL D+ N KL DFG +K TG R
Sbjct: 110 KYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
+ V GT + +PE ++ K+DV+S G ++E+L+
Sbjct: 168 S-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT------------------ 204
Query: 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA--ATLALQCLNNEPKLRPRMSEVL 361
KP ++ + I PQ +H + A L C+ E + RP E+L
Sbjct: 205 -EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 47/281 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEV 139
+F +LG+G FG V + + G+ + A+K LK + + + E
Sbjct: 1 DFNFLMVLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMK 194
L P + + C + +RL V E++ G L H+ + G PQ + +A +
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
V GL FLH +IYRD K N++LD+E + K++DFG+ K T +
Sbjct: 112 V------GLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
GT Y APE +A D +++GV+L E+L+G+ D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-----------------E 204
Query: 315 DKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D+ +LF+ IM+ + YP+ + A ++ + P R
Sbjct: 205 DEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 146 HHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
+HP LV L C + E+RL V E++ G L H+ R+ P A I A L
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LN 110
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAP 263
+LH E +IYRD K N+LLD+E + KL+D+G+ K G GD T + GT Y AP
Sbjct: 111 YLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAP 165
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323
E + D ++ GV++ E+++GR D VG + P + + LF+++
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD--IVGSSDN------PDQNTEDYLFQVI 217
Query: 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
K + P+ + AA++ LN +PK R
Sbjct: 218 LEK-QIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G G +G VYK D + G +VA+K +K E + E++ L + HPN
Sbjct: 11 IGSGTYGDVYKA-RDIAT--------GELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V G L + +V E+ GSL++ +++ PLS V KGL +LH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV----------MGTHG 259
E+ I+RD K +NILL + + KL+DFG VS Q+ +GT
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSFIGTPY 166
Query: 260 YAAPEYVA---TGRLTTKSDVYSFGVVLLEL 287
+ APE A G K D+++ G+ +EL
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 74/280 (26%), Positives = 111/280 (39%), Gaps = 47/280 (16%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG+G F +YKG Q L PG + V +K L + + + + + QL H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+LVKL G C+ EN ++V E++ G L+ L R +S ++ VA A L +L D
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 209 AESQVIYRDFKASNILL----DAEFN---AKLSDFGLAK-AGPTGDRTHVSTQVMGTHGY 260
++++ + NIL+ E KLSD G+ +R +
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI------ 171
Query: 261 AAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-- 316
APE + G+ LT +D +SFG LLE+ S + LS
Sbjct: 172 -APECIRNGQASLTIAADKWSFGTTLLEICS------------------NGEEPLSTLSS 212
Query: 317 -RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
K D + P A L QC +P RP
Sbjct: 213 SEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 80/316 (25%), Positives = 135/316 (42%), Gaps = 39/316 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HH 147
LGEG FG V + + KP + VAVK LK + + + ++E+ + + H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + L++ +
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A A+G+ +L A + I+RD A N+L+ + K++DFGLA+ D +T
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ APE + T +SDV+SFGV+L E+ + +G PY
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---------LG--------GSPYP 238
Query: 314 S-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LEAPK 371
+LF+++ P H + +C + P RP +++ L+R L
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298
Query: 372 NSAKLSQSEPHRQTGP 387
L S P Q P
Sbjct: 299 TDEYLDLSVPFEQYSP 314
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQ 144
S +GEG +G V + + G+ VA+KK+ P F+ + L E+ L +
Sbjct: 11 SYIGEGAYGMVCSA-THKPT--------GVKVAIKKISP--FEHQTFCQRTLREIKILRR 59
Query: 145 LHHPNLVK----LIGYCLEGENRL-LVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIG 198
H N++ + E N + +V E M E L++ Q LS
Sbjct: 60 FKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQ 114
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGT 257
+GL ++H A V++RD K SN+LL+ + K+ DFGLA+ A P D T T+ + T
Sbjct: 115 ILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 258 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
Y APE + + TK+ D++S G +L E+LS R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 136 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L E+ L L HPN++ + ++ L+ E+ G+L + + R+ Q + +
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
++++H A +++RD K NI L KL DFG++K G ++ V+
Sbjct: 107 LFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV 162
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315
GT Y +PE + KSD+++ G VL EL + +T +
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYEL----LTLKRTFDATNPLNLVV------- 211
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLAL--QCLNNEPKLRPRMSEVLA 362
+I+ G P + +++ ++L L +P+ RP EVL
Sbjct: 212 -----KIVQ---GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 36/213 (16%)
Query: 92 EGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLGQLH 146
EG +G VY+ + + G +VA+KKLK + KE L E+N L +L
Sbjct: 15 EGTYGVVYRA---RDKKT------GEIVALKKLK---MEKEKEGFPITSLREINILLKLQ 62
Query: 147 HPNLVKL----IGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGA 199
HPN+V + +G L + +V E++ K +E QP + + +
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQL 115
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
G+ LHD + +++RD K SN+LL+ K+ DFGLA+ G TQ++ T
Sbjct: 116 LSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171
Query: 260 YAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y APE + +T D++S G + ELL+ +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 38/216 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-------WLTEVNYL 142
+GEG +G VY+ SG +VA+KK++ + E L E+ L
Sbjct: 15 IGEGTYGIVYRARDTT---------SGEIVALKKVRMD-----NERDGIPISSLREITLL 60
Query: 143 GQLHHPNLVKL----IGYCLEGENRLLVYEFMPK--GSLENHLFRRGPQPLSWAVRMKVA 196
L HPN+V+L +G L+ + LV E+ + SL +++ P P S + +
Sbjct: 61 LNLRHPNIVELKEVVVGKHLD--SIFLVMEYCEQDLASLLDNM----PTPFSESQVKCLM 114
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
+ +GL +LH E+ +I+RD K SN+LL + K++DFGLA+ G T +
Sbjct: 115 LQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVV 170
Query: 257 THGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T Y APE + T + D+++ G +L ELL+ +
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 48/302 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQL-HH 147
LGEG FG V + L KP VAVK LK + + + ++E+ + + H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + LS+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A A+G+ +L A + I+RD A N+L+ + K++DFGLA+ D H+
Sbjct: 144 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 196
Query: 254 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308
T+G + APE + T +SDV+SFGV+L E+ + +G
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LG-------- 239
Query: 309 AKPYLS-DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
PY +LF+++ P + + C + P RP +++ L+R+
Sbjct: 240 GSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
Query: 368 EA 369
A
Sbjct: 300 LA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT--EVNYLGQLH 146
+LG+G FG V+ ++ P +G + A+K LK + T E + L +++
Sbjct: 3 VLGQGSFGKVFL----VRKITG--PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 147 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWA---VRMKVAIGAAKG 202
HP +VKL Y + E +L L+ +F+ G L F R + + + V+ +A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLA-ELALA 110
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L LH +IYRD K NILLD E + KL+DFGL+K ++ S GT Y A
Sbjct: 111 LDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 166
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCA------------VDKTKVGIEQSLVDWAK 310
PE V T +D +SFGV++ E+L+G + K K+G+ Q L A+
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 226
Query: 311 PYLSDKRKLFR 321
L R LF+
Sbjct: 227 SLL---RALFK 234
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-16
Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVN 140
FR +LG+GGFG V + +G + A KKL+ + + G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52
Query: 141 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L +++ +V L Y E ++ L LV M G L+ H++ G + A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
GL LH + +++YRD K NILLD + ++SD GLA P G + +V GT G
Sbjct: 112 CCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
Y APE V R T D ++ G +L E+++G+ + K I KR+
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--------------KREE 212
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ ++ +Y +K + A +L L +PK R
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 71/211 (33%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
+LG+G FG V L+ K SG + AVK LK + + +TE L
Sbjct: 2 VLGKGSFGKVM--------LARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 146 H-HPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHL--FRRGPQPLS--WAVRMKVAIGA 199
HP L +L C + +RL V EF+ G L H+ RR + + +A + A
Sbjct: 53 RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--- 108
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
L FLHD +IYRD K N+LLD E + KL+DFG+ K G +T ++ GT
Sbjct: 109 ---LMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPD 161
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
Y APE + D ++ GV+L E+L G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 81/295 (27%), Positives = 123/295 (41%), Gaps = 44/295 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHP 148
+G+G FG V+KG ID + VVA+K + E + E + E+ L Q P
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+ K G L+ ++ E++ GS + L P PL + KGL +LH
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHS 119
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
+ I+RD KA+N+LL KL+DFG+ AG D +GT + APE +
Sbjct: 120 EKK--IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 269 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 326
+K+D++S G+ +EL G P+ L + LF I
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE------------------PPHSELHPMKVLFLIPKNN 217
Query: 327 ---LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 378
L G Y + CLN EP RP E+L + K ++ L++
Sbjct: 218 PPTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTE 268
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 40/296 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEV 139
NFR + +G G F VY+ G+ VA+KK++ + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---------TCLLDGVPVALKKVQIFDLMDAKARADCIKEI 53
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI 197
+ L QL+HPN++K +E +V E G L + F++ + + K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
L +H +V++RD K +N+ + A KL D GL + + +T + ++GT
Sbjct: 114 QLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317
Y +PE + KSD++S G +L E+ + P+ DK
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA------------------LQSPFYGDKM 211
Query: 318 KLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369
L+ + YP + L C+N +P+ RP ++ V + +R+ A
Sbjct: 212 NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 56/203 (27%), Positives = 83/203 (40%), Gaps = 25/203 (12%)
Query: 93 GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEV-----NYLGQLHH 147
G FG VY K +G A+K LK + +T V + Q
Sbjct: 7 GAFGSVYLA---------KKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGES 56
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
P + KL + LV E++ G + + G P WA + G+ LH
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWA--KQYIAEVVLGVEDLH 114
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+I+RD K N+L+D + KL+DFGL++ G + + +GT Y APE +
Sbjct: 115 Q--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETIL 166
Query: 268 TGRLTTKSDVYSFGVVLLELLSG 290
SD +S G V+ E L G
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 67/205 (32%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLH 146
+G G FG VY + VVA+KK+ G Q +++W + EV +L +L
Sbjct: 23 IGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
HPN ++ G L LV E+ GS + L +PL V GA +GL +L
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEY 265
H +I+RD KA NILL KL DFG A P + +GT + APE
Sbjct: 132 HS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEV 182
Query: 266 VAT---GRLTTKSDVYSFGVVLLEL 287
+ G+ K DV+S G+ +EL
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 33/249 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEW--LTEV 139
+ +G G FG V+ + +S A+K + PE + +E E
Sbjct: 2 DLERIKTVGTGTFGRVHL---VRDRIS------EHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
L ++ HP +++L + E + R L + E++P G L ++L G S + I
Sbjct: 53 RVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
A L +LH E ++YRD K NILLD E + KL+DFG AK DRT + GT
Sbjct: 111 VCA--LEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGT 161
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQSLVDWAKPYLSDK 316
Y APE + + D ++ G+++ E+L G D GI + + L+ K
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI-------LAGK 214
Query: 317 RKLFRIMDT 325
+ R +D
Sbjct: 215 LEFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 147 HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
+P LV L C + +RL LV E++ G L H+ R+ P A I A L F
Sbjct: 55 NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNF 111
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHGYAAPE 264
LH E +IYRD K N+LLDA+ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE 166
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324
+ D ++ GV++ E+++GR D + P ++ + LF+++
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITDNPDMNTEDYLFQVIL 216
Query: 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
K + P+ + A+ + LN +PK R
Sbjct: 217 EK-PIRIPRFLSVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 2e-15
Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLH 146
+G G FG VY + + VVA+KK+ G Q +++W + EV +L ++
Sbjct: 33 IGHGSFGAVYFA----RDVRTNE-----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
HPN ++ G L LV E+ GS + L +PL + GA +GL +L
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEY 265
H +I+RD KA NILL KL+DFG A A P + +GT + APE
Sbjct: 142 H--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEV 192
Query: 266 VAT---GRLTTKSDVYSFGVVLLEL 287
+ G+ K DV+S G+ +EL
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 25/209 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LTEVNYLGQ 144
+GEG +G VYK +G +VA+KK++ E E + E++ L +
Sbjct: 7 IGEGTYGVVYKA----RDKL-----TGEIVALKKIRLET---EDEGVPSTAIREISLLKE 54
Query: 145 LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
L+HPN+V+L+ + EN+L LV+EF+ L+ ++ L + +G+
Sbjct: 55 LNHPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
+ H +V++RD K N+L+D E KL+DFGLA+A RT+ T + T Y AP
Sbjct: 113 AYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVVTLWYRAP 168
Query: 264 EYVATGRL-TTKSDVYSFGVVLLELLSGR 291
E + R +T D++S G + E+++ R
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQL-HH 147
LGEG FG V + + KP + VAVK LK + + + ++E+ + + H
Sbjct: 23 LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + +++ +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A+G+ +L A + I+RD A N+L+ K++DFGLA+ D +T
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + T +SDV+SFGV++ E+ +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 68/230 (29%), Positives = 103/230 (44%), Gaps = 32/230 (13%)
Query: 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL 136
L T F ++GEG +G VYK + + G +VA+K + +E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIE-DEEEEIK 50
Query: 137 TEVNYLGQL-HHPNLVKLIGYCLE-----GENRL-LVYEFMPKGS---LENHLFRRGPQP 186
E N L + +HPN+ G ++ +++L LV E GS L L ++G +
Sbjct: 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KR 109
Query: 187 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTG 245
L + +GL +LH E++VI+RD K NILL KL DFG+ A+ T
Sbjct: 110 LKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 246 DRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG 290
R + GT + APE +A +SDV+S G+ +EL G
Sbjct: 168 GRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEV 139
N+R LLG+G FG VY + A G + V + PE + KE E+
Sbjct: 3 NWRLGKLLGQGAFGRVYLCY-------DADTGRELAVKQVQFDPESPETSKEVNALECEI 55
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
L L H +V+ G + R L E MP GS+++ L G L+ V K
Sbjct: 56 QLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTR 113
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VMG 256
+G+++LH + +++RD K +NIL D+ N KL DFG +K T + + V G
Sbjct: 114 QILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T + +PE ++ K+D++S G ++E+L+ +
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 21/204 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G FG VYK + +G++ A K + + + ++++ E++ L HPN
Sbjct: 13 LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+VKL+ N ++ EF G+++ + +PL+ V + L +LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH-- 120
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYV-- 266
E+++I+RD KA NIL + + KL+DFG+ AK T R +GT + APE V
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---RDSFIGTPYWMAPEVVMC 177
Query: 267 ATGR---LTTKSDVYSFGVVLLEL 287
T + K+DV+S G+ L+E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHP 148
+G+G G VY + +G VA+K++ + Q KE + E+ + + HP
Sbjct: 27 IGQGASGTVY---------TAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V + L G+ +V E++ GSL + + A + + A L FLH
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LEFLH- 132
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
+QVI+RD K+ NILL + + KL+DFG A T +++ ST V GT + APE V
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 269 GRLTTKSDVYSFGVVLLELLSG 290
K D++S G++ +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 33/275 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVN 140
FR +LG+GGFG V + +G + A KKL+ + + G L E
Sbjct: 2 FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52
Query: 141 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L +++ +V L Y E ++ L LV M G L+ H++ G + A
Sbjct: 53 ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL 111
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
GL L +++YRD K NILLD + ++SD GLA P G+ V +V GT G
Sbjct: 112 CCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVG 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
Y APE + + T D + G ++ E++ G+ K K +++ VD
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR----------- 215
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
R+ + + +Y +K + A ++ L PK R
Sbjct: 216 -RVKEDQ--EEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL---KPEGFQGHKE-------WLTE 138
LG G FG VYK + + + ++A+K++ P + +E ++E
Sbjct: 7 HLGSGAFGCVYK--VRKKN------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 139 VNYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF------RRGPQPLSWAV 191
V + QL HPN+V+ LE + +V + + L H +R + W +
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+++ + L +LH E ++++RD +NI+L + ++DFGLAK
Sbjct: 119 FVQMVLA----LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKL 170
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 287
T V+GT Y+ PE V K+DV++FG +L ++
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLG-Q 144
+LG+G FG V+ L+ K G+ A+K LK + + + E L
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 145 LHHPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
HP L L YC EN V E++ G L H+ L A I G
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--ICG 108
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L FLH ++YRD K NILLD + + K++DFG+ K GD + GT Y A
Sbjct: 109 LQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIA 164
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE + + T D +SFGV+L E+L G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 76/215 (35%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHP 148
+G+G +G VYK ++ K GS + AVK L P +E E N L L +HP
Sbjct: 30 IGKGTYGKVYK-------VTNKKDGS--LAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79
Query: 149 NLVKLIGYC-----LEGENRLLVYEFMPKGS---LENHLFRRGPQPLSWAVRMKVAIGAA 200
N+VK G L G LV E GS L L G Q L A+ + GA
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QRLDEAMISYILYGAL 138
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
GL LH+ +++I+RD K +NILL E KL DFG++ A T R +T V GT +
Sbjct: 139 LGLQHLHN--NRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSV-GTPFW 194
Query: 261 AAPEYVATGR-----LTTKSDVYSFGVVLLELLSG 290
APE +A + + DV+S G+ +EL G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 148 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTF 205
P LV L Y + + +L L+ +++ G L HL++R S VR+ +A I A L
Sbjct: 65 PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA--LDH 120
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTHGYAAP 263
LH + +IYRD K NILLD+E + L+DFGL+K +R + GT Y AP
Sbjct: 121 LH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175
Query: 264 EYVATGRLTTKS--DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
E + G D +S GV+ ELL+G A T G + S + ++ R
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG--ASPFTVDGEQNSQSEISR----------R 223
Query: 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
I+ +K +P+ + A + L +PK R
Sbjct: 224 ILKSKP--PFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 49/147 (33%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 147 HPNLVKLIGYCL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP L L +C E+ V E++ G L H+ G + A I GL
Sbjct: 55 HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--ICGLQ 110
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
FLH + +IYRD K N+LLD + + K++DFG+ K G+ ++ GT Y APE
Sbjct: 111 FLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE 166
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGR 291
+ + D +SFGV+L E+L G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 33/275 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVN 140
FR +LG+GGFG V + +G + A K+L+ + + G L E
Sbjct: 2 FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52
Query: 141 YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L +++ +V L Y E ++ L LV M G L+ H++ G + A
Sbjct: 53 ILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
GL LH +YRD K NILLD + ++SD GLA P G+ +GT G
Sbjct: 112 LCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVG 166
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
Y APE + R T D + G ++ E++ G+ K +++ VD
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----------- 215
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
R+++T+ Y K + A ++ L +PK R
Sbjct: 216 -RVLETE--EVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 40/295 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK---PEGFQGHKEWLTEV 139
NF+ + +G G F VY+ L KP VA+KK++ + ++ + E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRA----TCLLDRKP-----VALKKVQIFEMMDAKARQDCVKEI 53
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI 197
+ L QL+HPN++K + +E +V E G L + F++ + + K +
Sbjct: 54 DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
+ +H +V++RD K +N+ + A KL D GL + + +T + ++GT
Sbjct: 114 QLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317
Y +PE + KSD++S G +L E+ QS P+ DK
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM------------AALQS------PFYGDKM 211
Query: 318 KLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368
LF + YP + + L C+ +P RP + V I +++
Sbjct: 212 NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH 146
+G G G VYK + +G V+AVK+++ G + +K L +++ + + H
Sbjct: 21 GEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH 71
Query: 147 H-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
P +VK GY + + + E M + + L +R P+ + K+ + K L +
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
L + + VI+RD K SNILLDA N KL DFG+ +G D + T+ G Y APE
Sbjct: 130 LKE-KHGVIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTRSAGCAAYMAPER 185
Query: 266 V----ATGRLTTKSDVYSFGVVLLELLSGR 291
+ + ++DV+S G+ L+EL +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 35/215 (16%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLG-Q 144
+LG+G FG V + G+ V A+K LK + + +TE L
Sbjct: 2 VLGKGSFGKV---------MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 145 LHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLF-----RRGPQPLS--WAVRMKVA 196
HP L L C + ++RL V E++ G L +F R+ +P S +A + +A
Sbjct: 53 AKHPFLTALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLA 108
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
L FLH VIYRD K NILLDAE + KL+DFG+ K G T +T G
Sbjct: 109 ------LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCG 158
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T Y APE + D ++ GV++ E+++G+
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 49/287 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNY-LGQLHH 147
LG G +G V K +H +G ++AVK+++ Q K L +++ + +
Sbjct: 9 LGRGAYGVVDKM---RH------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLEN---HLFRRG---PQPLSWAVRMKVAIGAAK 201
P V G + + E M SL+ ++ +G P+ + K+A+ K
Sbjct: 60 PYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPED----ILGKIAVSIVK 114
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
L +LH ++ VI+RD K SN+L++ KL DFG+ +G D + T G Y
Sbjct: 115 ALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVD-SVAKTIDAGCKPYM 170
Query: 262 APEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAKPYLSD 315
APE + KSDV+S G+ ++EL +GR D K +Q +V+ P L
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA 230
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
++ D +CL K RP E+L
Sbjct: 231 EKFSPEFQD-----------------FVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 87/306 (28%), Positives = 130/306 (42%), Gaps = 68/306 (22%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LTEVNYLG 143
LG+G FG VY + +G +VA+KK+K + W L EV L
Sbjct: 7 LGDGTFGSVYLARNKE----------TGELVAIKKMK----KKFYSWEECMNLREVKSLR 52
Query: 144 QL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+L HPN+VKL E + V+E+M +G+L + R +P S +V + +G
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR----THVSTQVMGTH 258
L +H +RD K N+L+ K++DFGLA+ R +VST+
Sbjct: 112 LAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR----- 162
Query: 259 GYAAPEYVATGRLTTKS---DVYSFGVVLLELLS------GRCAVD---KTKVGIEQSLV 306
Y APE + R T+ S D+++ G ++ EL + G +D K I L
Sbjct: 163 WYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK----ICSVLG 216
Query: 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPKLRP 355
K + KL KLG ++PQ A+ A L L +PK RP
Sbjct: 217 TPTKQDWPEGYKLAS----KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP 272
Query: 356 RMSEVL 361
S+ L
Sbjct: 273 TASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-LTEVNY 141
NF+ LGEG + VYKG +G +VA+K++ + +G + E++
Sbjct: 1 NFKQLEKLGEGTYATVYKG---------RNRTTGEIVALKEIHLDAEEGTPSTAIREISL 51
Query: 142 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGA 199
+ +L H N+V+L + EN+L LV+E+M K L+ ++ G L
Sbjct: 52 MKELKHENIVRLHD-VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL 109
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
KG+ F H E++V++RD K N+L++ KL+DFGLA+A T + V T
Sbjct: 110 LKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165
Query: 260 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
Y AP+ + R +T D++S G ++ E+++GR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 41/222 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK----KLKPEGFQGHKEWLTE 138
+F LG G G V K H +P SG+++A K ++KP + + E
Sbjct: 2 DFEKLGELGAGNGGVVTKV---LH-----RP-SGLIMARKLIHLEIKPAI---RNQIIRE 49
Query: 139 VNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
+ L + + P +V G + +GE + + E M GSL+ L + G P + + K++I
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEN--ILGKISI 106
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-- 255
+GLT+L + + ++++RD K SNIL+++ KL DFG VS Q++
Sbjct: 107 AVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG------------VSGQLIDS 153
Query: 256 ------GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
GT Y +PE + T +SD++S G+ L+E+ GR
Sbjct: 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G FG VYK +G + A K ++ + + ++++ E+ L +HP
Sbjct: 20 LGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 150 LVKLIG-YCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFL 206
+VKL+G + +G+ +++ EF P G+++ + RG V + + A L +L
Sbjct: 71 IVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA---LQYL 126
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEY 265
H ++I+RD KA N+LL + + KL+DFG+ AK T R +GT + APE
Sbjct: 127 H--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEV 181
Query: 266 VATGRLTT-----KSDVYSFGVVLLEL 287
V + K+D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 80/271 (29%), Positives = 112/271 (41%), Gaps = 40/271 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
LLG+G FG V + + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKV---------ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP L L Y + +RL V E+ G L HL R A I +A L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LG 109
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH V+YRD K N++LD + + K++DFGL K G + T GT Y APE
Sbjct: 110 YLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPE 165
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IM 323
+ D + GVV+ E++ GR Y D KLF I+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELIL 208
Query: 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
++ ++P+ + A +L L +PK R
Sbjct: 209 MEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 19/214 (8%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEV 139
N+R LLG G FG VY + A G + V P+ + KE E+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCY-------DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55
Query: 140 NYLGQLHHPNLVKLIGYCLEG--ENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
L L H +V+ G CL E +L ++ E+MP GS+++ L G L+ V +
Sbjct: 56 QLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYT 112
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ-VM 255
+G+++LH + +++RD K +NIL D+ N KL DFG +K T + + V
Sbjct: 113 RQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
GT + +PE ++ K+DV+S ++E+L+
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 28/207 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGM-VVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+GEG FG +Y L+ AK S V+ L + + EV L ++ HP
Sbjct: 8 IGEGSFGKIY--------LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 149 NLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR-RG-----PQPLSWAVRMKVAIGAAK 201
N+V + RL +V E+ G L + R RG Q LSW V++ +
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------ 112
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
GL +HD ++++RD K+ NI L AKL DFG+A+ D ++ +GT Y
Sbjct: 113 GLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYY 168
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLEL 287
+PE K+D++S G VL EL
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLH 146
LG G FG V I +H G+G A+K LK K+ E + L +L
Sbjct: 26 LGTGSFGRVR---IAKHK------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 147 HPNLVKLIGYC-LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP +V + C + ENR+ + EF+ G L HL + G P A + A
Sbjct: 77 HPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--FE 132
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH +IYRD K N+LLD + + K++DFG AK P DRT + GT Y APE
Sbjct: 133 YLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPE 185
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSG 290
+ + D ++ GV+L E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 4e-14
Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 7/175 (4%)
Query: 116 GMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL 175
G VA+K++ + + + E+ + +L +PN+V + L G+ +V E++ GSL
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 176 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235
+ + A + + A L FLH +QVI+RD K+ N+LL + + KL+D
Sbjct: 104 TDVVTETCMDEAQIAAVCRECLQA---LEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTD 158
Query: 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
FG A T +++ ST V GT + APE V K D++S G++ +E++ G
Sbjct: 159 FGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 49/230 (21%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH----KEWLTEV 139
+ +G G +G V +D+ + G VA+KK+ F K L E+
Sbjct: 2 YELLKPIGSGAYGVVCSA-VDKRT--------GRKVAIKKI-SNVFD-DLIDAKRILREI 50
Query: 140 NYLGQLHHPNLVKLIG-------------YCLEGENRLLVYEFMPKGSLENHLFR--RGP 184
L L H N++ L+ Y +V E M E L + + P
Sbjct: 51 KLLRHLRHENIIGLLDILRPPSPEDFNDVY--------IVTELM-----ETDLHKVIKSP 97
Query: 185 QPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-G 242
QPL+ ++ + +GL +LH A VI+RD K SNIL+++ + K+ DFGLA+
Sbjct: 98 QPLT-DDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
P D T+ + T Y APE + + TK+ D++S G + ELL+ +
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 77/271 (28%), Positives = 114/271 (42%), Gaps = 40/271 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
LLG+G FG V + + +G A+K L+ E E +TE L
Sbjct: 2 LLGKGTFGKV---------ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP L L Y + +RL V E+ G L HL R A I +A L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LE 109
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH + V+YRD K N++LD + + K++DFGL K G + T + GT Y APE
Sbjct: 110 YLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 165
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IM 323
+ D + GVV+ E++ GR Y D +LF I+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHERLFELIL 208
Query: 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
++ ++P+ + A +L L +PK R
Sbjct: 209 MEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQ-L 145
+G+G FG V + +H G AVK L+ + KE + E N L + +
Sbjct: 3 IGKGSFGKVL---LAKHKAD------GKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR--RGPQPLS--WAVRMKVAIGAA 200
HP LV L Y + ++L V +++ G L HL R P+P + +A + A+G
Sbjct: 54 KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG-- 110
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+LH +IYRD K NILLD++ + L+DFGL K G +T ++ GT Y
Sbjct: 111 ----YLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEY 162
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
APE + D + G VL E+L G
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 39/213 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY-------L 142
+G+GG+G V ++ + K +G +VA+K++K L EV + L
Sbjct: 9 VGQGGYGQV---FLAK------KKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55
Query: 143 GQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAI 197
LVKL+ Y + + L L E++P G L G + M A+
Sbjct: 56 TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
A L ++H RD K N L+DA + KL+DFGL+K T + V+G+
Sbjct: 115 DALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGS 161
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
Y APE + D +S G +L E L G
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLG-Q 144
+LG+G FG V + G G AVK LK + + + E L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
+P L L E+ V EF+ G L H+ +G L A I GL
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQ 110
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
FLH +IYRD K N++LD + + K++DFG+ K GD ++ GT Y APE
Sbjct: 111 FLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPE 166
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGR 291
+ + T D +SFGV+L E+L G+
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 79/273 (28%), Positives = 112/273 (41%), Gaps = 44/273 (16%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
LLG+G FG V + + SG A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKV---------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP L L Y + ++RL V E++ G L HL R + S L
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALD 109
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH +++YRD K N++LD + + K++DFGL K G T T + GT Y APE
Sbjct: 110 YLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM- 323
+ D + GVV+ E++ GR Y D KLF ++
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELIL 208
Query: 324 --DTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D K +P+ + A +L L +P R
Sbjct: 209 MEDIK----FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 80/270 (29%), Positives = 113/270 (41%), Gaps = 37/270 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
LLG+G FG V + + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKV---------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
HP L L Y + +RL V E+ G L HL R A I +A L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LD 109
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+LH +E V+YRD K N++LD + + K++DFGL K G T + GT Y APE
Sbjct: 110 YLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 166
Query: 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324
+ D + GVV+ E++ GR Y D KLF ++
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----------------YNQDHEKLFELIL 209
Query: 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ ++P+ + A +L L +PK R
Sbjct: 210 ME-EIRFPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLTEVNYLG 143
+GEG +G VYK D+ + G +VA+KK++ EGF + E+ L
Sbjct: 13 GQIGEGTYGQVYKA-RDKDT--------GELVALKKVRLDNEKEGFP--ITAIREIKILR 61
Query: 144 QLHHPNLVKL----------IGYCLEGENRLLVYEFMPK---GSLENHLFRRGPQPLSWA 190
QL+H N+V L + + + LV+E+M G LE+ L +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI--K 119
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
MK + +GL + H ++RD K SNILL+ + KL+DFGLA+ + +
Sbjct: 120 SFMKQLL---EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 251 STQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGR 291
+ +V+ T Y PE + R DV+S G +L EL + +
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQL 145
+LG+G FG V L+ K G+ + A+K LK + + + E L
Sbjct: 7 VLGKGSFGKV--------MLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVRMKVAIGAA 200
P + + C + +RL V E++ G L + + G P + +A + +
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI----- 112
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
GL FLH +IYRD K N++LD+E + K++DFG+ K T + GT Y
Sbjct: 113 -GLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDY 167
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295
APE +A D ++FGV+L E+L+G+ +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK----KLKPEGFQGHKEWLTE 138
+F S LG G G V K QH KP SG+++A K ++KP + + E
Sbjct: 6 DFERISELGAGNGGVVTKV---QH-----KP-SGLIMARKLIHLEIKP---AIRNQIIRE 53
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVA 196
+ L + + P +V G + E M GSL+ L +R P+ + KV+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVS 109
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
I +GL +L + + Q+++RD K SNIL+++ KL DFG++ G D ++ +G
Sbjct: 110 IAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 164
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T Y +PE + + +SD++S G+ L+EL GR
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-LTEVNYLGQLH 146
LL EG FG ++ G ID KPG V VK +K + L E L L
Sbjct: 13 LLQEGTFGRIFYGILID------EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 147 HPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHL------FRRGPQPLSWAVRMKVAIGA 199
H N++ ++ C+E GE ++Y +M G+L+ L PQ LS + +AI
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPT-----GDRTHVSTQ 253
A G+++LH VI++D A N ++D E K++D L++ P GD + +
Sbjct: 127 ACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
M A E + ++ SDV+SFGV+L EL++
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 40/281 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+LG+G +G VY + +A+K++ + + E+ L H
Sbjct: 15 VLGKGTYGIVYAARDLSTQVR---------IAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLH 207
N+V+ +G E + E +P GSL L + GP + + +GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 208 DAESQVIYRDFKASNILLDAEFNA-KLSDFG----LAKAGPTGDRTHVSTQVMGTHGYAA 262
D +Q+++RD K N+L++ K+SDFG LA P + GT Y A
Sbjct: 126 D--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177
Query: 263 PEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
PE + G +D++S G ++E+ +G+ ++ +P + +F
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK-----------PPFIELGEPQAA----MF 222
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
++ K+ + P+ + A L+C +P R ++L
Sbjct: 223 KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 4e-13
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 44/220 (20%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL------KPEGFQGHKEWLTEVNYLG 143
LG+GGFG V + +G + A KKL K +G++G + E L
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILA 48
Query: 144 QLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR--------RGPQPLSWAVRMK 194
++H +V L Y + + L LV M G L H++ P+ + ++
Sbjct: 49 KVHSRFIVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI- 106
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVS 251
GL LH + ++IYRD K N+LLD + N ++SD GLA K G + + +
Sbjct: 107 -----ISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA- 158
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
GT G+ APE + D ++ GV L E+++ R
Sbjct: 159 ----GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 115 SGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
+G VAVKK+ Q + EV + HH N+V + L G+ +V EF+ G+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 175 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234
L + + A V + + L++LH+ VI+RD K+ +ILL ++ KLS
Sbjct: 106 LTDIVTHTRMNEEQIAT---VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLS 160
Query: 235 DFGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 288
DFG VS +V +GT + APE ++ T+ D++S G++++E++
Sbjct: 161 DFGFC--------AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 289 SG 290
G
Sbjct: 213 DG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVN 140
PD +G G FG V+ S P G VA+KK+ P FQ K E+
Sbjct: 2 VEPDRPIGYGAFGVVW---------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELK 51
Query: 141 YLGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L H N++ + E +V E M + L + PQPLS + +KV
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVS--PQPLS-SDHVKV 107
Query: 196 AI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
+ +GL +LH A +++RD K N+L+++ K+ DFGLA+ + H++ +V
Sbjct: 108 FLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 255 MGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGR 291
+ T Y APE + G T+ D++S G + ELL R
Sbjct: 166 V-TQYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 47/221 (21%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQG-HKEWLTEVNYLGQL 145
+ +GEG +G VYK +G VA+KK++ P +G L E+ L QL
Sbjct: 5 AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 146 ---HHPNLVKLIGYC----LEGENRL-LVYEFM-----------PKGSLENHLFRRGPQP 186
HPN+V+L+ C + E +L LV+E + PK L +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD---- 111
Query: 187 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246
L + +G+ FLH ++++RD K NIL+ ++ K++DFGLA+
Sbjct: 112 LMRQL--------LRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYS 158
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 287
T V+ T Y APE + T D++S G + EL
Sbjct: 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G+G G VY + +G VA+K++ + + + E+ + + +PN
Sbjct: 27 IGQGASGTVY---------TAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V + L G+ +V E++ GSL + + A + + A L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LDFLH-- 132
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 269
+QVI+RD K+ NILL + + KL+DFG A T +++ ST V GT + APE V
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRK 190
Query: 270 RLTTKSDVYSFGVVLLELLSG 290
K D++S G++ +E++ G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEV 139
++P +G G +G V S SG VA+KK+ P F K L E+
Sbjct: 6 RYKPIENIGSGAYGVV---------CSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLREL 55
Query: 140 NYLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRM 193
L H N++ + + ++ +V + M E+ L QPL+
Sbjct: 56 KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTEEHIR 110
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG--DRTHVS 251
+GL ++H A VI+RD K SN+L++ + ++ DFG+A+ + + +
Sbjct: 111 YFLYQLLRGLKYIHSA--NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 252 TQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 291
T+ + T Y APE + + TT D++S G + E+L GR
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK----KLKPEGFQGHKEWLTE 138
+F S LG G G V+K KP SG+++A K ++KP + + E
Sbjct: 6 DFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKP---AIRNQIIRE 53
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
+ L + + P +V G + E M GSL+ L + G P + KV+I
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ--ILGKVSIA 111
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
KGLT+L + + ++++RD K SNIL+++ KL DFG++ G D ++ +GT
Sbjct: 112 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 166
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
Y +PE + + +SD++S G+ L+E+ GR
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 81/263 (30%), Positives = 118/263 (44%), Gaps = 40/263 (15%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF------QGHKEWLTEVNY 141
+LG+GG+G V++ + +G + A+K LK H + E N
Sbjct: 2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53
Query: 142 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L + HP +V LI Y + +L L+ E++ G L HL R G A I A
Sbjct: 54 LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA 112
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG-PTGDRTHVSTQVMGTHG 259
L LH + +IYRD K NILLDA+ + KL+DFGL K G TH GT
Sbjct: 113 --LEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIE 165
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAK----PY 312
Y APE + D +S G ++ ++L+G A ++ K I++ L K PY
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKILK--GKLNLPPY 222
Query: 313 LSD------KRKLFRIMDTKLGG 329
L+ K+ L R ++LG
Sbjct: 223 LTPEARDLLKKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 52/284 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVV---AVKKLKPEGFQGHKEWLTEVNYLGQLH 146
+GEG FG K + + + G V+ + K+ P + +E EV L +
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSP---KEREESRKEVAVLSNMK 57
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL-FRRG-----PQPLSWAVRMKVAIGAA 200
HPN+V+ E N +V ++ G L + +RG Q L W V++ +A
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---- 113
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
L +HD ++++RD K+ NI L + KL DFG+A+ ++ +GT Y
Sbjct: 114 --LKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYY 167
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
+PE KSD+++ G VL E+ + + A + G ++LV K+
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV----------LKII 214
Query: 321 RIMDTKLGGQYPQKAAHTAA---TLALQCLNNEPKLRPRMSEVL 361
R G YP ++H + L Q P+ RP ++ +L
Sbjct: 215 R-------GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 91 GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT---EVNYLGQLHH 147
G G +G VYK G A+KK K + Q + E+ L +L H
Sbjct: 9 GRGTYGRVYKAKRK-------NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 148 PNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI--GAAKGL 203
N+V L+ LE ++ L++++ + F R + +S M ++ G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLA-------KAGPTGDRTHVST 252
+LH + V++RD K +NIL+ E K+ D GLA K D
Sbjct: 122 HYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----- 174
Query: 253 QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 289
V+ T Y APE + R TK+ D+++ G + ELL+
Sbjct: 175 -VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 115 SGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
SG +VAVKK+ Q + EV + H N+V++ L G+ +V EF+ G+
Sbjct: 44 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 175 LENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232
L + + R + ++ V + K L+ LH VI+RD K+ +ILL + K
Sbjct: 104 LTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVK 156
Query: 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
LSDFG ++GT + APE ++ + D++S G++++E++ G
Sbjct: 157 LSDFGF--CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
+G G FG V K H SG ++AVK+++ + K L +++ + +
Sbjct: 11 EIGRGAFGTVNKML---H------KPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 148 -PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----RGPQPLSWAVRMKVAIGAAKG 202
P +VK G + + E M SL+ ++ + + K+A+ K
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +L + E ++I+RD K SNILLD N KL DFG+ +G D T+ G Y A
Sbjct: 120 LNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSI-AKTRDAGCRPYMA 175
Query: 263 PEYVATGRLT---TKSDVYSFGVVLLELLSGR 291
PE + +SDV+S G+ L E+ +G+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 2e-12
Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G+G G VY + +G VA++++ + + + E+ + + +PN
Sbjct: 28 IGQGASGTVY---------TAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V + L G+ +V E++ GSL + + A + + A L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA---LEFLH-- 133
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
+QVI+RD K+ NILL + + KL+DFG A+ P + + ++GT + APE V
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTR 190
Query: 269 GRLTTKSDVYSFGVVLLELLSG 290
K D++S G++ +E++ G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 64/294 (21%)
Query: 90 LGEGGFGFVY----KGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQ 144
LG+G FG VY K + + L K + V +L P E Q ++E L +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKE-----IPVGELNPNETVQANQE----AQLLSK 58
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRG------PQPLSWAVRMKVA 196
L HP +VK LE + ++ E+ L+ L + Q W +++ +
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
G+ ++H + ++++RD KA NI L K+ DFG+++ ++T G
Sbjct: 118 -----GVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTG 167
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-----IEQSLVDWAKP 311
T Y +PE + +KSD++S G +L E+ C + G + +V+ P
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM----CCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 312 YLSDK--RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
L + R+L IM + LN +P LRP +E+L
Sbjct: 224 SLPETYSRQLNSIMQSM--------------------LNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 36/215 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLTEVNYLGQL 145
+GEG +G VYK D+ + +A+KK++ EG + E++ L ++
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTA--IREISLLKEM 58
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL-----FRRGPQPL-SWAVRMKVAIG 198
H N+V+L + E RL LV+E++ L+ H+ F + P+ + ++ ++
Sbjct: 59 QHGNIVRLQD-VVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQI----- 111
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 257
+G+ + H +V++RD K N+L+D NA KL+DFGLA+A RT T + T
Sbjct: 112 -LRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVT 166
Query: 258 HGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGR 291
Y APE + R +T D++S G + E+++ +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 26/213 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
+G G FG V G ++ +PA+ V VK+L+ Q ++L E L H
Sbjct: 3 IGNGWFGKVILGEVNS-GYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR------GPQPLSWAVRMKVAIGAAKG 202
NL++ +G C E LLV EF P G L+ +L P P ++A A G
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT---TLQRMACEIALG 112
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L LH ++ I+ D N LL A+ K+ D+GL+ D Q+ + A
Sbjct: 113 LLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170
Query: 263 PEYV--ATGRL-----TTKSDVYSFGVVLLELL 288
PE V G L T +S+V+S GV + EL
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVN-YLGQ 144
++G+G FG V L + G AVK L+ + KE + E N L
Sbjct: 2 VIGKGSFGKV---------LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52
Query: 145 LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPLS--WAVRMKVAIGA 199
+ HP LV L Y + +L V +F+ G L HL R P+P + +A + A+G
Sbjct: 53 VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG- 110
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+LH ++YRD K NILLD++ + L+DFGL K G T +T GT
Sbjct: 111 -----YLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPE 161
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
Y APE + D + G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 74/293 (25%), Positives = 122/293 (41%), Gaps = 62/293 (21%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHP 148
LG+G +G VYK H +G+ +A+K+++ E + + + E++ L + P
Sbjct: 9 LGKGNYGSVYKVL---HR------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP 59
Query: 149 NLVKLIG-YCLEGENRLLVY---EFMPKGSL-----ENHLFRRGPQPLSWAVRMKVAIGA 199
+V G + +EG VY E+M GSL P+ V ++
Sbjct: 60 YIVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPED----VLRRITYAV 111
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD-RTHVSTQVMGTH 258
KGL FL + E +I+RD K +N+L++ KL DFG+ +G+ ++ +G
Sbjct: 112 VKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQ 165
Query: 259 GYAAPEYV----ATGRLT--TKSDVYSFGVVLLELLSGRCA----VDKTKVGIEQSLVDW 308
Y APE + T +SDV+S G+ +LE+ GR ++VD
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG 225
Query: 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
P L P + A +CLN P RP +++L
Sbjct: 226 DPPTL------------------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 85/314 (27%), Positives = 136/314 (43%), Gaps = 60/314 (19%)
Query: 17 SPRATSGASRISTRSSHSSAPS-TLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFT-- 73
+R +T+S P TLP+P ++ + LP P SSS+ A
Sbjct: 8 PGVPLPSTARHTTKSRPRRRPDLTLPLP-QRDPSLAVPLPLPPPSSSSSSSSSSSASGSA 66
Query: 74 ------FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE 127
+EL+ R +G G G VYK H +G + A+K +
Sbjct: 67 PSAAKSLSELERVNR-------IGSGAGGTVYKV---IHR------PTGRLYALKVI--- 107
Query: 128 GFQGHKEWLT-----EVNYLGQLHHPNLVKLIG-YCLEGENRLLVYEFMPKGSLENHLFR 181
+ H++ + E+ L ++HPN+VK + GE ++L+ EFM GSLE
Sbjct: 108 -YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSLEGTHIA 165
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
L+ VA G+ +LH +++RD K SN+L+++ N K++DFG+++
Sbjct: 166 DEQF-LA-----DVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 242 -GPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKS-DVYSFGVVLLELLSGRCAVD 295
T D + S +GT Y +PE + T G + D++S GV +LE GR
Sbjct: 218 LAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274
Query: 296 KTKVGIEQSLVDWA 309
+ G DWA
Sbjct: 275 VGRQG------DWA 282
|
Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 67/210 (31%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVN-YLGQ 144
++G+G FG V L + G AVK L+ + KE + E N L
Sbjct: 2 VIGKGSFGKV---------LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR----RGPQPLSWAVRMKVAIGAA 200
L HP LV L E V +++ G L HL R P+ +A + AIG
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG-- 110
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+LH +IYRD K NILLD++ + L+DFGL K G + T ++ GT Y
Sbjct: 111 ----YLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEY 162
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
APE + D + G VL E+L G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQG--- 131
E+ + +P +G G FG V S +G VA+KK+ KP F
Sbjct: 7 EITNRYVDLQP---VGMGAFGLV---------CSARDQLTGQNVAIKKIMKP--FSTPVL 52
Query: 132 HKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWA 190
K E+ L L H N++ L + E+ V E + G+ + L P +
Sbjct: 53 AKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFI 110
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
I +GL ++H A V++RD K SNIL++ + K+ DFGLA+ +
Sbjct: 111 QYFLYQI--LRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161
Query: 251 STQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGR 291
T + T Y APE + T + + D++S G + E+L G+
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 65/221 (29%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+ P +G G +G V S + VA+KK+ F K L
Sbjct: 4 DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLR 53
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGPQPLSWAV 191
E+ L L H N++ + + +R +VYE M + H R Q LS
Sbjct: 54 EIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDH 109
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+GL ++H A V++RD K SN+LL+A + K+ DFGLA+ T ++
Sbjct: 110 CQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFM 165
Query: 252 TQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGR 291
T+ + T Y APE + TT DV+S G + ELL GR
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 62/209 (29%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNYLGQLHH 147
++GEG FG + + QH S K A+K+++ P+ ++ E L ++ H
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK------YAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 148 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL-FRRG---PQP--LSWAVRMKVAIGAA 200
PN+V E + L +V E+ G L + +RG P+ L W V+M + +
Sbjct: 58 PNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ-- 114
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK--AGPTGDRTHVSTQVMGTH 258
H E +V++RD K+ NI L KL DFG A+ P + T V GT
Sbjct: 115 ------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTP 164
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLEL 287
Y PE KSD++S G +L EL
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL----KPEGFQGHKEWLTEVNYLGQL 145
+G+G FG V+K +H + +VA+KK+ + EGF L E+ L L
Sbjct: 20 IGQGTFGEVFKA---RHKKT------KQIVALKKVLMENEKEGFPITA--LREIKILQLL 68
Query: 146 HHPNLVKLIGYC---LEGENR-----LLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 194
H N+V LI C NR LV+EF G L N + + ++M
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 252
+ GL ++H +++++RD KA+NIL+ + KL+DFGLA+A + + T
Sbjct: 129 L-----NGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 253 QVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLEL 287
+ T Y PE + R D++ G ++ E+
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYL---G 143
+G+G FG VY+ K + + A+K L + KE + E N L
Sbjct: 1 IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51
Query: 144 QLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
P +V L + + ++ L LV ++M G L HL + G R K I A
Sbjct: 52 LDESPFIVGL-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYI-AELV 106
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L H + ++YRD K NILLDA + L DFGL+KA T ++T + GT Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164
Query: 263 PEYVATGRLTTKS-DVYSFGVVLLELLSG 290
PE + + TK D +S GV++ E+ G
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPL--SWAVRMKVAIGAAKGL 203
PN+V L Y + ++ LV + G L +H+ F P+ WA M VA+ A
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHVSTQVMGTHGYAA 262
LH ++ RD +NILLD + +L+ F ++ + D V Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301
PE T D +S G +L ELL+G+ V+ GI
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL 145
++G GGFG VY K +G + A+K L + QG L E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 146 HHPN--LVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+ + + Y ++L + + M G L HL + G S A A G
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILG 109
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY A
Sbjct: 110 LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMA 163
Query: 263 PEYVATG-RLTTKSDVYSFGVVLLELLSG 290
PE + G + +D +S G +L +LL G
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
E L QL HPN+V EGE+ LL V F G L + L + + L ++
Sbjct: 49 EAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
+ A L +LH E +++RD K N+ L K+ D G+A+ ++ +++ ++
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLI 163
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315
GT Y +PE + KSDV++ G + E+ + + A + + SLV
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLV--------- 211
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+RI++ KL P+ + L L+ P+ RP + +L
Sbjct: 212 ----YRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 54/193 (27%), Positives = 94/193 (48%), Gaps = 23/193 (11%)
Query: 108 LSPAKPGS-GMV-VAVKKLKPE------GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159
+ PGS G V VA K +P+ G +G L E L ++HP+++++ +
Sbjct: 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVS 128
Query: 160 GENRLLVYEFMP--KGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216
G +V +P L +L +R P P+ A+ ++ I +GL +LH ++I+R
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQI--LEGLRYLH--AQRIIHR 181
Query: 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 276
D K NI ++ + D G A+ P + + GT APE +A + +K+D
Sbjct: 182 DVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKAD 238
Query: 277 VYSFGVVLLELLS 289
++S G+VL E+L+
Sbjct: 239 IWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 44/217 (20%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLTEVNYLGQL 145
+GEG +G V+K ++ + +VA+K+++ EG L E+ L +L
Sbjct: 8 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSA--LREICLLKEL 56
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPK----------GSLENHLFRRGPQPLSWAVRMK 194
H N+V+L L + +L LV+E+ + G ++ + + S+ ++
Sbjct: 57 KHKNIVRLYD-VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK------SFMFQL- 108
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
KGL F H V++RD K N+L++ KL+DFGLA+A R + S +V
Sbjct: 109 -----LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEV 160
Query: 255 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSG 290
+ T Y P+ + +L +T D++S G + EL +
Sbjct: 161 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 101 GWIDQHSLSPAKPGSGMV-VAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158
GW + LS +G+ V VK+LK + E+L + + L HPN+++ +G C+
Sbjct: 6 GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV 65
Query: 159 EGENRLLVYEFMPKGSLE----NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214
E LLV+E+ G L+ + R L RM I A G+T +H + +
Sbjct: 66 EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH--KHNFL 121
Query: 215 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRL- 271
+ D N L ++ K+ D+G+ + D + APE V G L
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 272 ----TTKSDVYSFGVVLLELL 288
T S+V++ GV L EL
Sbjct: 182 TAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 56/155 (36%), Positives = 72/155 (46%), Gaps = 6/155 (3%)
Query: 136 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L E L Q++ P +V L E LV F+ G L +HL R G LS A
Sbjct: 41 LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA 100
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
+ A L LH + VIYRD K NILLD + + L DFGL K D +
Sbjct: 101 ELLCA--LENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFC 154
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
GT Y APE + T D ++ GV+L E+L+G
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL 145
++G GGFG VY K +G + A+K L + QG L E L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 146 HHPN--LVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+ + + Y ++L + + M G L HL + G S A G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILG 109
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L +H+ V+YRD K +NILLD + ++SD GLA + + H S +GTHGY A
Sbjct: 110 LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMA 163
Query: 263 PEYVATGR-LTTKSDVYSFGVVLLELLSG 290
PE + G + +D +S G +L +LL G
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 86/307 (28%), Positives = 129/307 (42%), Gaps = 46/307 (14%)
Query: 70 KAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF 129
K F+ + + +G+G +G V+K + K GS AVK L P
Sbjct: 6 KTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-------VLNKKNGSK--AAVKILDPI-H 55
Query: 130 QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLE-----GENRLLVYEFMPKGS---LENHLF 180
+E E N L L HPN+VK G + G+ LV E GS L
Sbjct: 56 DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
+RG + + + + A GL LH ++ I+RD K +NILL E KL DFG++
Sbjct: 116 KRGER-MEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS- 171
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-----LTTKSDVYSFGVVLLELLSGRCAVD 295
A T R +T V GT + APE +A + + DV+S G+ +EL G
Sbjct: 172 AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----- 225
Query: 296 KTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ L D L R LF+I + P+ ++ +CL + + R
Sbjct: 226 ------DPPLAD-----LHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
Query: 355 PRMSEVL 361
P +S++L
Sbjct: 275 PTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 115 SGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
SG VAVK + Q + EV + H N+V++ L GE ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 175 LENHL--FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232
L + + R + ++ V + L +LH VI+RD K+ +ILL + K
Sbjct: 105 LTDIVSQTRLNEEQIA-----TVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVK 157
Query: 233 LSDFG----LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 288
LSDFG ++K P ++GT + APE ++ T+ D++S G++++E++
Sbjct: 158 LSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 289 SG 290
G
Sbjct: 212 DG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 82/313 (26%), Positives = 126/313 (40%), Gaps = 59/313 (18%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP--EGFQGHKEWLTEVNY 141
++ ++G+G +G V ID H+ G VA+KK+ E L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKL 52
Query: 142 LGQLHHPNLVKLIGYCLEGENR-----LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
L L HP++V++ L R +V+E M + H + L+
Sbjct: 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFL 109
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----GPTGDRTHVST 252
+ L ++H A V +RD K NIL +A+ K+ DFGLA+ PT T
Sbjct: 110 YQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWT 164
Query: 253 QVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV---- 306
+ T Y APE + + T D++S G + E+L+G+ V + L+
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLL 224
Query: 307 -------------DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN---- 349
+ A+ YLS RK K + QK + A LAL+ L
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRK-------KQPVPFSQKFPN-ADPLALRLLERLLAF 276
Query: 350 EPKLRPRMSEVLA 362
+PK RP E LA
Sbjct: 277 DPKDRPTAEEALA 289
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLH 146
LG+G +G V S A+ VA+KK+ F K L E+ L
Sbjct: 8 LGQGAYGIVC-------SARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFR 59
Query: 147 -HPNLVKLIGYCLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
H N+ L Y ++ N L +YE + + L H R QPL+ A
Sbjct: 60 GHKNITCL--YDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQPLTDAHFQSFIYQIL 115
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGT 257
GL ++H A V++RD K N+L++A+ K+ DFGLA+ P + + T+ + T
Sbjct: 116 CGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 258 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
Y APE + + + TK+ DV+S G +L ELL +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT---- 137
+ + + +GEG +G V+K K G G VA+K+++ Q +E +
Sbjct: 1 QQYECVAEIGEGAYGKVFKA-------RDLKNG-GRFVALKRVR---VQTGEEGMPLSTI 49
Query: 138 -EVNYLGQLH---HPNLVKLIGYCL----EGENRL-LVYEFMPKGSLENHLFRRGPQPLS 188
EV L L HPN+V+L C + E +L LV+E + + L +L + P+P
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGV 107
Query: 189 WAVRMK-VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247
+K + +GL FLH +V++RD K NIL+ + KL+DFGLA+
Sbjct: 108 PTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSF 162
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T V+ T Y APE + T D++S G + E+ +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 58/274 (21%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 104 DQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWL----TEVNYLGQLHHPNLVKLIGYCL 158
DQ+S+ + V+ ++ K F GHK + E+ L ++ N++K+ G+ +
Sbjct: 32 DQNSIYKGIFNNKEVI-IRTFKK--FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88
Query: 159 EGENRL----LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214
+ + L L+ E+ +G L L + LS+ ++ +AI KGL L+ ++
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 215 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLT 272
Y++ + + L+ + K+ GL K + +V+ V Y + + + T
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYT 200
Query: 273 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY- 331
K D+YS GVVL E+ +G K+ E ++++ ++ K
Sbjct: 201 IKDDIYSLGVVLWEIFTG-------KIPFEN----------LTTKEIYDLIINKNNSLKL 243
Query: 332 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
P + C +++ RP + E+L L
Sbjct: 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 74/325 (22%), Positives = 116/325 (35%), Gaps = 82/325 (25%)
Query: 87 DSLLGE----GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT----E 138
+L+G+ + K KP + +VAVKK+ + KE L E
Sbjct: 3 LTLIGKCFEDLMIVHLAK----------HKP-TNTLVAVKKINLD--SCSKEDLKLLQQE 49
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS----LENHLFRRGPQPLSWAVRMK 194
+ QL HPN++ + + +V M GS L+ H F G L+ A +K
Sbjct: 50 IITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAFILK 108
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF----GLAKAG-------- 242
L ++H I+R KAS+ILL + LS + K G
Sbjct: 109 ---DVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163
Query: 243 -PTGDRTHV---STQVM--GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA--- 293
P ++ S +V+ GY KSD+YS G+ EL +G
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGY-----------NEKSDIYSVGITACELANG-HVPFK 211
Query: 294 -VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD------TKLGGQYPQKAAHTAAT----- 341
+ T++ +E+ V P L DK D + + + T
Sbjct: 212 DMPATQMLLEK--VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSE 269
Query: 342 ----LALQCLNNEPKLRPRMSEVLA 362
CL +P+ RP S++L
Sbjct: 270 HFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHK-EWLTEVNY 141
+ P + +G G +G VYK P SG VA+K ++ G + EV
Sbjct: 2 YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL 52
Query: 142 LGQLH---HPNLVKLIGYC----LEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRM 193
L +L HPN+V+L+ C + E ++ LV+E + + L +L + P L
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIK 111
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-T 252
+ +GL FLH + +++RD K NIL+ + KL+DFGLA+ ++ T
Sbjct: 112 DLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALT 165
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 288
V+ T Y APE + T D++S G + E+
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 40/249 (16%)
Query: 47 EKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQH 106
+K +S+S PK + + +K FN ++T LG G FG V
Sbjct: 11 KKKDSDSTKEPKRK------NKMKYEDFNFIRT----------LGTGSFGRVI------- 47
Query: 107 SLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENR 163
L+ K VA+K+ + K+ +E L ++HP V L G +
Sbjct: 48 -LATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106
Query: 164 LLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 221
LV EF+ G L R R P + ++ L F + ++YRD K
Sbjct: 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV------LIFEYLQSLNIVYRDLKPE 160
Query: 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFG 281
N+LLD + K++DFG AK T RT+ + GT Y APE + +D ++ G
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVVDT--RTYT---LCGTPEYIAPEILLNVGHGKAADWWTLG 215
Query: 282 VVLLELLSG 290
+ + E+L G
Sbjct: 216 IFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 32/210 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL---- 145
+GEG F V K Q +G A+K +K + F+ L +VN L ++
Sbjct: 7 IGEGTFSEVLKA---QSR------KTGKYYAIKCMK-KHFKS----LEQVNNLREIQALR 52
Query: 146 ---HHPNLVKLIGYCLEGE-NRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
HPN+++LI + + RL LV+E M E L + +PL
Sbjct: 53 RLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLL 110
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
K L +H + + +RD K NIL+ + KL+DFG + T+ + T Y
Sbjct: 111 KSLDHMH--RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWY 164
Query: 261 AAPEYVAT-GRLTTKSDVYSFGVVLLELLS 289
APE + T G K D+++ G V E+LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/204 (28%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LGEG + V+KG + L+ +VA+K+++ E +G + EV+ L L H
Sbjct: 14 LGEGTYATVFKG---RSKLTEN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L ++ LV+E++ K L+ ++ G V++ + +GL + H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCH- 121
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVA 267
+V++RD K N+L++ KL+DFGLA+A +T+ S +V+ T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLG 178
Query: 268 TGRLTTKSDVYSFGVVLLELLSGR 291
+ +T+ D++ G + E+ SGR
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 77/285 (27%), Positives = 120/285 (42%), Gaps = 44/285 (15%)
Query: 83 NFRPDSLLGEGGFGFVY-KGWIDQHSLSPAKPGSGMVVAVKKLKP----EGFQGHKEWLT 137
NF +LG G +G V+ + H SG + A+K LK + + + T
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD-------SGKLYAMKVLKKATIVQKAKTTEHTRT 53
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK-- 194
E L + + + Y + + +L L+ +++ G L HL +R R K
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--------ERFKEQ 105
Query: 195 ---VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ G L H + +IYRD K NILLD+ + L+DFGL+K D +
Sbjct: 106 EVQIYSGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERA 163
Query: 252 TQVMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309
GT Y AP+ V G D +S GV++ ELL+G A T G + S + +
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG--ASPFTVDGEKNSQAEIS 221
Query: 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ RI+ K YPQ+ + A + + L +PK R
Sbjct: 222 R----------RIL--KSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 60/193 (31%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 108 LSPAKPGSGMVVAV---------KKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLI-GYC 157
LS PGS V V KK+ + G K E++ L + H ++ LI Y
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY- 155
Query: 158 LEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 215
+ V MP K L ++ R GP PL A+ ++ + A L +LH +I+
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEA--LAYLH--GRGIIH 208
Query: 216 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS 275
RD K NI LD NA L DFG A T GT +PE +A K+
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268
Query: 276 DVYSFGVVLLELL 288
D++S G+VL E+
Sbjct: 269 DIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LGEG + VYKG + L+ +VA+K+++ E +G + EV+ L L H
Sbjct: 14 LGEGTYATVYKG---RSKLTDN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L ++ LV+E++ K L+ +L G V++ + +GL + H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH- 121
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVA 267
+V++RD K N+L++ KL+DFGLA+A +T+ S +V+ T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLG 178
Query: 268 TGRLTTKSDVYSFGVVLLELLSGR 291
+ +T+ D++ G + E+ +GR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 27/206 (13%)
Query: 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226
Y+ ++N L G + L+ + A+G+ FL A ++RD A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271
Query: 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AAPEYVATGRLTTKSDVYSFG 281
K+ DFGLA+ D H S V + APE + TT SDV+S+G
Sbjct: 272 QGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 282 VVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT 341
++L E+ SL P + + + + P A
Sbjct: 327 ILLWEIF---------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYD 371
Query: 342 LALQCLNNEPKLRPRMSEVLAILERL 367
+ ++C N+EP+ RP + I+E L
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)
Query: 202 GLTFL-------HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
GL F+ H +I+RD K++NILL + KL DFG +K V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
GT Y APE + K+D++S GV+L ELL+ + +P+
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF-- 245
Query: 315 DKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
D + +M L G+Y P + + L+++PK RP S++L
Sbjct: 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 28/270 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G F ++KG + + V +K L + + + + QL H +
Sbjct: 3 LGQGTFTKIFKGI--RREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLTFLHD 208
LV G C+ G+ ++V E++ GSL+ +L + +SW +++VA A L FL D
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLED 118
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH--GYAAPEYV 266
+ + + A N+LL E + K + K G V + + + PE +
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 267 ATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325
+ L+ +D +SFG L E+ SG D L ++KL + +
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQKKL-QFYED 220
Query: 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
+ Q P A L QC++ EP RP
Sbjct: 221 RH--QLPAPKWTELANLINQCMDYEPDFRP 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 64/245 (26%), Positives = 116/245 (47%), Gaps = 30/245 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LGEG + V+KG + L+ +VA+K+++ E +G + EV+ L L H
Sbjct: 13 LGEGTYATVFKG---RSKLT------ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L LV+E++ L+ +L G V++ +GL++ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH- 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVA 267
+ ++++RD K N+L++ + KL+DFGLA+A +T+ S +V+ T Y P+ +
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLG 177
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKL 327
+ +T D++ G +L E+ +GR + V E L+ FR++ T
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI-------------FRLLGTPT 224
Query: 328 GGQYP 332
+P
Sbjct: 225 EETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 58/191 (30%), Positives = 81/191 (42%), Gaps = 63/191 (32%)
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
A+G+ FL A + I+RD A NILL K+ DFGLA+
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-----------------DI 223
Query: 260 YAAPEYVATG--RL---------------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 302
Y P+YV G RL TT+SDV+SFGV+L E+ S +G
Sbjct: 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG-- 272
Query: 303 QSLVDWAKPYLSDK------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356
A PY + R+L T++ P+ A ++ L C +N P+ RP
Sbjct: 273 ------ASPYPGVQIDEEFCRRLKE--GTRMRA--PEYATPEIYSIMLDCWHNNPEDRPT 322
Query: 357 MSEVLAILERL 367
SE++ IL L
Sbjct: 323 FSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 120 AVKKLKPEGFQGHKE---WLTEVN-YLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGS 174
AVK L+ + KE ++E N L + HP LV L + + ++L V +++ G
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL-HFSFQTADKLYFVLDYINGGE 82
Query: 175 LENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230
L HL R P+ +A + A+G +LH ++YRD K NILLD++ +
Sbjct: 83 LFYHLQRERCFLEPRARFYAAEIASALG------YLHSL--NIVYRDLKPENILLDSQGH 134
Query: 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
L+DFGL K + T ++ GT Y APE + D + G VL E+L G
Sbjct: 135 IVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 55/251 (21%), Positives = 104/251 (41%), Gaps = 54/251 (21%)
Query: 75 NELKTATRNFRP-DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGF 129
N + + + + LGEG +G V K D + G +VA+KK+K
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDV 51
Query: 130 QGHKEW----------LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL 179
++ L E+ + ++ H N++ L+ +EG+ LV + M L+ +
Sbjct: 52 TKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV 110
Query: 180 FRRGPQPLSWAVRMKVA------IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233
R+ +R+ + + GL LH + ++RD +NI ++++ K+
Sbjct: 111 DRK--------IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKI 160
Query: 234 SDFGLAK-------AGPTGDRTHVS-----TQVMGTHGYAAPEYV-ATGRLTTKSDVYSF 280
+DFGLA+ + + T + T Y APE + + D++S
Sbjct: 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 281 GVVLLELLSGR 291
G + ELL+G+
Sbjct: 221 GCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 256
A+G+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 314
+ APE + TT+SDV+SFGV+L E+ S +G A PY
Sbjct: 242 ---WMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LG--------ASPYPGVQ 281
Query: 315 -DKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
++ R+ D T++ + P+ A + L C +PK RP S ++ IL L
Sbjct: 282 INEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 49/203 (24%)
Query: 181 RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
PL ++ + A+G+ FL A I+RD A N+LL AK+ DFGLA+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 241 AGPTGDRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRC-- 292
D + S V+ + + APE + T +SDV+S+G++L E+ S G+
Sbjct: 261 -----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
Query: 293 ---AVDK-----TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 344
V+ K G + S D+A P +++ IM
Sbjct: 316 PGILVNSKFYKMVKRGYQMSRPDFAPP------EIYSIMKM------------------- 350
Query: 345 QCLNNEPKLRPRMSEVLAILERL 367
C N EP RP S++ +++R
Sbjct: 351 -CWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HH 147
L+G G +G VYKG +H +G + A+K + G + +E E+N L + HH
Sbjct: 13 LVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHH 62
Query: 148 PNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
N+ G ++ + LV EF GS+ + + L + +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGY 260
GL+ LH + +VI+RD K N+LL KL DFG++ DRT +GT +
Sbjct: 123 GLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYW 177
Query: 261 AAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 290
APE +A KSD++S G+ +E+ G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 35/227 (15%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+ RP LG G G V+ +D VAVKK+ Q K L E+
Sbjct: 8 MDLRP---LGCGSNGLVFSA-VDSDC--------DKRVAVKKIVLTDPQSVKHALREIKI 55
Query: 142 LGQLHHPNLVKLIGYCLEGENRL--------------LVYEFMPKGSLENHLFRRGPQPL 187
+ +L H N+VK+ + L +V E+M + L N L + PL
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ---GPL 111
Query: 188 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK-AGPTG 245
S +GL ++H A V++RD K +N+ ++ E K+ DFGLA+ P
Sbjct: 112 SEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 246 DRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
++ + T Y +P + + TK+ D+++ G + E+L+G+
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G G +G VYK +G + A+K +K E + E+ + H N
Sbjct: 17 IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V G L + + EF GSL++ GP LS + V+ +GL +LH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
++RD K +NILL + KL+DFG+ A+ T + +GT + APE A
Sbjct: 126 GK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAV 180
Query: 269 GR---LTTKSDVYSFGVVLLEL 287
R D+++ G+ +EL
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQG--H-KEWLTEV 139
++ S +G G +G V D +G VA+KKL +P FQ H K E+
Sbjct: 17 YQNLSPVGSGAYGQVCSA-FDT--------KTGRKVAIKKLSRP--FQSAIHAKRTYREL 65
Query: 140 NYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGPQPLSWAVRM 193
L + H N++ L+ + LV M G+ N++ + Q LS
Sbjct: 66 RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC--QKLSDDHIQ 121
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
+ +GL ++H A +I+RD K SNI ++ + K+ DFGLA+ T D T
Sbjct: 122 FLVYQILRGLKYIHSA--GIIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEM---TG 174
Query: 254 VMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
+ T Y APE + ++ D++S G ++ ELL+G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 66/254 (25%), Positives = 104/254 (40%), Gaps = 66/254 (25%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGHKEWLTEV-- 139
+F ++G G FG V + Q + G + A+KKL K E + KE + V
Sbjct: 2 DFESIKVIGRGAFGEVR---LVQKKDT------GHIYAMKKLRKSEMLE--KEQVAHVRA 50
Query: 140 --NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG----PQPLSWAVR 192
+ L + +P +VKL Y + EN L L+ E++P G + L ++ + +
Sbjct: 51 ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL-------------- 238
+AI + L ++H RD K N+LLDA+ + KLSDFGL
Sbjct: 110 TILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161
Query: 239 --AKAGPTGDRTHVSTQ--------------------VMGTHGYAAPEYVATGRLTTKSD 276
+ A P+ +S +GT Y APE + D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221
Query: 277 VYSFGVVLLELLSG 290
+S GV++ E+L G
Sbjct: 222 WWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 17/221 (7%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LGEG + VYKG +G +VA+K + + +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L E V+E+M L ++ + + VR+ +GL ++H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH- 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVA 267
+++RD K N+L+ KL+DFGLA+A +T+ S V T Y P+ +
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308
++ D++ G + +E+L G+ A EQ W
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP------EGFQGHKEWL 136
NF +LG G +G V+ +G + A+K L+ H
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR-- 52
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
TE N L + + + Y + E +L L+ +++ G + HL++R S ++
Sbjct: 53 TERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSED-EVRF 109
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
G L H + ++YRD K NILLD+E + L+DFGL+K + ++ +
Sbjct: 110 YSGEII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFC 167
Query: 256 GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSG 290
GT Y APE + K+ D +S G+++ ELL+G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 71/257 (27%), Positives = 106/257 (41%), Gaps = 40/257 (15%)
Query: 50 NSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLS 109
+ +L K+ LS A +L+ +F ++G G FG V + +H
Sbjct: 11 DIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQ---LVRHK-- 65
Query: 110 PAKPGSGMVVAVKKLKPEGFQGHKE------WLTEVNYLGQLHHPNLVKLIGYCLEGENR 163
S V A+K L F+ K W E + + + +V+L Y + +
Sbjct: 66 ----SSKQVYAMKLLSK--FEMIKRSDSAFFW-EERDIMAHANSEWIVQLH-YAFQDDKY 117
Query: 164 L-LVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDF 218
L +V E+MP G L N L P WA + +A+ A + F+H RD
Sbjct: 118 LYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--------RDV 168
Query: 219 KASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTT 273
K N+LLD + KL+DFG K G T V GT Y +PE + + G
Sbjct: 169 KPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGR 226
Query: 274 KSDVYSFGVVLLELLSG 290
+ D +S GV L E+L G
Sbjct: 227 ECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 58/202 (28%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G G +G VYK +G + AVK +K E E+ + + H N
Sbjct: 17 VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V G L E + E+ GSL++ GP LS V +GL +LH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLAYLHSK 125
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGL-AKAGPTGDRTHVSTQVMGTHGYAAPEYVA- 267
++RD K +NILL + KL+DFG+ AK T + +GT + APE A
Sbjct: 126 GK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAV 180
Query: 268 --TGRLTTKSDVYSFGVVLLEL 287
G D+++ G+ +EL
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 52/183 (28%), Positives = 85/183 (46%), Gaps = 18/183 (9%)
Query: 116 GMVVAVKKL-KPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVY 167
G+ VAVKKL +P Q H K E+ L ++H N++ L+ E ++ LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 168 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227
E M + + +S+ + + G+ LH A +I+RD K SNI++ +
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKS 158
Query: 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 287
+ K+ DFGLA+ T + T + T Y APE + D++S G ++ EL
Sbjct: 159 DCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 288 LSG 290
+ G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 47/233 (20%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG----HKEWLTEVNYLGQ 144
L+G+GG G VY + P VA+KK++ E K +L E
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAAD 58
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFR--RGPQPLSWAVRMKVAIGA- 199
L HP +V + C +G+ VY MP +G L + + LS + K ++GA
Sbjct: 59 LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 200 -------AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA------------- 239
+ ++H V++RD K NILL + D+G A
Sbjct: 116 LSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 240 KAGPTGDRTHVST---QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
T +++GT Y APE + + +D+Y+ GV+L ++L+
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 41/139 (29%), Positives = 62/139 (44%), Gaps = 17/139 (12%)
Query: 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224
+V E++ G L G P+ A RM A L +LH+ +++RD K N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHN--YGIVHRDLKPDNLL 133
Query: 225 LDAEFNAKLSDFGLAKAG-------------PTGDRTHVSTQVMGTHGYAAPEYVATGRL 271
+ + + KL+DFGL+K G R + QV GT Y APE +
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 272 TTKSDVYSFGVVLLELLSG 290
D ++ G++L E L G
Sbjct: 194 GKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 65/245 (26%), Positives = 93/245 (37%), Gaps = 51/245 (20%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTE 138
++F+ LLG+G G V+ L K G+G + A+K L + + LTE
Sbjct: 1 KHFKKIKLLGKGDVGRVF--------LVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTE 51
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW----AVRMK 194
L L HP L L LV ++ P G L L +R QP R
Sbjct: 52 QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGKCLSEEVARFY 108
Query: 195 VA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV--- 250
A + A L +LH ++YRD K NILL + LSDF L+K
Sbjct: 109 AAEVLLA--LEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164
Query: 251 ------------------------STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 286
S +GT Y APE ++ + D ++ G++L E
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224
Query: 287 LLSGR 291
+L G
Sbjct: 225 MLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 52/173 (30%), Positives = 73/173 (42%), Gaps = 27/173 (15%)
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMG 256
AKG+ FL A + I+RD A NILL K+ DFGLA+ P R + +
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LS 314
+ APE + T +SDV+SFGV+L E+ S +G A PY +
Sbjct: 246 --KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LG--------ASPYPGVK 286
Query: 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ R + + P L C + EP RP SE++ L L
Sbjct: 287 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 46/147 (31%), Positives = 65/147 (44%), Gaps = 10/147 (6%)
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
P +V+L + + +V E+MP G L N L P WA + A L +H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA--LDAIH 159
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+I+RD K N+LLD + KL+DFG T V GT Y +PE +
Sbjct: 160 SM--GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLK 216
Query: 268 T----GRLTTKSDVYSFGVVLLELLSG 290
+ G + D +S GV L E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 46/232 (19%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGH-- 132
E+ R+ + +G G +G V S +G VA+KKL +P FQ
Sbjct: 12 EVPDRYRDLKQ---VGSGAYGTV---------CSALDRRTGAKVAIKKLYRP--FQSELF 57
Query: 133 -KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPK--GSLENHLFRRG 183
K E+ L + H N++ L+ + LV FM G L H +
Sbjct: 58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLS 116
Query: 184 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243
+ + V + KGL ++H A +I+RD K N+ ++ + K+ DFGLA+
Sbjct: 117 EDRIQFLVYQML-----KGLKYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--- 166
Query: 244 TGDRTHVSTQVMG---THGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR 291
+++ G T Y APE + T D++S G ++ E+L+G+
Sbjct: 167 -----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 36/170 (21%)
Query: 134 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS----- 188
W+ ++ Y Q + +N LV E+ P G L + L R
Sbjct: 61 PWIPQLQYAFQ--------------DKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQ 105
Query: 189 -WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247
+ + +AI + + ++H RD K N+L+D + KL+DFG A A T ++
Sbjct: 106 FYLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSA-ARLTANK 156
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKS------DVYSFGVVLLELLSGR 291
S +GT Y APE + T K D +S GV+ E++ GR
Sbjct: 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
+E++ L H +VK + LL+ E+ G L + +R + L + +V
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 197 IGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
+ + + L + S+ +++RD K++NI L KL DFG +K V++
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315
GT Y APE R + K+D++S GV+L ELL+ +P+
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274
Query: 316 KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
++ IM L G+Y P + L L+ P LRP ++L
Sbjct: 275 SQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEW-LTEVNYLGQLH 146
++GEG +G V K +H + +VA+KK K E + KE L E+ L L
Sbjct: 8 VVGEGAYGVVLKC---RHK------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+V+L LV+E++ K LE L P + K + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
H ++ +++RD K N+L+ KL DFG A+ G + T+ + T Y +PE +
Sbjct: 117 H--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173
Query: 267 ATGRLTTKSDVYSFGVVLLELLSGR 291
D++S G +L EL G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
AKG++FL A I+RD A NILL K+ DFGLA+ V
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + T +SDV+S+G++L E+ S
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHP 148
LGEG + VYKG +G +VA+K ++ + +G + E + L L H
Sbjct: 13 LGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L E LV+E++ + + P L +GL+++H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFLFQLLRGLSYIH- 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-YVA 267
+ +++RD K N+L+ KL+DFGLA+A T+ S +V+ T Y P+ +
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWYRPPDVLLG 177
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCA 293
+ +T D++ G + +E++ G A
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 77/311 (24%), Positives = 132/311 (42%), Gaps = 48/311 (15%)
Query: 78 KTATRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL 136
++ ++++ +++G G FG VY+ ID + VA+KK+ + ++E L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICID----------TSEKVAIKKVLQDPQYKNRELL 111
Query: 137 TEVNYLGQLHHPNLVKLIGY----CLEGENRLL----VYEFMPKGSLENHL--FRRGPQP 186
N L+H N++ L Y C + + + V EF+P+ ++ ++ + R
Sbjct: 112 IMKN----LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHA 166
Query: 187 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTG 245
L + + + L ++H + +RD K N+L+D + KL DFG AK G
Sbjct: 167 LPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224
Query: 246 DRTHVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLE------LLSGRCAVDKTK 298
R S + + Y APE + TT D++S G ++ E + SG+ +VD+
Sbjct: 225 QR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL- 280
Query: 299 VGIEQSL-------VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 351
V I Q L + P +D K + L +P+ A Q L EP
Sbjct: 281 VRIIQVLGTPTEDQLKEMNPNYADI-KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339
Query: 352 KLRPRMSEVLA 362
R E LA
Sbjct: 340 LKRLNPIEALA 350
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 33/212 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LTEVNYLGQ 144
LGEG + VYKG + L+ G +VA+K+++ E H+E + E + L
Sbjct: 13 LGEGSYATVYKG---RSKLT------GQLVALKEIRLE----HEEGAPFTAIREASLLKD 59
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L H N+V L + LV+E++ K +++ G + VR+ +
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDC--GGGLSMHN--VRL-FLFQLLR 114
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
GL + H +V++RD K N+L+ KL+DFGLA+A +T+ S +V+ T Y
Sbjct: 115 GLAYCHQ--RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYR 170
Query: 262 APEYVATGR--LTTKSDVYSFGVVLLELLSGR 291
P+ V G +T D++ G + E+ +GR
Sbjct: 171 PPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 43/134 (32%), Positives = 59/134 (44%), Gaps = 18/134 (13%)
Query: 165 LVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAAKGLTFLHDAESQVIYRDFKA 220
+V E+MP G L N L P WA + +A+ A + F+H RD K
Sbjct: 120 MVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKP 170
Query: 221 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSD 276
N+LLD + KL+DFG T V GT Y +PE + + G + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 229
Query: 277 VYSFGVVLLELLSG 290
+S GV L E+L G
Sbjct: 230 WWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 65/276 (23%), Positives = 102/276 (36%), Gaps = 78/276 (28%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQ----GHKEWLTEVNYLGQ 144
+G G FG V L K + + A+K L K + H + E + L +
Sbjct: 9 IGIGAFGEV--------CLV-RKVDTNALYAMKTLRKADVLMRNQAAHVK--AERDILAE 57
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA----VRMKVAIGAA 200
+ +VKL + +N V +++P G + + L R G A + AI +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR-THVST------- 252
+ F+H RD K NIL+D + + KL+DFGL TG R TH S
Sbjct: 118 HKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSKYYQKGDH 165
Query: 253 -------------------------------------QVMGTHGYAAPEYVATGRLTTKS 275
++GT Y APE + T
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 276 DVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAK 310
D +S GV+L E+L G+ + T + +++W
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 66/248 (26%), Positives = 108/248 (43%), Gaps = 43/248 (17%)
Query: 73 TFNELKTATRNFRPDSLLGEGGFGFV---YKGWIDQHSLSPAKPGSGMVVAVKKL-KPEG 128
TF LK +N +P +G G G V Y +D++ VA+KKL +P
Sbjct: 12 TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAVLDRN------------VAIKKLSRPFQ 55
Query: 129 FQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEFMPKGSLENHLFR 181
Q H K E+ + ++H N++ L+ E ++ LV E M +
Sbjct: 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME 115
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
+ +S+ + + G+ LH A +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 116 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 168
Query: 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVD 295
T + + T + T Y APE + D++S G ++ E L GR +D
Sbjct: 169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
Query: 296 KTKVGIEQ 303
+ IEQ
Sbjct: 226 QWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 46/167 (27%), Positives = 80/167 (47%), Gaps = 27/167 (16%)
Query: 131 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS-- 188
G +W+T ++Y Q + NL ++ Y + G+ L+ +F E+ L P+ ++
Sbjct: 58 GDNQWITTLHYAFQDEN-NLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARF 106
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
+ M +AI + L ++H RD K NIL+D + +L+DFG + D T
Sbjct: 107 YLAEMVIAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGT 157
Query: 249 HVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 290
S+ +GT Y +PE + G+ + D +S GV + E+L G
Sbjct: 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 10/97 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTE----VNYLGQL 145
LG G FG V ++ + K + M VAVK LKP +E L ++YLG
Sbjct: 43 LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-- 96
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 182
+H N+V L+G C G L++ E+ G L N L R+
Sbjct: 97 NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 73 TFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQG 131
T E+ +N P +G G +G V + +G+ VAVKKL +P FQ
Sbjct: 11 TIWEVPERYQNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRP--FQS 56
Query: 132 ---HKEWLTEVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRR 182
K E+ L + H N++ L+ LE N + LV M G+ N++ +
Sbjct: 57 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK- 113
Query: 183 GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242
Q L+ + +GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+
Sbjct: 114 -CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH- 169
Query: 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T D T + T Y APE + ++ D++S G ++ ELL+GR
Sbjct: 170 -TDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK----LKPEGFQGHKEWLTEVNYLGQL 145
+GEG +G VYK +G +VA+KK + EG L E++ L L
Sbjct: 9 IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57
Query: 146 HH-PNLVKLIGYCLE------GENRL-LVYEFMP---KGSLENHLFRRGP-QPLSWAVRM 193
+V+L+ +E G+ L LV+E++ K ++++ RGP +PL
Sbjct: 58 SESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN--GRGPGRPLPAKTIK 113
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG--PTGDRTHV 250
KG+ H + V++RD K N+L+D + K++D GL +A P TH
Sbjct: 114 SFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH- 170
Query: 251 STQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSG 290
+++ T Y APE + +T D++S G + E+
Sbjct: 171 --EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 53/237 (22%)
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAA 200
+ Q+ H +L + G C+ G ++V EF+ G L+ L + +G P++W ++ VA A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 201 KGLTFLHDAESQVIYRDFKASNILL--------DAEFNAKLSDFGLAKAGPTGDRTHVST 252
L++L D +++ + A NILL + F KLSD G++ + R
Sbjct: 128 SALSYLED--KNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALS--REERVE 182
Query: 253 QVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLEL-------LSGRCAVDKTKVGIEQS 304
++ + APE V G L+T +D +SFG LLE+ L R +K +
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER------ 232
Query: 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+ K +L P+ + ATL QCL EP RP +L
Sbjct: 233 -------FYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HH 147
++G G +G VYKG +H +G + A+K + + +E E+N L + HH
Sbjct: 23 VVGNGTYGQVYKG---RHV------KTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHH 72
Query: 148 PNLVKLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
N+ G ++ + LV EF GS+ + + L + +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGY 260
GL LH +VI+RD K N+LL KL DFG++ DRT +GT +
Sbjct: 133 GLAHLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYW 187
Query: 261 AAPEYVAT-----GRLTTKSDVYSFGVVLLELLSG 290
APE +A +SD++S G+ +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 34/214 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGH---KEWLTEVNYLGQ 144
+G G +G V ID+ + G VA+KKL +P FQ K E+ L
Sbjct: 22 QVGSGAYGSVCSA-IDKRT--------GEKVAIKKLSRP--FQSEIFAKRAYRELTLLKH 70
Query: 145 LHHPNLVKLIGY---CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ H N++ L+ + G+ Y MP ++ L + PLS +
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG---TH 258
GL ++H A +I+RD K N+ ++ + K+ DFGLA+ H ++ G T
Sbjct: 129 GLKYIHSA--GIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTR 178
Query: 259 GYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
Y APE + ++ D++S G ++ E+L+G+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 46/178 (25%), Positives = 67/178 (37%), Gaps = 45/178 (25%)
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTF 205
+VK+ + N L+ EF+P G + L ++ + +AI A L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------------GPTGD---- 246
+H RD K N+LLDA+ + KLSDFGL P D
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 247 --------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
R ++ +GT Y APE D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 37/172 (21%)
Query: 131 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFR---RGPQP 186
G + W+T LH Y + EN L LV ++ G L L + R P+
Sbjct: 58 GDRRWIT------NLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED 102
Query: 187 LS--WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGP 243
++ + M +AI + L ++H RD K N+LLD + +L+DFG +
Sbjct: 103 MARFYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLA 154
Query: 244 TGDRTHVSTQVMGTHGYAAPEYV-----ATGRLTTKSDVYSFGVVLLELLSG 290
G T S +GT Y +PE + GR + D +S GV + E+L G
Sbjct: 155 DG--TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 47/226 (20%)
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKG 202
Q+ H ++V L G C+ ++V EF+ G L+ LF R L+ + KVA A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 203 LTFLHDAESQVIYRDFKASNILL-----DAEFNA--KLSDFGLAKAGPTGDRTHVSTQ-V 254
L++L D + +++ + NILL D E KLSD G+ P T +S Q
Sbjct: 118 LSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PI---TVLSRQEC 168
Query: 255 MGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLEL-LSGRCAV-DKTKVGIEQSLVDWAKP 311
+ + APE V + L+ +D +SFG L E+ +G + DKT
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-------------- 214
Query: 312 YLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRP 355
L++K + + GQ + A L C+N +P RP
Sbjct: 215 -LAEKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 43/248 (17%)
Query: 73 TFNELKTATRNFRPDSLLGEGGFGFV---YKGWIDQHSLSPAKPGSGMVVAVKKL-KPEG 128
TF LK +N +P +G G G V Y ++++ VA+KKL +P
Sbjct: 19 TFTVLKR-YQNLKP---IGSGAQGIVCAAYDAILERN------------VAIKKLSRPFQ 62
Query: 129 FQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL------EGENRLLVYEFMPKGSLENHLFR 181
Q H K E+ + ++H N++ L+ E ++ +V E M +
Sbjct: 63 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
+ +S+ + + G+ LH A +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 123 LDHERMSYLLYQMLC-----GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART 175
Query: 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE------LLSGRCAVD 295
T + + T + T Y APE + D++S G ++ E L G +D
Sbjct: 176 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 232
Query: 296 KTKVGIEQ 303
+ IEQ
Sbjct: 233 QWNKVIEQ 240
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 20/146 (13%)
Query: 156 YCLEGENRL-LVYEFMPKGSLENHLFR---RGPQPLS--WAVRMKVAIGAAKGLTFLHDA 209
Y + EN L LV ++ G L L + R P+ ++ + M +AI + L ++H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--- 266
RD K N+LLD + +L+DFG + D T S+ +GT Y +PE +
Sbjct: 126 ------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 267 --ATGRLTTKSDVYSFGVVLLELLSG 290
G+ + D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ G ++ V+ T Y
Sbjct: 130 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVV-TRYYR 184
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGR 291
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 52/169 (30%), Positives = 75/169 (44%), Gaps = 34/169 (20%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL-KPEGFQGHKEWLTEV-- 139
+F ++G+G FG V + Q K +G + A+K L K E F+ K+ L V
Sbjct: 2 DFHTVKVIGKGAFGEVR---LVQ------KKDTGKIYAMKTLLKSEMFK--KDQLAHVKA 50
Query: 140 --NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLS------WA 190
+ L + P +V L Y + L L+ EF+P G L L + S +
Sbjct: 51 ERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYM 107
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
+AI A L F+H RD K NIL+D + KLSDFGL+
Sbjct: 108 AECVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
TE + L ++HP++++L G + L+ +P+ + + + + ++ + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
+ + +LH E+++I+RD KA NI ++ + L DFG A P + G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T APE +A D++S G+VL E+ +
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 62/259 (23%), Positives = 96/259 (37%), Gaps = 79/259 (30%)
Query: 90 LGEGGFGFV-YKGWIDQHSLSPAKP-------GSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
LG G FG V +D H+L K V VK + + EW+ ++ Y
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAVRMKVAI 197
Q + +N V +++P G + + L R P+ L+ + + +AI
Sbjct: 69 SFQ--------------DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI 114
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---------------- 241
+ + F+H RD K NIL+D + + KL+DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 242 -----GPT-----------GDRTHVSTQ-------------VMGTHGYAAPEYVATGRLT 272
P+ GDR Q ++GT Y APE + T
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 273 TKSDVYSFGVVLLELLSGR 291
D +S GV+L E+L G+
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 51/221 (23%), Positives = 93/221 (42%), Gaps = 58/221 (26%)
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG--PQPLS--WAVRM 193
E + L + + +V+L + +N V +++P G + + L R G P+ L+ + +
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL---------AKAGPT 244
A+ + + F+H RD K NIL+D + + KL+DFGL +K +
Sbjct: 111 TCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 245 GD---------------------------------RTH---VSTQVMGTHGYAAPEYVAT 268
GD R H ++ ++GT Y APE +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 269 GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDW 308
T D +S GV+L E+L G+ + +T + + +++W
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
HPN++ G ++ FM GS + L P+ +S A+ + GA +GL +L
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYL 117
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSD----FGLAKAGPTG----DRTHVSTQVMGTH 258
H ++ I+R+ KAS+IL+ + LS + L + G D ST V+
Sbjct: 118 H--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-- 173
Query: 259 GYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGR 291
+ +PE + KSD+YS G+ EL +GR
Sbjct: 174 -WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 41/166 (24%), Positives = 62/166 (37%), Gaps = 45/166 (27%)
Query: 162 NRLLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217
N L+ EF+P G + L ++ + + +AI + L F+H RD
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--------RD 126
Query: 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------------------------- 248
K N+LLD++ + KLSDFGL RT
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 249 ----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
++ +GT Y APE D +S GV++ E+L G
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 138 EVNYLGQLHHPNLVKL--------IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW 189
E+ LG+L+H N++K+ Y + + +Y FM + F +PL
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKDRPLLK 267
Query: 190 AVR--MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247
R MK + A + ++HD ++I+RD K NI L+ + L DFG A +R
Sbjct: 268 QTRAIMKQLLCA---VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK-ER 321
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+GT +PE +A +D++S G++LL++LS
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
A G+ FL A ++RD A N+L+ K+ DFGLA+ D S +
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-----DIMRDSNYISKGST 301
Query: 260 Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + TT SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+GL ++H A +I+RD K SN+ ++ + ++ DFGLA+ D T + T Y
Sbjct: 129 RGLKYIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181
Query: 261 AAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
APE + ++ D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQL-HH 147
LG G FG V ++ + K + + VAVK LK +E L +E+ L L H
Sbjct: 46 LGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR 182
N+V L+G C G L++ E+ G L N L ++
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 44/151 (29%), Positives = 67/151 (44%), Gaps = 8/151 (5%)
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK--GSLENHLFRRGPQPLSWAVRMKV 195
E L +L HP ++ L+ + G LV +PK L +L R +PL A V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGAR-LRPLGLAQVTAV 265
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
A + ++H +I+RD K N+L++ + L DFG A T +
Sbjct: 266 ARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 286
GT APE +A T D++S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 35/94 (37%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQL-H 146
LG G FG V I + K S VAVK LK EG +K +TE+ L + H
Sbjct: 15 LGRGAFGKV----IQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGH 69
Query: 147 HPNLVKLIGYCLEGENRLLV-YEFMPKGSLENHL 179
H N+V L+G C + L+V E+ G+L N+L
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 62/258 (24%), Positives = 105/258 (40%), Gaps = 49/258 (18%)
Query: 90 LGEGGFGFVYK-----GWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ 144
+G G +G VYK G D+ G+G+ ++ + E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 145 LHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSWAVRMKVA 196
L HPN++ L L +R L++++ F R P L + +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK-----AGPTGDR 247
G+ +LH + V++RD K +NIL+ E K++D G A+ P D
Sbjct: 115 YQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
V+ T Y APE + R TK+ D+++ G + ELL+ + I+ S
Sbjct: 173 ----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS-- 226
Query: 307 DWAKPYLSDK-RKLFRIM 323
PY D+ ++F +M
Sbjct: 227 ---NPYHHDQLDRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 45/170 (26%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRG------PQPLSW 189
E+ L +L HPN++ L L +R L++++ F R P L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 190 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAK----- 240
++ + G+ +LH + V++RD K +NIL+ E K++D G A+
Sbjct: 108 SMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLS 289
P D V+ T Y APE + R TK+ D+++ G + ELL+
Sbjct: 166 LKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQL-H 146
+LG G FG V +G + LS ++P M VAVK LKP K+ L +E+ + L
Sbjct: 44 ILGSGAFGKVVEG--TAYGLSRSQPV--MKVAVKMLKPTARSSEKQALMSELKIMTHLGP 99
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 181
H N+V L+G C + ++ E+ G L N+L +
Sbjct: 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 33/188 (17%)
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL---FRRGPQPLSWAVR 192
EVN + +L H N+V+ I L N+ L + EF G L ++ ++ + A+
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI- 120
Query: 193 MKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLD----------AEFN------- 230
+ + L + H+ + +V++RD K NI L A+ N
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELL 288
AK+ DFGL+K H +GT Y +PE + T KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 289 SGRCAVDK 296
SG+ K
Sbjct: 238 SGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQLH-H 147
LG G FG V + H LS ++ S M VAVK LK K+ L +E+ + L H
Sbjct: 45 LGSGAFGRVVEA--TAHGLSHSQ--STMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 181
N+V L+G C +G ++ E+ G L ++L R
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 87/405 (21%), Positives = 156/405 (38%), Gaps = 74/405 (18%)
Query: 8 SSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEG--EILS 65
+SAR ++ R T+ ++ SH A +T + N E P PK + L
Sbjct: 49 NSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTT-NVEVAPPPKKKKVTYALP 107
Query: 66 SSNLKAFTF-----NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVA 120
+ + + F ++ +T+ F+ SLLGEG FG V + W D+ K V
Sbjct: 108 NQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAW-DR------KRKEYCAVK 160
Query: 121 VKKLKPEGFQGHKEWLTEVNYLGQLHHPN------LVKLIGYCLEGENRLLVYEFMPK-- 172
+ + P+ + K E+ ++ ++ + L+K+ Y + + MPK
Sbjct: 161 IVRNVPKYTRDAK---IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI--VMPKYG 215
Query: 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232
L + + + GP ++ G A L + H E +++ D K NIL+ E +
Sbjct: 216 PCLLDWIMKHGPFSHRHLAQIIFQTGVA--LDYFH-TELHLMHTDLKPENILM--ETSDT 270
Query: 233 LSDFGLAKAGPTG-------------DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 279
+ D +A P D H T ++ T Y +PE V +D++S
Sbjct: 271 VVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 280 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTA 339
G ++ EL +G+ D D + +M+ LG + A
Sbjct: 331 MGCIIYELYTGKLLYDT-----------------HDNLEHLHLMEKTLGRLPSEWAGRCG 373
Query: 340 ATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 384
A N+ +LRP PK+ A+++++ P R+
Sbjct: 374 TEEARLLYNSAGQLRP-----------CTDPKHLARIARARPVRE 407
|
Length = 467 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.002
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 146 HHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
+PN +KL Y + +L+ +++ G L + L + G LS A K+ + L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALN 123
Query: 205 FLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVM--GTHGYA 261
LH +I+ D K N+L D A+ L D+GL K + T GT Y
Sbjct: 124 DLHKH--NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYF 173
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSG 290
+PE + D ++ GV+ ELL+G
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 22/154 (14%)
Query: 93 GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPN 149
G FG VY G K + + AVK +K + E + L P
Sbjct: 15 GAFGKVYLGR---------KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 150 LVKLIGYCLEGENRL-LVYEFMPKGSLEN--HLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
+V L Y L+ N + LV E++ G +++ H++ + ++ +K A L +L
Sbjct: 66 IVHLY-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYL 120
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
H +I+RD K N+L+ E + KL+DFGL+K
Sbjct: 121 H--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 421 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.49 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.4 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.33 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.07 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.94 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.83 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.8 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.74 | |
| PLN02236 | 344 | choline kinase | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.47 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.21 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.19 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.08 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.99 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.98 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.88 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.86 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.81 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.57 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.51 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.15 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.12 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.02 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.89 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-54 Score=390.05 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=208.8
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-------HHHHHHHHHHHhcCCCCCccc
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-------HKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~ 152 (421)
..+.|.+.+.||+|+||.|-+|+.+. +|+.||||++....... .....+|+++|++|+|||||+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~ 240 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR 240 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE
Confidence 45679999999999999999996554 79999999998654332 233569999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC---C
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---F 229 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~ 229 (421)
++++|...+..||||||++||+|.+.+..++. +.+.....++.|++.|+.||| ..||+||||||+|||+..+ .
T Consensus 241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 241 IKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EeeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcce
Confidence 99999999999999999999999999987765 777777899999999999999 4589999999999999765 7
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCC---CccccchhhhHHHHHHHhCCCccCCCcccchhhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 306 (421)
.+||+|||+|+..... ....++|||+.|.|||++.++.+ ..++|||||||+||-+++|.+||......
T Consensus 317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~------ 387 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD------ 387 (475)
T ss_pred EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC------
Confidence 7999999999986543 35678999999999999987653 34889999999999999999999765321
Q ss_pred hhhhhhhhchhhHhHhh-hccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIM-DTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+.+.+ ..++ .......++++..+||.+||..||++|||+.|+|..
T Consensus 388 ----------~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 388 ----------PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ----------ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1112222 2221 112346789999999999999999999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=382.27 Aligned_cols=253 Identities=27% Similarity=0.406 Sum_probs=211.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.+.++.||+|..|+||+++.+ .+++.+|+|++..+.. ...+++.+|+++++.++|||||.+||.|....
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk---------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHK---------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEc---------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 4566788999999999999654 4789999999954432 34467899999999999999999999999988
Q ss_pred -eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 162 -NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 162 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...|+||||++|+|.+++...+ .+++...-.++.++++||.|||.. .+||||||||+||||+..|.|||||||.+.
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 5999999999999999997664 489999999999999999999952 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
...+. ...+++||..|||||.+.+..|+.++||||||++++|+++|+.||....... .+.-.+.
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~------------~~~~~Ll 291 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY------------LDIFELL 291 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC------------CCHHHHH
Confidence 76543 4567999999999999999999999999999999999999999997641100 0111122
Q ss_pred HhhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 321 RIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 321 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+-.......|.. +++++.+||..||++||.+||++.++++.
T Consensus 292 ~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 292 CAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22222233344554 89999999999999999999999999963
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-53 Score=402.28 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=214.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.+|..++.||+|||+.||.+.+.. +|+.||+|++.+... ...+.+.+|++|.+.|+|||||+++++|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 579999999999999999996643 689999999976433 33467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.++.|||+|+|..++|..++.++ +.+++.++..+..||+.||.|||+ .+|+|||||..|+||+++.++||+||||
T Consensus 89 Ds~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~--~~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS--LGIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred cCCceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh--cCceecccchhheeecCcCcEEecccce
Confidence 999999999999999999999754 459999999999999999999995 4699999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|...+..... ..+.|||+.|.|||++....++..+||||+|||||.||.|++||+..... ..
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------------et 226 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------------ET 226 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------------HH
Confidence 9987754332 45699999999999999999999999999999999999999999865421 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+.... ...|..++.++.+||.++|+.||.+|||+++|+.
T Consensus 227 y~~Ik~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 227 YNKIKLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHHhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222222 2456688999999999999999999999999995
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-54 Score=373.17 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=210.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceee-EEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIG-YCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~-~~~ 158 (421)
.+|++++.||+|.||+||++... .+|..+|.|.+..+..+. ...+..|+.+|++|+|||||++++ .|.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~---------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCL---------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeec---------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 36889999999999999999544 468999999998654433 356889999999999999999998 455
Q ss_pred eCCe-EEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCc--eeeccCCCCcEEeCCCCcEEE
Q 014623 159 EGEN-RLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ--VIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~~~-~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl 233 (421)
+++. ++||||||.+|+|..+|.. ...+.+++..+|.++.|++.||..+|++-.+ |+||||||.||+|+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 5555 8999999999999999964 3446699999999999999999999974344 999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+|||+++.+.... ....+.+|||.||+||++.+..|+.++|||||||++|||+.-+.||.+...
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~-------------- 233 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL-------------- 233 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------------
Confidence 9999999876533 345678999999999999999999999999999999999999999987521
Q ss_pred hchhhHhHhhhcccCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
-.+.+.+...-....| ...+.++..||..|+..||+.||+...++..+
T Consensus 234 ---~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 234 ---LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ---HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1222333333333344 78899999999999999999999854444333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=378.16 Aligned_cols=249 Identities=28% Similarity=0.439 Sum_probs=204.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.+|.+.+.||+|+||+||+|+.+. ++..||||.+..... ...+.+..|+.+|+.++|||||.+++++..
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred ccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 579999999999999999997654 578999999987643 334557899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC------CcEEE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKL 233 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------~~~kl 233 (421)
.+..|||||||.||+|.++|++++. +++..+..++.||+.||++|| .++||||||||+||||+.. -.+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999999999999999988764 999999999999999999999 5579999999999999764 45899
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+|||+|+....+. ...+.||++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||+..........
T Consensus 157 ADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~-------- 225 (429)
T KOG0595|consen 157 ADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY-------- 225 (429)
T ss_pred cccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--------
Confidence 9999999876443 45679999999999999999999999999999999999999999986542111100
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
-..........+...+..+.+|+...|..++.+|-+..+..
T Consensus 226 -------~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 226 -------IKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred -------HhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 00111122233445566666788888888888887766554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=385.32 Aligned_cols=257 Identities=33% Similarity=0.546 Sum_probs=218.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcE-EEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV-VAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
...+.+.||.|+||+||+|.++. .. ||||++....... .+.|.+|+.+|.+|+|||||+++|++.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g-----------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRG-----------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCC-----------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34555669999999999998874 44 9999998654433 4589999999999999999999999998
Q ss_pred CC-eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCc-eeeccCCCCcEEeCCCC-cEEEeec
Q 014623 160 GE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEF-NAKLSDF 236 (421)
Q Consensus 160 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-ivHrDlkp~Nill~~~~-~~kl~Df 236 (421)
.. ..++||||+++|+|.+++.+.....+++..++.++.+||.|+.|||+. + |||||||++||||+.++ ++||+||
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~--~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE--GPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--CCeeecccChhhEEEcCCCCEEEECCC
Confidence 87 799999999999999999875445699999999999999999999954 5 99999999999999998 9999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccc--cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|+++...... ...+...||..|||||++. ...|+.|+||||||++||||+||+.||.....
T Consensus 189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------------- 251 (362)
T KOG0192|consen 189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------------- 251 (362)
T ss_pred ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------------
Confidence 9998754322 1233367999999999999 56899999999999999999999999987542
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
............+...+..++..+..|+.+||..||.+||++.+++..|+.+...
T Consensus 252 -~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 252 -VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 2223344445566666777999999999999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=375.66 Aligned_cols=243 Identities=29% Similarity=0.410 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|+++++||+|+||+||.++.+ .+++.+|+|++++..... .+....|..+|..++||+||+++..|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~---------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF 94 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKK---------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF 94 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEc---------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence 357999999999999999999655 368999999998764433 34567899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+.+|||+||+.||.|...|.+.+. +++..+..++..|+.||.|||+ .|||||||||+|||||.+|+++|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccc
Confidence 999999999999999999999987765 8999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+|+...... ....++|||+.|||||++.+..|+.++|.||||+++|||++|..||.+.+..
T Consensus 171 L~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------- 231 (357)
T KOG0598|consen 171 LCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------- 231 (357)
T ss_pred cchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----------------
Confidence 998644332 2345699999999999999999999999999999999999999999876431
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 355 (421)
.+.+.+........+...+.++++++.++|..||++|.
T Consensus 232 ~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 232 KMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 12222222222334555889999999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=386.00 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=215.6
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC-CCCCcccee
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQL-HHPNLVKLI 154 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~ 154 (421)
....+|.+++.||.|+|++|++|.... +++.+|||++.+.... ..+.+.+|-.+|.+| .||.|++||
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy 140 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY 140 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE
Confidence 345689999999999999999996543 6899999999765432 234567899999999 799999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
..|.++..+|+|+||+++|+|.++|.+.+. +++.....++.+|+.||+||| .+|||||||||+||||+++|++||+
T Consensus 141 ~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 141 FTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred EEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEe
Confidence 999999999999999999999999998866 899999999999999999999 5689999999999999999999999
Q ss_pred eccCcccCCCCCCc---------ce--eeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 235 DFGLAKAGPTGDRT---------HV--STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 235 Dfg~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
|||.|..+...... .. ..+++||..|++||+|..+..+..+|||+||||||+|+.|.+||.+...
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---- 292 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---- 292 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH----
Confidence 99999876432221 11 2569999999999999999999999999999999999999999987542
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+.+++.. ...+++..++.+.+||.++|..||.+|+|+.+|.+.
T Consensus 293 ------------yliFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 293 ------------YLIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ------------HHHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1222223222 235677888999999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=382.85 Aligned_cols=290 Identities=58% Similarity=0.987 Sum_probs=245.8
Q ss_pred CCcccCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC
Q 014623 68 NLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH 147 (421)
Q Consensus 68 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 147 (421)
....|++.++..++++|.....||+|+||.||+|...+ |..||||.+.........+|.+|+.++.+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H 130 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH 130 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence 55679999999999999999999999999999998764 57899998876544314569999999999999
Q ss_pred CCccceeeEEEeCC-eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CceeeccCCCCcEEe
Q 014623 148 PNLVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILL 225 (421)
Q Consensus 148 p~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrDlkp~Nill 225 (421)
||+|+|+|||.+.+ +.+||+||+.+|+|.++|......+++|..+++|+.++|.||+|||... ..|||||||+.||||
T Consensus 131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL 210 (361)
T KOG1187|consen 131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL 210 (361)
T ss_pred cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence 99999999999998 5999999999999999997655337899999999999999999999732 259999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
|++.++||+|||+|+..... .........||.+|+|||++..+..+.++||||||++|.||++|+.+.+.........+
T Consensus 211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 99999999999999765431 11111111799999999999999999999999999999999999988876554444457
Q ss_pred hhhhhhhhhchhhHhHhhhcccC-CCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLG-GQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+|..+.+.+. .+.++++..+. ..++. ..-..+..+..+|++.+|.+||++.+|++.|+.+..
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88887766555 78888888876 55554 567779999999999999999999999999976544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=379.95 Aligned_cols=258 Identities=31% Similarity=0.479 Sum_probs=226.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+.+++++.||+|-||.||+|+++.. ..||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 34567788999999999999999863 369999988653 3346788999999999999999999999998
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+.++|||||+..|+|.++|.......+.....+.++.|||+|++||+++ ++|||||...||||++++.+||+|||||+
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--CccchhhhhhheeeccCceEEEccccccc
Confidence 8999999999999999999886667799999999999999999999965 69999999999999999999999999999
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...++... ......-...|.|||.+..+.++.|||||||||+||||+| |+.||.+.. ...+
T Consensus 352 ~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev 413 (468)
T KOG0197|consen 352 LIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEV 413 (468)
T ss_pred ccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHH
Confidence 65544432 2223334678999999999999999999999999999999 999988753 4556
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+.++.+.+...|..++.++.+|+..||..+|++|||+..+...|+.+-.
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 78888999999999999999999999999999999999999999988743
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=370.83 Aligned_cols=268 Identities=27% Similarity=0.360 Sum_probs=214.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHH--HHHHHHHhcCC-CCCccceeeE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW--LTEVNYLGQLH-HPNLVKLIGY 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-hp~iv~~~~~ 156 (421)
..++|.+.+.||.|+||.||+|.... +|+.||||.++..-.. .+++ +||++.|++|+ |||||++.++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Ev 77 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEV 77 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHH
Confidence 44689999999999999999996544 6888999999865433 3333 58999999998 9999999999
Q ss_pred EEeCC-eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 157 CLEGE-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 157 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
+.+.+ .+++||||| ..+|++++..+ +..+++..+..|+.||+.||+|+| .+|+.||||||+|||+..+..+||+|
T Consensus 78 i~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 78 IRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred hhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEecc
Confidence 99988 999999999 55999999777 678999999999999999999999 66899999999999999888999999
Q ss_pred ccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhh
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY 312 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~-~~~~~ 312 (421)
||+|+.+.... ..+..+.|.||+|||++.. +.|+.+.||||+|||++|+.+-+..|.+...-+... +.+ ...|.
T Consensus 154 FGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred cccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 99999876544 3456889999999998864 669999999999999999999999998875432211 111 11221
Q ss_pred hh---chhhHhHhhhcccCCCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 313 LS---DKRKLFRIMDTKLGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 313 ~~---~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.. ....+...+.-.+.... -+.++.++.+||.+||..||++|||+.++++.-
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11 11222333332222111 134788999999999999999999999999753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=348.23 Aligned_cols=266 Identities=25% Similarity=0.313 Sum_probs=205.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.|+.+.++|+|+||+||+++.+ .+|+.||||++..... ...+-.++|+++|++|+|+|+|.++++|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk---------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK---------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC---------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 35888899999999999999654 4799999999864432 223557899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
...++||+|||+. ++.+.+.+.. ..++...+..++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk--~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHK--NNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhh--cCeecccCChhheEEecCCcEEeccchhh
Confidence 9999999999977 5555565443 458999999999999999999995 46999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 317 (421)
+.... .....+..+.|.||+|||++.| ..|+..+||||+||++.||++|...|.+...-+.-..+ ....+....-.
T Consensus 149 R~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 149 RTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred HhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 98763 2234567889999999999988 57999999999999999999999999876532221111 11111111111
Q ss_pred hHhHh--hhcccCC----------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRI--MDTKLGG----------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~--~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.++.. +..+++. ..-+.++.-+.+|+.+||..||++|++.++++.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11110 0000000 011456778999999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=335.27 Aligned_cols=267 Identities=28% Similarity=0.365 Sum_probs=210.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.+|...+.||+|.||.||+|++.. +|+.||||+++.....+ ....++|++.|+.++|+||+.++|+|.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 478889999999999999997554 68999999998764432 2457899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+.+.||+||++ .+|+..|..+. ..++...+..++.+++.||+|||+ +.|+||||||.|+||+.+|.+||+|||+|
T Consensus 73 ~~~l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~--~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 73 KSNLSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS--KWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred CCceEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh--hhhhcccCCccceEEcCCCcEEeecccch
Confidence 999999999995 49999885544 568999999999999999999995 46999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh---hhhhhhhhhh-
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS---LVDWAKPYLS- 314 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~- 314 (421)
+.+....... ...+-|.+|+|||++.|. .|+..+||||.|||+.||+-|.+.|.+... +++. +.....|..+
T Consensus 149 r~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 149 RFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred hccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCccc
Confidence 9987655432 334779999999988875 599999999999999999998877776543 2221 1112222111
Q ss_pred --chhhHhHh-----hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 315 --DKRKLFRI-----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 315 --~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
+...+... .........-..+++++.+|+.+||..||.+|+++.|++++=
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11111111 111111223356778889999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=369.17 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=208.9
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC----Cc-cCHHHHHHHHHHHhcCC-CCCccce
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE----GF-QGHKEWLTEVNYLGQLH-HPNLVKL 153 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hp~iv~~ 153 (421)
..++|.+++.||+|+||+|++|+... ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l 85 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL 85 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence 34689999999999999999996554 5789999987664 11 23345668999999998 9999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAK 232 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 232 (421)
++++.....+++||||+.||+|.+++.+.+ .+.+..+..++.|++.|++|||+ +||+||||||+|||++.+ +++|
T Consensus 86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~--~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHS--RGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEecCCCCCEE
Confidence 999999999999999999999999998744 48889999999999999999994 589999999999999999 9999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCC-CC-ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
|+|||++.... .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+....
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----------- 228 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----------- 228 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----------
Confidence 99999999763 1222456799999999999999977 86 689999999999999999999987431
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKA-AHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+...+ ..-...+|..+ +.++.+|+.+||..||.+|+++.+|++
T Consensus 229 ------~~l~~ki-~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 229 ------PNLYRKI-RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ------HHHHHHH-hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111111 11122345556 999999999999999999999999993
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=359.18 Aligned_cols=257 Identities=30% Similarity=0.471 Sum_probs=210.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|..++.||+|+||.||++...+ +|+.+|||.+........+.+.+|+.+|++|+|||||+++|.....+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 468889999999999999996554 48899999987653333566889999999999999999999755444
Q ss_pred --eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeeccC
Q 014623 162 --NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGL 238 (421)
Q Consensus 162 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~ 238 (421)
.++++|||+.+|+|.+++.+.+. .+++..+..+..||++||+|||+ +|||||||||+||||+. ++.+||+|||+
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 68999999999999999988876 69999999999999999999994 57999999999999999 79999999999
Q ss_pred cccCCC-CCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 239 AKAGPT-GDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 239 a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+..... .........+.||+.|||||++..+ ....++|||||||++.||+||+.||.... ...
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~---------------~~~ 229 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF---------------EEA 229 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc---------------chH
Confidence 987653 1111223357899999999999863 33459999999999999999999997520 011
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
..+..+.........|..++.++.++|.+|+..||.+|||+.++|+..-
T Consensus 230 ~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 230 EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 2223333333333667789999999999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=362.91 Aligned_cols=266 Identities=26% Similarity=0.316 Sum_probs=206.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.|+.++.||+|+||.||+|++. .+|+.||+|++..+.. .......+||.||++|+||||+++.+...+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~---------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDL---------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeec---------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 46888899999999999999654 4799999999986653 233456799999999999999999999887
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
. ..+|||+|||+. ||.-++... .-.+++.++..++.||+.||+||| .+||+|||||..|||||.+|.+||+|||
T Consensus 188 ~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 188 KLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred cCCceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEecccc
Confidence 6 689999999976 888888543 345999999999999999999999 5689999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~~~~ 314 (421)
||+++...... ..+..+-|.||+|||+++|. .|+.++|+||.||||.||+.|++.|.+...-..- .+... ..|. .
T Consensus 264 LAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~-e 341 (560)
T KOG0600|consen 264 LARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT-E 341 (560)
T ss_pred ceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC-h
Confidence 99987654433 24556779999999999886 5999999999999999999999999876542211 11111 1111 1
Q ss_pred chhhHhHhhh---cccCCCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMD---TKLGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~---~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+.+....+-. .+....+ ....+..+.+|+..+|..||++|.|+.++|.
T Consensus 342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111000000 0000011 1355678889999999999999999999884
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=370.26 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=216.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
..|...+.||+|+.|.||.|... .++..||||.+........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~---------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKI---------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhcchhhhccccccceeeeeec---------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 46888899999999999999543 467889999998887777778899999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.+|+||||++||+|.|.+.... +++.++..++..++.||+||| .+||+|||||.+|||++.+|.+||+|||+|..
T Consensus 344 eLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred eeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 9999999999999999996544 899999999999999999999 56899999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
+..... ...+.+||++|||||++....|++++||||||++++||+-|++||-.+... +.+..
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----------------rAlyL 480 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------------RALYL 480 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----------------HHHHH
Confidence 655432 356789999999999999999999999999999999999999999653321 11111
Q ss_pred hh-hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+. ........+..++..+.+|+.+||..|+++|+++.|+|+.
T Consensus 481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 1223345678899999999999999999999999999963
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=340.73 Aligned_cols=238 Identities=29% Similarity=0.385 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+.+.||.|+||.|.+++.+. +|..+|+|+++....-.. +...+|..+|+.+.||+++++++.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred hhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 578999999999999999997654 589999999987655433 34578999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+...++|||||++||.|..++++.++ +++..+..++.+|+.||+|||+ .+|++|||||+|||||.+|.+||+|||+
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeeeccCCcEEEEeccc
Confidence 99999999999999999999977655 8999999999999999999995 4699999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+..... .-+.|||+.|+|||++..+.|+.++|.|||||++|||+.|..||..... ...
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------------~~i 249 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------------IQI 249 (355)
T ss_pred eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------------HHH
Confidence 9876442 3458999999999999999999999999999999999999999976532 122
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 355 (421)
..+++...+ .+|...+.++.+||.++|+.|-.+|.
T Consensus 250 Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 250 YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 233334433 57888999999999999999999993
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=370.11 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=206.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCC-CCCccceee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLH-HPNLVKLIG 155 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~ 155 (421)
..++|+++++||+|.||+|+++..+. +++.+|||++++... ++.+..+.|.+|+.... ||.++.++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~ 436 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS 436 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc
Confidence 34689999999999999999996554 678999999998765 33455778999988875 999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
.|...+++|+||||+.||++..+++ ...+++..+..++..|+.||.||| .+||||||||.+|||||.+|++||+|
T Consensus 437 ~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiAD 511 (694)
T KOG0694|consen 437 CFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIAD 511 (694)
T ss_pred ccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEecc
Confidence 9999999999999999999554442 234999999999999999999999 56899999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||||+...... ....++|||+.|+|||++.+..|+.++|.|||||+|||||.|..||.+.+..
T Consensus 512 FGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------------- 574 (694)
T KOG0694|consen 512 FGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------------- 574 (694)
T ss_pred cccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------
Confidence 99999754322 2456799999999999999999999999999999999999999999876431
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
+....++.. ...+|..++.++..+++++|..+|++|..+
T Consensus 575 -e~FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -EVFDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111112221 225788899999999999999999999854
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=363.41 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=205.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|.++++||+|+||.||+|+- ..+|..+|+|++++..... .+.+..|-.+|....+++||++|..|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarK---------k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARK---------KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred cccchhheeeccccceeEEEEEE---------ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 36899999999999999999954 4479999999998765433 34567799999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+++||||||++||++..+|.+.+. +++..+..++.+++.|+..|| +.|+|||||||+|+|||..|++||+|||
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeecccc
Confidence 999999999999999999999987765 899999999999999999999 5689999999999999999999999999
Q ss_pred CcccCCCC----------------------CCcc-----------------------eeeccccccceecccccccCCCC
Q 014623 238 LAKAGPTG----------------------DRTH-----------------------VSTQVMGTHGYAAPEYVATGRLT 272 (421)
Q Consensus 238 ~a~~~~~~----------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~ 272 (421)
||.-.... +... .....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98532110 0000 00126799999999999999999
Q ss_pred ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccC
Q 014623 273 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNE 350 (421)
Q Consensus 273 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~d 350 (421)
..+|+||||||+||||.|.+||...... ....+++.-+ +.......++.++.+||.+||. |
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~----------------~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQ----------------ETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-C
Confidence 9999999999999999999999876532 1122222222 2222334667899999999999 9
Q ss_pred CCCCCC---HHHHHH
Q 014623 351 PKLRPR---MSEVLA 362 (421)
Q Consensus 351 P~~Rpt---~~ell~ 362 (421)
|++|.. +.||.+
T Consensus 430 ~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKK 444 (550)
T ss_pred HHHhcCcccHHHHhc
Confidence 999985 556543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.72 Aligned_cols=254 Identities=28% Similarity=0.365 Sum_probs=216.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.|++++.||.|.-|+||++.+.. ++..+|+|++.++..... .++..|-+||..++||.++.||..|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 467888999999999999997664 468999999987765443 45677999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..|+|||||+||+|..+++++....+++..+..++..++.||+||| ..|||+|||||+||||.++|+|-|+||.|
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeeeccc
Confidence 9999999999999999999999998899999999999999999999999 56899999999999999999999999998
Q ss_pred cccCCC---------------------------------CCC---------------------cceeeccccccceeccc
Q 014623 239 AKAGPT---------------------------------GDR---------------------THVSTQVMGTHGYAAPE 264 (421)
Q Consensus 239 a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE 264 (421)
+..... ... ......++||-.|.|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 743210 000 00122478999999999
Q ss_pred ccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHH
Q 014623 265 YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 344 (421)
Q Consensus 265 ~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 344 (421)
++.|...+.++|+|+|||++|||++|..||.+.. ....+..++...+.-...+.++..+.+||+
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~----------------~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN----------------NKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC----------------chhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 9999999999999999999999999999998864 344555566555554444588899999999
Q ss_pred hccccCCCCCCC----HHHHHH
Q 014623 345 QCLNNEPKLRPR----MSEVLA 362 (421)
Q Consensus 345 ~~l~~dP~~Rpt----~~ell~ 362 (421)
++|.+||.+|.. +.||-.
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHhccChhhhhccccchHHhhc
Confidence 999999999997 666653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=349.57 Aligned_cols=263 Identities=27% Similarity=0.360 Sum_probs=212.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH-HHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.+.|++..+||.|..++||+|+... +++.||||++..+..... +.+.+|++.|+.++||||++++..|..
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 3689999999999999999997654 478999999987765544 778899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..+|+||.||.+|++.+++...-...+++..+..++.+++.||.||| .+|.||||||+.||||+.+|.|||+|||.+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCceee
Confidence 999999999999999999998887788999999999999999999999 668999999999999999999999999976
Q ss_pred ccC-CCCCCccee-eccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 240 KAG-PTGDRTHVS-TQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 240 ~~~-~~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
-.. ..+...... .+++||++|||||+++. ..|+.|+||||||++..||.+|..||.....-..-...--..|....
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 433 333333333 56899999999999654 46999999999999999999999999865431111110000000000
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
......+.....+..+..+|..||..||.+|||++++++
T Consensus 254 --------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 --------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred --------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111122355668999999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=363.70 Aligned_cols=267 Identities=30% Similarity=0.415 Sum_probs=209.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 46899999999999999999975321 1223467899999875432 2335688999999999 8999999999887
Q ss_pred eC-CeEEEEEEcCCCCChHHHHhhcC------------------------------------------------------
Q 014623 159 EG-ENRLLVYEFMPKGSLENHLFRRG------------------------------------------------------ 183 (421)
Q Consensus 159 ~~-~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 183 (421)
.. ...++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 45789999999999999986532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccc
Q 014623 184 ------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257 (421)
Q Consensus 184 ------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 257 (421)
...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++...............++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 1247788889999999999999994 58999999999999999999999999999865332222122234467
Q ss_pred cceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHH
Q 014623 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 336 (421)
Q Consensus 258 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (421)
..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+...+........+..++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----------------EFCQRLKDGTRMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----------------HHHHHHhcCCCCCCCCCCC
Confidence 88999999999999999999999999999997 999997643210 0111111111223345667
Q ss_pred HHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 337 HTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 337 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+.+|+.+||..||.+||++.++++.|+.+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.33 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=212.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.-|++++.||.|+-|.|-+|+ +..+|+.+|||++..... .....+.+|+-+|+.+.||||+.+|++++
T Consensus 12 GpwkLgkTLG~Gstg~vrlak---------h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAK---------HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhhh---------cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 358999999999999999994 455899999999976521 11234678999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
++.++|+|.||++||.|++++.+++. +.+..+..++.||+.|+.|||. .+|+||||||+|+||+..+++||+|||+
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhhhcccCEeeeccce
Confidence 99999999999999999999988876 8889999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCC-ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
|.....+. ...+-||++.|.+||+++|..|+ .++||||.|||||.|++|++||++.. .+
T Consensus 159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-----------------ir 218 (786)
T KOG0588|consen 159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-----------------IR 218 (786)
T ss_pred eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-----------------HH
Confidence 98744433 45678999999999999999985 58999999999999999999998542 12
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+...+..+ ....|..++.++++||.+||..||.+|.|+.||++..
T Consensus 219 ~LLlKV~~G-~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 219 VLLLKVQRG-VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHHHHHHcC-cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 222222111 1245789999999999999999999999999999753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=350.43 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=212.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHH---HHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..+|.+.+.||+|+||.|-+|+.. ..|+.||||.+++....+..+ +.+|++||..|+||||+.+|.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~---------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH---------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc---------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 358999999999999999998543 368999999998877665544 56899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
+..+.+.|||||..+|.|+||+.+.+. +++..+..++.||+.|+.||| +++++|||||.+|||||.|+++||+|||
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999999987765 999999999999999999999 6789999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
++..+.... ...++||++-|.+||++.|..| ++.+|-|||||+||.|+.|..||++.+- .
T Consensus 199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------------k 259 (668)
T KOG0611|consen 199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------------K 259 (668)
T ss_pred hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------------H
Confidence 998875543 3467999999999999999988 5689999999999999999999997531 1
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.-+.++-...++ .+..+.++.-||+.||..||++|.|+.+|...
T Consensus 260 ~lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 260 RLVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 112222222222 23446678889999999999999999999865
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=362.23 Aligned_cols=278 Identities=26% Similarity=0.402 Sum_probs=218.8
Q ss_pred HHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCcc
Q 014623 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLV 151 (421)
Q Consensus 74 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv 151 (421)
..++....+.+.+++.||+|.||+||+|+|.. .||||++...... ..+.|.+|+.++++-+|-||+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence 35556666778899999999999999999875 3999999866543 346799999999999999999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
-+.|+|..... .||+.||+|-+|+.+|+-.. ..+.....+.|+.||+.|+.|||. ++|||||||..||||.+++.|
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA--K~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA--KNIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh--hhhhhhhccccceEEccCCcE
Confidence 99999987766 99999999999999997654 458999999999999999999995 469999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 308 (421)
||+||||+.....-..........|...|||||+++.+ .|++.+|||||||++|||++|.+||.... .++.+...
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIifmV 605 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIFMV 605 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEEEe
Confidence 99999999754322222222334578899999999754 58999999999999999999999998322 22222211
Q ss_pred hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCCCCCcccCCC
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 380 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~~~~~~~~~~ 380 (421)
...++. .........++.++.+|+..||..++++||.+.+|+..|+.+.........+.++
T Consensus 606 GrG~l~-----------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~ 666 (678)
T KOG0193|consen 606 GRGYLM-----------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASE 666 (678)
T ss_pred cccccC-----------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCc
Confidence 111110 0011223577889999999999999999999999999999887744333333333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=358.68 Aligned_cols=245 Identities=30% Similarity=0.424 Sum_probs=212.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|.+.+.||+|.||.||+|+ ++.+.+.||+|.+.+.... ..+.+.+|++|++.|+|||||.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr---------rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR---------RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeecc---------cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 478899999999999999994 4557899999999876543 34567899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
..++|+|.||+.| +|..+|...+. ++++.+..++.+++.||.|||+ .+|+|||+||+|||++.+|.+|+||||+|
T Consensus 73 ~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs--~rilhrd~kPqniLl~~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHS--NRILHRDMKPQNILLEKGGTLKLCDFGLA 147 (808)
T ss_pred cceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHh--cCcccccCCcceeeecCCCceeechhhhh
Confidence 9999999999976 99999976654 8999999999999999999995 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
+.... .+.+.+...||+.|||||++.++.|+..+|+||||||+|||++|++||.... +
T Consensus 148 r~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------------------i 205 (808)
T KOG0597|consen 148 RAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------------------I 205 (808)
T ss_pred hhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------------------H
Confidence 98655 3445667889999999999999999999999999999999999999996432 2
Q ss_pred hHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+++.... .-.+|...+..+..++..+|.+||.+|.+-.+++.
T Consensus 206 ~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 206 TQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22222222 12456788999999999999999999999999884
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=324.47 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=215.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+++.||+|.||.||+|+.+. ++..||+|++.+... .....+.+|++|...|+||||+++|++|.
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred hhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 479999999999999999997654 578999999876543 23356789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+....||++||..+|.|+..|.......+++.....++.|+|.||.|+| .++|+||||||+|+|++..|.+||+|||.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999999999998766677999999999999999999999 55799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+.....+ ...+.|||..|.+||...+..++..+|+|++|++.||++.|..||..... ...
T Consensus 171 sV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------------~et 230 (281)
T KOG0580|consen 171 SVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------------SET 230 (281)
T ss_pred eeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----------------HHH
Confidence 8765432 34568999999999999999999999999999999999999999976431 111
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..++.. ....+|..++.++.+||.+||..+|.+|....|+++.-
T Consensus 231 YkrI~k--~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 231 YKRIRK--VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred HHHHHH--ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 222222 22345688999999999999999999999999998753
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=372.30 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=218.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceee-EEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIG-YCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~-~~~ 158 (421)
..++++.++|.+|||+.||+|.+.. .|..+|+|++-..+....+.+.+|+++|+.|+ |+|||.++| ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 4578899999999999999997665 34889999988777777788999999999997 999999999 332
Q ss_pred e------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 E------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
. .-+++|+||||.||.|-|++..+....+++.++++|+.++++|+++||.....|||||||-+||||+.+|++|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1256799999999999999987766669999999999999999999998888899999999999999999999
Q ss_pred EeeccCcccCCCCCCccee-------eccccccceeccccc---ccCCCCccccchhhhHHHHHHHhCCCccCCCcccch
Q 014623 233 LSDFGLAKAGPTGDRTHVS-------TQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 302 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 302 (421)
|||||.|......-..... -...-|+.|+|||++ .+..+++|+|||||||+||-||+...||++..
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---- 262 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---- 262 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----
Confidence 9999998753322211100 012358999999976 57789999999999999999999999998652
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...++...+.....+.++..+.+||+.||+.||.+||++-++++.+-++....
T Consensus 263 ----------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ----------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ----------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 13445555555555789999999999999999999999999999988876543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=329.96 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=205.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.|..+..|++|+||.||+|+++ .+++.||+|.++.+.... --..++|+.+|.+++|||||.+-.+...
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk---------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDK---------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccC---------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 35788899999999999999654 468999999997543211 1235799999999999999999988774
Q ss_pred --CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 --GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
-+.+|||||||+. +|..++..-. +++....+..+..|++.||+||| .+.|+|||||++|+|++..|.+||+|||
T Consensus 147 ~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred cccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccc
Confidence 3579999999976 9999886654 67999999999999999999999 5579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccc--hhhhhhhhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI--EQSLVDWAKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~ 314 (421)
+|+.++... ...+..+-|.||+|||++.+. .|++++|+||+|||+.||+++++.|.+...-. +..+.....|...
T Consensus 223 LAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~ 300 (419)
T KOG0663|consen 223 LAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEA 300 (419)
T ss_pred hhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccc
Confidence 999876543 234557789999999999875 59999999999999999999999998765422 1122222222111
Q ss_pred chhhH-----------hHhhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKL-----------FRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~-----------~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+ .+.....++..+... +++..++|+..+|..||.+|.|+.+.|+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11000 000111112222222 6788999999999999999999999885
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.53 Aligned_cols=271 Identities=27% Similarity=0.319 Sum_probs=210.4
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEec--CCCccCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK--PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
....+|...+.||+|+||.|+.|.+.. +|+.||||++. .......++.++|+++|+.++|+||+.++++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence 345678888999999999999996554 68999999987 3444455788999999999999999999998
Q ss_pred EEe-----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 157 CLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 157 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
+.. -+..|+|+|+| +.+|...|..+.. ++...+..+++|++.||.|+|+. +|+||||||.|+|++.+..+
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~n~~c~l 164 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLLNADCDL 164 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc--cccccccchhheeeccCCCE
Confidence 875 35689999999 6799999966543 89999999999999999999965 69999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh--
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW-- 308 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-- 308 (421)
||+|||+|+...........+..+-|.||.|||++.. ..|+.+.||||+||||.||++|+..|.+.+.-..-.+...
T Consensus 165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 9999999998754323333466788999999998764 5799999999999999999999999988765322222211
Q ss_pred hhhhhhchhh-----HhHhhhc-ccCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 309 AKPYLSDKRK-----LFRIMDT-KLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 309 ~~~~~~~~~~-----~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..|....... ....+.. ..... .-+..++.+.+|+.+||..||.+|+|++|+|+.
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110000 1111110 00011 113678899999999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=353.40 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=218.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|..++++|+|+||.+++++.+ ..+..+++|.+....... .....+|+.+++++.|||||.+++.|..
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk---------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK---------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc---------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 57899999999999999998443 456799999997655433 3457899999999999999999999999
Q ss_pred CCe-EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 160 GEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
++. .+|||+||+||+|.+.|.+.....+++..++.|+.|++.|+.||| .++|+|||||+.|||++.++.|||+|||+
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhh
Confidence 888 899999999999999998877778999999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+...... ....+.+||+.|+.||++.+.+|+.|+|||||||++|||++-+.+|...+. ..
T Consensus 153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------------~~ 213 (426)
T KOG0589|consen 153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------------SE 213 (426)
T ss_pred hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------------HH
Confidence 99876544 234568999999999999999999999999999999999999999987542 22
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+...+........+...+.++..+|..||..+|..||++.++|..
T Consensus 214 Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 214 LILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222233333556778999999999999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=369.04 Aligned_cols=266 Identities=30% Similarity=0.492 Sum_probs=227.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+.++.+.||+|+||+||+|...+.. -......||||.++..... ...+|.+|+++|..|+|||||+|+|+|.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 45677789999999999999766532 1234568999999877655 678899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
+..+||+|||..|||.++|....+ .+++..+.+.|+.|||.|+.||-++ .+|||||-..|+||.++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--HFVHRDLATRNCLVGEN 639 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--cccccchhhhhceeccc
Confidence 999999999999999999965421 2388899999999999999999854 59999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 307 (421)
..|||+||||++.+-..++........-..+||+||.+..+.|+++||||||||+|||+++ |..||.+..
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--------- 710 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--------- 710 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---------
Confidence 9999999999998766666655544555789999999999999999999999999999999 999987643
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+.+.+.+..+.....|..++.+++.|+..||+.+|.+||+++||-..|+.+...
T Consensus 711 --------n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 --------NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2334444555555778999999999999999999999999999999999986543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=354.69 Aligned_cols=265 Identities=28% Similarity=0.424 Sum_probs=209.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+... ....++..||||+++.... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 35799999999999999999975321 1233567899999975432 3345688999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC-------------------------------------------------------
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG------------------------------------------------------- 183 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 183 (421)
..+..++||||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCC
Q 014623 184 ------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245 (421)
Q Consensus 184 ------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 245 (421)
...+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 1246788899999999999999994 57999999999999999999999999999865443
Q ss_pred CCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 246 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ....+.+.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------------~~~~~~~~ 331 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------------SKFYKMIK 331 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------------HHHHHHHH
Confidence 32222222345678999999999999999999999999999998 88898654211 11112222
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.......+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus 332 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 2222223344567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=355.03 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=210.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+... ....++..||+|.++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 35799999999999999999976432 1223456899999975432 2345678999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC-------------------------------------------------------
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG------------------------------------------------------- 183 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 183 (421)
.....++||||+.+|+|.+++.+..
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999999985431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcce
Q 014623 184 -------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250 (421)
Q Consensus 184 -------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 250 (421)
...+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1246788899999999999999994 5899999999999999999999999999986543322222
Q ss_pred eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCC
Q 014623 251 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG 329 (421)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (421)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......+......
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----------------~~~~~~~~~~~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----------------SKFYKMVKRGYQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----------------HHHHHHHHcccCc
Confidence 222345678999999998999999999999999999997 99999754211 1111222222222
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 330 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 330 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
..+...+.++.+++.+||+.||.+||++.+|++.|+++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33344578899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=341.67 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=204.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 37788999999999999997654 5789999998754322 22457789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+|+|.+++.......+++..++.++.|++.||+||| ..||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999998886655456899999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+
T Consensus 150 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-------------~~~ 213 (285)
T cd05631 150 VQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-------------EEV 213 (285)
T ss_pred EEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-------------HHH
Confidence 8653322 123457899999999999999999999999999999999999999764321110 001
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
...+ ......++...+.++.+||.+||..||.+||+ +.++++
T Consensus 214 ~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 214 DRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111 11112344567789999999999999999997 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=336.98 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=207.0
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--------------cCHHHHHHHHHHHh
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--------------QGHKEWLTEVNYLG 143 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~ 143 (421)
....++|++++.||+|.||.|-+|++.. +++.||||++.+... ...+...+|+.+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK 163 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK 163 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH
Confidence 3445789999999999999999997654 589999999975321 12356789999999
Q ss_pred cCCCCCccceeeEEEe--CCeEEEEEEcCCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCC
Q 014623 144 QLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 220 (421)
Q Consensus 144 ~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp 220 (421)
+|.|||||+|+.+..+ .+.+|||+|||..|.+... ....+ +++.+++.++.+++.||+|||.+ |||||||||
T Consensus 164 kl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q--giiHRDIKP 238 (576)
T KOG0585|consen 164 KLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ--GIIHRDIKP 238 (576)
T ss_pred hcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc--Ceeccccch
Confidence 9999999999998875 4679999999998877542 23334 89999999999999999999954 799999999
Q ss_pred CcEEeCCCCcEEEeeccCcccCCCCC---CcceeeccccccceecccccccCC----CCccccchhhhHHHHHHHhCCCc
Q 014623 221 SNILLDAEFNAKLSDFGLAKAGPTGD---RTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCA 293 (421)
Q Consensus 221 ~Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~p 293 (421)
.|+||+++|.+||+|||.+..+..+. ........+||+.|+|||...++. .+.+.|||||||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 99999999999999999998663221 111122368999999999887743 35589999999999999999999
Q ss_pred cCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
|.+... .....++++..+.....+++.+++.+||.+||.+||++|.++.+|.....
T Consensus 319 F~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 319 FFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred cccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 976431 22234555555555555678999999999999999999999999976653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=342.61 Aligned_cols=273 Identities=26% Similarity=0.438 Sum_probs=207.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCC-------CCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLS-------PAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
.++|++.+.||+|+||.||+|.+...... ..+...+..||+|.+..... .....+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 35799999999999999999986542110 01233456899999876432 23456889999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceee
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 215 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 215 (421)
+++++.+.+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~ivH 161 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS--LNFVH 161 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH--CCccc
Confidence 99999999999999999999999999865321 236778889999999999999994 57999
Q ss_pred ccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh--CCCc
Q 014623 216 RDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCA 293 (421)
Q Consensus 216 rDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~p 293 (421)
|||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544332222333456789999999998899999999999999999987 5567
Q ss_pred cCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
|....... ..... ...............+..++..+.+|+.+||..||.+|||+.+|...|+
T Consensus 242 ~~~~~~~~---~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENA-------GEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHH-------HHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76432110 00000 0000000011111223456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=347.22 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=209.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..|+..+.||+|.||.||+|.+.. +++.||+|++..+.... .+++.+|+.+|..++++||.++|+.+..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred cccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 467888999999999999996554 68999999998775543 46778899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..+|++||||.||++.+++..... +.+..+..++.+++.||.|||. .+.+|||||+.|||+..+|.+||+|||++-
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~--~~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHS--EKKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhh--cceecccccccceeEeccCcEEEEecceee
Confidence 999999999999999999965543 4777788889999999999995 469999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
........ ..+++||+.|||||++....|+.++||||||++.+||++|.+|+...... ...
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvl 220 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVL 220 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEE
Confidence 76543322 36799999999999999889999999999999999999999999764321 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.++.......+...++..+.+|+..||+.||+.||++.++++
T Consensus 221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 122222233344577889999999999999999999999985
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=346.85 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=195.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|...+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+++++.++|+||+++++++...
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 356778999999999999997643 4789999998654322 235688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+.. ...+..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 145 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DfG~~~ 216 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLINSAKNVKIADFGVSR 216 (353)
T ss_pred CeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999986532 25667788899999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
....... .....+||..|+|||++.. ...+.++|||||||++|||++|+.||.........
T Consensus 217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~------------ 282 (353)
T PLN00034 217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA------------ 282 (353)
T ss_pred ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH------------
Confidence 6543211 1234579999999998743 23456899999999999999999999743221111
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.....+........+..++.++.+||.+||..||++||++.|+++.
T Consensus 283 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 283 --SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --HHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111223345677889999999999999999999999863
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=342.18 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=217.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH--HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..-|.+.+.||+|.|++|.+| .+..+|+.||||++.+...+.. ..+++|++.|+.++|||||++|.+..
T Consensus 17 AGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 456889999999999999998 4556899999999988766544 45789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe-CCCCcEEEeecc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFG 237 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~Dfg 237 (421)
....+|||+|+=++|+|+|||.+.. ..+.+..+.+++.||+.|+.|+| +..+|||||||+||.+ ..-|-+||+|||
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeecc
Confidence 9999999999999999999998765 45999999999999999999999 4569999999999876 566889999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCc-cccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
++..+..+.. ..+.||+..|.|||++.|..|+. ++||||||||||.|++|+.||.... +.
T Consensus 165 FSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DS 225 (864)
T KOG4717|consen 165 FSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DS 225 (864)
T ss_pred ccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------ch
Confidence 9998877664 35689999999999999999975 8999999999999999999998653 33
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+.+..+++-++ ..|..++.++.+||..||..||.+|.++++|..
T Consensus 226 ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 44445555443 567899999999999999999999999999974
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=345.94 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=198.6
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.||+|+||.||++.... +|+.||+|+++.... .....+.+|+.+++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 469999999999997543 588999999875422 22345778999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~ 147 (323)
T cd05571 72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence 9999999999999997654 48899999999999999999994 5799999999999999999999999999875322
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----------------~~~~~~~ 208 (323)
T cd05571 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELIL 208 (323)
T ss_pred CCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----------------HHHHHHH
Confidence 211 223467999999999999999999999999999999999999999754311 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
.. ...++..++.++.+||.+||..||++|| ++.++++
T Consensus 209 ~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 209 ME-EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred cC-CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 10 1234556788999999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=342.88 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=202.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 368999999999999999997654 578999999865432 23355788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+.+++|.+++.... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEEecCc
Confidence 9999999999999999999997654 48889999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... ....+|++.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 148 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----------------~ 206 (291)
T cd05612 148 AKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----------------I 206 (291)
T ss_pred chhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 9865332 123578999999999999999999999999999999999999997643110 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~ 363 (421)
...+... ...++...+..+.+||.+||..||.+|++ +.++++.
T Consensus 207 ~~~i~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YEKILAG--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHhC--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0111111 11334556778999999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=336.25 Aligned_cols=246 Identities=21% Similarity=0.325 Sum_probs=201.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEEEe----C
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLE----G 160 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 160 (421)
..||+|++|.||+|.+. |+.||||.++...... .+.+.+|+.+|++++||||+++++++.+ .
T Consensus 26 ~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred eEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 67999999999999763 6789999997654333 3567799999999999999999999877 3
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+.+|+|.+++.+.. .+++.....++.+++.||.|||.. .+++||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 46889999999999999997654 488899999999999999999953 368899999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||...... ..
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----------------~~ 230 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----------------EI 230 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----------------HH
Confidence 643321 23568899999999876 67999999999999999999999999764311 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.............+..++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 231 ~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111122222344467889999999999999999999999999998864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=343.38 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=207.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 3689999999999999999997654 578899999876432 223568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 75 DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred CCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 999999999999999999997654 388999999999999999999963 36999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh-----
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS----- 314 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----- 314 (421)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ..+...
T Consensus 152 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF--GRPVVDGEEGE 225 (331)
T ss_pred ccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--cccccccccCC
Confidence 7653321 23457899999999999999999999999999999999999999654321111000 000000
Q ss_pred --------------------------chhhHhHh-hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 315 --------------------------DKRKLFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 315 --------------------------~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
........ ............++.++.+||.+||..||++|||+.++++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00000111 111111111224678899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=347.17 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=202.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 478999999999999999997654 578999999875422 23356789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+++..++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS--KDIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999999999997654 37888899999999999999995 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------------~~ 223 (329)
T PTZ00263 165 AKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----------------RI 223 (329)
T ss_pred ceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----------------HH
Confidence 98654322 2367999999999999999999999999999999999999999754311 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~ 363 (421)
...+.... ...+..++..+.+||.+||..||.+|++ +.+++..
T Consensus 224 ~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 224 YEKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111111 1234456778999999999999999996 5676643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.66 Aligned_cols=263 Identities=29% Similarity=0.498 Sum_probs=212.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+.... .......|++|.+...... ....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPN----ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCC----CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 46899999999999999999765421 1234568999998754322 235688999999999999999999999998
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
...+++|||+++++|.+++..... ..+++..++.++.|++.||.||| ..|++|+||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVG 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEc
Confidence 999999999999999999976422 34788899999999999999999 45799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~ 305 (421)
.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------ 232 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999976543332222334557889999999988899999999999999999998 9999875431
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
..+...+........+..++.++.+|+.+||+.||.+||++.+|++.|+.+
T Consensus 233 -----------~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 -----------QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----------HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 112222222333344567789999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=347.37 Aligned_cols=239 Identities=30% Similarity=0.483 Sum_probs=203.1
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
++-||.|+.|.||+|+++ ++.||||+++.- + ..+|+.|++|+|+||+.+.|+|.....+|||
T Consensus 129 LeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-----k--ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-----K--ETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hhhhccCcccceeeeecc-----------CceehhHHHhhh-----h--hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 456999999999999876 467999987521 1 2588999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
||||..|-|...|.... .+.......|..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||.++.....
T Consensus 191 MEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h--KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH--KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred eeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh--hHhhhccCCCceEeeccceEEeccccchHhhhhh-
Confidence 99999999999996554 488899999999999999999965 4999999999999999999999999998865432
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
...-.|+||..|||||++++...+.|+|||||||+|||||||..||..-+. .. -+.-.-...
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sA------------IIwGVGsNs 327 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SA------------IIWGVGSNS 327 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----he------------eEEeccCCc
Confidence 223468999999999999999999999999999999999999999975321 11 111222334
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
+....|..+++.+.-||+.||...|..||++.+|+..|+-
T Consensus 328 L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 328 LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 4456788999999999999999999999999999988763
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=314.74 Aligned_cols=266 Identities=25% Similarity=0.360 Sum_probs=211.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|||+.||++. ...+++.+|+|++.....++.+..++|++..++++||||++++++...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~---------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVK---------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred cCceEEEeeeecCCCceeeeeec---------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 35799999999999999999984 344688999999988877788889999999999999999999987664
Q ss_pred C-----CeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 160 G-----ENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 160 ~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
+ ...||++.|...|+|.+.+... +...+++.+++.|+.+|++||.+||.....++||||||.|||+.+.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 3 3489999999999999999653 33459999999999999999999997666699999999999999999999
Q ss_pred EeeccCcccCCCCCCcce-------eeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccch
Q 014623 233 LSDFGLAKAGPTGDRTHV-------STQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 302 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 302 (421)
|.|||.++...-.-.... .....-|..|+|||.+. +...++++|||||||+||+|+.|..||+.....-.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 999999875431111000 01123588999999885 45678899999999999999999999975422100
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+ -........+........++.+.+||+.||+.||.+||++.+++..++.+.
T Consensus 250 -S-------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 -S-------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -e-------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 001111112222223348899999999999999999999999999998764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=359.79 Aligned_cols=253 Identities=22% Similarity=0.256 Sum_probs=206.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.|.+.+.||+|+||.||+|..... .+..||+|.+..........+.+|+.+|+.++||||+++++++..++.
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 489999999999999999965432 256788898765544444567789999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 163 RLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
.||||||++||+|.+++... ...++++..+..++.|++.||.|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999999988542 23458899999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
..............+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----------------~~~ 280 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----------------EIM 280 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHH
Confidence 765433222344577999999999999999999999999999999999999999754210 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+........+..++.++.+||.+||..||++||++.+++.
T Consensus 281 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111111112234456788999999999999999999999874
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=348.84 Aligned_cols=267 Identities=27% Similarity=0.402 Sum_probs=211.7
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLH-HPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 157 (421)
..++|++++.||+|+||.||+|.+... .....+..||||++...... ..+.+.+|+++|+.+. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 356899999999999999999976432 12234567999999754332 2356889999999996 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcC------------------------------------------------------
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRG------------------------------------------------------ 183 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 183 (421)
......|||||||++|+|.++|.+..
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999999886531
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 184 ----------------------------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 184 ----------------------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
...+++..+..++.|++.||.|||+ .+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhE
Confidence 1236778889999999999999994 5799999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccch
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 302 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~ 302 (421)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 999999999999999986543322222233456788999999999999999999999999999997 99998754211
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
......+........+..++.++.+++.+||..||++||++.+|.+.|+++.
T Consensus 347 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 --------------STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 0111112222222344567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.45 Aligned_cols=272 Identities=26% Similarity=0.318 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCC-ccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPN-LVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~-iv~~~~~~~ 158 (421)
..|...+.||+|+||+||+|+... +|+.||+|++..+... .-....+|+-+|+.|+|+| |+.+++++.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeee
Confidence 346667789999999999997654 5899999999865432 2345689999999999999 999999999
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
..+ .+++|+||+ ..+|..++..... ..++...+..++.||+.||+|||+ ++|+||||||+||||+++|.
T Consensus 82 ~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~--~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS--HGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred ecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCcceEEECCCCc
Confidence 877 789999999 5599999977653 357778999999999999999995 57999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh--hhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVD 307 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~ 307 (421)
+||+|||+|+.+..... ..+..++|.+|+|||++.+. .|+..+||||+|||++||++++..|.+........ +..
T Consensus 159 lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 159 LKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred EeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 99999999997553332 24557889999999999987 69999999999999999999999998765421110 111
Q ss_pred hhhhhhhchhhHhHhhhcc--cCCCC-C-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 014623 308 WAKPYLSDKRKLFRIMDTK--LGGQY-P-------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI--LERL 367 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~--~~~~~-~-------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~~ 367 (421)
...|.......+....+.+ +.... + +.......+++.+||+.+|.+|.|+..++++ +..+
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111111111111100000 00000 1 1222588999999999999999999999876 4444
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=345.53 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=204.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 368999999999999999997654 478999999875422 23456788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..|+||||++|++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEEEeCcC
Confidence 9999999999999999999997654 48889999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 317 (421)
+..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .+..+
T Consensus 148 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--------- 213 (333)
T cd05600 148 SKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--------- 213 (333)
T ss_pred Cccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---------
Confidence 986533 223467999999999999999999999999999999999999999764321100 00000
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+...........++.++.+||.+||..+|.+||++.+++..
T Consensus 214 --~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 --KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000000000112457889999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=330.97 Aligned_cols=259 Identities=24% Similarity=0.427 Sum_probs=208.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+... ...+..||+|.++..... ....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLP------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecC------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 5789999999999999999976532 234678999998865322 234688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.+.. ..+++..++.++.|++.||+||| +.|++||||||+|||++.++.++|+|||.+.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999999999997643 35889999999999999999999 5579999999999999999999999999876
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 156 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----------------~~ 217 (266)
T cd05064 156 EDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----------------DV 217 (266)
T ss_pred cccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HH
Confidence 53222111 1112335678999999999999999999999999999875 99999754211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+.+........+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 122222222334556788899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=333.19 Aligned_cols=261 Identities=27% Similarity=0.451 Sum_probs=210.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|.+.+.||+|+||.||+|.+... ....++..||+|.++..... ..+.+.+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 4688899999999999999976432 11234678999998765443 346788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
...++||||+++++|.+++...+ ...+++..+..++.|++.||.||| ..|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCC
Confidence 99999999999999999997543 234788889999999999999999 4579999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 307 (421)
+.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------- 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------- 231 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence 9999999999975433222222233456788999999999999999999999999999998 99998654321
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.....+........+..++..+.+++.+||..||++||++.|+++.|+
T Consensus 232 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 ----------EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111111122222234467788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.90 Aligned_cols=255 Identities=27% Similarity=0.346 Sum_probs=201.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
+|++.+.||+|+||.||+++... ...+++.||+|++..... ...+.+..|+.+++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 48899999999999999987542 233588999999864321 2234577899999999 499999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..++||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999997654 38899999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+++........ .....+||..|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 151 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------------- 216 (332)
T cd05614 151 LSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ------------- 216 (332)
T ss_pred CCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-------------
Confidence 99865432221 12346799999999998865 4788999999999999999999999643221110
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
..+...+. ......+..++..+.+++.+||..||++|| ++.++++
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 217 SEVSRRIL-KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHh-cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00111110 111234456778899999999999999999 6677765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=333.98 Aligned_cols=266 Identities=28% Similarity=0.464 Sum_probs=214.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|.+.+.||+|+||.||+|.+... ....++..+++|.+........+.+.+|+++++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4688899999999999999975432 122346679999987665555567889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
..++||||+.+++|.+++..... ..+++..++.++.||+.||+||| .+||+||||||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEcc
Confidence 99999999999999999965431 34788999999999999999999 558999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhh
Q 014623 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~ 306 (421)
++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------ 232 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------ 232 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------
Confidence 99999999999976543332222233556889999999999999999999999999999998 99998654321
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+.+........+...+..+.+++.+||..+|.+||++.+|++.|+++..+
T Consensus 233 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -----------EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -----------HHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 01111112222223344677899999999999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.71 Aligned_cols=266 Identities=28% Similarity=0.462 Sum_probs=212.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|.+.+.||+|+||.||++..... ....++..+|+|.+........+.+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 35799999999999999999975331 12234667999998765545556788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG-----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
+..++||||+.+++|.+++.... ...+++..++.++.|++.||+||| ..|++||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCC
Confidence 99999999999999999996543 134899999999999999999999 45799999999999999999
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~ 308 (421)
.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------- 230 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------- 230 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999986543322222223445778999999998899999999999999999998 999986543210
Q ss_pred hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....+........+...+.++.+|+.+||+.||.+||++.++++.|+++..
T Consensus 231 ----------~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 231 ----------VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred ----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 011111111112233456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=341.97 Aligned_cols=267 Identities=30% Similarity=0.415 Sum_probs=209.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|..... ....+++.||+|+++.... ...+.+..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred HHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 46899999999999999999965331 2234578999999875432 2235677899999999 7999999999876
Q ss_pred eC-CeEEEEEEcCCCCChHHHHhhcCC-----------------------------------------------------
Q 014623 159 EG-ENRLLVYEFMPKGSLENHLFRRGP----------------------------------------------------- 184 (421)
Q Consensus 159 ~~-~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 184 (421)
.. ...+++|||+.+++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 567899999999999999864321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeecccccc
Q 014623 185 ------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258 (421)
Q Consensus 185 ------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 258 (421)
..+++..+..++.|++.||+||| .+||+||||||+|||++.++.++|+|||++................++.
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 25788999999999999999999 5589999999999999999999999999998754332222222345677
Q ss_pred ceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHH
Q 014623 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH 337 (421)
Q Consensus 259 ~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (421)
.|+|||++.+..++.++|||||||++|+|++ |..||.+..... .+...+........+...+.
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 303 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----------------EFCRRLKEGTRMRAPEYATP 303 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCH
Confidence 8999999999999999999999999999998 999997532110 01111112222223445667
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 338 TAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 338 ~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
++.+++.+||+.+|++||++.++++.|+++..
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=343.98 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=203.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+.+.||+|+||.||+|.+... .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 4699999999999999999976542 246899999864321 23456788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~ 177 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGF 177 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence 9999999999999999999997664 38899999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 178 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------------~ 236 (340)
T PTZ00426 178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----------------I 236 (340)
T ss_pred CeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----------------H
Confidence 9865332 234679999999999999889999999999999999999999997543210 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
...+... ...++...+..+.++|.+||+.||.+|+ ++.++++.
T Consensus 237 ~~~i~~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 237 YQKILEG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHhcC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111111 1124456677899999999999999995 78887753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=336.26 Aligned_cols=264 Identities=24% Similarity=0.404 Sum_probs=209.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+... .......||+|.++.... ...+++.+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 5799999999999999999986542 112234599999875432 3346788999999999999999999988764
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..++|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccc
Confidence 5789999999999999997654 347888999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~ 220 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 220 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 7654332222222334678999999999999999999999999999998 99999754211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...+........+..++..+.+++.+||..+|.+||++.+++..|..+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 2222222222334456678899999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=332.53 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=207.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+... .....+..||+|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999976542 2233567899999864332 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
.+...++||||+.+++|.+++.+... ..+++..+..++.|++.||.||| ..|++|+||||+|||+++++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCC
Confidence 99999999999999999999965321 23577888999999999999999 457999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 309 (421)
++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------- 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------- 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---------
Confidence 99999999876543322222222345788999999998899999999999999999999 78888654321
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
...+.+........+..++..+.+++.+||+.||++||++.++++.|+
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 229 --------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111111111233456778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=339.84 Aligned_cols=243 Identities=29% Similarity=0.390 Sum_probs=198.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.||+|+||.||++.... +++.||+|++..... .....+.+|+++++.++||||+++++++...+..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 469999999999997644 578999999975422 23356788999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~ 147 (328)
T cd05593 72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHS--GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT 147 (328)
T ss_pred EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence 9999999999999886654 48899999999999999999994 5799999999999999999999999999875332
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+.+.
T Consensus 148 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----------------~~~~~~~ 208 (328)
T cd05593 148 DA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELIL 208 (328)
T ss_pred cc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----------------HHHHHhc
Confidence 21 1223467999999999999999999999999999999999999999754211 0111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
. .....+..++.++.+||.+||..||.+|+ ++.++++.
T Consensus 209 ~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 209 M-EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c-CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 11234456778899999999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=333.35 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=201.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +++.+|+|++..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 369999999999999999997654 578899999875432 223567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.++.+..+.... ..+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 99999999999887666544322 34889999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 318 (421)
......... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......... ......+.......
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07848 148 RNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMK 226 (287)
T ss_pred ccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHH
Confidence 875432211 1234578999999999999899999999999999999999999997653211110 00100000000000
Q ss_pred -------HhHhhhccc------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 -------LFRIMDTKL------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 -------~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
......... .......++.++.+||.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 227 LFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00112235778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=338.98 Aligned_cols=240 Identities=28% Similarity=0.371 Sum_probs=195.4
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999997654 57899999986432 22335677899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++......
T Consensus 72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 147 (312)
T cd05585 72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147 (312)
T ss_pred EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence 99999999999997654 48899999999999999999994 579999999999999999999999999997543222
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+...
T Consensus 148 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----------------~~~~~~~~~- 208 (312)
T cd05585 148 --DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----------------EMYRKILQE- 208 (312)
T ss_pred --CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcC-
Confidence 1233467999999999999999999999999999999999999999754311 001111111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCH---HHHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRM---SEVLA 362 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~ 362 (421)
...++..++..+.+||.+||..||.+||++ .+++.
T Consensus 209 -~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 209 -PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 123445677889999999999999999864 55543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.42 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=204.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 3689999999999999999996653 578899998875432 223568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 151 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence 999999999999999999997654 378889999999999999999952 36999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh----hh-----
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW----AK----- 310 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----~~----- 310 (421)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 152 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 152 GQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 7543221 2335789999999999988899999999999999999999999975432111110000 00
Q ss_pred ---------------hhhh---chhhHhHhhhcccCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 ---------------PYLS---DKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ---------------~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+... ....+...+........ ....+.++.+||.+||+.||++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 00000111111111111 1135678999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.78 Aligned_cols=242 Identities=28% Similarity=0.366 Sum_probs=197.5
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.||+|+||.||++.... +|..||+|++..... .....+.+|+++++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 469999999999997543 578999999875422 22345678999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+.+++|..++.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 147 (323)
T cd05595 72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 147 (323)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence 9999999999999886654 48899999999999999999994 5799999999999999999999999999875322
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .......
T Consensus 148 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~ 209 (323)
T cd05595 148 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILM 209 (323)
T ss_pred CCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhc
Confidence 221 1234679999999999999999999999999999999999999997543210 0011111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
. ....+..++.++.+||.+||..||.+|+ ++.++++
T Consensus 210 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 210 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 1123456778999999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=346.44 Aligned_cols=252 Identities=23% Similarity=0.292 Sum_probs=197.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.... +++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 368999999999999999996543 578999999864321 22355778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||++||+|.+++.... .+++..+..++.|++.||+||| ..||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999997654 4888899999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------------------------ceeeccccccceecccccccCCCCc
Q 014623 239 AKAGPTGDRT---------------------------------------------HVSTQVMGTHGYAAPEYVATGRLTT 273 (421)
Q Consensus 239 a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 273 (421)
++.+...... ......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 0001257999999999999999999
Q ss_pred cccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCC
Q 014623 274 KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEP 351 (421)
Q Consensus 274 ~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP 351 (421)
++|||||||++|||++|..||....... ....+........++ ..++.++.+||.+||. +|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHE----------------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHH----------------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999999999999999997543210 000111100011111 2456789999999997 77
Q ss_pred CCC---CCHHHHHHH
Q 014623 352 KLR---PRMSEVLAI 363 (421)
Q Consensus 352 ~~R---pt~~ell~~ 363 (421)
.+| +++.+++..
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 765 589888864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.42 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=196.0
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHH---hcCCCCCccceeeEE
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYL---GQLHHPNLVKLIGYC 157 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~hp~iv~~~~~~ 157 (421)
|++.+.||+|+||.||+|.+.. +++.||||+++.... ...+.+.+|++++ +.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 6788999999999999997654 578999999975421 2234556666554 567899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..|+||||+.+++|..++.. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLLDTEGFVKIADFG 146 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCcEEeCccc
Confidence 999999999999999999988854 248999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++........ .....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 147 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---------------- 208 (324)
T cd05589 147 LCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---------------- 208 (324)
T ss_pred CCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 9875332221 2234679999999999999999999999999999999999999997643210
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
....+... ...++..++..+.++|.+||..||.+|| ++.++++
T Consensus 209 ~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 209 VFDSIVND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHHhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01111111 1124456778899999999999999999 4566654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=326.82 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=211.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|.+.+.||+|+||.||+|.+.. .++.+|+|.+.... .....+.+|+++++.++|+||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence 468888999999999999997654 47789999987543 33467889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.......+++..++.++.|++.||+||| ..|++||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 9999999999999999997766566899999999999999999999 45899999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.... ...
T Consensus 154 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----------------~~~ 215 (263)
T cd05052 154 MTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVY 215 (263)
T ss_pred cccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence 5433211 1112234567999999998999999999999999999998 99998754321 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
..+........+..++..+.+++.+||..||++||++.++++.|+.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22222233344556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=329.17 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=213.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..+|++.+.||.|+||.||+|.+.. +..+++|.+..........+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 3568999999999999999997643 678999999877655567788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.....+++..++.++.|++.||.||| .+|++|+||||+|||++.++.+||+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccchh
Confidence 99999999999999999998766566899999999999999999999 5579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ .....++..|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----------------~~~ 213 (261)
T cd05148 153 LIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----------------HEV 213 (261)
T ss_pred hcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHH
Confidence 65432211 123345678999999988899999999999999999998 8999975431 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+........+..++..+.+++.+||..||.+|||+.++++.|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 214 YDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111222223334456778899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=343.53 Aligned_cols=267 Identities=32% Similarity=0.440 Sum_probs=219.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..+..+.+.||+|+||.||+|.+..... .....||||..+... .....++++|+++|+.++|||||++||++
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~-----~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNG-----FKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCC-----ceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677999999999999998875321 011228999988533 34457899999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.....+++|||+|.||+|.++|.++.. .++..+...++.+.+.||+|||++ ++|||||-.+|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k--~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK--NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC--CCcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999999988764 589999999999999999999954 69999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+++.... .........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+... .
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----------------~ 369 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----------------Y 369 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----------------H
Confidence 9986431 1111111124678999999999999999999999999999999 8889987542 1
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCCCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 373 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~~~ 373 (421)
.....++....+...+...+.++..++.+||..+|++||++.++.+.|+.+......
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 222333356667777788899999999999999999999999999999988765543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.89 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=208.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+... ....+..+++|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~-----~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLP-----GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecC-----CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 4688899999999999999976431 223467899999875432 2235678899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG---------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
...|+||||+.+++|.+++.... ...+++..+..++.|++.||.||| .+|++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence 99999999999999999985432 124778888999999999999999 4589999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 304 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~ 304 (421)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----- 232 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----- 232 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 9999999999999986544332222334456778999999988889999999999999999998 9989865421
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
..+.+.+........+..++..+.+++.+||+.||.+||++.+|++.|..
T Consensus 233 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ------------QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112222222223344567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.68 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=208.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3579999999999999999997543 46799998875432 346788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+++|||+.+++|.+++.+.....+++..++.++.+++.||+|||. .+++||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999999977655668889999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----------------~ 213 (261)
T cd05072 152 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----------------V 213 (261)
T ss_pred ecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----------------H
Confidence 75432211 1122345678999999988889999999999999999998 999996542111 1
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+...........++.++.+++.+||..+|++||+++++++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 214 MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111111112222345677899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.48 Aligned_cols=251 Identities=27% Similarity=0.347 Sum_probs=214.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCC-CCCccceee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLH-HPNLVKLIG 155 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hp~iv~~~~ 155 (421)
....|.+.+.||+|.||.||++..+ .+|+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~---------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREK---------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEec---------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3468999999999999999999654 368999999998765543 357889999999998 999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC----CCcE
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFNA 231 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~ 231 (421)
+|+.....++|||+|.||.|.+.|.+. .+++..+..++.|++.++.|||+ .||+||||||+|+|+.. ++.+
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcE
Confidence 999999999999999999999999877 28999999999999999999995 58999999999999943 3579
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+......
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------- 246 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------- 246 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---------
Confidence 9999999998765 2235568999999999999999999999999999999999999999987653211
Q ss_pred hhhchhhHhHhhhc--ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 312 YLSDKRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 312 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+... .+.......++..+.++|++||..||.+|+|+.++|..
T Consensus 247 -------~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 247 -------FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1122222 23344557889999999999999999999999999984
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=324.37 Aligned_cols=260 Identities=26% Similarity=0.453 Sum_probs=209.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+... .++...||+|.++..... ....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLP------GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccC------CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 5799999999999999999987542 123568999998755332 235688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.||| ..+|+|+||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999999999997644 35899999999999999999999 4579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----------------~~ 217 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----------------DV 217 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----------------HH
Confidence 7652222212222345678999999998899999999999999999998 99998653211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+........+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111122223345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.31 Aligned_cols=252 Identities=23% Similarity=0.268 Sum_probs=198.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|++++.||+|+||+||+|.+.. +++.||||++..... .....+.+|+++++.++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 58889999999999999997544 578999999975432 223467889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||++||+|.+++.+.. .+++..+..++.||+.||.||| ..||+||||||+||||+.++.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 999999999999999999997654 3788889999999999999999 458999999999999999999999999997
Q ss_pred ccCCCCCC---------------------------------------------cceeeccccccceecccccccCCCCcc
Q 014623 240 KAGPTGDR---------------------------------------------THVSTQVMGTHGYAAPEYVATGRLTTK 274 (421)
Q Consensus 240 ~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 274 (421)
..+..... .......+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 54311000 000123579999999999999999999
Q ss_pred ccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh--cccCCCCCHHHHHHHHHHHHhc--cccC
Q 014623 275 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQC--LNNE 350 (421)
Q Consensus 275 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~--l~~d 350 (421)
+|||||||++|||++|..||........ ...++. ..........++.++.+||.+| +..+
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTET----------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHH----------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCccc
Confidence 9999999999999999999976432110 111111 1111112234678899999984 4556
Q ss_pred CCCCCCHHHHHHH
Q 014623 351 PKLRPRMSEVLAI 363 (421)
Q Consensus 351 P~~Rpt~~ell~~ 363 (421)
+..|+++.+++..
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 6669999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=345.21 Aligned_cols=251 Identities=25% Similarity=0.318 Sum_probs=200.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 368999999999999999997654 578999999975322 22345678999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||+.+|+|.+++.... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEeeccc
Confidence 9999999999999999999997654 48999999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCc------------------------------------ceeeccccccceecccccccCCCCccccchhhhH
Q 014623 239 AKAGPTGDRT------------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 282 (421)
Q Consensus 239 a~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 282 (421)
+......... ......+||+.|+|||++.+..++.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 8754321100 0011246999999999999999999999999999
Q ss_pred HHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCC---H
Q 014623 283 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPR---M 357 (421)
Q Consensus 283 il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~ 357 (421)
++|+|++|..||....... ....++... ........++.++.+||.+||. +|.+|++ +
T Consensus 228 il~el~~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQE----------------TYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred HHHHhhcCCCCCCCCCHHH----------------HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 9999999999997643210 001111111 1111112457789999999996 9999998 8
Q ss_pred HHHHH
Q 014623 358 SEVLA 362 (421)
Q Consensus 358 ~ell~ 362 (421)
.+++.
T Consensus 291 ~~ll~ 295 (364)
T cd05599 291 NEIKS 295 (364)
T ss_pred HHHhc
Confidence 88875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=336.02 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=198.5
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.+.||+|+||.||+++... ...+++.||+|+++.... .....+.+|+.+|+.++||||+++++++..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~~------~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVT------GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEcc------cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 3679999999999997542 123578999999875321 223456789999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.|+||||+.+++|.+++.+.+ .+.+..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 75 LYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999999999997654 37888888999999999999994 57999999999999999999999999998753
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... .....+|++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~ 212 (323)
T cd05584 151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKI 212 (323)
T ss_pred ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHH
Confidence 32221 123467999999999999988999999999999999999999999764321 111111
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
... ....+..++..+.+||.+||..||.+|| ++.+++.
T Consensus 213 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 213 LKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111 1234456678899999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.82 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=207.0
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
...++|++.+.||+|+||+||+|.+.. +|+.||||++...... ....+.+|+.++..++|+||+++++.
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~ 99 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecc
Confidence 345689999999999999999997544 5789999998765432 33467789999999999999999887
Q ss_pred EEeCC--------eEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 157 CLEGE--------NRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 157 ~~~~~--------~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
+...+ ..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||+ .||+||||||+|||++
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~ 177 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLC 177 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEe
Confidence 65432 367999999999999998653 23458899999999999999999994 5799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 306 (421)
.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------ 251 (496)
T PTZ00283 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------ 251 (496)
T ss_pred CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 99999999999998654332222334578999999999999999999999999999999999999999754311
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+............+..++.++.+|+.+||..||.+||++.+++..
T Consensus 252 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 -----------EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111111112223456678899999999999999999999999863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=344.08 Aligned_cols=252 Identities=27% Similarity=0.341 Sum_probs=204.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+.+.||+|+||+||+|.+.. +++.||||++..... .....+.+|++++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 369999999999999999997654 578999999875422 23356788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+++..++||||+.+++|.+++.+. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCC
Confidence 999999999999999999999776 348899999999999999999995 5899999999999999999999999999
Q ss_pred cccCCCCC---------------------------CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCC
Q 014623 239 AKAGPTGD---------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291 (421)
Q Consensus 239 a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 291 (421)
+....... .........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98654332 001123457999999999999999999999999999999999999
Q ss_pred CccCCCcccchhhhhhhhhhhhhchhhHhHhhh--cccCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 014623 292 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAI 363 (421)
Q Consensus 292 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~ 363 (421)
.||....... ....+.. ..........++.++.+||.+||. ||.+|++ +.+++..
T Consensus 228 ~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 228 PPFYSDTLQE----------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCCHHH----------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9997653211 0111111 111111122357899999999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=323.56 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. ++.||+|.++... ...+.+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 4579999999999999999997542 4679999987654 2356788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.......+++..+..++.|++.||.||| ..|++||||||+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 99999999999999999997665556899999999999999999999 4579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ .......+..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~ 213 (261)
T cd05068 152 VIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----------------EV 213 (261)
T ss_pred EccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HH
Confidence 75432211 1111223457999999998899999999999999999999 99999754311 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+........+..++..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111222222233456678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.74 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=200.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||.|+||.||+|.... ++..||+|.++.... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 579999999999999999996553 578999999875432 2234677899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCccee
Confidence 999999999965 9999886543 347888999999999999999994 579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-h------h
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-K------P 311 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~------~ 311 (421)
....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ ..... . +
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 152 AKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 6432221 1233568999999998875 568999999999999999999999997654321111 00000 0 0
Q ss_pred hhhchhhHhHhhhcccCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 YLSDKRKLFRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.................. ......+.++.+||.+||..||.+|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000001111111110000 011234678899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=327.52 Aligned_cols=262 Identities=26% Similarity=0.428 Sum_probs=209.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||++..... ....++..+++|.+..........+.+|+++++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 35788899999999999999965431 22345678999998765555556788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP-------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
...+++|||+.+++|.+++..... ..+++..++.++.|++.||+||| ..|++||||||+|||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcC
Confidence 999999999999999999975432 24788999999999999999999 557999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhh
Q 014623 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~ 306 (421)
++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----- 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----- 232 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----
Confidence 99999999999976543222112223345788999999999999999999999999999998 999986532110
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.............+..++..+.+|+.+||..||.+||++.+|++.|+
T Consensus 233 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 ------------AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ------------HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111111122233456778999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=337.82 Aligned_cols=243 Identities=28% Similarity=0.364 Sum_probs=197.0
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
++.||+|+||.||+++... ...+|+.+|+|++..... .....+.+|++++++++||||+++++++...+..|
T Consensus 1 l~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKIT------GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred CceeeeCCCEEEEEEEEec------cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence 3679999999999986532 223588999999975432 22345678999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus 75 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 75 LILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999999999996654 48999999999999999999995 5799999999999999999999999999976543
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... .....+|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .....+..
T Consensus 151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----------------~~~~~i~~ 212 (318)
T cd05582 151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----------------ETMTMILK 212 (318)
T ss_pred CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----------------HHHHHHHc
Confidence 221 223467999999999999888999999999999999999999999754311 00111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 359 (421)
. ....+..++..+.+||.+||+.||.+||++.+
T Consensus 213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 11344567788999999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=341.12 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=197.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||+||+|.... +++.||+|++..... .....+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 368999999999999999996543 578999999975322 22345778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+....|+||||++||+|.+++.+.. .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccC
Confidence 9999999999999999999997654 48999999999999999999994 5899999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------------ceeeccccccceecccccccCCCCccccchhhhHHHH
Q 014623 239 AKAGPTGDRT---------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 285 (421)
Q Consensus 239 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 285 (421)
++........ ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 8754321100 0112457999999999999999999999999999999
Q ss_pred HHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccc--cCCCCCCCHHHHH
Q 014623 286 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLN--NEPKLRPRMSEVL 361 (421)
Q Consensus 286 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~--~dP~~Rpt~~ell 361 (421)
||++|..||....... ....+........++ ..++.++.++|.+|+. .++..||++.+|+
T Consensus 228 ell~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~ 291 (363)
T cd05628 228 EMLIGYPPFCSETPQE----------------TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIK 291 (363)
T ss_pred HHHhCCCCCCCCCHHH----------------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence 9999999997643210 011111111111111 2356788899988664 2333568999998
Q ss_pred HH
Q 014623 362 AI 363 (421)
Q Consensus 362 ~~ 363 (421)
..
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=329.49 Aligned_cols=267 Identities=25% Similarity=0.339 Sum_probs=197.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC---CCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQL---HHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~ 156 (421)
++|++.+.||+|+||.||+|.+... .+..||+|.++..... ....+.+|+.+++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 3799999999999999999975432 3678999998754322 223456677776655 69999999998
Q ss_pred EEe-----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 157 CLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 157 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
+.. ....++||||+. ++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCE
Confidence 852 356899999995 699999977655668999999999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccc-hhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-EQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~ 310 (421)
||+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+..... ...+.....
T Consensus 150 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 150 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 999999997654321 2234678999999999988899999999999999999999999997653211 111111100
Q ss_pred -hhhhchhhHh----HhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 -PYLSDKRKLF----RIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 -~~~~~~~~~~----~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+...+..... ........ ......++..+.+|+.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 00000000 0011245678889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=361.33 Aligned_cols=267 Identities=31% Similarity=0.459 Sum_probs=220.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.....+++.||+|+||.||.|....... ......||||.++... .....+|++|+.+|+.++|||||+++|++.+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~----~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPG----SVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCC----CccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3456778899999999999998765321 1113468999887653 3455789999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRR-----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
....+|++|||+||+|..+|.+. ....+.....+.++.+||.|+.||+++ ++|||||...|+||++...+||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheeecccCcEEEc
Confidence 99999999999999999999765 134589999999999999999999954 69999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
|||||+.+...+.........-...|||||.+..+.++.|+|||||||+|||++| |..||.....
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------------- 910 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------------- 910 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------------
Confidence 9999996554444433333234578999999999999999999999999999999 8999976432
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+.+...+... +.+.|..++..+++|+..||+.+|++||++..|++.+..+...
T Consensus 911 --~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 911 --FEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --HHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22222233333 6778899999999999999999999999999999988876543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=338.12 Aligned_cols=244 Identities=30% Similarity=0.386 Sum_probs=198.0
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.||+|+||.||++.... +++.||+|++..... .....+.+|+++++.++||||+++++++...+..|
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 469999999999996543 578999999975432 22345678999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||+ ..||+||||||+|||++.++.+||+|||+++....
T Consensus 72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999886654 48899999999999999999995 25799999999999999999999999999875322
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+.+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----------------~~~~~i~ 209 (325)
T cd05594 149 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELIL 209 (325)
T ss_pred CCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----------------HHHHHHh
Confidence 211 123467999999999999999999999999999999999999999754321 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
. ....++..++.++.+||.+||+.||.+|+ ++.++++.
T Consensus 210 ~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 210 M-EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred c-CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 11123455678899999999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=327.63 Aligned_cols=263 Identities=29% Similarity=0.424 Sum_probs=209.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 478899999999999999976432 1122346789998875532 23356889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCC
Q 014623 162 NRLLVYEFMPKGSLENHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 219 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 219 (421)
..+++|||+.+++|.+++.... ...+++..++.++.|++.||.||| ..|++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence 9999999999999999986421 134788899999999999999999 4579999999
Q ss_pred CCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCc
Q 014623 220 ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTK 298 (421)
Q Consensus 220 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~ 298 (421)
|+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999976533222111223345778999999988889999999999999999998 999996542
Q ss_pred ccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
. ..+.+.+........+..++.++.+++.+||+.+|.+||++.++++.|+++.
T Consensus 235 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 P-----------------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred H-----------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1 1112222222233344566788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=330.56 Aligned_cols=267 Identities=23% Similarity=0.293 Sum_probs=198.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.... +++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 3689999999999999999997653 5789999998754322 23456789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+. ++|.+++.... ..+.+..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 150 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ--RYILHRDLKPQNLLISDTGELKLADFGLA 150 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECCCCcc
Confidence 999999999995 68888886543 347888999999999999999995 57999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh--hhhh-hhhhhhhc
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVD-WAKPYLSD 315 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~-~~~~~~~~ 315 (421)
........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .... ...+....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 151 RAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 75432221 1234568999999998865 45888999999999999999999999764321110 0000 00000000
Q ss_pred hhhH---hHhhhcccCCCCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKL---FRIMDTKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~---~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ............+ ...+..+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 0000000000000 012457889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=335.06 Aligned_cols=242 Identities=29% Similarity=0.404 Sum_probs=196.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCC-CCccceeeEEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHH-PNLVKLIGYCL 158 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 158 (421)
+|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+..|++++..+.| ++|+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 48899999999999999997654 578899999875421 234567789999999976 56888999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 9999999999999999999997654 37889999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+........ .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~ 209 (324)
T cd05587 148 CKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------EL 209 (324)
T ss_pred ceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 875322221 233467999999999999999999999999999999999999999754311 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
...+.. ....++..++.++.+++.+||..||.+|++.
T Consensus 210 ~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 210 FQSIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 1123445677889999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=329.34 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=211.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||++.+... .....+..+|+|.++.... ...+.+.+|+.+++++ +|+||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 35799999999999999999975321 1233467899999875432 2335688999999999 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+.+++|.+++.......+++..+..++.+++.||.|||+ .+|+|+||||+|||++.++.++|+|||+
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999976554458999999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+................++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----------------~ 251 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----------------S 251 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----------------H
Confidence 986543322112223446788999999999999999999999999999998 99998754321 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+..........+...+..+.+++.+||..+|++||++.+++..|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111222222223345567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=324.87 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=205.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||+||+|.+.... ......+++|.+..... ....++..|+.+++.+.||||+++++++. +
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEG-----DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCC-----CceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 47899999999999999999875421 11123578888764322 22356677888999999999999999875 4
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 56789999999999999997543 358999999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||++.++.++.++|||||||++|||++ |..||.+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----------------V 220 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 6543332222334557788999999998899999999999999999998 999997643211 1
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+........+..++.++.+++.+||..||.+||++.++++.|..+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 112222222222334566788999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=328.51 Aligned_cols=253 Identities=29% Similarity=0.433 Sum_probs=204.5
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|++.+.||+|+||.||++.+.. +++.||+|++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 47889999999999999997643 4789999998754322 22456789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++.......+++..+..++.|++.||.|||+ .|++||||||+||++++++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR--ERIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999999998876555568999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ....+|+..|+|||++.+..++.++|||||||++|+|++|..||.+...... ...+
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------------~~~~ 213 (285)
T cd05605 150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------------REEV 213 (285)
T ss_pred eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------------HHHH
Confidence 86543221 2235789999999999988999999999999999999999999976432110 0011
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
...+. .....++..++..+.+||.+||..||.+|| ++.+++..
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 214 ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11111 112234456788899999999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=344.92 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=199.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+|++.+.||+|+||.||+|.... +++.||||++..... .....+.+|+.+|+.++|+||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 68999999999999999997553 578999999865322 223557789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 999999999999999999997654 37888889999999999999994 57999999999999999999999999998
Q ss_pred ccCCCCCC-----------------------------------------cceeeccccccceecccccccCCCCccccch
Q 014623 240 KAGPTGDR-----------------------------------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVY 278 (421)
Q Consensus 240 ~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 278 (421)
..+..... .......+||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 53210000 0001235799999999999999999999999
Q ss_pred hhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh--cccCCCCCHHHHHHHHHHHHhccccCCCCCC-
Q 014623 279 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPKLRP- 355 (421)
Q Consensus 279 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp- 355 (421)
||||++|+|++|..||......... ..+.. ..........++.++.++|.+|+ .+|.+|+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQ----------------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHH----------------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 9999999999999999765321110 00110 11111122346778889999976 5999999
Q ss_pred --CHHHHHHH
Q 014623 356 --RMSEVLAI 363 (421)
Q Consensus 356 --t~~ell~~ 363 (421)
++.+++..
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 88988854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=337.98 Aligned_cols=267 Identities=25% Similarity=0.381 Sum_probs=197.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||+|.+.. ++..||||.+.... ......+.+|+++++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 58899999999999999997543 57899999987432 22335678999999999999999999988643
Q ss_pred -----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 161 -----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 161 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 72 SRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT--ANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred CCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEcc
Confidence 2479999999 569999886554 38899999999999999999995 5799999999999999999999999
Q ss_pred ccCcccCCCCCC-cceeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-h
Q 014623 236 FGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-K 310 (421)
Q Consensus 236 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~ 310 (421)
||+++....... .......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ ..... .
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 999976432221 112234679999999998876 678999999999999999999999997654211100 00000 0
Q ss_pred hhhhc--------hhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PYLSD--------KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+.... .......+........ ....+..+.++|.+||..||++||++.+++..
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0000011111100000 11345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=330.42 Aligned_cols=269 Identities=27% Similarity=0.413 Sum_probs=212.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||++.+..... .....+..+|+|.+..... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 3579999999999999999997644211 1122356799999976432 2345678899999999 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
..+..++||||+.+++|.+++..... ..+++..++.++.|++.||+||| ..|++||||||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil 172 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVL 172 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheE
Confidence 99999999999999999999976432 24788899999999999999999 458999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999876543221111112234568999999998889999999999999999998 8888865321
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+........+..++.++.+|+.+||..+|.+||++.++++.|+++...
T Consensus 249 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -------------HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111222222223334456778999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=327.37 Aligned_cols=255 Identities=35% Similarity=0.578 Sum_probs=201.8
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.+.||.|.||.||+|.+.. .....+..|+||.++.... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 45789999999999999873 2333577899999965432 23578899999999999999999999999888899
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+++|+|.++|.......+++..++.++.||+.||.|||+ .+++|+||+++|||++.++.+||+|||++.....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~--~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS--NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH--TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 99999999999999988755669999999999999999999995 4699999999999999999999999999987633
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
...........+...|+|||.+.+..++.++||||||+++|||++ |..||..... ..+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----------------~~~~~~~ 218 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----------------EEIIEKL 218 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----------------HHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------ccccccc
Confidence 332222333456789999999999999999999999999999999 7788865421 1122222
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
........+..++..+.++|..||..||.+||++.++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22233344566788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=343.78 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=197.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+|++++.||+|+||.||+|.... +++.+|+|++..... .....+.+|+++++.++|+||+++++++.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 58899999999999999996543 578999999875422 223457789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..|+||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 999999999999999999997654 47888899999999999999994 57999999999999999999999999997
Q ss_pred ccCCCCC---------------------------------------------CcceeeccccccceecccccccCCCCcc
Q 014623 240 KAGPTGD---------------------------------------------RTHVSTQVMGTHGYAAPEYVATGRLTTK 274 (421)
Q Consensus 240 ~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 274 (421)
..+.... ........+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 5321000 0001123579999999999999999999
Q ss_pred ccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh--cccCCCCCHHHHHHHHHHHHhccccCCC
Q 014623 275 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD--TKLGGQYPQKAAHTAATLALQCLNNEPK 352 (421)
Q Consensus 275 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~ 352 (421)
+|||||||++|||++|..||....... ....+.. ..........++.++.++|.+|+ .+|.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLE----------------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHH----------------HHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999999999999999997643210 1111111 11111122356788899998876 5999
Q ss_pred CCCC---HHHHHH
Q 014623 353 LRPR---MSEVLA 362 (421)
Q Consensus 353 ~Rpt---~~ell~ 362 (421)
+|++ +.+++.
T Consensus 292 ~R~~~~~~~ei~~ 304 (382)
T cd05625 292 DRLGKNGADEIKA 304 (382)
T ss_pred HcCCCCCHHHHhc
Confidence 9997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=324.10 Aligned_cols=274 Identities=32% Similarity=0.463 Sum_probs=208.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG- 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 160 (421)
.|++.+.||+|+||+||++.... ....++..||+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred hceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34899999999999999876543 2334678999999876532 2345678999999999999999999987653
Q ss_pred -CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 -ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
...++||||+.+++|.+++... .+++..++.++.|++.||.||| ..||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeecccc
Confidence 4578999999999999999654 3899999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||........... ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~-~~~~~~ 232 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQG-QMTVVR 232 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh-ccccc-ccchhh
Confidence 8654322211 11223456779999999888899999999999999999999999865432111100 00000 001111
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+............+..++..+.+++.+||..+|++||++.++++.|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222223344567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.48 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=205.6
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|.+++.||+|+||.||+|.+... ...+..||+|.++..... ....+.+|+++++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQD------DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecC------CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 67889999999999999976532 224578999998764332 2356889999999999999999999887655
Q ss_pred e------EEEEEEcCCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 162 N------RLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 162 ~------~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
. .+++|||+++++|..++... ....+++..++.++.|++.||.|||+ .+++||||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeE
Confidence 4 78999999999999988543 22358899999999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---------- 222 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---------- 222 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----------
Confidence 9999999986544332211222335678999999988889999999999999999999 88888654311
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+...+........+..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 -------EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111222222234456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.82 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=211.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||++...... .......+|+|.+..... ....++.+|+.+++.+ +|+||+++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD----NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCC----CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3457899999999999999999765421 123457899999875432 2335678899999999 799999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRR--------------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
..+...+++|||+.+++|.+++... ....+++..++.++.|++.||.||| ..||+||||||+||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Ni 163 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNV 163 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeE
Confidence 9999999999999999999999653 2345889999999999999999999 45799999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccch
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 302 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~ 302 (421)
|++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-- 241 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-- 241 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence 999999999999999986544322211222334678999999988899999999999999999997 99998654321
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.....+........+..++..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus 242 ---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ---------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111222222222344556778999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.97 Aligned_cols=267 Identities=19% Similarity=0.293 Sum_probs=192.7
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC------CCCc
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH------HPNL 150 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hp~i 150 (421)
+....++|++.+.||+|+||+||+|.+.. +++.||||+++... .....+..|+++++.++ |.+|
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 33446789999999999999999997643 47889999986432 12233455666666654 4568
Q ss_pred cceeeEEEeC-CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 151 VKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 151 v~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
+.+++++... ...|+|||++ |++|.+++.+.. .+++..+..++.||+.||.|||+. .|||||||||+|||++.++
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSD 269 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCC
Confidence 8899888754 5788999998 789999887654 488999999999999999999952 4799999999999998765
Q ss_pred ----------------cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCc
Q 014623 230 ----------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 293 (421)
Q Consensus 230 ----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 293 (421)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.|
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998864322 12347899999999999999999999999999999999999999
Q ss_pred cCCCcccchhhhh-hhhhhh---hh------chhhHhHhhhcc------------cCCC--CCHHHHHHHHHHHHhcccc
Q 014623 294 VDKTKVGIEQSLV-DWAKPY---LS------DKRKLFRIMDTK------------LGGQ--YPQKAAHTAATLALQCLNN 349 (421)
Q Consensus 294 f~~~~~~~~~~~~-~~~~~~---~~------~~~~~~~~~~~~------------~~~~--~~~~~~~~l~~li~~~l~~ 349 (421)
|.+.......... ...... +. ....+....... .... ........+.+||.+||..
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9765432111111 000000 00 000000000000 0000 0011245678999999999
Q ss_pred CCCCCCCHHHHHH
Q 014623 350 EPKLRPRMSEVLA 362 (421)
Q Consensus 350 dP~~Rpt~~ell~ 362 (421)
||.+|||+.|+++
T Consensus 425 dP~~R~ta~e~L~ 437 (467)
T PTZ00284 425 DRQKRLNARQMTT 437 (467)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999996
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=320.71 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=201.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 468889999999999999997643 4579999887543 23467889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++.... ..+++..++.++.|++.||.||| ..|++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 9999999999999999986543 24889999999999999999999 55799999999999999999999999999986
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ...
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----------------~~~ 211 (256)
T cd05114 150 VLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----------------EVV 211 (256)
T ss_pred cCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHH
Confidence 5332211 1112335668999999988889999999999999999999 89999754321 011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..+........+...+..+.+++.+||+.+|++||++.+++..|
T Consensus 212 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 212 EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11111111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=327.75 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=208.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+... .....+..||+|+++..... ....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 3578889999999999999976542 12234678999999754322 235578899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
...++++||+.+++|.+++.... ...+++..++.++.|++.||.||| ..||+||||||+|||++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEec
Confidence 99999999999999999985321 134788889999999999999999 45799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~ 305 (421)
.++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------ 232 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 232 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999886544332222233456789999999988889999999999999999998 8888865321
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
..+...+........+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus 233 -----------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -----------QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11122222222233456778889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=313.68 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=207.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.+.|.+.++||+|.|+.||++ .+..+|+.+|+|++....+ ...+++.+|++|-+.|+||||+++.+.+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~ 80 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 80 (355)
T ss_pred chhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence 357889999999999999987 4555789999998864433 35577889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~D 235 (421)
.....|||+|++.|++|..-|..+ ...++..+-..+.||+++|.|+| .+||||||+||+|+|+.. ..-+||+|
T Consensus 81 ~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 81 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred ccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceeecc
Confidence 999999999999999998877655 34788888999999999999999 568999999999999943 34599999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+|.....+. ....++||+.|||||++...+|+..+|||+-|||||-|+.|.+||.+...
T Consensus 157 FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---------------- 217 (355)
T KOG0033|consen 157 FGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---------------- 217 (355)
T ss_pred cceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----------------
Confidence 99998876322 34568899999999999999999999999999999999999999977432
Q ss_pred hhhHhH-hhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFR-IMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~-~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.+ ++... +.....+.+++++.+|+++||..||.+|.|+.|.|.
T Consensus 218 -~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 218 -HRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -HHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11222 22222 223344688999999999999999999999999885
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=332.14 Aligned_cols=242 Identities=27% Similarity=0.415 Sum_probs=193.6
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.||+|+++.... ...+.+..|..++..+ +||||+++++++..++..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999997654 578899999875421 2234455677777654 799999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.||+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 99999999999999987654 48889999999999999999994 579999999999999999999999999997543
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .+...+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----------------~~~~~i 208 (316)
T cd05592 148 NGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----------------ELFDSI 208 (316)
T ss_pred CCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHH
Confidence 322 1233467999999999999999999999999999999999999999764321 011111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA 362 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~ 362 (421)
.. ....++..++.++.+||.+||..||.+||++. +++.
T Consensus 209 ~~-~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 209 LN-DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred Hc-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11 11234455678899999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=326.57 Aligned_cols=262 Identities=26% Similarity=0.431 Sum_probs=209.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.... ....+..||+|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVV----KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccC----CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 457999999999999999999876421 123467899999875432 233567899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
....++||||+.+++|.+++..... ..+++..++.++.|++.||.||| ..+++||||||+|||++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCE
Confidence 9999999999999999999965322 23678889999999999999999 5589999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++...............++..|+|||.+.++.++.++|||||||++|+|++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---------- 228 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---------- 228 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH----------
Confidence 9999999976543332222233456789999999988889999999999999999998 99998653321
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
...+.+........+..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 -------EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111122222222334556789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=334.12 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=196.6
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
++||+|+||.||+|.+.. +++.||+|+++.... .....+.+|..++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 479999999999997654 578999999975432 2234577899999888 699999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+++++|.+++.+.. .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccccc
Confidence 99999999999999886654 4899999999999999999999 4579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... ......+||..|+|||++.+..++.++|||||||++|+|++|+.||+....... +.........+.+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--------~~~~~~~~~~~~~ 217 (329)
T cd05588 148 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN--------PDQNTEDYLFQVI 217 (329)
T ss_pred cCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc--------ccccchHHHHHHH
Confidence 211 122346799999999999999999999999999999999999999964321100 0000001111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR------MSEVLA 362 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~ 362 (421)
... ....+..++..+.++|.+||+.||.+|++ +.++++
T Consensus 218 ~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 218 LEK-QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HcC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111 12345567788999999999999999997 456653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.39 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=199.0
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+.. +++.+|+|.+..... .....+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 469999999999997643 478899998765432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.... ..+++..++.++.|++.||.||| ..|++||||||+|||++.++.+||+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCccccccc
Confidence 99999999999996543 34889999999999999999999 5579999999999999999999999999987643322
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (421)
.........++..|+|||.+.++.++.++|||||||++|+|++ |..||...... .....+..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~ 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQ 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHc
Confidence 1111111123457999999998899999999999999999998 88888643211 11112222
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 326 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
......+..++..+.+|+.+||..+|++||++.++++.|+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2223344566788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=333.43 Aligned_cols=243 Identities=27% Similarity=0.366 Sum_probs=195.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.||+|++..... .....+..|.+++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 469999999999997643 578999999875422 2334567888888866 799999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+++++|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~ 147 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR--HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI 147 (321)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999999987654 48889999999999999999994 579999999999999999999999999987543
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~ 209 (321)
T cd05591 148 LNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESIL 209 (321)
T ss_pred cCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 2334679999999999999999999999999999999999999997643210 011111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-------RMSEVLAI 363 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~ell~~ 363 (421)
... ...+..++.++.++|.+||..||++|+ ++.++++.
T Consensus 210 ~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 210 HDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111 123445678899999999999999999 67777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.93 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=210.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCC-CCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLH-HPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 158 (421)
.++|.+++.||+|+||.||+|.+... .....++.||+|+++...... ...+.+|+++|..+. ||||+++++++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 35688999999999999999987532 122346789999997653322 346889999999997 999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC------------------------------------------------------
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP------------------------------------------------------ 184 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------ 184 (421)
..+..++||||+.+|+|.+++.+...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98999999999999999999965321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCc
Q 014623 185 ------------------------------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222 (421)
Q Consensus 185 ------------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 222 (421)
..+++..+..++.|++.||.||| ..+++||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcce
Confidence 13566778889999999999999 5589999999999
Q ss_pred EEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccc
Q 014623 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGI 301 (421)
Q Consensus 223 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~ 301 (421)
||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~- 348 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN- 348 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence 9999999999999999986433222112223457889999999998889999999999999999998 88898653211
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
......+........+..++.++.+|+.+||..+|.+||++.+|+..|+++.
T Consensus 349 ---------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ---------------EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111222222223344566789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=330.89 Aligned_cols=265 Identities=27% Similarity=0.457 Sum_probs=220.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.+...+.+.||+|-||.|.++.... +..||||.++.+.... .++|.+|+++|.+|+||||+.++++|..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 3567889999999999999986543 6889999998775544 4789999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++.+++||||+++|+|.+++.+............+++.||+.|++||.+. ++|||||.+.|||+++++++||+|||++
T Consensus 607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~--nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL--NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh--chhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999999887544356667788999999999999965 5999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh--CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+-.-.++........+-..+|||+|.+..++++.++|+|+||+++||+++ ...||...... ..++ +..
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vve-------n~~ 754 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVE-------NAG 754 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHH-------hhh
Confidence 98777777777777888999999999999999999999999999999887 56677543211 1111 111
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+..--........|.-++..+.+++.+||..|-.+||+++++...|++.
T Consensus 755 ~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 755 EFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111112223345678999999999999999999999999999888764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=340.91 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=197.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|.+.+.||+|+||.||++.+.. +++.||+|.... ..+.+|+++++.|+||||+++++++....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 579999999999999999997654 578999997532 34678999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++|||++ +++|..++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus 157 ~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~--~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 157 FTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHE--NRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred eeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 999999999 568988886654 37889999999999999999995 5799999999999999999999999999975
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccc-----hhhh---hhhhh--h
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-----EQSL---VDWAK--P 311 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~---~~~~~--~ 311 (421)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...+ ..... +
T Consensus 232 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 232 PVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred cccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 322211 12234679999999999999999999999999999999999998875432100 0000 00000 0
Q ss_pred --hhhc-hhhHhHhh----hcccC--CCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 --YLSD-KRKLFRIM----DTKLG--GQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 --~~~~-~~~~~~~~----~~~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+..+ ...+.... ..... ... ....+.++.+||.+||..||.+|||+.|+++
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 311 NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00001100 00000 000 1245678999999999999999999999985
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=333.19 Aligned_cols=238 Identities=29% Similarity=0.423 Sum_probs=193.0
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.||+|++.... ......+..|..++..+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 469999999999997654 57899999987532 12335567888888776 699999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+.+++|.+++.+.. .+++..+..++.|++.||+||| ..||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~ 147 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 147 (320)
T ss_pred EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence 99999999999999887654 4889999999999999999999 4579999999999999999999999999987533
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .+.+.+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------------~~~~~i 208 (320)
T cd05590 148 FNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----------------DLFEAI 208 (320)
T ss_pred cCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----------------HHHHHH
Confidence 2221 223467999999999999999999999999999999999999999764321 111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
... ....+..++.++.++|.+||..||.+|+++.
T Consensus 209 ~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 209 LND-EVVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred hcC-CCCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 110 1123445678899999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.20 Aligned_cols=202 Identities=27% Similarity=0.360 Sum_probs=175.7
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-C-----CCccce
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-H-----PNLVKL 153 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~iv~~ 153 (421)
+.-+|.+.++||+|+||.|.+|++.. +++.||||+++... .-..+...|+.+|..|+ | -|+|++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 34478899999999999999997654 68999999998653 22344567999999997 4 489999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC--CcE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNA 231 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~ 231 (421)
+++|...++.|||+|.+ ..+|+++|..+...+++...+..++.||+.||.+|| +.||||+||||+||||..- ..|
T Consensus 254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred eeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCce
Confidence 99999999999999999 669999999988888999999999999999999999 5689999999999999653 369
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcc
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 299 (421)
||+|||.++.....- . +.+-+..|+|||++.|..|+.+.||||||||++||++|.+.|.+...
T Consensus 331 KVIDFGSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 331 KVIDFGSSCFESQRV----Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred eEEecccccccCCcc----e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 999999998754322 2 56778999999999999999999999999999999999999987654
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=336.83 Aligned_cols=268 Identities=23% Similarity=0.255 Sum_probs=203.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
...+|++.+.||+|+||.||++.... ...+..||+|.+... ..+.+|+++|+.++||||+++++++..
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-------~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~ 157 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-------DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW 157 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-------CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence 44689999999999999999986532 224678999988643 234589999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++|||++. ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 158 ~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 158 KSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccc
Confidence 999999999994 6898888443 348999999999999999999994 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-------h
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-------P 311 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~-------~ 311 (421)
................||..|+|||++.+..++.++|||||||++|||++|+.||.+....... .+..... .
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 7655443332333567999999999999999999999999999999999999999765432111 0100000 0
Q ss_pred hhh-chhhH---hHhhhcccCCCC--C-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 312 YLS-DKRKL---FRIMDTKLGGQY--P-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 312 ~~~-~~~~~---~~~~~~~~~~~~--~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
+.. ....+ ........+..+ + ...+.++.++|.+||..||++||++.+++..-
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 000 00000 001111111111 1 13356788999999999999999999998754
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=326.04 Aligned_cols=268 Identities=26% Similarity=0.410 Sum_probs=208.8
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|..... .....+..||+|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 356899999999999999999976532 1122356899998865432 22345778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
..+..++||||+.+|+|.+++.+... .......+..++.|++.||.||| .++|+||||||+|||++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCc
Confidence 99999999999999999999965321 23466778899999999999999 457999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 309 (421)
++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--------- 228 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------- 228 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---------
Confidence 99999999986543322222223345778999999998899999999999999999998 78888653211
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.....+........+..++..+.+++.+||+.||++||++.++++.|++...+
T Consensus 229 --------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 229 --------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred --------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 11111111111122344567899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=339.20 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=201.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||++.... +++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~ 112 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF 112 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4579999999999999999997654 578999999864321 2234467899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+++..++||||++||+|.+++... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~kL~DfG 187 (370)
T cd05596 113 QDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (370)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEcCCCCEEEEecc
Confidence 9999999999999999999988653 37888889999999999999995 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC----CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 188 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------- 253 (370)
T cd05596 188 TCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------------- 253 (370)
T ss_pred ceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------------
Confidence 9976543221 112346799999999988653 4788999999999999999999999764321
Q ss_pred hchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
.....++.......++ ..++.++.+||.+||..+|.+ |+++.+++..
T Consensus 254 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 ---GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111121111111122 246789999999999999987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=332.73 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=193.3
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.+|+|+++.... .....+.+|+.++..+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 479999999999997654 578999999976432 2234567888888776 799999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+++++|..++.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence 99999999999998886654 48899999999999999999994 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||..|+|||++.+..++.++|||||||++|+|++|..||......... .......+.+.+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~--------~~~~~~~~~~~i 217 (329)
T cd05618 148 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTEDYLFQVI 217 (329)
T ss_pred CCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc--------ccccHHHHHHHH
Confidence 2111 123467999999999999999999999999999999999999999632211000 000001111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.. .....+...+..+.+||.+||..||.+||++
T Consensus 218 ~~-~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 218 LE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred hc-CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1223456677889999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.34 Aligned_cols=269 Identities=25% Similarity=0.408 Sum_probs=212.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||+|.+..... .....+..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 4679999999999999999997543110 112345689999987542 23345688999999999 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
.....++||||+.+++|.+++.+... ..+++..++.++.|++.||.||| ..|++||||||+|||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEE
Confidence 99999999999999999999976421 34778889999999999999999 458999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---- 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence 99999999999999986543332222223345678999999988889999999999999999998 7888865421
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+........+..++..+.+|+.+||..+|.+||++.++++.|+++...
T Consensus 246 -------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -------------HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 111122222222233456678899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=339.27 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=200.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
..++|++.+.||+|+||.||++.... +++.+|+|++..... .....+.+|+.+++.++||||++++++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34689999999999999999997654 578999999864221 223457789999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+++..|+||||+++|+|.+++... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998543 37888999999999999999994 57999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCC----CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|++........ ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------------ 253 (370)
T cd05621 187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------------ 253 (370)
T ss_pred ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------------
Confidence 99986543221 1123567999999999987543 788999999999999999999999754321
Q ss_pred hhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
.....++........+ ..++..+.+++.+||..++.+ |+++.++++.
T Consensus 254 ----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 ----GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111222211111222 245788999999999855543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=332.73 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=196.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
+|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+..|..++..+ .|++|+++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 48889999999999999997653 578999999875432 2223466788888777 5899999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCC
Confidence 9999999999999999999987654 38889999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----------------~~ 209 (323)
T cd05616 148 CKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------EL 209 (323)
T ss_pred ceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 975432221 223467999999999999999999999999999999999999999764321 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
...+... ...++...+.++.+++.+||+.||.+|++.
T Consensus 210 ~~~i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111111 123455678899999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=331.08 Aligned_cols=241 Identities=28% Similarity=0.424 Sum_probs=193.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +|+.||+|+++.... .....+..|..++..+ +||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 479999999999997654 578999999875421 2334566788887754 899999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+.+++|.+++.... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence 99999999999999987654 38889999999999999999994 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||..|+|||++.+..++.++|||||||++|+|++|..||...... .+.+.+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----------------~~~~~~ 208 (316)
T cd05620 148 FGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----------------ELFESI 208 (316)
T ss_pred cCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----------------HHHHHH
Confidence 2221 234577999999999999999999999999999999999999999754321 111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS-EVL 361 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell 361 (421)
.. .....+..++.++.+||.+||..||.+|+++. +++
T Consensus 209 ~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 209 RV-DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred Hh-CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11 11223445677899999999999999999974 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=337.30 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=201.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+.+.||+|+||+||++.... +++.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 468999999999999999997554 578999999975432 23345778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEECCCCCEEeccCCC
Confidence 9999999999999999999997652 358999999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc------cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
+......... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----------- 216 (330)
T cd05601 149 AARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----------- 216 (330)
T ss_pred CeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----------
Confidence 9865443322 223457899999999986 4567889999999999999999999997543210
Q ss_pred hhchhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....++... ........++..+.+||.+||. +|.+||++.+++.
T Consensus 217 -----~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 217 -----TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 011111111 1111123467889999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=323.92 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=197.1
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||+|+||.||++.... +|+.+|+|.+...... ....+..|+++++.++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999997654 5889999998653322 223456799999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.|++|.+++.......+++..++.++.|++.||.||| ..||+||||||+|||++.++.++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 99999999999887666666899999999999999999999 4579999999999999999999999999987654322
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
......|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus 150 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~------------~~~~~~~~~~~ 214 (277)
T cd05607 150 ---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK------------EELKRRTLEDE 214 (277)
T ss_pred ---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH------------HHHHHHhhccc
Confidence 123356899999999999888999999999999999999999999753221110 00001111111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.. .....++.++.+|+.+||+.||.+||++.|+++.+
T Consensus 215 ~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 215 VK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 11 11134677899999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.20 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=204.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|++.+.||+|+||.||+|.+.. ...||+|.++.... ..+.+.+|+++++.++|+||+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence 579999999999999999996543 24599999976433 3467889999999999999999999764 45
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.+.....+++..+..++.|++.||+||| ..+++||||||+||+++.++.++|+|||++..
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 6899999999999999997654455789999999999999999999 45799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----------------~~~ 213 (262)
T cd05071 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------------EVL 213 (262)
T ss_pred ccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----------------HHH
Confidence 5433221 1122346678999999988899999999999999999999 88888654311 011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...........+..++..+.+++.+||+.||++||++.++++.|+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111112223456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=319.23 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 3579999999999999999996543 45699999876543 3467889999999999999999999874 4
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+++|||+.+++|.+++.......+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEEeCCceEEeCCceeee
Confidence 568999999999999999976555568999999999999999999994 579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------~~ 212 (260)
T cd05070 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----------------EV 212 (260)
T ss_pred eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----------------HH
Confidence 65432211 1122335668999999988889999999999999999999 89999654211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
...+........+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 213 LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122222223445667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.09 Aligned_cols=238 Identities=27% Similarity=0.361 Sum_probs=190.5
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||+||+|.+.. +|+.||+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 469999999999997654 578999999875422 12234455554 56789999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+++|.+++.+.. .+++..+..++.||+.||.||| ..||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 147 (323)
T cd05575 72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (323)
T ss_pred EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence 99999999999999987654 4888999999999999999999 4579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----------------~~~~i~ 209 (323)
T cd05575 148 EHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----------------MYDNIL 209 (323)
T ss_pred cCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHH
Confidence 222 12334679999999999999999999999999999999999999997543110 001111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
... ...+...+..+.++|.+||+.||.+||++.
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 210 NKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111 123345678899999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=318.88 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=208.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +++.||||.+..... .....+.+|+++++.++||||+++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 479999999999999999997654 478999998764322 22346788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
..+..++||||+++++|.+++... ....+++..++.++.|++.||.||| ..|++|+||||+|||++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988542 2344788899999999999999999 558999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-------------- 214 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-------------- 214 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--------------
Confidence 99886543221 12235688999999999888899999999999999999999999865432111
Q ss_pred hhHhHhhhc-ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 317 RKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 317 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.+...+.. ..........+..+.+++.+||..+|++||++.+++..|+++.
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 215 -SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11111111 1111223456788999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.73 Aligned_cols=262 Identities=27% Similarity=0.409 Sum_probs=206.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|.+.+.||+|+||.||+|.+.... ....+..|++|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRD----GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCC----CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 357899999999999999999775411 1124678999988654322 23568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC---cE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NA 231 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 231 (421)
.+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .+++||||||+|||++.++ .+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE--NHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchheEEEeccCCCcce
Confidence 9999999999999999999976532 248899999999999999999995 5799999999999998765 59
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---------- 228 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---------- 228 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999986533221111112334568999999998999999999999999999997 99999764321
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.+...+........+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 -------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 -------EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111222222222344566788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.95 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=207.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|... .++.+|+|.+..... ....+.+|+.+++.++|+||+++++++. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 467999999999999999999643 367899999876543 3467889999999999999999999864 5
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+++|||+.+++|.+++.......+++..++.++.|++.||+||| ..|++||||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 67899999999999999997766567899999999999999999999 5579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~ 212 (260)
T cd05067 151 LIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----------------EV 212 (260)
T ss_pred ecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----------------HH
Confidence 65422211 1223345678999999988889999999999999999999 99999754311 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
...+........+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122222223344567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.25 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=200.3
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC-
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG- 160 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 160 (421)
|.+++.||+|+||.||+|.+.... ....+|+|.++... ......+.+|+++++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 457889999999999999765421 12368999887542 22345678899999999999999999987532
Q ss_pred -----CeEEEEEEcCCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 161 -----ENRLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 161 -----~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
...+++|||+.+|+|.+++... ....+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCE
Confidence 2468999999999999987432 22447899999999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++...............++..|++||++.+..++.++|||||||++|+|++ |..||......
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---------- 221 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---------- 221 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999987644332111222345778999999999899999999999999999999 88898653211
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+...+........+..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus 222 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 -------EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111111111123345677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=318.80 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=202.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 468899999999999999996543 3459999987543 33467889999999999999999999999888
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++..... .+++..++.++.|++.||.||| ..|++|+||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 89999999999999999976443 5899999999999999999999 55799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|++||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----------------~~~ 211 (256)
T cd05113 150 VLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----------------ETV 211 (256)
T ss_pred cCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHH
Confidence 5432211 1112335678999999988889999999999999999998 99998654321 011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
..+........+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 EKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111111112223345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=317.11 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=205.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-----CHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-----GHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
+.|.+.+.||+|+||.||.+.... +++.+|+|.+...... ....+.+|+++++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 468999999999999999996543 4789999998644221 22457789999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| ..|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999999999999997654 3788899999999999999999 557999999999999999999999999
Q ss_pred cCcccCCCCCCcce-eeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 237 GLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 237 g~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|++........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------- 213 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------------- 213 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---------------
Confidence 99875433211111 12356788999999999988999999999999999999999999653211
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...............+..++..+.++|.+||..+|.+||++.+++..
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 -AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111112222233455678889999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=316.72 Aligned_cols=249 Identities=29% Similarity=0.460 Sum_probs=203.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE-eC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~ 160 (421)
++|++.+.||+|+||.||++... |..+|+|.++... ..+.+.+|+.+++.++|+||+++++++. .+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence 47899999999999999998543 5679999986542 3467889999999999999999999765 45
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.....+++..++.++.|++.||+||| ..|++||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccce
Confidence 67899999999999999997766556889999999999999999999 4589999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..+
T Consensus 151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----------------~~~ 208 (256)
T cd05082 151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDV 208 (256)
T ss_pred eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 543322 12344678999999988899999999999999999997 9999865321 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+........+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 209 VPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111222222234456678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.38 Aligned_cols=241 Identities=29% Similarity=0.441 Sum_probs=193.2
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhc-CCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQ-LHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.||||+++.... .....+..|..++.. ++||||+++++++.+.+..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 469999999999997654 578899999875421 223445677788775 4899999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+|+|.+++.... .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence 99999999999999997643 4788899999999999999999 4579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||..|+|||++.+..++.++|||||||++|+|++|..||...... .+.+.+
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----------------~~~~~i 208 (316)
T cd05619 148 LGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----------------ELFQSI 208 (316)
T ss_pred CCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHH
Confidence 2221 223467999999999999999999999999999999999999999754321 111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS-EVL 361 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell 361 (421)
... ...++..++.++.++|.+||..||.+||++. +++
T Consensus 209 ~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 209 RMD-NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HhC-CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 1123445677899999999999999999996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=321.42 Aligned_cols=277 Identities=28% Similarity=0.384 Sum_probs=209.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe--
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-- 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 159 (421)
.+|++.+.||+|+||.||++.... ....++..||+|.+........+.+.+|+++++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 578999999999999999997542 2344688999999876655555678899999999999999999998754
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+++++|.+++.+.. ..+++..++.++.|++.||+||| ..||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 346899999999999999996543 34889999999999999999999 558999999999999999999999999999
Q ss_pred ccCCCCCCcce-eeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
........... .....++..|+|||++.+..++.++|||||||++|||++|..++............... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK-QGQMIVYH 234 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc-ccccchHH
Confidence 87543322111 11122345699999999889999999999999999999988776433211100000000 00000111
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
+...+........+..++..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1222222222233456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=316.47 Aligned_cols=251 Identities=31% Similarity=0.519 Sum_probs=208.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence 357899999999999999999653 57899999986644 456788999999999999999999999988
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.......+++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccccc
Confidence 99999999999999999997766556899999999999999999999 5579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...... ....++..|+|||++.++.++.++||||||+++|+|++ |..||...... .+
T Consensus 151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~ 208 (256)
T cd05039 151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DV 208 (256)
T ss_pred cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----------------HH
Confidence 653221 12334668999999988889999999999999999997 99998654211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+........+...+..+.++|.+||..+|++||++.++++.|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111112222233445678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.74 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=196.0
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||+||+|.+.. ++..||||+++... ......+.+|.++++.+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 469999999999997654 47889999987542 12334567888998887 699999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence 99999999999999887654 48999999999999999999994 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 148 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----------------~~~~i~ 209 (318)
T cd05570 148 LGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----------------LFQSIL 209 (318)
T ss_pred cCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 1234679999999999999999999999999999999999999997543110 001111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA 362 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~ 362 (421)
.. ....+..++..+.+||.+||..||.+||++ .+++.
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 210 ED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 112345567889999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=315.86 Aligned_cols=259 Identities=25% Similarity=0.409 Sum_probs=210.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||+|.++.... ...+.+.+|+++++.++|+||+++++++.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 579999999999999999997653 478899998864322 22457889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
..+..++||||+++++|.+++... ....+++..++.++.+++.||.||| ..|++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence 999999999999999999998642 2345789999999999999999999 458999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.........
T Consensus 151 ~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------------- 215 (267)
T cd08224 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS------------- 215 (267)
T ss_pred ceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-------------
Confidence 99876543221 122356889999999998888999999999999999999999999654321110
Q ss_pred hhHhHhhhcccCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 317 RKLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
....+........+. ..+..+.++|.+||..+|++||++.+|++.|+++.
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 216 --LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111111111112222 66778999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.08 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=206.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|.+.+.||+|+||.||+|.+.. +++.|++|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 47788999999999999997654 478999999865432 3346688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.......+++..++.++.+++.||.||| ..|++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 99999999999999999998764556899999999999999999999 5589999999999999999999999999988
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ...
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~ 210 (256)
T cd08529 150 LLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-----------------ALI 210 (256)
T ss_pred eccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------------HHH
Confidence 6544322 123356889999999999999999999999999999999999999754311 001
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...........+..++..+.+++.+||..+|++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 211 LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111111222334667889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=319.91 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=206.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||+||+|.+.... ......||+|++...... ....+.+|+.+++.+.|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDG-----ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCC-----CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 57899999999999999999765421 111235899998754332 34567889999999999999999998865
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+++|||+++|+|.+++.... ..+++..++.++.|++.||.||| .+||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 45789999999999999986543 35889999999999999999999 4579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------------~~~ 220 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----------------REI 220 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------------HHH
Confidence 7543322111112234678999999998899999999999999999998 8999865321 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...+........+..++..+.+++.+||..||++||++.++++.|+.+...+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1222222222233456778999999999999999999999999998875544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.86 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=208.0
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCH----HHHHHHHHHHhcC-CCCC
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGH----KEWLTEVNYLGQL-HHPN 149 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~hp~ 149 (421)
..-..|...+.||+|..++|-++ .++.+|..+|+|++..... ... ++-.+|+.||+++ .||+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY 84 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc
Confidence 34457888899999999999887 4555788899998864221 111 3345799999998 5999
Q ss_pred ccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 150 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
|+++.|+|+.....++|+|.|+.|.|+|+|...-. +++....+++.|+.+|+.||| .++||||||||+|||++++.
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNM 160 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeecccc
Confidence 99999999999999999999999999999977654 899999999999999999999 55799999999999999999
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceeccccccc------CCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
++||+|||+++....+.. ....|||++|.|||.+.. ..|+..+|+||+|||||.|+.|..||-+...
T Consensus 161 ~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---- 233 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---- 233 (411)
T ss_pred ceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----
Confidence 999999999998877654 346899999999998853 4588899999999999999999999965321
Q ss_pred hhhhhhhhhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.--+.-++..++ ......+++....+||.+||+.||.+|.|++|+|..
T Consensus 234 ------------mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ------------MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ------------HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111222233332 233345788899999999999999999999999863
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=322.56 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=195.7
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||+|+||+||++.+.. +++.+|+|.+...... ..+.+..|+++++.++|+||+++++++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 7999999999996543 5789999998754332 224567899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 167 YEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.++|+|||++.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 9999999999887542 23458999999999999999999994 5799999999999999999999999999976543
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ .......+.
T Consensus 150 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------------~~~~~~~~~ 214 (280)
T cd05608 150 GQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------------NKELKQRIL 214 (280)
T ss_pred CCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------------HHHHHHhhc
Confidence 322 12345789999999999999999999999999999999999999975432110 000001000
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
. .....+..++..+.+++.+||+.||++|| ++.++++
T Consensus 215 ~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 215 N-DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred c-cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0 11133456778899999999999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.86 Aligned_cols=270 Identities=26% Similarity=0.411 Sum_probs=211.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
..+|++++.||+|+||.||+|.+..... .....+..+|+|.++.... ...+.+.+|+++++++ +|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3579999999999999999997643210 1112345789998875432 2345788999999999 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
..+..+++|||+.+++|.+++.+.. ...+.+..++.++.|++.||.||| ..|++||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nil 166 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVL 166 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEE
Confidence 9999999999999999999997642 124778888999999999999999 458999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 242 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 242 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence 99999999999999986543322211222334567999999999999999999999999999998 8888865431
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
......+........+..++..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus 243 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 -------------EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------------HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1111222222222334556778999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=317.29 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=202.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 458899999999999999996542 45799999865432 3456888999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++..... .+++..++.++.|++.||+||| ..|++||||||+||+++.++.+||+|||+++.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCccccee
Confidence 99999999999999999976443 5899999999999999999999 45799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~~ 211 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------------EVV 211 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----------------HHH
Confidence 5432211 1111223457999999999999999999999999999999 89999753221 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..+........+..++..+.+++.+||..+|++||++.++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11112222233445788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=326.43 Aligned_cols=269 Identities=26% Similarity=0.425 Sum_probs=209.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||+|....... ........+|+|.++.... .....+.+|+++++.+ .||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 3578999999999999999997543110 1123456799999875432 2345678899999999 5999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
.....++||||+.+++|.+++.... ...+++..+..++.|++.||.||| ..|++||||||+|||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nil 166 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVL 166 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEE
Confidence 9899999999999999999996542 134788899999999999999999 558999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--- 243 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--- 243 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986543221111112234567999999998899999999999999999999 88888654211
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.....+........+..++.++.+++.+||..+|++||++.++++.|+++...
T Consensus 244 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 --------------ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred --------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11111122222233456677899999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=335.06 Aligned_cols=246 Identities=26% Similarity=0.417 Sum_probs=206.9
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYE 168 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 168 (421)
+||+|+||+||-|++.. +...+|||.+........+-+.+|+.+.+.|+|.|||+++|.+.+++.+-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 69999999999997654 578899999987666666678899999999999999999999999999999999
Q ss_pred cCCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-CCCcEEEeeccCcccCCCCC
Q 014623 169 FMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 169 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~ 246 (421)
-++||+|.+++... ++..-++.++-.+-+||++||.||| ++.|||||||-+||||+ -.|.+||+|||-++....-+
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin 730 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN 730 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence 99999999999654 3323378888899999999999999 55699999999999995 57899999999998754332
Q ss_pred CcceeeccccccceecccccccC--CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
....++.||..|||||++..+ .|+.++|||||||++.||.||++||-..... ...+++..-
T Consensus 731 --P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGm 793 (1226)
T KOG4279|consen 731 --PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGM 793 (1226)
T ss_pred --ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhcc
Confidence 345678999999999999765 4899999999999999999999999654321 112333333
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
-+.-...|..++.++..+|.+|+.+||.+||++.++|.
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 34445678899999999999999999999999999985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=323.92 Aligned_cols=272 Identities=24% Similarity=0.421 Sum_probs=204.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCC-----CCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceee
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSL-----SPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~ 155 (421)
++|++.+.||+|+||.||++....... .....+....||+|.+..... .....+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 589999999999999999987643210 001122345689999876432 23356889999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGP----------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
++...+..++||||+.+++|.+++..... ..+.+..++.++.|++.||.||| ..|++||||||+|||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nill 162 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCLV 162 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEEE
Confidence 99999999999999999999999865321 23678889999999999999999 4579999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh--CCCccCCCcccchh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIEQ 303 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~pf~~~~~~~~~ 303 (421)
+.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-- 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-- 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence 9999999999999976543322222223445778999999998899999999999999999998 666776432111
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
..... ...............+...+..+.+|+.+||..||++||++.+|+..|+
T Consensus 241 -~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 -VIENT-------GEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHH-------HHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 00000 0000000011111223345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=330.10 Aligned_cols=267 Identities=29% Similarity=0.390 Sum_probs=205.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+... ....+++.||||.++..... ....+.+|+.++..+ +|+||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 35899999999999999999975431 12345789999999754322 235678999999999 6899999999876
Q ss_pred eC-CeEEEEEEcCCCCChHHHHhhcCC-----------------------------------------------------
Q 014623 159 EG-ENRLLVYEFMPKGSLENHLFRRGP----------------------------------------------------- 184 (421)
Q Consensus 159 ~~-~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------- 184 (421)
.. ...++||||+.+|+|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 467899999999999999865321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceee
Q 014623 185 ------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252 (421)
Q Consensus 185 ------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 252 (421)
..+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 236777888999999999999994 589999999999999999999999999997653322211122
Q ss_pred ccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCC
Q 014623 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 331 (421)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (421)
...++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....+........
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~~~ 303 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEGTRMRA 303 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH----------------HHHHHHhccCCCCC
Confidence 2345678999999999999999999999999999997 999986532110 01111111112222
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 332 PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 332 ~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
+...+.++.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 304 ~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 304 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33456688999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=316.48 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=206.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+|++.+.||+|+||.||++.+.. ++..+|+|.++... ....+.+.+|+.+++.++|+||+++++.+..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 47889999999999999996543 57889999986432 233456788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++.......+++..++.++.|++.||.||| ..||+|+||||+||+++.++.++|+|||++..
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 9999999999999999987655556889999999999999999999 55899999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 150 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----------------~~~~ 210 (255)
T cd08219 150 LTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK-----------------NLIL 210 (255)
T ss_pred eccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH-----------------HHHH
Confidence 543221 123456889999999998888999999999999999999999999754211 1111
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+........+..++..+.+||.+||+.||++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111122223345567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.00 Aligned_cols=241 Identities=26% Similarity=0.338 Sum_probs=191.1
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||+||+|.+.. +++.||+|++..... .....+..|.. +++.++|+||+++++++...+..
T Consensus 1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 469999999999997654 478899999875322 12233444444 56788999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+++|.+++.... .+.+..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~ 147 (325)
T cd05602 72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 147 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence 99999999999999997654 37788888999999999999994 579999999999999999999999999997533
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~ 209 (325)
T cd05602 148 EHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNIL 209 (325)
T ss_pred cCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 2334679999999999999999999999999999999999999997543210 001111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
.. ....+..++..+.++|.+||+.||.+|+++.+.+
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 210 NK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred hC--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11 1123346778899999999999999999886543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=315.69 Aligned_cols=250 Identities=30% Similarity=0.414 Sum_probs=200.1
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
.||+|+||.||+|.+.. .+++..+|+|+++..... ..+.+.+|+.+++.+.|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~-------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-------KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec-------CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 58999999999997643 234778999998754322 2456889999999999999999999875 5577999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.... .+++..+..++.|++.||.||| ..||+||||||.|||++.++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 74 MELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence 99999999999996543 4889999999999999999999 4579999999999999999999999999998654332
Q ss_pred Ccc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 247 RTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 247 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... ......++..|+|||++....++.++|||||||++|||++ |..||...... .+...+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~~~i~ 212 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----------------EVTQMIE 212 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHH
Confidence 211 1112234578999999988889999999999999999998 99999754321 1122222
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.......+..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2223344556788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=321.17 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=210.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+... ....+..|++|.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~-----~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDE-----KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecC-----CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 356899999999999999999987642 12346789999887542 223456789999999999999999999877
Q ss_pred e-CCeEEEEEEcCCCCChHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 159 E-GENRLLVYEFMPKGSLENHLFRRGP------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 159 ~-~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
. +...++++||+.+++|.+++..... ..+++..++.++.+++.||+||| +.+++||||||+|||++.++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcE
Confidence 6 4678999999999999999865422 35889999999999999999999 4579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |+.||......
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------- 226 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---------- 226 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----------
Confidence 9999999986543332222223446778999999988889999999999999999999 99999754211
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.+...+........+..++..+.+++.+||..||++||++.+++..|+.+.
T Consensus 227 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 227 -------EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111111122222233445778999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=323.18 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=204.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.... ....+++|.++... ....+.+.+|++++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 57899999999999999999765421 22357888877422 22345688999999999 79999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
....++||||+++++|.+++.+... ..+++..++.++.|++.||+||| ..||+||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence 9999999999999999999965421 24788899999999999999999 4589999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 304 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~ 304 (421)
+.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---- 225 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---- 225 (297)
T ss_pred CCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----
Confidence 999999999999986432111 0111223457999999988899999999999999999997 99999754321
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.....+........+..++..+.+|+.+||..+|.+||++.+++..|+.+...
T Consensus 226 -------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 226 -------------ELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111222222233455778899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=323.21 Aligned_cols=273 Identities=26% Similarity=0.412 Sum_probs=209.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCC-------CCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLS-------PAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
..+|++.+.||+|+||.||+|.+...... ..+...+..||+|.+..... ...+.+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35799999999999999999977543211 12233456799999876533 23456889999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRG---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
+++++..+...+++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+ .||+||||||+||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dlkp~Ni 161 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCccccccchhce
Confidence 9999999999999999999999999997644 1258899999999999999999994 5799999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh--CCCccCCCcccc
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGI 301 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~pf~~~~~~~ 301 (421)
+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999976543332222334556788999999988889999999999999999998 677776432110
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
...... ..............+..++.++.+++.+||+.||.+||++.+|+..|+
T Consensus 242 ---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAG-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHH-------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 000000 000000111111223445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=326.32 Aligned_cols=238 Identities=29% Similarity=0.379 Sum_probs=189.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
++||+|+||.||+|.+.. +++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 479999999999997653 578999999865422 12234555554 57889999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+++++|..++.... .+.+..+..++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 147 (321)
T cd05603 72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV 147 (321)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence 99999999999998886543 47888889999999999999994 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~ 209 (321)
T cd05603 148 EPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----------------MYDNIL 209 (321)
T ss_pred CCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----------------HHHHHh
Confidence 221 12334679999999999999899999999999999999999999997643110 001111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
.. ....+...+..+.++|.+||+.||.+|+++.
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1233455677899999999999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.12 Aligned_cols=252 Identities=30% Similarity=0.434 Sum_probs=203.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|++.+.||+|+||.||++.+.. +++.+|+|.+....... ...+.+|+.+++.++|+||+.+++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 37788999999999999997654 57899999987543322 2356789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.......+++..+..++.|++.||.||| ..||+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 999999999999999999987655556899999999999999999999 457999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-------------~~ 213 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EV 213 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-------------HH
Confidence 76543221 123578999999999999999999999999999999999999997643211100 00
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
... ........+..++.++.+|+.+||+.||.+||| +.++++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 ERL-VKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Hhh-hhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 001111233456778999999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=318.96 Aligned_cols=270 Identities=26% Similarity=0.368 Sum_probs=202.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
-.|.-.+++|.|+||.||.|.... +++.||||.+-.+..- --+|+++|+.++|||||++.-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 357788999999999999998765 3788999988654321 127999999999999999988887432
Q ss_pred -----eEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEEE
Q 014623 162 -----NRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKL 233 (421)
Q Consensus 162 -----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl 233 (421)
...+||||++. +|.+++... ....++...+.-+..||++||+|||+ .||+||||||+|+|+|.+ |.+||
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEe
Confidence 23589999965 999998642 23457788888899999999999995 579999999999999876 89999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh-hhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAK 310 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~-~~~ 310 (421)
||||.|+....+... .+..-|..|+|||.+.|. .|+.+.||||.||++.||+-|+..|.+......- .+.. ...
T Consensus 168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 999999987765543 335568999999988875 6999999999999999999999999885432111 1111 111
Q ss_pred hhhhchhhH---------hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhhcCC
Q 014623 311 PYLSDKRKL---------FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEAP 370 (421)
Q Consensus 311 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~~~~ 370 (421)
|..++...+ .++........+....++++.+|+.++|..+|.+|.++.|++. .++.+..+
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 111111100 0111111111234567889999999999999999999999984 45665544
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=336.88 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=197.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.... +++.||+|++..... .....+.+|+.++..++|+||+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 368899999999999999996654 578999999874321 23356778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||++||+|.+++.+.. .+++..+..++.|++.||.||| ..||+||||||+|||++.+|.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999999999997654 3889999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------------ceeeccccccceecccccccCCCCccccchhhhHHHH
Q 014623 239 AKAGPTGDRT---------------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLL 285 (421)
Q Consensus 239 a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 285 (421)
+......... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8754321100 0012357999999999999999999999999999999
Q ss_pred HHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCCCCCCC---HHHH
Q 014623 286 ELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEV 360 (421)
Q Consensus 286 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt---~~el 360 (421)
||++|..||........ ...+........++ ...+.++.+||.+|+ .||.+|++ +.++
T Consensus 228 el~tG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 228 EMLIGYPPFCSETPQET----------------YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred ecccCCCCCCCCCHHHH----------------HHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 99999999976432110 11111111111111 235778999999977 49999995 5555
Q ss_pred HH
Q 014623 361 LA 362 (421)
Q Consensus 361 l~ 362 (421)
+.
T Consensus 291 ~~ 292 (360)
T cd05627 291 KS 292 (360)
T ss_pred hc
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=315.13 Aligned_cols=253 Identities=30% Similarity=0.445 Sum_probs=204.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||+|.+.. +..+|+|.+.... ...+.+.+|+++++.++|+||+++++++. .+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 568999999999999999997643 3468999886543 33467889999999999999999998874 45
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.......+++..+..++.|++.||.||| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 6899999999999999997765556889999999999999999999 55799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...
T Consensus 152 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~~ 213 (260)
T cd05069 152 IEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----------------EVL 213 (260)
T ss_pred ccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHH
Confidence 5432211 1122345678999999988889999999999999999999 89999754211 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
..+........+...+..+.+++.+||..||.+||++.++++.|++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111222223345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=316.95 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=209.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.+.. +++.++||.+..... ....++.+|+.+++.++|+||+++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 468899999999999999996543 478999998765332 22356789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
..+..+++|||+.+++|.+++... ....+++..++.++.+++.||.||| ..|++|+||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 999999999999999999988642 2345889999999999999999999 557999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------------- 215 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS------------- 215 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-------------
Confidence 99876543221 122356889999999998888999999999999999999999999654321110
Q ss_pred hhHhHhh-hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 317 RKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 317 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
..+.+ ............+..+.+++.+||..||.+|||+.+|++.++++.
T Consensus 216 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 216 --LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --HhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 01111 111111122457789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=316.45 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=208.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +..+|||.+.... ...+++.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 34689999999999999999997543 4679999987654 345678899999999999999999999998
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+++++|.+++.......+++..+..++.+++.||.||| .+|++|+||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccccc
Confidence 889999999999999999997765556899999999999999999999 557999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.... .
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~ 212 (261)
T cd05034 151 RLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----------------E 212 (261)
T ss_pred eeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 765432211 1112234568999999998889999999999999999998 99999654211 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
....+........+...+.++.+++.+||..+|++||++.++++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 213 VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111112222223334557789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=319.48 Aligned_cols=276 Identities=29% Similarity=0.399 Sum_probs=208.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+.|++.+.||+|+||.||++.+.. ....++..||+|.++... ......+.+|+.+++.+.|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 457899999999999999997643 234468899999987543 22335688999999999999999999988775
Q ss_pred --CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 --ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
...++||||++|++|.+++.+.. ..+++..++.++.|++.||+||| .+|++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCcc
Confidence 56889999999999999986543 34889999999999999999999 56899999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++........ .......++..|+|||++.+..++.++|||||||++|+|++++.|+................ .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~--~~~~~ 233 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG--QMTVT 233 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc--cccHH
Confidence 9865433221 11223556778999999988889999999999999999999876653221100000000000 00001
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.....+........+..++..+.+|+.+||+.||++||++.+++..|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111222222233456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=317.02 Aligned_cols=260 Identities=25% Similarity=0.464 Sum_probs=205.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+.... +.+..||||.+.... .....++..|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 77 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCC------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence 45889999999999999999765421 124579999987542 22345788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+.+++|.+++.... ..+++..++.++.|++.||.||| ..|++|+||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 78 RPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999999999986543 35889999999999999999999 4589999999999999999999999999987
Q ss_pred cCCCCCCcceeeccc---cccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 241 AGPTGDRTHVSTQVM---GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
............... .+..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---------------- 218 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------- 218 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----------------
Confidence 654322111111111 2457999999998999999999999999999886 99998654311
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.....+........+..++..+.+++.+||..+|++||++.+|+..|+++
T Consensus 219 -~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 219 -DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111222233445677899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=313.41 Aligned_cols=253 Identities=33% Similarity=0.508 Sum_probs=201.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+... ...+..+|+|.+...... ..+.+.+|+++++.+.|+||+++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~------~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMK------SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeecc------CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 4699999999999976542 123578999998866543 3456889999999999999999999765 5678999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.... .+++..++.++.|++.+|.||| ..+++|+||||+|||++.++.+||+|||+++......
T Consensus 74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 99999999999997665 4889999999999999999999 4579999999999999999999999999998654332
Q ss_pred Ccce-eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 247 RTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 247 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... .+...+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-----------------~~~~~~~ 212 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-----------------EVIAMLE 212 (257)
T ss_pred cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-----------------HHHHHHH
Confidence 2111 111223467999999998899999999999999999998 99999754321 1111122
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.......+..++..+.++|.+||..+|.+||++.++++.|+++.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 22222344566788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=325.93 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=197.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.+.. +++.||+|++..... .....+.+|..++..++|+||+.+++++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 479999999999999999997654 578899999864321 22344678999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||+.||+|.+++.+.. ..+++..+..++.|++.||+||| ..||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccc
Confidence 9999999999999999999997643 34888999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+......... .....+|++.|+|||++.+ +.++.++|||||||++|+|++|+.||......
T Consensus 149 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------------- 214 (331)
T cd05624 149 CLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------------- 214 (331)
T ss_pred eeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------------
Confidence 9765432221 1233579999999998875 46888999999999999999999999754321
Q ss_pred hchhhHhHhhhcccCCCCC---HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
.....+.........+ ..++.++.++|.+||..++.+ |+++.++++.
T Consensus 215 ---~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 215 ---ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0111111111111111 245788999999999876544 4578877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.93 Aligned_cols=257 Identities=23% Similarity=0.267 Sum_probs=201.2
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccce
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
.....++|++.+.||+|+||.||++.... +++.+|+|++..... .....+.+|+.+++.++||||+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 33445789999999999999999997654 578999999864221 223456789999999999999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
++++..++..++||||+.+|+|.+++... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL 183 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKL 183 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999998653 37888889999999999999994 57999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccC----CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------- 253 (371)
T cd05622 184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------- 253 (371)
T ss_pred EeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---------
Confidence 99999986543221 122346799999999998754 3788999999999999999999999764321
Q ss_pred hhhhhchhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKL--RPRMSEVLAIL 364 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~L 364 (421)
.....++... ........++..+.++|.+||..++.+ |+++.++++..
T Consensus 254 -------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -------HHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111111111 111122357888999999999844433 67898888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=318.17 Aligned_cols=256 Identities=26% Similarity=0.309 Sum_probs=201.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +++.+|+|++..........+.+|+.+++.++||||+++++++..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~ 78 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR 78 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Confidence 3579999999999999999997643 4789999999765444455677899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++.
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999999986554 48899999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
....... ......|+..|+|||.+. ...++.++|+|||||++|+|++|..||......... .... ..
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~------~~ 224 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMS------KS 224 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeee------cC
Confidence 6532211 122356889999999874 345788999999999999999999998643211000 0000 00
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..... .......++..+.++|.+||..+|++||+++++++.|
T Consensus 225 ---~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 225 ---NFQPP--KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---CCCCC--CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0011124567899999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=327.12 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=196.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCC-CCCccceeeEEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLH-HPNLVKLIGYCL 158 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 158 (421)
+|++.+.||+|+||.||+|.... +|+.||+|++..... ...+.+..|..++..+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 47788999999999999996543 578999999875321 23345678888988886 578888999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEecccc
Confidence 9999999999999999999997654 3889999999999999999999 45899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++....... .....+||..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 148 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~ 209 (323)
T cd05615 148 CKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------------EL 209 (323)
T ss_pred ccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 875432221 123467999999999999999999999999999999999999999764321 01
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
...+... ...++..++.++.+++.+||..+|.+|++.
T Consensus 210 ~~~i~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 FQSIMEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111111 123445667889999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=312.51 Aligned_cols=241 Identities=29% Similarity=0.398 Sum_probs=204.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHH---HHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|..+++||+|.||+|.+++.+ .+++.+|+|+++++......+ -+.|-++|+..+||.+..+.-.|.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEK---------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREK---------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred chhhHHHHhcCCccceEEEEeec---------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 57888999999999999998544 479999999999876654443 357999999999999999988899
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+.+|+||||..||.|+..|.+.. .+++.....+-..|+.||.|||+ ++||+||||.+|+|+|.+|++||+|||+
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs--~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHS--RNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhh--CCeeeeechhhhheeccCCceEeeeccc
Confidence 9999999999999999998886543 48888888899999999999995 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+.... ......++|||+.|.|||++....|+.++|.|.+||++|||++|++||...+ ...
T Consensus 315 CKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------------h~k 375 (516)
T KOG0690|consen 315 CKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------------HEK 375 (516)
T ss_pred chhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------------hhH
Confidence 986433 2334567999999999999999999999999999999999999999997543 223
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 355 (421)
+++++... ..++|..+++++..|+..+|..||.+|.
T Consensus 376 LFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 LFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 33332211 1257788999999999999999999996
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=334.17 Aligned_cols=264 Identities=23% Similarity=0.257 Sum_probs=197.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..+|.+.+.||+|+||.||+|.+.. .++.||||.... ..+.+|+++|++|+|+|||++++++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4579999999999999999997654 478899996432 2356899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++|||++ .++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 233 ~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 233 GLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred CEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999999999 468988886543 358999999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc-----chhhhhhhhhh---h
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-----IEQSLVDWAKP---Y 312 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~---~ 312 (421)
...............||..|+|||++.+..++.++|||||||+||||++|..++...... ....+...... .
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 654332222233467999999999999999999999999999999999988765332211 01111110000 0
Q ss_pred ---hhc--hhhHhHhhh----cccCCCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 ---LSD--KRKLFRIMD----TKLGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ---~~~--~~~~~~~~~----~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... ...+...+. ....... ....+.++.+||.+||..||.+|||+.|+|+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 000000000 0000000 01334578899999999999999999999864
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=327.53 Aligned_cols=244 Identities=27% Similarity=0.373 Sum_probs=194.2
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.+.. +++.+|+|+++.... ...+.+.+|+.++..+ +|+||+.+++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 479999999999997654 478999999976432 2234577899998888 599999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+++++|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence 99999999999999886654 48999999999999999999995 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......+.+
T Consensus 148 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~----------~~~~~~~~~~ 215 (327)
T cd05617 148 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM----------NTEDYLFQVI 215 (327)
T ss_pred CCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc----------ccHHHHHHHH
Confidence 211 1233577999999999999999999999999999999999999999643221110 0011111111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.. .....+...+..+.++|.+||..||.+|+++
T Consensus 216 ~~-~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 216 LE-KPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred Hh-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11 1223455677889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=353.70 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=202.8
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
...++|++++.||+|+||+||+|.+.. ++..+|+|++...... ....+..|+.+|+.|+|||||+++++
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~ 80 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 344689999999999999999997654 5789999998754332 33568899999999999999999998
Q ss_pred EEeC--CeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCC-----CceeeccCCCCcEEeCC
Q 014623 157 CLEG--ENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAE-----SQVIYRDFKASNILLDA 227 (421)
Q Consensus 157 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~ivHrDlkp~Nill~~ 227 (421)
|... ..+||||||+.+++|.++|.... ...+++..++.|+.||+.||.|||+.. .+||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 8653 56899999999999999996532 245899999999999999999999643 45999999999999964
Q ss_pred -----------------CCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc--CCCCccccchhhhHHHHHHH
Q 014623 228 -----------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELL 288 (421)
Q Consensus 228 -----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~ 288 (421)
.+.+||+|||++....... .....+||+.|+|||++.+ ..++.++||||||||||+|+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 2348999999998654322 1234679999999999865 45889999999999999999
Q ss_pred hCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHh
Q 014623 289 SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILER 366 (421)
Q Consensus 289 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~ 366 (421)
+|..||...... ..+...+.... .......+.++.+||..||..+|.+||++.+++. .+..
T Consensus 238 TGk~PF~~~~~~----------------~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 238 SGKTPFHKANNF----------------SQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HCCCCCCcCCcH----------------HHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 999999653210 01111111110 0111235678999999999999999999999984 5554
Q ss_pred hc
Q 014623 367 LE 368 (421)
Q Consensus 367 ~~ 368 (421)
+.
T Consensus 301 i~ 302 (1021)
T PTZ00266 301 VG 302 (1021)
T ss_pred cC
Confidence 43
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.55 Aligned_cols=273 Identities=24% Similarity=0.414 Sum_probs=205.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCC-------CCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccce
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLS-------PAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
++|++.+.||+|+||.||++.+...... .....++..+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5799999999999999999865431100 01123456799999875432 234578899999999999999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGP---------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
++++...+..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+ .|++|+||||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Nil 162 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCL 162 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheEE
Confidence 9999999999999999999999999976432 236678899999999999999994 57999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh--CCCccCCCcccch
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS--GRCAVDKTKVGIE 302 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~pf~~~~~~~~ 302 (421)
++.++.++|+|||++................++..|++||+..++.++.++|||||||++|||++ |..||........
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999986543322222223345678999999888889999999999999999998 7788865322110
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
.. .................+..++..+.+|+.+||..||.+||++.+|++.|++
T Consensus 243 --~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 --IE--------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HH--------HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0000000000011112234566889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.89 Aligned_cols=253 Identities=34% Similarity=0.508 Sum_probs=207.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+.... ..+..+++|.+....... ...+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 46999999999999775421 247789999998654433 56788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 167 YEFMPKGSLENHLFRRG-------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
|||+++++|.+++.... ...+++..++.++.|++.||+||| ..|++|+||||+||+++.++.+||+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999997652 245899999999999999999999 568999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
................++..|+|||.+....++.++|||||||++|+|++ |..||..... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~ 215 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----------------EE 215 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----------------HH
Confidence 87654332222334567889999999988889999999999999999999 6999976421 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
+.+.+........+..++.++.+++.+||..+|.+||++.+++..|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 216 VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11222222233445667889999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=329.11 Aligned_cols=240 Identities=29% Similarity=0.354 Sum_probs=190.9
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHH-HHhcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
+.||+|+||.||+|.... +|+.+|+|++..... .....+..|.. +++.++||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 469999999999997543 578999999865321 22234555554 46778999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+++|..++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~ 147 (325)
T cd05604 72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147 (325)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence 99999999999999886554 48899999999999999999994 579999999999999999999999999987532
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
.... .....+|+..|+|||++.+..++.++|||||||++|+|++|..||....... ......
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~ 209 (325)
T cd05604 148 AQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNIL 209 (325)
T ss_pred CCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHH
Confidence 2221 2234679999999999999999999999999999999999999997543210 011111
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
... .......+..+.++|.+||..+|.+||++.+.
T Consensus 210 ~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 210 HKP--LVLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred cCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 111 12233567788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.43 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=204.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|++.+.||+|+||.||+|.+.. ++..+++|.+..........+.+|+.+++.++|+||+++++.+..+.
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 589999999999999999997543 47889999998766566677889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++... .+++..+..++.|++.||+||| ..||+||||||+|||++.++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 999999999999999998543 3788899999999999999999 45799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ...
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----------------~~~ 227 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------------LYL 227 (296)
T ss_pred cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----------------HHH
Confidence 433221 12235688999999999888899999999999999999999999975432100 000
Q ss_pred hh-hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.. ........+..++..+.+++.+||..+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00 011111223456778999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=322.87 Aligned_cols=261 Identities=29% Similarity=0.464 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
++|.+.+.||+|+||.||+|.+.... ....+++|.+..... .....+.+|++++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence 47889999999999999999765421 123567777764322 2335678899999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
++..++||||+++++|.+++.+.. ...+++..++.++.|++.||+||| ..|++||||||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili 157 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILV 157 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEe
Confidence 999999999999999999997543 124788999999999999999999 5589999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 304 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~ 304 (421)
+.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 230 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---- 230 (303)
T ss_pred cCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----
Confidence 999999999999986422111 1111234567999999988889999999999999999998 99999654321
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
.....+........+...+..+.+|+.+||+.+|++||++.+++..|.++....
T Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 231 -------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred -------------HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111111122233445678899999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.60 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=204.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+++++.++||||+++++++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 368999999999999999996543 578899999875432 2235578999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. .+++|+||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999999999999997653 488999999999999999999962 479999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh------
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS------ 314 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~------ 314 (421)
...... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||....................
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 543221 2346789999999999888899999999999999999999999965432111111100000000
Q ss_pred ----------chh---hHhHhhhcccCCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 315 ----------DKR---KLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 315 ----------~~~---~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... .....+........ ...++.++.+|+.+||..+|++||++.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00000000000111 12356789999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=318.92 Aligned_cols=252 Identities=28% Similarity=0.408 Sum_probs=202.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|+..+.||.|+||+||+|.+.. +++.+|+|.+...... ....+.+|+++++.++|+||+.+++++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence 36778999999999999997654 5789999998754332 22346789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++.......+++..+..++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999999999999999998876555569999999999999999999994 57999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||......... ..+
T Consensus 150 ~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-------------~~~ 213 (285)
T cd05632 150 VKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-------------EEV 213 (285)
T ss_pred eecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHH
Confidence 7643222 122357899999999999899999999999999999999999999754321100 001
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
...+. .....++...+.++.+|+.+||..||++||+ +.+++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 214 DRRVL-ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHhhh-ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01110 0011234456778899999999999999999 566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=342.47 Aligned_cols=275 Identities=27% Similarity=0.476 Sum_probs=235.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
....+.++||.|.||.||+|+++... +....||||.++....+ .+.+|+.|+.||.+++||||++|.|+....
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pg------kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPG------KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hheEEEEEEecccccceecccccCCC------CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 45678899999999999999887532 34568999999876543 345799999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+||.|||++|+|..+|..+..+ +...++..++..|+.|+.||-++ ++|||||...|||++.+..+|++||||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm--~YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM--NYVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc--CchhhhhhhhheeeccceEEEecccccee
Confidence 9999999999999999999877754 88899999999999999999954 69999999999999999999999999999
Q ss_pred cCCCCCCcceeecccc--ccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMG--THGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
..+++... ..++.-| ..+|.|||.+...+++.++||||+|++|||.++ |..||-... ++
T Consensus 780 vledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQ 841 (996)
T KOG0196|consen 780 VLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQ 841 (996)
T ss_pred ecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hH
Confidence 87665422 2222222 578999999999999999999999999999887 888876542 45
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCCCCCcccCCCCCC
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 383 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~~~~~~~~~~~~~ 383 (421)
++.+.++..++...|.+++..|.+|+..||++|-.+||.+.+|+..|+++.+.+.+.........+
T Consensus 842 dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r 907 (996)
T KOG0196|consen 842 DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPR 907 (996)
T ss_pred HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCC
Confidence 566777888888899999999999999999999999999999999999998887776555544444
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.44 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||++.+.. +..+++|.+.... ...+.+.+|+++++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 4689999999999999999996543 4569999887543 234568899999999999999999998877
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+++|||+.+++|.+++.+.....+++..++.++.|++.||.||| ..|++|+||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCccee
Confidence 77899999999999999997765556888899999999999999999 5589999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++|+|||||++|+|++ |..||...... ..
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----------------~~ 212 (260)
T cd05073 151 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----------------EV 212 (260)
T ss_pred eccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----------------HH
Confidence 65432211 1122345677999999988889999999999999999998 99999754211 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
...+........+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111222222334567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=319.39 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=206.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... ....++..+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 35799999999999999999976431 1123467899999875532 234568889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP--------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 219 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 219 (421)
+...++||||+.+++|.+++..... ..+++..++.++.|++.||+||| .++++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~ 157 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLA 157 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeeccccc
Confidence 9999999999999999999964321 23678888999999999999999 5589999999
Q ss_pred CCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCc
Q 014623 220 ASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTK 298 (421)
Q Consensus 220 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~ 298 (421)
|+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999875433221111222334677999999988899999999999999999998 888886432
Q ss_pred ccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
.. .....+........+..++..+.+|+.+||+.+|.+||++.|++..|++
T Consensus 238 ~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HE-----------------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HH-----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 0111111111112334567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.80 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=204.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+++.+|+++++.++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 579999999999999999997643 5789999998754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG---------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
+++..++||||++|++|.+++.... ....++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCC
Confidence 9999999999999999999986421 1235667788999999999999994 5799999999999999999
Q ss_pred cEEEeeccCcccCCCCCC----------------cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCc
Q 014623 230 NAKLSDFGLAKAGPTGDR----------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA 293 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 293 (421)
.+||+|||++........ .......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999976521110 0011235799999999999999999999999999999999999999
Q ss_pred cCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhcC
Q 014623 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEA 369 (421)
Q Consensus 294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~~~ 369 (421)
|.......... ...+...........++..+.+++.+||..||++|+ ++.++++.|+....
T Consensus 231 F~~~~~~ki~~---------------~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 231 YRRKKGRKISY---------------RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred CCCcchhhhhh---------------hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 97532210000 000000000001124567889999999999999997 67788888887644
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=340.53 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=195.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++++.||+|+||.||+|.... +++.||||.+.... ....+|+.+|+.++|+||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4579999999999999999997643 57899999886432 2345799999999999999999887532
Q ss_pred --------CeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-
Q 014623 161 --------ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF- 229 (421)
Q Consensus 161 --------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 229 (421)
..+++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+ .||+||||||+||||+.++
T Consensus 132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~ 208 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTH 208 (440)
T ss_pred ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCC
Confidence 24678999996 478777753 233458899999999999999999995 5799999999999998665
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD 307 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~ 307 (421)
.+||+|||+++....... ....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+....... ....
T Consensus 209 ~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 209 TLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred ceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 699999999986543322 2245789999999988764 6899999999999999999999999765321110 0100
Q ss_pred -hhhhhhhchhhH----hH-----hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 308 -WAKPYLSDKRKL----FR-----IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 308 -~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
...+........ .. .....+...++...+.++.+||.+||..||.+|||+.+++. .++.+
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 001100000000 00 00000111123345678999999999999999999999984 44444
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.23 Aligned_cols=260 Identities=25% Similarity=0.458 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+... ...+..+|+|.++.... ...+.+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLP------GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecC------CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5789999999999999999976432 11245799999875432 2235688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.. ..+++..++.++.|++.||.||| ..|++||||||+|||++.++.++|+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999999999997654 35789999999999999999999 4579999999999999999999999999998
Q ss_pred cCCCCCCcce-eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
.......... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----------------~ 217 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----------------D 217 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----------------H
Confidence 7544322111 111223568999999998899999999999999999886 99998654211 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
....+........+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 218 VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111111111222345677899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=330.40 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=197.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||++.+.. +|..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 44789999999999999999996543 57899999987542 22345678999999999999999999988
Q ss_pred EeCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.... ..|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~--~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCE
Confidence 6543 47999999965 67666632 27888889999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhh-hh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVD-WA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~-~~ 309 (421)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+...... ..... ..
T Consensus 163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 239 (359)
T cd07876 163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239 (359)
T ss_pred EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999997643221 12345789999999999999999999999999999999999999976532110 00000 00
Q ss_pred hhhhh---chh-hHhHhhhccc------------------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYLS---DKR-KLFRIMDTKL------------------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~~---~~~-~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+... ... .......... ........+..+.+||.+||..||++|||+.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000 0000000000 000112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=314.92 Aligned_cols=263 Identities=24% Similarity=0.397 Sum_probs=209.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+.... ......+|+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEG-----EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCC-----CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 57899999999999999999865421 112346899988765432 33568899999999999999999998877
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+.+++|.+++..... .+++..++.++.|++.||+|||+ .|++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 788999999999999999976543 48999999999999999999994 689999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||.+....++.++|+|||||++|||++ |..||..... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~ 220 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----------------VEI 220 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----------------HHH
Confidence 7553322211112223568999999988889999999999999999998 9999976431 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+........+..++..+.+++.+||..+|.+||++.++++.|.++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 122222222233445667889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=311.76 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=199.4
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVY 167 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 167 (421)
.||+|+||.||+|.+... ..+..||+|++...... ..+.+.+|+.+++.++|+||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~-------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC-------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 389999999999976432 23567999998765332 2356889999999999999999999875 45789999
Q ss_pred EcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCC
Q 014623 168 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247 (421)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 247 (421)
||+.+++|.+++.... ..+++..++.++.|++.||.||| ..|++||||||+|||++.++.+||+|||++........
T Consensus 74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence 9999999999986433 35899999999999999999999 45899999999999999999999999999976543322
Q ss_pred cce-eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc
Q 014623 248 THV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325 (421)
Q Consensus 248 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (421)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+...+..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------------~~~~~~~~~ 213 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----------------PEVMSFIEQ 213 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----------------HHHHHHHHC
Confidence 111 111223578999999988889999999999999999996 9999975431 112222223
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 326 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
......+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 233344566788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=327.05 Aligned_cols=267 Identities=29% Similarity=0.435 Sum_probs=223.4
Q ss_pred HHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCcccee
Q 014623 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 76 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
++........+.+.||.|-||.||.|.+... .++....||||..+.+. .+..+.|+.|+.+|+.++|||||+++
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~-----~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDP-----EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEeccc-----ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 3333445566778999999999999988653 23345579999998743 34567899999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
|+|.+ ...|+|||.++.|.|..++..+.. .++......++.||+.||+|||+. ++|||||...|||+....-+||+
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecCcceeeec
Confidence 99865 578999999999999999977664 488899999999999999999976 59999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
|||+++..+........ ...-..-|||||-+.-..++.++|||.|||.+||++. |..||.+-..
T Consensus 534 DFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-------------- 598 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-------------- 598 (974)
T ss_pred ccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--------------
Confidence 99999998876655433 3334678999999999999999999999999999987 9999987542
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+.-.++.+-+...|+.|++.++.|+.+||+.+|.+||++.++...|..+..
T Consensus 599 ---sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 599 ---SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 22233345566678899999999999999999999999999999988876553
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.79 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=195.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC---CCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQL---HHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hp~iv~~~~~~ 157 (421)
+|++.+.||+|+||+||+|.+.. +++.||+|.++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 58899999999999999997654 5789999998753221 223455677776655 699999999987
Q ss_pred Ee-----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 158 LE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 158 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.. ....++||||+. ++|.+++.......+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEE
Confidence 64 245789999996 489998877655568999999999999999999994 5799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-h
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-K 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~-~ 310 (421)
|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...... .
T Consensus 149 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07863 149 LADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 225 (288)
T ss_pred ECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC
Confidence 99999998654322 122356899999999999989999999999999999999999999654321110 011000 0
Q ss_pred hhhhchhhHhHhhhcccC-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+................. ....+.++..+.+||.+||..||.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000000000 0111345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=326.97 Aligned_cols=241 Identities=27% Similarity=0.343 Sum_probs=187.4
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC---CCCCccceeeEEEeCCeE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQL---HHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hp~iv~~~~~~~~~~~~ 163 (421)
||+|+||+||+|.+.. +++.||+|++...... ....+..|..++..+ .||||+++++++...+..
T Consensus 1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 7999999999997654 5789999998643221 223345566666654 699999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~ 147 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHK--YDIVYRDLKPENILLDATGHIALCDFGLSKANL 147 (330)
T ss_pred EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence 99999999999999987654 48899999999999999999994 579999999999999999999999999987543
Q ss_pred CCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
.... .....+||..|+|||++.+. .++.++|||||||++|+|++|..||...... ...+.
T Consensus 148 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----------------~~~~~ 208 (330)
T cd05586 148 TDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----------------QMYRN 208 (330)
T ss_pred CCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----------------HHHHH
Confidence 2221 23346799999999998765 4899999999999999999999999764321 01111
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP----RMSEVLA 362 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~ell~ 362 (421)
+...........++.++.++|.+||..||.+|| ++.++++
T Consensus 209 i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 209 IAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111000011123577889999999999999998 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=325.97 Aligned_cols=253 Identities=21% Similarity=0.227 Sum_probs=196.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.... +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 479999999999999999997654 57899999986422 123345778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+++..|+||||+.+++|.+++.+.. ..+++..+..++.||+.||+||| ..||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCc
Confidence 9999999999999999999996533 34889999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 149 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----------- 216 (331)
T cd05597 149 CLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----------- 216 (331)
T ss_pred eeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----------
Confidence 8765432221 1223569999999999863 4578899999999999999999999975432100
Q ss_pred hchhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPK--LRPRMSEVLAI 363 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~--~Rpt~~ell~~ 363 (421)
...+...... ......++..+.++|.+||..++. .|+++.+++..
T Consensus 217 -----~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 -----YGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----HHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011111100 111124678899999998865443 37899888865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=331.35 Aligned_cols=246 Identities=30% Similarity=0.433 Sum_probs=205.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..|.-++.||.|+||.||.|++.. +.+.||||.+...+- ..+.+++.|++.|++++|||+|.+.|+|.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 346677889999999999997654 578999999976543 34567889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.+...||||||| -|+-.|++.-. .+++.+..+..|+.+.+.||+|||++ +.||||||..|||+++.|.|||+|||.
T Consensus 97 re~TaWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 97 REHTAWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred ccchHHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccc
Confidence 999999999999 55888877433 35689999999999999999999976 599999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|..... ..+|+|||+|||||++. .+.|+-++||||||++..||...++|+.... .
T Consensus 173 Asi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN----------------A 230 (948)
T KOG0577|consen 173 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----------------A 230 (948)
T ss_pred hhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----------------H
Confidence 876543 34699999999999885 4679999999999999999999999976542 2
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+..+......-......+..+..|+..||+.-|.+|||..+++.
T Consensus 231 MSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 231 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23333333333333345788999999999999999999999998875
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=313.13 Aligned_cols=260 Identities=26% Similarity=0.468 Sum_probs=206.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|+..+.||+|+||.||+|.+... ......+++|.++... ......+..|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMP------GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 4688889999999999999976532 1123479999987543 22345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.||| ..|++|+||||+||+++.++.+||+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999999999986543 45889999999999999999999 4579999999999999999999999999997
Q ss_pred cCCCCCCccee-eccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTHVS-TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
........... .....+..|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----------------~~ 218 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----------------HE 218 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----------------HH
Confidence 65432211111 11223457999999988889999999999999999997 9999965321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
....+........+..++..+.+++.+||..+|++||++.+|++.|+++
T Consensus 219 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111222222233345678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.63 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=202.5
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|++|.||+|.+... ......+|||.+..... ...+.+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 4689999999999987542 12234699999987766 455678899999999999999999999888 889999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+++++|.+++.......+++..++.++.|++.||.||| ..|++|+||||+||+++.++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999999997755346899999999999999999999 4589999999999999999999999999998764422
Q ss_pred Cc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 247 RT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 247 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .......
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~ 215 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKKIDK 215 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHh
Confidence 11 11123456788999999998899999999999999999998 999996532110 0000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.......+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11111223456778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.85 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=229.8
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCcccee
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
++++-...+......||.|.||.||.|.|+.++ -.||||.++.+. -..++|+.|+.+|+.++|||+|+++
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys---------lTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---------LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccc---------eeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence 344444456667788999999999999998864 569999998654 4457899999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
|+|..+..+|||+|||..|+|.+||.+-.+..++....+.++.||..|+.||. .+++|||||...|+|+.++..+|++
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEee
Confidence 99999999999999999999999998887777888999999999999999999 5579999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
||||++.+..+.++. .....-.+-|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+
T Consensus 408 DFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------------- 471 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------------- 471 (1157)
T ss_pred ccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------------
Confidence 999999876655432 222334678999999999999999999999999999999 888988753
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+..+++..++.+.|..|++..++|++.||+.+|.+||++.|+-..++.+
T Consensus 472 --lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 472 --LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 4556788889999999999999999999999999999999999999888764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=322.27 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=200.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|.++..... ....+.+|+.+++.++|+||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 579999999999999999996543 4788999998754322 234577899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccccce
Confidence 999999999965 8888886543 34788899999999999999999 4589999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhh-----
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPY----- 312 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~-~~~~----- 312 (421)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .... ..+.
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 153 AKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred ecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 6433221 1223567899999998865 458899999999999999999999997654321111 1100 0000
Q ss_pred -hhchhhHhHhhhcccCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 -LSDKRKLFRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 -~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..........-...... .....++.++.+||.+||..||.+|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000000 011245778899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.22 Aligned_cols=266 Identities=25% Similarity=0.332 Sum_probs=199.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|.+.+.||+|+||.||++.+.. +++.||||.+.... ....+++.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 47889999999999999996543 57899999986532 22345788999999999999999999999877
Q ss_pred C-----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 161 E-----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 161 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
+ ..|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHHEEECCCCCEEecc
Confidence 6 7899999995 58888885543 48999999999999999999994 5799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhh-hhhh
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AKPY 312 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~-~~~~ 312 (421)
||+++........ ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+........ +... ..+.
T Consensus 147 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~ 225 (372)
T cd07853 147 FGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225 (372)
T ss_pred ccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999865432211 22335678999999998774 47899999999999999999999997654321111 1110 0000
Q ss_pred hhch----hhHhHhhhc-ccCC-------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSDK----RKLFRIMDT-KLGG-------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~----~~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+. ......+.. .... ......+.++.+||.+||..||.+|||+.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000 000000000 0000 1122346788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=312.40 Aligned_cols=250 Identities=27% Similarity=0.455 Sum_probs=202.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---------HHHHHHHHHHHhcCCCCCccce
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---------HKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
+|.+.+.||.|+||.||+|.+.. +++.+|+|.+....... .+.+.+|+.+++.++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 48889999999999999996543 47789999886543321 1457789999999999999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.||| ..|++||||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l 147 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKI 147 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEe
Confidence 999999999999999999999999997654 4788899999999999999999 457999999999999999999999
Q ss_pred eeccCcccCCCCCCc----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRT----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
+|||+++........ .......|+..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------- 218 (267)
T cd06628 148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------- 218 (267)
T ss_pred cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---------
Confidence 999999866422111 1112346889999999999888999999999999999999999999754210
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.... .......+...+..+.++|.+||+.||.+||++.++++
T Consensus 219 -------~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 219 -------QAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -------HHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 12222344567789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.01 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=198.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|++++++++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 368889999999999999996543 578899999865422 2335688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|..+. .+++..+..++.|++.||.||| ..||+|+||||+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcce
Confidence 9999999999999986542 3678888999999999999999 4589999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
...... ....+|+..|+|||++.+..++.++|+|||||++|+|++|..||........... .....
T Consensus 144 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~----------~~~~~ 209 (279)
T cd06619 144 QLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM----------PLQLL 209 (279)
T ss_pred eccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc----------hHHHH
Confidence 654322 2346789999999999998999999999999999999999999965321110000 00011
Q ss_pred Hhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 321 RIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 321 ~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+.+... .........+.++.+++.+||..+|++||++.+++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111 1111123456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.13 Aligned_cols=276 Identities=29% Similarity=0.408 Sum_probs=212.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
++|++.+.||+|+||.||+|.+... ...++..+|||.+...... ....+.+|+++++.+.|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPL-----GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCC-----CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 4688889999999999999976542 2345789999999866443 35678899999999999999999999877
Q ss_pred -CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 160 -GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
....++||||+++++|.+++..... .+++..++.++.|++.||+||| ..|++|+||||+|||++.++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 5678999999999999999976542 4899999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+.......... ......++..|++||.+.+..++.++|||||||++|+|++|..||............. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~ 233 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVT 233 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHH
Confidence 98765322211 1112234567999999988889999999999999999999999986533211100000 00000112
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+...+........+..++.++.+|+.+||..+|++||++.+|+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 22222233333333455668899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.53 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=201.4
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+.... .....+..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 46999999999999765421 1122346799998865432 3346788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-----cEEEeec
Q 014623 167 YEFMPKGSLENHLFRRG-----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSDF 236 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~Df 236 (421)
|||+++++|.+++.+.. ...+++..++.++.|++.||.||| ..+++|+||||+|||++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999999996532 233788899999999999999999 45799999999999999877 8999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|++................++..|+|||++.++.++.++|||||||++|+|++ |..||......
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------------- 220 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------------- 220 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---------------
Confidence 99976543322222223445788999999999999999999999999999998 99998643211
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.....+........+..++..+.++|.+||..+|.+||++.+|++.|+
T Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 221 --EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 111111112222334567788999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.47 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=200.8
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
....|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 34678999999999999999996654 47899999987543 3445678899999998 6999999999987
Q ss_pred eC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.. ...++||||+.+++|.+++.......+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEE
Confidence 53 457899999999999999976555568999999999999999999995 5799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
|+|||++........ ......|+..|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 152 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~----- 224 (272)
T cd06637 152 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 224 (272)
T ss_pred EccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----
Confidence 999999976533221 123467899999999886 34588899999999999999999999964321100
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
................++..+.+|+.+||..||.+||++.++++
T Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 225 -----------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----------HHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111111111222345678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=308.53 Aligned_cols=248 Identities=31% Similarity=0.468 Sum_probs=200.1
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||.|+||.||++.+.. ++.|++|.+...... ....+.+|+++++.++|+||+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 469999999999996542 678999998765443 445788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.+.. ..+++..++.++.+++.+|.||| .++++||||||+|||++.++.++|+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence 99999999999996543 35788999999999999999999 5579999999999999999999999999997654222
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (421)
.........++..|+|||++.++.++.++|||||||++|+|++ |..||....... ....+..
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~ 210 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIES 210 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhc
Confidence 1111112234567999999988899999999999999999999 888886543211 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 326 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
......+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2222334566788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.65 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=193.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
...+|++.+.||+|+||.||+|.... +++.||+|+.... ....|+.+++.++|+||+++++++..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34579999999999999999997654 4678999975432 23469999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++|||++ .++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 129 GAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA--QRIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred CCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEecCccc
Confidence 99999999999 468888886543 458999999999999999999994 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCcc-CCCcccchhh-------hhhhhh-
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAV-DKTKVGIEQS-------LVDWAK- 310 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~-------~~~~~~- 310 (421)
+...... ......||..|+|||++.+..++.++|||||||++|||+++..++ .......... +.....
T Consensus 205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~ 281 (357)
T PHA03209 205 QFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281 (357)
T ss_pred cccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence 7532211 123456899999999999999999999999999999999865554 3322110000 000000
Q ss_pred ------hhh--hchhhHhHhhhcccC--CCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 ------PYL--SDKRKLFRIMDTKLG--GQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ------~~~--~~~~~~~~~~~~~~~--~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+. .........+..... ..+ ...++.++.+||.+||+.||.+|||+.|++..
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 000 000000000000000 000 01345577789999999999999999999863
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.95 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=202.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
+|++.+.||+|++|.||++.+.. +++.+|+|.+..... ...+.+.+|+++++.++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 48899999999999999997643 467899999865432 234567889999999999999999998764
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+++++|.+++.......+++..++.++.+++.+|++|| ..|++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccce
Confidence 446789999999999999997755556899999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----------------~~ 211 (257)
T cd08223 150 RVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS----------------LV 211 (257)
T ss_pred EEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH----------------HH
Confidence 76543221 2234568999999999999999999999999999999999999997543110 00
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... .......+...+..+.+++.+||+.||.+||++.+++.
T Consensus 212 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 212 YRII-EGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHH-hcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111 11112234567788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=320.47 Aligned_cols=253 Identities=21% Similarity=0.234 Sum_probs=197.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.+.. +++.+|+|++..... .....+.+|+.++..++|+||+++++++.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 368999999999999999997654 478899999864221 12234678999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+.+|+|.+++.+.. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecch
Confidence 9999999999999999999997643 348888999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 149 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------------ 215 (332)
T cd05623 149 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------------ 215 (332)
T ss_pred heecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------------
Confidence 875433221 1223357999999999886 3468889999999999999999999997543210
Q ss_pred hchhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
....+......... ...++.++.+|+.+||..++.+ |+++.++++.
T Consensus 216 ----~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 216 ----TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111111111111 2356788999999999665544 6789988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=310.47 Aligned_cols=247 Identities=32% Similarity=0.530 Sum_probs=202.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||++.. .++.+|+|.+.... ....+.+|+.+++.++||||+++++++.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-N 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C
Confidence 4689999999999999998743 36779999987542 34578899999999999999999998865 4
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.......+++..++.++.|++.||.||| ..|++||||||+||+++.++.+||+|||++..
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 5799999999999999997766556899999999999999999999 56899999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
..... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...... ...
T Consensus 150 ~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~ 207 (254)
T cd05083 150 GSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----------------EVK 207 (254)
T ss_pred ccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----------------HHH
Confidence 43211 12334568999999988899999999999999999998 99999754321 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
..+........+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 208 ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2222222333345667889999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=318.85 Aligned_cols=254 Identities=27% Similarity=0.359 Sum_probs=204.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 368899999999999999996643 5789999999765433 3356788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+.+++|.+++.+.....+++..+..++.|++.||+||| ..|++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecch
Confidence 9999999999999999999997665566899999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCc---------------------------ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCC
Q 014623 239 AKAGPTGDRT---------------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291 (421)
Q Consensus 239 a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 291 (421)
+......... .....+.|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8754321110 0112346889999999999888999999999999999999999
Q ss_pred CccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 014623 292 CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR----MSEVLA 362 (421)
Q Consensus 292 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~ 362 (421)
.||...... ...................+..+.++|.+||..||++||+ +.+++.
T Consensus 230 ~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 230 TPFKGSNRD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCchH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999754321 1111111111111112236889999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=313.36 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=207.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|...... .....+.+++|.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIE----EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCC----cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 57899999999999999999875431 2344678999988754433 346788999999999999999999999998
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP-------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
+..++||||+++++|.+++..... ..+++..++.++.|++.||.||| ..+|+||||||+|||++.++.++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEE
Confidence 999999999999999999976541 25899999999999999999999 457999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 159 ~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------------ 225 (275)
T cd05046 159 SLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------------ 225 (275)
T ss_pred cccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------------
Confidence 999998754322211 1223456788999999988889999999999999999999 88888643211
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
...............+..++..+.+++.+||..+|.+||++.+++..|.
T Consensus 226 ----~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 ----EVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----HHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0111111111112233456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.12 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=206.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||.|+||.||.+.... ++..+++|.+.... .....++.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 58899999999999999986543 57889999886543 23345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+++|||+.+++|.+++.+.....+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 999999999999999999977645568999999999999999999994 579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ....
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~ 211 (256)
T cd08221 150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----------------NLVV 211 (256)
T ss_pred Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----------------HHHH
Confidence 6543321 223456899999999998888999999999999999999999999754211 0111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+..... ...+..++.++.+++.+||..+|.+||++.++++.
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 212 KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111111 12234567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.09 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=200.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||+|.+.. +++.+|+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 478889999999999999996543 57889999987664444456788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++...+ .+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 9999999999999999986654 48899999999999999999994 5799999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
..... .......|+..|+|||++. ...++.++|+|||||++|+|++|..||.........
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--------------- 218 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--------------- 218 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---------------
Confidence 43221 1123457899999999874 456888999999999999999999998643221100
Q ss_pred HhHhhhcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......... .....++..+.++|.+||..+|++||++.+|++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 219 -FLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -HhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000000 011134567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=311.76 Aligned_cols=252 Identities=30% Similarity=0.470 Sum_probs=197.3
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 165 (421)
+.||+|+||.||+|.+.+.. ....+++|.++.... .....+.+|++++.++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 46999999999999775421 123578888874322 2345678899999999 79999999999999999999
Q ss_pred EEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 166 VYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
||||+.+++|.+++..... ..+++..++.++.|++.||+||| ..|++||||||+|||++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence 9999999999999965431 24788999999999999999999 4589999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 152 kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---------- 218 (270)
T cd05047 152 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 218 (270)
T ss_pred EECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----------
Confidence 999999986422111 1111223567999999988889999999999999999997 99999654211
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.....+........+..++.++.+|+.+||..||.+||++.+++..|+++.
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111111122222233456678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.33 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=204.3
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC-CCCcccee
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH-HPNLVKLI 154 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~ 154 (421)
.+..+.|.+++.||+||.+.||++.... ...+|+|.+..... ....-|.+|+..|.+|+ |.+||+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~ 426 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY 426 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence 3456789999999999999999986543 35677776544322 33456899999999995 99999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
||-..++.+||||||= ..+|..+|.++......+ .+..+..|++.|+.++|. .||||.||||.|+|+-. |.+||+
T Consensus 427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~--~gIVHSDLKPANFLlVk-G~LKLI 501 (677)
T KOG0596|consen 427 DYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ--HGIVHSDLKPANFLLVK-GRLKLI 501 (677)
T ss_pred eeeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH--hceeecCCCcccEEEEe-eeEEee
Confidence 9999999999999985 569999998776554444 677888999999999995 47999999999999954 589999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccC-----------CCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
|||+|..+..+.......+.+||+.||+||.+... ..+.++||||||||||+|+.|+.||....
T Consensus 502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----- 576 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----- 576 (677)
T ss_pred eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----
Confidence 99999998887777777789999999999988532 25678999999999999999999997532
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHH-HHHHHHHhccccCCCCCCCHHHHHH
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH-TAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+..+.+......++..-.. ++.++++.||+.||.+||++.++|.
T Consensus 577 ----------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 ----------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 122334455555454455432222 3999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.02 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=198.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||++.+.. +++.+|||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 45789999999999999999996543 578899999875432 2335678899999999999999999988
Q ss_pred EeC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
... ...++||||+.+ +|.+.+.. .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCE
Confidence 643 347999999965 77776643 3788889999999999999999 5589999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hh-hhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SL-VDWA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~-~~~~ 309 (421)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+....... .. ....
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (355)
T cd07874 159 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_pred EEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999998653322 223467899999999999999999999999999999999999999765421110 00 0000
Q ss_pred hhhh---hch-hhHhHhhhcc---------------c---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYL---SDK-RKLFRIMDTK---------------L---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~---~~~-~~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+.. ... .......... . ........+..+.+||.+||..||.+|||+.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 000 0000000000 0 001122345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=314.33 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=202.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+.+++.++|+||+++++++..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 579999999999999999996654 57889999998765555677889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|..++.+.. ..+++..+..++.|++.+|.||| ..|++||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999988875543 35899999999999999999999 55899999999999999999999999999875
Q ss_pred CCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
..... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 160 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---------------- 221 (292)
T cd06644 160 NVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---------------- 221 (292)
T ss_pred ccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----------------
Confidence 33221 11234568899999998853 44678999999999999999999998653210
Q ss_pred hhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+...... ....+..++.++.++|.+||..+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 RVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111111100 11223456678999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.40 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=196.6
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
...++|++.+.||+|+||.||+|.+.. +++.||||.+..... .....+.+|+++++.++|+||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhh
Confidence 456789999999999999999996543 578999999875422 233557789999999999999999998
Q ss_pred EEeC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 157 CLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 157 ~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
+... ...+++|+++ +++|.+++.. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~~~~~~ 156 (343)
T cd07878 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCE 156 (343)
T ss_pred hcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEECCCCC
Confidence 7643 3468999998 7899887743 248999999999999999999994 57999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW 308 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~ 308 (421)
+||+|||++...... ....+||..|+|||++.+ ..++.++|||||||++|+|++|..||......... .....
T Consensus 157 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07878 157 LRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231 (343)
T ss_pred EEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 999999999865432 234578999999999877 56899999999999999999999999764321100 00000
Q ss_pred h-hhh---hhc--hhhHhHhhhcccCCC-------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 309 A-KPY---LSD--KRKLFRIMDTKLGGQ-------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 309 ~-~~~---~~~--~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
. .+. ... .......+ ..+... .....++.+.+||.+||..||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 000 00000000 000000 001234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=308.83 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=195.4
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEE-eCCeEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-EGENRLL 165 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~l 165 (421)
+.||+|+||.||+|.+... ...+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDS------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecC------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 4689999999999986432 1235679999885432 233457888999999999999999999776 4556889
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCC
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 245 (421)
||||+.+++|.+++.+.. ....+..+..++.|++.||.||| ..+++||||||+|||++.++.+||+|||+++.....
T Consensus 75 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999999999996543 23677778889999999999999 457999999999999999999999999999754322
Q ss_pred CCcc--eeeccccccceecccccccCCCCccccchhhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 246 DRTH--VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 246 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
.... ......++..|+|||.+.+..++.++|||||||++|||++| ..||...... .....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----------------~~~~~ 214 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----------------DITVY 214 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHH
Confidence 1110 11123457789999999888999999999999999999995 5566543210 11111
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+........+...+..+.+++.+||..+|++||++.+++..|+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111122223445678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=309.16 Aligned_cols=251 Identities=28% Similarity=0.374 Sum_probs=205.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||.|+||.||+|.... +++.+++|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 579999999999999999996543 46789999998765556677889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||.||| ..|++|+||+|+||+++.++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchh
Confidence 9999999999999999886642 34889999999999999999999 45799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
...... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||........
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---------------- 212 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---------------- 212 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----------------
Confidence 543221 12335688899999998776 788999999999999999999999975432110
Q ss_pred HhHhhhc---ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....... ..........+.++.+++.+||..+|.+||++.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0011123456788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=310.91 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|.+.+.||+|+||.||+|.+.... .....++||...... ....+.+.+|+.+++.++|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence 356889999999999999999765321 224568999887654 2344578899999999999999999998765
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+++++|.+++.+.. ..+++..++.++.+++.||.||| ..|++|+||||+|||++.++.++|+|||++
T Consensus 79 -~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 79 -NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCcee
Confidence 56789999999999999997644 34899999999999999999999 557999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----------------- 216 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND----------------- 216 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----------------
Confidence 765433211 1122334568999999988889999999999999999996 999997643211
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....+........+..++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 217 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001111111223345667899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=326.09 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=197.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||++++.. +++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 34689999999999999999997544 478899999875422 2345678999999999999999999987
Q ss_pred EeC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
... ...|+||||+.+ +|.+++.. .+++..+..++.|++.||.||| .+||+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred cccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcE
Confidence 643 357999999954 78777743 2788889999999999999999 4589999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh-hh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~-~~ 309 (421)
||+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+....... .+.. ..
T Consensus 166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 242 (364)
T cd07875 166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242 (364)
T ss_pred EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999998653322 223467899999999999999999999999999999999999999765421110 0000 00
Q ss_pred hhhh---hchh-hHhHhhhcc------------------cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYL---SDKR-KLFRIMDTK------------------LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~---~~~~-~~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+.. .... .+....... .........+..+.+||.+||..||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 000000000 0001112235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=317.33 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=205.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||.|+||.||++.... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999997543 4789999999766555566788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+. .+++..+..++.|++.+|.|||+ .|++||||||+|||++.++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 9999999999999999998543 37888999999999999999995 579999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||........ ..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~----------------~~ 225 (297)
T cd06656 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LY 225 (297)
T ss_pred EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh----------------ee
Confidence 6433221 12235688999999999998899999999999999999999999965432100 00
Q ss_pred Hhh-hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ........+...+..+.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000011223456778899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=315.97 Aligned_cols=264 Identities=25% Similarity=0.408 Sum_probs=205.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|+..+.||+|+||.||+|.+.... ......+|+|.+....... ...+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~- 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEG-----ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS- 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCC-----CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-
Confidence 57889999999999999999875421 0112368999887543322 2367889999999999999999998865
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++++||+++|+|.+++.... ..+++..++.++.|++.||.||| .+||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEccccccc
Confidence 45679999999999999986543 34788899999999999999999 5579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-----------------~ 220 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-----------------I 220 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------H
Confidence 6543322211222345778999999998899999999999999999997 899997542111 1
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...+........+..++..+.+++.+||..+|++||++.+++..|+.+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 221 PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111111112223345678899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=307.01 Aligned_cols=256 Identities=33% Similarity=0.522 Sum_probs=206.1
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
+.+.+.||.|+||.||++.+.... ...+..+|+|.+...... ..+.+..|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLS-----GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCC-----CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 457789999999999999876521 123588999999765433 45678899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.+++|||+.+++|.+++.......+++..++.++.|++.||+||| ..|++|+||||+||+++.++.++|+|||++...
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999999997655433899999999999999999999 558999999999999999999999999999876
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
......... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+
T Consensus 154 ~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~ 215 (258)
T smart00219 154 YDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----------------EEVLE 215 (258)
T ss_pred ccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHH
Confidence 543222111 2236789999999988889999999999999999998 7888865321 11111
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+........+...+.++.+++.+||..||.+|||+.++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2222222233445778899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=310.51 Aligned_cols=256 Identities=26% Similarity=0.321 Sum_probs=192.1
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+.. ..++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 469999999999997643 12456799999876543 2334678899999999999999999999998899999
Q ss_pred EEcCCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 167 YEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|||+++++|.+++.... ....++..+..++.|++.||+||| ..|++|+||||+||+++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999996532 123567778889999999999999 4579999999999999999999999999997543
Q ss_pred CCCCcceeeccccccceecccccccC-------CCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATG-------RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
............++..|+|||++.+. .++.++|||||||++|+|++ |..||.......... ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~------ 222 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT------ 222 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH------
Confidence 33222222235678889999988642 35789999999999999996 999996543211000 00
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
.................+..+.+++..|| .+|++|||+.+|+..|+
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 ---VREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---hhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000001112235667889999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.99 Aligned_cols=247 Identities=32% Similarity=0.482 Sum_probs=197.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
++||.|+||.||+|... .+..+|+|.+...... ....+.+|+++++.++||||+++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 46999999999999643 2678999998755322 234678999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+++++|.+++.... ..+++..++.++.+++.+|.||| ..|++||||||+||+++.++.+||+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 99999999999986543 34789999999999999999999 4589999999999999999999999999987543221
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (421)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+..
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----------------~~~~~~~ 209 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----------------AREQVEK 209 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----------------HHHHHHc
Confidence 11 1112234567999999988889999999999999999998 999997542210 1111112
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 326 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
......+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2222334556789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=315.60 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=205.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|++.+.||.|+||.||+|.+.. +++.|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 469999999999999999996543 57899999987665555677889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++... .+++..+..++.+++.||+|||+ .|++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~--~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999999999999999988543 38899999999999999999995 5799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||........ ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----------------~~~ 226 (296)
T cd06655 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LYL 226 (296)
T ss_pred cccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHH
Confidence 543221 12235688999999999988899999999999999999999999976532110 001
Q ss_pred hhhc-ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ......+..++..+.++|.+||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1000 0011223456778999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=313.51 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=202.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 368899999999999999997653 478999998875421 2235688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+++++|..++.... ...+++..+..++.+++.||.|||+ ..||+|+||||+||+++.++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999998886532 2358999999999999999999995 247999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC------CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
....... .....++..|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 151 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----------- 215 (286)
T cd06622 151 GNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI----------- 215 (286)
T ss_pred ccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-----------
Confidence 7653221 22356788999999885543 57899999999999999999999965321100
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+..+. .......+..++.++.++|.+||..+|++||++.+++.
T Consensus 216 --~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 216 --FAQLSAIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --HHHHHHHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00011111 11222345568889999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=312.72 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=201.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.|++.+.||.|+||.||+|.+.. ++..+++|.+........+.+.+|+++++.++|+||+++++++..++.
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE
Confidence 36788999999999999997654 477899999876555555678899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++||||+.+++|..++.+.. ..+++..+..++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++...
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 999999999999998876533 458999999999999999999994 57999999999999999999999999998764
Q ss_pred CCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
.... .......++..|+|||++. +..++.++|||||||++|+|++|..||...... .
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~ 215 (282)
T cd06643 154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----------------R 215 (282)
T ss_pred cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----------------H
Confidence 3221 1123456899999999874 345788999999999999999999998653210 0
Q ss_pred hHhHhhhc-ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
........ ......+..++..+.++|.+||..||.+||++.+++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 216 VLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111110 01112234567889999999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=311.40 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||.|+||.||+|.+.. ++..+|+|.+.... ......+.+|+++++.++|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 368899999999999999997653 57899999987553 23345678899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++|+||+.+++|.+++... .+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||+++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 146 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSG 146 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999999999654 5899999999999999999999 4579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
...... .......++..|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----------------~~~ 207 (274)
T cd06609 147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----------------RVL 207 (274)
T ss_pred eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----------------HHH
Confidence 764332 1223456888999999999888999999999999999999999999654311 000
Q ss_pred HhhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+........+.. ++.++.+++.+||..+|++||++.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 208 FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111122222 6778999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.91 Aligned_cols=248 Identities=29% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeE
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
|.+++.||+|+||.||+| ++..+|..+|||.+..+ .+.+++..|+.+|+++..|+||++||.|.....+
T Consensus 35 FDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 567788999999999999 55568999999998765 4668899999999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+|||||-.|++.+.+..+ ++++.+..+..++...+.||.|||.. .-||||||..|||++.+|..||+|||.|....
T Consensus 104 WIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~--~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL--KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH--HHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 9999999999999988554 36799999999999999999999965 47999999999999999999999999997653
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
+. .....+++||+.|||||++..-.|+.++||||||++..||..|++||.....-.. ++-+-
T Consensus 181 DT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIP 242 (502)
T KOG0574|consen 181 DT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIP 242 (502)
T ss_pred hh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEecc
Confidence 32 2234568899999999999999999999999999999999999999975432110 00000
Q ss_pred -hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 324 -DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 324 -~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...-.-..|...+.++.+++++||..+|++|-|+.++++.
T Consensus 243 T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0111123467889999999999999999999999988764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=328.98 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=217.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.++.++||+|.||+|++|.|.+.. ++-..||||.++..... ....|++|+.+|.+|+|+|+++|||+..+ .
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 4567889999999999999998632 23456899999877655 55789999999999999999999999887 7
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
...||||++++|+|.+.|.+.....+-......++.|||.|+.||.++ ++|||||-..|+||-..-.|||+||||.+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk--rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK--RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--hhhhhhhhhhhheecccceeeeecccceec
Confidence 788999999999999999886666788899999999999999999954 699999999999998888999999999998
Q ss_pred CCCCCCcce-eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 242 GPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 242 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...++.... .....-...|+|||.+....++.++|+|+|||+||||++ |..||.+-. .-.+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qI 324 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQI 324 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHH
Confidence 765443322 222234678999999999999999999999999999999 888997642 2345
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+.++.+-+...+..+++++++++..||..+|.+||++.+|.+.+
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 566666667778899999999999999999999999999997543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=315.21 Aligned_cols=200 Identities=24% Similarity=0.357 Sum_probs=161.4
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRL 164 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 164 (421)
++.||+|+||+||+|.... ..+++.+|+|.+..... ...+.+|+.+++.++||||+++++++.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~-------~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD-------GKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEcc-------CCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 4689999999999997543 12467899999875532 3457789999999999999999998864 45688
Q ss_pred EEEEcCCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe----CCCCcEEE
Q 014623 165 LVYEFMPKGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKL 233 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 233 (421)
+||||+. ++|.+++... ....+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999994 5888887532 12348889999999999999999994 579999999999999 45678999
Q ss_pred eeccCcccCCCCCCc-ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 234 SDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 999999865432211 112346789999999998774 58999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.89 Aligned_cols=253 Identities=31% Similarity=0.500 Sum_probs=199.9
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHH--HHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK--EWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|++.+.||+|+||+||++.... +++.+|+|++......... ...+|+.+++.++|+||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 6788999999999999997655 5779999999876544332 2356999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.... .+++..++.++.|+++||++||+ .|++|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~--~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHS--KGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHH--TTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc
Confidence 9999999999999999997443 38999999999999999999995 4799999999999999999999999999975
Q ss_pred CCCCCCcceeeccccccceecccccc-cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
... .........++..|+|||++. +..++.++||||||+++|+|++|..||.............. ...
T Consensus 148 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---------~~~ 216 (260)
T PF00069_consen 148 LSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---------ILK 216 (260)
T ss_dssp STS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---------HHH
T ss_pred ccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh---------ccc
Confidence 311 112334567899999999998 78899999999999999999999999986521111100000 000
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....... .........+.++|.+||..||++||++.++++
T Consensus 217 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 RPLPSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp THHHHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000112378999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=299.10 Aligned_cols=255 Identities=23% Similarity=0.259 Sum_probs=201.9
Q ss_pred HhcCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 80 ATRNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
++++|++. ++||-|-.|.|..+..+ .+|+.+|+|++... ....+|++..-.. .|||||.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k---------~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHK---------RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEEEec---------cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 45677764 67999999999988544 47899999998532 4456788875554 599999999988
Q ss_pred Ee----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCc
Q 014623 158 LE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFN 230 (421)
Q Consensus 158 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~ 230 (421)
.+ ...+.+|||.++||.|+..|..++...+.+..+..|+.||+.|+.|||+. +|.||||||+|+|... |..
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~--nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM--NIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc--chhhccCChhheeeecCCCCcc
Confidence 74 34678999999999999999999999999999999999999999999976 5999999999999954 456
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||+|+...... ...+.|-|++|.|||++....|+...|+|||||++|-|++|.+||.......
T Consensus 203 lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--------- 270 (400)
T KOG0604|consen 203 LKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--------- 270 (400)
T ss_pred eEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---------
Confidence 9999999998754322 2345788999999999999999999999999999999999999996432110
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.....+.-.....-.+.......+++++.++|+.+|..+|.+|.|+.++++.
T Consensus 271 -ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 -ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0001111111111122223336889999999999999999999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=309.18 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=201.7
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|++.+.||+|+||.||+|.+.. ...++..+|||++..... ...+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS------EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec------cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6788999999999999997653 234578999999876432 23456789999999999999999999886542
Q ss_pred ------eEEEEEEcCCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 162 ------NRLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 162 ------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
..+++++|+.+++|.+++... ....+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCE
Confidence 247889999999999887432 12347888899999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--------- 223 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--------- 223 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---------
Confidence 9999999986543322212223445678999999988889999999999999999999 888886543210
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
+...+........+...+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 224 --------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111111122234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=313.13 Aligned_cols=266 Identities=24% Similarity=0.317 Sum_probs=199.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||+|.... ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 48889999999999999997653 4788999998754322 235678899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+. ++|.+++..... ..+++..++.++.|++.||.||| ..|++|+||||+|||++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 99999999996 689888865432 45899999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhh-hhhhhh---h
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLV-DWAKPY---L 313 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~-~~~~~~---~ 313 (421)
....... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....... ... .+..+. +
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 7643322 112234578899999988654 4788999999999999999999999764321110 000 000000 0
Q ss_pred h---chhhHhHhhh---cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 S---DKRKLFRIMD---TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~---~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .......... ..........++.++.++|.+||..||.+|||+.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000000 00000112246778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=312.89 Aligned_cols=260 Identities=25% Similarity=0.366 Sum_probs=203.3
Q ss_pred CHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCcc
Q 014623 73 TFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLV 151 (421)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv 151 (421)
++.+.....+.|++.+.||.|+||.||+|.+.. +++.+|+|++.... .....+..|+.+++++ +|+||+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEE
Confidence 344444556789999999999999999997654 47889999986543 2335677899999888 699999
Q ss_pred ceeeEEEe------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 152 KLIGYCLE------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 152 ~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
++++++.. ....+++|||+.+++|.+++.......+++..++.++.|++.||.|||+ .||+|+||||+||++
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dl~~~nili 154 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLL 154 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE
Confidence 99998853 4578999999999999999976555568888899999999999999994 579999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
+.++.++|+|||++........ ......|+..|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 155 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred CCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 9999999999999876432211 123356899999999876 346888999999999999999999999653211
Q ss_pred chhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..................++..+.+||.+||..||.+||++.+|++
T Consensus 233 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 ----------------RALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----------------hhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0011111111111122346778999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=307.87 Aligned_cols=250 Identities=28% Similarity=0.459 Sum_probs=200.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
+|++.+.||.|+||.||+|... +++.+|+|.+...... ....+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 5889999999999999999643 3778999988643211 12457789999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+.+..++||||+.+++|.+++.+.. .+++..+..++.|++.||+||| ..+|+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~df 146 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDF 146 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccc
Confidence 999999999999999999999997654 3788999999999999999999 457999999999999999999999999
Q ss_pred cCcccCCCCC----CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 237 GLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 237 g~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|++....... .........|+..|+|||++.+..++.++|+|||||++|+|++|..||.......
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------- 215 (265)
T cd06631 147 GCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------- 215 (265)
T ss_pred hhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----------
Confidence 9987542111 1111223568899999999998889999999999999999999999996532110
Q ss_pred hhchhhHhHhhhc-ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
........ ......+..++.++.++|.+||..+|.+||++.+++.
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 216 -----AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011111 1112234557788999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=292.78 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=197.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 160 (421)
+...+..||.|+.|.||++..+. +|..+|||.+...+. ...++++..+.++.+.+ +|+||+.+|+|..+
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 44556779999999999997654 588999999976543 34467888888876664 99999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++.||.| ...+..++ ++-..++++..+-.+...++.||.||-.+ .||+|||+||+|||+|+.|++||||||++.
T Consensus 164 ~dV~IcMelM-s~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred chHHHHHHHH-HHHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEEccCCCEEeecccccc
Confidence 9999999998 43455555 34445699999999999999999999874 489999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
...+.. ..+.-.|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+-... ..
T Consensus 241 rlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------------Fe 302 (391)
T KOG0983|consen 241 RLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------------FE 302 (391)
T ss_pred eeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---------------HH
Confidence 654433 2344668999999998863 46899999999999999999999999874321 12
Q ss_pred hHhHhhhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+..+++.. .... ....++.+.+++..||..|+.+||...++++.
T Consensus 303 ~ltkvln~e-PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 303 VLTKVLNEE-PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHhcC-CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 222222211 1111 12478899999999999999999999999863
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.27 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=204.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||++.... +|+.+|+|.+..... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 58899999999999999997643 478899999875422 2335688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.......+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 999999999999999999976555568899999999999999999994 579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ....
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~ 211 (256)
T cd08218 150 VLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVL 211 (256)
T ss_pred ecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHH
Confidence 6543221 122356888999999998888999999999999999999999998643210 0011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+ .......+...+.++.++|.+||+.+|++||++.++++
T Consensus 212 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 212 KII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHh-cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 11122234566788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=312.21 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=203.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||.|+||.||++.+.. ++..+|+|.+........+.+.+|+++++.++|+||+++++++....
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence 569999999999999999997653 47889999997665555567889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.+.. ..+++..++.++.|++.||.||| ..||+|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence 9999999999999999986543 35899999999999999999999 45799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
...... ......|+..|+|||++. ...++.++|+|||||++|+|++|..||.......
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------------- 215 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------------- 215 (280)
T ss_pred hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---------------
Confidence 433221 123456899999999875 3447789999999999999999999997542110
Q ss_pred hhHhHhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 317 RKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 317 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
......... .....+..++.++.++|.+||..+|.+||++.+++..
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 216 -VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -HHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011111110 0112234567789999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.67 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=201.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+++++.++||||+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 468889999999999999997642 56799998875433 3457889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.... ..+++..++.++.+++.+|+||| ..+++|+||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceee
Confidence 9999999999999999986543 34788999999999999999999 45799999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||++.++.++.++||||||+++|+|++ |..||...... ...
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----------------~~~ 211 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----------------EVV 211 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----------------HHH
Confidence 4332211 1112335678999999998899999999999999999998 99999754311 111
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
+.+........+...+..+.+|+.+||..+|++||++.++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 212 ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11111111122334567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=329.15 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=207.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.|.|+..||.|+||.||+|..+. ++...|.|++........++++-|++||..+.||+||++++.|+..+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 457888899999999999996543 46677889988777777788999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.+||+.|||.||-+...+...+ ..+.+.++..+++|++.||.|||+. +|||||||..|||++-+|.++|+|||.+-.
T Consensus 103 kLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~--~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ--NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc--chhhhhccccceEEEecCcEeeeccccccc
Confidence 9999999999999988876655 4599999999999999999999964 699999999999999999999999998754
Q ss_pred CCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
... ......+++||++|||||++. ..+|+.++||||||++|.||..+.+|-..... .
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----------------M 241 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----------------M 241 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----------------H
Confidence 221 112245689999999999875 45799999999999999999999988654221 1
Q ss_pred hhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+.+.++....- ....|...+..+.+++.+||..||..||++.++++
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22222221111 11245688899999999999999999999999985
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=308.20 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=204.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..|+..+.||.|+||.||+|.+.. ++..+|+|.+..... .....+.+|+++++.+.|+||+++++++.++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 357888999999999999997654 478899999875432 3345688899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+.+++|.+++... .+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEcccccce
Confidence 9999999999999999988543 4788899999999999999999 4579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......++..|+|||++.+..++.++|+|||||++|+|++|..||...... ...
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----------------~~~ 210 (277)
T cd06640 150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----------------RVL 210 (277)
T ss_pred eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----------------hHh
Confidence 6543221 122356788999999998888999999999999999999999999754321 011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+........+..++..+.+++.+||..+|++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1111122233455678899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.93 Aligned_cols=266 Identities=20% Similarity=0.247 Sum_probs=195.5
Q ss_pred CCceeccc--CceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 86 PDSLLGEG--GFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 86 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++++||+| +|++||++.... +|+.||+|.+..... .....+.+|+++++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~ 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 72 (327)
T ss_pred hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence 56789999 788999996543 689999999976532 22345678999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++.++.++++||+.+..
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~ 150 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGLRSNLS 150 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEEecCCcEEEcccchhhc
Confidence 99999999999999999976554558999999999999999999994 5799999999999999999999999986543
Q ss_pred CCCCCC-c----ceeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhh
Q 014623 242 GPTGDR-T----HVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYL 313 (421)
Q Consensus 242 ~~~~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~ 313 (421)
...... . .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .......+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 151 MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccc
Confidence 221110 0 01122356788999999876 45899999999999999999999999753321100 0000000000
Q ss_pred hchhh------------------Hh---------HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRK------------------LF---------RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~------------------~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+... .. ..............++..+.+||.+||..||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 00 000000001122345678999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.47 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=203.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc------cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF------QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
+|+..+.||+|+||.||++.... +++.+|+|++..... ...+.+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 48889999999999999996543 578899999875431 123567899999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEee
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSD 235 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~D 235 (421)
+.+.+..++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999999999997654 48889999999999999999994 5799999999999998776 599999
Q ss_pred ccCcccCCCCCCc--ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 236 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
||++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----------- 216 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----------- 216 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-----------
Confidence 9998765432111 112235688999999999888899999999999999999999999964332110
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+..........+...+.++.+++.+||..+|++||++.+++.
T Consensus 217 --~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 217 --LALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --HHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111111122233455677889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=305.52 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=192.0
Q ss_pred ceecccCceeEEEEEecCCCCC---CCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLS---PAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
+.||+|+||.||+|.+...... .........+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4699999999999976432110 0111234568999887655445567888999999999999999999999988999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-------EEEeecc
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-------AKLSDFG 237 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-------~kl~Dfg 237 (421)
+||||+.+++|..++.+.. ..+++..++.++.||+.||+||| ..||+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999988886543 34899999999999999999999 457999999999999987664 8999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccc-cCCCCccccchhhhHHHHHHH-hCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------------- 218 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------------- 218 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------------
Confidence 98754321 2345788999999886 466899999999999999998 58888765321110
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
........ ........++.+||.+||+.||.+||++.+|+..|
T Consensus 219 ----~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ----ERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----HHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00111111 11122356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.62 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=203.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||++.... ++..+|+|.+..... .....+.+|+++++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 58889999999999999997653 478899999875433 2345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeeccCc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLA 239 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~a 239 (421)
+..++||||+++++|.+++.......+++..++.++.+++.+|.||| .+|++|+||+|+||+++.++ .+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 99999999999999999998765556899999999999999999999 45899999999999998654 5899999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... .
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----------------~ 209 (256)
T cd08220 150 KILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----------------L 209 (256)
T ss_pred eecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----------------H
Confidence 86543321 223568899999999998889999999999999999999999997543210 0
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
............+..++..+.+++.+||..+|++|||+.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111112234456788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.31 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=190.6
Q ss_pred eecccCceeEEEEEecCCCCC---------------CCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccce
Q 014623 89 LLGEGGFGFVYKGWIDQHSLS---------------PAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~---------------~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
.||+|+||.||+|.+...... ..+......|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999976432110 01223345689999876544444568889999999999999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---- 229 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---- 229 (421)
++++......++||||+++++|..++.+.. ..+++..+..++.|++.||+||| ..||+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999886533 35788999999999999999999 55899999999999997654
Q ss_pred ---cEEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHH-hCCCccCCCcccchhh
Q 014623 230 ---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQS 304 (421)
Q Consensus 230 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~ 304 (421)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||.........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence 3899999988643221 12357788999998875 56899999999999999995 699998654321100
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
....... ..+......+.++|.+||+.+|++||++.+|++.|
T Consensus 232 ----------------~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 ----------------RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ----------------HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0111111 12223345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.88 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=204.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||.|+||.||+|.+.. ++..+++|.+..... .+.+.+|+++++.++|+||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 579999999999999999997654 467899999875532 567889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..|++|||+.+++|.+++.... ..+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 9999999999999999986543 45899999999999999999999 45799999999999999999999999999986
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ...
T Consensus 149 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----------------~~~ 210 (256)
T cd06612 149 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----------------IFM 210 (256)
T ss_pred cccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----------------hhh
Confidence 543321 12335578899999999988999999999999999999999999975432110 000
Q ss_pred hhh-cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .......+..++..+.++|.+||..||++||++.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 211 IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 00011123456678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=316.69 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=208.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.+.|+.-++||+||||.||-+.... +|+.+|.|.+.+.... .....++|-.||.+++.+.||.+--.|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3578889999999999999885544 6999999988654332 234567899999999999999998889
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
+..+.+||||..|+||+|.-.|...+...+++..+..++.+|+.||++|| +.+||+|||||+|||||+.|+++|+|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISDLG 332 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISDLG 332 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeeccc
Confidence 99999999999999999999998877777999999999999999999999 5579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
||..+..+.. ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||........ .
T Consensus 333 LAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------------~ 395 (591)
T KOG0986|consen 333 LAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------------R 395 (591)
T ss_pred eEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------H
Confidence 9998766553 2345899999999999999999999999999999999999999965432111 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.-...........++...++++.+|.+.+|..||.+|...
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0111111222345678899999999999999999999754
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=311.50 Aligned_cols=264 Identities=27% Similarity=0.380 Sum_probs=206.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||+||++.+.. ++..+|+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 578899999999999999997653 478899998865432 3346788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+. .+++||||||+||+++.++.++|+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~ 152 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSG 152 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCccc
Confidence 99999999999999999987654 488999999999999999999952 479999999999999999999999999986
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......+.... . ..-.....
T Consensus 153 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~--~~~~~~~~ 223 (284)
T cd06620 153 ELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---P--MGILDLLQ 223 (284)
T ss_pred chhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---h--hHHHHHHH
Confidence 542221 22357899999999998889999999999999999999999999754321110000 0 00000011
Q ss_pred HhhhcccCCCCC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 321 RIMDTKLGGQYP-QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 321 ~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...... ....+ ..++.++.+|+.+||..||++||++.|++....-+
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 224 QIVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred HHhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 111111 11111 23667899999999999999999999999865433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.82 Aligned_cols=251 Identities=29% Similarity=0.378 Sum_probs=189.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|..... .....+++|.+...... ....+.+|+.+++.++|+||+++++++......++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 3699999999999965331 23457899987654322 234678999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 167 YEFMPKGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|||+.+|+|.+++..... ....+..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999999976432 224677888999999999999994 579999999999999999999999999987543
Q ss_pred CCCCcceeeccccccceeccccccc-------CCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
............++..|+|||++.. ..++.++|||||||++|+|++ |..||.......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------------- 217 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------------- 217 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------------
Confidence 3221111222345678999998743 356789999999999999999 788886542110
Q ss_pred hhhHhHhhhc---cc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 316 KRKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 316 ~~~~~~~~~~---~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+...+.. .. ....+...+..+.+++..|| .||++||++.+|++.|
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 218 --VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00011000 00 11223456778888999998 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=312.86 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=199.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||.|+||.||+|.+.. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 579999999999999999996543 578899999875432 2234677899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+. ++|.+++.+.. ..+++..+..++.|++.||.||| ..||+|+||||+|||++.++.++|+|||++.
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 99999999996 58988886543 34788999999999999999999 4579999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~~~~~~~~ 317 (421)
....... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.......... +.... .+......
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 153 AKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred ccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 6432221 12234578999999988654 47889999999999999999999997654321110 00000 00000000
Q ss_pred hH------hHhhhcccCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KL------FRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~------~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+ .......... .....++..+.+||.+||..||.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 0000000000 011245678899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=323.85 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=210.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH--HHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..|.+.+.||+|.|+.|.+|+... ++..||||.+++...... ..+.+|+++|+.|+|||||+++.+...
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 579999999999999999996544 688999999987655433 347899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
...+|+||||+.+|.+++++.+.+. +.+..+..++.|++.|++|||+ .+|||||||.+||||+.+.++||+|||++
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccc
Confidence 9999999999999999999988876 5668889999999999999995 46999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
..+..+. ...++||++.|.|||++.+..| ++.+|+||||++||.|+.|.+||++.......
T Consensus 203 ~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr--------------- 264 (596)
T KOG0586|consen 203 TFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR--------------- 264 (596)
T ss_pred eeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------
Confidence 9876433 4567999999999999999887 46899999999999999999999976431110
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.+..++ ..+.-++.++.++|+++|..+|.+|++++++.+
T Consensus 265 -~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 -PRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -chheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11122222 345567889999999999999999999999875
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=305.18 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=199.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.+|++.+.||+|+||.||+|.+.. +++.||||.+..... ...+.+.+|+.+++.+.|+||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 478999999999999999997543 578999998864321 123467789999999999999999998
Q ss_pred EEeC--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 157 CLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 157 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+.+. ...++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEEC
Confidence 8763 46789999999999999987654 37888899999999999999994 579999999999999999999999
Q ss_pred eccCcccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
|||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------------- 214 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------------- 214 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--------------
Confidence 99998764321111 112235688999999999888899999999999999999999999964321
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+..........+...+..+.++|.+||. +|.+||++++++.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 215 --MAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --HHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111111222233456777889999999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.46 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=198.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.+|...+.||+|+||.||+|.... ++..+++|.+..... .....+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 368999999999999999996543 578999998864422 122457789999999999999999998
Q ss_pred EEe--CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 157 CLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 157 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+.+ ....+++|||+.+++|.+++.... .+++...+.++.|++.||+||| ..+|+||||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEc
Confidence 875 357789999999999999997654 3788899999999999999999 5579999999999999999999999
Q ss_pred eccCcccCCCCCC-cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
|||++........ ........++..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------------- 214 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------------- 214 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------------
Confidence 9999875432111 1111235588999999999988899999999999999999999999975321
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+............+...+..+.+++ +||..+|++||++.+|+.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 --MAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --HHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111111122334556677888888 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.82 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=202.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||++.+.. +++.+|+|++..... ...+.+.+|+++++.+.||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 368999999999999999997654 478899999865432 23356788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+++..++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+ .|++|+||+|+|||++.++.+||+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999997664 48899999999999999999994 5899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ..
T Consensus 148 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~ 206 (290)
T cd05580 148 AKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------------QI 206 (290)
T ss_pred ccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 9875443 22356899999999998888999999999999999999999999754310 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
....... ....+...+..+.++|.+||..||.+|+ ++.+++.
T Consensus 207 ~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 YEKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0111111 1123445678899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.17 Aligned_cols=281 Identities=20% Similarity=0.268 Sum_probs=191.2
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCC------CCCCcE----EEEEEecCCCccCHHHHHHHHHHHhcCCC
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAK------PGSGMV----VAVKKLKPEGFQGHKEWLTEVNYLGQLHH 147 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~------~~~~~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~h 147 (421)
....++|++++.||+|+||+||++.++........ ...+.. ++.|.+... ......+.+|+.+|+.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCC
Confidence 34457899999999999999999876432110000 000011 111222111 1223457899999999999
Q ss_pred CCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 148 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
+||+++++++...+..|+||+++ +++|.+++.... ........+..++.||+.||.|||+ .||+||||||+|||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NIL 299 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIF 299 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence 99999999999999999999999 557887775432 1123355677899999999999994 57999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCc-cCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p-f~~~~~~~~~ 303 (421)
|+.++.+||+|||+++.+...... .....+||..|+|||++.+..++.++|||||||++|||++|..+ |.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999876443221 22346799999999999999999999999999999999998764 4322211111
Q ss_pred hhhhhh-------hhhhhchhhHhHhhhcccCC----CCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 304 SLVDWA-------KPYLSDKRKLFRIMDTKLGG----QYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 304 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+.... ..+......+...+...... ..+ ...+.++.++|.+||..||.+|||+.|++..
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 00001111111111111000 000 1234567888999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.76 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=201.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.|+..+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+++++.++|+||+++++++..++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence 46677889999999999996543 477899999875432 23356789999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.. ..+++..+..++.+++.||.||| ..|++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 99999999999999998854 34788999999999999999999 56899999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------------~~~ 211 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----------------VLF 211 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----------------HHh
Confidence 543221 1223568899999999998889999999999999999999999986432110 001
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+...........++..+.++|.+||..+|++||++.+++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111111122334567789999999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=304.86 Aligned_cols=257 Identities=28% Similarity=0.378 Sum_probs=205.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||.|+||+||+|.+.. ++..+++|++..... .....+.+|+++++.++|+||+++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 479999999999999999997543 477899999875432 2446788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++|||++.+++|.+++..... ..+++..+..++.|++.||+||| ..|++|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 999999999999999999976543 45899999999999999999999 557999999999999999999999999998
Q ss_pred ccCCCCCCcc--eeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 240 KAGPTGDRTH--VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
.......... ......|+..|+|||++... .++.++|+|||||++|+|++|..||....... ......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~------- 220 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL------- 220 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh-------
Confidence 7655433221 22345689999999998877 78899999999999999999999997543210 000000
Q ss_pred hhHhHhhhcccCCC-CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKLGGQ-YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......... ....++..+.+++.+||..||++||++.+++.
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 221 ----QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----cCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000001000 11356788999999999999999999999886
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=303.61 Aligned_cols=248 Identities=31% Similarity=0.478 Sum_probs=202.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
+|+..+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 57888999999999999997643 478899999865332 2335688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..+...+++|||+++++|.+++.+.. .+++..+..++.|++.||+||| ..|++|+||+|+||+++.++.+||+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCc
Confidence 99999999999999999999997654 4788999999999999999999 4579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
++....... ......|+..|++||.+.... ++.++|+|||||++|+|++|..||......
T Consensus 148 ~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---------------- 208 (258)
T cd06632 148 MAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---------------- 208 (258)
T ss_pred cceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----------------
Confidence 987654322 123466899999999987776 899999999999999999999999654310
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...............+..++..+.+++.+||..+|++||++.+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 209 AAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0011111111122334556788999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=309.25 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=192.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVY 167 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 167 (421)
+.||.|+||.||+|....... ........+++|.+........+.+.+|+.+++.+.||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999997643210 001124568888886554444567888999999999999999999999989999999
Q ss_pred EcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc--------EEEeeccCc
Q 014623 168 EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AKLSDFGLA 239 (421)
Q Consensus 168 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~kl~Dfg~a 239 (421)
||+.+|+|.+++..... .+++..++.++.|++.||+||| +.||+||||||+|||++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999999976543 5889999999999999999999 457999999999999987765 699999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCC-CccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
..... .....++..|+|||++.+. .++.++|||||||++|+|++|. .||.......
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------------- 213 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------------- 213 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH----------------
Confidence 75432 1235678899999998764 5889999999999999999984 5554322110
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
....... ....+.....++.+|+.+||+.||++|||+.++++.|
T Consensus 214 -~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 214 -KLQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -HHHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111111 1123344557889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.49 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=198.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
+..+...+||+|+|-+||+|.+. .+|..||.-.++.... ...++|..|+.+|+.|+|+|||++|+++
T Consensus 40 Ry~k~~evLGrGafKtVYka~De---------~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDE---------EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred ceeehhhhcccccceeeeecccc---------ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 44566789999999999999654 3577777655543222 3347899999999999999999999998
Q ss_pred EeCCe--EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEEEe
Q 014623 158 LEGEN--RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLS 234 (421)
Q Consensus 158 ~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~ 234 (421)
.+... +.+|+|.+..|+|..|+.+.+. ++...+..|+.||+.||.|||++...|||||||.+||||+.+ |.|||+
T Consensus 111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 111 VDTDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred ecCCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeec
Confidence 87655 7899999999999999988765 889999999999999999999999999999999999999765 889999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|+|||....... ....+|||.|||||++. ..|+..+||||||++|.||+|+..||..-..
T Consensus 189 DLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--------------- 248 (632)
T KOG0584|consen 189 DLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--------------- 248 (632)
T ss_pred chhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---------------
Confidence 999998765433 33478999999999886 8899999999999999999999999964221
Q ss_pred chhhHhHhhhcccCCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQ----KAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..++......+..|. --.+++.+||.+||.. ..+|+|+.|+|.
T Consensus 249 ----~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 249 ----PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 112222111122221 2246889999999999 899999999985
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=306.05 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=199.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc----------CHHHHHHHHHHHhcCCCCCccc
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ----------GHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
+|.+.+.||.|+||.||+|.... +|+.+|+|.++..... ..+.+.+|+.+++.++|+||++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 58889999999999999996543 5789999988642111 1235678999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
+++++...+..++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHS--KGILHRDLKADNLLVDADGICK 148 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh--CCeeecCCChhhEEEcCCCeEE
Confidence 9999999999999999999999999997653 48888999999999999999994 5799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCC--CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
|+|||++................|+..|+|||.+.... ++.++|+||||+++|+|++|..||......
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---------- 218 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---------- 218 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----------
Confidence 99999997654322111223356889999999987654 788999999999999999999999643211
Q ss_pred hhhhchhhHhHhhhcc----cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.......... ........++..+.++|.+||..+|++||++.+++..
T Consensus 219 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 219 ------AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ------HHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0001111111 1111223457899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.40 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=199.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.+.....||+|+||.||+|.+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 344455689999999999996543 47889999987665555667889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeeccCc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLA 239 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~a 239 (421)
..++||||+.+++|.+++.... ....++..+..++.|++.||+||| ..||+||||||+||+++. ++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999999997542 212277888899999999999999 457999999999999976 678999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC--CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
........ ......|+..|+|||++.+.. ++.++|+||||+++|+|++|..||........
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--------------- 219 (268)
T cd06624 157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--------------- 219 (268)
T ss_pred eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---------------
Confidence 76533221 122345789999999986644 78899999999999999999999964321100
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..............+..++.++.+++.+||..+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 220 AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000111111122345567788999999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=303.15 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=189.5
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|..... .....+++|.+..... ...+.+.+|+.+++.++||||+++++.+......++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 3599999999999865331 1244677887765432 3446788999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 167 YEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
|||+.+++|.+++.+.. ........++.++.|++.||+|||+ .+++||||||+|||++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 99999999999997542 2335667788899999999999994 5799999999999999999999999999864322
Q ss_pred CCCcceeeccccccceeccccccc-------CCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
..........+++..|+|||++.. ..++.++|||||||++|||++ |..||....... .....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~-------- 221 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHV-------- 221 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH--------
Confidence 222122234568899999998753 235779999999999999997 566775432110 00000
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
+................+..+.+++..|| .+|++||++.+|++.|.
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 --IKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred --HhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 00000000111223346678889999999 68999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.10 Aligned_cols=277 Identities=22% Similarity=0.272 Sum_probs=202.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
...|++...||+|+||.||+|...+.+ ....+.+|||.++.+.. .......+|+.+++.++||||+.+..+|.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n-----~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTN-----DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCC-----cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 457999999999999999999654421 12245799999986522 11245789999999999999999999988
Q ss_pred e-CCeEEEEEEcCCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC----Cc
Q 014623 159 E-GENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FN 230 (421)
Q Consensus 159 ~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~ 230 (421)
. +...+|++||.+. +|+..|+-.. ...++...+..++.||+.|+.|||+ +-|+||||||.||||..+ |.
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--NWvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--NWVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh--hheeeccCCcceEEEeccCCccCe
Confidence 7 7789999999976 9999885321 2458888999999999999999995 459999999999999877 89
Q ss_pred EEEeeccCcccCCCCCCcc-eeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchhh----
Q 014623 231 AKLSDFGLAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS---- 304 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---- 304 (421)
|||+|||+++.+.+.-... ....++-|.+|+|||++.|.. |+.+.||||+|||+.||+|-.+.|.+.+......
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999875433222 223466799999999998865 8999999999999999999999997655432221
Q ss_pred ------hhh-hh------hhhhhchh---hHhHhhhcccCCCC--------CHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 305 ------LVD-WA------KPYLSDKR---KLFRIMDTKLGGQY--------PQKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 305 ------~~~-~~------~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
+.. .. +|.+.... .....+........ ...-++...+|+.+||..||.+|.|+.+.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 110 00 11111100 01111111110000 01123347899999999999999999999
Q ss_pred HHHHH
Q 014623 361 LAILE 365 (421)
Q Consensus 361 l~~L~ 365 (421)
++..-
T Consensus 335 leh~y 339 (438)
T KOG0666|consen 335 LEHPY 339 (438)
T ss_pred hcccc
Confidence 97543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=303.66 Aligned_cols=255 Identities=24% Similarity=0.385 Sum_probs=202.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----------cCHHHHHHHHHHHhc-CCCCCcc
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----------QGHKEWLTEVNYLGQ-LHHPNLV 151 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hp~iv 151 (421)
.|.+.+.||+|+||.||+|.+... +++.+|+|.+..... ....++.+|+.++.+ ++|+||+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 478889999999999999976541 367899998753221 123456788888865 7899999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
++++++..++..++||||+++++|.+++.. .....+++..++.++.|++.+|.|||+ ..|++|+||+|+|||++.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCC
Confidence 999999999999999999999999998854 233458899999999999999999995 25799999999999999999
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
.++|+|||++....... ......|+..|++||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-------- 220 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-------- 220 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--------
Confidence 99999999998654332 2234568999999999998889999999999999999999999986532110
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
..................+..+.++|.+||..||++||++.++.+++.
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 --------LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 001111111111112245678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=311.80 Aligned_cols=264 Identities=22% Similarity=0.289 Sum_probs=188.5
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe--CCeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRL 164 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 164 (421)
+..||+|+||.||+|..... .++..+|+|.+..... ...+.+|+++++.++||||+++++++.. +...+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEE
Confidence 46899999999999975431 2467899999875432 3457789999999999999999998854 45789
Q ss_pred EEEEcCCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe----CCCCcEEE
Q 014623 165 LVYEFMPKGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKL 233 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~kl 233 (421)
+||||+. ++|.+++... ....+++..+..++.|++.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07867 77 LLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh--CCEEcCCCCHHHEEEccCCCCCCcEEE
Confidence 9999985 5888877432 12347888999999999999999994 579999999999999 56678999
Q ss_pred eeccCcccCCCCCCc-ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-------h
Q 014623 234 SDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------S 304 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~ 304 (421)
+|||+++........ .......||..|+|||++.+. .++.++|||||||++|||++|..||......... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07867 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ 233 (317)
T ss_pred eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence 999999865433211 112345789999999998764 5889999999999999999999999754322110 0
Q ss_pred hhhh----hhhhhhchhhH---------hHhhhccc---------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 305 LVDW----AKPYLSDKRKL---------FRIMDTKL---------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 305 ~~~~----~~~~~~~~~~~---------~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ..+...+.... ........ ...........+.+|+.+||..||.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 234 LDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred HHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000000000 00000000 00001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=310.03 Aligned_cols=260 Identities=27% Similarity=0.372 Sum_probs=200.5
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccce
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKL 153 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 153 (421)
+.+....++|++.+.||+|+||.||++.+.. +++.+|+|++.... .....+.+|+.+++.+ +|+||+++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeee
Confidence 3444566789999999999999999996643 47889999886532 2235677899999999 69999999
Q ss_pred eeEEE-----eCCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 154 IGYCL-----EGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 154 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
++++. .++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili~ 158 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV--NKTIHRDVKGNNILLT 158 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh--CCccccCCCHHhEEEC
Confidence 99874 345689999999999999988532 22457888999999999999999994 5799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccc
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 301 (421)
.++.++|+|||++........ ......|+..|+|||++.. ..++.++|||||||++|+|++|..||.......
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 159 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred CCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 999999999999876543221 1223568999999998753 457889999999999999999999986542100
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhc-ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDT-KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+...... ......+..++..+.+||.+||..||++||++.++++.+
T Consensus 237 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ----------------ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----------------HHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000000 001112233466799999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=302.60 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=204.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
+|.+.+.||.|+||.||++.+.. ++..+|+|.+..... ...+.+..|+++++.++|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 48889999999999999996543 578899999875433 233567889999999999999999998764
Q ss_pred -CCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhC---CCceeeccCCCCcEEeCCCCcEEE
Q 014623 160 -GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDA---ESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
+...+++|||+.+++|.+++... ....+++..++.++.+++.||.|||.. ..+++|+||||+||+++.++.+||
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 45679999999999999999653 234589999999999999999999943 347999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------------- 215 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------------- 215 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------------
Confidence 99999987654332 12345689999999999988899999999999999999999999976431
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+.+.+........+...+..+.+++.+||..+|++||++.+|++.
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 ---LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112222222233455677899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=310.67 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=199.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.|.....||.|+||.||++.... ++..||||.+........+.+.+|+.+++.++|+||+++++.+..++.
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 44556779999999999996543 478999999876544455678899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++||||+++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 99999999999999988432 37889999999999999999995 47999999999999999999999999998754
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|..||........ ...+...
T Consensus 169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------------~~~~~~~ 233 (292)
T cd06658 169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------------MRRIRDN 233 (292)
T ss_pred ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHhc
Confidence 32221 12335689999999999888899999999999999999999999975421100 0000000
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+.... ......+..+.+++.+||..||.+|||+.++++.
T Consensus 234 ~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 LPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111 1122456788999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=303.94 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=199.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||.|+||.||+|.+.. +++.+++|++..... ....+.+|+.+++.+ .|+||+++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIK 74 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEe
Confidence 4789999999999999999997643 477899999876543 345688999999999 69999999999876
Q ss_pred CC------eEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 GE------NRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 ~~------~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.. ..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~~l~p~ni~~~~~~~~ 152 (275)
T cd06608 75 KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE--NKVIHRDIKGQNILLTKNAEV 152 (275)
T ss_pred cCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEEccCCeE
Confidence 44 4899999999999999986533 3568999999999999999999994 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 306 (421)
+|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|..||......
T Consensus 153 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------ 224 (275)
T cd06608 153 KLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------ 224 (275)
T ss_pred EECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------
Confidence 999999987643322 12234568999999998754 34678999999999999999999999643211
Q ss_pred hhhhhhhhchhhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+...... ....+...+.++.+||.+||..||.+|||+.+++.
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 225 ----------RALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----------HHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01111111111 11122346778999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=351.20 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=210.9
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..-+|.-+..||.|.||.||.|.+. .+|+..|+|.++.... ...+.+.+|+.++..|+|||+|++||+-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~---------~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNL---------DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecC---------CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee
Confidence 3457888889999999999999544 4799999998875433 2335577899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..+|.||||++|+|.+++..... +++.....+..|++.|++||| +.|||||||||+||||+.+|.+|++|||
T Consensus 1304 vHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred ecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeeccc
Confidence 999999999999999999999965543 667777778899999999999 5589999999999999999999999999
Q ss_pred CcccCCCCCCc--ceeeccccccceecccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 238 LAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 238 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
.|..+.....+ .......||+.|||||++.+. ....+.|||||||++.||+||+.||...+
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-------------- 1445 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-------------- 1445 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--------------
Confidence 99876544211 112246799999999999764 45668999999999999999999997532
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
....+.-.+..+.....|..++.+-.++|.+||..||++|+++.|+++.
T Consensus 1446 --ne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1446 --NEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --chhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 3334444445555667788899999999999999999999999988864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.09 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=203.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||.|+||.||++.+.. +++.+++|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 367888999999999999997654 478899999876533 3345688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+++|||+.+++|.+++.... ..+++..+..++.|++.+|+|||+ ..|++|+||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 99999999999999999997653 458899999999999999999995 1589999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
...... .....++..|+|||++.+..++.++||||||+++|+|++|..||.......... . ....
T Consensus 150 ~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~----------~~~~ 214 (265)
T cd06605 150 QLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-F----------ELLQ 214 (265)
T ss_pred hhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-H----------HHHH
Confidence 543221 112668899999999999899999999999999999999999996542210000 0 0011
Q ss_pred HhhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... .....+.. ++.++.++|.+||..||++||++.+++.
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 215 YIVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 11122222 7788999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=309.92 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=201.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|.+.+.||+|+||.||++.... +++.|++|.+..... .....+.+|+++++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 368899999999999999996543 478899999875432 22346778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.++..++||||++|++|.+++.... .+++..+..++.+++.||.||| ..|++||||||+|||++.++.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCC
Confidence 9999999999999999999996654 4888999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCC-------------cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 239 AKAGPTGDR-------------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 239 a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
++....... ........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---- 223 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---- 223 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 864211100 001112457889999999988889999999999999999999999997543210
Q ss_pred hhhhhhhhhchhhHhHhhhcccC-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
........... ......++.++.++|.+||+.||++||+..++.+.|+.
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 ------------LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ------------HHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00011111100 01112467789999999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=306.28 Aligned_cols=266 Identities=26% Similarity=0.325 Sum_probs=199.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 468999999999999999997653 478999998864322 223557889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||++++.|..++.... .+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccc
Confidence 999999999999988877765433 48999999999999999999994 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh-hhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 317 (421)
........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+......... ............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 148 RILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred eecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87544321 1223457889999998876 4578899999999999999999999976442111100 000000000000
Q ss_pred hHh---Hhh----hcccCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLF---RIM----DTKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~---~~~----~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ... ....... .....+..+.+|+.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 000 0000000 01234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=308.33 Aligned_cols=265 Identities=23% Similarity=0.277 Sum_probs=196.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||+|.+.. +|+.+|+|.+...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 48889999999999999997654 5789999998754322 224567899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+ .|++||||||+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 99999999996 58888876543 348999999999999999999994 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh--hhhhhhh-hhhhch
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK-PYLSDK 316 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~-~~~~~~ 316 (421)
....... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||......... .+..... +.....
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 148 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred ccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 6543221 122345788999999887654 789999999999999999999886432211100 0000000 000000
Q ss_pred hhHhHhhhcccC---------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKLG---------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
............ ......++.++.++|.+||..||.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000 0112345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=300.70 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=191.5
Q ss_pred ceecccCceeEEEEEecCCCCCC-CCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSP-AKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
+.||+|+||.||+|.+....... ........+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999876532100 00122346788887655433 5678899999999999999999999888 778999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-------cEEEeeccCc
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-------NAKLSDFGLA 239 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-------~~kl~Dfg~a 239 (421)
|||+.+++|.+++.+... .+++..++.++.|++.||.||| ..||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999976542 5889999999999999999999 45799999999999999887 7999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC--CCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||..........
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------------ 217 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------------ 217 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH------------
Confidence 86433 1234567789999998876 78999999999999999999 577776542111000
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..... ...+......+.+++.+||..+|.+||++.++++.|
T Consensus 218 -----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 218 -----FYQDQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----HHhcC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000 011111227889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.17 Aligned_cols=267 Identities=25% Similarity=0.330 Sum_probs=201.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||.|+||.||+|.+.. +|+.||+|.+..... .....+.+|+.+++.++|+||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 58899999999999999997643 478899999876542 2245688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA--NGIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 9999999999 999999986544 458999999999999999999995 579999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhh-hhh------h
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAK------P 311 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~-~~~------~ 311 (421)
....... .......|+..|+|||++.+. .++.++|||||||++|+|++|..+|.......... ... ... +
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 148 LFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred cccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 7644322 112335689999999988654 46889999999999999999988886543211000 000 000 0
Q ss_pred hhhchhhHhHhhhcccC----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 312 YLSDKRKLFRIMDTKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+............. .......+..+.++|.+||..+|.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000000 00112446899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=309.63 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=200.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.|.....||+|+||.||+|.... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++.
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE 92 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe
Confidence 34556679999999999996543 478899999876554555678899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++||||+++++|.+++... .+++..++.++.|++.||.||| ..|++||||||+|||++.++.+||+|||++...
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 99999999999999877542 3789999999999999999999 457999999999999999999999999998754
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ . ..
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~---------------~~ 228 (297)
T cd06659 168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--M---------------KR 228 (297)
T ss_pred ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---------------HH
Confidence 33221 12346689999999999988899999999999999999999999975432100 0 00
Q ss_pred hhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 323 MDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 323 ~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+... .........+..+.++|.+||..+|.+||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0011123456788999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=307.59 Aligned_cols=267 Identities=27% Similarity=0.353 Sum_probs=201.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +++.|++|.++.... ...+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 368999999999999999996653 478999999875422 234678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.++.+..++.+. ..+++..++.++.+++.||.||| ..|++|+||+|+||+++.++.+||+|||++
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 99999999999886666555433 34889999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhh-hhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~~~ 317 (421)
........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||........... ............
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence 87654332 122346688999999999888 789999999999999999999999975432110000 000000000000
Q ss_pred hHh---------Hhhh----cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLF---------RIMD----TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~---------~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... +... ......++..++.++.+||.+||..+|++||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000 00001123345788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=307.28 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=203.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|.+.+.||.|+||.||++.... ++..+++|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 589999999999999999996543 46789999987655555567889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++.+. .+++..+..++.+++.||.||| ..|++|+||||+||+++.++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999998653 3788899999999999999999 55799999999999999999999999998875
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||......... ...
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~------------- 227 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLI------------- 227 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eeh-------------
Confidence 543222 122356889999999998888999999999999999999999999754321100 000
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..........+..++..+.++|.+||..+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111233466789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.75 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=195.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHH-HhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNY-LGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||++.+.. +|+.||+|.++.... .....+..|+.+ ++.++||||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 368899999999999999996543 589999999876432 223455666665 566789999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
++..++||||++ ++|.+++... ....+++..++.++.|++.||.|||+. .+++||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999995 6888887542 224589999999999999999999942 379999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceeccccccc----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
++....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.......
T Consensus 150 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------ 214 (283)
T cd06617 150 ISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF------------ 214 (283)
T ss_pred ccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH------------
Confidence 998653321 1223568889999998865 456889999999999999999999996432110
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+...............++.++.++|.+||..+|++||++.++++
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 215 ---QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111111112346788999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=303.46 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=203.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+|++.+.||.|+||.||+|.+.. ++..+|+|.+..... ...+.+.+|++++++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 48889999999999999997643 578899999975433 234678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++... ..+++..+..++.|+++||.||| ..|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 99999999999999999999765 35889999999999999999999 457999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... .+
T Consensus 148 ~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------------~~ 210 (258)
T cd05578 148 TKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD--------------QI 210 (258)
T ss_pred cccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH--------------HH
Confidence 8654332 123456888999999998888999999999999999999999999765421111 01
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM--SEVL 361 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~ell 361 (421)
...... .....+...+..+.++|.+||..||.+||++ .+++
T Consensus 211 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 RAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111111 2233455677899999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.76 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=201.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|.+.+.||+|+||.||+|.... +++.+++|.+...... ....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 58899999999999999996543 4788999998766543 456788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++|+||+.+++|.+++.... .+++..++.++.+++.||.||| ..|++|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccccccc
Confidence 99999999999999999997653 3788889999999999999999 4579999999999999999999999999988
Q ss_pred cCCCCCCcce--eeccccccceecccccccCC---CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 241 AGPTGDRTHV--STQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 241 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
.......... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~------------- 214 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ------------- 214 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-------------
Confidence 7543322111 11356788999999998766 88899999999999999999999975421100
Q ss_pred hhhHhHhhhcccCCCCCH--HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQ--KAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+........+. .++..+.++|.+||+.+|.+||++.+++.
T Consensus 215 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 215 ---IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000001111111222 34778899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=302.06 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=202.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
-|++.+.||.|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence 47888999999999999996543 478999999865432 23356788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++... .+++..+..++.+++.+|.||| ..|++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 999999999999999988543 4889999999999999999999 56899999999999999999999999999876
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ....
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------------~~~~ 211 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----------------KVLF 211 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----------------HHHH
Confidence 543221 122356888999999998888899999999999999999999999653211 0111
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+........+..++.++.+++.+||..+|.+||++.+++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111222344567889999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=299.19 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=207.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+|++.+.||.|++|.||+|.+.. +++.+++|++..... .....+.+|+.++..++|+||+++++++...+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG 72 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence 68899999999999999996654 578999999876644 33567889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++++|.+++... ..+++..++.++.|++.+|.|||+. .|++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 73 EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 999999999999999999765 3489999999999999999999941 6899999999999999999999999999986
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .....
T Consensus 150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~ 213 (264)
T cd06623 150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF--------------FELMQ 213 (264)
T ss_pred cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH--------------HHHHH
Confidence 5433222 1245688999999999988899999999999999999999999976532100 01111
Q ss_pred hhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+........+.. ++..+.++|.+||..+|++||++.++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111111223334 77899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.05 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=196.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.... +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 579999999999999999997543 4788999998754322 224567899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+ +|.+++.+... .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECcccccc
Confidence 999999999974 99998866543 5889999999999999999999 4579999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh--hhhhh-hhhhh--
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA-KPYLS-- 314 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~-~~~~~-- 314 (421)
....... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ..... .+...
T Consensus 152 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 152 AKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred ccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 5432211 1122356889999998875 458899999999999999999999996544211110 00000 00000
Q ss_pred -chhhHhHhhhcccCC-------CCCHHH--HHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 -DKRKLFRIMDTKLGG-------QYPQKA--AHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 -~~~~~~~~~~~~~~~-------~~~~~~--~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
............... ...... ..++.+++.+||..+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 000112 267889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.90 Aligned_cols=265 Identities=27% Similarity=0.330 Sum_probs=199.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-----CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-----GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
+|.+.+.||+|+||.||+|.+.. +++.||||.+...... ....+..|+++++.++|+||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 47888999999999999997654 4789999999765433 234567899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..++||||+ +++|.+++.... ..+++..++.++.||++||.|||+ .|++|+||||+|||++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS--NWILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCChhhEEEcCCCCEEEccce
Confidence 9999999999999 899999996654 358999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~~~~ 314 (421)
++......... .....++..|+|||++.+ ..++.++|||||||++|+|++|..+|......... ..... ..+...
T Consensus 148 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 148 LARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchh
Confidence 99875443211 223456788999998865 45788999999999999999998877654321100 00000 000000
Q ss_pred ch---hhHhHhhhcccC-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DK---RKLFRIMDTKLG-----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~---~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.. ............ .......+..+.++|.+||..||++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00 000000000000 0011345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.76 Aligned_cols=266 Identities=26% Similarity=0.335 Sum_probs=199.0
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||.|+||.||+|.+.. ++..||||.+...... ....+.+|+++++.++||||+++++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 48889999999999999997543 5789999998754322 235678999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+. ++|.+++.......+++..+..++.|++.||+||| ..|++|+||+|+||+++.++.+||+|||++.
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 99999999995 68999887665566899999999999999999999 4579999999999999999999999999987
Q ss_pred cCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhh----h
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYL----S 314 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~----~ 314 (421)
....... ......++..|+|||++.+.. ++.++|||||||++|+|+||+.||......... .......... .
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 6543221 122345788999999887654 688999999999999999999999754321100 0000000000 0
Q ss_pred chhhHh---HhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLF---RIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~---~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+. ........ ......++.++.++|.+||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 00000000 0011235677889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=299.72 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=203.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|.+.+.||+|+||.||++.+.. +|..+|+|.+..... ...+.+.+|+++++.++|+||+++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 47889999999999999997654 477899999875432 2345678999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-EEEeeccCc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLA 239 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-~kl~Dfg~a 239 (421)
...++||||+.+++|.+++.+.....+++..+..++.+++.||.|||+ .+++|+||||+||++++++. +||+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 999999999999999999977655568999999999999999999994 57999999999999988864 699999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~ 211 (257)
T cd08225 150 RQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----------------QLV 211 (257)
T ss_pred hhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------------HHH
Confidence 76543221 122346889999999998888999999999999999999999999653211 001
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...... .........+..+.++|.+||..+|++||++.+++..
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhcc-cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111 1112234556789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=296.76 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=207.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||.|+||.||++.+.. ++..+++|.+..... .....+.+|+++++.++|+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 58889999999999999997653 478899999976544 3446688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
...++||||+++++|.+++.... ...+++..++.++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~--~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--RKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHHeEEcCCCcEEECCccc
Confidence 99999999999999999997653 3568999999999999999999994 5899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----------------~ 210 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----------------E 210 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----------------H
Confidence 98754432 1233457899999999998888999999999999999999999999654311 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+............+..++..+.+++.+||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 211 LALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111111122334466788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=302.31 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=200.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.|...+.||+|++|.||++.+.. ++..+++|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 45667899999999999997543 478899999875544455668899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++|+||+.+++|.+++.. ..+++..++.++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 9999999999999999866 248889999999999999999994 57999999999999999999999999988754
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||......... ..+...
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-------------~~~~~~ 230 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-------------KRIRDN 230 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-------------HHHHhc
Confidence 33221 123356899999999998888999999999999999999999998653211000 000000
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. ......+..++..+.+++.+||..+|++||++.++++
T Consensus 231 ~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 L--PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred C--CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 0001112236678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=303.97 Aligned_cols=241 Identities=30% Similarity=0.441 Sum_probs=204.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
.+|.++.+||+|+||.|.+| ...++.+.+|||+++++..... +--+.|-++|... +-|.+++++.+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred cccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 57889999999999999999 5556789999999987644222 2235677888766 478999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..-+.+|+||||+.||+|.-.|+..+. +.+..+..++..|+-||-+|| .+|||+||||.+||+|+.+|++||+|||
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeecc
Confidence 999999999999999999999987765 777888899999999999999 5689999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++.-..+. ....++|||+.|+|||++....|+.++|.||+||+||||+.|+.||++.+. .
T Consensus 496 mcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-----------------~ 556 (683)
T KOG0696|consen 496 MCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----------------D 556 (683)
T ss_pred cccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-----------------H
Confidence 998644333 235679999999999999999999999999999999999999999998643 2
Q ss_pred hHh-HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 014623 318 KLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356 (421)
Q Consensus 318 ~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 356 (421)
.++ .+++.. -.+|..++.++.+++...|...|.+|..
T Consensus 557 elF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 ELFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 222 223332 2578899999999999999999999963
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.03 Aligned_cols=258 Identities=30% Similarity=0.395 Sum_probs=200.0
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccce
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKL 153 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~ 153 (421)
..+....++|.+.+.||+|+||.||++.... +++.+|+|++.... .....+.+|+.+++.+ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~ 84 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF 84 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence 3344456789999999999999999996543 57899999986532 2235667899999998 79999999
Q ss_pred eeEEEeC-----CeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 154 IGYCLEG-----ENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 154 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
++++... ...++||||+.+++|.+++... ....+++..++.++.|++.||.||| ..|++|+||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~ 162 (291)
T cd06639 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEc
Confidence 9998754 3589999999999999988542 2345889999999999999999999 45899999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-----CCCccccchhhhHHHHHHHhCCCccCCCcccc
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 301 (421)
.++.+||+|||++......... .....|+..|+|||++... .++.++|||||||++|+|++|+.||......
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~- 239 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV- 239 (291)
T ss_pred CCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-
Confidence 9999999999998865432211 2235688999999987643 3678999999999999999999999754211
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+....... .....+......+.++|.+||..+|++||++.+++.
T Consensus 240 ---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 240 ---------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ---------------HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0011110000 011123345668999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=291.97 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=207.1
Q ss_pred CHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCcc
Q 014623 73 TFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLV 151 (421)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv 151 (421)
+|.++-..+ .+.||+|+|+.|-.+... .+|..+|||++.+.......++.+|++++..++ |+||+
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i---------~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nil 139 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSI---------QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNIL 139 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeee---------ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHH
Confidence 455544433 378999999999887543 368899999999887777889999999999995 99999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN- 230 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~- 230 (421)
+++++|+++..+|||||.+.||+|...|.++.. +++..+.++..+|+.||.||| .+||.||||||+|||......
T Consensus 140 qLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 140 QLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKV 215 (463)
T ss_pred HHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCc
Confidence 999999999999999999999999999987654 899999999999999999999 568999999999999966544
Q ss_pred --EEEeeccCcccCCCCCC-----cceeeccccccceecccccc---c--CCCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 231 --AKLSDFGLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVA---T--GRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 231 --~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
+|||||.+..-...... +....+.+|+..|||||++. + ..|+.+.|.||||+|||-|++|..||.+.-
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 89999998754322211 11223578999999999763 2 358999999999999999999999997643
Q ss_pred ccchhhhhhhh--hhhhhchhhHhHhhhcc-c--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 299 VGIEQSLVDWA--KPYLSDKRKLFRIMDTK-L--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 299 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .-|. .+...-...+++-+..+ + .......++.++.+||..+|..|+.+|.++.+++.
T Consensus 296 g~d----CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 296 GAD----CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCc----CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 210 0011 11111112222222222 1 12223588999999999999999999999988876
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=300.89 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=198.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC---CCCccceeeEEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH---HPNLVKLIGYCL 158 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~ 158 (421)
.|++.+.||.|+||.||+|.+.. +++.+|+|.+..... .....+.+|+.+++.+. ||||+++++++.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 47888999999999999997643 478999999875432 33456788999999886 999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.+...++||||+.+++|.+++... .+++..++.++.+++.+|.||| ..||+|+||+|+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 147 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGV 147 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCc
Confidence 999999999999999999988543 4889999999999999999999 55899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+........ ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||.........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------------- 211 (277)
T cd06917 148 AALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------------- 211 (277)
T ss_pred eeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--------------
Confidence 987654331 12335689999999988654 4788999999999999999999999754321100
Q ss_pred hHhHhhhcccCCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQ-KAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+........+. ..+.++.+++.+||..||++||++.+++.
T Consensus 212 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 212 ---MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---hccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000000011111 25678999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=305.65 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=199.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 368899999999999999997653 4788999987654322 23567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++.... .+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCcEEEEeeeee
Confidence 999999999999988888765443 38999999999999999999995 57999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 317 (421)
........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ..............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 148 RTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred eeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH
Confidence 76543321 2233568899999998875 44788999999999999999999999654321100 00000000000000
Q ss_pred hHh---Hhhhcc----cC-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLF---RIMDTK----LG-----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~---~~~~~~----~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ...... .. ......++..+.+|+.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 000000 00 0011345778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=301.41 Aligned_cols=245 Identities=30% Similarity=0.436 Sum_probs=195.5
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||+|+||+||++.+.. +|+.+|+|.+..... .....+.+|+++++.++||||+++++++...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 6999999999996543 478999999865332 2234567899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+++++|.+++.+.....+++..++.++.|++.||.||| ..|++||||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence 99999999999997766556899999999999999999999 4579999999999999999999999999987654321
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
......++..|+|||++.+..++.++|||||||++|+|++|+.||......... ..+.+.. ..
T Consensus 150 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~-~~ 212 (277)
T cd05577 150 ---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------------EELKRRT-LE 212 (277)
T ss_pred ---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------------HHHHhcc-cc
Confidence 122345788999999998888999999999999999999999999754321100 0011100 01
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
.....+...+..+.++|.+||+.||.+|| ++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 12223445688899999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=293.11 Aligned_cols=248 Identities=31% Similarity=0.473 Sum_probs=204.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
+|.+.+.||+|++|.||++.+.. ++..+++|++........+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 47888999999999999997653 478899999987655456778899999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.+++|||+.+++|.+++.... ..+++..+..++.+++.+|.+||. .|++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 999999999999999986653 458999999999999999999994 68999999999999999999999999999876
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... .....++..|++||++.+..++.++|+||||+++|+|++|..||...... ......
T Consensus 149 ~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~ 209 (253)
T cd05122 149 SDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----------------KALFKI 209 (253)
T ss_pred ccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----------------HHHHHH
Confidence 54331 23466889999999998888999999999999999999999999754210 000000
Q ss_pred hhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 323 MDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 323 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.. ...... ...++..+.++|.+||..||++|||+.+++.
T Consensus 210 ~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 210 AT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred Hh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 111111 1223678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.10 Aligned_cols=243 Identities=27% Similarity=0.377 Sum_probs=188.9
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHH---hcCCCCCccceeeEEEeCCe
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYL---GQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l---~~l~hp~iv~~~~~~~~~~~ 162 (421)
.||+|+||.||++.+.. +++.+|+|.+...... ....+.+|..++ ....|+||+.+++++..++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 48999999999997643 5789999998654322 122334454433 33479999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++...
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 999999999999999987654 48999999999999999999995 57999999999999999999999999998754
Q ss_pred CCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
.... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||......... .+ .
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------------~~-~ 208 (279)
T cd05633 148 SKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EI-D 208 (279)
T ss_pred cccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--------------HH-H
Confidence 3322 123568999999998864 56899999999999999999999999754321110 00 0
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
..........+..++.++.++|.+||..||.+|| ++.++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 209 RMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0111122234556788999999999999999999 58887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=301.70 Aligned_cols=267 Identities=24% Similarity=0.297 Sum_probs=196.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.... ++..+|+|.+....... ...+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 3679999999999999999996543 47889999987543322 2456789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+. ++|.+++.... ..+.+..+..++.|++.||.|||+ .||+|+||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 150 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLA 150 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEEcCCCcEEEeccccc
Confidence 999999999995 68877775443 347788888999999999999994 57999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh---hhhhhc
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA---KPYLSD 315 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---~~~~~~ 315 (421)
+....... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.............+. .+....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 151 RAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred cccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 75432221 12234578999999988764 5788999999999999999999999765432111100000 000000
Q ss_pred hhhHh---HhhhcccCCCCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLF---RIMDTKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~---~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... ...........+ ...+..+.+++.+||..||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 000000000000 012567889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=296.20 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=201.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-----ccCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.+|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ......+.+|+++++.++|+||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 479999999999999999996543 57899999875321 1223567889999999999999999998
Q ss_pred EEeC--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 157 CLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 157 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+.+. ...+++|||+++++|.+++..... +++..+..++.|++.||.||| ..|++|+||||+||+++.++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEC
Confidence 8764 468899999999999999976543 788889999999999999999 5579999999999999999999999
Q ss_pred eccCcccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
|||+++........ .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------- 214 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------------- 214 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------------
Confidence 99999865321110 111235688999999999988899999999999999999999999965321
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+.+..........+...+..+.+++.+||. ++..||++.+++.
T Consensus 215 --~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 --MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222222223344567788999999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=294.71 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=207.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|++|.||+|.+.. +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 47888999999999999997653 478999999876543 3356788999999999999999999999988
Q ss_pred --CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 --ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
...++||||+.+++|.+++.... .+++..++.++.+++.+|+|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccccc
Confidence 88999999999999999997665 58999999999999999999995 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+................++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------------~~~ 212 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---------------MAA 212 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---------------HHH
Confidence 98765443211123456889999999998888999999999999999999999999765310 011
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.............+...+..+.++|.+||..||++||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111112223445566889999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=299.38 Aligned_cols=253 Identities=27% Similarity=0.389 Sum_probs=205.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..+.|.+.+.||.|+||.||+|.+.. ++..+++|++..... ....+.+|+++++.++|+||+++++++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 34678889999999999999997653 467899999976543 45678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.... ..+++..++.++.+++.||.||| ..|++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 999999999999999999997764 35899999999999999999999 468999999999999999999999999988
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|++||++.+..++.++|+|||||++|+|++|..||....... ..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----------------~~ 225 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----------------AL 225 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----------------HH
Confidence 75433221 1223457889999999988889999999999999999999999986532110 00
Q ss_pred hHhhhcccC-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 320 FRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 320 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
......... ......++..+.++|.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111111 11122367789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=302.44 Aligned_cols=248 Identities=30% Similarity=0.420 Sum_probs=197.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.|.+.+.||+|+||.||+|.... +++.||+|.+...... ..+.+.+|+++++.++||||+++++++.
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 569999999999999999997643 4789999998644322 2346789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEECCCCCEEEeecCc
Confidence 9999999999996 57777775433 358999999999999999999994 5799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+...... ....++..|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------------- 221 (307)
T cd06607 162 ASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------------- 221 (307)
T ss_pred ceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--------------
Confidence 8764322 2356788999999874 4568889999999999999999999986543211
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
....+.........+..++..+.++|.+||..+|++||++.+++...
T Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 222 --ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00111111111112234677899999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=300.13 Aligned_cols=256 Identities=28% Similarity=0.362 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|+..+.||.|++|.||++.+.. +++.+|+|.+..... .....+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 367888999999999999997653 478899999875433 2345688999999999999999999988653
Q ss_pred --CeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 161 --ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+..++||||+++++|.+++.. .....++...+..++.|++.||+||| ..|++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 468999999999999988754 22345788999999999999999999 457999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc--chhhhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG--IEQSLVDWAKPYLS 314 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~ 314 (421)
|++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+...
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 222 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--- 222 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---
Confidence 9987543222 12355788999999999899999999999999999999999999765321 00011111000
Q ss_pred chhhHhHhhhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+.... ....+..+.+++.+||..+|.+|||+.|++.
T Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 223 -------MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -------CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000001 1235678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=296.31 Aligned_cols=243 Identities=27% Similarity=0.360 Sum_probs=198.3
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||.|+||.||++.+.. +++.+|+|++..... ...+.+.+|+++++.++|+||+++++++.+++..++|
T Consensus 1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 7999999999997653 478999999875432 2335688999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~ 147 (262)
T cd05572 72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147 (262)
T ss_pred EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence 99999999999997654 38889999999999999999994 579999999999999999999999999998764432
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ...........
T Consensus 148 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~ 210 (262)
T cd05572 148 ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGN 210 (262)
T ss_pred ---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccC
Confidence 1233568899999999988889999999999999999999999997653210 01111112112
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
.....+...+..+.++|.+||..+|++||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233445556889999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=336.68 Aligned_cols=258 Identities=24% Similarity=0.276 Sum_probs=211.7
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCcc
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLV 151 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv 151 (421)
.+++...++|.++++||+|+||.|.+++.++ +++.+|+|++.+... ....-|..|-.+|..-+.+=|+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence 3444556799999999999999999997655 689999999987433 2334577788999988899999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.++-.|.+.+++||||||++||+|..++.+.. .+++..+..++..|+.||..||+ .|+|||||||+|||||..|++
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~--mgyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS--MGYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh--ccceeccCCcceeEecccCcE
Confidence 99999999999999999999999999997776 58999999999999999999995 489999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccc----c-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA----T-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 306 (421)
||+|||.|-.+..+. .......+|||.|.+||++. + +.|+..+|+|||||++|||++|..||.....
T Consensus 215 kLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------- 286 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------- 286 (1317)
T ss_pred eeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-------
Confidence 999999998766433 33455678999999999985 3 5699999999999999999999999965321
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPR---MSEVLAI 363 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~ 363 (421)
.....++++..-...+| ..++.++.+||.+.+. +|+.|.. +.++...
T Consensus 287 ---------veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 287 ---------VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ---------HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22333444443333444 5789999999999885 5888887 8777653
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=309.14 Aligned_cols=264 Identities=23% Similarity=0.306 Sum_probs=197.7
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 45789999999999999999996553 57899999986432 22335677899999999999999999988
Q ss_pred EeC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
... ...|+||||+. ++|.+.+... ++...+..++.|++.||+|||+ .||+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nil~~~~~~~ 157 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTL 157 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCE
Confidence 643 35799999995 5888887533 7888899999999999999994 589999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhh-hh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVD-WA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~-~~ 309 (421)
||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.... ..+.. ..
T Consensus 158 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 234 (353)
T cd07850 158 KILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234 (353)
T ss_pred EEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999986543221 2335678999999999999999999999999999999999999975432110 00000 00
Q ss_pred hhh---hhchh-hHhHhhh---------------ccc----CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPY---LSDKR-KLFRIMD---------------TKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~---~~~~~-~~~~~~~---------------~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+. ..... ....... ... ........+..+.++|.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00000 0000000 000 00012245677899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=301.78 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=199.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||.|+||.||+|.+.. +++.+++|.++..... ....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 468999999999999999997653 4788999998754322 22356789999999999999999999887
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
. +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.++|+|||
T Consensus 76 ~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 76 SNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD--NWILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred cCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCcEEEeecC
Confidence 7 88999999996 49999886644 358999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh-hhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~-~~~~~~~ 314 (421)
++........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||......... .... +..+...
T Consensus 152 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (293)
T cd07843 152 LAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229 (293)
T ss_pred ceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchH
Confidence 9986544321 122345788999999887644 688999999999999999999999754321110 0000 0000000
Q ss_pred chh-----------hHhHhhhcccCCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKR-----------KLFRIMDTKLGGQYPQK-AAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~-----------~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .........+...++.. ++..+.++|.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 230 IWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 00000001111122222 5778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=318.04 Aligned_cols=201 Identities=31% Similarity=0.454 Sum_probs=171.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
-|...+.||+|+||.||+|+. ..+|+.||||.+..... ...+++.+|+++|++|+|+|||+++++-+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrn---------ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRN---------KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKF 84 (732)
T ss_pred ceeehhhhcCCccceeeeecc---------cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccc
Confidence 356678899999999999954 44799999999987543 45577899999999999999999999755433
Q ss_pred ------eEEEEEEcCCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe--CCCC--c
Q 014623 162 ------NRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEF--N 230 (421)
Q Consensus 162 ------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~--~ 230 (421)
...+|||||.||+|...+.+- +...+++...+.++.+++.||.||| ++|||||||||+||++ .++| .
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceE
Confidence 457999999999999999653 2356999999999999999999999 6789999999999998 3334 3
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCC
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
.||+|||.|+..+.+. ...+++||..|.+||++.. +.|+..+|.|||||++|+.+||..||...
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 7999999999877655 4567999999999999985 78999999999999999999999999643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=300.87 Aligned_cols=267 Identities=23% Similarity=0.276 Sum_probs=195.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCC-CCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLH-HPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ....+.+|+.+++.+. |+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 368999999999999999997654 5789999988654322 2356788999999995 699999999988
Q ss_pred eCCe-----EEEEEEcCCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CC
Q 014623 159 EGEN-----RLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EF 229 (421)
Q Consensus 159 ~~~~-----~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~ 229 (421)
..+. .|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCC
Confidence 7665 8999999975 8988886543 2358999999999999999999994 57999999999999998 88
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD 307 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~ 307 (421)
.+||+|||++......... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... .+..
T Consensus 149 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999999998765332111 122356889999998865 45789999999999999999999999764321110 0000
Q ss_pred hh-hhhh---hchhhHhHhhhc-ccC----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 WA-KPYL---SDKRKLFRIMDT-KLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~~-~~~~---~~~~~~~~~~~~-~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.. .+.. ............ ... ....+.++..+.++|.+||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 000000000000 000 0011246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.94 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=199.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..|...+.||+|+||.||++.+.. ++..+|+|.+...... ....+.+|+++++.++|+|++++++++.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 347888999999999999997643 4789999998754322 2346788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.++..++||||+. |+|.+++.... ..+++..+..++.+++.||.||| ..||+||||+|+||+++.++.++|+|||+
T Consensus 96 ~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 96 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred eCCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCC
Confidence 9999999999996 47877775432 45899999999999999999999 55799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+...... ....|+..|+|||++. .+.++.++|||||||++|+|++|..||......
T Consensus 172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------------- 230 (317)
T cd06635 172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 230 (317)
T ss_pred ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---------------
Confidence 8754321 2356889999999874 456888999999999999999999998653210
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...................+..+.+++.+||+.+|.+||++.+++..+..+
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 231 -SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 111111111111122345677899999999999999999999999866543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.21 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=195.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 160 (421)
+|...+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+.++.++. |+||+++++++...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence 46667889999999999997653 578999999875432 23456788999999996 99999999999999
Q ss_pred CeEEEEEEcCCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 161 ENRLLVYEFMPKGSLENHL---FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+++|||+. ++|.++. .......+++..+..++.+++.||+|||+ ..+++||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg 153 (288)
T cd06616 76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFG 153 (288)
T ss_pred CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecc
Confidence 99999999985 4665543 23333568999999999999999999995 2479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
++........ .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .
T Consensus 154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~------------ 217 (288)
T cd06616 154 ISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-F------------ 217 (288)
T ss_pred hhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-H------------
Confidence 9976433221 1234688999999998776 6899999999999999999999999754210 0
Q ss_pred chhhHhHhhh---cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 315 DKRKLFRIMD---TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 315 ~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+.+... ..+.......++.++.+||.+||..+|++||++.+|+..
T Consensus 218 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 218 --DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --HHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111110 111112223467889999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=291.37 Aligned_cols=248 Identities=31% Similarity=0.520 Sum_probs=204.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|.+.+.||+|++|.||++.... +++.+++|.+..... .....+.+|++++++++|+|++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 48889999999999999996543 477899999987654 3445788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+++|||+.+++|.+++... ..+++..++.++.|++.+|.||| ..||+||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEeccccce
Confidence 9999999999999999999765 34899999999999999999999 4589999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
........ .....++..|+|||.+.+..++.++|||+||+++|+|++|..||...... ....
T Consensus 148 ~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----------------~~~~ 209 (254)
T cd06627 148 KLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----------------AALF 209 (254)
T ss_pred ecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----------------HHHH
Confidence 76543321 23356889999999988888899999999999999999999999653210 0001
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .......+..++..+.+++.+||..+|++||++.+++.
T Consensus 210 ~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 210 RIV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 11222344566789999999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=301.09 Aligned_cols=262 Identities=16% Similarity=0.157 Sum_probs=187.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH-----------HHHHHHHHHHhcCCCCC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-----------KEWLTEVNYLGQLHHPN 149 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp~ 149 (421)
.++|++.+.||+|+||.||+|.+.... ..+..+|+|+......... .....+...+..+.|+|
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDH------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCc------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 468999999999999999999765421 1145667776443221111 11223445566778999
Q ss_pred ccceeeEEEeCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 150 LVKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 150 iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
|+++++++.... ..+++|+++ ..++.+.+.... ..++..+..++.|++.||.|||+ .+|+||||||+|||+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill 159 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMV 159 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE
Confidence 999998766543 346788887 447777665432 25678889999999999999994 579999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
+.++.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999865322211 1112356999999999999999999999999999999999999999765321
Q ss_pred chhhhhhhhhhhhhchhhH-hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 301 IEQSLVDWAKPYLSDKRKL-FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
...... ..... .++..... ....++..+.+++..||..+|++||++.++++.|
T Consensus 240 ~~~~~~--------~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 GNLIHA--------AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHHH--------hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110000 00000 11111111 1234568899999999999999999999999876
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=300.47 Aligned_cols=267 Identities=22% Similarity=0.283 Sum_probs=197.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|++|.||+|.+.. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 468999999999999999996543 578899999865432 223567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeeccC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~ 238 (421)
....++||||+. ++|.+++.......+++..+..++.||+.||+|||+ +|++|+||+|+||+++. ++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEccccc
Confidence 999999999995 588888866555557888889999999999999994 57999999999999985 55799999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh-hhhhhh--
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WAKPYL-- 313 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~-~~~~~~-- 313 (421)
+........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||......... .... ...+..
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 976433211 12234678899999988664 5788999999999999999999999754321100 0000 000000
Q ss_pred -hchhhHhHh--hhcccCCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 -SDKRKLFRI--MDTKLGGQ----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 -~~~~~~~~~--~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+... ........ .....+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 00000000 11345678899999999999999999999985
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=303.79 Aligned_cols=270 Identities=23% Similarity=0.303 Sum_probs=197.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+|++.+.||+|+||.||+|.+... ..+..||+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 488899999999999999976531 247899999998633 2333567889999999999999999999998
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC----CCc
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRG---PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA----EFN 230 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~ 230 (421)
. ...++||||+.+ +|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEEcCCCCccce
Confidence 8 789999999964 7777774322 2358899999999999999999994 57999999999999999 899
Q ss_pred EEEeeccCcccCCCCCC-cceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-----
Q 014623 231 AKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ----- 303 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----- 303 (421)
+||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999986543322 1122335678999999988764 5889999999999999999999999765432200
Q ss_pred --h---hhhhh-hhhhh------chhhHhHhhhcccCCCCC-----------HHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 304 --S---LVDWA-KPYLS------DKRKLFRIMDTKLGGQYP-----------QKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 304 --~---~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
. +.... .+... ................++ ...+..+.+++.+||..||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0 00000 00000 000000000000000111 1345678999999999999999999998
Q ss_pred HH
Q 014623 361 LA 362 (421)
Q Consensus 361 l~ 362 (421)
+.
T Consensus 311 l~ 312 (316)
T cd07842 311 LE 312 (316)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=298.88 Aligned_cols=265 Identities=25% Similarity=0.305 Sum_probs=198.8
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|++.+.||.|++|.||+|.+.. +|..||+|++...... ....+.+|+++++.++|+||+++++++.+.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 6788999999999999997653 4789999998754322 2356788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..+++|||+. ++|.+++.......+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~--~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 9999999994 699999977654568999999999999999999995 5799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhhc----
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD---- 315 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~---- 315 (421)
....... .....++..|+|||++.+. .++.++||||||+++|+|++|..||......... ............
T Consensus 149 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 149 FGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 4332211 1223568899999988664 5788999999999999999999999754321100 000000000000
Q ss_pred ---hhhHhHhhhc---ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 ---KRKLFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ---~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......... ..........+..+.++|.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0000112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=302.48 Aligned_cols=266 Identities=26% Similarity=0.315 Sum_probs=196.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||+|.++...... ...+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG 77 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence 579999999999999999997653 57899999987543221 2345689999999999999999999876
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
. +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 78 KHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred CCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCCEEECccc
Confidence 5 56899999996 58988886543 458999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhhc
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD 315 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~ 315 (421)
++........ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .+..........
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 9987543321 1222345788999998865 45789999999999999999999999754322111 111100000000
Q ss_pred hhhHhHhhh----cccCC-C------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMD----TKLGG-Q------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~----~~~~~-~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
......... ..... . .....+..+.++|.+||..||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 00000 0 00124678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.43 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=204.0
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||+|+||.||++.... +++.+++|.+..... .....+.+|+++++.++|+||+++++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 48889999999999999996543 578899999875432 2335677899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
...++||||+++++|.+++.+.. ...+++..++.++.+++.||+||| ..|++|+||+|+||+++.++.+||+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 99999999999999999986622 245888999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...... .
T Consensus 150 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----------------~ 208 (256)
T cd08530 150 SKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----------------D 208 (256)
T ss_pred hhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------H
Confidence 9875443 122356788999999999888999999999999999999999999754321 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+............+...+.++.+++.+||..+|++||++.+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 209 LRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111222222344567888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=295.11 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=188.9
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHH---HHHhcCCCCCccceeeEEEeCCe
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEV---NYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.||+|+||.||+|.... +++.||+|.+....... ...+..|. +.++...||||+.+++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 48999999999996543 57899999987543221 12233343 34455679999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++||||+.|++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 999999999999999886543 48999999999999999999995 57999999999999999999999999998754
Q ss_pred CCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
.... .....|+..|+|||++.++ .++.++|||||||++|+|++|..||......... ....
T Consensus 148 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--------------~~~~ 209 (278)
T cd05606 148 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDR 209 (278)
T ss_pred CccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--------------HHHH
Confidence 3322 2235789999999998754 6899999999999999999999999764321110 0001
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
.. .......+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 210 ~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 210 MT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred Hh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 10 1111233445678999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=303.98 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=193.0
Q ss_pred ceeccc--CceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEG--GFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 163 (421)
..||+| +||+||++.+.. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 456666 999999996543 5889999998754322 235678899999999999999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+++|.+++.+.....+++..+..++.|++.||+||| ..||+||||||+|||++.++.++++||+.+....
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 99999999999999998765556899999999999999999999 4579999999999999999999999998654321
Q ss_pred CCCCc-ce----eeccccccceecccccccC--CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh--
Q 014623 244 TGDRT-HV----STQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS-- 314 (421)
Q Consensus 244 ~~~~~-~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-- 314 (421)
..... .. .....++..|+|||++.+. .++.++|||||||++|+|++|..||................++..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 11100 00 0012345679999998764 478899999999999999999999976432111000000000000
Q ss_pred -----chhh-----------------Hh-----HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 -----DKRK-----------------LF-----RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 -----~~~~-----------------~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... .. ..............++..+.+|+.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 00 000001111223457789999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=296.61 Aligned_cols=266 Identities=26% Similarity=0.358 Sum_probs=199.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+|++.+.||.|++|.||+|.+.. +|..||||.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 48889999999999999997643 5789999998765332 3456778999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .|++||||||+||++++++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 99999999975 8988886543 2458999999999999999999995 479999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhhh-hhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDW-AKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~-~~~~~~~~~ 317 (421)
....... ......++..|++||++.+. .++.++|||||||++|+|++|..||.+...... ...... ..+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence 6433211 12234578899999988664 578899999999999999999999976542111 001110 001000000
Q ss_pred hHhH--hhhccc-------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFR--IMDTKL-------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~--~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.. ...... .....+..+..+.+++.+||+.||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 000000 00111345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=306.04 Aligned_cols=268 Identities=26% Similarity=0.333 Sum_probs=196.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +|..||+|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 4689999999999999999996643 578999999864322 233567889999999999999999998764
Q ss_pred C-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 G-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
. ...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~--~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 75 PSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEC
Confidence 4 35799999995 588877743 348999999999999999999994 579999999999999999999999
Q ss_pred eccCcccCCCCCC-cceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-h
Q 014623 235 DFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-K 310 (421)
Q Consensus 235 Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~-~ 310 (421)
|||++........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ...... .
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~ 228 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999876433221 111223568999999998755 46889999999999999999999999754321100 000000 0
Q ss_pred hhhhchhh--------HhHhhhcccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PYLSDKRK--------LFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+...+... ............ ..+..+.++.++|.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000000000 012346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=294.87 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=196.4
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||.|+||.||++.+.. +|+.+++|.+..... .....+.+|+++++.++|+||+++++.+..+...|++
T Consensus 1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999997653 478999999876544 3345678899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.+.. .+++..++.++.|++.||.||| ..|++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~ 147 (265)
T cd05579 72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR 147 (265)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence 99999999999997654 4899999999999999999999 5589999999999999999999999999987644332
Q ss_pred C------cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 247 R------THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 247 ~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
. ........++..|++||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~ 211 (265)
T cd05579 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------IFQ 211 (265)
T ss_pred ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 1 112234567889999999988889999999999999999999999997543110 000
Q ss_pred HhhhcccCCCCCHH--HHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQK--AAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 321 ~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
....... ..+.. .+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 212 NILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111111 12222 3788999999999999999999965555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.00 Aligned_cols=259 Identities=25% Similarity=0.292 Sum_probs=193.1
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCccceeeEEEeC-
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG- 160 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~- 160 (421)
|++.+.||+|+||.||+|.... ++..+|+|.++.... .......+|+.+++++. |+||+++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 6788999999999999997643 478899999875422 22234457889998885 99999999999987
Q ss_pred -CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 -ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .|++||||+|+||+++. +.+||+|||++
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEecccc
Confidence 88999999996 58888886543 358999999999999999999994 57999999999999999 99999999999
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 317 (421)
........ .....++..|+|||++.. +.++.++|||||||++|+|++|..||...+.... .......... ..
T Consensus 147 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~---~~ 220 (282)
T cd07831 147 RGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP---DA 220 (282)
T ss_pred cccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCC---CH
Confidence 86543221 123567899999997654 5578899999999999999999999976542110 0000000000 00
Q ss_pred hHhHhhhcc--cCCC-----------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTK--LGGQ-----------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~--~~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.+..... .... ....++..+.++|.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 0000 01245789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=298.31 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=197.6
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
.....||+|+||.||++.... ++..||+|.+..........+.+|+.+++.++|+||+++++++..++..+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 334679999999999996654 57899999986554445567889999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+||||+++++|.+++... .+++..+..++.|++.+|+|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~--~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 94 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 999999999999987433 37889999999999999999995 5799999999999999999999999999875433
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......... ..+.....
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~-------------~~~~~~~~ 233 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-------------KMIRDNLP 233 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHhhCC
Confidence 221 123356889999999998888999999999999999999999999754221000 00000000
Q ss_pred cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 325 TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 325 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .....++..+.+++.+||..+|.+||++.+++.
T Consensus 234 ~~~--~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 234 PKL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccc--CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 000 112345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=306.11 Aligned_cols=273 Identities=27% Similarity=0.382 Sum_probs=200.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcC-CCCCccceeeE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQL-HHPNLVKLIGY 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 156 (421)
..++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... ......+.+|+.+++.+ +|+||++++++
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45689999999999999999997643 47889999885432 22335577899999999 99999999998
Q ss_pred EEeC--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 157 CLEG--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 157 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+... ...++||||+. ++|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 76 IKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEe
Confidence 8653 46899999996 5999888654 47888899999999999999994 579999999999999999999999
Q ss_pred eccCcccCCCCCCc---ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh
Q 014623 235 DFGLAKAGPTGDRT---HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA 309 (421)
Q Consensus 235 Dfg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~ 309 (421)
|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999865433221 12234568999999998765 457889999999999999999999997543211100 00000
Q ss_pred hh-hhhc--------hhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 014623 310 KP-YLSD--------KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI--LERL 367 (421)
Q Consensus 310 ~~-~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~~ 367 (421)
.. ...+ .......+..... ......++.++.++|.+||+.||++||++.+++.. +..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00 0000 0000000000000 01112357789999999999999999999999963 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=264.31 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=202.5
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.|.-.+.||+|.||+||+|+..+ +++.||+|.++.++.+ .-...++|+.+|+.|+|.|||+++++...+
T Consensus 3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 46667889999999999996554 6899999998765332 235678999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+.+.+|+||| ..+|..+...-+ ..++.+.+..++.|++.||.++|++ ++.||||||+|.||+.+|++||+|||+++
T Consensus 74 kkltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 74 KKLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred ceeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999 558988887654 3489999999999999999999965 59999999999999999999999999999
Q ss_pred cCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHh-CCCccCCCcccchhhhh--hhhhhhhhch
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV--DWAKPYLSDK 316 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~--~~~~~~~~~~ 316 (421)
.++-.-. .....+-|.+|.+|.++.|.. |+...|+||-|||+.|+.. |++.|.+.+....-..+ ....+..++.
T Consensus 150 afgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 8754332 233456699999999998764 8999999999999999987 77778776553322111 1111111111
Q ss_pred hhHhHhhhcccCCCCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYP---------QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.++-+-.....++ +.....-++|+.++|.-+|.+|.++++.++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1121211111111111 344556678999999999999999988765
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=306.88 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=199.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||.|+||.||+|.... ++..||+|.+..... .....+.+|+.+|+.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 3689999999999999999996554 578999999875422 33456778999999999999999999876
Q ss_pred e----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 159 E----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 159 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
. ....++||||+. ++|.+++.... .+++..+..++.|++.||.||| ..||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEec
Confidence 3 356899999995 68998886544 3899999999999999999999 4579999999999999999999999
Q ss_pred eccCcccCCCCCCc--ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-h-hh
Q 014623 235 DFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D-WA 309 (421)
Q Consensus 235 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~-~~ 309 (421)
|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............ . ..
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 99999764332211 11224578999999998865 45889999999999999999999999765432111000 0 00
Q ss_pred hhhh---hc--hhhHhHhhhc-ccCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYL---SD--KRKLFRIMDT-KLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~---~~--~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+.. .. ...+...... ..... .....+.++.++|.+||+.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000 00 0000010000 00001 113457889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=291.91 Aligned_cols=249 Identities=23% Similarity=0.269 Sum_probs=194.0
Q ss_pred HHHHHhcCCCCCcee--cccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccc
Q 014623 76 ELKTATRNFRPDSLL--GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVK 152 (421)
Q Consensus 76 ~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~ 152 (421)
+.....++|.+.+.+ |.|+||.||++.... ++..+|+|.+........ |+.....+ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~ 73 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIK 73 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEE
Confidence 334445677777776 999999999996543 578899999875433221 22222222 6999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cE
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NA 231 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~ 231 (421)
+++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .|++||||||+||+++.++ .+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred EEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEeCCCCeE
Confidence 9999999999999999999999999997654 58999999999999999999994 5799999999999999988 99
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
+|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-------- 215 (267)
T PHA03390 150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-------- 215 (267)
T ss_pred EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--------
Confidence 99999998765322 1245789999999999989999999999999999999999999744321100
Q ss_pred hhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 014623 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLA 362 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~ 362 (421)
...+.... ..........+..+.++|.+||+.+|.+|++ ++++++
T Consensus 216 ----~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 ----LESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----HHHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00111111 1111233467889999999999999999995 688874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=306.35 Aligned_cols=270 Identities=26% Similarity=0.339 Sum_probs=200.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||+||+|.... ++..||||.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~ 74 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence 4579999999999999999996543 58899999987532 223456778999999999999999999876
Q ss_pred eC-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
.. ...++||||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 75 PPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHS--ANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEE
Confidence 54 34799999995 68998886543 48999999999999999999994 57999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKP 311 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~ 311 (421)
+|||++....... .......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...... .......
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999998654322 11234567899999998765 468899999999999999999999997653211100 0000000
Q ss_pred -------hhhchhhHhHhh---hcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 014623 312 -------YLSDKRKLFRIM---DTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI--LERL 367 (421)
Q Consensus 312 -------~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~--L~~~ 367 (421)
+..+ ......+ ...... .....++..+.++|.+||+.+|.+||++.+++.. +..+
T Consensus 228 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 228 PSEEDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CChHHhhhcCc-hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 0000000 000000 0113467889999999999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=292.16 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=188.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHH-hcCCCCCccceeeEEEeCCeE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYL-GQLHHPNLVKLIGYCLEGENR 163 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~~ 163 (421)
+.||.|+||.||+|.... +++.||+|.+....... ...+..|..++ ..++|+||+++++++..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 579999999999996543 47899999987543222 12334454444 445899999999999999999
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
++||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 99999999999999997654 47889999999999999999995 579999999999999999999999999987543
Q ss_pred CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ .....
T Consensus 149 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~ 206 (260)
T cd05611 149 E------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV----------------FDNIL 206 (260)
T ss_pred c------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHH
Confidence 2 2235688999999999888899999999999999999999999975432110 00000
Q ss_pred hc--ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 324 DT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 324 ~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.. .........++..+.+++.+||..+|++||++.++.+.|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred hcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11 111122235678899999999999999999775554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=305.65 Aligned_cols=245 Identities=26% Similarity=0.333 Sum_probs=202.5
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEeCCeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 164 (421)
.++||.|.||+||-|. +.++|+.||||++.+..+.. ...+.+|+.||+.+.||.||.+...|+..+..+
T Consensus 569 devLGSGQFG~VYgg~---------hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGK---------HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HhhccCCcceeeecce---------ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 4789999999999985 44579999999998776643 356778999999999999999999999999999
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC---CcEEEeeccCccc
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKA 241 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~Dfg~a~~ 241 (421)
+|||.+ .|++.++|.......+++.....++.||+.||.||| ..+|+|+||||+|||+... -.+||||||+|+.
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 999999 557777776666667999999999999999999999 4579999999999999654 3599999999998
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
+.... ...+.+||+.|.|||+++.+.|+..-|+||.|||+|--+.|..||...+.-.++ .+
T Consensus 717 IgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ----------------IQ 777 (888)
T KOG4236|consen 717 IGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ----------------IQ 777 (888)
T ss_pred cchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH----------------hh
Confidence 76543 345689999999999999999999999999999999999999999764321111 11
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...--+......+++.++.+||..+|+..-.+|.++...+.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11111122233578889999999999999999999887664
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=296.51 Aligned_cols=259 Identities=26% Similarity=0.332 Sum_probs=201.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
+|++.+.||+|+||.||++.... ...+++.+|||.++.... ...+.+.+|++++..+ +|+||+++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 47888999999999999987542 223578899999874322 2234577899999999 599999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..+...++||||+.+++|.+++.... .+++..+..++.|++.+|.|||+ .|++||||+|+||+++.++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECc
Confidence 99999999999999999999986543 48888999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCC--CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+++........ ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------------- 216 (288)
T cd05583 151 LSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS------------- 216 (288)
T ss_pred ccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-------------
Confidence 98765433211 122356889999999987665 78899999999999999999999964321100
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
...+.+.+.. .....+..++..+.+++.+||..||++|||+.++.+.|+.
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 217 QSEISRRILK-SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHc-cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0011111111 1123345567789999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=296.35 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=204.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCC-CCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLH-HPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 157 (421)
++|.+.+.||.|+||.||+|.+.. ++..+++|++..... .....+.+|+.+++.+. |+||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 368999999999999999997653 578999999875322 22356788999999998 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCc
Confidence 99999999999999999999997664 48999999999999999999994 579999999999999999999999999
Q ss_pred CcccCCCCCCc------------------ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcc
Q 014623 238 LAKAGPTGDRT------------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299 (421)
Q Consensus 238 ~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 299 (421)
++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 98765432211 122335678999999999888899999999999999999999999976431
Q ss_pred cchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 014623 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM----SEVLA 362 (421)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~ 362 (421)
. ....... ......+..++..+.++|.+||..+|.+||++ .+++.
T Consensus 228 ~----------------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 Y----------------LTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H----------------HHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0011111 12223445668889999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=294.50 Aligned_cols=255 Identities=27% Similarity=0.338 Sum_probs=198.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
.|++.+.||.|+||.||++.... ...+|..||+|++..... ...+.+.+|+++++.+ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 47889999999999999997542 123578999999875322 2235677899999999 599999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..+...++||||+++++|.+++.... .+.+..+..++.|++.||.||| ..|++||||+|+|||++.++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence 99999999999999999999997654 4788899999999999999999 5589999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC--CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... .
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------------~ 216 (290)
T cd05613 151 LSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-------------S 216 (290)
T ss_pred cceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-------------c
Confidence 99765432211 12245689999999988753 46789999999999999999999996432110 0
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
...+...+.. ....++..++..+.+++.+||..||++|| ++.+++.
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 217 QAEISRRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111111111 11223455678899999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=297.06 Aligned_cols=269 Identities=25% Similarity=0.304 Sum_probs=194.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.... +++.||||.+...... ....+.+|+++++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3579999999999999999996543 5789999988644322 2234568999999999999999999887
Q ss_pred eCC--------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 EGE--------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
... ..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR--NKILHRDMKAANILITKDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEECCCCc
Confidence 543 4599999995 58888875543 358999999999999999999994 57999999999999999999
Q ss_pred EEEeeccCcccCCCCCCc--ceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
+||+|||++......... .......++..|+|||++.+.. ++.++||||||+++|+|++|..||.............
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999765432211 1122345788999999886654 7889999999999999999999997654321111110
Q ss_pred h-hh----hhhhchhhHhHhhhcccCCCC---------CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 W-AK----PYLSDKRKLFRIMDTKLGGQY---------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~-~~----~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .. ............-........ ....+..+.+||.+||..||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0 00 000000000000000000000 0112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=294.67 Aligned_cols=271 Identities=27% Similarity=0.411 Sum_probs=206.0
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~~~ 160 (421)
...+.++||+|.||.||+|.+. ++.||||++... ....|.+|-.|.+. ++|+||++++++-...
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 4567788999999999999775 478999999743 44567777777665 5799999999987655
Q ss_pred C----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-------CCCceeeccCCCCcEEeCCCC
Q 014623 161 E----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD-------AESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 161 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-------~~~~ivHrDlkp~Nill~~~~ 229 (421)
. .++||++|.+.|+|.+||..+- ++|....+++..+++||+|||. .+.+|+|||||..||||..|+
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 5 7899999999999999997665 8999999999999999999995 245799999999999999999
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCC-CC-----ccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LT-----TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
++.|+|||+|..+..+.........+||.+|||||++.+.. +. .+.||||+|.+||||++....++.......+
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq 433 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ 433 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence 99999999999887655544445588999999999987643 22 2689999999999999977655422221111
Q ss_pred hhhh---hhhhhhhchhhHhHhhhcccCCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCCC
Q 014623 304 SLVD---WAKPYLSDKRKLFRIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKN 372 (421)
Q Consensus 304 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~~ 372 (421)
.-++ ...|.+++.+. -.+..+.+..++. ....-+.+.+..||+.|++.|.|+.=+.+++.++.....
T Consensus 434 lpfe~evG~hPt~e~mq~--~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 434 LPFEAEVGNHPTLEEMQE--LVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CchhHHhcCCCCHHHHHH--HHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111 01111211111 1122333333332 345578899999999999999999999999988866543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.83 Aligned_cols=272 Identities=22% Similarity=0.273 Sum_probs=205.6
Q ss_pred HHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC--CC---
Q 014623 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH--HP--- 148 (421)
Q Consensus 74 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp--- 148 (421)
+........+|.+.+.+|+|+||.|-.+++.. ++..||||+++.-. .-.+..+-|+++|.++. .|
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~ 150 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGK 150 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCc
Confidence 33444557899999999999999999997664 37899999987432 22345677999999994 23
Q ss_pred -CccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 149 -NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 149 -~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
-+|.+.+||...++.|||+|.+ |-+++++|..++-.+++...+..+..|++++++|||+ .+++|.||||+|||+..
T Consensus 151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~--~kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD--LKLTHTDLKPENILFVS 227 (415)
T ss_pred eEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh--cceeecCCChheEEEec
Confidence 3788889999999999999998 7799999999888889999999999999999999994 57999999999999932
Q ss_pred --------------------CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHH
Q 014623 228 --------------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLEL 287 (421)
Q Consensus 228 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 287 (421)
+..|+|+|||.|+...... ...+.|..|.|||++++-.++..+||||+||||+||
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 2358999999998744332 457789999999999999999999999999999999
Q ss_pred HhCCCccCCCcccchhhhhh-hhhhhhh---chhhHhHhhhcc------------------------cCCCCCHHHHHHH
Q 014623 288 LSGRCAVDKTKVGIEQSLVD-WAKPYLS---DKRKLFRIMDTK------------------------LGGQYPQKAAHTA 339 (421)
Q Consensus 288 ~tg~~pf~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~------------------------~~~~~~~~~~~~l 339 (421)
++|...|...+....-.+.+ ...|... ....-.+..... ............+
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 99999997655321111111 1111100 000000000000 0001123456679
Q ss_pred HHHHHhccccCCCCCCCHHHHHHH
Q 014623 340 ATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 340 ~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+||++||..||.+|+|+.|++..
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999999853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.58 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=205.8
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccC------HHHHHHHHHHHhcCCCCCc
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQG------HKEWLTEVNYLGQLHHPNL 150 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~------~~~~~~E~~~l~~l~hp~i 150 (421)
....++|-++.+||+|||+.||+|++.. ..+.||+|+-..+. +.+ .+...+|.+|.+.|.||.|
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI 529 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI 529 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee
Confidence 3445678899999999999999996543 47899999865332 111 2346799999999999999
Q ss_pred cceeeEEE-eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC---
Q 014623 151 VKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--- 226 (421)
Q Consensus 151 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--- 226 (421)
|++|++|. +.+.+|-|+|||+|.+|..||..... +++..+..|+.||+.||.||......|||-||||.||||.
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 99999987 55678999999999999999976643 8999999999999999999998888899999999999994
Q ss_pred CCCcEEEeeccCcccCCCCCCcc-----eeeccccccceecccccccC----CCCccccchhhhHHHHHHHhCCCccCCC
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVATG----RLTTKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
..|.+||+|||+++.++...... ....+.||.||++||++.-+ .++.++||||+|||+|..+.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 45789999999999876554432 33457799999999987533 4788999999999999999999999865
Q ss_pred cccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.+. . ....+... ........+.++.++.++|++||+..-++|..+.++..
T Consensus 688 qsQQdI--L--------qeNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 688 QSQQDI--L--------QENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhHHHH--H--------hhhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 332110 0 01111111 11122334678899999999999999999998887754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.47 Aligned_cols=246 Identities=31% Similarity=0.437 Sum_probs=194.9
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.|...+.||+|+||+||+|.+.. +++.+++|.+...... ....+.+|+++++.++|+|++++++++.+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 37778889999999999996543 5789999998754332 22457889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..|+||||+. ++|.+++.... ..+++..++.++.|++.+|.||| ..|++|+||+|+||+++.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 999999999995 58888775433 45899999999999999999999 457999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
..... .....|+..|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------------- 227 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------- 227 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---------------
Confidence 64322 12356889999999874 4568889999999999999999999986543210
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..................+..+.+|+.+||+.+|.+||++.+++..
T Consensus 228 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 228 -ALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111111223455678999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=300.47 Aligned_cols=267 Identities=25% Similarity=0.319 Sum_probs=195.4
Q ss_pred cCCC-CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--------------HHHHHHHHHHHhcCC
Q 014623 82 RNFR-PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--------------HKEWLTEVNYLGQLH 146 (421)
Q Consensus 82 ~~y~-~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~ 146 (421)
++|. +.+.||.|+||+||+|.+.. +++.||||.+....... ...+.+|+++++.++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 78 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence 4665 46789999999999997543 47899999986543221 124678999999999
Q ss_pred CCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 147 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
|+||+++++++...+..++||||+. ++|.+++.... .+++.....++.|++.||.||| ..|++|+||+|+|||++
T Consensus 79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~ 153 (335)
T PTZ00024 79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFIN 153 (335)
T ss_pred CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEEC
Confidence 9999999999999999999999996 69999886543 3889999999999999999999 45799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCC------------CcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCc
Q 014623 227 AEFNAKLSDFGLAKAGPTGD------------RTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCA 293 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p 293 (421)
.++.++|+|||++....... .........++..|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999997654111 00111223568899999988764 468899999999999999999999
Q ss_pred cCCCcccchh-hhhhhhh-hhh---hchhhHhHh--hhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 294 VDKTKVGIEQ-SLVDWAK-PYL---SDKRKLFRI--MDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 294 f~~~~~~~~~-~~~~~~~-~~~---~~~~~~~~~--~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
|......... .+..... +.. ......... ...... .......+..+.++|.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 9765421110 0111000 000 000000000 000000 0011234678899999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=295.67 Aligned_cols=269 Identities=25% Similarity=0.294 Sum_probs=196.8
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+.. +++.||+|.++.... .....+.+|+++++.++||||+++++++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~ 75 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV 75 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehee
Confidence 45689999999999999999997653 478899999875432 2234567899999999999999999988
Q ss_pred EeCC----------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 158 LEGE----------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 158 ~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
.+.. ..++||||+.+ +|.+++... ...+++..+..++.|++.||+||| ..||+|+||||+||+++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~ 151 (302)
T cd07864 76 TDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNN 151 (302)
T ss_pred cCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECC
Confidence 7654 78999999975 777777554 335899999999999999999999 558999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-h
Q 014623 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-L 305 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~ 305 (421)
++.+||+|||++......... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.......... +
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~ 230 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI 230 (302)
T ss_pred CCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 999999999999865443321 11223467889999988654 57889999999999999999999997543211100 0
Q ss_pred hhhh-hhhhhchhhHhHh-----hhc-----ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 306 VDWA-KPYLSDKRKLFRI-----MDT-----KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 306 ~~~~-~~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... .+.......+... ... .........++..+.+++.+||..||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000000000 000 0000011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=295.81 Aligned_cols=249 Identities=29% Similarity=0.403 Sum_probs=196.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.|...+.||+|+||.||+|.+.. ++..+++|.+..... ....++.+|+++++.++|+|++++++++.
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 357778899999999999997643 478899999864322 22346778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.....++||||+. ++|.+++.... ..+++..+..++.+++.||.||| ..+++||||+|+|||++.++.++|+|||+
T Consensus 86 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 86 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCccc
Confidence 9999999999996 58887775433 34889999999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------------- 220 (308)
T cd06634 162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 220 (308)
T ss_pred ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---------------
Confidence 8764321 2356888999999874 356788999999999999999999998653210
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
...................+..+.+||.+||..+|.+||++.+++....
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 221 -SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011111111111123456778999999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=292.81 Aligned_cols=264 Identities=28% Similarity=0.340 Sum_probs=199.8
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|.+.+.||.|++|.||++.... +++.+++|.+...... ....+.+|+++++.++|+||+++++++..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 6778999999999999996543 5788999998765433 3456788999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+ +|.+++.... ..+++..++.++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS--HGILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH--CCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 99999999965 8888886643 458999999999999999999994 5799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhh-hh-hhhhhhhchhh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VD-WAKPYLSDKRK 318 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~-~~~~~~~~~~~ 318 (421)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... .. ...+.......
T Consensus 148 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 148 FGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred cCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 644321 12234578899999998776 788999999999999999999999966442111000 00 00000000000
Q ss_pred HhH---hhhcccC-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFR---IMDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~---~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ....... ......++.++.++|.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 0000000 0112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=307.35 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=210.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.+++.+..||-||||.|-++..+.. ...+|+|++++...-+ .+.+..|-++|..++.|.||++|..|.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 3566677899999999999876542 2258899888765433 345678999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+....||+||-|-||.|+..|..++. ++..++..++..+++|++|||+ .|||+|||||+|++++.+|-+||.|||+
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhh
Confidence 99999999999999999999977765 8888889999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+.+..+..+. ++|||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.+. ...
T Consensus 567 AKki~~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp----------------mkt 627 (732)
T KOG0614|consen 567 AKKIGSGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP----------------MKT 627 (732)
T ss_pred HHHhccCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch----------------HHH
Confidence 99988776543 59999999999999999999999999999999999999999987643 111
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~ 363 (421)
...++...-...+|..++..+.+||++++..+|.+|.. +.+|...
T Consensus 628 Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 628 YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 22222222334577888999999999999999999975 5666554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=284.30 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcC-CCCCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQL-HHPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l-~hp~iv~~~~~ 156 (421)
.++|+++++||+|+|++|.+++.. ++.+.+|+|+++++-+... .-...|-.+.... +||.+|.+..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~---------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLK---------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccceeeeeecCcchhhhhheehc---------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 368999999999999999998544 4678999999987644332 3345677777766 69999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
|..+..+++|.||++||+|.-.++++.. ++++.+..+...|+.||.||| .+|||+||||.+|+||+..|++||+|+
T Consensus 320 fqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdy 395 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDY 395 (593)
T ss_pred hcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeeccc
Confidence 9999999999999999999888866543 899999999999999999999 678999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+++..... .....++|||+.|.|||++++..|+..+|.|+|||+++||+.|+.||+--..+. +.....
T Consensus 396 gmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n---------~d~nte 464 (593)
T KOG0695|consen 396 GMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTE 464 (593)
T ss_pred chhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchh
Confidence 999864332 234567999999999999999999999999999999999999999997433211 111122
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 356 (421)
.-+++++..+ ....|..++-.+..+++..|++||.+|..
T Consensus 465 dylfqvilek-qiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 465 DYLFQVILEK-QIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHHHhhh-cccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 2233333222 23456677778889999999999999953
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.20 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=188.6
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.-..+|+.+++||+||||.||+++++- +|+.+|||++.... ......+.+|++.|.+|+|||||++|..+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW 546 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW 546 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence 334578888999999999999997654 58999999997654 22335678999999999999999976422
Q ss_pred Ee-----------------------------------------------------------------C------------
Q 014623 158 LE-----------------------------------------------------------------G------------ 160 (421)
Q Consensus 158 ~~-----------------------------------------------------------------~------------ 160 (421)
.+ +
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 10 0
Q ss_pred ------------------------------------------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 014623 161 ------------------------------------------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198 (421)
Q Consensus 161 ------------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 198 (421)
..+||-||||+..+|.+++.++... -.....|+++.+
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFre 705 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFRE 705 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHH
Confidence 0136889999987777777665531 146788999999
Q ss_pred HHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC----------------CCCCcceeeccccccceec
Q 014623 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP----------------TGDRTHVSTQVMGTHGYAA 262 (421)
Q Consensus 199 i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~a 262 (421)
|++||+|+| +.|||||||||.||||++++.|||+|||+|+... .+......+..+||.-|+|
T Consensus 706 IlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 706 ILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999 5579999999999999999999999999998611 0111113456789999999
Q ss_pred ccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCC--CCHHHHH
Q 014623 263 PEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAH 337 (421)
Q Consensus 263 PE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 337 (421)
||++.+. .|+.|+|+||||+||+||+. ||.... +....+..+-...+... +....-.
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~~~~~~ 845 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFFDPEHP 845 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccccccch
Confidence 9999765 49999999999999999984 465321 11111111111111111 2233444
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 014623 338 TAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 338 ~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.-..+|++||+.||.+|||+.|+|.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5678999999999999999999984
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.53 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=194.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLH-HPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 159 (421)
++|++.+.||.|+||.||+|.+.. ++..+|||.++..... ....+.+|+.++..+. |+||+++++++..
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 578999999999999999997654 4788999999754322 3345667877776664 9999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+ +++|.+++.... ..+++..+..++.+++.||+|||+. .||+||||+|+||+++.++.+||+|||++
T Consensus 86 ~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~ 162 (296)
T cd06618 86 DSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGIS 162 (296)
T ss_pred CCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccc
Confidence 99999999998 457877775533 3689999999999999999999952 47999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC----CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
........ .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 225 (296)
T cd06618 163 GRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-------------- 225 (296)
T ss_pred hhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--------------
Confidence 76533221 12245788999999987554 7889999999999999999999996532110
Q ss_pred hhhHhHhhhcccC-CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 316 KRKLFRIMDTKLG-GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 316 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
......+..... ......++.++.+|+.+||..||.+||++.+++..
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 -EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111111100 01112356789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.99 Aligned_cols=267 Identities=21% Similarity=0.234 Sum_probs=194.5
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|.+++.+|.|+++.||++. .+++.||||++.... ....+.+.+|+++++.++|+||+++++++...+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 72 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHK-----------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72 (314)
T ss_pred hhhhHhhcCCceEEEEEec-----------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC
Confidence 3455556666665555542 257899999987652 234467889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||.+..
T Consensus 73 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~--~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 73 ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCcceEEEecCCceEEecCcccee
Confidence 99999999999999999987655568899999999999999999994 5799999999999999999999999998865
Q ss_pred CCCCCC-----cceeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhh-
Q 014623 242 GPTGDR-----THVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPY- 312 (421)
Q Consensus 242 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~- 312 (421)
...... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 432111 011123456788999999876 358899999999999999999999997543211100 00000000
Q ss_pred hh------chhhH--------hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LS------DKRKL--------FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~------~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.. ..... ................+.++.+|+.+||..||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00000 00000011112334667889999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=291.24 Aligned_cols=265 Identities=26% Similarity=0.353 Sum_probs=197.4
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC-
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG- 160 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 160 (421)
|.+.+.||.|+||.||+|.+.. +++.+|+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 6778999999999999997654 47899999998653 22335678899999999999999999999887
Q ss_pred -CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 -ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccce
Confidence 889999999964 8988886543 358999999999999999999994 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhhhch
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~-~~~~~~ 316 (421)
......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ....... +.....
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 148 RPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226 (287)
T ss_pred eeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhc
Confidence 876543211 1223456888999998765 45789999999999999999999999765421110 0000000 000000
Q ss_pred h---hH--hHhhh------cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 R---KL--FRIMD------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~---~~--~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .+ ..... ..+.......++..+.+++.+||..+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00 00000 00000011113778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=289.67 Aligned_cols=264 Identities=26% Similarity=0.325 Sum_probs=195.7
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcC---CCCCccceeeEEE
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQL---HHPNLVKLIGYCL 158 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l---~hp~iv~~~~~~~ 158 (421)
|++.+.||+|+||.||+|.+.. ++..+|+|.++...... ...+.+|+.+++.+ +|+||+++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 6788999999999999997653 47899999997543221 23455677776655 5999999999998
Q ss_pred eCCe-----EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EGEN-----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
..+. .+++|||+. ++|.+++.......+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||
T Consensus 72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~--~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS--HRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhEEEccCCCEEE
Confidence 8776 899999996 489998876554568999999999999999999995 57999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KP 311 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~~ 311 (421)
+|||++........ .....++..|+|||++.+..++.++|+|||||++|+|++|..||.......... ..... .+
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC
Confidence 99999977543321 123457889999999999899999999999999999999999997644221100 00000 00
Q ss_pred h----hhchhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 Y----LSDKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 ~----~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. ................ .......+..+.++|.+||+.||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000000000 1112355788899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.31 Aligned_cols=273 Identities=26% Similarity=0.339 Sum_probs=204.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+|++.+.||.|+||.||+|.... +++.+|||.+.... ....+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 58899999999999999997543 47899999987643 23446788999999999999999999998876
Q ss_pred C-----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 161 E-----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 161 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
. ..|+||||+. ++|.+++.+.. .+++..++.++.+++.||+|||+ .||+||||||+|||++.++.++|+|
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~--~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEcc
Confidence 5 7899999996 58988886544 58999999999999999999994 5799999999999999999999999
Q ss_pred ccCcccCCCCCCc-ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hh
Q 014623 236 FGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KP 311 (421)
Q Consensus 236 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~-~~ 311 (421)
||++......... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||......... .+.... .+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 9999875443210 112335678999999999887 7899999999999999999999999765421110 000000 00
Q ss_pred hhh-----chhhHhHhhhc-ccC-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhhcC
Q 014623 312 YLS-----DKRKLFRIMDT-KLG-----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEA 369 (421)
Q Consensus 312 ~~~-----~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~~~ 369 (421)
... ........+.. ... .......+..+.++|.+||+.+|.+||++.+++. .++.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000 00000001000 000 0011235778999999999999999999999997 3555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=334.87 Aligned_cols=264 Identities=32% Similarity=0.520 Sum_probs=203.7
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
....|...+.||+|+||.||+|.+.. ++..||||.+...... ...|++++++++|||||++++++.+
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 34568888999999999999997643 4789999998654322 1356889999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-CCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.+..++||||+++|+|.+++. .+++..+..++.|++.||+|||.. ..+|+||||||+||+++.++..++. ||.
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 999999999999999999994 278899999999999999999954 4579999999999999999888775 665
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||+.... .......|......+ ..
T Consensus 829 ~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~ 900 (968)
T PLN00113 829 PGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CH 900 (968)
T ss_pred cccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cc
Confidence 543211 1123678999999999999999999999999999999999999954322 222233333222111 11
Q ss_pred HhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
....++..... ........++.+++.+||+.||++||++.++++.|+++...
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 12222222211 22345566788999999999999999999999999987553
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=290.58 Aligned_cols=264 Identities=27% Similarity=0.375 Sum_probs=197.1
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCC-CCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 161 (421)
|.+.+.||+|+||+||+|.+.. +++.|+||.+...... ......+|+..++.++ |+||+++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 6788999999999999997654 4788999998654322 2233457999999998 999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+ +++|.+++.......+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK--HGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 999999999 8899999877654568999999999999999999994 5799999999999999999999999999976
Q ss_pred CCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhhhhhhc----
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAKPYLSD---- 315 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~---- 315 (421)
...... .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||......... ....+.......
T Consensus 149 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 149 IRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred ccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 543221 223567889999998754 45788999999999999999999999655321111 000000000000
Q ss_pred hhhHhHhhhcccC-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......+..... .......+..+.++|.+||..+|.+||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000 0001122578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=288.00 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=194.7
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecC---CCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP---EGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
+|.+.+.||+|+||.||++.+... +..+++|+++. ... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA---------VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC---------CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 588999999999999999976542 33344554432 211 2233566799999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
.+....++||||+.+++|.+++.. .....+++..++.++.|++.||.||| ..|++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence 999999999999999999998864 22345899999999999999999999 458999999999999975 5699999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------------- 211 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------------- 211 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---------------
Confidence 999876543221 223356788999999998888999999999999999999999999643210
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....... .......+..++.++.++|.+||..+|++||++.+++.
T Consensus 212 -~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 212 -SVVLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -HHHHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0001111 11122234567789999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=302.11 Aligned_cols=267 Identities=23% Similarity=0.296 Sum_probs=195.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..+|++.+.||.|+||.||+|.+.. ++..||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 4689999999999999999996543 5789999998776655667788999999999999999999876543
Q ss_pred --------------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 161 --------------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 161 --------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
...++||||+. ++|.+++... .+++..++.++.||+.||.||| ..||+||||||+|||++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~ 148 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFIN 148 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEc
Confidence 35789999996 5898887532 3889999999999999999999 45799999999999997
Q ss_pred C-CCcEEEeeccCcccCCCCCCc-ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 227 A-EFNAKLSDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 227 ~-~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
. ++.+||+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4 567899999999764322111 11122457889999998754 45888999999999999999999999754321111
Q ss_pred hhhhhhhhhhh--chhhHh----Hhhh-cccCCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 304 SLVDWAKPYLS--DKRKLF----RIMD-TKLGGQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 304 ~~~~~~~~~~~--~~~~~~----~~~~-~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......+... +..... .... ...... .....+.++.+||.+||..||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 10000000000 000000 0000 000000 11235678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=298.61 Aligned_cols=268 Identities=24% Similarity=0.276 Sum_probs=192.5
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
+|++.+.||+|+||.||++.+... ..+..+|+|.+..... ...+.+.+|+.+++.+ .|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence 478889999999999999976532 1267899999874322 2245678899999999 59999999987543
Q ss_pred C----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 160 G----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 160 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
. ...+++|||+. ++|.+++.... .+++..++.++.||+.||.||| ..||+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 74 FPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred ccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeCc
Confidence 2 45788999985 68999886543 4889999999999999999999 45799999999999999999999999
Q ss_pred ccCcccCCCCCCc--ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccc-hhhhhhhh-h
Q 014623 236 FGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-EQSLVDWA-K 310 (421)
Q Consensus 236 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~-~ 310 (421)
||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... ........ .
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999865432211 11223578999999998765 468999999999999999999999997643210 00000000 0
Q ss_pred hhhh------ch--hhHhHhhhcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLS------DK--RKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~------~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+... .. ............. ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00 0000000000000 011223678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=300.39 Aligned_cols=270 Identities=23% Similarity=0.292 Sum_probs=198.9
Q ss_pred HHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCcc
Q 014623 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLV 151 (421)
Q Consensus 74 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv 151 (421)
..++....++|.+.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++|+||+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv 79 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc
Confidence 34455677899999999999999999996543 578999999875422 2235677899999999999999
Q ss_pred ceeeEEEeC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 152 KLIGYCLEG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 152 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
++++++... ...+++++++ +++|.+++... .+++..++.++.|++.||.||| ..||+||||||+||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll 153 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAV 153 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEE
Confidence 999987643 3467888887 78998887543 3889999999999999999999 4579999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ- 303 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~- 303 (421)
+.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 154 NEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred cCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999998764321 223567899999998866 56888999999999999999999999654321110
Q ss_pred hhhhhh-------hhhhhch--hhHhHhhhcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 304 SLVDWA-------KPYLSDK--RKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 304 ~~~~~~-------~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...... .+..... ......+...... ......+..+.++|.+||..||.+||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 0000000 0000000000000 0011246678999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=285.17 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=192.7
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHH-hcCCCCCccceeeEEEeCCe
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYL-GQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~~~~ 162 (421)
+-+..||.|+||+|++- .++.+|+.+|||.++.... ...++++.|.+.. +.-++||||++||....++.
T Consensus 67 qdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred HHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 33567999999999987 4555799999999987765 4556788888865 44579999999999999999
Q ss_pred EEEEEEcCCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 163 RLLVYEFMPKGSLENHL---FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.|+.||+| ..+|..+- .......+++..+-.|....+.||.||-. +..|||||+||+||||+..|.+||||||++
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccch
Confidence 99999999 44665433 22333458888888888889999999975 346999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccc--cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
......- ..+...|-..|||||.+. +..|+.++|+||||++|||+.||..|+.+.....+
T Consensus 216 GqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe--------------- 277 (361)
T KOG1006|consen 216 GQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE--------------- 277 (361)
T ss_pred HhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---------------
Confidence 7643321 223456888999999885 34699999999999999999999999987543111
Q ss_pred hHhHhhhcccC----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.+.+..... ....-+.+..+..+|.-||.+|-..||.+.++++
T Consensus 278 ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 278 QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11111111111 1111357888999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.11 Aligned_cols=269 Identities=28% Similarity=0.343 Sum_probs=193.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.+|+|.+...... ....+.+|+++++.++|+||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 3689999999999999999997654 4788999988643322 1235678999999999999999999876
Q ss_pred eCC--------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 EGE--------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 ~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
... ..++||||+. ++|...+.... ..+++..+..++.|+++||.|||+ .||+|+||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~~~~~~ 153 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILIDNQGI 153 (311)
T ss_pred cccccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEECCCCC
Confidence 433 4699999995 47777775433 358999999999999999999995 57999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcc---------eeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 231 AKLSDFGLAKAGPTGDRTH---------VSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
++|+|||++.......... ......++..|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999997643322111 11234678899999987654 5889999999999999999999999754432
Q ss_pred chhh-hhhhhh-hh---hhchhhHhHhhhcccCCCCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 301 IEQS-LVDWAK-PY---LSDKRKLFRIMDTKLGGQYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 301 ~~~~-~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ...... +. +.....+............+ ......+.++|.+||..||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110 000000 00 00000000000000000011 123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=299.32 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=198.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.... ++..||||.+...... ....+.+|+.+++.++|+||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 46789999999999999999996543 5789999998643222 234678999999999999999999988
Q ss_pred EeCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.... ..++||||+ +++|.+++.. ..+++..++.++.|++.||.||| ..||+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCE
Confidence 7553 458999999 7799888753 24889999999999999999999 4579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~ 309 (421)
+|+|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|..||........ .......
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999999865332 123467899999998876 4588899999999999999999999975432110 0000000
Q ss_pred hhh----h----h-chhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 310 KPY----L----S-DKRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 310 ~~~----~----~-~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
... . . ........+..... ......++..+.++|.+||..||.+|||+.+++. .++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 000 0 0 00000000000000 0011245667899999999999999999999984 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=294.75 Aligned_cols=266 Identities=26% Similarity=0.338 Sum_probs=197.5
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceee
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~ 155 (421)
..+.++|.+.+.||.|+||.||+|.+.. +++.+|+|.+..... ...+.+.+|+++++.++||||+++++
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 76 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence 3456789999999999999999997554 578999998864322 23356778999999999999999999
Q ss_pred EEEe-CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 156 YCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 156 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
++.. ....++||||+ +++|.+++... .+....+..++.|++.||.|||+ .||+||||+|+|||++.++.++|+
T Consensus 77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili~~~~~~~l~ 150 (328)
T cd07856 77 IFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILINENCDLKIC 150 (328)
T ss_pred eEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeECCCCCEEeC
Confidence 8875 56789999998 66898887532 37788888999999999999994 579999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWAKPY 312 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~ 312 (421)
|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ....+.....
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999754321 123467889999998766 5689999999999999999999999975432110 0011100000
Q ss_pred hhc------hhhHhHhhh-cccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSD------KRKLFRIMD-TKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~------~~~~~~~~~-~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+ .....+.+. .......+ ..++..+.++|.+||+.+|++||++.+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000001100 00011111 2356789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.05 Aligned_cols=146 Identities=29% Similarity=0.382 Sum_probs=129.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|++.. +++.||||+++...... ...+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 579999999999999999997654 47899999997543322 256778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.....||||||+.|++|.+++.... .+.+..++.++.||+.||.|||. .||+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~--~gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR--HGIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 9999999999999999999997654 37888999999999999999995 4799999999999999999999999999
Q ss_pred cc
Q 014623 239 AK 240 (421)
Q Consensus 239 a~ 240 (421)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 85
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.65 Aligned_cols=266 Identities=22% Similarity=0.311 Sum_probs=194.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||+|.+.. +|+.||+|.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 4689999999999999999996543 578999999875322 22345789999999999999999999887
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
... ..++||||+. .+|..++. ..+++..+..++.|++.||+|||+ .|++||||||+|||++.++.+|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dlkp~NIll~~~~~~k 157 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELK 157 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEE
Confidence 543 4689999995 47766552 248889999999999999999994 5799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~ 310 (421)
|+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .+.....
T Consensus 158 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 232 (342)
T cd07879 158 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232 (342)
T ss_pred EeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999764322 123567889999998876 45888999999999999999999999765321100 0000000
Q ss_pred ---hhhhc---hhhHhHhhhc--c-cCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 311 ---PYLSD---KRKLFRIMDT--K-LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 311 ---~~~~~---~~~~~~~~~~--~-~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
+...+ .......... . .... ..+..+..+.+||.+||+.||.+||++.+++. .++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 0000000000 0 0000 01234567899999999999999999999985 35554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=281.51 Aligned_cols=237 Identities=32% Similarity=0.407 Sum_probs=194.4
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
||+|+||.||++.... +++.+++|.+...... ....+.+|+++++.++|+||+++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 7999999999997643 4789999998765433 234678899999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 246 (421)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~ 147 (250)
T cd05123 72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG 147 (250)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence 99999999999997654 48899999999999999999994 579999999999999999999999999997654332
Q ss_pred CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
. ......++..|++||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 148 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----------------~~~~~~~~-- 207 (250)
T cd05123 148 S--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----------------EIYEKILK-- 207 (250)
T ss_pred C--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----------------HHHHHHhc--
Confidence 1 123456888999999998888899999999999999999999999754320 00111111
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 359 (421)
.....+...+..+.+++.+||..||++||++.+
T Consensus 208 ~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 122344555788999999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=301.91 Aligned_cols=241 Identities=26% Similarity=0.306 Sum_probs=197.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
...|.+...+|.|+|+.|-.+... .++...++|++.....+ ..+|+.++... +||||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~---------~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS---------PTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeeeecc---------ccccchhheeccccccc----cccccchhhhhcCCCcceeecceecC
Confidence 467888899999999999988443 46788999999866222 23566666555 69999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe-CCCCcEEEeeccC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-~~~~~~kl~Dfg~ 238 (421)
+.+.|+|||++.|+-|.+.+..... ....+..|+.+|+.|+.|||+ .|+|||||||+|||+ +..|+++|+|||.
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEech
Confidence 9999999999999999888866543 226677899999999999995 589999999999999 6889999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++..... ..+.+-|..|.|||++....|++++||||||++||+|++|+.||.....+
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------ 519 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------ 519 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------
Confidence 9876543 22356789999999999999999999999999999999999999765432
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.++........+...++..+.+||.+||+.||.+|+++.+++..
T Consensus 520 -~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 -IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12222222333447889999999999999999999999999863
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=306.58 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=220.2
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC-CccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
..+..++||.|+||+||+|.|-.. ...-..+||||++... ......++++|+-+|.+|+|||++++++++....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pe-----ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPE-----GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecC-----CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 356678999999999999988653 2223457999998654 3345678999999999999999999999987665
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
+.||++|+++|+|.|+++... ..+.....+.|+.||+.|+.||| +.++|||||-..||||..-..+||+|||+++.
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 889999999999999997643 45888899999999999999999 55799999999999999999999999999998
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
..............-.+.|||-|.++...|+.++|||||||++||++| |..|+++.. ...+.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~ 910 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIP 910 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhh
Confidence 766554433333334678999999999999999999999999999999 999998753 23455
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+++...+...|+.++.+++.++.+||..|+..||+++++.+.+.++.+.
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 56666666778899999999999999999999999999999988876543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=299.98 Aligned_cols=263 Identities=25% Similarity=0.327 Sum_probs=197.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.+.|+||+++++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 45789999999999999999997654 478899999865321 2335577899999999999999999987
Q ss_pred EeCCe------EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEGEN------RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
...+. .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCE
Confidence 76554 89999999 6799998864 348999999999999999999995 579999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVDWA 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~ 309 (421)
+|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..+....
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~ 232 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLV 232 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Confidence 99999999865432 223567889999998865 3678899999999999999999999975432110 0000000
Q ss_pred h--------hhhhc-hhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 K--------PYLSD-KRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~--------~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. ....+ .......+.......+ ....+..+.++|.+||..||.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 00000 0000000000000000 1124778999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=287.65 Aligned_cols=264 Identities=27% Similarity=0.362 Sum_probs=198.3
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
|++.+.||+|+||.||+|.... +++.+|+|.+.... ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 6677899999999999996543 57899999987653 223356778999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+. ++|.+++.+.. ..+++..++.++.+++.||.|||+ .||+||||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS--HRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 9999999997 59999997653 348999999999999999999994 5799999999999999999999999999986
Q ss_pred CCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhh-hhh-----
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK-PYL----- 313 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~-~~~----- 313 (421)
...... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||......... ....... +..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 148 FGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred cCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 543221 12234567889999998776 7899999999999999999999999765421110 0000000 000
Q ss_pred -hch---hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 -SDK---RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 -~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+. ................+..+..+.++|.+||..||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0000000000000011234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=285.95 Aligned_cols=264 Identities=26% Similarity=0.405 Sum_probs=199.6
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCcccee
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLI 154 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~ 154 (421)
-+++.++..+.+.||+|.||.||+|.|+ |+.||||++... +...+.+|.+|.+. |+|+||+.++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence 3456788999999999999999999986 788999999764 33456777777654 6999999999
Q ss_pred eEEEeCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCCCcEE
Q 014623 155 GYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNIL 224 (421)
Q Consensus 155 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nil 224 (421)
+.-..++ ++|||.+|.+.|+|+|+|.++ .++....++++..+|.||++||.. +..|.|||||..|||
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 8765433 679999999999999999774 389999999999999999999942 345999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCC--cceeeccccccceecccccccCC----CC--ccccchhhhHHHHHHHhCC-----
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVATGR----LT--TKSDVYSFGVVLLELLSGR----- 291 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~--~~~DiwslG~il~el~tg~----- 291 (421)
+..+|.+.|+|+|||........ .......+||.+|||||++...- +. ..+||||||.++||++-..
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 99999999999999976544321 22233468999999999986532 21 2589999999999998632
Q ss_pred -----CccCCCcccchhhhhhhhhhhhhchhhHhHhh-hcccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 292 -----CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 292 -----~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
.||.+.... .| ....+.+.+ ..+++...| ..+-..+..|++.||..||.-|.|+--+
T Consensus 429 ~eey~~Pyyd~Vp~---------DP---s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPS---------DP---SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred ehhhcCCcccCCCC---------CC---CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 333221110 01 111111111 112222222 3667788899999999999999999999
Q ss_pred HHHHHhhcC
Q 014623 361 LAILERLEA 369 (421)
Q Consensus 361 l~~L~~~~~ 369 (421)
-+.|.++..
T Consensus 497 KKtl~~l~~ 505 (513)
T KOG2052|consen 497 KKTLAKLSN 505 (513)
T ss_pred HHHHHHHhc
Confidence 999988764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=303.51 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=207.7
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
.-.+.|++.+.||.|.+|.||+++... ++...|+|++.... +..+++..|.++|+.+ .|||++.+|++|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345678999999999999999996543 57888888876553 3345667789999888 599999999998
Q ss_pred Ee-----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 158 LE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 158 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.. ++++|||||||.||+..|++.......+.|..+..|+..++.||.+|| ++.++|||||-.|||++.+|.||
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEE
Confidence 74 568999999999999999998776778999999999999999999999 55799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccC-----CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
|+|||++....... ....+++||+.|||||++... .|+.++|+||||++..||.-|.+|+.+...
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------- 233 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------
Confidence 99999987654322 224568899999999999643 478899999999999999999999876432
Q ss_pred hhhhhhhchhhHhHhhh-cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 WAKPYLSDKRKLFRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...++.+.. .......+...+..+.++|..||..|-.+||++.++++
T Consensus 234 --------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 --------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 122222211 12223346788999999999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.29 Aligned_cols=267 Identities=28% Similarity=0.433 Sum_probs=218.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
..++..+.+.||+|.||.|++|......... ......||||.++..... ..+.+..|+++|+.+ .|+||+.++|++
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred chhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3345567779999999999999866532111 112567999999865443 456788999999999 599999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcC------------C--CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRG------------P--QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
...+..++|+||+..|+|.+++.... . ..+.....+.++.|||.|++||++. ++|||||-..||
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--~~vHRDLAaRNV 449 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--PCVHRDLAARNV 449 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--CccchhhhhhhE
Confidence 99899999999999999999997655 0 1388899999999999999999954 699999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccc--cccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCccc
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM--GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVG 300 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~ 300 (421)
|+..+..+||+|||+|+............ -. -...|||||.+....|+.++||||||++||||++ |..||.+..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999755444332111 11 2455999999999999999999999999999999 888886521
Q ss_pred chhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
....+.+.+..+.+...|..++.+++++++.||+.+|++||++.++.+.|+..
T Consensus 527 --------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 --------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 12334556777778888999999999999999999999999999999999884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.28 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=191.2
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH---HHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
|..++.||-|+||+|.+++- ..+...+|+|.+++.++-.. ..+..|-.||..-..+-||+||-.|.+.
T Consensus 631 Fvkik~iGvGAFGeV~Lv~K---------vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRK---------VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred eEEEeeecccccceeEEEee---------cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 56677899999999999843 33567899999876554332 2355788999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+.+|+||+|++||++..+|.+.+- +.+..+..++..+..|+++.| +.|+|||||||+|||||.+|+|||+|||||+
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999999988764 888889999999999999999 5589999999999999999999999999996
Q ss_pred cCCCCCCcc----------------------------------------eeeccccccceecccccccCCCCccccchhh
Q 014623 241 AGPTGDRTH----------------------------------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSF 280 (421)
Q Consensus 241 ~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 280 (421)
-+....... .....+||+.|+|||++....|+..+|.||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 432110000 0112579999999999999999999999999
Q ss_pred hHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 014623 281 GVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355 (421)
Q Consensus 281 G~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 355 (421)
|||||||+.|+.||-.......+. +..|- ..+...+...++.++.+||.+++ .+++.|.
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw~---------------~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINWR---------------NFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeehh---------------hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999997654433221 11221 11112334567788888888765 3567776
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.07 Aligned_cols=221 Identities=24% Similarity=0.256 Sum_probs=178.4
Q ss_pred cCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCC
Q 014623 93 GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 172 (421)
Q Consensus 93 G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 172 (421)
|.||.||++++.. +++.+|+|.+.... .+.+|...+....||||+++++++.+.+..++||||+.+
T Consensus 4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 8999999997654 57899999987543 223455555556799999999999999999999999999
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceee
Q 014623 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252 (421)
Q Consensus 173 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 252 (421)
++|.+++.+.. .+++..+..++.|++.||.||| +.||+||||||+||+++.++.++|+|||++....... .
T Consensus 70 ~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~ 140 (237)
T cd05576 70 GKLWSHISKFL--NIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----D 140 (237)
T ss_pred CCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----c
Confidence 99999997654 3889999999999999999999 5589999999999999999999999999886543321 2
Q ss_pred ccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC
Q 014623 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 332 (421)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (421)
...++..|+|||++.+..++.++|+|||||++|+|++|..||....... ........+
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------------~~~~~~~~~ 198 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------------NTHTTLNIP 198 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------------ccccccCCc
Confidence 2445778999999988889999999999999999999998875321100 000111234
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 333 QKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 333 ~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
..++..+.++|.+||+.||++||++.
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 45677899999999999999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.95 Aligned_cols=262 Identities=22% Similarity=0.355 Sum_probs=197.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----C---CCccce
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----H---PNLVKL 153 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~iv~~ 153 (421)
.+|.+.++||.|.|++||++++.+ ..+.||+|+.+... .-.+..+.||++|+.++ | .+||+|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 689999999999999999999876 36899999997542 22356788999999884 2 469999
Q ss_pred eeEEEe----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-
Q 014623 154 IGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE- 228 (421)
Q Consensus 154 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~- 228 (421)
++.|.. +.+.|||+|++ |.+|..+|.+..-+.++...+..|+.||+.||.|||. +.||||.||||+|||+..+
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccc
Confidence 999984 56899999999 8899999988877889999999999999999999997 5799999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 014623 229 -------------------------------------------------------------------------------- 228 (421)
Q Consensus 229 -------------------------------------------------------------------------------- 228 (421)
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 014623 229 -------------------------------------------------------------------------------- 228 (421)
Q Consensus 229 -------------------------------------------------------------------------------- 228 (421)
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence
Q ss_pred -----CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCc---cc
Q 014623 229 -----FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK---VG 300 (421)
Q Consensus 229 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~---~~ 300 (421)
..|||+|||-|+.+.. ..+.-+-|..|+|||++.+..|++.+||||++|++|||+||...|+... ..
T Consensus 386 ~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~ 460 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS 460 (590)
T ss_pred CCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence 0134444444443211 1122345888999999999999999999999999999999999996432 22
Q ss_pred chhh-hh---hh--------------hhhhhhchhh-----------HhHhhhcccCCCCCHHHHHHHHHHHHhccccCC
Q 014623 301 IEQS-LV---DW--------------AKPYLSDKRK-----------LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEP 351 (421)
Q Consensus 301 ~~~~-~~---~~--------------~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 351 (421)
.+.. +. +. .+.|+..... +.+++..+ ..++.....++.+++.-||+.+|
T Consensus 461 rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eK--Y~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 461 RDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEK--YEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred ccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHH--hCCCHHHHHHHHHHHHHHHhcCc
Confidence 2221 11 11 1111111111 11111111 24567888899999999999999
Q ss_pred CCCCCHHHHHH
Q 014623 352 KLRPRMSEVLA 362 (421)
Q Consensus 352 ~~Rpt~~ell~ 362 (421)
++|||+.+.+.
T Consensus 539 eKR~tA~~cl~ 549 (590)
T KOG1290|consen 539 EKRPTAAQCLK 549 (590)
T ss_pred cccccHHHHhc
Confidence 99999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.02 Aligned_cols=273 Identities=25% Similarity=0.328 Sum_probs=199.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..|.-...||+|.||.||+|+.++ +|+.||+|++.-+. ..--...++|+++|..|+|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 356667889999999999996544 57888988754321 1112456799999999999999999887753
Q ss_pred --------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 --------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
...+||||.+|+. +|.-++... ...++...+..++.++..||.|+|+. .|+|||+|++|+||+.+|.+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLITKDGIL 163 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEEcCCceE
Confidence 2347999999966 888877433 34589999999999999999999954 59999999999999999999
Q ss_pred EEeeccCcccCCCCCCc--ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh-
Q 014623 232 KLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD- 307 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~- 307 (421)
||+|||+++.+...... ...+..+-|.+|.+||.+.|. .|+++.|||+-|||+.||+++.+-|.+........++.
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99999999876543321 112345569999999988875 59999999999999999999999998766543322221
Q ss_pred -------hhhhhhhchhhHhHhhhcc-cCC----C-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 308 -------WAKPYLSDKRKLFRIMDTK-LGG----Q-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 308 -------~~~~~~~~~~~~~~~~~~~-~~~----~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
..+|..+.. .+.+.+... +.. . .+-.-.+++.+|+.++|..||.+|+++++++...-...
T Consensus 244 LcGs~tkevWP~~d~l-pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNL-PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HhccCCcccCCCcccc-hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 112222111 111111110 000 0 01122458889999999999999999999987654443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=270.03 Aligned_cols=268 Identities=26% Similarity=0.414 Sum_probs=201.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC--CccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE--GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.+.+..+.||.|+||+||.+ .+..+|+.||+|++..- .....+++.+|+++|..++|.|++..+++...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQP 123 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQP 123 (449)
T ss_pred ccCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence 35667799999999999987 56667999999988642 23445788999999999999999999987654
Q ss_pred CC-----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 GE-----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
.. ++|+++|.+ ..+|...|. .++.++...+.-+++||++||+|||+. +|.||||||.|+|++.|..+|||
T Consensus 124 ph~dfFqEiYV~TELm-QSDLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 124 ANPSFFQELYVLTELM-QSDLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CCchHHHHHHHHHHHH-Hhhhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEeccCceEEec
Confidence 32 456788888 457877774 345688889999999999999999965 69999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccc-hhhhhh-hhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGI-EQSLVD-WAKP 311 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~-~~~~ 311 (421)
|||+++..+..+... .+..+-|.+|.|||+++|.. |+.++||||.|||+.||+..+..|.....-. .+.+.+ ...|
T Consensus 199 DFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 999999876554433 34456699999999998864 9999999999999999999999997654322 122222 2233
Q ss_pred hhhchhhHh-----HhhhcccCC---------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 312 YLSDKRKLF-----RIMDTKLGG---------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 312 ~~~~~~~~~-----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
.+++.+... .++....+. ..+.....+..+++.++|..||++|.+..+.+..+
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 333222111 111111111 11235556788899999999999999999888654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=266.82 Aligned_cols=271 Identities=24% Similarity=0.328 Sum_probs=224.4
Q ss_pred HHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccc
Q 014623 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 74 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
..++.....++++..++-+|.||.||.|.|... ....+.+.|-+|.++....+ ....++.|...+..+.|||+..
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 445556677899999999999999999988752 12233456777777654322 2356789999999999999999
Q ss_pred eeeEEEe-CCeEEEEEEcCCCCChHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 153 LIGYCLE-GENRLLVYEFMPKGSLENHLFR------RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 153 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
+.+++.+ ....++++.+..-|+|..++.. ...+.+...+...++.|++.|++||| +.|+||.||...|++|
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvI 429 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVI 429 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhccee
Confidence 9998875 4567889999989999999961 23455777888899999999999999 4579999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 304 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~ 304 (421)
++...+||+|-.+++.....++............||+||.+.+..|+.++|+||||++||||+| |+.|+...+
T Consensus 430 dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID------ 503 (563)
T KOG1024|consen 430 DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID------ 503 (563)
T ss_pred hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC------
Confidence 9999999999999998777776655555666889999999999999999999999999999999 888886532
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+...+..+.+...|.+++++++.++.-||+..|++||+++++..-|.++
T Consensus 504 -----------PfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 504 -----------PFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -----------HHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 3345566667777788899999999999999999999999999999888765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.39 Aligned_cols=268 Identities=18% Similarity=0.227 Sum_probs=171.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeE---
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY--- 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~--- 156 (421)
..++|.+.+.||+|+||.||+|.+.... ...+..||+|.+..... .+.+..| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-----~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-----SKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCc-----cccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3468999999999999999999876521 12378899998764321 1111111 1222222233222221
Q ss_pred ---EEeCCeEEEEEEcCCCCChHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhhCCCceee
Q 014623 157 ---CLEGENRLLVYEFMPKGSLENHLFRRGPQ------------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIY 215 (421)
Q Consensus 157 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 215 (421)
...+...++||||+.+++|.+++...... ......+..++.||+.||.|||+ .||+|
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiH 278 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVH 278 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEe
Confidence 23556789999999999999998654210 01233456789999999999994 57999
Q ss_pred ccCCCCcEEeCC-CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccC----------------------CCC
Q 014623 216 RDFKASNILLDA-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG----------------------RLT 272 (421)
Q Consensus 216 rDlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 272 (421)
|||||+|||++. ++.+||+|||+++....... .....+++++.|+|||++... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999985 57899999999986543221 223457889999999976432 234
Q ss_pred ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCC------CCCHHHHHHHHHHHHhc
Q 014623 273 TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGG------QYPQKAAHTAATLALQC 346 (421)
Q Consensus 273 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~ 346 (421)
.++|||||||+||||+++..+++.........+.... .+...+.......... ...........+||.+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRND----YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcC----CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 4679999999999999987765432111100000000 0000111111111000 00011233456899999
Q ss_pred cccCCCCCCCHHHHHHH
Q 014623 347 LNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 347 l~~dP~~Rpt~~ell~~ 363 (421)
|..||.+|||+.++++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=261.95 Aligned_cols=237 Identities=32% Similarity=0.454 Sum_probs=193.8
Q ss_pred CceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCC
Q 014623 94 GFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPK 172 (421)
Q Consensus 94 ~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 172 (421)
+||.||+|.+.. +++.+++|++....... .+.+.+|++.++.++|+||+++++++......+++|||+.+
T Consensus 1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 589999997653 47899999998765544 67888999999999999999999999999999999999999
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceee
Q 014623 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252 (421)
Q Consensus 173 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 252 (421)
++|.+++..... +++..++.++.+++.++.+||. .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 72 ~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~ 144 (244)
T smart00220 72 GDLFDLLKKRGR--LSEDEARFYARQILSALEYLHS--NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLT 144 (244)
T ss_pred CCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHH--cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccc
Confidence 999999976543 7889999999999999999994 579999999999999999999999999998754432 223
Q ss_pred ccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC
Q 014623 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP 332 (421)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (421)
...++..|++||.+.+..++.++|||+||+++|+|++|..||..... .....+.+.........
T Consensus 145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----------------~~~~~~~~~~~~~~~~~ 208 (244)
T smart00220 145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----------------LLELFKKIGKPKPPFPP 208 (244)
T ss_pred cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----------------HHHHHHHHhccCCCCcc
Confidence 45688899999999888899999999999999999999999965211 11111111111111111
Q ss_pred HH--HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 333 QK--AAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 333 ~~--~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.. ++.++.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11 6678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.70 Aligned_cols=275 Identities=20% Similarity=0.237 Sum_probs=184.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCC-------CCCCCCCcEEEEEEecCCCccCHHH--------------HHHHH
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLS-------PAKPGSGMVVAVKKLKPEGFQGHKE--------------WLTEV 139 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 139 (421)
.++|++.++||+|+||+||+|.+...... ......++.||||.+........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999975332110 1123456789999987543222222 33466
Q ss_pred HHHhcCCCCCc-----cceeeEEEe--------CCeEEEEEEcCCCCChHHHHhhcCC----------------------
Q 014623 140 NYLGQLHHPNL-----VKLIGYCLE--------GENRLLVYEFMPKGSLENHLFRRGP---------------------- 184 (421)
Q Consensus 140 ~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------- 184 (421)
.++.+++|.++ ++++++|.. ....+|||||+.+++|.+++.....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777765544 667776653 3568999999999999999864211
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccc
Q 014623 185 QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264 (421)
Q Consensus 185 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 264 (421)
..+++..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||++......... ......+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence 124567788999999999999994 57999999999999999999999999999764332211 111233578999999
Q ss_pred ccccCC--------------------CC--ccccchhhhHHHHHHHhCCC-ccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 265 YVATGR--------------------LT--TKSDVYSFGVVLLELLSGRC-AVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 265 ~~~~~~--------------------~~--~~~DiwslG~il~el~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
++.... |+ .+.||||+|||+|+|++|.. ||....... ..... +..+...+..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~----~~~~~~~~r~ 455 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQ----YDNDLNRWRM 455 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhh----ccchHHHHHh
Confidence 875432 11 24799999999999999876 664321100 00000 0000111111
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEP---KLRPRMSEVLAI 363 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~ell~~ 363 (421)
..............++...+|+.+||..+| .+|+|+.|++++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111111122234567889999999999866 689999999863
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=276.80 Aligned_cols=269 Identities=21% Similarity=0.206 Sum_probs=203.9
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC------CCCc
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH------HPNL 150 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hp~i 150 (421)
......+|.+....|+|-|++|..|.+.. .|..||||+|..+.. -.+.-+.|+++|++|+ --|.
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 33455678888889999999999996554 466999999987643 2345578999999996 3589
Q ss_pred cceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 151 VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 151 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
++++..|...+++|||+|-+ ..+|.++|.+.+. ..+....+..++.|+..||..|- +.||+|.||||+|||+++..
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCc
Confidence 99999999999999999998 6699999987654 45778888999999999999998 66899999999999998764
Q ss_pred -cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh-
Q 014623 230 -NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD- 307 (421)
Q Consensus 230 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~- 307 (421)
.+||||||.|.....+..+ -+.-+..|.|||++.|..|+...|+||+||+||||.||+..|.+........+..
T Consensus 574 ~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5899999999876654432 2344678999999999999999999999999999999999998876533221111
Q ss_pred hhhhhhhch----------------------------------------hhHhHhhhcc-cCCCCCHHHHHHHHHHHHhc
Q 014623 308 WAKPYLSDK----------------------------------------RKLFRIMDTK-LGGQYPQKAAHTAATLALQC 346 (421)
Q Consensus 308 ~~~~~~~~~----------------------------------------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 346 (421)
...++.... ..+...+... .........-..+.+|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 111100000 0000111000 01111235566888999999
Q ss_pred cccCCCCCCCHHHHHH
Q 014623 347 LNNEPKLRPRMSEVLA 362 (421)
Q Consensus 347 l~~dP~~Rpt~~ell~ 362 (421)
|..||++|.|+.++|.
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=244.32 Aligned_cols=205 Identities=27% Similarity=0.373 Sum_probs=165.9
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
..+....+..||+|++|.|-+-+..+ +|..+|+|.+...-. +..++.++|+.+..+. .+|++|.+||.+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 34555667889999999997765443 689999999975432 3446788899986655 699999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
......|+.||.+ ..+|..+-.+ .....+++..+-+++..+++||.|||++ ..++|||+||.||||+.+|.+||||
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcc
Confidence 9999999999999 4577665432 2335589999999999999999999984 5799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceeccccccc----CCCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT----GRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
||++-...+.-. .+-..|-..|||||.+.. ..|+.++||||||+++.||.+++.||+...
T Consensus 193 FGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 193 FGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 999976543221 122457889999998853 369999999999999999999999997654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.36 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=196.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 159 (421)
.++|++.+.+|+|.|+.||.|.. ..+.+.++||+++.- ..+.+.+|++||+.|. ||||++++++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~---------~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGIN---------ITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccc---------cCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 46899999999999999999953 335788999999853 3466889999999997 9999999999886
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEEEeec
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDF 236 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~Df 236 (421)
. ....||+||+++.+...+-. .++...+..++.+++.||.|||+. ||+|||+||.|++|+.. -.++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~--GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM--GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc--CcccccCCcceeeechhhceeeeeec
Confidence 5 45789999998877766552 266677888999999999999965 79999999999999864 46999999
Q ss_pred cCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-----------
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS----------- 304 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----------- 304 (421)
|+|.....+.... -.+.+..|--||++.. ..|+..-|+|||||+|..|+..+.||.......++.
T Consensus 178 GLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred chHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 9999876655332 2456888999998865 458999999999999999999999997655443331
Q ss_pred hhhhhhhhhhc-hhhHhHhhhcccC--------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 305 LVDWAKPYLSD-KRKLFRIMDTKLG--------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 305 ~~~~~~~~~~~-~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+..+...+.-+ ......++....+ .......++++.+|+.++|..|..+|+|+.|.++.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111111 0111111111111 11122446899999999999999999999998853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=285.18 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=184.9
Q ss_pred CCCCceecccCcee-EEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEeCC
Q 014623 84 FRPDSLLGEGGFGF-VYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGE 161 (421)
Q Consensus 84 y~~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 161 (421)
|.-.+++|.|+.|+ ||+|... |+.||||.+-.+. ...+.+|+..|+.- .|||||++|+.-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44557799999986 7899765 6789999886432 23456899999988 4999999999888888
Q ss_pred eEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---C--CcEEEe
Q 014623 162 NRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---E--FNAKLS 234 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~--~~~kl~ 234 (421)
..||+.|.| ..+|.+++... ..........+.+..|++.||++||+ .+||||||||+||||+. + ..++|+
T Consensus 577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEec
Confidence 999999999 45999999763 11111213457788999999999996 46999999999999965 3 468999
Q ss_pred eccCcccCCCCCCcce-eeccccccceecccccccCCCCccccchhhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHV-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|||+++....+..... .....||-+|+|||++....-+.++|||||||++|+.++| ..||...-...
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------- 722 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------- 722 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-----------
Confidence 9999998765543322 2346799999999999998888899999999999999995 89997542110
Q ss_pred hhchhhHhHhhhccc---CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTKL---GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..++.... ......++ ++.+||.+|++.+|..||++.+|+.
T Consensus 723 -------~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 723 -------ANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------hhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111100 00111222 8899999999999999999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=271.28 Aligned_cols=197 Identities=23% Similarity=0.326 Sum_probs=168.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCC---CCCc
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--------HKEWLTEVNYLGQLH---HPNL 150 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---hp~i 150 (421)
.+|..++.||.|+||.|++|.++. +...|+||.+.++..-. .-.+-.|++||..|+ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 468999999999999999996654 46789999998764311 112346999999997 9999
Q ss_pred cceeeEEEeCCeEEEEEEcC-CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC
Q 014623 151 VKLIGYCLEGENRLLVYEFM-PKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229 (421)
Q Consensus 151 v~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~ 229 (421)
++++++|++++.+||+||-. +|.+|+++|..+.+ +++..+..|+.|++.|+++||+ .||||||||-+|+.++.+|
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~--~~ivhrdikdenvivd~~g 707 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHD--QGIVHRDIKDENVIVDSNG 707 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccc--cCceecccccccEEEecCC
Confidence 99999999999999999975 56799999977655 8999999999999999999995 5799999999999999999
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCC-ccccchhhhHHHHHHHhCCCccC
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~pf~ 295 (421)
.+||+|||.+-....+. ...++||..|.|||++.|..|- ..-|||+||++||.++...-||.
T Consensus 708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999987755544 3458999999999999998874 46899999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.56 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=196.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..+|.-++.+|.|.- .|..|. +...++.||+|++.... ....++..+|+.++..++|+||++++.+|.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~---------D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ft 85 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAF---------DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFT 85 (369)
T ss_pred eeeeeeecccCCCCc-eEEecc---------hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccC
Confidence 468888999999998 666663 33357889999876542 233467889999999999999999999987
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
-.. ..|+|||++ ..+|...+.- .++..++..++.|++.|+.|||+ .||+||||||+||++..++.+|
T Consensus 86 P~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 86 PQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred ccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh--cceeecccCcccceecchhhee
Confidence 543 468999999 5599998862 37778899999999999999995 5899999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh--hhhhh--
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDW-- 308 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~-- 308 (421)
|.|||+|+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+...- ++ ...+.
T Consensus 159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~i-dQ~~ki~~~lg 234 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHI-DQWNKIIEQLG 234 (369)
T ss_pred eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHH-HHHHHHHHHhc
Confidence 9999999875433 2345578899999999999988999999999999999999999999865431 11 00000
Q ss_pred --hhhhhhchhhHhHhhh------------cccC-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 309 --AKPYLSDKRKLFRIMD------------TKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 309 --~~~~~~~~~~~~~~~~------------~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+..+.....+..- ..+. ...+..-...+.+++.+||..||++|.++.++|..
T Consensus 235 tpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0111111111111100 0000 01112345678899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-33 Score=271.76 Aligned_cols=253 Identities=26% Similarity=0.316 Sum_probs=203.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|.+...+|.|+||.||++++.. +++..|+|+++.+.....+-+..|+-+++.++|||||.+++.+...
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR 84 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence 4689999999999999999996554 6899999999988777777778899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+.+|++||||.||+|.+.-+-. .++++.++...+...+.+|+|||+. |-+|||||-.|||+++.|.+|++|||.+-
T Consensus 85 dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~--gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ--GKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC--CcccccccccceeecccCceeecccCchh
Confidence 9999999999999999866433 4599999999999999999999954 68999999999999999999999999986
Q ss_pred cCCCCCCcceeeccccccceeccccc---ccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
.+... ......+.||++|||||+. +.+.|...+|||++|+...|+-.-+.|........ .+....+
T Consensus 161 qitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTk------- 229 (829)
T KOG0576|consen 161 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTK------- 229 (829)
T ss_pred hhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhc-------
Confidence 54321 2234568999999999976 46779999999999999999988777754322110 0000000
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
-.......+.+...++.+.+|++.||..+|++||+++.++
T Consensus 230 ----S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 230 ----SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ----cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 0001111123356778899999999999999999987765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=232.08 Aligned_cols=211 Identities=37% Similarity=0.564 Sum_probs=181.0
Q ss_pred ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEE
Q 014623 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYE 168 (421)
Q Consensus 90 lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 168 (421)
||+|.+|.||++.... +++.+++|++...... ....+.+|+++++.+.|++|+++++++......+++||
T Consensus 1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 6899999999997643 4788999999866432 24678899999999999999999999999899999999
Q ss_pred cCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeeccCcccCCCCCC
Q 014623 169 FMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKAGPTGDR 247 (421)
Q Consensus 169 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 247 (421)
|+.+++|.+++.... ..++...++.++.+++.+|.+||. .|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~--~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHS--NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 999899999997653 348899999999999999999995 48999999999999999 89999999999986543321
Q ss_pred cceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc
Q 014623 248 THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326 (421)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (421)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 --~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------- 187 (215)
T cd00180 149 --LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------- 187 (215)
T ss_pred --hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence 12235578899999998877 788899999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 327 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+.+++.+||..+|++||++.++++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=236.03 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=185.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEE-E
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYC-L 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~-~ 158 (421)
.+.|.+.+.||+|.||.+-++..+ .+...+++|.+... .....+|.+|...--.|. |.||+..|++. .
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr---------~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHR---------QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeecc---------CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 357999999999999999999544 46788999988765 355678999998877775 99999998864 4
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC--CCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~Df 236 (421)
..+.++++|||++.|+|..-+... .+.+.....++.|++.|+.|+|++ ++||||||.+||||- +...+|||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred cCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeec
Confidence 556778999999999999877543 378888899999999999999975 599999999999992 3347999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccC-----CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
|+.+..+.. ....-.+..|.+||+.... ...+.+|||.||+|+|..+||++||...... +.....|.
T Consensus 168 G~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~-- 239 (378)
T KOG1345|consen 168 GLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWE-- 239 (378)
T ss_pred ccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHH--
Confidence 999864431 1123346789999976432 2567899999999999999999999843221 11111111
Q ss_pred hhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
...+-..... .+.-...++.+..+.++-|..++.+|--..++.
T Consensus 240 ------~w~~rk~~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 240 ------QWLKRKNPAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred ------HHhcccCccC-chhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 1111111111 111235677888999999999999995444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=229.64 Aligned_cols=200 Identities=36% Similarity=0.467 Sum_probs=171.4
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
|.+.+.||.|++|.||++.... +++.+++|.+...... ..+.+.+|++.++.++|+|++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 5678899999999999997653 4678999999866544 56778899999999999999999999999899
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.++++||+.+++|.+++...... +++..+..++.+++.+|.+||. .+++|+||++.||+++.++.++|+|||++...
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~--~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHS--LGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 99999999999999999765422 7888999999999999999994 48999999999999999999999999998875
Q ss_pred CCCCCcceeeccccccceeccccc-ccCCCCccccchhhhHHHHHHHhCCCccCC
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRCAVDK 296 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~pf~~ 296 (421)
...... ......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 149 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 443200 12335678899999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=237.90 Aligned_cols=272 Identities=25% Similarity=0.298 Sum_probs=198.4
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceee
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIG 155 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 155 (421)
+....+.|+...+||+|.|++||++.+... ...++.||+|.+.... .-.++.+|+++|..+. +.||+++.+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchh
Confidence 445567899999999999999999976541 2357899999987653 3356889999999995 999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEe
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLS 234 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~ 234 (421)
++..+++.++||||++.....++... ++...+..++..++.||.++| .+|||||||||.|+|.+. .+.-.|+
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEE
Confidence 99999999999999999888887743 667888999999999999999 668999999999999975 4678999
Q ss_pred eccCcccCCCCC------------------------------------------CcceeeccccccceecccccccC-CC
Q 014623 235 DFGLAKAGPTGD------------------------------------------RTHVSTQVMGTHGYAAPEYVATG-RL 271 (421)
Q Consensus 235 Dfg~a~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~ 271 (421)
|||+|...+... .........||++|.|||++... .-
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997211000 00001124599999999998764 57
Q ss_pred CccccchhhhHHHHHHHhCCCccCCCcccchhh---hhhhh-----------hh--hhh--------chhhHhHhh--hc
Q 014623 272 TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS---LVDWA-----------KP--YLS--------DKRKLFRIM--DT 325 (421)
Q Consensus 272 ~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~---~~~~~-----------~~--~~~--------~~~~~~~~~--~~ 325 (421)
++++||||.|+|+..+++++.||.......+.. ...+. .. .+. ....-++-+ ..
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 889999999999999999999996544322110 00000 00 000 000000000 00
Q ss_pred cc--------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 326 KL--------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 326 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.. ........+..+.+|+.+||..||.+|.|+++.|..
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 011122345588999999999999999999999853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=269.23 Aligned_cols=196 Identities=20% Similarity=0.224 Sum_probs=137.8
Q ss_pred cCCC-CCccceeeEE-------EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceee
Q 014623 144 QLHH-PNLVKLIGYC-------LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 215 (421)
Q Consensus 144 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivH 215 (421)
.++| .||+.++++| .+...++++|||+ +++|.++|... ...+++..++.++.||+.||.||| .+||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH--SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH--hCCeee
Confidence 3445 5888888877 2334567889987 66999999643 345899999999999999999999 458999
Q ss_pred ccCCCCcEEeCCCC-------------------cEEEeeccCcccCCCCCC--------------cceeeccccccceec
Q 014623 216 RDFKASNILLDAEF-------------------NAKLSDFGLAKAGPTGDR--------------THVSTQVMGTHGYAA 262 (421)
Q Consensus 216 rDlkp~Nill~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~a 262 (421)
|||||+||||+..| .+||+|||+++....... .......+||++|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 455556665543211000 000112468899999
Q ss_pred ccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHH
Q 014623 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 342 (421)
Q Consensus 263 PE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 342 (421)
||++.+..|+.++|||||||+||||++|..|+...... ... +.. .... ...........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~-----------~~~---~~~~-~~~~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSS-----------LRH---RVLP-PQILLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHH-----------HHH---hhcC-hhhhhcCHHHHHH
Confidence 99999999999999999999999999998876532110 000 000 0000 0001113345688
Q ss_pred HHhccccCCCCCCCHHHHHH
Q 014623 343 ALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 343 i~~~l~~dP~~Rpt~~ell~ 362 (421)
+.+||..+|.+||++.+++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 99999999999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=222.91 Aligned_cols=264 Identities=22% Similarity=0.205 Sum_probs=199.1
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC----CCCccceeeEE-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH----HPNLVKLIGYC- 157 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----hp~iv~~~~~~- 157 (421)
+|++.+.||+|+||.||++.+.... ...+|+|............+..|..++..+. ..++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 7999999999999999999765421 4578999877653332235677888888886 26899999988
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-----CcEE
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-----FNAK 232 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-----~~~k 232 (421)
......++||+.+ |.+|.++........++..+...++.|++.+|.+|| ..|++||||||+|+++... ..+.
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~ 167 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLY 167 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEE
Confidence 4777889999998 899999886666677999999999999999999999 5589999999999999765 3599
Q ss_pred EeeccCcc--cCCCCCCc---c--e-eeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 233 LSDFGLAK--AGPTGDRT---H--V-STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 233 l~Dfg~a~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
|.|||+++ ........ . . ...+.||..|.++.+..+...+.+.|+||++.++.+|+.|.+||........
T Consensus 168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-- 245 (322)
T KOG1164|consen 168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-- 245 (322)
T ss_pred EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--
Confidence 99999998 32222111 0 1 1235699999999999999999999999999999999999999966442211
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.....+..............+..+.++...+-..+...+|....+...|......
T Consensus 246 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 -----------KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -----------HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 0111111111111112233455666777777778999999999999998776543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=206.84 Aligned_cols=166 Identities=25% Similarity=0.220 Sum_probs=126.0
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceee
Q 014623 173 GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252 (421)
Q Consensus 173 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 252 (421)
|+|.+++..++ ..+++..++.++.|++.||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999997543 4599999999999999999999953 3 999999999999999 99987653321
Q ss_pred ccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccC--CC
Q 014623 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQ 330 (421)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 330 (421)
..|++.|+|||++.+..++.++|||||||++|||++|..||....... ..... +......... ..
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~~ 130 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEI-----------LLNGMPADDPRDRS 130 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHH-----------HHHHhccCCccccc
Confidence 368999999999999999999999999999999999999996532110 00000 0000000000 01
Q ss_pred CCHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 331 YPQKAAH--TAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 331 ~~~~~~~--~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.+..... .+.++|.+||..+|.+||++.++++.+..+.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1233444 6999999999999999999999999887653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=222.73 Aligned_cols=178 Identities=17% Similarity=0.136 Sum_probs=132.3
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-----ccCHHHHHHHHHHHhcCCCCCccce
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
....+|.+.+.||+|+||+||+|++... ++..+|||++.... ......+.+|+++|+.++|+||+..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 4457899999999999999999976532 36778999875331 1123568899999999999999853
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC-CCCcEEeCCCCcEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAK 232 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~k 232 (421)
+.. .+..|+||||++|++|.. +.. .. ...++.+++.+|.|||+ .||+|||| ||+|||++.++.+|
T Consensus 87 l~~---~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 87 LLA---TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred EEE---cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEE
Confidence 322 246799999999999963 211 11 14578899999999994 58999999 99999999999999
Q ss_pred EeeccCcccCCCCCCcce------eeccccccceecccccccCC------CCccccch
Q 014623 233 LSDFGLAKAGPTGDRTHV------STQVMGTHGYAAPEYVATGR------LTTKSDVY 278 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Diw 278 (421)
|+|||+|+.+........ ....++++.|+|||.+.... .+...|-|
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999999986543321111 13467889999999886432 23346666
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=201.24 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=196.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 160 (421)
-.|++++.||+|.||+.+.|.. .-+++.||||.-.... ..-.+..|.+..+.|. .++|..+|-+..++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~N---------l~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKN---------LYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred ccceeccccccCcceeeecccc---------cccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 4799999999999999999943 3358899999754332 2234667888888774 79999999888888
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-----cEEEee
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-----NAKLSD 235 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-----~~kl~D 235 (421)
.+..||||++ |-+|+|++.--+ ..++..++..++.|++.-++|+|++ .+|+|||||+|+||..-+ .|.|+|
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k--~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK--DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc--ceeecccCccceeecCCCCCCCceEEEEe
Confidence 8899999998 889999875433 4599999999999999999999955 599999999999996433 489999
Q ss_pred ccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 236 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|+.+.+.... .......||.+||+-....|..-+.+.|+-|||-+++++|-|.+||.+..-..
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--------- 243 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--------- 243 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc---------
Confidence 9999876543321 12345679999999999999999999999999999999999999998754211
Q ss_pred hhhhchhhHhHhhhcccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 311 PYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.+....++-+.+..-. .....+.++..-+.-.-..+-.+-|..+-+...+..+.
T Consensus 244 ----nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 244 ----NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ----hHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 1122222222221111 11345667777777777778888888877776665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=240.01 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=190.8
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEec-----CCCccCH-HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-----PEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
....++|.|++|.|+....... .+.++.|.+. .+..... ..+..|+.+-..|.|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~---------~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSD---------LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEecCC---------CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 5678899999998877654332 2223333222 1111111 12556788888899999998888777
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.....-+||||++ +|+.++.+.. .+....+..++.|++.||.|+|+ .||.|||||++|+++..+|.+||+|||.
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~~~~g~lki~Dfg~ 466 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLVTENGILKIIDFGA 466 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEEecCCceEEeecCc
Confidence 76666666999999 9999997763 37788889999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCc--ceeeccccccceecccccccCCCCc-cccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhh
Q 014623 239 AKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTT-KSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLS 314 (421)
Q Consensus 239 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~ 314 (421)
+..+...... .....++|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.......... ...+... ..
T Consensus 467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~-~~ 545 (601)
T KOG0590|consen 467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ-RN 545 (601)
T ss_pred ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc-cc
Confidence 9876554444 5566789999999999999999988 5899999999999999999997654432221 0000000 00
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
.... .......++...+.+|.+||+.||.+|.|+++|++ +++.+
T Consensus 546 ~~~~---------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 546 IFEG---------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred cccC---------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 0000 00112466778899999999999999999999985 44443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=195.33 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=196.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 158 (421)
....|++++.||.|+||.+|+|.. ..+|+.||||+-+... ....+..|.++.+.|+ ...|..+.-++.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~---------i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGIS---------ITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eccceEEEEeecCCchhheeeeee---------ccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 346799999999999999999944 4469999999876543 2345778999999987 477888888888
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC---CcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~D 235 (421)
+.....|||+.+ |.+|.+++.--. ..++..+++.++.|++.-++|+| .+++|||||||+|+|..-+ ..+.|+|
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEe
Confidence 888999999998 889999885322 34888999999999999999999 5579999999999999644 4589999
Q ss_pred ccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 236 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+++.+.+.... .......||..|.+-....+...+.+.|+-|+|.+|.++.-|.+||.+.......
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~------- 230 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK------- 230 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-------
Confidence 9999876543221 1223467999999988777788888999999999999999999999875432211
Q ss_pred hhhhchhhHhHhhhcccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 311 PYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
++..++.+.+.... .-...+.++.-.+.-|-..--++-|+..-+...+.-+-
T Consensus 231 ------QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 231 ------QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred ------HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 11222222222111 12345667777788888887888888776666555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=202.07 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=199.2
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
.+..+|.+...|..|+|+|..+ -+++|++....... ..+|..|.-.|+-+.||||+.+++.|....+
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 4456688999999999998753 36777776544332 2467889999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe--eccCcc
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS--DFGLAK 240 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~--Dfg~a~ 240 (421)
+.++..|++.|+|+..++......++..++.+++.++++|++|||+.+.=|.---|....++||++.+.+|. |--++.
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999998887777888899999999999999999977545555788999999999887774 321111
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCC---ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
........+.||+||.+....-+ .++|+|||.+++|||.|...||..... .+
T Consensus 342 ---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp----------------me 396 (448)
T KOG0195|consen 342 ---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP----------------ME 396 (448)
T ss_pred ---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc----------------hh
Confidence 11123357899999999876543 479999999999999999999975431 22
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.-.++....++...|+.++..+..|+.-|++.||.+||.+..|+-.|+++.
T Consensus 397 cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233445566777888999999999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=204.64 Aligned_cols=253 Identities=33% Similarity=0.462 Sum_probs=195.0
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCC-CccceeeEEEe
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHP-NLVKLIGYCLE 159 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp-~iv~~~~~~~~ 159 (421)
|.+.+.||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 678899999999999999654 568999987654433 56788999999999988 79999999977
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeecc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFG 237 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg 237 (421)
....+++++++.++++.+++..... ..+.......++.|++.++.|+|. .+++||||||+||+++..+ .++++|||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 7778999999999999977755432 258889999999999999999994 4799999999999999988 69999999
Q ss_pred CcccCCCCCCcc----eeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 238 LAKAGPTGDRTH----VSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 238 ~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
++.......... ......|+..|++||.+.+ ..++...|+|++|++++++++|..||.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~--------- 218 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS--------- 218 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---------
Confidence 998554333221 2356789999999999987 578889999999999999999999976543210
Q ss_pred hhhhchhhHhHhhhcc----cCCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTK----LGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
........+... ...... ......+.+++.+|+..+|..|.+..+....
T Consensus 219 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 219 ----ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----cHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000100000 000111 2234678899999999999999988877653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=193.69 Aligned_cols=172 Identities=12% Similarity=0.074 Sum_probs=132.2
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHH---------HHHHHHHHhcCCCCC
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---------WLTEVNYLGQLHHPN 149 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hp~ 149 (421)
...++|++.++||.|+||.||++.. ++..+|||++.......... +.+|++.+.++.|++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G 96 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG 96 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence 3568999999999999999998632 14569999997554333222 578999999999999
Q ss_pred ccceeeEEEeC--------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCC
Q 014623 150 LVKLIGYCLEG--------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 221 (421)
Q Consensus 150 iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 221 (421)
|..+.+++... ...+|||||++|.+|.++.. ++. ....+++.+|..|| ..|++||||||+
T Consensus 97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~ 164 (232)
T PRK10359 97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH--QHGMVSGDPHKG 164 (232)
T ss_pred CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH--HcCCccCCCChH
Confidence 99999886643 35789999999999988641 222 24568899999999 558999999999
Q ss_pred cEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHH
Q 014623 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELL 288 (421)
Q Consensus 222 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 288 (421)
||+++.+| ++|+|||........... ..++....|+.++|+|+||+++..+.
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988 999999988754321111 00344555778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=181.10 Aligned_cols=139 Identities=17% Similarity=0.178 Sum_probs=106.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--C-------H-----------------HHHHHHHH
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--G-------H-----------------KEWLTEVN 140 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~ 140 (421)
...||+|+||.||+|... +|+.||||+++..... . . .....|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 578999999999999643 4889999999754211 1 0 11234999
Q ss_pred HHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCceeeccCC
Q 014623 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAESQVIYRDFK 219 (421)
Q Consensus 141 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrDlk 219 (421)
++..+.++++.....+.. ...+|||||+.|+++...+... ..++...+..++.|++.+|.++ |+ .||+|||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlk 145 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD--CRLVHADLS 145 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCC
Confidence 999998887754433322 2238999999888776554333 3488899999999999999999 64 479999999
Q ss_pred CCcEEeCCCCcEEEeeccCcccC
Q 014623 220 ASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 220 p~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
|+|||++ ++.++|+|||+|...
T Consensus 146 P~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 146 EYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHEEEE-CCcEEEEEccccccC
Confidence 9999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.4e-23 Score=189.22 Aligned_cols=197 Identities=22% Similarity=0.299 Sum_probs=141.4
Q ss_pred CCCCccceeeEEEe---------------------------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 014623 146 HHPNLVKLIGYCLE---------------------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198 (421)
Q Consensus 146 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 198 (421)
+|||||.++++|.+ ...+|+||..++ .+|..++..+. .+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 49999999887763 234689999884 49999997665 566777888999
Q ss_pred HHHHHHHhhhCCCceeeccCCCCcEEe--CCCC--cEEEeeccCcccCCCCC----CcceeeccccccceecccccccCC
Q 014623 199 AAKGLTFLHDAESQVIYRDFKASNILL--DAEF--NAKLSDFGLAKAGPTGD----RTHVSTQVMGTHGYAAPEYVATGR 270 (421)
Q Consensus 199 i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~ 270 (421)
+++|+.||| +.||.|||||.+|||| ++++ .++|+|||+|-.-+... ........-|...-||||+.....
T Consensus 350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 4589999999999999 4443 37899999885422211 111122345778899999875322
Q ss_pred -----C-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHH
Q 014623 271 -----L-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL 344 (421)
Q Consensus 271 -----~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 344 (421)
. -.++|.|+.|.+.||+++..-||.+...... +... .........+..+++.+.+|+.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L------------~~r~----Yqe~qLPalp~~vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL------------DTRT----YQESQLPALPSRVPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee------------chhh----hhhhhCCCCcccCChHHHHHHH
Confidence 1 2389999999999999999999976322110 0000 1111222356678889999999
Q ss_pred hccccCCCCCCCHHHHHHHH
Q 014623 345 QCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 345 ~~l~~dP~~Rpt~~ell~~L 364 (421)
.+|+.||.+|++..-....|
T Consensus 492 ~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHhcCCccccCCccHHHhHH
Confidence 99999999999876555444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-24 Score=207.13 Aligned_cols=229 Identities=28% Similarity=0.358 Sum_probs=181.2
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 165 (421)
++|.|.||.|+++.-. .....|..+|+|++++..... ......|..++..++ ||.+|++.-.+......++
T Consensus 1 vlg~g~~gkvfLvrk~------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHh------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 4799999999986321 223357788999887543321 113345778888886 9999999999999999999
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCC
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 245 (421)
++++..||+|...+.+... +.+.....+...++.+++++| ..+|+|||+|++||+++.+|++++.|||+++..-..
T Consensus 75 ~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999999999887755433 566666777788999999999 568999999999999999999999999999865433
Q ss_pred CCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc
Q 014623 246 DRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325 (421)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (421)
.. .|||..|||||++. ....++|.||||+++++|++|..||... ....++.
T Consensus 151 ~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~- 201 (612)
T KOG0603|consen 151 KI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILK- 201 (612)
T ss_pred hh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhh-
Confidence 21 28999999999987 6788899999999999999999999751 1111111
Q ss_pred ccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 326 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.....|......+.+++..++..+|..|.-.
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1225678899999999999999999999854
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-22 Score=173.88 Aligned_cols=142 Identities=18% Similarity=0.148 Sum_probs=109.1
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---------------------C-----HHHHHHHH
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---------------------G-----HKEWLTEV 139 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~ 139 (421)
+.+.||+|+||.||+|.+. +|+.||||+++..... . ...+.+|.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 3578999999999999643 4889999998764211 0 11235788
Q ss_pred HHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCC
Q 014623 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 219 (421)
Q Consensus 140 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 219 (421)
+.+.++.|++|.....+... ..+|||||+.|+++...+... ..++......++.+++.+|.++|. ..||+|||||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlk 145 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLS 145 (190)
T ss_pred HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCC
Confidence 99999999988655444333 248999999887654433222 237778889999999999999995 1589999999
Q ss_pred CCcEEeCCCCcEEEeeccCcccCC
Q 014623 220 ASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 220 p~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|+|||++ ++.++|+|||++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecC
Confidence 9999998 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=212.61 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=176.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCH---HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGH---KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+|...+.||.+.|=+|.+|+.++ |. |+||++-+.. .-.. ++-+.|++ ...++|||.+.+.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 57778999999999999986543 44 8999886543 2222 33344555 55668999999988877
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.....|||-+|+.. +|+|.|..+.- +...+.+.|+.||+.||.-+| +.||+|||||.+||||+.-.=+.|+||-.
T Consensus 92 t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred hhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcccc
Confidence 77788999999955 99999955543 677788889999999999999 56899999999999999987899999965
Q ss_pred cccC-CCCCCcceeeccc----cccceecccccccC-----------CCCccccchhhhHHHHHHHh-CCCccCCCcccc
Q 014623 239 AKAG-PTGDRTHVSTQVM----GTHGYAAPEYVATG-----------RLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGI 301 (421)
Q Consensus 239 a~~~-~~~~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~ 301 (421)
-+.. ...+......-+. .-..|.|||.+-.. ..+++.||||+||+++||++ |+++|.-..
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--- 243 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--- 243 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---
Confidence 4321 1111111111122 23579999977431 15678999999999999999 688885321
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+..+-.....+.+...+.++ ...++.||..|++.||.+|.++++.|.....+.
T Consensus 244 ---L~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 244 ---LLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ---HHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11111000001111111111 226789999999999999999999998754443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=171.97 Aligned_cols=187 Identities=18% Similarity=0.131 Sum_probs=136.2
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC----HHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG----HKEWLTEVNYLGQLH-HPNLVKLIGYCLE 159 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 159 (421)
-+...|++|+||+||.+.. .+..++.+.+.....-. ...+.+|+++|++|. |++|++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 3567899999999997632 36778877776543311 124778999999995 5889999886
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC-CCCcEEeCCCCcEEEeeccC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF-KASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl-kp~Nill~~~~~~kl~Dfg~ 238 (421)
+..+++|||+.|.+|...+.. . ...++.+++.+|.++| ..||+|||| ||+|||++.+|.++|+|||+
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~------~---~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR------G---DLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh------h---hHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 456999999999998754321 1 1346788999999999 458999999 79999999999999999999
Q ss_pred cccCCCCCCc---ce--------eeccccccceecccccccC-CCC-ccccchhhhHHHHHHHhCCCccCCC
Q 014623 239 AKAGPTGDRT---HV--------STQVMGTHGYAAPEYVATG-RLT-TKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 239 a~~~~~~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
+......... .. ..-...++.|+.|+...-. ..+ ...+.++.|+-+|.++|+..++-..
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9864432210 00 0011257778888744322 223 4678999999999999999887543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=184.52 Aligned_cols=233 Identities=20% Similarity=0.271 Sum_probs=146.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCC----------CC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHH----------PN 149 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------p~ 149 (421)
.++.++.||.|+++.||.+.+.. +++.+|+|++..... ...+.+.+|.-....+.+ -.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r 83 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR 83 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence 45667899999999999996544 689999999864432 223455566554444322 12
Q ss_pred ccceeeEEE---------eC---C-----eEEEEEEcCCCCChHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHhh
Q 014623 150 LVKLIGYCL---------EG---E-----NRLLVYEFMPKGSLENHLF---RRGPQ--PLSWAVRMKVAIGAAKGLTFLH 207 (421)
Q Consensus 150 iv~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~---~~~~~--~~~~~~~~~~~~~i~~~l~~lH 207 (421)
++..++... .. . +.+++|+-+ -++|.+++. ..... .+.....+.+..|++..+++||
T Consensus 84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 333333222 11 1 236788877 568888763 22221 2334455666689999999999
Q ss_pred hCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc--------CCCCccccchh
Q 014623 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--------GRLTTKSDVYS 279 (421)
Q Consensus 208 ~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diws 279 (421)
+ .|++|+||+|+|+|++.+|.++|+||+.....+... .. ...+..|.+||.... -.++.+.|.|+
T Consensus 163 ~--~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 S--YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp H--TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred h--cceEecccceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 5 479999999999999999999999999887643211 11 234577999997643 24788999999
Q ss_pred hhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCC
Q 014623 280 FGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354 (421)
Q Consensus 280 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 354 (421)
||+++|.|.+|..||+......... . .+ ..+. ++++.+..||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~------------~--------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPE------------W--------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSG------------G--------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCcccccc------------c--------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999998653221110 0 11 1344 889999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=200.09 Aligned_cols=196 Identities=21% Similarity=0.237 Sum_probs=153.7
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGY 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 156 (421)
....|.|.+.||+|+||+||+|...+ |+.||+|+-+....-. |.--.+++.+|+ -+.|..+...
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~----------~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN----------GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC----------CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHH
Confidence 34568888999999999999995432 8999999877653221 111223344444 3566677777
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-------CC
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EF 229 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-------~~ 229 (421)
+...+.-+||+||.+.|+|.+++. ..+.+++...+.+..|++..++.||. .+|||+||||+|+||.. .-
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCccc
Confidence 777888899999999999999997 44569999999999999999999994 57999999999999942 33
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCC
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 292 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 292 (421)
.++|+|||.+..+.--.........++|-.+-.+|+..|..++..+|.|.|..+++-||.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 499999999864322111223445778999999999999999999999999999999999973
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=166.20 Aligned_cols=136 Identities=20% Similarity=0.206 Sum_probs=103.8
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-----CCCCccceeeEEEe
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-----HHPNLVKLIGYCLE 159 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 159 (421)
.-.+.||+|+||.||. ... ++.. +||++........+.+.+|+++++.+ .||||+++++++..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 3457899999999995 211 2333 68988765445567789999999999 57999999999987
Q ss_pred CC---e-EEEEEEc--CCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhhCCCceeeccCCCCcEEeCC----C
Q 014623 160 GE---N-RLLVYEF--MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL-TFLHDAESQVIYRDFKASNILLDA----E 228 (421)
Q Consensus 160 ~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l-~~lH~~~~~ivHrDlkp~Nill~~----~ 228 (421)
+. . +.+|||| +.+++|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~--~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD--NRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEeccCCCC
Confidence 64 3 3378999 5579999999553 24544 35577777777 89994 57999999999999964 3
Q ss_pred CcEEEeeccCc
Q 014623 229 FNAKLSDFGLA 239 (421)
Q Consensus 229 ~~~kl~Dfg~a 239 (421)
+.++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 47999996544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-22 Score=202.02 Aligned_cols=208 Identities=26% Similarity=0.327 Sum_probs=143.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.+|..++.|..|+||.||+++.+. +...+|+|+-+.+ .+++- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~---------trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccc---------cccchhhcccccc------hhhhc--cccccCCccee----------
Confidence 578899999999999999985543 4567888543221 11111 22333344443
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
|+-..++..-+..+... +.+++|||+ .||+|||+||+|.||+.-|++|++|||+.+.
T Consensus 136 -----------gDc~tllk~~g~lPvdm----------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM----------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred -----------chhhhhcccCCCCcchh----------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhh
Confidence 34444443333333222 678999994 5899999999999999999999999999875
Q ss_pred CCCCCCc-------------ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccch-hhhhh
Q 014623 242 GPTGDRT-------------HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-QSLVD 307 (421)
Q Consensus 242 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~ 307 (421)
....... ......|||+.|.|||++....|+..+|+|++|+|+||++-|+.||.++..... ..++.
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 3221111 112346899999999999999999999999999999999999999988643211 01110
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 355 (421)
. .....+-....+.+++++|.++|+.+|..|-
T Consensus 273 d----------------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 D----------------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h----------------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 0000111345677899999999999999997
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.9e-22 Score=186.87 Aligned_cols=173 Identities=27% Similarity=0.378 Sum_probs=127.9
Q ss_pred eEEEEEEcCCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 162 NRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
.+|+.|++|...+|.+||..+ .....++.....++.|++.+++| ++.+|+|+||.||+...+..+||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence 578999999999999999643 33457788889999999999999 369999999999999999999999999998
Q ss_pred cCCCCC----CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 241 AGPTGD----RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 241 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
...... .....+..+||.+||+||++.+..|+.++||||||+||+||+. =...|...
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------------ 466 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------------ 466 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------------
Confidence 655433 1223456789999999999999999999999999999999997 22222110
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 359 (421)
..+..+-+..+...+ ..--+.-..|+.++|...|.+||++.+
T Consensus 467 -~t~~d~r~g~ip~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 -ATLTDIRDGIIPPEF-LQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -HhhhhhhcCCCChHH-hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 000011111110000 111224457999999999999994433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=179.33 Aligned_cols=216 Identities=25% Similarity=0.387 Sum_probs=161.9
Q ss_pred HhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCC
Q 014623 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 221 (421)
Q Consensus 142 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~ 221 (421)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.....++.+|+.||.|||+..- ..|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence 4678899999999999999999999999999999999965 44568999999999999999999996432 389999999
Q ss_pred cEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCC-------CCccccchhhhHHHHHHHhCCCcc
Q 014623 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-------LTTKSDVYSFGVVLLELLSGRCAV 294 (421)
Q Consensus 222 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~el~tg~~pf 294 (421)
|++++....+||+|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987754211111112223456799999887642 356799999999999999999999
Q ss_pred CCCcccch-hhhhhhhhhhhhchhhHhHhhhcccCCCCC--HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 295 DKTKVGIE-QSLVDWAKPYLSDKRKLFRIMDTKLGGQYP--QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 295 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
+....... ..+...... ......+.... ....+++..++..||..+|.+||++..+-..++.+-.
T Consensus 159 ~~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 76433221 111111110 00000111111 1445578999999999999999999999988877654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5e-20 Score=166.37 Aligned_cols=147 Identities=17% Similarity=0.106 Sum_probs=110.4
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------------------------CHHH
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------------------------GHKE 134 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~ 134 (421)
.....|.+.+.||+|+||.||+|.++ ..+|+.||+|+++..... ....
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~--------~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDF--------DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLW 96 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEec--------CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHH
Confidence 33446899999999999999999622 225889999998754211 0122
Q ss_pred HHHHHHHHhcCCCCC--ccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCc
Q 014623 135 WLTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ 212 (421)
Q Consensus 135 ~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 212 (421)
+.+|++++..+.+.+ +.+++++ ...++||||+.|.+|..++.... .........++.|++.+|.+|| ..|
T Consensus 97 ~~~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~g 168 (237)
T smart00090 97 AEKEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY--KEG 168 (237)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH--hcC
Confidence 457999999997532 3344432 23589999999988876553322 3555667789999999999999 557
Q ss_pred -eeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 213 -VIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 213 -ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
|+||||||+||+++ ++.++|+|||++...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999999999 889999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=160.83 Aligned_cols=134 Identities=21% Similarity=0.311 Sum_probs=111.3
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.||+|++|.||+|.+. |..+++|+........ ...+.+|+.++..+.|++|.....++..
T Consensus 2 ~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 70 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD 70 (211)
T ss_pred cccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence 67999999999999652 5678999866433211 1356789999999999999888777777
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||++|++|.+++.... . ....++.+++.+|.++| ..|++|+|++|.|||++ ++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 888899999999999999985432 1 67889999999999999 45799999999999999 788999999988
Q ss_pred cc
Q 014623 240 KA 241 (421)
Q Consensus 240 ~~ 241 (421)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 64
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=158.85 Aligned_cols=130 Identities=20% Similarity=0.352 Sum_probs=104.8
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--------GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.||+|+||.||+|.+. +..+++|........ ...++.+|+++++.+.|+++.....++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4899999999999642 567899986543221 124567899999999988776666666677
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||++|++|.+++..... .++.+++.+|.+|| ..|++|+|++|+||+++ ++.++|+|||++.
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 778999999999999998744321 77899999999999 45799999999999999 7899999999987
Q ss_pred c
Q 014623 241 A 241 (421)
Q Consensus 241 ~ 241 (421)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=156.03 Aligned_cols=145 Identities=17% Similarity=0.058 Sum_probs=109.5
Q ss_pred HHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc----------------------CHH
Q 014623 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ----------------------GHK 133 (421)
Q Consensus 76 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~ 133 (421)
++......|.+.+.||+|+||.||++... +|+.||||++...... ...
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRL 78 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHH
Confidence 33334445899999999999999998642 4789999987643210 011
Q ss_pred HHHHHHHHHhcCCCCC--ccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 014623 134 EWLTEVNYLGQLHHPN--LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 211 (421)
Q Consensus 134 ~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 211 (421)
.+.+|+.++..+.|.+ +...++ ....++||||++|++|.++... .....++.+++.++.++|. .
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~ 144 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--H 144 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--C
Confidence 2567888888887774 444443 2456899999999998765421 2345788899999999994 5
Q ss_pred ceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 212 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 212 ~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
||+||||||+||++++++.++|+|||++.....
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 899999999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.6e-19 Score=179.57 Aligned_cols=137 Identities=21% Similarity=0.272 Sum_probs=109.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC--Cc------cCHHHHHHHHHHHhcCCCCCccc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE--GF------QGHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
...|...+.||+|+||+||+|.+.. ..+++|+.... .. ...+++.+|+++++.++|++|+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 400 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence 3456778999999999999987643 22333332111 11 11245789999999999999998
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
...++......++||||++|++|.+++. ....++.+++.+|.+|| ..|++||||||+|||+ .++.++
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEE
Confidence 8877777778899999999999999884 34678899999999999 4579999999999999 677899
Q ss_pred EeeccCccc
Q 014623 233 LSDFGLAKA 241 (421)
Q Consensus 233 l~Dfg~a~~ 241 (421)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-20 Score=185.60 Aligned_cols=256 Identities=23% Similarity=0.250 Sum_probs=193.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCC-CCCccceeeEEEe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLE 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 159 (421)
.|.+.+.||+|+|+.|-+...... ....+|+|.+.... ....+....|..+-+.+. |.|++.+++...+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence 577788899999999987644321 24567777665443 122233345777777787 9999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeeccC
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~ 238 (421)
.+..+++++|..|+++.+.+........+...+..++.|+..++.|+|. ..++.|+||||+|.+++..+ .+++.|||+
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999999999999998832222235566677899999999999995 34799999999999999999 999999999
Q ss_pred cccCCC-CCCcceeecccc-ccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPT-GDRTHVSTQVMG-THGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|..+.. ..........+| ++.|+|||...+. ......|+||.|+++..+++|..|+.........
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------ 239 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------ 239 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc------------
Confidence 988766 444445556788 9999999998885 4566899999999999999999999765432210
Q ss_pred hhhHhHhhhc--ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....... ...............+++.+++..+|..|.+.+++..
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 240 ---YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---ceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0111111 1112233566778889999999999999999888753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-17 Score=147.10 Aligned_cols=135 Identities=21% Similarity=0.223 Sum_probs=100.8
Q ss_pred Cceec-ccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-------------cCHHHHHHHHHHHhcCCCCCc--
Q 014623 87 DSLLG-EGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-------------QGHKEWLTEVNYLGQLHHPNL-- 150 (421)
Q Consensus 87 ~~~lg-~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~i-- 150 (421)
...|| .||.|+||.+... +..++||.+..... ....++.+|+.++..|.|++|
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v 104 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV 104 (239)
T ss_pred CceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC
Confidence 35576 7888888877542 56789988753221 122467889999999998775
Q ss_pred cceeeEEEeCC----eEEEEEEcCCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 151 VKLIGYCLEGE----NRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 151 v~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
+..+++..... ..++|||+++| .+|.+++... .++.. .+.+++.+|.+|| ..||+||||||+|||+
T Consensus 105 P~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv 175 (239)
T PRK01723 105 PRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILL 175 (239)
T ss_pred ceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEE
Confidence 66676644322 23599999997 6898887542 24443 3568899999999 5589999999999999
Q ss_pred CCCCcEEEeeccCccc
Q 014623 226 DAEFNAKLSDFGLAKA 241 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~ 241 (421)
+.++.++|+|||.+..
T Consensus 176 ~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 DPDGKFWLIDFDRGEL 191 (239)
T ss_pred cCCCCEEEEECCCccc
Confidence 9999999999998875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.8e-17 Score=134.67 Aligned_cols=134 Identities=20% Similarity=0.097 Sum_probs=111.0
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CCccceeeEEEeCCeE
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEGENR 163 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~ 163 (421)
+.+.||.|.++.||++... +..+++|....... ...+.+|+.+++.+.| .++.+++.++...+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4578999999999999653 25799999876543 4567889999999976 5899999888877889
Q ss_pred EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC-CceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 164 LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 164 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
+++|||+.|+.+..+ +......++.+++.+|+++|... .+++|+||+|+||+++..+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988777653 44566778899999999999532 4799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=141.33 Aligned_cols=138 Identities=22% Similarity=0.142 Sum_probs=95.6
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHH----------------------HHHHHHH
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKE----------------------WLTEVNY 141 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~ 141 (421)
+.+.||+|+||+||+|... +++.||||++....... ... ...|...
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 70 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN 70 (187)
T ss_pred CCcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence 3578999999999999643 37889999987532211 111 1245555
Q ss_pred HhcCCCC--CccceeeEEEeCCeEEEEEEcCCCCChHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC
Q 014623 142 LGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENH-LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218 (421)
Q Consensus 142 l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 218 (421)
+..+.+. .+.+.+++ ...++||||+.++.+... +.... .. ..+..++.+++.++.++|. ..||+|+||
T Consensus 71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl 141 (187)
T cd05119 71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR-EAGLVHGDL 141 (187)
T ss_pred HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCC
Confidence 6555433 24444432 346899999998544321 11111 11 5567889999999999995 158999999
Q ss_pred CCCcEEeCCCCcEEEeeccCcccCC
Q 014623 219 KASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 219 kp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
||+||+++ ++.++|+|||.+....
T Consensus 142 ~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 142 SEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ChhhEEEE-CCcEEEEECccccccc
Confidence 99999999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-15 Score=143.74 Aligned_cols=252 Identities=24% Similarity=0.236 Sum_probs=183.5
Q ss_pred cCCCCCceecc--cCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC-CCCccceeeE
Q 014623 82 RNFRPDSLLGE--GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH-HPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hp~iv~~~~~ 156 (421)
..+.+.+.+|. |.+|.||.+.... ..++..+|+|.-+.... .....=++|+...+.++ |+|.++.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 46778899999 9999999986532 33578899987433221 22223346777777774 9999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhhCCCceeeccCCCCcEEeCCC-CcE
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK----GLTFLHDAESQVIYRDFKASNILLDAE-FNA 231 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~----~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~ 231 (421)
+...+..++-+|+| +.+|..+...... -++...++..+.+... ||.++|+ ++++|-|+||+||++..+ ..+
T Consensus 187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs--~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHS--NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCC--Ccccccccchhheeccccccee
Confidence 99999999999999 5788888765443 2666777888888888 9999994 579999999999999999 889
Q ss_pred EEeeccCcccCCCCCCcce---eeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHV---STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 308 (421)
+++|||+...+..+..... .....|...|++||. ..+.++...|||+||.++.+..++............
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W------ 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW------ 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCCc------
Confidence 9999999988766552221 122357788999995 466788999999999999999998766543211100
Q ss_pred hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.++-...+..++-...+.++..++..|++.++-.|++...+..
T Consensus 336 -----------~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 -----------SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0100111222233344556666999999999999999877764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=140.97 Aligned_cols=141 Identities=19% Similarity=0.149 Sum_probs=95.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH----------------------------------
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---------------------------------- 132 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------------- 132 (421)
.+.||.|++|.||+|... +|+.||||+.+.......
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 467999999999999764 378999999865421100
Q ss_pred ------HHHHHHHHHHhcCC----CCCccceeeEEE-eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 014623 133 ------KEWLTEVNYLGQLH----HPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201 (421)
Q Consensus 133 ------~~~~~E~~~l~~l~----hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~ 201 (421)
-++.+|++.+.++. |.+-+.+-.++. .....+|||||++|++|.++...... ... ...++..++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLAR 267 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHH
Confidence 01345555555542 222233222222 23456899999999999987643211 122 2334555544
Q ss_pred -HHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 202 -GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 202 -~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
.+..+| ..|++|+|++|.||+++.++.++|+|||++....
T Consensus 268 ~~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 268 SFLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 367788 4589999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.3e-13 Score=131.70 Aligned_cols=164 Identities=20% Similarity=0.220 Sum_probs=124.3
Q ss_pred CCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHH
Q 014623 115 SGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194 (421)
Q Consensus 115 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 194 (421)
++..|.|...+...........+-++.|+.|+||||+++++.++.....|||+|.+ ..|..++.+.+ ......
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~ 108 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL 108 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence 46778888776654433345667888999999999999999999999999999998 47777775543 455667
Q ss_pred HHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCcc
Q 014623 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 274 (421)
Q Consensus 195 ~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 274 (421)
.+.||+.||.|||+ +.+++|++|.-+.|+|++.|.+||++|.++........ ......--..|..|+.+.... -.
T Consensus 109 Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s 183 (690)
T KOG1243|consen 109 GLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WS 183 (690)
T ss_pred HHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cc
Confidence 78899999999986 45799999999999999999999999998875433221 011111223456666432222 34
Q ss_pred ccchhhhHHHHHHHhC
Q 014623 275 SDVYSFGVVLLELLSG 290 (421)
Q Consensus 275 ~DiwslG~il~el~tg 290 (421)
.|.|.|||++++++.|
T Consensus 184 ~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 IDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhhHHHHHHHHhCc
Confidence 6999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6.4e-14 Score=126.05 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=137.0
Q ss_pred HhcCCCCCccceeeEEEeCC-----eEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCcee
Q 014623 142 LGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214 (421)
Q Consensus 142 l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 214 (421)
|-.+-|.|||+++.|+.+.. ...++.||+..|+|..+|++. ....+......+|+.||+.||.|||+....|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 44456999999998877544 467999999999999999653 33457777888999999999999999998999
Q ss_pred eccCCCCcEEeCCCCcEEEeeccCcccCC--CCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCC
Q 014623 215 YRDFKASNILLDAEFNAKLSDFGLAKAGP--TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 292 (421)
Q Consensus 215 HrDlkp~Nill~~~~~~kl~Dfg~a~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 292 (421)
|+++..+-|++..+|-+||+----..... ............+-++|.+||.-.....+.++|||+||....+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999999999999988885211100000 0000001112335688999996655667779999999999999998865
Q ss_pred ccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 293 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
--........ ....+... ... .....-+.++.+||...|..||++.+++..
T Consensus 281 q~tnseS~~~------------~ee~ia~~-i~~-------len~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 281 QSTNSESKVE------------VEENIANV-IIG-------LENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred ccCCCcceee------------hhhhhhhh-eee-------ccCccccCcCcccccCCCCCCcchhhhhcC
Confidence 4221110000 00000000 000 001112468889999999999999988743
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.3e-13 Score=116.83 Aligned_cols=130 Identities=21% Similarity=0.079 Sum_probs=93.7
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLV-KLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~l 165 (421)
.+.|+.|.++.||++... +..+++|+...... ....+.+|+.+++.+.+.+++ +++.+ .....++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence 367899999999998642 56799998765432 122356789999888655544 44443 3334589
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC---CceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
||||++|.++.+.. .. ...++.+++.+|+.||... .+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 69 v~e~i~G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 69 ITEFIEGSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEEecCCCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99999998876530 11 1235678999999999542 1359999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.1e-14 Score=139.49 Aligned_cols=144 Identities=17% Similarity=0.159 Sum_probs=92.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC------------------------------
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG------------------------------ 131 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 131 (421)
..|.. +.||+|++|.||+|..+. +|+.||||+++......
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 45666 789999999999997653 48899999997542100
Q ss_pred ----HH------HHHHHHHHHhcCC----CCCccceeeEEEe-CCeEEEEEEcCCCCChHHHH--hhcCC--CCCCHHHH
Q 014623 132 ----HK------EWLTEVNYLGQLH----HPNLVKLIGYCLE-GENRLLVYEFMPKGSLENHL--FRRGP--QPLSWAVR 192 (421)
Q Consensus 132 ----~~------~~~~E~~~l~~l~----hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l--~~~~~--~~~~~~~~ 192 (421)
.+ ++.+|+..+.++. +.+.+.+-.++.+ ....+|||||+.|+.|.++. ...+. ..+....+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 01 1334444444442 3333443333332 45568999999999998743 22221 01222223
Q ss_pred HHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----cEEEeeccCcccCCC
Q 014623 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----NAKLSDFGLAKAGPT 244 (421)
Q Consensus 193 ~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~~kl~Dfg~a~~~~~ 244 (421)
..++.|+. ..|++|+|+||.||+++.+| .++++|||++.....
T Consensus 270 ~~~~~Qif---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQVF---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHH---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33333432 34799999999999999888 999999999976543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=8.6e-13 Score=114.43 Aligned_cols=145 Identities=13% Similarity=0.124 Sum_probs=98.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---------------cc------C-HHHH----HHHHH
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---------------FQ------G-HKEW----LTEVN 140 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---------------~~------~-~~~~----~~E~~ 140 (421)
...||.|.-+.||.|...... .....+..+|||+.+... +. . .+.+ .+|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 467999999999999643210 011135789999875311 00 0 1122 37999
Q ss_pred HHhcCCC--CCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhCCCceeecc
Q 014623 141 YLGQLHH--PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL-HDAESQVIYRD 217 (421)
Q Consensus 141 ~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~ivHrD 217 (421)
.|+++.. -++..++++ ...+|||||+.+..+..-..+.. .++......+..+++.+|..| | ..||||+|
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGD 150 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK--ECNLVHAD 150 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH--hCCeecCC
Confidence 9998853 456666654 46689999997654422111211 244555667788999999998 7 45899999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
|++.|||++ ++.++|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.7e-12 Score=108.20 Aligned_cols=143 Identities=19% Similarity=0.219 Sum_probs=109.4
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--------GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.+.+|-+|+-+.|+++.+. |+.++||.-...... ..++..+|+++|.++.--.|.-..-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 5678999999999998664 677888864332221 235677899999998755665555567
Q ss_pred EeCCeEEEEEEcCCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc---EEE
Q 014623 158 LEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKL 233 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl 233 (421)
.+.....|+|||++| .++.+++...............++..|-+.+.-|| .++|||+||..+||+|..++. +.|
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEE
Confidence 788888999999976 47888887665444444444788899999999999 568999999999999966553 589
Q ss_pred eeccCccc
Q 014623 234 SDFGLAKA 241 (421)
Q Consensus 234 ~Dfg~a~~ 241 (421)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-12 Score=108.40 Aligned_cols=131 Identities=22% Similarity=0.323 Sum_probs=99.4
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..+++|+-+.+|.+.+. |..+++|.-....... ..+-.+|++++.++.--.|...+=++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 46889999999998553 3446666533222211 1345689999998876666555556677
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.....|+|||++|..|.+++... ...++..+-..+.-|| ..||+|+||.++||++..++ +.++||||+
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECCcc
Confidence 78888999999999999888654 1456677778888999 66899999999999998774 999999998
Q ss_pred cc
Q 014623 240 KA 241 (421)
Q Consensus 240 ~~ 241 (421)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 74
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.3e-13 Score=140.81 Aligned_cols=247 Identities=21% Similarity=0.227 Sum_probs=169.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.+.+.+.+-+|.++.++.+ ....+|...++|+......- ..+....+-.++-...+|.++...-.+.
T Consensus 804 d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~ 874 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP 874 (1205)
T ss_pred ccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence 45677778889999999876 23334555555554322111 1111122222222234566666555555
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.....+|+|+|+.+++|...++..+ +.+..-....+..+..+++|||+. .++|+|++|.|+|+..+|..++.|||.
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~--~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS--LRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc--hhhcccccccchhhcccCCcccCcccc
Confidence 6677899999999999999987655 355555566777788899999953 489999999999999999999999984
Q ss_pred cccCCCC--------C---------------------CcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh
Q 014623 239 AKAGPTG--------D---------------------RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289 (421)
Q Consensus 239 a~~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 289 (421)
....... . .........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 4321100 0 0001223578999999999999999999999999999999999
Q ss_pred CCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcc-c-CCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 290 GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK-L-GGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 290 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
|..||.....+ .+++.+... . ...-+...+.++.+++...|..++.+|-.+.
T Consensus 1031 g~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999765421 111111111 1 1122356778889999999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.3e-13 Score=129.76 Aligned_cols=248 Identities=21% Similarity=0.176 Sum_probs=173.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHH--HHHHHHHHhcC-CCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE--WLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
..+|.++..||.|.|+.|+....+ ..++..+++|.+...-.....+ -+.|+.+...+ .|.+++..+..+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r--------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKR--------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeec--------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 346888889999999999987532 2357789999887654333322 24566666666 488888888877
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEEEeec
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDF 236 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~Df 236 (421)
....+.|+-.|||+++++...+.- ...+++...+++..|++.++.++|++ .++|+|+||+||++..+ +..++.||
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~--~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK--LFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch--hhhcccccccceeeccchhhhhcccc
Confidence 777788899999999988766622 23377778889999999999999954 69999999999999876 77899999
Q ss_pred cCcccCCCCCCcceeecccccccee--cccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYA--APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|++..+... .....+.-+++ +++......+..+.|+|+||..+.+.+++...-....
T Consensus 412 ~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------------- 470 (524)
T KOG0601|consen 412 GCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---------------- 470 (524)
T ss_pred cccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------------
Confidence 998642211 11123334444 4444556678889999999999999998864322110
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
....+..... .........+..+.+.++..++..||.+.++....+.
T Consensus 471 ---~~~~i~~~~~--p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 ---QSLTIRSGDT--PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---cceeeecccc--cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0111111111 1112333777888999999999999998887655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-11 Score=109.55 Aligned_cols=141 Identities=21% Similarity=0.270 Sum_probs=103.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCC--CCccceeeEEEeC---C
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEG---E 161 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~---~ 161 (421)
+.|+.|.++.||++... +|+.+++|....... .....+.+|+++++.+.+ .++.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 67899999999998542 156799998765432 134567889999999875 3457777766553 2
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC--------------------------------
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-------------------------------- 209 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------------------------------- 209 (421)
..++||||++|.++.+.+.. ..++......++.+++.+|.+||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 56899999999888775531 1255666666777777777777731
Q ss_pred ----------------------CCceeeccCCCCcEEeCC--CCcEEEeeccCccc
Q 014623 210 ----------------------ESQVIYRDFKASNILLDA--EFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ----------------------~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~a~~ 241 (421)
...++|+|+.+.|||++. ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.4e-10 Score=107.00 Aligned_cols=168 Identities=20% Similarity=0.244 Sum_probs=124.5
Q ss_pred ceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE----eCCeEEEEEEcC
Q 014623 95 FGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL----EGENRLLVYEFM 170 (421)
Q Consensus 95 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~ 170 (421)
-.+.|+++.+. +|..+++|++.............-+++++++.|.|||++.++|. .+..+++|++|.
T Consensus 289 ~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 35677875443 58899999995443333323345678999999999999998877 345789999998
Q ss_pred CC-CChHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 171 PK-GSLENHLFRR-------------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 171 ~~-~~L~~~l~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
++ ++|.++-... .+....+..+|.++.|+..||.++|+ .|+..+-|.+.+||++.+.+++|...
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs--sGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS--SGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh--cCceeecccHhHeEeeCcceEEEecc
Confidence 76 5777765322 12347789999999999999999995 47989999999999999999999888
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCC
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC 292 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 292 (421)
|.......+.. |-+. --.+-|.=.||.+++.|.||..
T Consensus 438 ~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 438 GIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 77665443220 0011 1224688889999999999964
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.9e-10 Score=101.71 Aligned_cols=124 Identities=15% Similarity=0.138 Sum_probs=89.1
Q ss_pred CcEEEEEEecCCCcc-----------CHHHHHHHHHHHhcCCCCCc--cceeeEEEe-----CCeEEEEEEcCCCC-ChH
Q 014623 116 GMVVAVKKLKPEGFQ-----------GHKEWLTEVNYLGQLHHPNL--VKLIGYCLE-----GENRLLVYEFMPKG-SLE 176 (421)
Q Consensus 116 ~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~i--v~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 176 (421)
|+.+.||........ ....+.+|...+..|..-+| ..+++++.. ....+||||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 567899976433211 11146789998888853333 334445443 23578999999876 798
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-------CCcEEEeeccCccc
Q 014623 177 NHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-------EFNAKLSDFGLAKA 241 (421)
Q Consensus 177 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-------~~~~kl~Dfg~a~~ 241 (421)
+++........+......++.+++..+.-|| ..||+|+||++.|||++. ++.+.|+||+.+..
T Consensus 125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 125 DYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 8885432233556677789999999999999 558999999999999975 46799999998853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-09 Score=100.10 Aligned_cols=262 Identities=17% Similarity=0.162 Sum_probs=160.0
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeE------
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGY------ 156 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~------ 156 (421)
...++.||+|+-+.+|-.-. -.-.+.|+............ +..|... .||-+-.-+.|
T Consensus 13 i~~gr~LgqGgea~ly~l~e------------~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~ 77 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE------------VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLH 77 (637)
T ss_pred cCCCccccCCccceeeecch------------hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhh
Confidence 35678899999999996411 11235577765543332222 2223332 46544331111
Q ss_pred -EEeCCeEEEEEEcCCCCCh-HHHHh----hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 157 -CLEGENRLLVYEFMPKGSL-ENHLF----RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 157 -~~~~~~~~lv~e~~~~~~L-~~~l~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
...+...-++|..+.|..- .++.. ++.--...|...++.+..++.+.+.|| +.|.+-+|+.++|+|+++++.
T Consensus 78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCce
Confidence 0122236688888877532 22221 122234789999999999999999999 557999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhC-CCccCCCcccchh-
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQ- 303 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg-~~pf~~~~~~~~~- 303 (421)
+.|.|-+.-... .......-.+|...|.+||... +-.-+...|.|.||+++++|+.| +.||.+.....+.
T Consensus 156 V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 999975433221 1122233457899999999654 23346679999999999999996 9999765432111
Q ss_pred -----hhhhhhhhhhhchhhHhHhhhcccCCCC-CHHHHHHHHHHHHhccccC--CCCCCCHHHHHHHHHhhcC
Q 014623 304 -----SLVDWAKPYLSDKRKLFRIMDTKLGGQY-PQKAAHTAATLALQCLNNE--PKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 304 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d--P~~Rpt~~ell~~L~~~~~ 369 (421)
.+......+-.+. +.-...-.... -..+++++..|..+|+... +.-|||++.++..|..+..
T Consensus 233 ~p~E~~Ia~g~f~ya~~~----~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 233 NPLETDIAHGRFAYASDQ----RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred Ccchhhhhcceeeechhc----cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 0000000000000 00000000011 1356778888888998654 5689999999998887664
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.7e-10 Score=98.81 Aligned_cols=147 Identities=16% Similarity=0.077 Sum_probs=99.6
Q ss_pred cCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----------------------
Q 014623 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---------------------- 129 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------------- 129 (421)
..++.+.....-+.++..||-|.-+.||.|... .|..+|||.-+....
T Consensus 81 LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~ 150 (304)
T COG0478 81 LALHALVKRGIVEAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLY 150 (304)
T ss_pred HHHHHHHHcChHHhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhh
Confidence 334444444445778899999999999999654 388999997542110
Q ss_pred cCHHHHHHHHHHHhcCCCC--CccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 014623 130 QGHKEWLTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207 (421)
Q Consensus 130 ~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH 207 (421)
.......+|.++|..|... .|.+.+++ +...+||||++|-.|...-. ...+... ++..|++-+..+-
T Consensus 151 ~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~---il~~il~~~~~~~ 219 (304)
T COG0478 151 VSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDE---ILDKILEEVRKAY 219 (304)
T ss_pred hHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC----cccCHHH---HHHHHHHHHHHHH
Confidence 0112356899999999644 67777664 56789999999876654321 1122333 3333333333332
Q ss_pred hCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 208 ~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..||||+|+.+-|||++++|.++++||--+..
T Consensus 220 --~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 220 --RRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred --HcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 34799999999999999999999999976654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.3e-10 Score=95.48 Aligned_cols=97 Identities=22% Similarity=0.217 Sum_probs=62.5
Q ss_pred HHHHHHHHhcCCCC--CccceeeEEEeCCeEEEEEEcCC--CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhhC
Q 014623 135 WLTEVNYLGQLHHP--NLVKLIGYCLEGENRLLVYEFMP--KGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF-LHDA 209 (421)
Q Consensus 135 ~~~E~~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~-lH~~ 209 (421)
..+|++.|.++..- ++.+++++. ..+|||||+. |..+..+.... ++......++.+++..+.. +|
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~-- 124 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH-- 124 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH--
Confidence 56899999999755 466666542 3479999998 65555444322 1122344566677774544 57
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
..||+|+||.+.|||++++ .+.|+|||.+...
T Consensus 125 ~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 125 KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 5589999999999999888 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-10 Score=115.54 Aligned_cols=152 Identities=22% Similarity=0.310 Sum_probs=106.2
Q ss_pred HHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCccee-------eccccccceeccccccc
Q 014623 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS-------TQVMGTHGYAAPEYVAT 268 (421)
Q Consensus 196 ~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 268 (421)
+.+++.|+.|+|.. .++||++|.|++|.++.+|.+||+.|+.+............ .-..-...|.|||++.+
T Consensus 105 l~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hhcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34455999999974 58999999999999999999999999988654332111000 00123568999999999
Q ss_pred CCCCccccchhhhHHHHHHH-hCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhcc
Q 014623 269 GRLTTKSDVYSFGVVLLELL-SGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCL 347 (421)
Q Consensus 269 ~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 347 (421)
...+.++|+|||||++|.+. .|+.-+.......... .......--...+...++.++.+-+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 88899999999999999999 4555444332111110 11111111112234678889999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 014623 348 NNEPKLRPRMSEVLA 362 (421)
Q Consensus 348 ~~dP~~Rpt~~ell~ 362 (421)
..+..-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997776654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-08 Score=89.27 Aligned_cols=105 Identities=21% Similarity=0.215 Sum_probs=81.3
Q ss_pred HHHHHHHHHHhcCCCC--CccceeeEEEeC----CeEEEEEEcCCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 014623 133 KEWLTEVNYLGQLHHP--NLVKLIGYCLEG----ENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205 (421)
Q Consensus 133 ~~~~~E~~~l~~l~hp--~iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~ 205 (421)
.+..+|...+..|..- .+.+.+++.... ...+||+|++++. +|.+++..... .+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4677888888877533 344555655542 2458999999884 79998865333 5556678899999999999
Q ss_pred hhhCCCceeeccCCCCcEEeCCCC---cEEEeeccCccc
Q 014623 206 LHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKA 241 (421)
Q Consensus 206 lH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~a~~ 241 (421)
|| ..||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 134 lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99 55899999999999998887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.4e-08 Score=84.34 Aligned_cols=146 Identities=18% Similarity=0.143 Sum_probs=103.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC---C---ccCHHHHHHHHHHHhcCCCCC--ccce
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE---G---FQGHKEWLTEVNYLGQLHHPN--LVKL 153 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~hp~--iv~~ 153 (421)
..+.-.---|+||.+.|+..... |..+-+|.-..- . ......|.+|+..|+.|..-+ +.++
T Consensus 18 ~~wve~pN~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~p 86 (216)
T PRK09902 18 GDWVEEPNYRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKI 86 (216)
T ss_pred CceecCCCcCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCcc
Confidence 33433344577999999987543 345777765411 0 124567899999999885322 4444
Q ss_pred eeEEE-e----CCeEEEEEEcCCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 154 IGYCL-E----GENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 154 ~~~~~-~----~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
. ++. . .-..+||+|-+.| .+|.+++......+.+......++.+++..+.-|| ..|+.|+|+.+.|||++.
T Consensus 87 v-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~ 163 (216)
T PRK09902 87 V-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKT 163 (216)
T ss_pred c-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecC
Confidence 4 222 1 1235799998754 58888886654445677778889999999999999 558999999999999986
Q ss_pred CCc--EEEeeccCccc
Q 014623 228 EFN--AKLSDFGLAKA 241 (421)
Q Consensus 228 ~~~--~kl~Dfg~a~~ 241 (421)
+|. ++++||.-++.
T Consensus 164 ~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 164 EGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCeeEEEEEhhccch
Confidence 677 99999976653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.82 E-value=1e-07 Score=85.53 Aligned_cols=138 Identities=14% Similarity=0.145 Sum_probs=84.7
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ccceeeEEEeCCeEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGYCLEGENRLL 165 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~~~~~l 165 (421)
..||.|..+.||+.. +..+++|...... ......+|.++++.+..-+ +.+.+++....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 568999999999841 3457889876532 3345678999998886433 4677777777778889
Q ss_pred EEEcCCCCC-hHHHH---------------------hhcCCCCCCHHHHHH-HHH----------HHHH-HHHHhh--hC
Q 014623 166 VYEFMPKGS-LENHL---------------------FRRGPQPLSWAVRMK-VAI----------GAAK-GLTFLH--DA 209 (421)
Q Consensus 166 v~e~~~~~~-L~~~l---------------------~~~~~~~~~~~~~~~-~~~----------~i~~-~l~~lH--~~ 209 (421)
|||+++|.+ +...+ +.............. +.. .+.. ...+|. ..
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998864 11111 110000111111000 000 0001 111221 12
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
...++|+|+.|.||++++++ +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 33578999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.7e-08 Score=100.11 Aligned_cols=141 Identities=16% Similarity=0.152 Sum_probs=91.8
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC------------------------------H----H
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG------------------------------H----K 133 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~----~ 133 (421)
+.|+.++-|.||+|.+.. |+.||||+.+..-... . +
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 679999999999998764 8999999987531100 0 0
Q ss_pred ------HHHHHHHHHhcCC-----CCCccceeeEE-EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 014623 134 ------EWLTEVNYLGQLH-----HPNLVKLIGYC-LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201 (421)
Q Consensus 134 ------~~~~E~~~l~~l~-----hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~ 201 (421)
++.+|+..+.+++ .++| .+=.+| .......|+|||++|..+.+...... ...+...+.....++.-
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence 1345666555542 2322 222222 23456789999999999988753222 22554433333332221
Q ss_pred HHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 202 ~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
-.-+- .|+.|.|..|.||+++.+|.+.+.|||+......
T Consensus 279 ~q~~~----dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLR----DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHh----cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 11122 3799999999999999999999999999977554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.9e-07 Score=80.55 Aligned_cols=137 Identities=12% Similarity=0.089 Sum_probs=90.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHH---------HHHHHHHHhcCC---C
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---------WLTEVNYLGQLH---H 147 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h 147 (421)
...+|.+.+++-......|.+-.. .|+.+++|..+.......+. ..+++..+..+. .
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 456788888888888777777543 36789999887654332222 233444444443 2
Q ss_pred CCccceeeEEE-----eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCc
Q 014623 148 PNLVKLIGYCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222 (421)
Q Consensus 148 p~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 222 (421)
-.+..++.+.. .....+|+|||++|..|.+... +.+ .+...+++++.-|| ..|+.|+|..|.|
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgN 165 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGN 165 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCc
Confidence 23333333222 2244578999999988876541 222 23456677899999 4589999999999
Q ss_pred EEeCCCCcEEEeeccCcc
Q 014623 223 ILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 223 ill~~~~~~kl~Dfg~a~ 240 (421)
++++.++ ++++||+..+
T Consensus 166 Flv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEECCc-EEEEECcccc
Confidence 9998664 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.1e-07 Score=82.28 Aligned_cols=139 Identities=18% Similarity=0.083 Sum_probs=82.8
Q ss_pred eecccCc-eeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEEE
Q 014623 89 LLGEGGF-GFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 89 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 166 (421)
.|..|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|
T Consensus 5 ~~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 70 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLL 70 (244)
T ss_pred ecCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEE
Confidence 3445555 788987321 3568888876543 234567888888874 44466777777666678999
Q ss_pred EEcCCCCChHHHH-------------------hhcC--CCCCCHH--HHHHHHH--------------------HHHHHH
Q 014623 167 YEFMPKGSLENHL-------------------FRRG--PQPLSWA--VRMKVAI--------------------GAAKGL 203 (421)
Q Consensus 167 ~e~~~~~~L~~~l-------------------~~~~--~~~~~~~--~~~~~~~--------------------~i~~~l 203 (421)
||+++|.+|.... +... ..+.... ....... .+...+
T Consensus 71 ~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (244)
T cd05150 71 TSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELY 150 (244)
T ss_pred EEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHH
Confidence 9999998776432 0000 0011100 0000000 011111
Q ss_pred HHhhh-----CCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 204 TFLHD-----AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 204 ~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..|-. ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 151 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 151 AELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22210 124589999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5e-07 Score=79.95 Aligned_cols=154 Identities=21% Similarity=0.191 Sum_probs=97.4
Q ss_pred ccCHHHHHHHhcCCCCCcee---cccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-----------------
Q 014623 71 AFTFNELKTATRNFRPDSLL---GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ----------------- 130 (421)
Q Consensus 71 ~~~~~~~~~~~~~y~~~~~l---g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------- 130 (421)
..++..+.....+..+.... +.|.-+.||+|.. +.+..+|+|+++.....
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~----------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~ 103 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAET----------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS 103 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc----------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence 34566666666676666654 5677778999743 24788999998642211
Q ss_pred --CHHH-----HHHHHHHHhcCC--CCCccceeeEEEeCCeEEEEEEcCCCCCh-HHHHhhcCCCCCCHHHHHHHHHHHH
Q 014623 131 --GHKE-----WLTEVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSL-ENHLFRRGPQPLSWAVRMKVAIGAA 200 (421)
Q Consensus 131 --~~~~-----~~~E~~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~i~ 200 (421)
.... ...|+..|+++. +=.+.+.+++. ...|||||+....+ .-.| ..-++.......+..+++
T Consensus 104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v 176 (268)
T COG1718 104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVV 176 (268)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHH
Confidence 1111 235777777774 33444555443 34699999944211 1111 111123334556667777
Q ss_pred HHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 201 ~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
+.+.-|-. ..++||+||..-|||+. ++.+.|+|||-|....
T Consensus 177 ~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 177 EYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 77776653 35799999999999999 7799999999887543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.4e-06 Score=72.99 Aligned_cols=130 Identities=16% Similarity=0.154 Sum_probs=88.8
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCcc-ceeeEEEeCCe
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLV-KLIGYCLEGEN 162 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~ 162 (421)
.+..+.|++|++|.||++.+. |..+|+|+-+.+. ....+..|+++|..+.--++- ++|.|. .
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~ 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----E 86 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence 355678999999999999875 4579999877653 346678899999998765543 344443 2
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCC-CCcEEeCCCCcEEEeeccCccc
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK-ASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk-p~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.++.|||+.|-.|.++.... +..+ +..+++..--|- ..||-|..|. |..++|..++.+.|+||.-|+.
T Consensus 87 ~~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 34569999998887765321 2222 233444433343 3479999986 4445555555999999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.4e-06 Score=79.02 Aligned_cols=74 Identities=15% Similarity=0.134 Sum_probs=46.2
Q ss_pred CceecccCcee-EEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC---CccceeeEEEeC--
Q 014623 87 DSLLGEGGFGF-VYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP---NLVKLIGYCLEG-- 160 (421)
Q Consensus 87 ~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~~~-- 160 (421)
.+.|+.|+... ||+. +..+++|..... .....+.+|+++++.|... .+..+++.....
T Consensus 2 ~~~~~~gG~~n~vy~~--------------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~ 65 (235)
T cd05155 2 IEPVDSGGTDNATFRL--------------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEG 65 (235)
T ss_pred ceeccCCCcccceEEc--------------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccC
Confidence 35678777764 8875 234778876542 2334678899999887532 234444433222
Q ss_pred -CeEEEEEEcCCCCChH
Q 014623 161 -ENRLLVYEFMPKGSLE 176 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~ 176 (421)
...+++|++++|.++.
T Consensus 66 ~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 66 YPWPWSVYRWLEGETAT 82 (235)
T ss_pred CCcceEEEEeecCCCCC
Confidence 2348899999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.4e-08 Score=99.86 Aligned_cols=189 Identities=16% Similarity=0.096 Sum_probs=132.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~ 159 (421)
++-|.....+++|+++++|+.+... .+....+++... ....-++++|.+++||| .+..++-+..
T Consensus 241 ~kws~~fh~fvK~altknpKkRpta----------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~ 305 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTA----------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG 305 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCCh----------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc
Confidence 3445556678999999999864322 223335555433 22335789999999999 6777776777
Q ss_pred CCeEEEEEEcCCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 160 GENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 160 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+...+++|+++.++ +....+. .....+.......++..-+++++++|+.. -+|+| ||+..+ +..+..||+.
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v 377 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAV 377 (829)
T ss_pred ccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccC
Confidence 77889999999776 2222111 11111333344555666778899999532 48898 887766 5799999998
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
........ ....+.+++.++|||+.....+....|.|++|+-..+|.-|..|-.
T Consensus 378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 87654432 2445789999999999999999999999999987777777776653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.9e-07 Score=79.83 Aligned_cols=141 Identities=20% Similarity=0.167 Sum_probs=80.4
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC--CccceeeEEEe---CC
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP--NLVKLIGYCLE---GE 161 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~~~~---~~ 161 (421)
++.|+.|..+.||++... +..+++|..... .....+.+|..+++.|... .+.+++.+... ..
T Consensus 2 i~~l~~G~~n~~~~v~~~-----------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEEC-----------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 367899999999998543 247999987654 3445677888888887532 35566654432 33
Q ss_pred eEEEEEEcCCCCChHH----------------HHh---hc--CCCCCCHHH---------HHHH------------HHHH
Q 014623 162 NRLLVYEFMPKGSLEN----------------HLF---RR--GPQPLSWAV---------RMKV------------AIGA 199 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~----------------~l~---~~--~~~~~~~~~---------~~~~------------~~~i 199 (421)
..+++|++++|..+.. .+. .. ......... .... ...+
T Consensus 69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL 148 (239)
T ss_dssp EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence 4689999999987776 111 11 001111100 0000 0111
Q ss_pred HH-HHHHhhh-----CCCceeeccCCCCcEEeC-CCCcEEEeeccCcc
Q 014623 200 AK-GLTFLHD-----AESQVIYRDFKASNILLD-AEFNAKLSDFGLAK 240 (421)
Q Consensus 200 ~~-~l~~lH~-----~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~a~ 240 (421)
.. .+..++. ....++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 11 2233331 245699999999999999 66667899998664
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.8e-06 Score=85.67 Aligned_cols=141 Identities=18% Similarity=0.164 Sum_probs=89.8
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------------------------------------
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------------------------------------ 130 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------------ 130 (421)
.+.||.-+.|.||+|+.++ |+.||||+-+..-..
T Consensus 166 ~~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred cchhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 3679999999999997764 899999987642100
Q ss_pred -CHHHHHHHHHHHhcC----CCCCc---cceeeEEE-eCCeEEEEEEcCCCCChHHHH--hhcCCCCCCHHHHHHHHHHH
Q 014623 131 -GHKEWLTEVNYLGQL----HHPNL---VKLIGYCL-EGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAIGA 199 (421)
Q Consensus 131 -~~~~~~~E~~~l~~l----~hp~i---v~~~~~~~-~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~~~i 199 (421)
..-+|.+|++...++ .|-+. |.+=.++. ......|+||||+|..+.|+- .+.+ ++...+..-+.+.
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~ 312 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEA 312 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHH
Confidence 001244555544443 34441 11222222 234678999999998877653 3333 5555444444333
Q ss_pred HHHHHHhhhCCCceeeccCCCCcEEeCC----CCcEEEeeccCcccCCC
Q 014623 200 AKGLTFLHDAESQVIYRDFKASNILLDA----EFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 200 ~~~l~~lH~~~~~ivHrDlkp~Nill~~----~~~~kl~Dfg~a~~~~~ 244 (421)
..-.-+.| |++|+|-.|.||+++. ++.+.+-|||+......
T Consensus 313 ~~~qIf~~----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 YLEQIFKT----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHhc----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 32222333 7999999999999983 67899999999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.2e-06 Score=72.03 Aligned_cols=128 Identities=20% Similarity=0.290 Sum_probs=88.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC----------------ccCHHHHHHHHHHHhcCC----
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG----------------FQGHKEWLTEVNYLGQLH---- 146 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~---- 146 (421)
...||+|+.-.||.-= .....+||+..... ....++..+|+.....+.
T Consensus 6 ~~~i~~G~~R~cy~HP------------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~ 73 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP------------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG 73 (199)
T ss_pred CcccccCCCceEEECC------------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence 4679999999999631 13347889887665 112345566766655554
Q ss_pred --CCCccceeeEEEeCCeEEEEEEcCCC------CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC
Q 014623 147 --HPNLVKLIGYCLEGENRLLVYEFMPK------GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218 (421)
Q Consensus 147 --hp~iv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 218 (421)
+.+|.+++|+...+...-+|+|.+.+ .+|.+++.... ++. .....+.++.. ||- ..+|+.+||
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f~~---~l~--~~~Iv~~dl 144 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEFKR---YLL--DHHIVIRDL 144 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHHHH---HHH--HcCCeecCC
Confidence 78999999999999999999998643 36788884433 554 44455555544 443 234999999
Q ss_pred CCCcEEeCCC--C--cEEEee
Q 014623 219 KASNILLDAE--F--NAKLSD 235 (421)
Q Consensus 219 kp~Nill~~~--~--~~kl~D 235 (421)
+|.||++..+ + .++|+|
T Consensus 145 ~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CcccEEEEecCCCceEEEEEe
Confidence 9999999432 2 578887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.33 E-value=8e-06 Score=87.33 Aligned_cols=82 Identities=18% Similarity=0.240 Sum_probs=55.8
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCC-CCCc--cceeeEEEeC--
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLH-HPNL--VKLIGYCLEG-- 160 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hp~i--v~~~~~~~~~-- 160 (421)
.+.|+.|.+..+|+...... .....+++|+...... .....+.+|+++|+.+. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~-------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG-------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCC-------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 56789999999998754321 0113577777644322 23356789999999995 6664 7777777654
Q ss_pred -CeEEEEEEcCCCCCh
Q 014623 161 -ENRLLVYEFMPKGSL 175 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L 175 (421)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 457899999988653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.2e-05 Score=66.48 Aligned_cols=100 Identities=25% Similarity=0.272 Sum_probs=78.2
Q ss_pred HHHHHHhcCCC-CCccceeeEEEeCCeEEEEEEcCCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC-
Q 014623 137 TEVNYLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENH---LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES- 211 (421)
Q Consensus 137 ~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~- 211 (421)
.|.-+|+.+.+ +++.+++|+| ..++|.||...+++... +... ...+|..+..++.++++.+.+++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57888888875 6999999988 33689999977666421 1111 236899999999999999999985322
Q ss_pred ceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 212 QVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 212 ~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
.+.-.|++++|+-++++|++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 3778899999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.1e-05 Score=71.15 Aligned_cols=77 Identities=10% Similarity=-0.024 Sum_probs=54.1
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC---CCccceeeEEEeC--
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH---PNLVKLIGYCLEG-- 160 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~~~-- 160 (421)
-.+.||.|..+.||..... +..+++|..+.. .....+..|+..|+.|.- -.+.++++++...
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-----------~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-----------QGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred eeeecCCccceeEEEEEcC-----------CCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 3467999999999986432 224667775431 123467789999988852 3677888877543
Q ss_pred -CeEEEEEEcCCCCCh
Q 014623 161 -ENRLLVYEFMPKGSL 175 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L 175 (421)
+..+||||+++|.++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 568999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.9e-05 Score=71.30 Aligned_cols=137 Identities=17% Similarity=0.084 Sum_probs=75.6
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLVY 167 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv~ 167 (421)
.+..|-...+|+... ++..+++|..........-...+|.++++.+..-++ .+++... . .++||
T Consensus 3 ~~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 355677888998742 255788887654321110124578888888864333 3344332 2 36999
Q ss_pred EcCCCCChHH--------------HHhh---cC--CCCCCHHH-HHHHHHHH---------HHHHHHhhh------CCCc
Q 014623 168 EFMPKGSLEN--------------HLFR---RG--PQPLSWAV-RMKVAIGA---------AKGLTFLHD------AESQ 212 (421)
Q Consensus 168 e~~~~~~L~~--------------~l~~---~~--~~~~~~~~-~~~~~~~i---------~~~l~~lH~------~~~~ 212 (421)
||++|..+.. .+.+ .. ..+++... +..+..++ ...+..+-. ....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 9999876532 1111 11 11122111 11111111 111111111 1235
Q ss_pred eeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 213 VIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 213 ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
++|+|+.+.||++++++ +.|+||..+..
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 89999999999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.9e-05 Score=72.92 Aligned_cols=141 Identities=17% Similarity=0.115 Sum_probs=81.2
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ccceee------EEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIG------YCL 158 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~------~~~ 158 (421)
.+.|..|....+|+.... +..+++|+... .....+..|+.+++.|.+-+ +.+++. +..
T Consensus 19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 456777887899987432 34688898764 22345566787777774322 344433 122
Q ss_pred eCCeEEEEEEcCCCCChHH----HH----------hhcC-C--------CCCCHHHHH----------HHHHHHHHHHHH
Q 014623 159 EGENRLLVYEFMPKGSLEN----HL----------FRRG-P--------QPLSWAVRM----------KVAIGAAKGLTF 205 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~----~l----------~~~~-~--------~~~~~~~~~----------~~~~~i~~~l~~ 205 (421)
..+..++||+|++|..+.. .+ +... . ....+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 3456689999999876532 01 1100 0 001111100 001112233333
Q ss_pred hhh-----CCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 206 LHD-----AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 206 lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
+.. ...+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 332 234799999999999999987778999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.5e-05 Score=67.18 Aligned_cols=77 Identities=19% Similarity=0.087 Sum_probs=46.6
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 165 (421)
.+.|..|-...+|+..... +.+..+++|+....... .....+|+.+++.+...+ ..++++.+. ..+
T Consensus 3 i~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcE
Confidence 3567778888999874321 02457889977543211 112246888888885333 344444332 248
Q ss_pred EEEcCCCCChH
Q 014623 166 VYEFMPKGSLE 176 (421)
Q Consensus 166 v~e~~~~~~L~ 176 (421)
||||++|.++.
T Consensus 70 l~e~i~G~~l~ 80 (235)
T cd05157 70 IYEFIPGRTLE 80 (235)
T ss_pred EEEeeCCCcCC
Confidence 99999987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.2e-05 Score=81.65 Aligned_cols=195 Identities=22% Similarity=0.250 Sum_probs=132.9
Q ss_pred HHHHHHHhcCCCCCccceeeEEEeCCeEE----EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC
Q 014623 136 LTEVNYLGQLHHPNLVKLIGYCLEGENRL----LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES 211 (421)
Q Consensus 136 ~~E~~~l~~l~hp~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 211 (421)
..|+..+.+..|+|++.++.|.......- +..++|...++...+...+. ++......+..++.+||+|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 34667788889999999998876544332 44578888888888866554 777888889999999999999653
Q ss_pred ceeeccCCCC---cEEeCCCCcEEEe--eccCcccCCCCCCcceeeccccccceecccccccCCCCcc--ccchhhhHHH
Q 014623 212 QVIYRDFKAS---NILLDAEFNAKLS--DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK--SDVYSFGVVL 284 (421)
Q Consensus 212 ~ivHrDlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~il 284 (421)
+.|.-|... +-..+..+.+.++ ||+........... ....-+..|.++|......+..+ .|+|.+|.++
T Consensus 307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 444444333 3444556667777 99888765443322 12334566788887766666554 7999999999
Q ss_pred HHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 285 LELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 285 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..+..|..+-... .....++. ........++..+|+..+.++|+++.++++..
T Consensus 383 ~~~~~~~~i~~~~-------------------~~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS-------------------AVPVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccc-------------------cchhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9998876432111 00111111 11111677899999999999999999998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00011 Score=63.70 Aligned_cols=125 Identities=31% Similarity=0.456 Sum_probs=86.6
Q ss_pred cCCCCCceecccCc-eeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC----------cc-----------CHHHHHHHH
Q 014623 82 RNFRPDSLLGEGGF-GFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG----------FQ-----------GHKEWLTEV 139 (421)
Q Consensus 82 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~-----------~~~~~~~E~ 139 (421)
.+++.++.||.|.- |.||++.+. |..+|+|+++... .. -..-|..|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 67889999999999 999999875 6789999943210 00 012356787
Q ss_pred HHHhcCC---CCCc--cceeeEEEeCC------------------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHH
Q 014623 140 NYLGQLH---HPNL--VKLIGYCLEGE------------------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196 (421)
Q Consensus 140 ~~l~~l~---hp~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 196 (421)
+...+|+ +.++ |+.+||..-.. ...||.||+.... .+.. .-+
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~ 170 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDI 170 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHH
Confidence 7766664 5566 88999875331 1247788775532 1222 234
Q ss_pred HHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 197 ~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.++.+-+..+| ..||+-+|+++.|.. .-||+|||.+
T Consensus 171 ~~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence 56667788899 568999999999985 3589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.0005 Score=65.29 Aligned_cols=32 Identities=25% Similarity=0.293 Sum_probs=27.1
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||+|+.+.|||++.+...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 35799999999999998765568999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00018 Score=69.69 Aligned_cols=77 Identities=19% Similarity=0.176 Sum_probs=52.4
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC------C-ccCHHHHHHHHHHHhcCC---CCCccceeeE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE------G-FQGHKEWLTEVNYLGQLH---HPNLVKLIGY 156 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 156 (421)
.+.||.|.+..||++.... .++.++||.-... . ....+++..|.+.|+.+. ..++.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 3679999999999986542 1247999984311 1 123456677888888763 3456777765
Q ss_pred EEeCCeEEEEEEcCCCCC
Q 014623 157 CLEGENRLLVYEFMPKGS 174 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~ 174 (421)
+.+..++||||+++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 4466789999998644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00027 Score=66.69 Aligned_cols=142 Identities=17% Similarity=0.114 Sum_probs=78.8
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ccceeeE------EE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGY------CL 158 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~------~~ 158 (421)
.+.++.|....+|+.... +..+++|+..... ....+..|++++..|...+ +.+++.. ..
T Consensus 27 i~~~~~G~~n~~y~v~t~-----------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~ 93 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-----------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST 93 (307)
T ss_pred ccccCCccccceEEEEeC-----------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence 456777777899987422 2357788775421 2234456677776664222 3343331 12
Q ss_pred eCCeEEEEEEcCCCCChHH-----------H---HhhcCC---CC-------CCHHHHH------------HHHHHHHHH
Q 014623 159 EGENRLLVYEFMPKGSLEN-----------H---LFRRGP---QP-------LSWAVRM------------KVAIGAAKG 202 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~-----------~---l~~~~~---~~-------~~~~~~~------------~~~~~i~~~ 202 (421)
..+..+++|+|++|..+.. . ++.... .. ..|.... .....+...
T Consensus 94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~ 173 (307)
T TIGR00938 94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE 173 (307)
T ss_pred cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence 2456789999998865321 1 111000 00 0010000 001112233
Q ss_pred HHHhhh-----CCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 203 LTFLHD-----AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 203 l~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
++++.. ...++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 444431 246799999999999999887778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00019 Score=67.53 Aligned_cols=81 Identities=21% Similarity=0.150 Sum_probs=48.2
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~lv 166 (421)
+.|..|-...||+....... .....++.+++|+..... .......+|+++++.+...+ ..++++++. -.+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence 45666777789987543211 122345789999976542 22233457888888875333 334555443 2368
Q ss_pred EEcCCCCChH
Q 014623 167 YEFMPKGSLE 176 (421)
Q Consensus 167 ~e~~~~~~L~ 176 (421)
|||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.79 E-value=2.9e-05 Score=71.35 Aligned_cols=135 Identities=16% Similarity=0.091 Sum_probs=90.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--cc---------------C-----HHHHHHHHH
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQ---------------G-----HKEWLTEVN 140 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~---------------~-----~~~~~~E~~ 140 (421)
-+.+++.||-|.-+.||.+-+. .|...++|+-+... +. . .-...+|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred hhhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 4678899999999999998554 37788888643211 00 0 012357888
Q ss_pred HHhcCC-C-CCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC
Q 014623 141 YLGQLH-H-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218 (421)
Q Consensus 141 ~l~~l~-h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 218 (421)
.|+.|. | --|.+.++ .+..++|||++.|..|...-+- .+...+..-+. .-+.-|- +.|+||+|.
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm---~~Iv~la--~~GlIHgDF 228 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLM---GLIVRLA--NHGLIHGDF 228 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-----CChHHHHHHHH---HHHHHHH--HcCceeccc
Confidence 888884 3 23445444 3567899999999888654321 23333333333 3333444 558999999
Q ss_pred CCCcEEeCCCCcEEEeeccCccc
Q 014623 219 KASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 219 kp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.-=||++++++.++++||--+..
T Consensus 229 NEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred chheeEEecCCCEEEeechHhhc
Confidence 99999999999999999975543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=2.8e-06 Score=91.29 Aligned_cols=175 Identities=13% Similarity=0.027 Sum_probs=120.8
Q ss_pred EEEEEecCCCccCHHHH-----HHHHHHHhcCCCCCccceeeEEEe--CCeEEEEEEcCCCCChHHHHhhcCC--CCCCH
Q 014623 119 VAVKKLKPEGFQGHKEW-----LTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGP--QPLSW 189 (421)
Q Consensus 119 vavK~~~~~~~~~~~~~-----~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~ 189 (421)
+.+|+.+.-+++...+- +.|..-++...|+++...+.-... ....+.+++|+.+|.+.+.|.+... .++..
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 45555554444333332 234444455678888776665443 3456899999999999999976432 22333
Q ss_pred HHHHHHHHHHHHHHHHhhhCC---CceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccc
Q 014623 190 AVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266 (421)
Q Consensus 190 ~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 266 (421)
..+.....+.+.+..-+|+.. .-.+|++||+-|.+|..+.++|++++|+.+.... .....+..++++.|+.+++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence 333333334355566666532 2268999999999999999999999999983222 22233456788999999988
Q ss_pred ccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 267 ATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 267 ~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
..-.++.++|+|..|+.+|++.-|..+|-
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 88889999999999999999998887763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=63.71 Aligned_cols=144 Identities=18% Similarity=0.142 Sum_probs=79.4
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 166 (421)
+.|-.|-.-.+|++..... ....++.+++|+..........+ .+|..+++.+..-++ .++++.+..+ .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 4455577788999754321 11234689999876543222222 468888888854333 3455554322 58
Q ss_pred EEcCCCCChHHH--------------H---hhcC----CCCCCHHHHHHHHHHH-----------------HHHHHHh--
Q 014623 167 YEFMPKGSLENH--------------L---FRRG----PQPLSWAVRMKVAIGA-----------------AKGLTFL-- 206 (421)
Q Consensus 167 ~e~~~~~~L~~~--------------l---~~~~----~~~~~~~~~~~~~~~i-----------------~~~l~~l-- 206 (421)
++|+++.+|... + +... ....-+..+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987766421 1 1111 0011122222222111 1111111
Q ss_pred --h--hCCCceeeccCCCCcEEeCC-CCcEEEeeccCccc
Q 014623 207 --H--DAESQVIYRDFKASNILLDA-EFNAKLSDFGLAKA 241 (421)
Q Consensus 207 --H--~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~a~~ 241 (421)
. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 11235899999999999976 46799999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=61.75 Aligned_cols=33 Identities=21% Similarity=0.445 Sum_probs=29.2
Q ss_pred CceeeccCCCCcEEeCCCCcEEEeeccCcccCC
Q 014623 211 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243 (421)
Q Consensus 211 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~ 243 (421)
..++|+|+.+.||+++.++-+-|+||+++....
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 358999999999999999889999999997643
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=60.84 Aligned_cols=30 Identities=27% Similarity=0.417 Sum_probs=25.6
Q ss_pred ceeeccCCCCcEEeCCCCc-EEEeeccCccc
Q 014623 212 QVIYRDFKASNILLDAEFN-AKLSDFGLAKA 241 (421)
Q Consensus 212 ~ivHrDlkp~Nill~~~~~-~kl~Dfg~a~~ 241 (421)
.++|+|+.+.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987555 56999998865
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0023 Score=60.19 Aligned_cols=140 Identities=17% Similarity=0.119 Sum_probs=85.8
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---------c-------------CHH----HHHHHH
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---------Q-------------GHK----EWLTEV 139 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~-------------~~~----~~~~E~ 139 (421)
+...|..|.-+.||.|.-. +|..+|||+++..-. . ..+ -...|+
T Consensus 148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4456788889999997433 477899998763110 0 011 123577
Q ss_pred HHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCC
Q 014623 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 219 (421)
Q Consensus 140 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlk 219 (421)
+-|.+|+.-.|.-.--+.. ....|||+|+- .+=+-.= +.....++...+..+-.+++..+.-|-. .+++||.||.
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLS 292 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLS 292 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchh
Confidence 7788776554432221111 23469999993 3222110 0111235655666666666666665543 4579999999
Q ss_pred CCcEEeCCCCcEEEeeccCccc
Q 014623 220 ASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 220 p~Nill~~~~~~kl~Dfg~a~~ 241 (421)
--|+|+.+ |.+.|+|-+-+..
T Consensus 293 EfN~Lyhd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLYHD-GKLYIIDVSQSVE 313 (520)
T ss_pred hhhheEEC-CEEEEEEcccccc
Confidence 99999965 4799999886654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00068 Score=66.19 Aligned_cols=165 Identities=27% Similarity=0.340 Sum_probs=93.0
Q ss_pred HHHHHHHHHHHhcCCCCCccceeeEEEeC-CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 014623 132 HKEWLTEVNYLGQLHHPNLVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 210 (421)
Q Consensus 132 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 210 (421)
...++...++++.+.|+|....+++.... ....+|||++ +.+|++.+..+.. .... ++ -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l---~~~s----------~~--~~--- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL---KDES----------LL--AH--- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc---chhh----------hc--cc---
Confidence 35667788999999999999998876643 3467899999 7799998865431 1110 01 12
Q ss_pred CceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhC
Q 014623 211 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290 (421)
Q Consensus 211 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 290 (421)
++.|- || ++++| -++.. | |- ...+|+|||++|.++.++.-|
T Consensus 87 -~~~~~-----~~-------~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 -GVLHL-----NI-------IYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -cccee-----hh-------hhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence 23332 12 33344 11110 0 10 111499999999999999999
Q ss_pred CCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 291 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 291 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
...+........ ......+.............. ...-.+.....++..+|+-..|..||...++
T Consensus 128 ~~l~~~~~~s~~---l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 128 ISLEAELTESEY---LEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred hHHHHHHHHHHH---HHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 876643321110 011111111111111110000 1123556677789999999999988855444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0065 Score=57.40 Aligned_cols=32 Identities=16% Similarity=0.198 Sum_probs=28.7
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||+|+.++|||+++++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.011 Score=56.36 Aligned_cols=73 Identities=18% Similarity=0.217 Sum_probs=46.9
Q ss_pred eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecC------CC-ccCHHHHHHHHHHHhcCC--CC-CccceeeEEE
Q 014623 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP------EG-FQGHKEWLTEVNYLGQLH--HP-NLVKLIGYCL 158 (421)
Q Consensus 89 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~~ 158 (421)
.||.|....||++.... .++.|+||.-.. +. .-...+...|...|+... .| .+.++|. .
T Consensus 2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~ 70 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F 70 (370)
T ss_pred cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence 57999999999996421 235799997431 11 123355567888887663 34 4555543 4
Q ss_pred eCCeEEEEEEcCCC
Q 014623 159 EGENRLLVYEFMPK 172 (421)
Q Consensus 159 ~~~~~~lv~e~~~~ 172 (421)
+.+...+|||+++.
T Consensus 71 D~e~~~~vMEdL~~ 84 (370)
T TIGR01767 71 DTEMAVTVMEDLSH 84 (370)
T ss_pred ccccceehHhhCcc
Confidence 56667799999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0032 Score=55.13 Aligned_cols=102 Identities=16% Similarity=0.129 Sum_probs=66.8
Q ss_pred EEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHH
Q 014623 119 VAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197 (421)
Q Consensus 119 vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 197 (421)
..+|++..-... ....+..+.+++.++. .|+++..- .+..+-++.|+|-.... .. ..++.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFIT 148 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHH
Confidence 344554433333 3345667888888764 56776532 33456689999833111 11 11222
Q ss_pred HHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 198 ~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.=+.+|.-.|+...+.+|+|-.|+||+-|..|.+||.|-+..
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 224668888987788999999999999999999999998754
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.012 Score=57.07 Aligned_cols=73 Identities=14% Similarity=0.121 Sum_probs=48.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-------cCHHHHHHHHHHHhcCC---CCCccceeeE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-------QGHKEWLTEVNYLGQLH---HPNLVKLIGY 156 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hp~iv~~~~~ 156 (421)
.+.||.|....||+.... +..++||.-..... ....+...|+..|+.+. ..++.+++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 567899999999997532 34588887542111 12344455677776653 2477778776
Q ss_pred EEeCCeEEEEEEcCCC
Q 014623 157 CLEGENRLLVYEFMPK 172 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~ 172 (421)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 65 556889999977
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0039 Score=57.94 Aligned_cols=74 Identities=20% Similarity=0.210 Sum_probs=45.6
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCccceeeEEEeCCe
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGEN 162 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~ 162 (421)
-.+.|+.|....+|+... +++.+.||+-.. .....|..|+.-|+.|. .-.+.+++++....+.
T Consensus 21 ~~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDT-----------DGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp EEEEE--SSSSEEEEEET-----------TS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeEecCCCChhheEEEEC-----------CCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 346789899999998752 367899998762 22235667777777773 4567788888887778
Q ss_pred EEEEEEcCCCC
Q 014623 163 RLLVYEFMPKG 173 (421)
Q Consensus 163 ~~lv~e~~~~~ 173 (421)
.+|||||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 89999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0059 Score=58.84 Aligned_cols=75 Identities=19% Similarity=0.262 Sum_probs=49.4
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecC-----CC-ccCHHHHHHHHHHHhcCC--CC-CccceeeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-----EG-FQGHKEWLTEVNYLGQLH--HP-NLVKLIGYC 157 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--hp-~iv~~~~~~ 157 (421)
.+.||.|.-..||++.+.. .++.|+||.-.. +. .-..++..-|.++|+.+. .| ++.++|.
T Consensus 34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-- 102 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-- 102 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence 4678999999999996521 135688886431 11 123456677888888764 45 4555554
Q ss_pred EeCCeEEEEEEcCCC
Q 014623 158 LEGENRLLVYEFMPK 172 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~ 172 (421)
.+.+...+|||+++.
T Consensus 103 ~D~e~~~~vMEdL~~ 117 (409)
T PRK12396 103 FDSVMNCCVMEDLSD 117 (409)
T ss_pred ECcHHhhHHHHhCcc
Confidence 456677899999854
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0078 Score=56.67 Aligned_cols=73 Identities=19% Similarity=0.168 Sum_probs=54.6
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+...|++|++- |++|.. + ....+.++..++.+.+..++-+.. +-.+-|||+.-+||||+ +|+|-|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 34557788875 555542 2 124567778888887776666654 44688999999999999 999999999999
Q ss_pred cc
Q 014623 240 KA 241 (421)
Q Consensus 240 ~~ 241 (421)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 85
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0032 Score=55.88 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=20.6
Q ss_pred ceeeccCCCCcEEe-CCCCcEEEeeccCcc
Q 014623 212 QVIYRDFKASNILL-DAEFNAKLSDFGLAK 240 (421)
Q Consensus 212 ~ivHrDlkp~Nill-~~~~~~kl~Dfg~a~ 240 (421)
.++|.||.+.|||+ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48899999999999 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.015 Score=54.90 Aligned_cols=30 Identities=23% Similarity=0.286 Sum_probs=26.0
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357999999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.015 Score=55.49 Aligned_cols=77 Identities=17% Similarity=0.237 Sum_probs=44.5
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 166 (421)
+.|..|=...+|+...... ...+..+++|+......... .-.+|..+++.+..-++ .++++++. +. +|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~------~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i 88 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEE------NGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG--NG--MI 88 (330)
T ss_pred EEeCCcccceEEEEEecCC------CCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC--Cc--Ee
Confidence 4455577777888754321 11234788998765322111 12468888888864444 34555542 22 58
Q ss_pred EEcCCCCCh
Q 014623 167 YEFMPKGSL 175 (421)
Q Consensus 167 ~e~~~~~~L 175 (421)
.+|++|..|
T Consensus 89 ~~fi~g~~l 97 (330)
T PLN02421 89 QSFINARTL 97 (330)
T ss_pred ehhhcCCCC
Confidence 999987765
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.019 Score=50.66 Aligned_cols=77 Identities=18% Similarity=0.198 Sum_probs=52.0
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCccceeeEEEeCCe
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGEN 162 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~ 162 (421)
..+.+..|..-..|...+. ...+.||+-.. .....|..|+.-|+.|. .-.|.+++.+.....+
T Consensus 20 er~~v~gG~inea~~v~dg-----------~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~ 85 (286)
T COG3001 20 EREEVSGGDINEAWRLRDG-----------TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH 85 (286)
T ss_pred cccccCCccccceeEeecC-----------CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe
Confidence 3455666777777765432 34678886432 22345666776666653 4567788888888999
Q ss_pred EEEEEEcCCCCChH
Q 014623 163 RLLVYEFMPKGSLE 176 (421)
Q Consensus 163 ~~lv~e~~~~~~L~ 176 (421)
.|+||||++-+.+.
T Consensus 86 sylVle~L~~~~~d 99 (286)
T COG3001 86 SYLVLEYLPTGPLD 99 (286)
T ss_pred eEEEEeeccCCCCC
Confidence 99999999876654
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0065 Score=57.99 Aligned_cols=61 Identities=18% Similarity=0.120 Sum_probs=41.4
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
..|+-+|..|.++..++...+ .++.....++.--+.|+.-+-..+ +++|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD-NFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD-NFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh-cceecccCCCcEEEEe
Confidence 456777888989988885544 344455555555555555443323 5999999999999943
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.16 Score=48.24 Aligned_cols=30 Identities=20% Similarity=0.252 Sum_probs=25.0
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 45689999999999995 4 588999998753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.075 Score=58.38 Aligned_cols=32 Identities=44% Similarity=0.467 Sum_probs=26.7
Q ss_pred CCceeeccCCCCcEEeCCCC--cEE-EeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEF--NAK-LSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~--~~k-l~Dfg~a~~ 241 (421)
..++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 45799999999999998875 554 999998754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.1 Score=50.77 Aligned_cols=82 Identities=16% Similarity=0.067 Sum_probs=44.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~l 165 (421)
.+.|..|-...+|++...... ...-..+.|.++.......... .-.+|+++++.+...++ .++++.+. .++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~---~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~----~g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGD---KDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG----DFT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCC---CCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC----CEE
Confidence 345656888889988643211 0000112345554322111111 11368889988865444 45555553 259
Q ss_pred EEEcCCCCChH
Q 014623 166 VYEFMPKGSLE 176 (421)
Q Consensus 166 v~e~~~~~~L~ 176 (421)
|.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.14 Score=48.54 Aligned_cols=28 Identities=29% Similarity=0.493 Sum_probs=25.6
Q ss_pred eeeccCCCCcEEeCCCCc-EEEeeccCcc
Q 014623 213 VIYRDFKASNILLDAEFN-AKLSDFGLAK 240 (421)
Q Consensus 213 ivHrDlkp~Nill~~~~~-~kl~Dfg~a~ 240 (421)
+||+|+.|+|||++.+.. +.++|||-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999875 8999999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 421 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-49 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-49 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-45 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-20 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 530 bits (1367), Expect = 0.0
Identities = 118/323 (36%), Positives = 184/323 (56%), Gaps = 30/323 (9%)
Query: 60 EGEIL--SSSNLKAFTFNELKTATRNFRP------DSLLGEGGFGFVYKGWIDQHSLSPA 111
E + L S + +F+F ELK T NF + +GEGGFG VYKG+++
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN------- 53
Query: 112 KPGSGMVVAVKKLK----PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVY 167
VAVKKL + +++ E+ + + H NLV+L+G+ +G++ LVY
Sbjct: 54 ----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109
Query: 168 EFMPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226
+MP GSL + L G PLSW +R K+A GAA G+ FLH E+ I+RD K++NILLD
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLD 167
Query: 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 286
F AK+SDFGLA+A +T ++++++GT Y APE + G +T KSD+YSFGVVLLE
Sbjct: 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLE 226
Query: 287 LLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 346
+++G AVD+ + Q L+D + +++ + +D K+ + ++A QC
Sbjct: 227 IITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQC 283
Query: 347 LNNEPKLRPRMSEVLAILERLEA 369
L+ + RP + +V +L+ + A
Sbjct: 284 LHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 504 bits (1300), Expect = e-180
Identities = 123/332 (37%), Positives = 180/332 (54%), Gaps = 16/332 (4%)
Query: 45 SKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWID 104
SK + S+ S ++ + + +L+ AT NF L+G G FG VYKG +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYR-VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 105 QHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRL 164
G VA+K+ PE QG +E+ TE+ L HP+LV LIG+C E +
Sbjct: 62 ----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111
Query: 165 LVYEFMPKGSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222
L+Y++M G+L+ HL+ +SW R+++ IGAA+GL +LH +I+RD K+ N
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSIN 169
Query: 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 282
ILLD F K++DFG++K G D+TH+ST V GT GY PEY GRLT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 283 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATL 342
VL E+L R A+ ++ +L +WA + +L +I+D L + ++
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288
Query: 343 ALQCLNNEPKLRPRMSEVLAILERLEAPKNSA 374
A++CL + RP M +VL LE + S
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 447 bits (1152), Expect = e-158
Identities = 132/335 (39%), Positives = 194/335 (57%), Gaps = 18/335 (5%)
Query: 56 TPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGS 115
P E + LK F+ EL+ A+ NF ++LG GGFG VYKG +
Sbjct: 4 VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------D 53
Query: 116 GMVVAVKKLKPEGFQGHK-EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGS 174
G +VAVK+LK E QG + ++ TEV + H NL++L G+C+ RLLVY +M GS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 175 LENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEFNA 231
+ + L R PL W R ++A+G+A+GL +LH + ++I+RD KA+NILLD EF A
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+ DFGLAK D THV+T V GT G+ APEY++TG+ + K+DV+ +GV+LLEL++G+
Sbjct: 174 VVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 292 CAVDKTKVGIEQS--LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 349
A D ++ + L+DW K L +K+ L ++D L G Y + +AL C +
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQS 291
Query: 350 EPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHRQ 384
P RP+MSEV+ +LE + + + E RQ
Sbjct: 292 SPMERPKMSEVVRMLEGDGLAERWEEWQKEEMFRQ 326
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 6e-82
Identities = 72/321 (22%), Positives = 119/321 (37%), Gaps = 41/321 (12%)
Query: 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG 131
L + + + G FG V+K + VAVK + Q
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ- 61
Query: 132 HKEWL--TEVNYLGQLHHPNLVKLIGYCLEGEN----RLLVYEFMPKGSLENHLFRRGPQ 185
W EV L + H N+++ IG G + L+ F KGSL + L
Sbjct: 62 --SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---N 116
Query: 186 PLSWAVRMKVAIGAAKGLTFLHDAESQ--------VIYRDFKASNILLDAEFNAKLSDFG 237
+SW +A A+GL +LH+ + +RD K+ N+LL A ++DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRC 292
LA G + +GT Y APE + + D+Y+ G+VL EL S
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 293 AVDKTKVGIEQSLVD--WAKPYLSDKRKL--FRIMDTKLGGQYPQKAAHTA-ATLALQCL 347
A D + P L D +++ + L + + A +C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 348 NNEPKLRPRMSEVLAILERLE 368
+++ + R V + +++
Sbjct: 297 DHDAEARLSAGCVGERITQMQ 317
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-64
Identities = 88/357 (24%), Positives = 151/357 (42%), Gaps = 61/357 (17%)
Query: 33 HSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGE 92
H P + P+ E + + +I + +L + +G
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAM-DGDDMDIP---------WCDLNIKEK-------IGA 47
Query: 93 GGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPN 149
G FG V++ W G VAVK L + F E+L EV + +L HPN
Sbjct: 48 GSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHD 208
+V +G + N +V E++ +GSL L + G + L R+ +A AKG+ +LH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
+++R+ K+ N+L+D ++ K+ DFGL++ + + S GT + APE +
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRD 213
Query: 269 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTK 326
KSDVYSFGV+L EL + + +P+ L+ + + +
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQ------------------QPWGNLNPAQVVAAVGFKC 255
Query: 327 LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPHR 383
+ P+ A + C NEP RP + ++ +L L K + P+R
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL------IKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-62
Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+G G FG V K W VA+K+++ E + K ++ E+ L +++HP
Sbjct: 16 VGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNHP 61
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFLH 207
N+VKL G CL LV E+ GSL N L P P + A M + ++G+ +LH
Sbjct: 62 NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 208 DAESQ-VIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
+ + +I+RD K N+LL A K+ DFG A D T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEV 174
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT 325
+ K DV+S+G++L E+++ R KP+ FRIM
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRR------------------KPFDEIGGPAFRIMWA 216
Query: 326 KLGGQYPQKAAHTAATLAL---QCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 382
G P + + +C + +P RP M E++ I+ L A P
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
Query: 383 RQTGP 387
+ + P
Sbjct: 277 QHSLP 281
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-62
Identities = 67/347 (19%), Positives = 115/347 (33%), Gaps = 54/347 (15%)
Query: 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG 131
+E N + L+G G +G VYKG +D VAVK Q
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ- 50
Query: 132 HKEWLTEVN--YLGQLHHPNLVKLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGP 184
++ E N + + H N+ + I LLV E+ P GSL +L
Sbjct: 51 --NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--- 105
Query: 185 QPLSWAVRMKVAIGAAKGLTFLHDAESQ-------VIYRDFKASNILLDAEFNAKLSDFG 237
W ++A +GL +LH + + +RD + N+L+ + +SDFG
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 238 LAK------AGPTGDRTHVSTQVMGTHGYAAPEY-------VATGRLTTKSDVYSFGVVL 284
L+ G+ + + +GT Y APE + D+Y+ G++
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 285 LELLSGRCAVDKTKVGIEQSLVDWAK-----PYLSDKRKLFRIMDTKL----GGQYPQKA 335
E+ RC + + + + P D + L + + A
Sbjct: 226 WEIFM-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284
Query: 336 AHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSEPH 382
+ C + + + R + L K H
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-62
Identities = 70/325 (21%), Positives = 121/325 (37%), Gaps = 46/325 (14%)
Query: 82 RNFRPDSL-----LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW 135
R FRP L LG+G FG K +G V+ +K+L + + +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHR----------ETGEVMVMKELIRFDEETQRTF 54
Query: 136 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L EV + L HPN++K IG + + + E++ G+L + + W+ R+
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSF 113
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------------AGP 243
A A G+ +LH +I+RD + N L+ N ++DFGLA+
Sbjct: 114 AKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 244 TGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303
V+G + APE + K DV+SFG+VL E++ A
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP----DYLP 227
Query: 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
+D+ + P + + ++C + +P+ RP ++
Sbjct: 228 RTMDFGLNVRGFLDRYC-----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 364 LERLEAPKNSAKLSQSEPHRQTGPV 388
LE L + +
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGF 301
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-62
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 54/305 (17%)
Query: 74 FNELKTATRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH 132
F +L T+ L E G ++KG W G + VK LK +
Sbjct: 9 FKQLNFLTK-------LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTR 49
Query: 133 --KEWLTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLS 188
+++ E L HPN++ ++G C + L+ +MP GSL N L +
Sbjct: 50 KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
+ +K A+ A+G+ FLH E + + ++++D + A++S + +
Sbjct: 110 QSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------FS 162
Query: 249 HVSTQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305
S M + APE +D++SF V+L EL++
Sbjct: 163 FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE-------------- 208
Query: 306 VDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
P+ LS+ ++ L P + + L C+N +P RP+ ++ I
Sbjct: 209 ----VPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
Query: 364 LERLE 368
LE+++
Sbjct: 265 LEKMQ 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-61
Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 49/294 (16%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-------KEWLTEVNY 141
+G+GGFG V+KG + VVA+K L +G +E+ EV
Sbjct: 27 IGKGGFGLVHKGRLVKD----------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ L+HPN+VKL G +V EF+P G L + L P+ W+V++++ + A
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIAL 133
Query: 202 GLTFLHDAESQVIYRDFKASNILLD-----AEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
G+ ++ + +++RD ++ NI L A AK++DFGL++ H + ++G
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 257 THGYAAPEYVATGRL---TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ APE T K+D YSF ++L +L+G D + +
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINMIR 243
Query: 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + P+ + C + +PK RP S ++ L L
Sbjct: 244 EEGLRP----------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-60
Identities = 84/310 (27%), Positives = 126/310 (40%), Gaps = 60/310 (19%)
Query: 74 FNELKTATRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH 132
F EL +G GGFG VY+ W G VAVK + + +
Sbjct: 6 FAELTLEEI-------IGIGGFGKVYRAFW------------IGDEVAVKAARHDPDEDI 46
Query: 133 ----KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLS 188
+ E L HPN++ L G CL+ N LV EF G L L + +
Sbjct: 47 SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIP 103
Query: 189 WAVRMKVAIGAAKGLTFLHD-AESQVIYRDFKASNILLDAEF--------NAKLSDFGLA 239
+ + A+ A+G+ +LHD A +I+RD K+SNIL+ + K++DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
+ RT + G + + APE + + SDV+S+GV+L ELL+G
Sbjct: 164 R---EWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------- 212
Query: 300 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
P+ + + + KL P A L C N +P RP
Sbjct: 213 -----------PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261
Query: 358 SEVLAILERL 367
+ +L L +
Sbjct: 262 TNILDQLTTI 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-59
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 74 FNELKTATRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH 132
++ R +G G FG VYKG W VAVK L
Sbjct: 23 DGQITVGQR-------IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQ 62
Query: 133 --KEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 190
+ + EV L + H N++ +GY +V ++ SL +HL +
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMK 120
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
+ +A A+G+ +LH +I+RD K++NI L + K+ DFGLA +H
Sbjct: 121 KLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 251 STQVMGTHGYAAPE---YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
Q+ G+ + APE + + +SDVY+FG+VL EL++G+
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL--------------- 223
Query: 308 WAKPY--LSDKRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
PY ++++ ++ ++ + L +CL + RP +L
Sbjct: 224 ---PYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRIL 280
Query: 362 AILERL 367
A +E L
Sbjct: 281 AEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-57
Identities = 70/356 (19%), Positives = 128/356 (35%), Gaps = 69/356 (19%)
Query: 44 PSKEKGNSESLPTPKSEGEILSSSNLKAFT--FNELKTATRNFRPDSLLGEGGFGFVYKG 101
P + P+ + +S L+ + F +L+ +G+G FG VY G
Sbjct: 2 PEMNLSLLSARSFPRKASQ--TSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHG 52
Query: 102 -WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNLVKLIGYCL 158
W + VA++ + E K + EV Q H N+V +G C+
Sbjct: 53 RWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218
+ ++ +L + + R L ++A KG+ +LH ++++D
Sbjct: 100 SPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDL 156
Query: 219 KASNILLDAEFNAKLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL---- 271
K+ N+ D ++DFGL G R G + APE +
Sbjct: 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 272 -----TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTK 326
+ SDV++ G + EL + P+ + I+
Sbjct: 216 DKLPFSKHSDVFALGTIWYELHAREW------------------PF--KTQPAEAIIWQM 255
Query: 327 LGGQYPQKAAHTA----ATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQ 378
G P + + + L C E + RP ++++ +LE+L PK + +LS
Sbjct: 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL--PKRNRRLSH 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 68/322 (21%), Positives = 117/322 (36%), Gaps = 55/322 (17%)
Query: 78 KTATRNFRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL 136
+T R+ +G+G +G V++G W ++ VAVK + K W
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 137 --TEVNYLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSWA 190
TE+ L H N++ I + + L+ + GSL ++L L
Sbjct: 49 RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTV 105
Query: 191 VRMKVAIGAAKGLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAG 242
+++ + A GL LH + +RD K+ NIL+ ++D GLA +
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 243 PTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 296
T + +GT Y APE V + D+++FG+VL E+ R +
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNG 224
Query: 297 T----------KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 346
V + S D K D+++ I + A L +C
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIPNRWFSDPTLTSLAK----LMKEC 279
Query: 347 LNNEPKLRPRMSEVLAILERLE 368
P R + L +++
Sbjct: 280 WYQNPSARLTALRIKKTLTKID 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 67/316 (21%), Positives = 111/316 (35%), Gaps = 57/316 (18%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL--TEVNYLGQL 145
+G+G +G V+ G W G VAVK W TE+ +
Sbjct: 44 QIGKGRYGEVWMGKW------------RGEKVAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 146 HHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
H N++ I ++G L+ ++ GSL ++L L +K+A +
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVS 145
Query: 202 GLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAGPTGDRTHVSTQ 253
GL LH + +RD K+ NIL+ ++D GLA T +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 254 VMGTHGYAAPEYVATGRL-------TTKSDVYSFGVVLLELLSGRCAVDKT--------- 297
+GT Y PE V L +D+YSFG++L E+ RC
Sbjct: 206 RVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYH 263
Query: 298 -KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356
V + S D + K + + + ++ L +C + P R
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRP-SFPNRWSSDECLRQMGK----LMTECWAHNPASRLT 318
Query: 357 MSEVLAILERLEAPKN 372
V L ++ ++
Sbjct: 319 ALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 8e-50
Identities = 65/310 (20%), Positives = 111/310 (35%), Gaps = 45/310 (14%)
Query: 89 LLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTE--VNYLGQL 145
+G+G FG V++G W + VAVK + + W E + L
Sbjct: 49 SIGKGRFGEVWRGKWRGEE------------VAVKIFSS---REERSWFREAEIYQTVML 93
Query: 146 HHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
H N++ I + LV ++ GSL ++L R ++ +K+A+ A
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTAS 150
Query: 202 GLTFLHDAESQ------VIYRDFKASNILLDAEFNAKLSDFGLA--KAGPTGDRTHVSTQ 253
GL LH + +RD K+ NIL+ ++D GLA T
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 254 VMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
+GT Y APE + ++D+Y+ G+V E+ RC++ + D
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYD 269
Query: 308 WAKPYLSDKRKLFRIMDTKL-----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
S + + + KL +A A + +C R +
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 363 ILERLEAPKN 372
L +L +
Sbjct: 330 TLSQLSQQEG 339
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 81/288 (28%), Positives = 126/288 (43%), Gaps = 26/288 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LGEG FG V P +G VAVK LKPE G + E+ L L+H
Sbjct: 29 LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 149 NLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G C E L+ EF+P GSL+ +L + ++ ++K A+ KG+ +L
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YA 261
Q ++RD A N+L+++E K+ DFGL KA T + +
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD----DRDSPVFWY 196
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
APE + + SDV+SFGV L ELL+ C D + + + ++ ++ R +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 322 IMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILERL 367
+ + G + P L +C +P R ++ E L
Sbjct: 256 LKE---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-48
Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 52/295 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
+G G FG V+ G +VAVK + ++L E L Q H
Sbjct: 122 IGRGNFGEVFSGRL----------RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
PN+V+LIG C + + +V E + G L R L +++ AA G+ +L
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-----AA 262
I+RD A N L+ + K+SDFG+++ G G A
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-----ASGGLRQVPVKWTA 283
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 319
PE + GR +++SDV+SFG++L E S G PY LS+++
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGAS------------------PYPNLSNQQTR 325
Query: 320 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPK 371
+ GG P+ L QC EP RP S + L+ + + +
Sbjct: 326 EFVEK---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-48
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 28/289 (9%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G FG V P + +G VVAVKKL+ + +++ E+ L L H N
Sbjct: 18 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 150 LVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
+VK G C R L+ E++P GSL ++L + + + ++ KG+ +L
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLG 131
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAA 262
+ I+RD NIL++ E K+ DFGL K P + G + A
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE----PGESPIFWYA 185
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + + + SDV+SFGVVL EL + + + + +F +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GNDKQ--GQMIVFHL 241
Query: 323 MDTKLGGQY----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
++ L P + +C NN RP ++ ++++
Sbjct: 242 IE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-48
Identities = 75/351 (21%), Positives = 131/351 (37%), Gaps = 41/351 (11%)
Query: 27 ISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRP 86
+S H +P + + + +LK
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKF--------------- 45
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH 146
LG+G FG V P + +G VVAVKKL+ + +++ E+ L L
Sbjct: 46 LQQLGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 147 HPNLVKLIGYCLEGENR--LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
H N+VK G C R L+ E++P GSL ++L + + + ++ KG+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGME 159
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L + I+RD NIL++ E K+ DFGL K P + G
Sbjct: 160 YL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIF 213
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319
+ APE + + + SDV+SFGVVL EL + + + + + + +
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 320 FRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + P + +C NN RP ++ ++++
Sbjct: 274 ELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 26/302 (8%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG+G FG V D P +G +VAVK+L+ G +++ E+ L LH
Sbjct: 31 LGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 150 LVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
+VK G ++ LV E++P G L + L R + L + + + KG+ +L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLG 144
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAA 262
+ ++RD A NIL+++E + K++DFGLAK P V+ G + A
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYA 198
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE ++ + +SDV+SFGVVL EL + C + ++ + + R L +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 323 MDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQS 379
+ G + P A A L C P+ RP S + L+ L + + +
Sbjct: 258 EE---GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
Query: 380 EP 381
Sbjct: 315 AH 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 88/289 (30%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LGEG FG V D P G+G +VAVK LK + G Q W E++ L L+H
Sbjct: 39 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 149 NLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
+++K G C + + LV E++P GSL ++L R L+ + A +G+ +L
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF--AQQICEGMAYL 150
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YA 261
H I+RD A N+LLD + K+ DFGLAKA P G + G +
Sbjct: 151 H--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWY 204
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
APE + + SDV+SFGV L ELL+ C D ++ + L + + R
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT-HC--DSSQSPPTKFLELIGIAQ--GQMTVLR 259
Query: 322 IMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + G+ P K L C E RP ++ IL+ +
Sbjct: 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 73/300 (24%), Positives = 116/300 (38%), Gaps = 58/300 (19%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG+G F ++KG + V +K L + + + + +L H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
+LV G C+ G+ +LV EF+ GSL+ +L ++ ++ +++VA A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL-- 129
Query: 209 AESQVIYRDFKASNILLDAEFN--------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
E+ +I+ + A NILL E + KLSD G++ V+
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 261 ------AAPEYVATGRL-TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY 312
PE + + +D +SFG L E+ S G KP
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD------------------KPL 219
Query: 313 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370
L +RKL D Q P A A L C++ EP RP ++ L L P
Sbjct: 220 SALDSQRKLQFYED---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 70/302 (23%), Positives = 124/302 (41%), Gaps = 49/302 (16%)
Query: 81 TRNFRPDSL-----LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKE 134
R + LG G FG VYKG P + VA+K+L+ + +KE
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGL-----WIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
L E + + +P++ +L+G CL L+ + MP G L +++ R + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
+ AKG+ +L + ++++RD A N+L+ + K++DFGLAK ++ +
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY----- 174
Query: 255 MGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 308
G + A E + T +SDV+S+GV + EL++ G
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------- 217
Query: 309 AKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
KPY D I G+ P + +C + RP+ E++
Sbjct: 218 -KPY--DGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
Query: 366 RL 367
++
Sbjct: 275 KM 276
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-44
Identities = 77/310 (24%), Positives = 127/310 (40%), Gaps = 56/310 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G +G VY+G W + VAVK LK E +E+L E + ++ HP
Sbjct: 21 LGGGQYGEVYEGVWKKYS----------LTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 69
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
NLV+L+G C ++ EFM G+L ++L Q +S V + +A + + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 127
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA------- 261
+ I+RD A N L+ K++DFGL++ ++ H A
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIKWT 179
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE +A + + KSDV++FGV+L E+ + G PY + +
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLSQV 221
Query: 319 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAK 375
+ + P+ L C P RP +E+ E + + S +
Sbjct: 222 YELLEK---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
Query: 376 LSQSEPHRQT 385
+ + R T
Sbjct: 279 VEKELGKRGT 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 78/306 (25%), Positives = 128/306 (41%), Gaps = 48/306 (15%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G +G VY+G W + VAVK LK E +E+L E + ++ HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 276
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
NLV+L+G C ++ EFM G+L ++L Q +S V + +A + + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
+ I+R+ A N L+ K++DFGL++ TGD + APE +A
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 269 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI--- 322
+ + KSDV++FGV+L E+ + G PY + + +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGM------------------SPYPGIDLSQVYELLEKD 435
Query: 323 --MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLSQS 379
M+ P+ L C P RP +E+ E + + S ++ +
Sbjct: 436 YRMER------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 489
Query: 380 EPHRQT 385
R T
Sbjct: 490 LGKRGT 495
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-43
Identities = 85/344 (24%), Positives = 139/344 (40%), Gaps = 77/344 (22%)
Query: 37 PSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFG 96
+ L P E + +S + N+K + +G+G FG
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWAL----NMKELKLLQT------------IGKGEFG 207
Query: 97 FVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIG 155
V G + G VAVK +K + + +L E + + QL H NLV+L+G
Sbjct: 208 DVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 156 YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214
+E + L +V E+M KGSL ++L RG L +K ++ + + +L + +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV 311
Query: 215 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEYVATGRL 271
+RD A N+L+ + AK+SDFGL K S+ + APE + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 272 TTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI-----M 323
+TKSDV+SFG++L E+ S GR PY + K + R+ M
Sbjct: 364 STKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPRVEKGYKM 405
Query: 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
D P + C + + RP ++ LE +
Sbjct: 406 DA------PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-43
Identities = 82/310 (26%), Positives = 141/310 (45%), Gaps = 46/310 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
+G G FG VYKG L + + VA+K LK + ++L E +GQ H
Sbjct: 52 IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+++L G + + +++ E+M G+L+ L R S + + G A G+ +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL-- 163
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEY 265
A ++RD A NIL+++ K+SDFGL++ +T G + APE
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEA 221
Query: 266 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI 322
++ + T+ SDV+SFG+V+ E+++ G +PY LS+ + I
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGE------------------RPYWELSNHEVMKAI 263
Query: 323 MDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 377
D G + P A + L +QC E RP+ +++++IL++L +S K
Sbjct: 264 ND---GFRLPTPMDCPSAIY---QLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317
Query: 378 QSEPHRQTGP 387
R +
Sbjct: 318 ADFDPRVSIR 327
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-43
Identities = 78/345 (22%), Positives = 144/345 (41%), Gaps = 49/345 (14%)
Query: 77 LKTATRNFRPDSL-----LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQ 130
+K R F+ L LG G FG V+KG P + V +K ++ + G Q
Sbjct: 3 MKVLARIFKETELRKLKVLGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQ 57
Query: 131 GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 190
+ + +G L H ++V+L+G C + LV +++P GSL +H+ R+ L
Sbjct: 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV-RQHRGALGPQ 115
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
+ + + AKG+ +L E +++R+ A N+LL + +++DFG+A P D
Sbjct: 116 LLLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---- 169
Query: 251 STQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQS 304
Q++ + + A E + G+ T +SDV+S+GV + EL++ G
Sbjct: 170 -KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA------------- 215
Query: 305 LVDWAKPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+PY +L + D G+ PQ + ++C + +RP E+
Sbjct: 216 -----EPY--AGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELA 268
Query: 362 AILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTP 406
R+ + + E P ++ + + P
Sbjct: 269 NEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEP 313
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-43
Identities = 79/317 (24%), Positives = 148/317 (46%), Gaps = 47/317 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
+G G FG V G + S + VA+K LK + +++L E + +GQ HP
Sbjct: 53 VGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+++L G + + ++V E+M GSL++ L + Q + + + G A G+ +L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYL-- 163
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH---GYAAPEY 265
++ ++RD A NIL+++ K+SDFGL + +T+ G + +PE
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEA 221
Query: 266 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI 322
+A + T+ SDV+S+G+VL E++S G +PY +S++ + +
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGE------------------RPYWEMSNQDVIKAV 263
Query: 323 MDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 377
+ G + P A + L L C + RP+ ++++IL++L S K+
Sbjct: 264 DE---GYRLPPPMDCPAALY---QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKII 317
Query: 378 QSEPHRQTGPVTVRKSP 394
S R + + + +
Sbjct: 318 TSAAARPSNLLLDQSNV 334
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-43
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 51/308 (16%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMV-VAVKKLKPE-GFQGHKEWLTEVNYLGQLH 146
LG G FG V +G + + + VA+K LK +E + E + QL
Sbjct: 18 LGCGNFGSVRQGVY---------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
+P +V+LIG C E +LV E G L L + + + + ++ + G+ +L
Sbjct: 69 NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL 126
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YA 261
E ++RD A N+LL AK+SDFGL+KA D + + G +
Sbjct: 127 --EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----AGKWPLKWY 180
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE + + +++SDV+S+GV + E LS G+ KPY +
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQ------------------KPYKKMKGPEV 222
Query: 319 LFRIMDTKLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKL 376
+ I G + L C + + RP V + S
Sbjct: 223 MAFIEQ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
Query: 377 SQSEPHRQ 384
H
Sbjct: 280 GHHHHHHH 287
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 68/288 (23%), Positives = 122/288 (42%), Gaps = 44/288 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LG G FG VYKG P + VA+K+L+ + +KE L E + + +P
Sbjct: 23 LGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
++ +L+G CL L+ + MP G L +++ + + + AKG+ +L
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYL-- 133
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAP 263
+ ++++RD A N+L+ + K++DFGLAK ++ + G + A
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMAL 188
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
E + T +SDV+S+GV + EL++ G KPY D I
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGS------------------KPY--DGIPASEI 228
Query: 323 MDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
G+ P + ++C + RP+ E++ ++
Sbjct: 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-42
Identities = 81/287 (28%), Positives = 121/287 (42%), Gaps = 49/287 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG+G FG V+ G W VA+K LK G + +L E + +L H
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L E E +V E+M KGSL + L + L + +A A G+ ++
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 296
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
++RD +A+NIL+ K++DFGLA+ + T + APE
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 355
Query: 269 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI--- 322
GR T KSDV+SFG++L EL + GR PY + ++ L ++
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGR------------------VPYPGMVNREVLDQVERG 397
Query: 323 --MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
M P + + L QC EP+ RP + A LE
Sbjct: 398 YRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-42
Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 55/290 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V G W Q+ VAVK +K EG E+ E + +L HP
Sbjct: 16 LGSGQFGVVKLGKWKGQYD-----------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LVK G C + +V E++ G L N+L G L + +++ +G+ FL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGMAFL-- 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAA 262
Q I+RD A N L+D + K+SDFG+ R + Q + + G ++A
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT-------RYVLDDQYVSSVGTKFPVKWSA 173
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 319
PE + ++KSDV++FG+++ E+ S G+ PY ++ +
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGK------------------MPYDLYTNSEVV 215
Query: 320 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
++ G P A+ T + C + P+ RP ++L+ +E L
Sbjct: 216 LKVSQ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
+G G FG VY G +D G + AVK L ++LTE + H
Sbjct: 33 IGRGHFGCVYHGTLLD-------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 148 PNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
PN++ L+G CL E L+V +M G L N + + + + AKG+ +L
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKYL 144
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV------MGTH 258
A + ++RD A N +LD +F K++DFGLA+ + H T M
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSD 315
A E + T + TTKSDV+SFGV+L EL++ G PY ++
Sbjct: 200 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------------PPYPDVNT 238
Query: 316 KRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
++ G P+ + L+C + + ++RP SE+++ + +
Sbjct: 239 FDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 55/290 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+G G FG V+ G W+++ VA+K ++ EG ++++ E + +L HP
Sbjct: 16 IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L G CLE LV EFM G L ++L R + + + + +G+ +L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL-- 120
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAA 262
E+ VI+RD A N L+ K+SDFG+ R + Q + G +A+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMT-------RFVLDDQYTSSTGTKFPVKWAS 173
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 319
PE + R ++KSDV+SFGV++ E+ S G+ PY S+ +
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGK------------------IPYENRSNSEVV 215
Query: 320 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
I G P+ A+ + C P+ RP S +L L +
Sbjct: 216 EDIST---GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-42
Identities = 80/293 (27%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK---EWLTEVNYLGQL 145
LG+G FG V +G W A G + VAVK LKP+ + +++ EVN + L
Sbjct: 26 LGDGSFGVVRRGEWD-------APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVAIGAAKGLT 204
H NL++L G L +V E P GSL + L + L R A+ A+G+
Sbjct: 79 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L + I+RD A N+LL K+ DFGL +A P D +V + H
Sbjct: 136 YL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE----HRKVPFA 189
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318
+ APE + T + SD + FGV L E+ + G+ +P+
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPW--IGLN 229
Query: 319 LFRIMDT--KLGGQYPQKAAHTAA--TLALQCLNNEPKLRPRMSEVLAILERL 367
+I+ K G + P+ + +QC ++P+ RP + L
Sbjct: 230 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-42
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQ 144
D LG G FG V KG+ VAVK LK E E L E N + Q
Sbjct: 22 DKELGSGNFGTVKKGYYQM-------KKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 74
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
L +P +V++IG C E+ +LV E G L +L + + + + G+
Sbjct: 75 LDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMK 131
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L ES ++RD A N+LL + AK+SDFGL+KA + + + HG
Sbjct: 132 YL--EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT----HGKWPVK 185
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + + ++KSDV+SFGV++ E S
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 89/378 (23%), Positives = 144/378 (38%), Gaps = 60/378 (15%)
Query: 14 STQSPRATSGASRISTRSSHSSAPSTLPI----PPSKEKGNSESLPTPKSEGEILSSSNL 69
R S A+ I I +K SE+L + + S L
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 70 KAFTFNELKTATRNFRPDSL-----LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKK 123
++ + +G G FG VY G +D G + AVK
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD-------NDGKKIHCAVKS 124
Query: 124 LKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFR 181
L ++LTE + HPN++ L+G CL E L+V +M G L N +
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
+ + + AKG+ FL A + ++RD A N +LD +F K++DFGLA+
Sbjct: 185 ETHN-PTVKDLIGFGLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR- 240
Query: 242 GPTGDRTHVSTQVMGTHGYA-------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 293
D + A A E + T + TTKSDV+SFGV+L EL++ G
Sbjct: 241 ----DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-- 294
Query: 294 VDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNN 349
PY ++ ++ G P+ + L+C +
Sbjct: 295 ----------------PPYPDVNTFDITVYLLQ---GRRLLQPEYCPDPLYEVMLKCWHP 335
Query: 350 EPKLRPRMSEVLAILERL 367
+ ++RP SE+++ + +
Sbjct: 336 KAEMRPSFSELVSRISAI 353
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 75/292 (25%), Positives = 134/292 (45%), Gaps = 51/292 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHP 148
+G G G V G + + VA+K LK + +++L+E + +GQ HP
Sbjct: 57 IGSGDSGEVCYGRL------RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+++L G G ++V E+M GSL+ L R + + + G G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL-- 167
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAAP 263
++ ++RD A N+L+D+ K+SDFGL++ +T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT----GGKIPIRWTAP 223
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLF 320
E +A ++ SDV+SFGVV+ E+L+ G +PY ++++ +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGE------------------RPYWNMTNRDVIS 265
Query: 321 RIMDTKLGGQYPQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + G + P A H L L C + + RPR S+++++L+ L
Sbjct: 266 SVEE---GYRLPAPMGCPHALH---QLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 63/292 (21%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+G+G FG V G + G VAVK +K + + +L E + + QL H
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 149 NLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
NLV+L+G +E + L +V E+M KGSL ++L RG L +K ++ + + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG------THGYA 261
+ ++RD A N+L+ + AK+SDFGL + STQ G T
Sbjct: 134 -EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT-------KEASSTQDTGKLPVKWT---- 181
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE + + +TKSDV+SFG++L E+ S GR PY + K
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDV 223
Query: 319 LFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ R+ G P + C + + +RP ++ LE +
Sbjct: 224 VPRVEK----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 59/301 (19%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH 146
LGEG FG V +G + G+ + VAVK +K + + +E+L+E +
Sbjct: 42 LGEGEFGSVMEGNLKQ-------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 147 HPNLVKLIGYCLEGENR-----LLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAI 197
HPN+++L+G C+E ++ +++ FM G L +L GP+ + +K +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV- 254
A G+ +L + ++RD A N +L + ++DFGL+K +GD R ++
Sbjct: 155 DIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 255 ---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310
+ A E +A T+KSDV++FGV + E+ + G
Sbjct: 213 VKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------------------T 248
Query: 311 PY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
PY + + ++ G + P+ + C +P RP S + LE+
Sbjct: 249 PYPGVQNHEMYDYLLH---GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
Query: 367 L 367
L
Sbjct: 306 L 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
LGEG FG VY+G + + G + VAVK K + +++++E + L H
Sbjct: 20 LGEGFFGEVYEGVYTN-------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQP-LSWAVRMKVAIGAAKGLTFL 206
P++VKLIG E E ++ E P G L ++L R + V ++ K + +L
Sbjct: 73 PHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL 129
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YA 261
++RD NIL+ + KL DFGL++ D + +
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS----VTRLPIKWM 181
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
+PE + R TT SDV+ F V + E+LS G+ +P+ L +K
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGK------------------QPFFWLENKDV 223
Query: 319 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAK 375
+ + G P TL +C + +P RPR +E++ L + + K+ A
Sbjct: 224 IGVLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 80/302 (26%), Positives = 122/302 (40%), Gaps = 57/302 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LGEG FG V+ + M+VAVK LK +++ E L L H +
Sbjct: 49 LGEGAFGKVFLA----ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-------------QPLSWAVRMKVA 196
+V+ G C EG L+V+E+M G L L GP PL + VA
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV-- 254
A G+ +L A ++RD N L+ K+ DFG+++ + D V +
Sbjct: 165 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 255 ----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309
M PE + + TT+SDV+SFGVVL E+ + G+
Sbjct: 223 PIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK------------------ 258
Query: 310 KPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
+P+ LS+ + I G + P+ + C EP+ R + +V A L+
Sbjct: 259 QPWYQLSNTEAIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
Query: 366 RL 367
L
Sbjct: 316 AL 317
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-41
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 55/290 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V G W Q+ VA+K +K EG E++ E + L H
Sbjct: 32 LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L G C + ++ E+M G L N+L R +++ + + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG------YAA 262
Q ++RD A N L++ + K+SDFGL+ R + + + G ++
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYTSSVGSKFPVRWSP 189
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 319
PE + + ++KSD+++FGV++ E+ S G+ PY ++
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGK------------------MPYERFTNSETA 231
Query: 320 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
I G P A+ T+ C + + RP +L+ + +
Sbjct: 232 EHIAQ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 72/314 (22%), Positives = 127/314 (40%), Gaps = 60/314 (19%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH 146
LG+G FG V + + GS + VAVK LK + +E+L E + +
Sbjct: 31 LGKGEFGSVREAQLKQ-------EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 147 HPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHLFRRGP----QPLSWAVRMKVA 196
HP++ KL+G L + +++ FM G L L L ++
Sbjct: 84 HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV 254
+ A G+ +L + I+RD A N +L + ++DFGL++ +GD R ++++
Sbjct: 144 VDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 255 ----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309
+ A E +A T SDV++FGV + E+++ G+
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------------------ 237
Query: 310 KPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
PY + + ++ G + P + L QC + +PK RP + + LE
Sbjct: 238 TPYAGIENAEIYNYLIG---GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
Query: 366 RLEAPKNSAKLSQS 379
+ + SQ
Sbjct: 295 NILGHLSVLSTSQD 308
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-41
Identities = 79/303 (26%), Positives = 123/303 (40%), Gaps = 58/303 (19%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LGEG FG V+ + + M+VAVK LK K++ E L L H +
Sbjct: 23 LGEGAFGKVFLA----ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKV 195
+VK G C +G+ ++V+E+M G L L GP L + + +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV- 254
A A G+ +L A ++RD N L+ A K+ DFG+++ + D V
Sbjct: 139 ASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 255 -----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDW 308
M PE + + TT+SDV+SFGV+L E+ + G+
Sbjct: 197 LPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQ---------------- 234
Query: 309 AKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
P+ LS+ + I G + P+ + L C EP+ R + E+ IL
Sbjct: 235 --PWFQLSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
Query: 365 ERL 367
L
Sbjct: 290 HAL 292
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 6e-41
Identities = 86/361 (23%), Positives = 141/361 (39%), Gaps = 56/361 (15%)
Query: 25 SRISTRSSHSSAP-STLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRN 83
S I ++P + EK S SE + + + T+ T
Sbjct: 327 SFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYE 386
Query: 84 FRPDSL-----LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWL 136
+ + + +GEG FG V++G ++ M VA+K K +++L
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMS-------PENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
E + Q HP++VKLIG E ++ E G L + L + L A + A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYA 497
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
+ L +L + ++RD A N+L+ + KL DFGL++ ST
Sbjct: 498 YQLSTALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKA 549
Query: 257 THG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310
+ G + APE + R T+ SDV+ FGV + E+L G K
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV------------------K 591
Query: 311 PY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
P+ + + + RI + G P T +L +C +P RPR +E+ A L
Sbjct: 592 PFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648
Query: 367 L 367
+
Sbjct: 649 I 649
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 79/319 (24%), Positives = 139/319 (43%), Gaps = 54/319 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LG+G FG VY+G + K VA+K + + E+L E + + + +
Sbjct: 33 LGQGSFGMVYEG----VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRMKVAIGAA 200
++V+L+G +G+ L++ E M +G L+++L P P S + +++A A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVSTQV---- 254
G+ +L ++ ++RD A N ++ +F K+ DFG+ + D R +
Sbjct: 149 DGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 312
M +PE + G TT SDV+SFGVVL E+ + +PY
Sbjct: 207 M------SPESLKDGVFTTYSDVWSFGVVLWEIATLAE------------------QPYQ 242
Query: 313 -LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER-LE 368
LS+++ L +M+ GG P L C PK+RP E+++ ++ +E
Sbjct: 243 GLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299
Query: 369 APKNSAKLSQSEPHRQTGP 387
SE ++ P
Sbjct: 300 PGFREVSFYYSEENKLPEP 318
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 53/294 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
+G+G FG VY G +ID + + + A+K L Q + +L E + L+H
Sbjct: 29 IGKGHFGVVYHGEYID-------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 148 PNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
PN++ LIG L E + +M G L + + + + A+G+ +L
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGMEYL 140
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK----AGPTGDRTHVSTQV----MGTH 258
AE + ++RD A N +LD F K++DFGLA+ + H ++
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT--- 195
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSD 315
A E + T R TTKSDV+SFGV+L ELL+ G PY +
Sbjct: 196 ---ALESLQTYRFTTKSDVWSFGVLLWELLTRGA------------------PPYRHIDP 234
Query: 316 KRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ G P+ + + QC +P +RP ++ +E++
Sbjct: 235 FDLTHFLAQ---GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 77/291 (26%), Positives = 120/291 (41%), Gaps = 57/291 (19%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V+ G + VAVK LK +G +L E N + QL H
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-----------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L + E ++ E+M GSL + L L+ + +A A+G+ F+
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA------- 261
E I+RD +A+NIL+ + K++DFGLA+ + A
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLAR--------LIEDNEYTAREGAKFPIKWT 177
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE + G T KSDV+SFG++L E+++ GR PY +++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRI------------------PYPGMTNPEV 219
Query: 319 LFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ + G + P L C P+ RP + ++LE
Sbjct: 220 IQNLER---GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 76/290 (26%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
+GEG FG V++G ++ + VA+K K +++L E + Q H
Sbjct: 23 IGEGQFGDVHQGIYMS-------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
P++VKLIG E ++ E G L + L R L A + A + L +L
Sbjct: 76 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYL- 132
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG-----YAA 262
+ ++RD A N+L+ + KL DFGL++ ST + G + A
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY------MEDSTYYKASKGKLPIKWMA 185
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKL 319
PE + R T+ SDV+ FGV + E+L G KP+ + + +
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGV------------------KPFQGVKNNDVI 227
Query: 320 FRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
RI + G P T +L +C +P RPR +E+ A L +
Sbjct: 228 GRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 85/321 (26%), Positives = 132/321 (41%), Gaps = 65/321 (20%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-H 146
++GEG FG V K I K G M A+K++K H+++ E+ L +L H
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------------PLSWAVR 192
HPN++ L+G C L E+ P G+L + L + LS
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ A A+G+ +L ++ Q I+RD A NIL+ + AK++DFGL++
Sbjct: 145 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EV 194
Query: 253 QVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 306
V T G + A E + TT SDV+S+GV+L E++S G
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--------------- 239
Query: 307 DWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
PY ++ ++ G + P L QC +P RP +++L
Sbjct: 240 ---TPYCGMTCAELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 363 ILER-LEAPKNSAKLSQSEPH 382
L R LE K + E
Sbjct: 294 SLNRMLEERKTYVNTTLYEKF 314
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 55/290 (18%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG G FG V+ + VAVK +K G + +L E N + L H
Sbjct: 196 LGAGQFGEVWMATYNKHTK-----------VAVKTMK-PGSMSVEAFLAEANVMKTLQHD 243
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LVKL + E ++ EFM KGSL + L + + A+G+ F+
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-- 300
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG---YAAPEY 265
+ I+RD +A+NIL+ A K++DFGLA+ D + + + G + APE
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTARE--GAKFPIKWTAPEA 356
Query: 266 VATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRI 322
+ G T KSDV+SFG++L+E+++ GR PY +S+ + +
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRI------------------PYPGMSNPEVIRAL 398
Query: 323 -----MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
M P+ + ++C N P+ RP + ++L+
Sbjct: 399 ERGYRMPR------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 81/284 (28%), Positives = 121/284 (42%), Gaps = 43/284 (15%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
LG+G FG V+ G W VA+K LK G + +L E + +L H
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
LV+L E E +V E+M KGSL + L + L + +A A G+ ++
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
++RD +A+NIL+ K++DFGLA+ + T + APE
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALY 438
Query: 269 GRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT 325
GR T KSDV+SFG++L EL + GR PY + ++ L ++
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGR------------------VPYPGMVNREVLDQVER- 479
Query: 326 KLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
G P + + L QC EP+ RP + A LE
Sbjct: 480 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 55/326 (16%)
Query: 46 KEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQ 105
+E+ N + + E + + SN R + D +G G F VYKG +D
Sbjct: 1 QEERNQQQDDIEELETKAVGMSN-----------DGRFLKFDIEIGRGSFKTVYKG-LDT 48
Query: 106 HSLSPAKPGSGMVVAVK--KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL---EG 160
+ + VA + + + + E L L HPN+V+ +G
Sbjct: 49 --------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100
Query: 161 ENRLLVY-EFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFK 219
+ +++ E M G+L+ +L R + V KGL FLH +I+RD K
Sbjct: 101 KKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLK 158
Query: 220 ASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 278
NI + + K+ D GLA R + V+GT + APE DVY
Sbjct: 159 CDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMYEEK-YDESVDVY 213
Query: 279 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAA 336
+FG+ +LE+ + PY + +++R + + + K A
Sbjct: 214 AFGMCMLEMATSEY------------------PYSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 337 HTAAT-LALQCLNNEPKLRPRMSEVL 361
+ C+ R + ++L
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 80/315 (25%), Positives = 122/315 (38%), Gaps = 55/315 (17%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
LG G FG VY+G S + VAVK L Q ++L E + + +H
Sbjct: 38 LGHGAFGEVYEGQVSG-----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKG 202
N+V+ IG L+ R ++ E M G L++ L P L+ + VA A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 203 LTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGD--RTHVSTQV--- 254
+L E+ I+RD A N LL AK+ DFG+A+ R +
Sbjct: 153 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 255 -MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY 312
M PE G T+K+D +SFGV+L E+ S G PY
Sbjct: 211 WM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------------MPY 246
Query: 313 --LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368
S++ L + GG P+ + QC ++P+ RP + +L +E
Sbjct: 247 PSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 369 APKNSAKLSQSEPHR 383
+ + +
Sbjct: 304 QDPDVINTALPIEYG 318
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-39
Identities = 74/302 (24%), Positives = 121/302 (40%), Gaps = 59/302 (19%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
LGE FG VYKG H PA VA+K LK + +E+ E +L HP
Sbjct: 17 LGEDRFGKVYKG----HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMK 194
N+V L+G + + +++ + G L L R P L +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD--RTHVST 252
+ A G+ +L + V+++D N+L+ + N K+SD GL + D + ++
Sbjct: 133 LVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 253 QV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307
+ M APE + G+ + SD++S+GVVL E+ S G
Sbjct: 191 LLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---------------- 228
Query: 308 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
+PY S++ + I + P L ++C N P RPR ++ +
Sbjct: 229 --QPYCGYSNQDVVEMIRN---RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 364 LE 365
L
Sbjct: 284 LR 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-39
Identities = 79/314 (25%), Positives = 120/314 (38%), Gaps = 53/314 (16%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
LG G FG VY+G S + VAVK L Q ++L E + + +H
Sbjct: 79 LGHGAFGEVYEGQVSG-----MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKG 202
N+V+ IG L+ R ++ E M G L++ L P L+ + VA A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 203 LTFLHDAESQVIYRDFKASNILLDAE---FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+L E+ I+RD A N LL AK+ DFG+A+ G
Sbjct: 194 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCA 246
Query: 260 Y-----AAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPY- 312
PE G T+K+D +SFGV+L E+ S G PY
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------------------MPYP 288
Query: 313 -LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369
S++ L + GG P+ + QC ++P+ RP + +L +E
Sbjct: 289 SKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
Query: 370 PKNSAKLSQSEPHR 383
+ + +
Sbjct: 346 DPDVINTALPIEYG 359
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 87 DSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQ 144
D LG G FG V +G + + VA+K LK +E + E + Q
Sbjct: 341 DIELGCGNFGSVRQGVYR--------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
L +P +V+LIG C E +LV E G L L + + + + ++ + G+
Sbjct: 393 LDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMK 450
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG----- 259
+L E ++R+ A N+LL AK+SDFGL+KA D + + G
Sbjct: 451 YL--EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----AGKWPLK 504
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+ APE + + +++SDV+S+GV + E LS
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 76/322 (23%), Positives = 133/322 (41%), Gaps = 57/322 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HH 147
LGEG FG V + KP + VAVK LK + + + ++E+ + + H
Sbjct: 43 LGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + +++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A+G+ +L A + I+RD A N+L+ K++DFGLA+ D ++
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYY 213
Query: 254 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307
T+G + APE + T +SDV+SFGV++ E+ + G
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS--------------- 258
Query: 308 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
PY + + + + G P + + C + P RP +++
Sbjct: 259 ---PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 364 LER-LEAPKNSAKLSQSEPHRQ 384
L+R L N L S+P Q
Sbjct: 313 LDRILTLTTNEEYLDLSQPLEQ 334
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 70/304 (23%), Positives = 127/304 (41%), Gaps = 56/304 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HH 147
LGEG FG V + KP + VAVK LK + + + ++E+ + + H
Sbjct: 89 LGEGCFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + +++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A+G+ +L A + I+RD A N+L+ K++DFGLA+ D ++
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDYY 259
Query: 254 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307
T+G + APE + T +SDV+SFGV++ E+ + G
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS--------------- 304
Query: 308 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
PY + + + + G P + + C + P RP +++
Sbjct: 305 ---PYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 364 LERL 367
L+R+
Sbjct: 359 LDRI 362
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 67/369 (18%), Positives = 131/369 (35%), Gaps = 49/369 (13%)
Query: 65 SSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL 124
SS + T N + + +GEG FG + + G +K++
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILV---KST------EDGRQYVIKEI 57
Query: 125 KPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 181
KE EV L + HPN+V+ E + +V ++ G L +
Sbjct: 58 NISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
+ + + L +HD ++++RD K+ NI L + +L DFG+A+
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 242 -GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300
T + + GT Y +PE KSD+++ G VL EL + +
Sbjct: 175 LNSTVELAR--ACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK--------- 222
Query: 301 IEQSLVDWAKPYLSDKRK--LFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRP 355
+ + K + +I+ G + ++ +L Q P+ RP
Sbjct: 223 ---------HAFEAGSMKNLVLKIIS----GSFPPVSLHYSYDLRSLVSQLFKRNPRDRP 269
Query: 356 RMSEVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLP 412
++ +L I +R+E + +++ + + P ++ S N
Sbjct: 270 SVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329
Query: 413 SHRQSPRVR 421
+ + +
Sbjct: 330 ITKPAAKYG 338
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 70/297 (23%), Positives = 120/297 (40%), Gaps = 58/297 (19%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+F+ L+G GGFG V+K +H + G +K++K +++ EV
Sbjct: 11 MDFKEIELIGSGGFGQVFKA---KHRID------GKTYVIKRVKYN----NEKAEREVKA 57
Query: 142 LGQLHHPNLVKLIGYCLEGENRL----------------LVYEFMPKGSLENHLFRRGPQ 185
L +L H N+V G + + EF KG+LE + +R +
Sbjct: 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 186 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPT 244
L + +++ KG+ ++H ++I RD K SNI L K+ DFGL +
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304
G RT GT Y +PE +++ + D+Y+ G++L ELL
Sbjct: 176 GKRT---RSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------------- 217
Query: 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+ + D + + +K L + L+ +P+ RP SE+L
Sbjct: 218 ----CDTAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRPNTSEIL 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-38
Identities = 78/365 (21%), Positives = 133/365 (36%), Gaps = 65/365 (17%)
Query: 27 ISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRP 86
+ +S P P K T NFR
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLA------------------------NFRI 36
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLG 143
+ +G G F VY+ G+ VA+KK++ K + E++ L
Sbjct: 37 EKKIGRGQFSEVYRA---ACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAIGAAK 201
QL+HPN++K +E +V E G L + F++ + + K +
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
L +H +V++RD K +N+ + A KL D GL + + T + V GT Y
Sbjct: 148 ALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYM 203
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
+PE + KSD++S G +L E+ + + P+ DK L+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYS 245
Query: 322 IMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLS 377
+ YP + L C+N +P+ RP ++ V + +R+ A ++ L
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT-ASSLE 304
Query: 378 QSEPH 382
H
Sbjct: 305 HHHHH 309
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-38
Identities = 76/339 (22%), Positives = 112/339 (33%), Gaps = 53/339 (15%)
Query: 28 STRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPD 87
+ S P S SE+L +P + S ++F
Sbjct: 15 TENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSR---------- 64
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQ 144
LG G +G V+K G + AVK+ F+G K+ L EV +
Sbjct: 65 --LGHGSYGEVFKV---------RSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEK 112
Query: 145 L-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
+ HP V+L EG L E SL+ H G L A L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLAL 170
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
LH +++ D K +NI L KL DFGL T Q G Y AP
Sbjct: 171 AHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAP 225
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323
E + G T +DV+S G+ +LE+ ++
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQLR 265
Query: 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
L ++ + ++ + L +PKLR +LA
Sbjct: 266 QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 78/303 (25%), Positives = 122/303 (40%), Gaps = 57/303 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HH 147
LG G FG V + + K + + VAVK LK + ++E+ + L H
Sbjct: 54 LGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP------------QPLSWAVRMKV 195
N+V L+G C G L++ E+ G L N L R+ S +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM 255
+ A+G+ FL A I+RD A N+LL AK+ DFGLA+ D + S ++
Sbjct: 170 SSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 222
Query: 256 GTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309
+ + APE + T +SDV+S+G++L E+ S G
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN----------------- 265
Query: 310 KPY---LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
PY L + + + D G Q P A ++ C EP RP ++ + L
Sbjct: 266 -PYPGILVNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321
Query: 365 ERL 367
+
Sbjct: 322 QEQ 324
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 67/312 (21%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHP 148
+GEG FG V++ + +VAVK LK E ++ E + + +P
Sbjct: 55 IGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR---------------- 192
N+VKL+G C G+ L++E+M G L L P +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 193 ------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246
+ +A A G+ +L +E + ++RD N L+ K++DFGL++ + D
Sbjct: 171 LSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 247 --RTHVSTQV----MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKV 299
+ + + M PE + R TT+SDV+++GVVL E+ S G
Sbjct: 229 YYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------- 275
Query: 300 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRP 355
PY ++ + ++ + D G P+ L C + P RP
Sbjct: 276 -----------PYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRP 321
Query: 356 RMSEVLAILERL 367
+ IL+R+
Sbjct: 322 SFCSIHRILQRM 333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-37
Identities = 78/321 (24%), Positives = 134/321 (41%), Gaps = 56/321 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-HH 147
LGEG FG V + L KP VAVK LK + + + ++E+ + + H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRM 193
N++ L+G C + ++ E+ KG+L +L R P + LS +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
A A+G+ +L A + I+RD A N+L+ + K++DFGLA+ D H+
Sbjct: 195 SCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYY 247
Query: 254 VMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307
T+G + APE + T +SDV+SFGV+L E+ + G
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------------- 292
Query: 308 WAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363
PY + + + + G P + + C + P RP +++
Sbjct: 293 ---PYPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 364 LERLEAPKNSAKLSQSEPHRQ 384
L+R+ A ++ ++ H
Sbjct: 347 LDRIVALTSNQEMGYYHHHHH 367
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-37
Identities = 66/352 (18%), Positives = 123/352 (34%), Gaps = 55/352 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH--KEWLTEVNYLGQLH 146
+G GG V++ + + A+K + E + E+ YL +L
Sbjct: 16 QIGSGGSSKVFQV---LNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 147 HPNL--VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
+ ++L Y + + +V E L + L ++ + + +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVH 122
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE 264
+H +++ D K +N L+ + KL DFG+A + V +GT Y PE
Sbjct: 123 TIHQ--HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 265 -----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 312
+ +++ KSDV+S G +L + G+ P+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------PFQ 221
Query: 313 --LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERL 367
++ KL I+D ++P + CL +PK R + E+LA + +
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281
Query: 368 EAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSPR 419
AK + E G + SP ++ + S SH S
Sbjct: 282 HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSS 333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-37
Identities = 82/312 (26%), Positives = 128/312 (41%), Gaps = 67/312 (21%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHH 147
LGEG FG V K VAVK LK ++ L+E N L Q++H
Sbjct: 31 LGEGEFGKVVKATAFH-----LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------------------Q 185
P+++KL G C + LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 186 PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245
L+ + A ++G+ +L AE ++++RD A NIL+ K+SDFGL++
Sbjct: 146 ALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 246 DRTHVSTQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKV 299
D + V + G + A E + TT+SDV+SFGV+L E+++ G
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN------- 251
Query: 300 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRP 355
PY + +R + G + P + L LQC EP RP
Sbjct: 252 -----------PYPGIPPERLFNLLKT---GHRMERPDNCSEEMYRLMLQCWKQEPDKRP 297
Query: 356 RMSEVLAILERL 367
+++ LE++
Sbjct: 298 VFADISKDLEKM 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 75/424 (17%), Positives = 141/424 (33%), Gaps = 68/424 (16%)
Query: 17 SPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNE 76
++ R S ++A S + G + S E +S
Sbjct: 4 HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-------- 55
Query: 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKE 134
R + +G GG V++ + + A+K + E Q
Sbjct: 56 -----RIYSILKQIGSGGSSKVFQV---LNE-------KKQIYAIKYVNLEEADNQTLDS 100
Query: 135 WLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 192
+ E+ YL +L + ++L Y + + +V E L + L ++
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS 159
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ + + +H + +++ D K +N L+ + KL DFG+A + V
Sbjct: 160 YWKNM--LEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 253 QVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301
+G Y PE + +++ KSDV+S G +L + G+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK---------- 264
Query: 302 EQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS 358
P+ ++ KL I+D ++P + CL +PK R +
Sbjct: 265 --------TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316
Query: 359 EVLA---ILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 415
E+LA + + AK + E G + SP ++ + S SH
Sbjct: 317 ELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHN 376
Query: 416 QSPR 419
S
Sbjct: 377 SSSS 380
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 76/341 (22%), Positives = 125/341 (36%), Gaps = 47/341 (13%)
Query: 22 SGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTAT 81
SG+ S +S T +K P + +L + LK + E +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAK---LQRLGPETEDNEGVLLTEKLKPVDY-EYREEV 57
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+G G FG V++ D+ +G AVKK++ E F+ E+
Sbjct: 58 HWMTHQPRVGRGSFGEVHRM-KDK--------QTGFQCAVKKVRLEVFRVE-----ELVA 103
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L P +V L G EG + E + GSL + + G L + A +
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALE 161
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAK--AGPTGDRTHVSTQVM-GT 257
GL +LH ++++ D KA N+LL ++ A L DFG A ++ ++ + GT
Sbjct: 162 GLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSD 315
+ APE V K D++S ++L +L+G P+
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------------------HPWTQYFR 261
Query: 316 KRKLFRIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
+I + + P A A + L EP R
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 80/314 (25%), Positives = 120/314 (38%), Gaps = 75/314 (23%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-H 146
LG G FG V + K + M VAVK LKP + ++E+ L L +
Sbjct: 31 LGAGAFGKVVEATAYGL-----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP----------------QPLSWA 190
H N+V L+G C G L++ E+ G L N L R+ L
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
+ + AKG+ FL A I+RD A NILL K+ DFGLA+
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLAR---------- 193
Query: 251 STQVMGTHGYA------------APEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKT 297
+ Y APE + T +SDV+S+G+ L EL S G
Sbjct: 194 --DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----- 246
Query: 298 KVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKL 353
PY + K ++++ K G P+ A + C + +P
Sbjct: 247 -------------PYPGMPVDSKFYKMI--KEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 354 RPRMSEVLAILERL 367
RP +++ ++E+
Sbjct: 292 RPTFKQIVQLIEKQ 305
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 62/321 (19%), Positives = 115/321 (35%), Gaps = 55/321 (17%)
Query: 59 SEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV 118
S G L + NL F + R + +G GG V++ + +
Sbjct: 8 SSGVDLGTENLY---FQSMSVKGRIYSILKQIGSGGSSKVFQV---LNE-------KKQI 54
Query: 119 VAVKKLKPEGFQGH--KEWLTEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPKGS 174
A+K + E + E+ YL +L + ++L Y + + +V E
Sbjct: 55 YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NID 113
Query: 175 LENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234
L + L ++ + + + +H +++ D K +N L+ + KL
Sbjct: 114 LNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLI 168
Query: 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-----------YVATGRLTTKSDVYSFGVV 283
DFG+A + V +GT Y PE + +++ KSDV+S G +
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228
Query: 284 LLELLSGRCAVDKTKVGIEQSLVDWAKPY---LSDKRKLFRIMDTKLGGQYPQKAAHTAA 340
L + G+ P+ ++ KL I+D ++P
Sbjct: 229 LYYMTYGKT------------------PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQ 270
Query: 341 TLALQCLNNEPKLRPRMSEVL 361
+ CL +PK R + E+L
Sbjct: 271 DVLKCCLKRDPKQRISIPELL 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-36
Identities = 67/306 (21%), Positives = 115/306 (37%), Gaps = 44/306 (14%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKP-GSGMVVAVKKLKPEGFQGHKEWLTEVN 140
+++ LGEGGF +V + G A+K++ Q +E E +
Sbjct: 29 KHYLFIQKLGEGGFSYVDL----------VEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 141 YLGQLHHPNLVKLIGYCLEGENR----LLVYEFMPKGSLENHL--FRRGPQPLSWAVRMK 194
+HPN+++L+ YCL L+ F +G+L N + + L+ +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTHVS 251
+ +G +GL +H +RD K +NILL E L D G G R ++
Sbjct: 139 LLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 252 TQVM----GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304
Q T Y APE + + ++DV+S G VL ++ G D +
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-- 254
Query: 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
S + + ++ L + +P RP + +L+ L
Sbjct: 255 ---------SVALAVQNQLSIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPLLLSQL 301
Query: 365 ERLEAP 370
E L+ P
Sbjct: 302 EALQPP 307
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 72/319 (22%), Positives = 115/319 (36%), Gaps = 80/319 (25%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-H 146
LG G FG V +K G + VAVK LK + + ++E+ + QL
Sbjct: 53 LGSGAFGKVMNATAYG-----ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-------------- 192
H N+V L+G C L++E+ G L N+L + + +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 193 -------MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245
+ A AKG+ FL ++RD A N+L+ K+ DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----- 220
Query: 246 DRTHVSTQVMGTHGYA------------APEYVATGRLTTKSDVYSFGVVLLELLS-GRC 292
+M Y APE + G T KSDV+S+G++L E+ S G
Sbjct: 221 -------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 293 AVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLN 348
PY + ++++ + G P A + C
Sbjct: 274 ------------------PYPGIPVDANFYKLI--QNGFKMDQPFYATEEIYIIMQSCWA 313
Query: 349 NEPKLRPRMSEVLAILERL 367
+ + RP + + L
Sbjct: 314 FDSRKRPSFPNLTSFLGCQ 332
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 83/306 (27%), Positives = 120/306 (39%), Gaps = 60/306 (19%)
Query: 90 LGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL-H 146
LG G FG V + K + VAVK LK H+ ++E+ L + H
Sbjct: 35 LGRGAFGQVIEADAFG-----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 147 HPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAV 191
H N+V L+G C G +++ EF G+L +L + L+
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ + AKG+ FL A + I+RD A NILL + K+ DFGLA+ D
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDP 202
Query: 252 TQVMGTHG-----YAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 305
V + APE + T +SDV+SFGV+L E+ S G
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------------- 249
Query: 306 VDWAKPY--LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
PY + + R + K G + P L C + EP RP SE++
Sbjct: 250 -----PYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302
Query: 362 AILERL 367
L L
Sbjct: 303 EHLGNL 308
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT----EV 139
++ LG GG VY L + VA+K + + +E L EV
Sbjct: 13 YKIVDKLGGGGMSTVYLAE--DTIL-------NIKVAIKAIFIP-PREKEETLKRFEREV 62
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
+ QL H N+V +I E + LV E++ +L ++ GP + A+
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN--FTNQI 120
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
G+ HD ++++RD K NIL+D+ K+ DFG+AKA T + V+GT
Sbjct: 121 LDGIKHAHDM--RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
Y +PE +D+YS G+VL E+L G
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 62/326 (19%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNY 141
+F P LG GGFG V++ ++ + A+K+++ P ++ + EV
Sbjct: 6 DFEPIQCLGRGGFGVVFEA---KNKVD------DCNYAIKRIRLPNRELAREKVMREVKA 56
Query: 142 LGQLHHPNLVKLIGYCLEGEN---------RLLVY---EFMPKGSLENHL-FRRGPQPLS 188
L +L HP +V+ LE ++ +Y + K +L++ + R +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA------- 241
+V + + + A+ + FLH +++RD K SNI + K+ DFGL A
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 242 ---GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298
T +GT Y +PE + + K D++S G++L ELL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFST----- 229
Query: 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRP 355
+E+ L + + ++P + L+ P RP
Sbjct: 230 -QMERVRT------------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERP 272
Query: 356 RMSEVLA--ILERLEAPKNSAKLSQS 379
++ + E L+ P + +S
Sbjct: 273 EAINIIENAVFEDLDFPGKTVLRQRS 298
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 60/311 (19%), Positives = 115/311 (36%), Gaps = 63/311 (20%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140
+F ++LG+G FG V K +++L A+KK++ + L+EV
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKA---RNALD------SRYYAIKKIRHTEEK-LSTILSEVM 54
Query: 141 YLGQLHHPNLVKLIGYCLEGENRL-------------LVYEFMPKGSLENHLFRRGPQPL 187
L L+H +V+ LE N + + E+ G+L + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQ 113
Query: 188 SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK------- 240
++ + L+++H +I+RD K NI +D N K+ DFGLAK
Sbjct: 114 QRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 241 ------AGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCA 293
G ++++ + GT Y A E + TG K D+YS G++ E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF-- 228
Query: 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIM---DTKLGGQYPQKAAHTAATLALQCLNNE 350
++ + + + + + + ++++
Sbjct: 229 -----------------STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 351 PKLRPRMSEVL 361
P RP +L
Sbjct: 272 PNKRPGARTLL 282
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 45/255 (17%), Positives = 77/255 (30%), Gaps = 23/255 (9%)
Query: 53 SLPTPKSEGEILSSSNLKAFT-FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPA 111
S P L A E + ++ LLGEG F VY+
Sbjct: 35 SKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA----TQGDLN 90
Query: 112 KPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP 171
+ +K KP + L +K L +LV E
Sbjct: 91 DAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYS 150
Query: 172 KGSLENHLFRRGP---QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--- 225
G+L N + + + + + A+ + +HD E +I+ D K N +L
Sbjct: 151 YGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNG 208
Query: 226 --------DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSD 276
D L D G + + + T T G+ E + + + + D
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQID 267
Query: 277 VYSFGVVLLELLSGR 291
+ + +L G
Sbjct: 268 YFGVAATVYCMLFGT 282
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 64/282 (22%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+LG+G +G VY G D + + +A+K++ + + E+ L H
Sbjct: 29 VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLH 207
N+V+ +G E + E +P GSL L + GP + +GL +LH
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 208 DAESQVIYRDFKASNILLDAEF-NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
D +Q+++RD K N+L++ K+SDFG +K + GT Y APE +
Sbjct: 140 D--NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEII 195
Query: 267 ---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK----L 319
G +D++S G ++E+ +G+ P+ + + +
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGK------------------PPF-YELGEPQAAM 235
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
F++ K+ + P+ + A L+C +P R +++L
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 56/212 (26%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT----EV 139
+R L+G GG G VY+ +VA+K + + T E
Sbjct: 36 YRLRRLVGRGGMGDVYEAE--DTVR-------ERIVALKLMSET-LSSDPVFRTRMQREA 85
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
G+L P++V + + + + L L R+GP AV +
Sbjct: 86 RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQI 143
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
L H A +RD K NIL+ A+ A L DFG+A A T + +GT
Sbjct: 144 GSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLY 200
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
Y APE + T ++D+Y+ VL E L+G
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-32
Identities = 74/345 (21%), Positives = 124/345 (35%), Gaps = 60/345 (17%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
R +L EGGF FVY+ Q GSG A+K+L + ++ + EV +
Sbjct: 28 LRLRVRRVLAEGGFAFVYEA---QDV------GSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 142 LGQL-HHPNLVKLIGYCLEGENR-------LLVYEFMPKGSLENHLFRRGPQ-PLSWAVR 192
+ +L HPN+V+ G+ L+ + KG L L + + PLS
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA---GPTGDRTH 249
+K+ + + +H + +I+RD K N+LL + KL DFG A P +
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 250 VSTQVM-------GTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCA-VDKTK 298
++ T Y PE + + K D+++ G +L L + D K
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 299 VGIEQSLVDW--AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356
+ I + L R M L P+ R
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAM-----------------------LQVNPEERLS 295
Query: 357 MSEVLAILERLEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSP 401
++EV+ L+ + A +N ++ P + R P
Sbjct: 296 IAEVVHQLQEIAAARN---VNPKSPITELLEQNGGYGSATLSRGP 337
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 69/305 (22%), Positives = 115/305 (37%), Gaps = 42/305 (13%)
Query: 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKE 134
+ + ++ +G G +G K + G ++ K+L +
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKI---RRK------SDGKILVWKELDYGSMTEAEKQM 51
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHL--FRRGPQPLSWA 190
++EVN L +L HPN+V+ ++ N L V E+ G L + + + Q L
Sbjct: 52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 191 VRMKVAIGAAKGLTFLHD---AESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGD 246
++V L H V++RD K +N+ LD + N KL DFGLA+
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
T V GT Y +PE + KSD++S G +L EL +
Sbjct: 172 FAK--TFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----------- 217
Query: 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---I 363
A K+ ++ +Y + + + LN + RP + E+L I
Sbjct: 218 --AFSQKELAGKIREGKFRRIPYRYSDELNE----IITRMLNLKDYHRPSVEEILENPLI 271
Query: 364 LERLE 368
LE
Sbjct: 272 LEHHH 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 42/267 (15%), Positives = 90/267 (33%), Gaps = 47/267 (17%)
Query: 55 PTPKSEGEILSSSNLKAFTFNELKTATR--NFRPDSLLGEGGFGFVYKGWIDQHSLSPAK 112
P + + + SNL + ++R L +G F + +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC---EKD----- 53
Query: 113 PGSGMVVAVKKLKPEGFQGHKEWLT-----------------EVNYLGQLHHPNLVKLIG 155
A+KK + + +++ E+ + + + + G
Sbjct: 54 ---NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 156 YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA------AKGLTFLHD 208
+ + + ++YE+M S+ ++ + + + +++H
Sbjct: 111 I-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH- 168
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268
E + +RD K SNIL+D KLSDFG ++ GT+ + PE +
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---G-SRGTYEFMPPE-FFS 223
Query: 269 GRLTT---KSDVYSFGVVLLELLSGRC 292
+ K D++S G+ L +
Sbjct: 224 NESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNY 141
+ LG GGFG+V + H + G VA+K+ + E ++E W E+
Sbjct: 15 PWEMKERLGTGGFGYVLRW---IHQDT------GEQVAIKQCRQELSPKNRERWCLEIQI 65
Query: 142 LGQLHHPNLVKLI------GYCLEGENRLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMK 194
+ +L+HPN+V + LL E+ G L +L + L
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVS 251
+ + L +LH E+++I+RD K NI+L K+ D G AK G +
Sbjct: 126 LLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELC 180
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T+ +GT Y APE + + T D +SFG + E ++G
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT----EV 139
+ +LG GG V+ VAVK L+ + + E
Sbjct: 14 YELGEILGFGGMSEVHLAR--DLRD-------HRDVAVKVLRAD-LARDPSFYLRFRREA 63
Query: 140 NYLGQLHHPNLVKL--IGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L+HP +V + G L +V E++ +L + + GP A+ V
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--V 121
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST-QV 254
A + L F H +I+RD K +NI++ A K+ DFG+A+A + T V
Sbjct: 122 IADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+GT Y +PE + +SDVYS G VL E+L+G
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 49/294 (16%)
Query: 83 NFRPDSLLGEGGFG-FVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+F P +LG G G VY+G D VAVK++ PE F EV
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-----------NRDVAVKRILPECFSFADR---EVQL 70
Query: 142 LGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L + HPN+++ + + + + E +L+ ++ ++ L +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTT 128
Query: 201 KGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKLSDFGLAKAGPTGDRT-HVSTQV 254
GL LH +++RD K NIL+ + A +SDFGL K G + + V
Sbjct: 129 SGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 255 MGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311
GT G+ APE + T D++S G V ++S P
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----------------P 229
Query: 312 YLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEVLA 362
+ ++ I+ H A L + + +P+ RP VL
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 62/259 (23%), Positives = 101/259 (38%), Gaps = 30/259 (11%)
Query: 41 PIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYK 100
P P K + P + + + + + R + LG+GGF ++
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD--PRSRRRYVRGRFLGKGGFAKCFE 59
Query: 101 GWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIG 155
+ + V A K L + E++ L H ++V G
Sbjct: 60 I---SDADT------KEVFAGKIVPKSLLLKPHQREKMS--MEISIHRSLAHQHVVGFHG 108
Query: 156 YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214
+ E + + +V E + SL RR A I G +LH ++VI
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH--RNRVI 163
Query: 215 YRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-T 272
+RD K N+ L+ + K+ DFGLA K G+R V GT Y APE V + + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKKGHS 219
Query: 273 TKSDVYSFGVVLLELLSGR 291
+ DV+S G ++ LL G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 56/230 (24%), Positives = 89/230 (38%), Gaps = 30/230 (13%)
Query: 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WL 136
T+ + +LG+G V++G +H + G + A+K F + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKKT------GDLFAIKVFNNISFLRPVDVQM 55
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRG-PQPLSWAVRM 193
E L +L+H N+VKL E R L+ EF P GSL L L + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTH 249
V G+ L E+ +++R+ K NI+ D + KL+DFG A+ D
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 250 VSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 291
+ GT Y P+ L D++S GV +G
Sbjct: 172 FVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 47/283 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
FR +LG+GGFG V +G + A KKL+ + + K L E
Sbjct: 185 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
L +++ +V L Y E ++ L LV M G L+ H++ G A R
Sbjct: 236 QILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA 293
Query: 199 -AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
GL LH +++YRD K NILLD + ++SD GLA P G +V GT
Sbjct: 294 EICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GT 348
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317
GY APE V R T D ++ G +L E+++G+ P+ K+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS------------------PFQQRKK 390
Query: 318 KL------FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
K+ + + +Y ++ + A +L Q L +P R
Sbjct: 391 KIKREEVERLVKEVPE--EYSERFSPQARSLCSQLLCKDPAER 431
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYL 142
+ + GG G++Y +++ G V +K L G + + E +L
Sbjct: 82 YEVKGCIAHGGLGWIYLAL--DRNVN------GRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 143 GQLHHPNLVKLIGYCLEGENRL-----LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
++ HP++V++ + + +V E++ SL+ P++ A+ +
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA--YLL 189
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVMG 256
L++LH ++Y D K NI+L E KL D G G + G
Sbjct: 190 EILPALSYLHSI--GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYG 239
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T G+ APE + T +D+Y+ G L L
Sbjct: 240 TPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LG+G FG VY + + ++A+K +L+ EG + E+
Sbjct: 21 PLGKGKFGNVYLA---REK------QNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQS 69
Query: 144 QLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
L HPN++++ Y R+ L+ EF P+G L L + G + + A
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADA 126
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L + H E +VI+RD K N+L+ + K++DFG + P R GT Y
Sbjct: 127 LHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLP 180
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE + K D++ GV+ E L G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-30
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LG+G FG VY + S ++A+K +L+ G + EV
Sbjct: 16 PLGKGKFGNVYLA---REK------QSKFILALKVLFKAQLEKAGVEHQLR--REVEIQS 64
Query: 144 QLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
L HPN+++L GY R+ L+ E+ P G++ L + + A
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANA 121
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
L++ H +VI+RD K N+LL + K++DFG + P+ RT + GT Y
Sbjct: 122 LSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCGTLDYLP 175
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE + K D++S GV+ E L G+
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 56/230 (24%), Positives = 89/230 (38%), Gaps = 30/230 (13%)
Query: 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WL 136
T+ + +LG+G V++G +H + G + A+K F + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRG---RHKKT------GDLFAIKVFNNISFLRPVDVQM 55
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRG-PQPLSWAVRM 193
E L +L+H N+VKL E R L+ EF P GSL L L + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAKLSDFGLAKAGPTGDRTH 249
V G+ L E+ +++R+ K NI+ D + KL+DFG A+ D
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 250 VSTQVMGTHGYAAPEYVATGRLTT--------KSDVYSFGVVLLELLSGR 291
+ GT Y P+ L D++S GV +G
Sbjct: 172 FVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 79/383 (20%), Positives = 129/383 (33%), Gaps = 66/383 (17%)
Query: 4 CLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTP------ 57
L D+ A + A ++ + +
Sbjct: 87 QLWKDIEDYDTADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPL 146
Query: 58 ----------KSEGEILSSSNLKAFT---FNELKTATRN-FRPDSLLGEGGFGFVYKGWI 103
E L S F + E + + F +LG GGFG V+
Sbjct: 147 LRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVF---- 202
Query: 104 DQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEG 160
K +G + A KKL + + K + + E L ++H +V L Y E
Sbjct: 203 ----ACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFET 256
Query: 161 ENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA--AKGLTFLHDAESQVIYRD 217
+ L LV M G + H++ + + A GL LH + +IYRD
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRD 314
Query: 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 277
K N+LLD + N ++SD GLA G GT G+ APE + D
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDY 372
Query: 278 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK-----LFR-IMDTKLGGQY 331
++ GV L E+++ R P+ + K L + +++ + Y
Sbjct: 373 FALGVTLYEMIAARG------------------PFRARGEKVENKELKQRVLEQAV--TY 412
Query: 332 PQKAAHTAATLALQCLNNEPKLR 354
P K + + L +P+ R
Sbjct: 413 PDKFSPASKDFCEALLQKDPEKR 435
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 52/291 (17%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL 136
R + LG+GGF ++ + + V A K L +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEI---SDADT------KEVFAGKIVPKSLLLKPHQREKMS-- 63
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
E++ L H ++V G+ E + + +V E + SL RR A
Sbjct: 64 MEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQV 254
I G +LH ++VI+RD K N+ L+ + K+ DFGLA K G+R V
Sbjct: 123 QI--VLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-- 176
Query: 255 MGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
GT Y APE V + + + + DV+S G ++ LL G+ + + +
Sbjct: 177 -GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------------- 220
Query: 314 SDKRKLF-RIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
++ + RI +Y P+ AA+L + L +P RP ++E+L
Sbjct: 221 ---KETYLRIKK----NEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 63/257 (24%), Positives = 108/257 (42%), Gaps = 40/257 (15%)
Query: 44 PSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWI 103
E+ + + E + + ++ + + LG G G V+K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISE-------LGAGNGGVVFKV-- 52
Query: 104 DQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162
H KP SG+V+A K + E + + E+ L + + P +V G
Sbjct: 53 -SH-----KP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105
Query: 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222
+ E M GSL+ + + + KV+I KGLT+L + + ++++RD K SN
Sbjct: 106 ISICMEHMDGGSLDQ--VLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSN 162
Query: 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ--------VMGTHGYAAPEYVATGRLTTK 274
IL+++ KL DFG VS Q +GT Y +PE + + +
Sbjct: 163 ILVNSRGEIKLCDFG------------VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 210
Query: 275 SDVYSFGVVLLELLSGR 291
SD++S G+ L+E+ GR
Sbjct: 211 SDIWSMGLSLVEMAVGR 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 52/306 (16%), Positives = 101/306 (33%), Gaps = 62/306 (20%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK--LKPEGFQGHKEWLTE 138
T F +G G FG V+K L G + A+K+ G + L E
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC---VKRLD------GCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 139 VNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAVRMKV 195
V L H ++V+ E ++ L+ E+ GSL + + R A +
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLD-------------------AEFNAKLSDF 236
+ +GL ++H +++ D K SNI + + K+ D
Sbjct: 121 LLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178
Query: 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-TGRLTTKSDVYSFGVVLLELLSGRCAVD 295
G + + G + A E + K+D+++ + ++
Sbjct: 179 GHVTR-----ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA----- 227
Query: 296 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
+P + + I +L + PQ + L ++ +P+ RP
Sbjct: 228 --------------EPLPRNGDQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRP 272
Query: 356 RMSEVL 361
++
Sbjct: 273 SAMALV 278
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LLG+G F VY+ + + G+ VA+K + G + EV
Sbjct: 18 LLGKGSFAGVYRA---ESIHT------GLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHC 66
Query: 144 QLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLS-WAVRMKVA-IGAA 200
QL HP++++L Y E N + LV E G + +L R +P S R + I
Sbjct: 67 QLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQI--I 122
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA-KAGPTGDRTHVSTQVMGTHG 259
G+ +LH +++RD SN+LL N K++DFGLA + ++ + GT
Sbjct: 123 TGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPN 177
Query: 260 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
Y +PE +AT +SDV+S G + LL GR
Sbjct: 178 YISPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G+G G VY +D + G VA++++ + + + E+ + + +PN
Sbjct: 28 IGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
+V + L G+ +V E++ GSL + + + V + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH-- 133
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG 269
+QVI+RD K+ NILL + + KL+DFG A T +++ ST V GT + APE V
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMV-GTPYWMAPEVVTRK 191
Query: 270 RLTTKSDVYSFGVVLLELLSG 290
K D++S G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 75/286 (26%), Positives = 113/286 (39%), Gaps = 53/286 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F ++G GGFG VY K +G + A+K L + + + L E
Sbjct: 190 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 140 NYLGQLH---HPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L + P +V + Y ++L + + M G L HL + G +
Sbjct: 241 IMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR---- 295
Query: 196 AIGAAK---GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
AA+ GL +H V+YRD K +NILLD + ++SD GLA + H
Sbjct: 296 -FYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--A 349
Query: 253 QVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWA 309
V GTHGY APE + G S D +S G +L +LL G KTK
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----------- 397
Query: 310 KPYLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
DK ++ R + + + P + +L L + R
Sbjct: 398 -----DKHEIDRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-27
Identities = 42/361 (11%), Positives = 79/361 (21%), Gaps = 66/361 (18%)
Query: 42 IPPSKEKGNSESLPTPKSEGEILSSS----NLKAFTFNELKTATRNFRPDSLLGEGGFGF 97
E+L P + E ++++ N + + L R + L G
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 98 VYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLI 154
V+ D A+K E +L + +
Sbjct: 78 VFLV-RDVER--------LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 155 GYC--------------------------LEGENRLLVYEFMPKGSLEN-----HLFRRG 183
N LL+ LE
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 184 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGP 243
+ + L +++ F N+ + + L D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK--GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 244 TGDRTHVSTQVMGTHGYAAPEYV--ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301
T YA E++ +T T + + G+ + + GI
Sbjct: 246 TRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+ + L L TL + LN + + R E +
Sbjct: 301 KG---------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
Query: 362 A 362
Sbjct: 352 E 352
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 79/280 (28%), Positives = 120/280 (42%), Gaps = 48/280 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHHP 148
+G+G FG V+KG ID + VVA+K + E + E + E+ L Q P
Sbjct: 30 IGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW-AVRMKVAIGAAKGLTFLH 207
+ K G L+ ++ E++ GS L GP + A ++ KGL +LH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILR---EILKGLDYLH 136
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+ I+RD KA+N+LL KL+DFG+A T + +T +GT + APE +
Sbjct: 137 --SEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQLTDTQIKRNT-FVGTPFWMAPEVIK 192
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK---RKLFRIMD 324
+K+D++S G+ +EL G +P S+ + LF I
Sbjct: 193 QSAYDSKADIWSLGITAIELARG-------------------EPPHSELHPMKVLFLIPK 233
Query: 325 T---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
L G Y + CLN EP RP E+L
Sbjct: 234 NNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 26/254 (10%)
Query: 43 PPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSL------LGEGGFG 96
G + +++ KA L+ P L +GEG G
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHEQFKA----ALRMVVDQGDPRLLLDSYVKIGEGSTG 59
Query: 97 FVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY 156
V ++HS G VAVK + Q + EV + H N+V++
Sbjct: 60 IVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216
L GE ++ EF+ G+L + + + L+ V + L +LH VI+R
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQV--RLNEEQIATVCEAVLQALAYLH--AQGVIHR 165
Query: 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 276
D K+ +ILL + KLSDFG A + D + V GT + APE ++ T+ D
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 277 VYSFGVVLLELLSG 290
++S G++++E++ G
Sbjct: 224 IWSLGIMVIEMVDG 237
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 72/301 (23%), Positives = 121/301 (40%), Gaps = 56/301 (18%)
Query: 81 TRNFRPDSL-----LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKE 134
+ + D L LG G +G V K +H P SG ++AVK+++ Q K
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKM---RH-----VP-SGQIMAVKRIRATVNSQEQKR 51
Query: 135 WLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHL--FRRGPQPLSWAV 191
L +++ + + P V G + + E M SL+ Q + +
Sbjct: 52 LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDI 110
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
K+A+ K L LH + VI+RD K SN+L++A K+ DFG+ +G D
Sbjct: 111 LGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKD 167
Query: 252 TQVMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307
G Y APE + + KSD++S G+ ++EL R
Sbjct: 168 IDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR---------------- 210
Query: 308 WAKPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
PY S ++L ++++ +L ++ + + QCL K RP E+
Sbjct: 211 --FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTS----QCLKKNSKERPTYPEL 264
Query: 361 L 361
+
Sbjct: 265 M 265
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-27
Identities = 78/283 (27%), Positives = 118/283 (41%), Gaps = 50/283 (17%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSL--SPAKPGSGMVVAVKKLKPEGFQGHKEW--LTE 138
F +LG+G FG V+ L + + + A+K LK + E
Sbjct: 25 QFELLKVLGQGSFGKVF--------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA- 196
+ L +++HP +VKL Y + E +L L+ +F+ G L L + + +A
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAE 134
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 255
+ A L LH +IYRD K NILLD E + KL+DFGL+K ++
Sbjct: 135 LALA--LDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFC 187
Query: 256 GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP--Y 312
GT Y APE V R T+S D +SFGV++ E+L+G
Sbjct: 188 GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT-------------------LPFQ 227
Query: 313 LSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D+++ I+ KL PQ + A +L P R
Sbjct: 228 GKDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-27
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140
F LGEG +G VYK H +G +VA+K++ E +E + E++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA---IHK------ETGQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
+ Q P++VK G + + +V E+ GS+ + + R + L+ +
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTL 135
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
KGL +LH + I+RD KA NILL+ E +AKL+DFG+A T +T + GT +
Sbjct: 136 KGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVI-GTPFW 191
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
APE + +D++S G+ +E+ G
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 94/359 (26%), Positives = 134/359 (37%), Gaps = 52/359 (14%)
Query: 4 CLQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEI 63
CLQ ++ + + + + + S S + E E+
Sbjct: 77 CLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEV 136
Query: 64 LSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK 123
+ T N F LLG+G FG V L K +G A+K
Sbjct: 137 SLAKPKHRVTMN-------EFEYLKLLGKGTFGKVI--------LVKEK-ATGRYYAMKI 180
Query: 124 LKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL 179
LK E E LTE L HP L L Y + +RL V E+ G L HL
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL 239
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
R A I L +LH +E V+YRD K N++LD + + K++DFGL
Sbjct: 240 SRERVFSEDRARFYGAEI--VSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
Query: 240 KAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKT 297
K G T + GT Y APE V ++ D + GVV+ E++ GR
Sbjct: 297 KEGIKDGAT---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL----- 347
Query: 298 KVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
P Y D KLF I+ ++ ++P+ A +L L +PK R
Sbjct: 348 -------------PFYNQDHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLG 143
+ LG+G FG VYK ++ + G + A K ++ + + ++++ E+ L
Sbjct: 21 WEIVGELGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILA 71
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
HP +VKL+G ++ EF P G+++ + + L+ V + L
Sbjct: 72 TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
FLH ++I+RD KA N+L+ E + +L+DFG++ A + + GT + AP
Sbjct: 131 NFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFI-GTPYWMAP 186
Query: 264 EYVATGRLT-----TKSDVYSFGVVLLELLSG 290
E V + K+D++S G+ L+E+
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/308 (18%), Positives = 98/308 (31%), Gaps = 48/308 (15%)
Query: 91 GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHP 148
G V ++ KP +G V V+++ E E++ +HP
Sbjct: 36 GFEDLMTVNLA---RY-----KP-TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V + +V FM GS ++ + ++ + G K L ++H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH- 145
Query: 209 AESQVIYRDFKASNILLDAEFNAKLSDFG-LAKAGPTGDRTHV----STQVMGTHGYAAP 263
++R KAS+IL+ + LS G R V + + +P
Sbjct: 146 -HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 264 EYVATGRL--TTKSDVYSFGVVLLELLSGR---CAVDKTKV------GIEQSLVDWAKPY 312
E + KSD+YS G+ EL +G + T++ G L+D +
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL-------------------QCLNNEPKL 353
+ G + + QCL P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324
Query: 354 RPRMSEVL 361
RP S +L
Sbjct: 325 RPSASTLL 332
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 82/280 (29%), Positives = 118/280 (42%), Gaps = 46/280 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F LLG+G FG V L K +G A+K L+ E E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVI--------LVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
L HP L L Y + +RL V E+ G L HL R A I
Sbjct: 57 RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GT 257
+A L +LH V+YRD K N++LD + + K++DFGL K G + T + GT
Sbjct: 116 SA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGT 168
Query: 258 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSD 315
Y APE V ++ D + GVV+ E++ GR P Y D
Sbjct: 169 PEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQD 209
Query: 316 KRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+LF I+ ++ ++P+ + A +L L +PK R
Sbjct: 210 HERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 27/240 (11%)
Query: 63 ILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK 122
I SS LK + + +G G +G V K H KP SG ++AVK
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKM---VH-----KP-SGQIMAVK 53
Query: 123 KLKPEGF-QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLEN--- 177
+++ + K+ L +++ + P +V+ G + + E M S +
Sbjct: 54 RIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYK 112
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
+++ + + K+ + K L L + ++I+RD K SNILLD N KL DFG
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 238 LAKAGPTG--DRTHVSTQVMGTHGYAAPEYVATGRL----TTKSDVYSFGVVLLELLSGR 291
++ G + T+ G Y APE + +SDV+S G+ L EL +GR
Sbjct: 172 IS-----GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 89/334 (26%), Positives = 142/334 (42%), Gaps = 48/334 (14%)
Query: 30 RSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSL 89
L + G E + +SS+L F+ L+ +
Sbjct: 10 HDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR----------V 59
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQ-L 145
+G G + V L K + + A++ +K E ++ TE + Q
Sbjct: 60 IGRGSYAKVL--------LVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 146 HHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGL 203
+HP LV L C + E+RL V E++ G L H+ R+ P A R A I A L
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLA--L 166
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAA 262
+LH E +IYRD K N+LLD+E + KL+D+G+ K G T T GT Y A
Sbjct: 167 NYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIA 221
Query: 263 PEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
PE + G S D ++ GV++ E+++GR D P + + LF+
Sbjct: 222 PE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQNTEDYLFQ 272
Query: 322 -IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
I++ ++ + P+ + AA++ LN +PK R
Sbjct: 273 VILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 38/281 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F ++G G + V L K + + A+K +K E ++ TE
Sbjct: 10 DFDLLRVIGRGSYAKVL--------LVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEK 60
Query: 140 NYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA- 196
+ Q +HP LV L C + E+RL V E++ G L H+ R+ P A R A
Sbjct: 61 HVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAE 118
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM- 255
I A L +LH E +IYRD K N+LLD+E + KL+D+G+ K G T T
Sbjct: 119 ISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 171
Query: 256 GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
GT Y APE + G S D ++ GV++ E+++GR D P +
Sbjct: 172 GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNPDQN 222
Query: 315 DKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ LF+ I++ ++ + P+ + AA++ LN +PK R
Sbjct: 223 TEDYLFQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 33/261 (12%), Positives = 72/261 (27%), Gaps = 62/261 (23%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK---------- 125
EL R ++LG+ + DQ + G V
Sbjct: 67 ELGERPRTLVRGTVLGQEDPYAYLEA-TDQET--------GESFEVHVPYFTERPPSNAI 117
Query: 126 ------------------PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC--LEGENRLL 165
+ + H ++ + + ++++ + +R
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 166 VYEFM--PKGSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKAS 221
+Y M + L L R+++ + + L LH +++ +
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPV 235
Query: 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GR 270
+I+LD L+ F R + G+ PE A
Sbjct: 236 DIVLDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTL 289
Query: 271 LTTKSDVYSFGVVLLELLSGR 291
+T D ++ G+V+ +
Sbjct: 290 MTFSFDAWALGLVIYWIWCAD 310
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 89/328 (27%), Positives = 132/328 (40%), Gaps = 65/328 (19%)
Query: 41 PIPPSKEKGNSESLPTPKSEGEILSSSNLKA----FTFNELKTATRNFRPDSLLGEGGFG 96
P P N P P + + SSN A F F LK ++G+G FG
Sbjct: 5 PQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHF--LK----------VIGKGSFG 52
Query: 97 FVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQ-LHHPNLVK 152
V L+ K + AVK L+ + KE ++E N L + + HP LV
Sbjct: 53 KVL--------LARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 153 LIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAE 210
L + + ++L V +++ G L HL R A R A I +A L +LH
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASA--LGYLH--S 157
Query: 211 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-GTHGYAAPEYVATG 269
++YRD K NILLD++ + L+DFGL K + T T GT Y APE V
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHK 213
Query: 270 RLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTK 326
+ ++ D + G VL E+L G P Y + +++ I++
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLP------------------PFYSRNTAEMYDNILNKP 255
Query: 327 LGGQYPQKAAHTAATLALQCLNNEPKLR 354
L Q ++A L L + R
Sbjct: 256 L--QLKPNITNSARHLLEGLLQKDRTKR 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 37/270 (13%)
Query: 33 HSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGE 92
H IP ++ ++ + G S + + F +G
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGH 64
Query: 93 GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPN 149
G FG VY D + VVA+KK+ G Q +++W + EV +L +L HPN
Sbjct: 65 GSFGAVYFA-RDVRN--------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
++ G L LV E+ + + L +PL V GA +GL +LH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH-- 171
Query: 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ------VMGTHGYAAP 263
+I+RD KA NILL KL DFG ++ +GT + AP
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANSFVGTPYWMAP 219
Query: 264 EYVATGRLTT---KSDVYSFGVVLLELLSG 290
E + K DV+S G+ +EL
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 73/348 (20%), Positives = 138/348 (39%), Gaps = 75/348 (21%)
Query: 65 SSSNLKAFTFNELKTATRNFRPDSL-----LGEGGFGFVYKGWIDQHSLSPAKPGSGMVV 119
S S+ K + + + L +G G G V+K + + +G V+
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKM---RF-----RK-TGHVI 53
Query: 120 AVKKLKPEG-FQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
AVK+++ G + +K L +++ + + H P +V+ G + + + E M + +
Sbjct: 54 AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK- 112
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
L +R P+ + K+ + K L +L + + VI+RD K SNILLD KL DFG
Sbjct: 113 -LKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFG 170
Query: 238 LAKAGPTG--DRTHVSTQVMGTHGYAAPEYVATGRL-----TTKSDVYSFGVVLLELLSG 290
++ G + G Y APE + ++DV+S G+ L+EL +G
Sbjct: 171 IS-----GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 291 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLAL-----Q 345
+ PY + + F ++ L + P H +
Sbjct: 226 Q------------------FPY-KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKD 266
Query: 346 CLNNEPKLRPRMSEVLA--------------------ILERLEAPKNS 373
CL + + RP+ +++L ++ + E+P++
Sbjct: 267 CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTESPRSG 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 42/219 (19%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLGQ 144
LG G + VYKG +++ + G+ VA+K++K + +E + E++ + +
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L H N+V+L LV+EFM K +++ P+ L + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 259
GL F H+ +++++RD K N+L++ KL DFGLA+A P + +V+ T
Sbjct: 120 GLAFCHE--NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 260 YAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y AP+ Y +T D++S G +L E+++G+
Sbjct: 174 YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHP 148
+G G V P VA+K++ E Q + L E+ + Q HHP
Sbjct: 23 IGSGATAVVQAA-YC-------AP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA------KG 202
N+V + + LV + + GS+ + + + + + + A +G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA---KAGPTGDRTHVSTQVMGTHG 259
L +LH ++ I+RD KA NILL + + +++DFG++ G R V +GT
Sbjct: 134 LEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 260 YAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
+ APE + R K+D++SFG+ +EL +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/313 (20%), Positives = 109/313 (34%), Gaps = 68/313 (21%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLG 143
+ +LG G G V Q S G VAVK++ + E+ L
Sbjct: 17 VVSEKILGYGSSGTVVF----QGSFQ------GRPVAVKRMLIDFCDIALM---EIKLLT 63
Query: 144 QL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSL-----ENHLFRRGPQPLSWAVRMKVAI 197
+ HPN+++ + E +L ++ + + +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------FNAKLSDFGLAK---A 241
A G+ LH ++I+RD K NIL+ +SDFGL K +
Sbjct: 123 QIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 242 GPTGDRTHVSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGRCAV 294
G + RT+++ GT G+ APE RLT D++S G V +LS
Sbjct: 181 GQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK---- 235
Query: 295 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMD-----TKLGGQYPQKAAHTAATLALQCLNN 349
G P+ + I+ ++ + + A L Q +++
Sbjct: 236 -----GKH--------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 350 EPKLRPRMSEVLA 362
+P RP +VL
Sbjct: 283 DPLKRPTAMKVLR 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 60/262 (22%), Positives = 109/262 (41%), Gaps = 41/262 (15%)
Query: 36 APSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGF 95
+ P P + +++ P P+ + + F F K LGEG F
Sbjct: 3 GTAAEPRPGAGSLQHAQPPPQPRKKR-------PEDFKF--GKI----------LGEGSF 43
Query: 96 GFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVK 152
V L+ + A+K L+ + E + + +L HP VK
Sbjct: 44 STVV--------LAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 153 LIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAE 210
L + + + +L + G L ++ + G + R A I +A L +LH
Sbjct: 95 LY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTAEIVSA--LEYLH--G 148
Query: 211 SQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR 270
+I+RD K NILL+ + + +++DFG AK + + +GT Y +PE + T +
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEK 207
Query: 271 LTTKS-DVYSFGVVLLELLSGR 291
KS D+++ G ++ +L++G
Sbjct: 208 SACKSSDLWALGCIIYQLVAGL 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 79/281 (28%), Positives = 115/281 (40%), Gaps = 47/281 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F +LG+G FG V+ L+ K + A+K LK + + + E
Sbjct: 18 DFILHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEK 68
Query: 140 NYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
L HP L + + + L V E++ G L H+ LS A I
Sbjct: 69 RVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-G 256
GL FLH ++YRD K NILLD + + K++DFG+ K GD T G
Sbjct: 128 --ILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 257 THGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLS 314
T Y APE + G+ S D +SFGV+L E+L G+ P +
Sbjct: 181 TPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQ 221
Query: 315 DKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D+ +LF I YP+ A L ++ EP+ R
Sbjct: 222 DEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 44/267 (16%)
Query: 48 KGNSESLPTPKSEGEI-LSSSNLKAFTFNELKTATRNFRPDSL---------LGEGGFGF 97
KG L + EI LS S K F F +L ++ P +L LG G G
Sbjct: 94 KGKRRPL---NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGE 150
Query: 98 VYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL---TEVNYLGQLHHPN 149
V ++ + VA++ K + L TE+ L +L+HP
Sbjct: 151 VKLA-FER--------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA 209
++K+ + + E+ +V E M G L + + + + + +LH+
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLHE- 257
Query: 210 ESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE-- 264
+ +I+RD K N+LL + + K++DFG +K + GT Y APE
Sbjct: 258 -NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVL 313
Query: 265 -YVATGRLTTKSDVYSFGVVLLELLSG 290
V T D +S GV+L LSG
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 88/359 (24%), Positives = 138/359 (38%), Gaps = 50/359 (13%)
Query: 5 LQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEIL 64
LQ + + + S L + K + + +
Sbjct: 267 LQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTI 326
Query: 65 SSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL 124
S + N + +F +LG+G FG V LS K G+ + AVK L
Sbjct: 327 SKFDNNG---NRDRMKLTDFNFLMVLGKGSFGKVM--------LSERK-GTDELYAVKIL 374
Query: 125 KPEGFQGHKEW---LTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHL 179
K + + + E L P L +L C + +RL V E++ G L H+
Sbjct: 375 KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
+ G AV I A GL FL +IYRD K N++LD+E + K++DFG+
Sbjct: 434 QQVGRFKEPHAVFYAAEI--AIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489
Query: 240 KAGPTGDRTHVSTQVM-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKT 297
K T T+ GT Y APE + + KS D ++FGV+L E+L+G+
Sbjct: 490 KENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA----- 540
Query: 298 KVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
P D+ +LF+ IM+ + YP+ + A + + P R
Sbjct: 541 -------------PFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 73/285 (25%), Positives = 111/285 (38%), Gaps = 52/285 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLS--PAKPGSGMVVAVKKLKPEGFQGHK---EW-L 136
F +LG+GG+G V+ +G + A+K LK +
Sbjct: 18 CFELLRVLGKGGYGKVF--------QVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 137 TEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
E N L ++ HP +V LI Y + +L L+ E++ G L L R G A +
Sbjct: 70 AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYL 127
Query: 196 A-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
A I A L LH + +IYRD K NI+L+ + + KL+DFGL K T
Sbjct: 128 AEISMA--LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THT 180
Query: 255 M-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP- 311
GT Y APE + ++ D +S G ++ ++L+G P
Sbjct: 181 FCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA-------------------PP 220
Query: 312 -YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+++K I+ KL P A L + L R
Sbjct: 221 FTGENRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 50/302 (16%), Positives = 101/302 (33%), Gaps = 40/302 (13%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHK 133
+ R + + L G + W++ + + + +
Sbjct: 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMD 106
Query: 134 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVR 192
++ + N V + + + K +L++ + RR + V
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA----------G 242
+ + I A+ + FLH +++RD K SNI + K+ DFGL A
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE 302
T +GT Y +PE + + K D++S G++L ELL +E
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QME 278
Query: 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAH---TAATLALQCLNNEPKLRPRMSE 359
+ + ++D R ++P + L+ P RP ++
Sbjct: 279 RVRI------ITDVRN----------LKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 360 VL 361
++
Sbjct: 323 II 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 10/82 (12%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVN 140
+F P +G GGFG V++ ++ + A+K+++ P ++ + EV
Sbjct: 6 TDFEPIQCMGRGGFGVVFEA---KNKV------DDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 141 YLGQLHHPNLVKLIGYCLEGEN 162
L +L HP +V+ LE
Sbjct: 57 ALAKLEHPGIVRYFNAWLETPP 78
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 25/209 (11%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK---KLKPEGFQGHKEWLTEVNYLGQLH 146
LG+G FG V + +G AVK K + + + L EV L QL
Sbjct: 34 LGKGSFGEVILC---KDK------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-MKVAIGAAKGLTF 205
HPN++KL + + LV E G L + + R A R ++ + +T+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG---ITY 141
Query: 206 LHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+H ++++RD K N+LL + N ++ DFGL+ + +GT Y A
Sbjct: 142 MHKN--KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIA 196
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGR 291
PE V G K DV+S GV+L LLSG
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 72/317 (22%), Positives = 123/317 (38%), Gaps = 70/317 (22%)
Query: 53 SLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAK 112
S+P E E ++ + F L+ +G+G FG V I Q +
Sbjct: 1 SMPPVFDENEDVNFDH-----FEILRA----------IGKGSFGKV---CIVQKN----- 37
Query: 113 PGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYE 168
+ + A+K + + E E+ + L HP LV L Y + E + +V +
Sbjct: 38 -DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVD 95
Query: 169 FMPKGSLENHLFRRG--PQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILL 225
+ G L HL + + V++ + + A L +L ++I+RD K NILL
Sbjct: 96 LLLGGDLRYHLQQNVHFKEE---TVKLFICELVMA--LDYLQ--NQRIIHRDMKPDNILL 148
Query: 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT--TKS-DVYSFGV 282
D + ++DF +A P + T + GT Y APE ++ + + + D +S GV
Sbjct: 149 DEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205
Query: 283 VLLELLSGRCAVDKTKVGIEQSLVDWAKPYL----SDKRKLFR-IMDTKLGGQYPQKAAH 337
ELL GR +PY + +++ T + YP +
Sbjct: 206 TAYELLRGR------------------RPYHIRSSTSSKEIVHTFETTVV--TYPSAWSQ 245
Query: 338 TAATLALQCLNNEPKLR 354
+L + L P R
Sbjct: 246 EMVSLLKKLLEPNPDQR 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/284 (28%), Positives = 119/284 (41%), Gaps = 53/284 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
NF +LG+G FG V L+ K +G + AVK LK + + +TE
Sbjct: 24 NFEFIRVLGKGSFGKVM--------LARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 140 NYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
L +HP L +L C + +RL V EF+ G L H+ + + A
Sbjct: 75 RILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-----F 128
Query: 198 GAAK---GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
AA+ L FLH + +IYRD K N+LLD E + KL+DFG+ K G T T
Sbjct: 129 YAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TAT 183
Query: 255 M-GTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP- 311
GT Y APE + L + D ++ GV+L E+L G P
Sbjct: 184 FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHA------------------PF 224
Query: 312 YLSDKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
++ LF I++ ++ YP A + + P +R
Sbjct: 225 EAENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 79/281 (28%), Positives = 120/281 (42%), Gaps = 47/281 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F +LG+G FG V LS K G+ + AVK LK + + + E
Sbjct: 21 DFNFLMVLGKGSFGKVM--------LSERK-GTDELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 140 NYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
L P L +L C + +RL V E++ G L H+ + G AV I
Sbjct: 72 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 130
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVM-G 256
L FL +IYRD K N++LD+E + K++DFG+ K T T+ G
Sbjct: 131 AIG--LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 183
Query: 257 THGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLS 314
T Y APE + + KS D ++FGV+L E+L+G+ P
Sbjct: 184 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQA------------------PFEGE 224
Query: 315 DKRKLFR-IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
D+ +LF+ IM+ + YP+ + A + + P R
Sbjct: 225 DEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 32/255 (12%), Positives = 70/255 (27%), Gaps = 61/255 (23%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK--------------- 125
R ++LG+ + DQ + G V
Sbjct: 77 PRTLVRGTVLGQEDPYAYLEAT-DQET--------GESFEVHVPYFTERPPSNAIKQMKE 127
Query: 126 -------------PEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG--ENRLLVYEFM 170
+ + H ++ + + ++++ + +R +Y M
Sbjct: 128 EVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM 187
Query: 171 PK--GSLENHLFRRGPQ--PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226
+ L L R+++ + + L LH +++ + +I+LD
Sbjct: 188 QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLD 245
Query: 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA----------TGRLTTKSD 276
L+ F R S G+A PE A +T D
Sbjct: 246 QRGGVFLTGFEHLV------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 277 VYSFGVVLLELLSGR 291
++ G+ + +
Sbjct: 300 TWTLGLAIYWIWCAD 314
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 72/350 (20%), Positives = 129/350 (36%), Gaps = 55/350 (15%)
Query: 46 KEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQ 105
+S +G++ ++ + F ++ + ++ LG G +G V +
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGM--FITSKKGHLSEMYQRVKKLGSGAYGEVLLC---R 57
Query: 106 HSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160
+ + A+K + + + L EV L L HPN++KL + +
Sbjct: 58 DK------VTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108
Query: 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 220
N LV E G L + + R A + + G+T+LH +++RD K
Sbjct: 109 RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV--LSGVTYLHKH--NIVHRDLKP 164
Query: 221 SNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDV 277
N+LL + + K+ DFGL+ + + +GT Y APE V + K DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDV 220
Query: 278 YSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP-YLSDKRKLFR-IMDTKLG--GQYPQ 333
+S GV+L LL+G P +++ R + K +
Sbjct: 221 WSIGVILFILLAGY------------------PPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 334 KAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLSQSE 380
+ A L Q L + + R + L I E ++ +L
Sbjct: 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LTEVNYLGQ 144
+GEG +G V+K ++ + G +VA+KK L E+ L Q
Sbjct: 11 IGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESED---DPVIKKIALREIRMLKQ 58
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
L HPNLV L+ LV+E+ ++ + L R + + + + + +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVN 116
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHGYAA 262
F H I+RD K NIL+ KL DFG A+ GP+ +V T Y +
Sbjct: 117 FCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD---EVA-TRWYRS 170
Query: 263 PE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
PE Y DV++ G V ELLSG
Sbjct: 171 PELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 80/329 (24%), Positives = 128/329 (38%), Gaps = 48/329 (14%)
Query: 41 PIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYK 100
+++ + + T + K NF +LG G +G V+
Sbjct: 13 GSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF- 71
Query: 101 GWIDQHSL--SPAKPGSGMVVAVKKLKPEGFQGHKEW----LTEVNYLGQL-HHPNLVKL 153
L + +G + A+K LK + TE L + P LV L
Sbjct: 72 -------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 154 IGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAES 211
Y + E +L L+ +++ G L HL +R ++ V I A L LH +
Sbjct: 125 H-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVLA--LEHLH--KL 178
Query: 212 QVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL 271
+IYRD K NILLD+ + L+DFGL+K + GT Y AP+ V G
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVRGGDS 237
Query: 272 -TTKS-DVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAKPYLSDKRKLFR-IMDT 325
K+ D +S GV++ ELL+G + + ++ R I+ +
Sbjct: 238 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------------SQAEISRRILKS 281
Query: 326 KLGGQYPQKAAHTAATLALQCLNNEPKLR 354
+ YPQ+ + A L + L +PK R
Sbjct: 282 EP--PYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 69/329 (20%), Positives = 111/329 (33%), Gaps = 55/329 (16%)
Query: 55 PTPKSEGEILSSSNLKAFTFNELKTATRNFRPD----SLLGEGGFGFVYKGWIDQHSLSP 110
S E L + ++ LG G +G V
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC--------- 55
Query: 111 AKPGSGMVVAVKKLK------------PEGFQGHKEWL-TEVNYLGQLHHPNLVKLIGYC 157
+ A+K +K + + E + E++ L L HPN++KL
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115
Query: 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217
+ + LV EF G L + R A + I G+ +LH +++RD
Sbjct: 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI--LSGICYLHKH--NIVHRD 171
Query: 218 FKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK 274
K NILL ++ N K+ DFGL+ + +GT Y APE V + K
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGTAYYIAPE-VLKKKYNEK 227
Query: 275 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLG--GQYP 332
DV+S GV++ LL G + +D+ + ++ K
Sbjct: 228 CDVWSCGVIMYILLCGYPPF-------------GGQ---NDQDIIKKVEKGKYYFDFNDW 271
Query: 333 QKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+ + A L L + R E L
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEAL 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 76/316 (24%), Positives = 121/316 (38%), Gaps = 56/316 (17%)
Query: 65 SSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL 124
+ +L + L+ F L+G G +G VYKG + G + A+K +
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVM 57
Query: 125 KPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIG-----YCLEGENRL-LVYEFMPKGSLEN 177
G +E E+N L + HH N+ G +++L LV EF GS+ +
Sbjct: 58 DVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
+ L + +GL+ LH + +VI+RD K N+LL KL DFG
Sbjct: 117 LIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-----TKSDVYSFGVVLLELLSGRC 292
++ A +T +GT + APE +A KSD++S G+ +E+ G
Sbjct: 175 VS-AQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-- 230
Query: 293 AVDKTKVGIEQSLVDWAKPYLSDK---RKLFRIMDT---KL-GGQYPQKAAHTAATLALQ 345
P L D R LF I +L ++ +K
Sbjct: 231 -----------------APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE----S 269
Query: 346 CLNNEPKLRPRMSEVL 361
CL RP +++
Sbjct: 270 CLVKNHSQRPATEQLM 285
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 24/299 (8%)
Query: 1 MGNCLQHSSARVDSTQS---PRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTP 57
MG+ H S+ VD ++ + +RS H+ A E+ +S T
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60
Query: 58 KSEGEILSSSNLKAFTFNELKTATRN----FRPDSLLGEGGFGFVYKGWIDQHSLSPAKP 113
+I + K N +LG G FG V+K +
Sbjct: 61 ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EET 111
Query: 114 GSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKG 173
+G+ +A K +K G + +E E++ + QL H NL++L + +LV E++ G
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 174 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-- 231
L + + L+ + +G+ +H + +++ D K NIL
Sbjct: 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQI 228
Query: 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
K+ DFGLA+ ++ GT + APE V ++ +D++S GV+ LLSG
Sbjct: 229 KIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 1e-23
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLT---EVNYL 142
+GEG +G VYK A+ G A+KK++ EG T E++ L
Sbjct: 10 IGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIP-----STTIREISIL 54
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGA 199
+L H N+VKL + +LV+E + K L+ L +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQL 109
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGT 257
G+ + HD +V++RD K N+L++ E K++DFGLA+A P TH +++ T
Sbjct: 110 LNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-T 163
Query: 258 HGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y AP+ Y +T D++S G + E+++G
Sbjct: 164 LWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 47/226 (20%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLT 137
+ LGEG + VYKG + +VA+K+++ E H+E +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMK 194
EV+ L L H N+V L ++ LV+E++ K L++ ++
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-----GNIINMHNVKL 104
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVST 252
+GL + H +V++RD K N+L++ KL+DFGLA+A PT +
Sbjct: 105 FLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--- 159
Query: 253 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
+V+ T Y P+ Y +T+ D++ G + E+ +GR
Sbjct: 160 EVV-TLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 39/223 (17%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G G +G VYK + A+K+++ G E+ L +L HPN
Sbjct: 29 VGRGTYGHVYKA-KRKD------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 150 LVKLIGYCLE-GENRL-LVYEFMP---KGSLENH---LFRRGPQPLSWAVRMKVAIGAAK 201
++ L L + ++ L++++ ++ H + P L + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNA----KLSDFGLAKA--GPTGDRTHVSTQVM 255
G+ +LH + V++RD K +NIL+ E K++D G A+ P + V+
Sbjct: 140 GIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 256 GTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
T Y APE Y T D+++ G + ELL+
Sbjct: 198 -TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LG G FG V G +H L+ G VAVK K++ G + E+ L
Sbjct: 18 TLGVGTFGKVKIG---EHQLT------GHKVAVKILNRQKIRSLDVVGKIK--REIQNLK 66
Query: 144 QLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
HP+++KL Y + +V E++ G L +++ + G A R+ I +A
Sbjct: 67 LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA- 123
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
+ + H V++RD K N+LLDA NAK++DFGL+ G+ S G+ YA
Sbjct: 124 -VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 177
Query: 262 APEYVATGRL--TTKSDVYSFGVVLLELLSGR 291
APE V +GRL + D++S GV+L LL G
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 77/283 (27%), Positives = 124/283 (43%), Gaps = 53/283 (18%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
+G+G F V +H L+ G VA+K +L P Q EV +
Sbjct: 23 IGKGNFAKVKLA---RHILT------GREVAIKIIDKTQLNPTSLQKLF---REVRIMKI 70
Query: 145 LHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
L+HPN+VKL + +E E L L+ E+ G + ++L G A I +A
Sbjct: 71 LNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA-- 126
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+ + H + ++++RD KA N+LLDA+ N K++DFG + G + G YAA
Sbjct: 127 VQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAA 181
Query: 263 PEYVATGRLTT--KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
PE + G+ + DV+S GV+L L+SG D Q+L ++L
Sbjct: 182 PE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL-----------KELR 223
Query: 321 RIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+ L G+Y P + L + L P R + +++
Sbjct: 224 ERV---LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 47/219 (21%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLGQ 144
+GEG +G VYK AK G +VA+K+++ + E + E++ L +
Sbjct: 29 VGEGTYGVVYK----------AKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKE 75
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
LHHPN+V LI LV+EFM K L+ + L + +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-----KTGLQDSQIKIYLYQLLR 130
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 259
G+ H ++++RD K N+L++++ KL+DFGLA+A P TH +V+ T
Sbjct: 131 GVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLW 184
Query: 260 YAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y AP+ Y +T D++S G + E+++G+
Sbjct: 185 YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LT 137
+ L+GEG +G V K ++ + G +VA+KK + +
Sbjct: 26 KYENLGLVGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESDD---DKMVKKIAMR 73
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
E+ L QL H NLV L+ C + + LV+EF+ ++ + L P L + V K
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVM 255
G+ F H +I+RD K NIL+ KL DFG A+ P +V
Sbjct: 132 QIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD---EVA 186
Query: 256 GTHGYAAPEY-VATGRLTTKSDVYSFGVVLLELLSGR 291
T Y APE V + DV++ G ++ E+ G
Sbjct: 187 -TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 31/299 (10%)
Query: 7 HSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSS 66
AR + P R RS + + +K N ++
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 67 SNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK---- 122
+ + K + + P ++G G V + + + +G AVK
Sbjct: 79 PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC-VHR--------ATGHEFAVKIMEV 129
Query: 123 ---KLKPEGFQGHKEWL-TEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLEN 177
+L PE + +E E + L Q+ HP+++ LI LV++ M KG L +
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189
Query: 178 HLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237
+L + + ++ + ++FLH + +++RD K NILLD +LSDFG
Sbjct: 190 YLTEKVALSEKETRSIMRSL--LEAVSFLHA--NNIVHRDLKPENILLDDNMQIRLSDFG 245
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSG 290
+ G++ ++ GT GY APE + D+++ GV+L LL+G
Sbjct: 246 FSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 29/255 (11%)
Query: 50 NSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLS 109
+ L K + L + E++ +F ++G G F V +
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA--------VV 80
Query: 110 PAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-L 165
K +G V A+K + E + E + L + +L + + EN L L
Sbjct: 81 KMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138
Query: 166 VYEFMPKGSLENHLFRRGPQ-PLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNI 223
V E+ G L L + G + P A R +A I A + +H ++RD K NI
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVH--RLGYVHRDIKPDNI 193
Query: 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY----- 278
LLD + +L+DFG V GT Y +PE + + Y
Sbjct: 194 LLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECD 252
Query: 279 --SFGVVLLELLSGR 291
+ GV E+ G+
Sbjct: 253 WWALGVFAYEMFYGQ 267
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLGQ 144
LGEG F VYK D+++ +VA+KK+K K+ L E+ L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L HPN++ L+ N LV++FM + ++++ L+ + + +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQ 123
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 259
GL +LH +++RD K +N+LLD KL+DFGLAK+ P TH QV+ T
Sbjct: 124 GLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRW 177
Query: 260 YAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y APE Y D+++ G +L ELL
Sbjct: 178 YRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT----EVNYLGQ 144
LLGEG +G V + S + AVK LK + + E+ L +
Sbjct: 12 LLGEGSYGKVKEVL---DSET------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 145 LHHPNLVKLIG-YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK- 201
L H N+++L+ E + ++ +V E+ G E + + + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDS-------VPEKRFPVCQAHG 113
Query: 202 -------GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
GL +LH ++++D K N+LL K+S G+A+A
Sbjct: 114 YFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 255 MGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGR 291
G+ + PE +A G T K D++S GV L + +G
Sbjct: 172 QGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 6e-23
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 46/219 (21%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLGQ 144
+GEG +G V+K ++ + +VA+K+++ + E L E+ L +
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L H N+V+L + LV+EF K ++ L + K
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLK 112
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTHVSTQVMGTHG 259
GL F H V++RD K N+L++ KL++FGLA+A P + +V+ T
Sbjct: 113 GLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLW 166
Query: 260 YAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
Y P+ Y +T D++S G + EL +
Sbjct: 167 YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAG 199
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHH 147
LGEG +G V + ++ VAVK + + E + E+ L+H
Sbjct: 14 TLGEGAYGEVQLA---VNRVT------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 148 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G N L E+ G L + + P A R + A + +L
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYL 121
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
H + +RD K N+LLD N K+SDFGLA +R + ++ GT Y APE +
Sbjct: 122 H--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-L 178
Query: 267 ATGRL--TTKSDVYSFGVVLLELLSGR 291
R DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
LG+G FG V K + + AVK K + L EV L +
Sbjct: 30 LGKGSFGEVLKC---KDR------ITQQEYAVKVINKASAKNKDTS---TILREVELLKK 77
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-MKVAIGAAKGL 203
L HPN++KL + + +V E G L + + +R A R +K +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---I 134
Query: 204 TFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
T++H +++RD K NILL + + + K+ DFGL+ + +GT Y
Sbjct: 135 TYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYY 189
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
APE V G K DV+S GV+L LLSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 60/281 (21%), Positives = 101/281 (35%), Gaps = 48/281 (17%)
Query: 23 GASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATR 82
G+S S P + P + ++ P + E
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE------------------S 43
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLT 137
++ LLG GGFG VY G + VA+K ++ G + +
Sbjct: 44 QYQVGPLLGSGGFGSVYSG---IRVSD------NLPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 138 -EVNYLGQLHH--PNLVKLIGYCLEGENRL-LVYEF-MPKGSLENHLFRRGPQPLSWAVR 192
EV L ++ +++L+ + E + L+ E P L + + RG A
Sbjct: 95 MEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARS 153
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVS 251
+ A + H+ V++RD K NIL+D KL DFG A
Sbjct: 154 FFWQVLEA--VRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 208
Query: 252 TQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGR 291
GT Y+ PE++ R + V+S G++L +++ G
Sbjct: 209 D---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 50/205 (24%), Positives = 86/205 (41%), Gaps = 20/205 (9%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP 148
+LG G F V+ + +G + A+K +K E+ L ++ H
Sbjct: 16 VLGSGAFSEVFLV-KQR--------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD 208
N+V L + LV + + G L + + RG A + + + +LH+
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV--LSAVKYLHE 124
Query: 209 AESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
+ +++RD K N+L + ++DFGL+K G + + GT GY APE
Sbjct: 125 --NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEV 178
Query: 266 VATGRLTTKSDVYSFGVVLLELLSG 290
+A + D +S GV+ LL G
Sbjct: 179 LAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT-EVNYLGQLHH 147
LGEG +G V + ++ VAVK + + E + E+ L+H
Sbjct: 14 TLGEGAYGEVQLA---VNRVT------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 148 PNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFL 206
N+VK G N L E+ G L + + P A R + A + +L
Sbjct: 65 ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYL 121
Query: 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV 266
H + +RD K N+LLD N K+SDFGLA +R + ++ GT Y APE +
Sbjct: 122 H--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-L 178
Query: 267 ATGRL--TTKSDVYSFGVVLLELLSGR 291
R DV+S G+VL +L+G
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 67/255 (26%), Positives = 106/255 (41%), Gaps = 32/255 (12%)
Query: 49 GNSESL--PTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSL-----LGEGGFGFVYKG 101
GN+ + + + + + + F + + D LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVM-- 58
Query: 102 WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCL 158
L K SG A+K L + K+ L E L ++ P LVKL
Sbjct: 59 ------LVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRD 217
+ N +V E++ G + +HL R G A R A I +LH + +IYRD
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT--FEYLHSLD--LIYRD 166
Query: 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-D 276
K N+L+D + +++DFG AK RT T + GT APE + + K+ D
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCGTPEALAPE-IILSKGYNKAVD 220
Query: 277 VYSFGVVLLELLSGR 291
++ GV++ E+ +G
Sbjct: 221 WWALGVLIYEMAAGY 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 55/252 (21%), Positives = 87/252 (34%), Gaps = 62/252 (24%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
+G+G +G V + + + A+K K++ + + TEV + +
Sbjct: 34 IGQGSYGVVRVAI---------ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG------ 198
LHHPN+ +L + + LV E G L + L V
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 199 -------------------------AAK-------GLTFLHDAESQVIYRDFKASNILLD 226
+ L +LH + +RD K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLFS 202
Query: 227 AEFNA--KLSDFGLAK---AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL--TTKSDVYS 279
+ KL DFGL+K G+ ++T+ GT + APE + T K D +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 280 FGVVLLELLSGR 291
GV+L LL G
Sbjct: 262 AGVLLHLLLMGA 273
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-22
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 33/233 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLT 137
+ S LG G FGFV+ + V VK K+ + + +
Sbjct: 25 KYSTMSPLGSGAFGFVWTA---VDKEKNKE------VVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 138 ---EVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGS-LENHLFRRGPQPLSWAVR 192
E+ L ++ H N++K++ E + LV E G L + R A
Sbjct: 76 VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
+ + + +L +I+RD K NI++ +F KL DFG A G +
Sbjct: 135 IFRQL--VSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 253 QVMGTHGYAAPEYVATGRLTT--KSDVYSFGVVLLELLSGR---CAVDKTKVG 300
GT Y APE V G + +++S GV L L+ C +++T
Sbjct: 191 ---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LG G FG V G +H L+ G VAVK K++ G E+ L
Sbjct: 23 TLGVGTFGKVKVG---KHELT------GHKVAVKILNRQKIRSLDVVGKIR--REIQNLK 71
Query: 144 QLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
HP+++KL Y + + + +V E++ G L +++ + G + R+ I +
Sbjct: 72 LFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG- 128
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
+ + H V++RD K N+LLDA NAK++DFGL+ G+ S G+ YA
Sbjct: 129 -VDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 182
Query: 262 APEYVATGRL--TTKSDVYSFGVVLLELLSGR 291
APE V +GRL + D++S GV+L LL G
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-22
Identities = 64/212 (30%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
LGEG FG V H + VA+K LK E E++YL
Sbjct: 16 TLGEGSFGKVKLA---THYKT------QQKVALKFISRQLLKKSDMHMRVE--REISYLK 64
Query: 144 QLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L HP+++KL Y + + +V E+ G L +++ + R I A
Sbjct: 65 LLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA- 120
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
+ + H ++++RD K N+LLD N K++DFGL+ G+ S G+ YA
Sbjct: 121 -IEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYA 174
Query: 262 APEYVATGRL--TTKSDVYSFGVVLLELLSGR 291
APE V G+L + DV+S G+VL +L GR
Sbjct: 175 APE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL-TEVNYLGQLHHP 148
LG G FG V+ + SG+ +K + + Q E + E+ L L HP
Sbjct: 30 LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW-----AVRMKVAIGAAKGL 203
N++K+ + N +V E G L + + + A MK + A L
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---L 137
Query: 204 TFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+ H V+++D K NIL K+ DFGLA+ + + + T GT Y
Sbjct: 138 AYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALY 192
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
APE V +T K D++S GVV+ LL+G
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 68/255 (26%), Positives = 98/255 (38%), Gaps = 36/255 (14%)
Query: 46 KEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQ 105
K K L K + +KA + +K +G G FG V
Sbjct: 43 KNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKV----------IGRGAFGEVQ------ 86
Query: 106 HSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGEN 162
L K + V A+K L + + E + + + P +V+L Y + +
Sbjct: 87 --LVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDR 142
Query: 163 RL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKA 220
L +V E+MP G L N + P WA R A + A L +H I+RD K
Sbjct: 143 YLYMVMEYMPGGDLVNLM-SNYDVPEKWA-RFYTAEVVLA--LDAIH--SMGFIHRDVKP 196
Query: 221 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSD 276
N+LLD + KL+DFG T V GT Y +PE + G + D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECD 255
Query: 277 VYSFGVVLLELLSGR 291
+S GV L E+L G
Sbjct: 256 WWSVGVFLYEMLVGD 270
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
LG+G FG V K + + AVK K + EV L +
Sbjct: 30 LGKGSFGEVLKC---KDR------ITQQEYAVKVINKASAKNKDTSTIL---REVELLKK 77
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-MKVAIGAAKGL 203
L HPN++KL + + +V E G L + + +R A R +K +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---I 134
Query: 204 TFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
T++H +++RD K NILL + + + K+ DFGL+ + +GT Y
Sbjct: 135 TYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
APE V G K DV+S GV+L LLSG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 58/253 (22%), Positives = 93/253 (36%), Gaps = 27/253 (10%)
Query: 50 NSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLS 109
N+ L K+ E L + +++ +F ++G G FG V
Sbjct: 42 NNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVV-------- 93
Query: 110 PAKPGSGMVVAVKKLKPEGFQGHKE---WLTEVNYLGQLHHPNLVKLIGYCLEGENRL-L 165
+ V A+K L E + E + L + L Y + +N L L
Sbjct: 94 -KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 166 VYEFMPKGSLENHLFR-RGPQPLSWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNI 223
V ++ G L L + P A R +A + A + +H + ++RD K NI
Sbjct: 152 VMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLAEMVIA--IDSVH--QLHYVHRDIKPDNI 206
Query: 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-----DVY 278
L+D + +L+DFG S V GT Y +PE + D +
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 279 SFGVVLLELLSGR 291
S GV + E+L G
Sbjct: 266 SLGVCMYEMLYGE 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 61/279 (21%), Positives = 96/279 (34%), Gaps = 35/279 (12%)
Query: 31 SSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSL- 89
S P+ + P E+ + + + + N + + + P +
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 90 ---------------LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE 134
LG G FG V++ + +G A K + +
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKET 200
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSL-ENHLFRRGPQPLSWAVRM 193
E+ + L HP LV L + +++YEFM G L E AV
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ KGL +H E+ ++ D K NI+ KL DFGL V
Sbjct: 261 MRQV--CKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV- 315
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
GT +AAPE + +D++S GV+ LLSG
Sbjct: 316 --TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLT---EVNYL 142
+G+G FG V+K + + G VA+KK+ EGF +T E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENEKEGFP-----ITALREIKIL 70
Query: 143 GQLHHPNLVKLIGYCLEGENRL--------LVYEFMP---KGSLENHLFRRGPQPLSWAV 191
L H N+V LI C + LV++F G L N + +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSE 125
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA--GPTGDRTH 249
+V GL ++H +++++RD KA+N+L+ + KL+DFGLA+A + +
Sbjct: 126 IKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 250 VSTQVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
T + T Y PE Y D++ G ++ E+ +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW-----LTEVNYLGQ 144
+G G +G VYK D HS G VA+K ++ G + EV L +
Sbjct: 17 IGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 145 LH---HPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
L HPN+V+L+ + E ++ LV+E + + L +L + P L +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM 255
+GL FLH + +++RD K NIL+ + KL+DFGLA+ T V+
Sbjct: 127 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV 181
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T Y APE + T D++S G + E+ +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 32/226 (14%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK--------KLKPEGFQGH 132
N+ P +LG G V + I + + AVK E Q
Sbjct: 16 YENYEPKEILGRGVSSVVRRC-IHK--------PTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 133 KEWL-TEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 190
+E EV+ L ++ HPN+++L LV++ M KG L ++L +
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
++ A+ + + LH +++RD K NILLD + N KL+DFG + G++
Sbjct: 127 RKIMRAL--LEVICALHK--LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-- 180
Query: 251 STQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVVLLELLSG 290
+V GT Y APE + D++S GV++ LL+G
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 22/205 (10%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
+G G +G V + G+ + A KK+ + + E+ + L HPN
Sbjct: 17 IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR-MKVAIGAAKGLTFLHD 208
+++L + + LV E G L + + S A R MK + A + + H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCHK 124
Query: 209 AESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
V +RD K N L + KL DFGLA G +GT Y +P+
Sbjct: 125 --LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ- 178
Query: 266 VATGRLTTKSDVYSFGVVLLELLSG 290
V G + D +S GV++ LL G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 65/292 (22%)
Query: 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK 133
F L+T LG G FG V+ L ++ +G A+K LK E K
Sbjct: 8 FQILRT----------LGTGSFGRVH--------LIRSR-HNGRYYAMKVLKKEIVVRLK 48
Query: 134 EW---LTEVNYLGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRG--PQPL 187
+ E L + HP ++++ + ++ ++ +++ G L + L + P P+
Sbjct: 49 QVEHTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV 107
Query: 188 SWAVRMKVA-IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246
+ + A + A L +LH +IYRD K NILLD + K++DFG AK D
Sbjct: 108 A---KFYAAEVCLA--LEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PD 158
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305
T+ T + GT Y APE V + + KS D +SFG+++ E+L+G
Sbjct: 159 VTY--T-LCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY-------------- 200
Query: 306 VDWAKP--YLSDKRKLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354
Y S+ K + +I++ +L ++P L + + + R
Sbjct: 201 -----TPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-21
Identities = 54/257 (21%), Positives = 99/257 (38%), Gaps = 26/257 (10%)
Query: 45 SKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSL---------LGEGGF 95
+ + +I + + + S+ LG G F
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAF 64
Query: 96 GFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIG 155
G V++ +++ +G V K + E++ + QLHHP L+ L
Sbjct: 65 GVVHRC-VEK--------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIY 215
+ +L+ EF+ G L + + +S A + A +GL +H E +++
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIVH 172
Query: 216 RDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT 273
D K NI+ + + + K+ DFGLA + + T +AAPE V +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGF 229
Query: 274 KSDVYSFGVVLLELLSG 290
+D+++ GV+ LLSG
Sbjct: 230 YTDMWAIGVLGYVLLSG 246
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 36/218 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLT---EVNYL 142
+GEG +G V+K D + G VA+K+++ EG L+ EV L
Sbjct: 19 IGEGAYGKVFKA-RDLKN-------GGRFVALKRVRVQTGEEGMP-----LSTIREVAVL 65
Query: 143 GQLH---HPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
L HPN+V+L + E +L LV+E + + L +L + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVSTQ 253
+ +GL FLH +V++RD K NIL+ + KL+DFGLA+ T
Sbjct: 125 MMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---V 179
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
V+ T Y APE + T D++S G + E+ +
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 62/263 (23%), Positives = 105/263 (39%), Gaps = 23/263 (8%)
Query: 33 HSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTA--TRNFRPDSLL 90
H + + E +S+ + + ++S + + + + F +S L
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 91 GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL 150
G G VY+ + G+ A+K LK K TE+ L +L HPN+
Sbjct: 62 GRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNI 110
Query: 151 VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE 210
+KL LV E + G L + + +G A I + + +LH E
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI--LEAVAYLH--E 166
Query: 211 SQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
+ +++RD K N+L + K++DFGL+K V GT GY APE +
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILR 223
Query: 268 TGRLTTKSDVYSFGVVLLELLSG 290
+ D++S G++ LL G
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCG 246
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 29/214 (13%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
+G+G F V + +G AVK K ++ E +
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSW-----AVRMKVAIGA 199
L HP++V+L+ +V+EFM L + +R + + M+ + A
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 200 AKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
L + H ++ +I+RD K +LL + KL FG+A G+ V+ +G
Sbjct: 143 ---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVG 195
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
T + APE V DV+ GV+L LLSG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL-TEVNYLG 143
LG G F V K ++ +G+ A K + + +E + EV+ L
Sbjct: 20 LGSGQFAIVKKC-REK--------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK-- 201
Q+ H N++ L + +L+ E + G L + L ++ ++ + A K
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQI 124
Query: 202 --GLTFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVM 255
G+ +LH ++ + D K NI+L D KL DFGLA G +
Sbjct: 125 LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIF 179
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
GT + APE V L ++D++S GV+ LLSG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEW 135
+ N+ LG+G F V + +G+ A K KL FQ +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLE-- 53
Query: 136 LTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
E +L HPN+V+L E LV++ + G L + R + A
Sbjct: 54 -REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA---KLSDFGLAKAGPTGDRTHVST 252
I + + + H + +++R+ K N+LL ++ KL+DFGLA +
Sbjct: 113 QI--LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW---H 165
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
GT GY +PE + + D+++ GV+L LL G
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-20
Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL-TEVNYLG 143
LG G F V K + G+G A K +L +E + EVN L
Sbjct: 13 LGSGQFAIVRKC-RQK--------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
++ HPN++ L + +L+ E + G L + L + A + I G+
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 121
Query: 204 TFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+LH ++ + D K NI+L + KL DFG+A G+ + GT
Sbjct: 122 HYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPE 176
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
+ APE V L ++D++S GV+ LLSG
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 44/207 (21%), Positives = 82/207 (39%), Gaps = 26/207 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN 149
LG G FG V++ + S K +K +G E++ L H N
Sbjct: 13 LGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRN 62
Query: 150 LVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK----GLTF 205
++ L E ++++EF+ + + + L+ + + L F
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LN----EREIVSYVHQVCEALQF 117
Query: 206 LHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
LH + + D + NI+ ++ K+ +FG A+ GD + + Y AP
Sbjct: 118 LH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSG 290
E ++T +D++S G ++ LLSG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 56/226 (24%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK----PEGFQGHKEWLT---EVNYL 142
LGEG +G VYK ID + VA+K+++ EG T EV+ L
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEHEEEGVP-----GTAIREVSLL 87
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMP---KGSLENHLFRRGPQPLSWAVRMKVAIGA 199
+L H N+++L L++E+ K ++ + +S V
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQL 141
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNA-----KLSDFGLAKA--GPTGDRTHVST 252
G+ F H + ++RD K N+LL + K+ DFGLA+A P TH
Sbjct: 142 INGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH--- 196
Query: 253 QVMGTHGYAAPE-------YVATGRLTTKSDVYSFGVVLLELLSGR 291
+++ T Y PE Y +T D++S + E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 64/281 (22%), Positives = 107/281 (38%), Gaps = 39/281 (13%)
Query: 27 ISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRP 86
+ + S S P P P + + +LP P ++ F +N
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60
Query: 87 DS------LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140
D +LG G G V + + + A+K L+ + EV
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIF---------NKRTQEKFALKMLQD-----CPKARREVE 106
Query: 141 YLGQL-HHPNLVKLIGYC---LEGENRL-LVYEFMPKGSLENHLFRRGPQPLS---WAVR 192
+ P++V+++ G L +V E + G L + + RG Q + +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTH 249
MK A + +LH + +RD K N+L NA KL+DFG AK + +
Sbjct: 167 MKSIGEA---IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-- 219
Query: 250 VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
++T T Y APE + + D++S GV++ LL G
Sbjct: 220 LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 54/220 (24%), Positives = 80/220 (36%), Gaps = 48/220 (21%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLG 143
+G G FG + L+ +VAVK E Q E+
Sbjct: 27 DIGSGNFGVARLM---RDKLT------KELVAVKYIERGAAIDENVQ------REIINHR 71
Query: 144 QLHHPNLVKLIGY-CLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L HPN+V+ + L ++ E+ G L + G R
Sbjct: 72 SLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAG--------RFSEDEARFF 121
Query: 202 ------GLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGDRTHVSTQ 253
G+++ H Q+ +RD K N LLD K+ DFG +K+ + +
Sbjct: 122 FQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--ST 177
Query: 254 VMGTHGYAAPEYVATGRL--TTKSDVYSFGVVLLELLSGR 291
V GT Y APE V + +DV+S GV L +L G
Sbjct: 178 V-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL-TEVNYLG 143
LG G F V K + +G+ A K + + +E + EV+ L
Sbjct: 20 LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
Q+ HPN++ L + +L+ E + G L + L ++ A I G+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 204 TFLHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+LH ++ + D K NI+L D KL DFGLA G + GT
Sbjct: 129 NYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPE 183
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
+ APE V L ++D++S GV+ LLSG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 50/287 (17%)
Query: 18 PRATSGASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNEL 77
PR TS A + + + S++K S+ + G+
Sbjct: 5 PRTTSFAE---SCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQ------------GPD 49
Query: 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT 137
+ ++ ++G G FG VY+ S G +VA+KK+ Q +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNR 96
Query: 138 EVNYLGQLHHPNLVKLIGY-----CLEGENRL-LVYEFMPKGSLENHL--FRRGPQPLSW 189
E+ + +L H N+V+L + + E L LV +++P+ ++ + R Q L
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP- 154
Query: 190 AVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGD- 246
+ +K+ + + L ++H + +RD K N+LLD + KL DFG AK G+
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 247 -RTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR 291
+++ ++ Y APE + T+ DV+S G VL ELL G+
Sbjct: 213 NVSYICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 57/274 (20%), Positives = 107/274 (39%), Gaps = 34/274 (12%)
Query: 32 SHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKA--FTFNELKTA---TRNFRP 86
+ S P+ + + + + ++ +S S + ++ + + ++
Sbjct: 7 YYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQN 66
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLG 143
+G G G V D VA+KKL FQ K E+ +
Sbjct: 67 LKPIGSGAQGIVCAA-YDAVL--------DRNVAIKKL-SRPFQNQTHAKRAYRELVLMK 116
Query: 144 QLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
++H N++ L+ LE + LV E M + +L + L +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLY 171
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
G+ LH A +I+RD K SNI++ ++ K+ DFGLA+ T + + T + T
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVT 226
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
Y APE + D++S G ++ E++ +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 53/238 (22%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK------KLKPEGFQGHKEWLT----- 137
+G+G +G V + A+K ++ GF
Sbjct: 20 EIGKGSYGVVKLA---YNEND------NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 138 ---------------EVNYLGQLHHPNLVKLIGYC-LEGENRL---LVYEFMPKGSLENH 178
E+ L +L HPN+VKL L+ N +V+E + +G +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVME- 127
Query: 179 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQ-VIYRDFKASNILLDAEFNAKLSDFG 237
+ P A + KG+ +LH Q +I+RD K SN+L+ + + K++DFG
Sbjct: 128 VPTLKPLSEDQARFYFQDL--IKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT---TKSDVYSFGVVLLELLSGRC 292
++ G +S V GT + APE ++ R DV++ GV L + G+C
Sbjct: 183 VS-NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 34/214 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
LG G F V + I + +G A K + + E L E+ L
Sbjct: 37 LGRGKFAVVRQC-ISK--------STGQEYAAKFLKKRRRGQDC---RAEILHEIAVLEL 84
Query: 145 L-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK-- 201
P ++ L +L+ E+ G + + + +S I K
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS----ENDVIRLIKQI 140
Query: 202 --GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
G+ +LH ++ +++ D K NILL + K+ DFG+++ +MG
Sbjct: 141 LEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMG 195
Query: 257 THGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
T Y APE + +TT +D+++ G++ LL+
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 34/213 (15%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HH 147
+LG G G V + + +G A+K L + EV++ Q
Sbjct: 36 VLGLGVNGKVLEC-FHR--------RTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81
Query: 148 PNLVKLIGYCLEGENR----LLVYEFMPKGSLENHLFRRGPQPLS---WAVRMKVAIGAA 200
P++V ++ + L++ E M G L + + RG Q + A M+ A
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA- 140
Query: 201 KGLTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGT 257
+ FLH + +RD K N+L E +A KL+DFG AK + T T
Sbjct: 141 --IQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YT 192
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
Y APE + + D++S GV++ LL G
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL---TEVNY 141
LG G G V ++ + VA+K K + L TE+
Sbjct: 18 LGSGACGEVKLA-FER--------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L +L+HP ++K+ + + E+ +V E M G L + + + +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--LL 125
Query: 202 GLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
+ +LH+ + +I+RD K N+LL + + K++DFG +K + GT
Sbjct: 126 AVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTP 180
Query: 259 GYAAPE---YVATGRLTTKSDVYSFGVVLLELLSG 290
Y APE V T D +S GV+L LSG
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HH 147
+LGEG V I+ + AVK ++ + EV L Q H
Sbjct: 20 VLGEGAHARVQTC-INL--------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 148 PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH 207
N+++LI + E + LV+E M GS+ +H+ +R A + + A L FLH
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV--ASALDFLH 128
Query: 208 DAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKA-GPTGDRTHVSTQVM----GTHG 259
+ + +RD K NIL + K+ DF L GD + +ST + G+
Sbjct: 129 N--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 260 YAAPEYVATGRLTTKS-----DVYSFGVVLLELLSG 290
Y APE V D++S GV+L LLSG
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWL-TEVNYLG 143
LG G F V K ++ +G+ A K + K +E + EV+ L
Sbjct: 19 LGSGQFAVVKKC-REK--------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
++ HPN++ L + +L+ E + G L + L + A I G+
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI--LNGV 127
Query: 204 TFLHDAESQVIYRDFKASNILL---DAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+LH Q+ + D K NI+L + K+ DFGLA G+ + GT
Sbjct: 128 YYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 182
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
+ APE V L ++D++S GV+ LLSG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 73/344 (21%), Positives = 124/344 (36%), Gaps = 57/344 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK---KLKPEGFQGHKEWLTEVNYLGQL- 145
+G G + + + M AVK K K + + E+ L +
Sbjct: 30 IGVGSYSVCKRCI---------HKATNMEFAVKIIDKSKRDPTE-------EIEILLRYG 73
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
HPN++ L +G+ +V E M G L + + R+ A + I K + +
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI--TKTVEY 131
Query: 206 LHDAESQVIYRDFKASNILL-DAEFNA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
LH V++RD K SNIL D N ++ DFG AK + + T +
Sbjct: 132 LHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFV 187
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
APE + D++S GV+L +L+G P + + L R
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPF-------------ANGPDDTPEEILAR 234
Query: 322 IMDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKN 372
I G++ + TA L + L+ +P R + VL I+ + P+
Sbjct: 235 IGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290
Query: 373 SAKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQ 416
+ + + S + + +SP+ S L R
Sbjct: 291 QLNRQDAPHLVKGA-MAATYSALNRNQSPVLEPVGRSTLAQRRG 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 31/221 (14%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+ ++ +G G G V D VA+KKL FQ K
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAA-YDAIL--------ERNVAIKKL-SRPFQNQTHAKRAYR 73
Query: 138 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 191
E+ + ++H N++ L+ LE + +V E M + +L + L
Sbjct: 74 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELD-HE 127
Query: 192 RMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
RM + G+ LH A +I+RD K SNI++ ++ K+ DFGLA T + +
Sbjct: 128 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFM 182
Query: 251 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T + T Y APE + D++S G ++ E++ G
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 27/244 (11%)
Query: 55 PTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPG 114
P S F N + N+ LG+G F V +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKT 52
Query: 115 SGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEF 169
+G+ A K KL FQ + E +L HPN+V+L E LV++
Sbjct: 53 TGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109
Query: 170 MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF 229
+ G L + R + A I + + + H + +++R+ K N+LL ++
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCH--SNGIVHRNLKPENLLLASKA 165
Query: 230 NA---KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLE 286
KL+DFGLA + GT GY +PE + + D+++ GV+L
Sbjct: 166 KGAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222
Query: 287 LLSG 290
LL G
Sbjct: 223 LLVG 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 39/245 (15%)
Query: 65 SSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKL 124
S N A + F+ + + G+G FG V G ++ + GM VA+KK+
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLG-KEKST--------GMSVAIKKV 56
Query: 125 KPEGFQGHKEW----LTEVNYLGQLHHPNLVKLI------GYCLEGENRL-LVYEFMPKG 173
Q + L + L LHHPN+V+L G + L +V E++P
Sbjct: 57 ----IQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD- 110
Query: 174 SLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230
+L + R + +KV + + + LH V +RD K N+L++
Sbjct: 111 TLHRCCRNYYRRQVAPP-PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG 169
Query: 231 A-KLSDFGLAKA-GPTGDRTH-VSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLE 286
KL DFG AK P+ + ++ Y APE + + TT D++S G + E
Sbjct: 170 TLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 287 LLSGR 291
++ G
Sbjct: 225 MMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-19
Identities = 67/330 (20%), Positives = 107/330 (32%), Gaps = 54/330 (16%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK---KLKPEGFQGHKEWLTEVNYLGQL- 145
LGEG F K S AVK K Q E+ L
Sbjct: 19 LGEGSFSICRKCV---------HKKSNQAFAVKIISKRMEANTQ------KEITALKLCE 63
Query: 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTF 205
HPN+VKL + + LV E + G L + ++ + A + + ++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL--VSAVSH 121
Query: 206 LHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+HD V++RD K N+L + K+ DFG A+ P + T YAA
Sbjct: 122 MHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAA 177
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + D++S GV+L +LSG+ + I
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTCTSAVEI 224
Query: 323 MDTKLGGQYP------QKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNS 373
M G + + + A L L +P R +MS + + + + N
Sbjct: 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN- 283
Query: 374 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 403
P + ++ N
Sbjct: 284 ---PLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 55/296 (18%)
Query: 31 SSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLL 90
SSH +A + ++ + + + S + + L+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 91 GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLTEVNYLGQLHH 147
G G +G V + D+ VVA+KK+ F+ K L E+ L +L+H
Sbjct: 62 GTGSYGHVCEA-YDKLE--------KRVVAIKKILRV-FEDLIDCKRILREIAILNRLNH 111
Query: 148 PNLVKL----IGYCLEGENRL-LVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAI-GA 199
++VK+ I +E + L +V E ++ + R P L+ + +K +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLYNL 165
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
G+ ++H A +++RD K +N L++ + + K+ DFGLA+ + + +
Sbjct: 166 LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 260 YAAP--------------EYVAT------------GRLTTKSDVYSFGVVLLELLS 289
+V T T DV+S G + ELL+
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 60/275 (21%), Positives = 104/275 (37%), Gaps = 53/275 (19%)
Query: 31 SSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLL 90
S + P PP + + P + E + +R LL
Sbjct: 1 SMLTKPLQGPPAPPG-----TPTPPPGGKDREAFEA----------------EYRLGPLL 39
Query: 91 GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLT-EVNYLGQ 144
G+GGFG V+ G + VA+K ++ EV L +
Sbjct: 40 GKGGFGTVFAG---HRLTD------RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 145 LH----HPNLVKLIGYCLEGENRL-LVYEF-MPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
+ HP +++L+ + E + LV E +P L +++ +GP + +
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGT 257
AA + H V++RD K NIL+D KL DFG A + GT
Sbjct: 150 AA--IQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GT 201
Query: 258 HGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGR 291
Y+ PE+++ + + V+S G++L +++ G
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 39/260 (15%)
Query: 45 SKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWID 104
S N L +++ A + + ++G G FG V++
Sbjct: 6 SNAPLNGVKLNPLDDPNKVIKV---LASDGKTGEQREIAYTNCKVIGNGSFGVVFQ---- 58
Query: 105 QHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGY-----CLE 159
AK VA+KK+ Q + E+ + + HPN+V L + +
Sbjct: 59 ------AKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108
Query: 160 GENRL-LVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIY 215
E L LV E++P+ ++ + + Q + + +K+ + + L ++H + +
Sbjct: 109 DEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSI--GICH 164
Query: 216 RDFKASNILLDAEFNA-KLSDFGLAKA-GPTGDRTH-VSTQVMGTHGYAAPEYVATGRL- 271
RD K N+LLD KL DFG AK + ++ Y APE +
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPELIFGATNY 219
Query: 272 TTKSDVYSFGVVLLELLSGR 291
TT D++S G V+ EL+ G+
Sbjct: 220 TTNIDIWSTGCVMAELMQGQ 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 26/209 (12%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK-----KLKPEGFQGHKEWLTEVNYLGQ 144
LG+G F V + K +G A KL Q + E
Sbjct: 19 LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
L HPN+V+L E + L+++ + G L + R + A I + +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQI--LEAVL 124
Query: 205 FLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
H + V++R+ K N+LL A KL+DFGLA GT GY
Sbjct: 125 HCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYL 180
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSG 290
+PE + D+++ GV+L LL G
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 54/236 (22%), Positives = 87/236 (36%), Gaps = 36/236 (15%)
Query: 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK 133
EL + + G +G V G+ VA+K++ G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRT 63
Query: 134 EW-----------LTEVNYLGQLHHPNLVKL----IGYCLEGENRL-LVYEFMPKGSLEN 177
L E+ L HHPN++ L + + ++L LV E M L
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-A 121
Query: 178 HLFRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236
+ +S ++ + GL LH+A V++RD NILL + + DF
Sbjct: 122 QVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDF 178
Query: 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
LA+ T + Y APE V + TK D++S G V+ E+ + +
Sbjct: 179 NLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 29/222 (13%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+ S +GEG +G V D + + VA+KK+ P F+ + L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSA-YDNLN--------KVRVAIKKISP--FEHQTYCQRTLR 74
Query: 138 EVNYLGQLHHPNLVKLIG----YCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVR 192
E+ L + H N++ + +E + +V + M + L + Q LS
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT--QHLS-NDH 129
Query: 193 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHV 250
+ + +GL ++H A V++RD K SN+LL+ + K+ DFGLA+ A P D T
Sbjct: 130 ICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 251 STQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T+ + T Y APE + + TKS D++S G +L E+LS R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 33/210 (15%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHP 148
LG G + V++ + + V VK LKP K+ E+ L L P
Sbjct: 44 LGRGKYSEVFEAI-NITN--------NEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWA-VR--MKVAIGAAKGLTF 205
N++ L + +R F + N F++ Q L+ +R M + K L +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL---KALDY 145
Query: 206 LHDAESQVIYRDFKASNILLDAEFNA-KLSDFGLAKAG-PTGDRTH-VSTQVMGTHGYAA 262
H +++RD K N+++D E +L D+GLA+ P + V+++ +
Sbjct: 146 CHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKG 198
Query: 263 PEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
PE + ++ S D++S G +L ++ +
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 56/239 (23%), Positives = 98/239 (41%), Gaps = 54/239 (22%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140
+ LG GG G V+ +D VA+KK+ Q K L E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSA-VDNDC--------DKRVAIKKIVLTDPQSVKHALREIK 60
Query: 141 YLGQLHHPNLVKLI-------------GYCLEGENRL-LVYEFMPKGSLENHLFRRGP-- 184
+ +L H N+VK+ L N + +V E+M + ++ +GP
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLL 118
Query: 185 ---------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLS 234
Q L +GL ++H A V++RD K +N+ ++ E K+
Sbjct: 119 EEHARLFMYQLL-------------RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIG 163
Query: 235 DFGLAK-AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
DFGLA+ P ++ + T Y +P + + TK+ D+++ G + E+L+G+
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+ +F+ SLLGEG +G V + + G +VA+KK++P F L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSA-THKPT--------GEIVAIKKIEP--FDKPLFALRTLR 58
Query: 138 EVNYLGQLHHPNLVKLI----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVR 192
E+ L H N++ + E N + ++ E M + + + Q LS
Sbjct: 59 EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST--QMLS-DDH 113
Query: 193 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
++ I + + LH + VI+RD K SN+L+++ + K+ DFGLA+ D +
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLAR---IIDESAAD 168
Query: 252 TQVMGTHGYAAPEYVAT------------GRLTTKSDVYSFGVVLLELLSGR 291
E+VAT + + DV+S G +L EL R
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+ + + +G G +G V ID+ S G VA+KKL FQ K
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSA-IDKRS--------GEKVAIKKL-SRPFQSEIFAKRAYR 72
Query: 138 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 191
E+ L + H N++ L+ L LV FM + L + S
Sbjct: 73 ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEK 127
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ KGL ++H A V++RD K N+ ++ + K+ DFGLA+ +V
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV 185
Query: 252 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T+ Y APE + + ++ D++S G ++ E+L+G+
Sbjct: 186 TRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 52/253 (20%), Positives = 99/253 (39%), Gaps = 52/253 (20%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
N+ L+G G +G+VY D+++ VA+KK+ F+ K L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLA-YDKNT--------EKNVAIKKV-NRMFEDLIDCKRILR 74
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRL------LVYEFMPKGSLENHLFR--RGPQPLSW 189
E+ L +L +++L + ++ L +V E ++ L + + P L+
Sbjct: 75 EITILNRLKSDYIIRLYD-LIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT- 127
Query: 190 AVRMKVAIG-AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT 248
+K + G F+H++ +I+RD K +N LL+ + + K+ DFGLA+ + T
Sbjct: 128 EEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 249 HVSTQVMGTHGYAAP---------EYVAT------------GRLTTKSDVYSFGVVLLEL 287
++ + +V T T D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 288 LSGRCAVDKTKVG 300
L+ +
Sbjct: 246 LNMLQSHINDPTN 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 55/202 (27%), Positives = 77/202 (38%), Gaps = 37/202 (18%)
Query: 176 ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235
E L+ + + AKG+ FL A + I+RD A NILL + K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 236 FGLAKAGPTGDRTHVSTQV------MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
FGLA+ M APE + T +SDV+SFGV+L E+ S
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 290 GRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQ 345
+G A PY + + R + K G + P L
Sbjct: 291 ---------LG--------ASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLD 331
Query: 346 CLNNEPKLRPRMSEVLAILERL 367
C + EP RP SE++ L L
Sbjct: 332 CWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 7/104 (6%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQL 145
LG G FG V + K + VAVK LK H+ ++E+ L +
Sbjct: 27 GKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 146 -HHPNLVKLIGYCLEGENRLLV-YEFMPKGSLENHLFRRGPQPL 187
HH N+V L+G C + L+V EF G+L +L + + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 58/258 (22%), Positives = 100/258 (38%), Gaps = 63/258 (24%)
Query: 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL 136
L+T+++ + LG G FG V + D S G A+KK+ Q +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEV-FDIES--------GKRFALKKV----LQDPRYKN 48
Query: 137 TEVNYLGQLHHPNLVKLIGY-------------------------------------CLE 159
E++ + L H N++KL+ Y
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 160 GENRL-LVYEFMPKGSLENHL--FRRGPQPLSWAVRMKVAI-GAAKGLTFLHDAESQVIY 215
L ++ E++P +L L F R + + + + I + + F+H + +
Sbjct: 109 QNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL--GICH 164
Query: 216 RDFKASNILLDAEFNA-KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TT 273
RD K N+L++++ N KL DFG AK + V+ + Y APE + T
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYIC--SRFYRAPELMLGATEYTP 221
Query: 274 KSDVYSFGVVLLELLSGR 291
D++S G V EL+ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
+R +G G +G V +D + G VA+KKL FQ K
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSA-VDGRT--------GAKVAIKKL-YRPFQSELFAKRAYR 73
Query: 138 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 191
E+ L + H N++ L+ L+ LV FM G+ L + + L
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDR 129
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ KGL ++H A +I+RD K N+ ++ + K+ DFGLA+ + +V
Sbjct: 130 IQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 252 TQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T+ Y APE + T++ D++S G ++ E+++G+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 64/240 (26%), Positives = 106/240 (44%), Gaps = 48/240 (20%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
R + LG+G +G V+K ID+ + G VVAVKK+ + FQ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFR 57
Query: 138 EVNYLGQLH-HPNLVKLIGYCL-EGENRL-LVYEFMPKGSLENHLFR--RGPQPLSWAVR 192
E+ L +L H N+V L+ + + + LV+++M E L R L V
Sbjct: 58 EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRA-NILE-PVH 110
Query: 193 MKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS 251
+ + K + +LH +++RD K SNILL+AE + K++DFGL+++ R +
Sbjct: 111 KQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 252 TQVMGTHGYAAP--------EYVAT------------GRLTTKSDVYSFGVVLLELLSGR 291
+ +YVAT + T D++S G +L E+L G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 33/211 (15%), Positives = 61/211 (28%), Gaps = 47/211 (22%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVN 140
+R G ++ D VA+ + P+G +E L+
Sbjct: 33 YRLLIFHGGVPPLQFWQAL-DTAL--------DRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L ++ P + +++ L+V E++ GSL+ + P P+ A+R A
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSPV-GAIR--AMQSLA 139
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
H A V S + + + + L+
Sbjct: 140 AAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA----------------------T 175
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+ D+ G L LL R
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNR 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 33/222 (14%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH---KEWLT 137
++ S +G G +G V + + +G+ VAVKKL FQ K
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKL-SRPFQSIIHAKRTYR 77
Query: 138 EVNYLGQLHHPNLVKLI-----GYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAV 191
E+ L + H N++ L+ LE N + LV M L N++ + Q L+
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVKC--QKLT-DD 132
Query: 192 RMKVAI-GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
++ I +GL ++H A+ +I+RD K SN+ ++ + K+ DFGLA+
Sbjct: 133 HVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH-----TADE 185
Query: 251 STQVMGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGR 291
T + T Y APE + ++ D++S G ++ ELL+GR
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 52/282 (18%), Positives = 99/282 (35%), Gaps = 46/282 (16%)
Query: 33 HSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGE 92
HSS + + + G +L+ + R ++ S
Sbjct: 7 HSSGVDL--GTENLYFQSMTTSLEALPTGTVLT------------DKSGRQWKLKSFQTR 52
Query: 93 GGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLT--------EVNYLGQ 144
G +Y+ +L+ ++ KL + + E +VN +
Sbjct: 53 DNQGILYEA-APTSTLTCDSGPQKQKFSL-KLDAKDGRLFNEQNFFQRAAKPLQVNKWKK 110
Query: 145 LHHPNLV---KLIGY-CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L+ L+ +G+ + + R LV + + SL++ L LS ++VA
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLL 169
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAK--LSDFGLAKAGPTGDRTHV------ST 252
L FLH E++ ++ + A NI +D E ++ L+ +G A HV +
Sbjct: 170 DALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHVAYVEGSRS 226
Query: 253 QVMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGR 291
G + + R +SD+ S G +L+ L G
Sbjct: 227 PHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLKWLYGF 265
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 49/211 (23%), Positives = 79/211 (37%), Gaps = 52/211 (24%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHP 148
LG G G V + + A+K L+ + EV + P
Sbjct: 26 LGLGINGKVLQI---------FNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 71
Query: 149 NLVKLIGYC----LEGENRLLVYEFMPKGSLENHLFRRGPQPLS--WAVRMKVAIGAAKG 202
++V+++ + L+V E + G L + + RG Q + A + +IG A
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA-- 129
Query: 203 LTFLHDAESQVIYRDFKASNILL-DAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+ +LH + +RD K N+L NA KL+DFG AK + G
Sbjct: 130 IQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTG-EK 174
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSG 290
Y D++S GV++ LL G
Sbjct: 175 Y-----------DKSCDMWSLGVIMYILLCG 194
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 53/278 (19%), Positives = 100/278 (35%), Gaps = 56/278 (20%)
Query: 43 PPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGW 102
++ L + GEI++ A ++ +G+GGFG +Y
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITD------------MAAAAWKVGLPIGQGGFGCIYLA- 54
Query: 103 IDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLV----------- 151
S GS VK + + TE+ + + P +
Sbjct: 55 ---DMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKY 107
Query: 152 ----KLIGYCLEGEN----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
K G L +N R ++ + L+ ++ + S +++++ L
Sbjct: 108 LGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQ-KIYEANAKRFSRKTVLQLSLRILDIL 165
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAK--LSDFGLAKA-GPTGDRTHVS----TQVMG 256
++H+ E ++ D KASN+LL+ + + L D+GLA P G + G
Sbjct: 166 EYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223
Query: 257 THGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T + A VA R + D+ G +++ L+G
Sbjct: 224 TIEFTSIDAHNGVAPSR---RGDLEILGYCMIQWLTGH 258
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 50/225 (22%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQL- 145
SL+G+G FG V K + D+ VA+K +K + F + EV L +
Sbjct: 60 SLIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMN 108
Query: 146 -------HHPNLVKLIGY-------CLEGENRLL---VYEFMPKGSLENHLFRRGPQPLS 188
++ +V L + CL E +L +Y+ L N FR L+
Sbjct: 109 KHDTEMKYY--IVHLKRHFMFRNHLCLVFE--MLSYNLYDL-----LRNTNFR--GVSLN 157
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGD 246
R K A L FL E +I+ D K NILL + K+ DFG +
Sbjct: 158 -LTR-KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQL 211
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
+ + Y +PE + D++S G +L+E+ +G
Sbjct: 212 GQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 57/259 (22%), Positives = 92/259 (35%), Gaps = 47/259 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK--KLKPEGFQGHKEWLTEVN 140
+R +G G FG +Y G D +G VA+K +K + Q H E
Sbjct: 10 RYRLGRKIGSGSFGDIYLG-TDIA--------AGEEVAIKLECVKTKHPQLHIES----K 56
Query: 141 YLGQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
+ + + EG+ ++V E + SLE LF + S + +A
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQM 114
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAK---LSDFGLAKA-GPTGDRTHV----S 251
+ ++H I+RD K N L+ + DFGLAK H+ +
Sbjct: 115 ISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172
Query: 252 TQVMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308
+ GT YA + R + D+ S G VL+ G K
Sbjct: 173 KNLTGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGSLPWQGLKAA-------- 221
Query: 309 AKPYLSDKRKLFRIMDTKL 327
+ ++K RI + K+
Sbjct: 222 -----TKRQKYERISEKKM 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 50/259 (19%), Positives = 92/259 (35%), Gaps = 45/259 (17%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+++ +GEG FG +++G + + VA+K + E
Sbjct: 11 HYKVGRRIGEGSFGVIFEG-TNLL--------NNQQVAIKFEPRR--SDAPQLRDEYRTY 59
Query: 143 GQLHH-PNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L + + + EG + +LV + + SLE L + S A
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAK-----LSDFGLAKA-GPTGDRTHV----S 251
+ +H+ ++YRD K N L+ + + DFG+ K + H+
Sbjct: 118 RVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 252 TQVMGTHGYAAPEYVAT--GR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308
+ GT Y + + T GR + + D+ + G V + L G K
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------- 224
Query: 309 AKPYLSDKRKLFRIMDTKL 327
++K+K RI + K
Sbjct: 225 -----TNKQKYERIGEKKQ 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 38/225 (16%), Positives = 87/225 (38%), Gaps = 38/225 (16%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH- 146
LG G F V+ D + VA+K ++ + + E+ L +++
Sbjct: 25 RKLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74
Query: 147 ----------HPNLVKLIGY----CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 192
+++KL+ + G + ++V+E + +L + + + +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------FNAKLSDFGLAKAGPTGD 246
+++ GL ++H +I+ D K N+L++ K++D G A
Sbjct: 134 KQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWY 188
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
H + + Y +PE + +D++S ++ EL++G
Sbjct: 189 DEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 41/165 (24%), Positives = 64/165 (38%), Gaps = 23/165 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK--KLKPEGFQGHKEWLTEVN 140
NFR +G G FG + G + + + VA+K +K Q H E+
Sbjct: 10 NFRVGKKIGCGNFGELRLG-KNLY--------TNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
P ++ + G+ +V E + SLE LF + S + +AI
Sbjct: 61 LGSGDGIP---QVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLI 115
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAK-----LSDFGLAK 240
+ ++H +IYRD K N L+ N + DF LAK
Sbjct: 116 SRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 48/224 (21%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNYLGQL 145
++G+G FG V K + D VA+K ++ + F H++ E+ L L
Sbjct: 102 LKVIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRF--HRQAAEEIRILEHL 150
Query: 146 --HHP----NLVKLIGY-------CLEGENRLL---VYEFMPKGSLENHLFRRGPQPLSW 189
N++ ++ C+ E LL +YE + K Q S
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNKF---------QGFSL 199
Query: 190 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDR 247
+ K A + L LH ++I+ D K NILL + + K+ DFG + +
Sbjct: 200 PLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEH 253
Query: 248 THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR 291
V T + Y APE + R D++S G +L ELL+G
Sbjct: 254 QRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 61/257 (23%), Positives = 97/257 (37%), Gaps = 43/257 (16%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
FR +G G FG +Y G + + VA+K + H + L E
Sbjct: 8 KFRLGRKIGSGSFGEIYLG-TNIQ--------TNEEVAIKLENVK--TKHPQLLYESKIY 56
Query: 143 GQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L + + + +EG+ +LV + + SLE LF + LS + +A
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMIN 114
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAK---LSDFGLAKA-GPTGDRTHV----STQ 253
+ F+H ++RD K N L+ A + DFGLAK T H+ +
Sbjct: 115 RVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 254 VMGTHGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310
+ GT YA + R + D+ S G VL+ L G K G
Sbjct: 173 LTGTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAG---------- 219
Query: 311 PYLSDKRKLFRIMDTKL 327
+ K+K +I + K+
Sbjct: 220 ---TKKQKYEKISEKKV 233
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 53/278 (19%), Positives = 93/278 (33%), Gaps = 59/278 (21%)
Query: 43 PPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGW 102
N P EG++L + +G GGFG +Y
Sbjct: 10 GVDLGTENLYFQSMPFPEGKVLD------------DMEGNQWVLGKKIGSGGFGLIYLA- 56
Query: 103 IDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLV----------- 151
+ A +K E +Q + +E+ + ++ + +
Sbjct: 57 FPTN--------KPEKDARHVVKVE-YQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY 107
Query: 152 ----KLIGY----CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
G R +V E + L+ + G S V + I L
Sbjct: 108 LGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKS-TVLQ-LGIRMLDVL 164
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAK--LSDFGLAKA-GPTGDRTHVS----TQVMG 256
++H E++ ++ D KA+N+LL + + L+D+GL+ P G+ G
Sbjct: 165 EYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222
Query: 257 THGYA---APEYVATGRLTTKSDVYSFGVVLLELLSGR 291
T + A + VA R +SDV G +L L G+
Sbjct: 223 TIEFTSLDAHKGVALSR---RSDVEILGYCMLRWLCGK 257
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 4e-08
Identities = 54/366 (14%), Positives = 109/366 (29%), Gaps = 91/366 (24%)
Query: 24 ASRISTRSSHSSAPSTLPIPPSKEKGNSESLPTPKSEGEILSSSNLKAFTFNELKTATRN 83
S I T S + + I +++ +++ K + S L+ + +L+ A
Sbjct: 95 MSPIKTEQRQPSMMTRMYIE-QRDRLYNDNQVFAK-----YNVSRLQ--PYLKLRQALLE 146
Query: 84 FRPDSLL---GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEV 139
RP + G G G K W+ + V K++ + F+ WL
Sbjct: 147 LRPAKNVLIDGVLGSG---KTWV-----------ALDVCLSYKVQCKMDFKIF--WLN-- 188
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L + P V LE +LL Y+ P + + +
Sbjct: 189 --LKNCNSPETV------LEMLQKLL-YQIDPNWTSRSDHSSNIKLRIHS------IQAE 233
Query: 200 AKGLTFLHD-AESQVIYRDFKASNILLDA-EFNAKL----SDFGLAKAGPTGDRTHVSTQ 253
+ L ++ + + + +A + K+ + TH+S
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTTHIS-L 291
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG-IEQSLVDWA--- 309
+ E L K +L + ++ I +S+ D
Sbjct: 292 DHHSMTLTPDE---VKSLLLK----YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 310 KPYL-SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN-EPKLRPRMSEVLAILERL 367
+ + KL I+++ LN EP +M + L++
Sbjct: 345 DNWKHVNCDKLTTIIES--------------------SLNVLEPAEYRKMFDRLSVF--- 381
Query: 368 EAPKNS 373
P ++
Sbjct: 382 --PPSA 385
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 3e-04
Identities = 64/431 (14%), Positives = 122/431 (28%), Gaps = 124/431 (28%)
Query: 1 MGNC---------LQHSSARVDSTQSPRATSGASRISTRSSHSSAPSTLPIPPSKEKGNS 51
+ NC LQ ++D + R+ ++ S + L K K
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL----LKSKPYE 244
Query: 52 ESLPTPKSEGEIL----SSSNLKAFTFN--ELKTATRNFR-PDSLLGEGGFGFVYKGWID 104
L +L ++ AF + L T TR + D L +D
Sbjct: 245 NCL-------LVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDFLSAATTTHIS----LD 292
Query: 105 QHSLSPAKPGSGMVVA------VKKLKPEGFQGH-----------KEWLTEVNYLGQLHH 147
HS++ ++ + L E + ++ L + ++
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 148 PNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRG----PQPLS--WA------V 191
L +I L E R + ++ L +F LS W V
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKM-FD-----RLS--VFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 192 RMKVAIGAAKGLTFLHDAESQV----IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDR 247
+ V L ES + IY + K + + + + D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPSIYLELKV-KLENEYALHRSIVDH----------- 452
Query: 248 THVSTQVMGTHGYAAPE-YVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
Y P+ + + + D Y + + L + + +
Sbjct: 453 ------------YNIPKTFDSDDLIPPYLDQYFYSHIGHHL---------KNIEHPERMT 491
Query: 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLN--------NEPKLRPRMS 358
+ +L FR ++ K+ A + LQ L N+PK ++
Sbjct: 492 LFRMVFLD-----FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
Query: 359 EVLAILERLEA 369
+L L ++E
Sbjct: 547 AILDFLPKIEE 557
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 6e-08
Identities = 41/270 (15%), Positives = 69/270 (25%), Gaps = 75/270 (27%)
Query: 70 KAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG- 128
F+ T + +GEG FG V++ D VA+K + EG
Sbjct: 9 GPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTP-----------VAIKIIAIEGP 56
Query: 129 -------FQGHKEWLTEVNYLGQLH---------HPNLVKLIGYCL-------------- 158
+ +E L E+ +L + L
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 159 ----------------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+ + +V EF G L + + S A +
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTAS 173
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG--PTGDRTHVSTQVMGTH-- 258
L + +RD N+LL KL K+ P+ +
Sbjct: 174 LAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
Query: 259 --------GYAAPEYVATGRLTTKSDVYSF 280
+ E + TG + D+Y
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 59/241 (24%), Positives = 86/241 (35%), Gaps = 68/241 (28%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQL- 145
LGEG FG V + D VA+K ++ + + E+N L ++
Sbjct: 25 GNLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIK 74
Query: 146 -------HHPNLVKLIGY-------CLEGENRLL---VYEFMPKGSLENHLFRRGPQPLS 188
V + + C+ E LL +EF L+ + F+ P PL
Sbjct: 75 EKDKENKFL--CVLMSDWFNFHGHMCIAFE--LLGKNTFEF-----LKENNFQ--PYPLP 123
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA----------------- 231
VR +A L FLH+ Q+ + D K NIL
Sbjct: 124 -HVR-HMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 232 --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS 289
+++DFG A T D H +T V H Y PE + DV+S G +L E
Sbjct: 180 SIRVADFGSA----TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 290 G 290
G
Sbjct: 235 G 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 62/247 (25%), Positives = 94/247 (38%), Gaps = 80/247 (32%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP-EGFQGHKEWLTEVNYLGQL- 145
LGEG FG V + D + G VAVK +K + + + +E+ L L
Sbjct: 20 DTLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLN 69
Query: 146 -------HHPNLVKLIGY-------CLEGENRLL---VYEFMPKGSLENHLFRRGPQPLS 188
V+++ + C+ E LL Y+F ++ + F P L
Sbjct: 70 TTDPNSTFR--CVQMLEWFEHHGHICIVFE--LLGLSTYDF-----IKENGFL--PFRLD 118
Query: 189 WAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA---------------- 231
+R K+A K + FLH ++ + D K NIL +++
Sbjct: 119 -HIR-KMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 232 --KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPE------YVATGRLTTKSDVYSFGVV 283
K+ DFG A T D H ST V H Y APE + + DV+S G +
Sbjct: 175 DIKVVDFGSA----TYDDEHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCI 223
Query: 284 LLELLSG 290
L+E G
Sbjct: 224 LIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 54/245 (22%), Positives = 84/245 (34%), Gaps = 72/245 (29%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK-PEGFQGHKEWLTEVNYLGQL- 145
+G+G FG V + AVK ++ + + + E + L ++
Sbjct: 41 RKMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKY--TRSAKIEADILKKIQ 89
Query: 146 ----HHPNLVKLIGY-------CLEGENRLL---VYEFMPKGSLENHLFRRGPQPLSWAV 191
++ N+VK G CL E L +YE + + + + +
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEI-----ITRNNYN--GFHIE-DI 139
Query: 192 RMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-DAEFNA------------------- 231
+ I K L +L + + D K NILL D F
Sbjct: 140 K-LYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 232 -----KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLL 285
KL DFG A T + + + Y APE V SD++SFG VL
Sbjct: 197 KSTGIKLIDFGCA----TFKSDYHGSIINTRQ-YRAPE-VILNLGWDVSSDMWSFGCVLA 250
Query: 286 ELLSG 290
EL +G
Sbjct: 251 ELYTG 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 51/266 (19%), Positives = 85/266 (31%), Gaps = 80/266 (30%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-- 145
LG G F V+ W Q VA+K +K + L E+ L +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGK---------KFVAMKVVKSAE-HYTETALDEIRLLKSVRN 92
Query: 146 ---HHPN---LVKLIGY-CLEGEN---RLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMK 194
+ PN +V+L+ + G N +V+E + G L + + Q L K
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKK 150
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-------------------------- 228
+ +GL +LH + ++I+ D K NILL
Sbjct: 151 IIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 229 -----------------------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEY 265
K++D G A + T+ Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 266 VATGRLTTKSDVYSFGVVLLELLSGR 291
+ T +D++S + EL +G
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 421 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.27 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.77 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.43 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.17 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.71 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.39 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.19 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.59 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.77 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=461.87 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=208.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+.+.+|+++|+.|+|||||++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 589999999999999999997654 5899999999765432 34578899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++.+|||||||+||+|.++|.......+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999999987766678999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
+..... .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.... ..+
T Consensus 173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~ 234 (350)
T 4b9d_A 173 RVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----------------NLV 234 (350)
T ss_dssp SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHH
T ss_pred eeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHH
Confidence 875432 12234578999999999999999999999999999999999999999765321 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+++... ....+..++.++.+||.+||..||.+|||+.|+++
T Consensus 235 ~~i~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 235 LKIISGS-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHcCC-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222222 22345567889999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=451.56 Aligned_cols=265 Identities=28% Similarity=0.466 Sum_probs=221.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|.+.+.||+|+||+||+|.+... ....++..||||+++.......++|.+|+++|++|+|||||++++++.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 5788999999999999999987542 233457899999998766666678999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRG-----------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
..+||||||++|+|.++|.+.+ ...+++..++.++.||+.||.|||+ ++||||||||+||||+.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccCHhhEEECCCCc
Confidence 9999999999999999997642 3469999999999999999999995 47999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~ 309 (421)
+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+...
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---------- 236 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---------- 236 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----------
Confidence 99999999986544433333344679999999999999999999999999999999998 8999976432
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........|..++.++.+|+.+||+.||++|||+.+|++.|+++..
T Consensus 237 -------~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 237 -------NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp -------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11222233333445667888999999999999999999999999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-61 Score=452.97 Aligned_cols=266 Identities=28% Similarity=0.448 Sum_probs=215.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|.+.+.||+|+||+||+|.+... ....++..||||+++.......++|.+|+++|++|+|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 4678889999999999999987642 233468899999998766666678999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 162 NRLLVYEFMPKGSLENHLFRRG-------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
..|||||||++|+|.++|.+.. ..++++..++.++.||+.||+|||+ .+||||||||+||||+.+
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~--~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG--LHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETT
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHhhEEECCC
Confidence 9999999999999999997643 2358999999999999999999995 479999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 307 (421)
+.+||+|||+++..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------- 266 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------- 266 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999987655444444456789999999999999999999999999999999999 8999976432
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+....+...|..+++++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 267 ---------~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 267 ---------TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 112222233334456678889999999999999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-60 Score=447.58 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=212.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
..|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+++|+.|+|||||+++++|.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 569999999999999999997654 58999999997665566677889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.+|||||||+||+|.+++.+. .+++..+..++.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+.
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 219 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEECCCCCEEEecCcCcee
Confidence 999999999999999999653 38999999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... ....
T Consensus 220 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----------------~~~~ 280 (346)
T 4fih_A 220 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----------------KAMK 280 (346)
T ss_dssp CCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------HHHH
T ss_pred cCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----------------HHHH
Confidence 644322 245689999999999999999999999999999999999999999764321 1111
Q ss_pred hhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.... ....+..+++++.+||.+||..||++|||+.|+++
T Consensus 281 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 281 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 12334577889999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=444.89 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=213.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||+||+|+... +|+.||||++.... ....+.+.+|+++|+.|+|||||+++++|.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 102 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 102 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 469999999999999999997654 58999999997532 234567889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+.+|||||||+||+|.++|.+.+. +++..+..++.||+.||+|||+ +||+||||||+||||+.+|.+||+|||+
T Consensus 103 ~~~~~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~--~~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 103 DDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 99999999999999999999987654 9999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+............+++||+.|||||++.+..|+.++|||||||++|+|++|..||.+.... ..
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----------------~~ 242 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG----------------LI 242 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 99775544444456789999999999999999999999999999999999999999765321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..++.... ..++..+++++.+||.+||..||.+|||+.|++.
T Consensus 243 ~~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 243 FAKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11222222 2355677889999999999999999999998754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-60 Score=443.07 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=217.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++++.+.||+|+||+||+|.+... ....+++.||||+++.... ...++|.+|+.+|++|+|||||+++|+|.+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3567889999999999999987532 2234578999999975432 3457899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
+..+||||||++|+|.++|.... ...+++..++.++.||+.||+|||+. +||||||||+||||+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVLVY 179 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceEEC
Confidence 99999999999999999996542 13589999999999999999999964 799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~ 305 (421)
+++.+||+|||+++..............+||+.|||||++.++.|+.++|||||||+||||+| |..||.+...
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999987544433333455789999999999999999999999999999999998 8999976432
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
..+...+........+..++.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 254 -----------~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 -----------QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----------HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122233333444456778899999999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=454.14 Aligned_cols=248 Identities=24% Similarity=0.342 Sum_probs=212.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 579999999999999999997654 58999999998776666677899999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.+|||||||+||+|.+++... .+++..+..++.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+.
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~--~~IiHRDiKp~NILl~~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSTTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEEEecCccceE
Confidence 999999999999999999654 38999999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
+..... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+..... ...
T Consensus 297 ~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----------------~~~ 357 (423)
T 4fie_A 297 VSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----------------AMK 357 (423)
T ss_dssp CCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----------------HHH
T ss_pred CCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----------------HHH
Confidence 644322 2456899999999999999999999999999999999999999997643211 111
Q ss_pred hhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.... .......++.++.+||.+||..||.+|||+.|+++
T Consensus 358 ~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 358 MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 12234567889999999999999999999999876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-59 Score=433.66 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=206.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.++ ..||||+++.... ...+.|.+|+.+|++++|||||++++++.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 357889999999999999999753 2489999875432 33467899999999999999999999875
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.+.++||||||+||+|.++|.... ..+++..++.++.||+.||+|||+ .+||||||||+||||++++.+||+|||+
T Consensus 103 -~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~--~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 103 -KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp -SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred -CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCccCHHHEEECCCCcEEEeeccC
Confidence 467899999999999999997543 459999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|+..............+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+....
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------------- 243 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------------- 243 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---------------
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---------------
Confidence 987654433334456789999999999864 45899999999999999999999999764321
Q ss_pred hhhHhHhhhccc----CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 316 KRKLFRIMDTKL----GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 316 ~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+.... ....+..++.++.+||.+||+.||++|||+.+|++.|+.++.+
T Consensus 244 -~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 244 -DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -HHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -HHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11111111111 1234457788999999999999999999999999999988654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-59 Score=439.19 Aligned_cols=253 Identities=26% Similarity=0.291 Sum_probs=208.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.|++.+.||+|+||+||+|++.. +|+.||||+++.+... .+|+.+|+.|+|||||++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 468888999999999999997654 5899999999865432 37999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeeccCcc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFGLAK 240 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg~a~ 240 (421)
.+|||||||+||+|.++|.+.+. +++..+..++.||+.||+||| .+|||||||||+||||+.+| .+||+|||+|+
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred EEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence 99999999999999999987654 999999999999999999999 45799999999999999988 59999999998
Q ss_pred cCCCCCCc---ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 241 AGPTGDRT---HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 241 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
........ .....++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.......
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------------- 265 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------------- 265 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH--------------
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--------------
Confidence 76543221 1223468999999999999999999999999999999999999999765432111
Q ss_pred hHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 318 KLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
..+..... ....+..+++++.+||.+||+.||.+|||+.|+++.|....
T Consensus 266 --~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 266 --LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp --HHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11111110 01245677889999999999999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-58 Score=428.18 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=200.2
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe--
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-- 159 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 159 (421)
|++.+.||+|+||+||+|.+.. ++..||+|++..... ...+.+.+|+++|+.|+|||||+++++|..
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 4777889999999999997654 588999999975432 234568899999999999999999999875
Q ss_pred --CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeec
Q 014623 160 --GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDF 236 (421)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Df 236 (421)
.+.+|||||||+||+|.+++.+.. .+++..+..++.||+.||+|||+.+.+||||||||+||||+. +|.+||+||
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 346899999999999999998765 489999999999999999999965444999999999999974 799999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+|+..... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+....
T Consensus 177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---------------- 235 (290)
T 3fpq_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---------------- 235 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----------------
T ss_pred cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----------------
Confidence 999864332 2346799999999998865 6999999999999999999999999754321
Q ss_pred hhHhHhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+...+... .....+...++++.+||.+||..||++|||+.|+++
T Consensus 236 ~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 236 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111 111223345678999999999999999999999985
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-58 Score=422.72 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=194.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||+||+|.+. .+|+.||||++..... .....+.+|+++|+.++|||||++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~---------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT---------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT---------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC---------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 57999999999999999999654 3689999999975433 23467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..||||||| +|+|.+++.+++ .+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~IiHRDiKP~NILl~~~~~vkl~DFGl 158 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR--HKIVHRDLKPENLLLDEHLNVKIADFGL 158 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCChHHeEECCCCCEEEeecCC
Confidence 999999999999 789999997765 49999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
|+...... ...+.+||+.|||||++.+..| +.++|||||||++|+|++|+.||.+....
T Consensus 159 a~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----------------- 218 (275)
T 3hyh_A 159 SNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----------------- 218 (275)
T ss_dssp C------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------
T ss_pred CeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-----------------
Confidence 98754332 2345789999999999998886 57999999999999999999999764321
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.+.+... ...++..+++++.+||.+||+.||++|||+.|+++
T Consensus 219 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 219 VLFKNISNG-VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHT-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111 12345667889999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=439.71 Aligned_cols=276 Identities=27% Similarity=0.372 Sum_probs=228.1
Q ss_pred cCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCC-CC
Q 014623 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHH-PN 149 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-p~ 149 (421)
+...+++...++|++++.||+|+||+||+|.+... .....++.||||.+...... ..+.+.+|+++|.+++| ||
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpn 129 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCc
Confidence 34455555668899999999999999999987653 22345678999999765433 34578999999999965 89
Q ss_pred ccceeeEEEeC-CeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCcee
Q 014623 150 LVKLIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214 (421)
Q Consensus 150 iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 214 (421)
||+++++|.+. +.++||||||++|+|.++|.+.. ...+++..++.++.||+.||+|||+. +||
T Consensus 130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--~ii 207 (353)
T 4ase_A 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCI 207 (353)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--TCC
T ss_pred EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--Cee
Confidence 99999998764 56899999999999999997532 23488999999999999999999964 799
Q ss_pred eccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCc
Q 014623 215 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 293 (421)
Q Consensus 215 HrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 293 (421)
||||||+||||+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..|
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 999999999999999999999999997655544444556789999999999999999999999999999999998 9999
Q ss_pred cCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
|.+... ...+...+....+...|..+++++.+||.+||+.||.+|||+.+|++.|+++..
T Consensus 288 f~~~~~----------------~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 288 YPGVKI----------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp STTCCC----------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCH----------------HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 976432 112233344444556677888999999999999999999999999999988753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=430.81 Aligned_cols=246 Identities=28% Similarity=0.344 Sum_probs=200.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|+... ...+++.||||+++..... ...++.+|+++|+.|+|||||++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKIS------GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECS------STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEcc------CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 579999999999999999997642 2335889999999754322 23467889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+.+|||||||+||+|.++|.+.+. +++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~--~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999999987654 8999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.... ...
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~ 235 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----------------ETM 235 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHH
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----------------HHH
Confidence 86543221 234578999999999999999999999999999999999999999865321 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
..+.... ...+..+++++.+||.+||+.||++|||+
T Consensus 236 ~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 236 TMILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1222222 24566788999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=416.26 Aligned_cols=270 Identities=24% Similarity=0.349 Sum_probs=202.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHH--HHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL--TEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||+||+|.+. |+.||||+++... .+.+. .|+..+..++|||||++++++.
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~ 67 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 356889999999999999999763 6789999997542 23333 4566667889999999999998
Q ss_pred eCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCCCcEEeCCC
Q 014623 159 EGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 159 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~ 228 (421)
+.+ .+|||||||++|+|.++|... .+++..+..++.|++.||+|||+. ..+||||||||+||||+.+
T Consensus 68 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~ 144 (303)
T 3hmm_A 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred ecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC
Confidence 654 579999999999999999764 389999999999999999999964 2379999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCc--ceeeccccccceecccccccC------CCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 229 FNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
+.+||+|||+++........ ......+||+.|||||++.+. .|+.++|||||||+||||+||..||......
T Consensus 145 ~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 99999999999865433321 122346899999999998764 3678999999999999999999887543321
Q ss_pred chhhhhhhhhhhhhchhhHhH-hhhcccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 301 IEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
... ..... +.......+.. ......+...+ ..++..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 225 ~~p-~~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 225 QLP-YYDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCT-TTTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccc-chhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 100 00000 00001111111 12223333333 2567789999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-56 Score=413.54 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=188.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++++.||+|+||+||+|.+.. +|+.||||+++.... ...+.+.+|+++|+.|+|||||++++++.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 358999999999999999997654 588999999975433 2345788999999999999999999998765
Q ss_pred C------------eEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 161 E------------NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 161 ~------------~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
+ .+|||||||.||+|.+++..... ....+..++.++.||+.||+|||+ +||+||||||+||||+.
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~--~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECT
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--CcCccccCcHHHeEECC
Confidence 4 36899999999999999976543 235667788999999999999995 47999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCCcc----------eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCC
Q 014623 228 EFNAKLSDFGLAKAGPTGDRTH----------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
+|.+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9999999999998765432211 1234689999999999999999999999999999999996 77542
Q ss_pred cccchhhhhhhhhhhhhchhhHhHhhhcccCCCCC---HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYP---QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ...+.... ...++ ...++.+.+||.+||+.||.+|||+.|+++
T Consensus 231 ~~~---------------~~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 MER---------------VRTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH---------------HHHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cHH---------------HHHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 110 00011111 11222 244566789999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=413.42 Aligned_cols=267 Identities=23% Similarity=0.295 Sum_probs=203.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|++.. +|+.||||+++.... ...+.+++|+++|+.|+|||||++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 4689999999999999999997654 589999999975432 23356889999999999999999999876
Q ss_pred e------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 E------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
. .+.+|||||||. |+|.+++.+.. .+++..+..++.||+.||.|||+ +|||||||||+|||++.+|.+|
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHS--AQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTCCEE
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CcCcCCCcCccccccCCCCCEE
Confidence 4 357899999995 68999997654 59999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCC--CcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhh
Q 014623 233 LSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW 308 (421)
Q Consensus 233 l~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~ 308 (421)
|+|||+|+.+.... ......+.+||+.|+|||++.+. .|+.++||||||||+|||++|+.||.+........ +...
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999998754322 12233467999999999998875 46999999999999999999999998764321111 1110
Q ss_pred h-hhhhhch-----hhHhHhhhcccCCCC-------CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 309 A-KPYLSDK-----RKLFRIMDTKLGGQY-------PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 309 ~-~~~~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .+..... ......+. .+.... .+.++.++.+||.+||..||.+|||+.|+++
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0000000 00000000 010010 1245678999999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=406.19 Aligned_cols=269 Identities=24% Similarity=0.288 Sum_probs=202.6
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
...++|++.+.||+|+||+||+|..+. +..+++.||||.+.... ...++.+|+++|+.+ +|||||+++++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQL------QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEB------TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcc------cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 456789999999999999999997652 22357899999987653 345678999999988 699999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEEEeec
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDF 236 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~kl~Df 236 (421)
.+.+..|||||||+||+|.+++. .+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+||
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~--~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ--FGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999999999983 38899999999999999999995 479999999999999876 79999999
Q ss_pred cCcccCCCCCCc--------------------------ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHh
Q 014623 237 GLAKAGPTGDRT--------------------------HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLS 289 (421)
Q Consensus 237 g~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~t 289 (421)
|+|+........ ......+||+.|+|||++.+. .|+.++||||||||+|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999764432110 112346899999999999876 58999999999999999999
Q ss_pred CCCccCCCcccchhh--hhhhh-hhh-------------------hhchhhHhHhhh---------------cccCCCCC
Q 014623 290 GRCAVDKTKVGIEQS--LVDWA-KPY-------------------LSDKRKLFRIMD---------------TKLGGQYP 332 (421)
Q Consensus 290 g~~pf~~~~~~~~~~--~~~~~-~~~-------------------~~~~~~~~~~~~---------------~~~~~~~~ 332 (421)
|+.||.......... +.... .+. ..+.....+.+. ........
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 999996544322110 00000 000 000000000000 00001112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 333 QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 333 ~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+++++.+||.+||..||.+|+|+.|+++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 345778999999999999999999999885
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=422.97 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=204.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHH---HHHHHHhcCCCCCccceee
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWL---TEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hp~iv~~~~ 155 (421)
++|+++++||+|+||+||+|+... +|+.||||++.+... .....+. .++.+++.++|||||++++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 579999999999999999997654 689999999964321 1222233 3467778889999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
+|.+.+.+|||||||.||+|.++|.+.+. +++..+..++.||+.||.||| ..|||||||||+||||+.+|.+||+|
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEecc
Confidence 99999999999999999999999987654 899999999999999999999 55899999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
||+|+...... ..+.+||+.|||||++.+ ..|+.++||||||||||||++|..||.+.......
T Consensus 336 FGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~----------- 400 (689)
T 3v5w_A 336 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------- 400 (689)
T ss_dssp CTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-----------
T ss_pred cceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----------
Confidence 99998764432 345799999999999975 57999999999999999999999999754321111
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
.+...+ ......++..++.++.+||.+||..||.+|++ +.||++
T Consensus 401 ---~i~~~i-~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 401 ---EIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---HHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---HHHHhh-cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111 11123456678899999999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=425.10 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=212.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++++.||+|+||+||+|.+.. +|+.||+|++........+.+.+|+++|+.|+|||||+++++|.+.
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3689999999999999999997654 6899999999876655667788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC--CcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~Dfg~ 238 (421)
+.+|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~--~~iiHRDlKp~Nill~~~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCChhhccccCCCCCCEEEeeccc
Confidence 99999999999999999996443 348999999999999999999995 479999999999999754 8999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+...... .....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.... ..
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----------------~~ 364 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------------ET 364 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HH
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HH
Confidence 99865433 234578999999999999999999999999999999999999999765321 11
Q ss_pred HhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+..+.... ........++.++.+||.+||..||.+|||+.|+++
T Consensus 365 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 365 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111 111223457889999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=387.92 Aligned_cols=267 Identities=25% Similarity=0.416 Sum_probs=219.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||.||+|.+..... ....++..||||+++.... ...+.+.+|+.+|+.+ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 3679999999999999999998753211 2234567899999976533 2345688999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
..+..|+||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchhhEE
Confidence 99999999999999999999976542 347899999999999999999995 47999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---- 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999986654333222334567889999999999999999999999999999999 9999976432
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
..+...+........+..++.++.+||.+||..||.+||++.++++.|+++.
T Consensus 312 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -------------GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122223333344456677889999999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=379.03 Aligned_cols=278 Identities=42% Similarity=0.694 Sum_probs=227.0
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
...++|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34578999999999999999999743 37899999988776666678899999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999986543 2358999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++................||+.|+|||++.+..++.++|||||||++|+|++|+.||.............|..... ..
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-cc
Confidence 99986543333333344679999999999999999999999999999999999999997654433222222221111 11
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........+...+..+.+++.+||..||++|||+.++++.|+.+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11222233344445678899999999999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=369.52 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=211.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 4689999999999999999996543 5889999999766666677889999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999999765 38999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------------~~ 226 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----------------LY 226 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------HH
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HH
Confidence 7544332 23456799999999999999999999999999999999999999976432110 01
Q ss_pred Hhh-hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 321 RIM-DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 321 ~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ........+..++..+.+||.+||..||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 227 LIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 111122345667888999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=374.64 Aligned_cols=291 Identities=44% Similarity=0.754 Sum_probs=231.5
Q ss_pred cCCCcccCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhc
Q 014623 66 SSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQ 144 (421)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~ 144 (421)
......+++.++....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+++++.
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~ 83 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISM 83 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGT
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHh
Confidence 344567888999999999999999999999999999532 3788999999765332 22368899999999
Q ss_pred CCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhC-CCceeeccCCCC
Q 014623 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--QPLSWAVRMKVAIGAAKGLTFLHDA-ESQVIYRDFKAS 221 (421)
Q Consensus 145 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~~ivHrDlkp~ 221 (421)
++||||+++++++...+..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+. ..||+||||||+
T Consensus 84 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp CCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred ccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 9999999999999999999999999999999999976532 3489999999999999999999953 127999999999
Q ss_pred cEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc-
Q 014623 222 NILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG- 300 (421)
Q Consensus 222 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~- 300 (421)
|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999987644332 2334466999999999999999999999999999999999999999632111
Q ss_pred -chhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 301 -IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 301 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.......+...... ................+...+..+.+++.+||..||.+|||+.+|++.|+...
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 243 DDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred ccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 11112222222111 11222333344445667888999999999999999999999999999998743
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=371.37 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=213.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||+||+|.+.. +++.||+|.+........+.+.+|+++++.++||||+++++++.+++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 579999999999999999997654 57899999987665566678899999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 157 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS--MNIIHRDLNSHNCLVRENKNVVVADFGLARL 157 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCcCeEEECCCCCEEEeeccccee
Confidence 9999999999999999997643 458999999999999999999995 4799999999999999999999999999986
Q ss_pred CCCCCCcc------------eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 242 GPTGDRTH------------VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 242 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----- 232 (310)
T 3s95_A 158 MVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----- 232 (310)
T ss_dssp CC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----
T ss_pred cccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----
Confidence 54332211 0114679999999999999999999999999999999999999986543211110
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.......... ..+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 233 ------~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 233 ------GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0001111111 1234556788999999999999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=371.33 Aligned_cols=273 Identities=24% Similarity=0.318 Sum_probs=208.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+. ++.||||++.... .......+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 368999999999999999999753 5789999997543 2223456789999999999999999999875
Q ss_pred C----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CCceeeccCCCCcEEeCCC
Q 014623 161 E----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA--------ESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 161 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--------~~~ivHrDlkp~Nill~~~ 228 (421)
. ..++||||+++|+|.+++.... +++..++.++.|++.||.|||+. ..||+||||||+|||++.+
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 4 4799999999999999996643 89999999999999999999943 1189999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-----CCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
+.+||+|||+++..............+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......
T Consensus 168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 247 (322)
T 3soc_A 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247 (322)
T ss_dssp CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence 99999999999765544333233446799999999999873 4667899999999999999999999765432211
Q ss_pred hhhhhhhhhhhchhhHhHh-hhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 304 SLVDWAKPYLSDKRKLFRI-MDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
......... .....+... ......... ....+.++.+||.+||+.||.+|||+.++++.|+++..
T Consensus 248 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 248 PFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp TTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111110000 011111111 111111111 13567789999999999999999999999999998864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=371.41 Aligned_cols=265 Identities=27% Similarity=0.447 Sum_probs=215.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... ...+..||||+++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVP------GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCT------TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecC------CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 35799999999999999999987532 12356799999976532 334578899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 999999999999999999996543 358999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~ 261 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------------R 261 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------H
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------H
Confidence 876543221 12223446788999999999999999999999999999999 9999975432 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
.+...+........+..++..+.+||.+||..||.+||++.+|++.|+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 262 DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 122223333344455677889999999999999999999999999999986543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=371.49 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=208.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3579999999999999999997643 588999999975432 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+++++|.+++..... +++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQ--KRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 99999999999999999999977654 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCC-ccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.....
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------------- 221 (328)
T 3fe3_A 161 SNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---------------- 221 (328)
T ss_dssp CGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred ceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 98654432 23457899999999999988875 79999999999999999999998653211
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+.... ...+..++.++.+||.+||..||.+|||+.++++
T Consensus 222 ~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 222 LRERVLRGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111111 2344567788999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=368.43 Aligned_cols=259 Identities=29% Similarity=0.458 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+. |..||||++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 468999999999999999999653 678999999765433 2356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCc--eeeccCCCCcEEeCCCCcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQ--VIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~--ivHrDlkp~Nill~~~~~~kl~D 235 (421)
..+..++||||+.+++|.+++.+... ..+++..++.++.|++.||+|||+ .| |+||||||+|||++.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN--RNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT--SSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCEECCCCChhhEEEeCCCcEEECC
Confidence 99999999999999999999975432 238899999999999999999995 46 99999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 183 fg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--------------- 245 (309)
T 3p86_A 183 FGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--------------- 245 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---------------
T ss_pred CCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------
Confidence 99997643322 1233467999999999999999999999999999999999999999764321
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...............+..++..+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 246 -QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111112233345667788999999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=368.52 Aligned_cols=249 Identities=28% Similarity=0.359 Sum_probs=208.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||+|+++... ......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~ 75 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence 579999999999999999997653 58899999997532 234466889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+
T Consensus 76 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 76 THDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999997664 38999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..
T Consensus 152 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~ 213 (337)
T 1o6l_A 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------------RL 213 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred hhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----------------HH
Confidence 986433221 234578999999999999999999999999999999999999999764321 00
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~ 363 (421)
...+... ...++..++.++.+||.+||..||.+|| ++.++++.
T Consensus 214 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 214 FELILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1111111 1234567788999999999999999999 89998763
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=377.09 Aligned_cols=275 Identities=28% Similarity=0.383 Sum_probs=223.1
Q ss_pred cCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCC
Q 014623 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPN 149 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~ 149 (421)
+....+....++|++.+.||+|+||.||+|.+... .+..+++.||||++...... ..+.+.+|++++..+ +|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn 87 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence 34455556678999999999999999999986532 23446789999999765332 335688999999999 7999
Q ss_pred ccceeeEEEeCCe-EEEEEEcCCCCChHHHHhhcCC--------------------------------------------
Q 014623 150 LVKLIGYCLEGEN-RLLVYEFMPKGSLENHLFRRGP-------------------------------------------- 184 (421)
Q Consensus 150 iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------- 184 (421)
|+++++++.+.+. .++||||+.+|+|.+++.....
T Consensus 88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9999999887554 8999999999999999976532
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 185 --------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 185 --------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence 128889999999999999999995 4799999999999999999999999999987654
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
...........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.... ......+
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------~~~~~~~ 309 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----------------EEFCRRL 309 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----------------HHHHHHH
T ss_pred cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----------------HHHHHHH
Confidence 444334455678999999999999999999999999999999998 99999764321 1122222
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
........+..++.++.++|.+||..||.+|||+.++++.|+++.
T Consensus 310 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 233333455667789999999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=370.44 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=205.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 589999999999999999997654 578999999865433 2235678999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLAT 153 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEEeCCCCEEEEEeeccc
Confidence 99999999999999999986543 48999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... .
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---------------~ 218 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------Y 218 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH---------------H
T ss_pred eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH---------------H
Confidence 6543333333345789999999999988775 77899999999999999999999765321110 1
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...............++..+.+||.+||..||.+|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 219 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111111112234567888999999999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=378.75 Aligned_cols=267 Identities=27% Similarity=0.396 Sum_probs=215.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... .+..+++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 35799999999999999999986542 1334678999999975432 334568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC---cE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NA 231 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~ 231 (421)
....++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++ .+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEEecCCCCceE
Confidence 9999999999999999999976532 348999999999999999999995 4799999999999998555 49
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------- 292 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 292 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 9999999975322222222334668999999999999999999999999999999998 9999976432
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+........+..++..+.+||.+||+.||.+||++.+|++.|+.+...
T Consensus 293 ------~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 293 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 122233333333344566788899999999999999999999999999987543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=378.94 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=214.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||.++.... .....+.+|+++|+.++||||+++++++..
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 4678999999999999999997754 478999999875432 223457899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 999999999999999999997643 348899999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...............++..|+|||++.++.++.++|||||||++|||++ |..||..... ..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----------------~~ 323 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----------------QQ 323 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----------------HH
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 86543221111122345788999999999999999999999999999998 9999976432 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
....+........+..++..+.+||.+||..||.+|||+.+|++.|+++.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 22233333344556677889999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=374.57 Aligned_cols=269 Identities=27% Similarity=0.408 Sum_probs=222.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+..... .....+..||||++..... .....+.+|+++++.+ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3689999999999999999998754321 1223467899999976533 2336688999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
..+..++||||+.+|+|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCcceEE
Confidence 99999999999999999999976542 358999999999999999999995 47999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654433333344567899999999999999999999999999999999 9999976432
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
..+...+........+..++.++.+||.+||..||.+||++.+|++.|+++...
T Consensus 300 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 122233333334445567788999999999999999999999999999988643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=361.68 Aligned_cols=261 Identities=24% Similarity=0.333 Sum_probs=208.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 4689999999999999999997543 5789999998654332 235688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..++||||++|++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD--MRIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999999997765 48999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 157 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--------------- 220 (294)
T 4eqm_A 157 IAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--------------- 220 (294)
T ss_dssp SSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH---------------
T ss_pred Cccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---------------
Confidence 9987543322 123346799999999999999999999999999999999999999976532110
Q ss_pred hHhHhhhccc---CCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhcCCC
Q 014623 318 KLFRIMDTKL---GGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEAPK 371 (421)
Q Consensus 318 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~~~~~ 371 (421)
....+.... .......++..+.++|.+||..||.+|| ++.++++.|+.+....
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 221 -AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -HHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -HHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 001111100 0012245678899999999999999999 8999999998875543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=370.68 Aligned_cols=250 Identities=26% Similarity=0.334 Sum_probs=206.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.... +|+.||+|++...... ..+.+.+|+.+|+.++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence 4689999999999999999997654 5889999999764332 346788999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----c
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----N 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~ 230 (421)
+++.+.+..++||||+.||+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~~~ 157 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPH 157 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEeCCCCCccC
Confidence 99999999999999999999999996554 48999999999999999999995 4799999999999998877 7
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.....
T Consensus 158 vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--------- 225 (361)
T 2yab_A 158 IKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 225 (361)
T ss_dssp EEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------
T ss_pred EEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---------
Confidence 9999999998765432 2234679999999999999999999999999999999999999997643211
Q ss_pred hhhhchhhHhHhhhcccC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+...... ......++..+.+||.+||..||.+|||+.++++
T Consensus 226 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 226 -------TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111110 0011345678999999999999999999999985
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=364.60 Aligned_cols=280 Identities=26% Similarity=0.379 Sum_probs=216.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||+||+|.+.. .+..+++.||||++........+.+.+|+++++.++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3689999999999999999997643 23446899999999876655567789999999999999999999998653
Q ss_pred --CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 --ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 56899999999999999997653 348999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+......... .......++..|+|||++.+..++.++|||||||++|+|++|..||................ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMIVF 239 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCC-THHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccc-cchhHH
Confidence 9875433221 12223457888999999999999999999999999999999999986542211110000000 000111
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.....+........+..++.++.+||.+||..||.+|||+.++++.|+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2223333444445567788999999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=364.73 Aligned_cols=266 Identities=30% Similarity=0.413 Sum_probs=219.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... ....++..||||++..... ...+.+.+|+++++.++||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 46899999999999999999976432 1123468899999976432 334668899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeecc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 217 (421)
.+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .||+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~d 175 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRD 175 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH--TTEECCC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH--CCCcccc
Confidence 9999999999999999999976532 348899999999999999999995 4799999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDK 296 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~ 296 (421)
|||+|||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987654433323334567889999999999999999999999999999999 9999976
Q ss_pred CcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.... .+...+........+..++..+.+||.+||..||.+||++.++++.|+++..
T Consensus 256 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 256 IPPE-----------------RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCGG-----------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHH-----------------HHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4321 1222223333334556778899999999999999999999999999998743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=371.64 Aligned_cols=249 Identities=29% Similarity=0.405 Sum_probs=203.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 156 (421)
.++|++.+.||+|+||.||+|.... +++.||||+++... ......+.+|..+++.+ +||||++++++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 4689999999999999999997654 58899999997532 23345678899999988 69999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+.+..|+||||+.||+|.+++.+... +++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+||
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NILl~~~g~ikL~DF 168 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADF 168 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCCcccCCCHHHEEECCCCCEEEccc
Confidence 9999999999999999999999977644 8999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||......
T Consensus 169 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------------- 230 (353)
T 3txo_A 169 GMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---------------- 230 (353)
T ss_dssp TTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred cceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----------------
Confidence 9998643322 2234578999999999999999999999999999999999999999765321
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM------SEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~ 362 (421)
.....+.... ..++..++..+.+||.+||..||.+||++ .+++.
T Consensus 231 ~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 DLFEAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111222221 23455678889999999999999999998 67764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=369.30 Aligned_cols=268 Identities=27% Similarity=0.402 Sum_probs=217.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+... ....+++.||||+++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 457899999999999999999987642 11234689999999865332 3456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP----------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 216 (421)
+.+..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ .||+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~--~~ivH~ 198 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHR 198 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCS
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecC
Confidence 99999999999999999999976431 458999999999999999999995 479999
Q ss_pred cCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccC
Q 014623 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD 295 (421)
Q Consensus 217 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~ 295 (421)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976433222222334568999999999999999999999999999999999 999997
Q ss_pred CCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 296 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.... ..+...+........+..++..+.+||.+||..||.+||++.++++.|+++...
T Consensus 279 ~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAH-----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCh-----------------HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 5432 111112222222334566778999999999999999999999999999997643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=366.32 Aligned_cols=267 Identities=26% Similarity=0.428 Sum_probs=199.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+.... .....||||++..... ...+.+.+|+++++.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQED------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccC------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 3468999999999999999999765421 1124799999976532 3346788999999999999999999999
Q ss_pred EeCCeE------EEEEEcCCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 158 LEGENR------LLVYEFMPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 158 ~~~~~~------~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
...... ++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAE 172 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECT
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc--CCcccCCCCcceEEEcC
Confidence 877655 99999999999999996532 2258999999999999999999995 47999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhh
Q 014623 228 EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~ 306 (421)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------ 246 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------ 246 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------
Confidence 99999999999987654433333334557889999999999999999999999999999999 99999764321
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
.....+........+..++..+.+||.+||..||.+|||+.++++.|+++....
T Consensus 247 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 247 -----------EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -----------GHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -----------HHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 112222222233445667789999999999999999999999999999986544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=372.61 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=203.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|.... +++.||+|+++..... ....+.+|..++..+ +||||+++++++
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 579999999999999999997654 5789999999754322 234577899999877 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..+|||||+.||+|.+++.+... +++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||
T Consensus 123 ~~~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 123 QTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EECCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999999977643 8999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||......... ......
T Consensus 199 la~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~--------~~~~~~ 268 (396)
T 4dc2_A 199 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTED 268 (396)
T ss_dssp TCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHH
T ss_pred eeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc--------chhhHH
Confidence 998633222 1244578999999999999999999999999999999999999999653221100 000011
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.+.+.+. .....++..++.++.+||.+||..||.+||++
T Consensus 269 ~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHh-ccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111111 11234566788899999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=367.79 Aligned_cols=263 Identities=24% Similarity=0.412 Sum_probs=210.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.... ..-...||+|.+..... .....+.+|+.+++.++||||+++++++. +
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEG-----ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTT-----CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hHceeeeeeeecCCceEEEEEEcCCC-----ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 57999999999999999999875421 11123588888864432 23345678999999999999999999875 5
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE--HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH--TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred CccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh--CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 67899999999999999996542 348888999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............|+..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~ 226 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----------------EV 226 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----------------HH
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----------------HH
Confidence 8755544444455678889999999999999999999999999999999 99999765321 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+........+..++.++.+||.+||..||.+||++.++++.|+++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 222222223334455667889999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=353.49 Aligned_cols=285 Identities=39% Similarity=0.664 Sum_probs=225.8
Q ss_pred CCcccCHHHHHHHhcCCCCC------ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC----ccCHHHHHH
Q 014623 68 NLKAFTFNELKTATRNFRPD------SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG----FQGHKEWLT 137 (421)
Q Consensus 68 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ 137 (421)
....+++.++...++.|... +.||+|+||.||+|.+. ++.||||++.... ....+.+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~ 79 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDITTEELKQQFDQ 79 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----------SCEEEEEEECCCTTSCTTTHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----------CceEEEEEEecccCcchHHHHHHHHH
Confidence 45668889999888887766 89999999999999642 6789999987532 123467889
Q ss_pred HHHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeec
Q 014623 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216 (421)
Q Consensus 138 E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 216 (421)
|+.+++.++||||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .||+||
T Consensus 80 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~ 157 (307)
T 2nru_A 80 EIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE--NHHIHR 157 (307)
T ss_dssp HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECS
T ss_pred HHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecC
Confidence 999999999999999999999999999999999999999999643 23458999999999999999999995 479999
Q ss_pred cCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCC
Q 014623 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDK 296 (421)
Q Consensus 217 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 296 (421)
||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999987654333333345679999999998764 588999999999999999999999976
Q ss_pred CcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....... ..+..........+...+... ....+...+..+.+++.+||..||.+||++.++++.|+++.+
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 237 HREPQLL--LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TBSSSBT--THHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred CcchHHH--HHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 5432111 111110011111122222222 234567888999999999999999999999999999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=371.43 Aligned_cols=264 Identities=27% Similarity=0.459 Sum_probs=204.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|.+.+.||+|+||.||+|.+.. ...++..||||.++.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKL------PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBC------TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhceeeeEEeeCCCeEEEEEEEec------CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 579999999999999999997542 123467899999976532 2345788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.+.. ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999997543 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----------------~~ 258 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----------------QD 258 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----------------HH
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 764432111 1112345778999999999999999999999999999998 9999975432 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
+...+........+..++..+.+||.+||..||.+||++.+|++.|+++....
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 22222333333445567789999999999999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=361.99 Aligned_cols=267 Identities=28% Similarity=0.429 Sum_probs=220.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+... .+..+++.||||++..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 46899999999999999999976431 2334678999999986543 2346788999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP----------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 222 (421)
..+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccce
Confidence 99999999999999999999976542 248999999999999999999995 479999999999
Q ss_pred EEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccc
Q 014623 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGI 301 (421)
Q Consensus 223 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~ 301 (421)
||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-
Confidence 9999999999999999987665444333445667889999999999999999999999999999999 99999765321
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
......+........+..++..+.+||.+||..||.+|||+.++++.|+++..
T Consensus 255 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 ---------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ---------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 11122222233334455677899999999999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=367.92 Aligned_cols=270 Identities=27% Similarity=0.384 Sum_probs=218.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+... ....++..||||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 346899999999999999999986431 1233577899999975432 3346788999999999 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeec
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGP---------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 216 (421)
...+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ .||+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCcccC
Confidence 999999999999999999999976532 237899999999999999999995 479999
Q ss_pred cCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccC
Q 014623 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVD 295 (421)
Q Consensus 217 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~ 295 (421)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986654433333445668899999999999999999999999999999998 999997
Q ss_pred CCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 296 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
..... ......+........+..++..+.+||.+||..||.+||++.++++.|+.+....
T Consensus 277 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 277 GIPVD----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TCCCS----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cCCcH----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 65321 1122233333344455667889999999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=360.81 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 76 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence 579999999999999999997654 58899999987532 134456788999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||+.||+|.+++.+.. .+++..+..++.||+.||.||| ..||+||||||+|||++.+|.+||+|||+
T Consensus 77 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 77 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGF 152 (318)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecCc
Confidence 9999999999999999999997654 3899999999999999999999 55899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 153 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~ 211 (318)
T 1fot_A 153 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KT 211 (318)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HH
T ss_pred ceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 9865432 23478999999999999999999999999999999999999999764321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
...++... ..++..++.++.+||.+||..||.+|| ++.++++
T Consensus 212 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 212 YEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11222222 234566788999999999999999999 8888875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=354.41 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=214.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhhceeeheecCCCccEEEEEEecC----------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3579999999999999999997653 5679999998654 3446789999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred CceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEEcCCCCEEeccccccc
Confidence 99999999999999999996543 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 155 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----------------~~~ 216 (269)
T 4hcu_A 155 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEV 216 (269)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHH
T ss_pred ccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----------------HHH
Confidence 6543221 11223456788999999999999999999999999999999 9999976432 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
...+........+...+..+.+++.+||..||.+||++.++++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 217 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 22222223334455667889999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=358.12 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=214.1
Q ss_pred ccCHHHHHHHhcC----------CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHH
Q 014623 71 AFTFNELKTATRN----------FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140 (421)
Q Consensus 71 ~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~ 140 (421)
.+++.+++...+. |...+.||+|+||.||+|.+.. +|+.||||++........+.+.+|+.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~ 94 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVV 94 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHH
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHH
Confidence 3566666655543 6777899999999999997653 48899999998776666778899999
Q ss_pred HHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCC
Q 014623 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 220 (421)
Q Consensus 141 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp 220 (421)
+++.++||||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+ .||+||||||
T Consensus 95 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp 169 (321)
T 2c30_A 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA--QGVIHRDIKS 169 (321)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSG
T ss_pred HHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCH
Confidence 999999999999999999999999999999999999998543 48999999999999999999995 4799999999
Q ss_pred CcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 221 SNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 221 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
+|||++.++.+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 170 ~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 170 DSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp GGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred HHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999987543321 233567999999999999999999999999999999999999999754321
Q ss_pred chhhhhhhhhhhhhchhhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 301 IEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
. ....+..... .......++..+.+||.+||..||.+|||+.++++.
T Consensus 248 ~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 Q----------------AMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H----------------HHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H----------------HHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0001111100 111234567789999999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=365.02 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=209.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||+||+|.+.... ..-...||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCC-----ceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 57999999999999999999875421 1113357889886433 24456789999999999999999999998875
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
. .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCChheEEECCCCCEEEccCccee
Confidence 4 789999999999999997654 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............||..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------------~~~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEI 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------------GGH
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----------------HHH
Confidence 6554443333344567889999999999999999999999999999999 9999976432 122
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+........+..++..+.+++.+||..||.+||++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 233333334445566788999999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=377.30 Aligned_cols=252 Identities=28% Similarity=0.450 Sum_probs=213.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 467889999999999999999763 5689999998654 456789999999999999999999998776
Q ss_pred C-eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 E-NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+ ..++||||+.+|+|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 5 78999999999999999987766568999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----------------~ 394 (450)
T 1k9a_A 337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------D 394 (450)
T ss_dssp EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----------------T
T ss_pred cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 854322 122357889999999999999999999999999999998 99999764321 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
+...+....+...+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 395 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 395 VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 222233334445667788999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=352.11 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=213.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4689999999999999999997653 56799999976543 446788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred CceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCcCcceEEECCCCCEEEccCccce
Confidence 99999999999999999997653 348999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~ 214 (268)
T 3sxs_A 153 YVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----------------EV 214 (268)
T ss_dssp ECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----------------HH
T ss_pred ecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----------------HH
Confidence 76543322 2233456778999999999899999999999999999999 99999754321 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+........+...+..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111222222334455677899999999999999999999999999988653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=383.68 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=220.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..+|++.+.||+|+||.||+|.+.. ++..||||.++... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4578999999999999999998764 46889999997654 3467899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...+|||||+.+|+|.+++.......+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999999987666679999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+... ..+
T Consensus 367 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----------------~~~ 428 (495)
T 1opk_A 367 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQV 428 (495)
T ss_dssp CCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GGH
T ss_pred eccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 7643321 12223456789999999999999999999999999999999 9999976532 122
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+.+........+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus 429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23334444455667788999999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=360.43 Aligned_cols=251 Identities=22% Similarity=0.234 Sum_probs=207.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4689999999999999999997654 57899999997543 3345678999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC--CCcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~ 238 (421)
+..++||||++|++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 99999999999999999996543 358999999999999999999995 47999999999999987 78999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 151 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------------~ 211 (321)
T 1tki_A 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------I 211 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred CeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH----------------H
Confidence 98765433 2345679999999999999889999999999999999999999997643211 0
Q ss_pred HhHhhhcccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+........ ....++.++.+||.+||..||.+|||+.++++.
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111000 012457789999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=373.86 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=194.1
Q ss_pred cCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHH-hcCCCCCccceeeEEEe
Q 014623 82 RNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL-GQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~ 159 (421)
++|.+. +.||+|+||+||+|.+.. +++.||||++... ..+.+|+.++ +.++||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 467665 789999999999997654 5889999998632 4567888887 44589999999999875
Q ss_pred ----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEE
Q 014623 160 ----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAK 232 (421)
Q Consensus 160 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k 232 (421)
...+||||||+.||+|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||++. ++.+|
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~k 204 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILK 204 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEE
Confidence 5678999999999999999987665669999999999999999999995 47999999999999987 78899
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.........
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------- 272 (400)
T 1nxk_A 205 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------- 272 (400)
T ss_dssp ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC---------
T ss_pred EEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc---------
Confidence 99999998654322 234578999999999999999999999999999999999999999764321100
Q ss_pred hhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
......+..... .......++.++.+||.+||..||.+|||+.++++..
T Consensus 273 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 273 ---PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp ---CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ---HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000011111111 1111245778899999999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=373.77 Aligned_cols=252 Identities=23% Similarity=0.266 Sum_probs=207.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.... +|+.+|+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 45689999999999999999996543 5889999999765432 335688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC---CCCcEEEe
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLS 234 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~ 234 (421)
.+.+..++||||+.||+|.+++..... +++..+..++.||+.||.|||+ .||+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~--~givHrDlKp~NIll~~~~~~~~vkL~ 155 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLA 155 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEeccCCCCcEEEc
Confidence 999999999999999999999977643 8999999999999999999995 4799999999999998 56789999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....
T Consensus 156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------------- 220 (444)
T 3soa_A 156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------------- 220 (444)
T ss_dssp CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------------
T ss_pred cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------------
Confidence 9999987654332 2234789999999999999999999999999999999999999997643211
Q ss_pred chhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+..... .......++.++.+||.+||..||.+|||+.++++
T Consensus 221 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 221 ---LYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---HHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111111 11122456789999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.30 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=221.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+.+|+++++.++||||+++++++.+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 45689999999999999999998765 47889999997543 345678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH--TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC--CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 99999999999999999999887767799999999999999999999954 7999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----------------~~ 220 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------------SQ 220 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------------GG
T ss_pred eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 87654332 22334567889999999999999999999999999999999 9999976432 12
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....+........+..++..+.+|+.+||..||.+||++.++++.|+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 221 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 223333334445556778899999999999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=361.80 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=205.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.... +|+.||+|++...... ..+.+.+|+.+|+.++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3579999999999999999997654 5889999998754322 356788999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----c
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----N 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~ 230 (421)
+++.+....++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~ 156 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPR 156 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSSSCC
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEecCCCCCCC
Confidence 99999999999999999999999996543 48999999999999999999995 4799999999999998887 7
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------- 225 (326)
T 2y0a_A 157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------- 225 (326)
T ss_dssp EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------
T ss_pred EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--------
Confidence 99999999987643322 2346799999999999999999999999999999999999999976432110
Q ss_pred hhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+..+..... .......++..+.+||.+||..||.+|||+.++++
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 --------LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --------HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --------HHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 00011245678899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=367.51 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=206.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +++.||+|++.... ......+.+|+++|+.++||||+++++++.
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 579999999999999999997654 58899999986432 234467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||+.||+|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQN--QRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEECCCCCEEEeccce
Confidence 9999999999999999999997654 48999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+....... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||..........
T Consensus 162 a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----------- 227 (384)
T 4fr4_A 162 AAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----------- 227 (384)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-----------
T ss_pred eeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-----------
Confidence 98764332 2345789999999999864 458999999999999999999999997543211111
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~ 362 (421)
+...+. .....++..++..+.+||.+||..||.+||+ +.+++.
T Consensus 228 ---~~~~~~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 228 ---IVHTFE-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---HHHHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---HHHHHh-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111111 1122455677889999999999999999998 677664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=363.82 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 579999999999999999997654 58899999986532 134467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||+.||+|.+++.+... +++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEECCCCCEEEccccc
Confidence 99999999999999999999987653 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 188 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~ 246 (350)
T 1rdq_E 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QI 246 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----------------HH
Confidence 9875432 23468999999999999999999999999999999999999999764321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
...+.... ..++..++.++.+||.+||..||.+||+ +.+|++
T Consensus 247 ~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 247 YEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11112221 2345667889999999999999999998 788775
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=361.32 Aligned_cols=264 Identities=24% Similarity=0.401 Sum_probs=208.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.... ..-...||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTT-----CSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCC-----ceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 57999999999999999999875431 1112346888876433 34557789999999999999999999998865
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
. .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred C-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh--CCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 4 789999999999999997654 358999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............+|..|+|||++.+..++.++|||||||++|+|++ |..||...... .+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~~ 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GH
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----------------HH
Confidence 7654433333334557889999999999999999999999999999999 99999765321 12
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...+........+..++.++.+||.+||..||.+||++.++++.|+++....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 2333333344455667889999999999999999999999999999987553
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=355.22 Aligned_cols=276 Identities=20% Similarity=0.264 Sum_probs=213.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 3679999999999999999997654 578999999975432 345678899999999999999999999987
Q ss_pred CC--eEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe----CCCCcEE
Q 014623 160 GE--NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAK 232 (421)
Q Consensus 160 ~~--~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~k 232 (421)
.. ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEeccCCCCceEE
Confidence 65 78999999999999999976432 348999999999999999999995 479999999999999 7888899
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccc--------cCCCCccccchhhhHHHHHHHhCCCccCCCcccch--
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE-- 302 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-- 302 (421)
|+|||+++....... ....+||+.|+|||++. +..++.++|||||||++|+|++|..||........
T Consensus 157 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 233 (319)
T 4euu_A 157 LTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (319)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred EccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence 999999987654332 23467999999999886 57789999999999999999999999975332111
Q ss_pred hhhhhhhhhhhhc-hhhHhHh------h--hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 303 QSLVDWAKPYLSD-KRKLFRI------M--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 303 ~~~~~~~~~~~~~-~~~~~~~------~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
............. ...+... . ...........++..+.+||.+||+.||.+|||+.|+++......-.
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 1111100000000 0000000 0 00111234578899999999999999999999999999998875543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=379.55 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=215.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred chHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 34679999999999999999997653 5689999998654 45678999999999999999999999876
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+|+|.+++.......+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||++
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 6678999999999999999976543458889999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+... ..
T Consensus 332 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----------------~~ 393 (454)
T 1qcf_A 332 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------------PE 393 (454)
T ss_dssp GGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------------HH
T ss_pred eEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----------------HH
Confidence 87543211 11123446788999999999999999999999999999999 9999976432 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
+...+........+..++..+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus 394 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 394 VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 2222333334445667888999999999999999999999999999987543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=364.80 Aligned_cols=252 Identities=26% Similarity=0.293 Sum_probs=204.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-----ccCHHHHHHHHHHHhcCCCCCccceee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-----FQGHKEWLTEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~~~~ 155 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 93 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3579999999999999999997654 58899999986321 124567889999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc---
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--- 230 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--- 230 (421)
++.+.+..|+||||++|++|.+++.+. ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivHrDlkp~NIl~~~~~~~~~ 171 (351)
T 3c0i_A 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAP 171 (351)
T ss_dssp EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECSSSTTCC
T ss_pred EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCChHHeEEecCCCCCc
Confidence 999999999999999999999888653 23458999999999999999999995 47999999999999987655
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------- 241 (351)
T 3c0i_A 172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF-------- 241 (351)
T ss_dssp EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHH--------
T ss_pred EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHH--------
Confidence 99999999987654321 23446799999999999999999999999999999999999999976421110
Q ss_pred hhhhchhhHhHhhhcccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+........ ....++.++.+||.+||..||.+|||+.++++
T Consensus 242 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 ---------EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---------HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---------HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111000 01245678999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=363.33 Aligned_cols=280 Identities=27% Similarity=0.369 Sum_probs=222.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE--e
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL--E 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 159 (421)
++|++.+.||+|+||.||+|.+.. .+..+++.||||++........+.+.+|+++++.++||||+++++++. +
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 589999999999999999997543 234468999999998776566677899999999999999999999887 4
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChhhEEECCCCCEEEcccccc
Confidence 566899999999999999997643 248999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... .......||..|+|||++.+..++.++|||||||++|+|++|..||............ ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~ 252 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSR 252 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHH
Confidence 876543322 1223356888899999999999999999999999999999999998754321110000 0001111223
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
+...+........+..++..+.+||.+||..||.+|||+.++++.|+.+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 253 LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 34444455555667788899999999999999999999999999999875543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=365.35 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=207.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45689999999999999999997654 5789999999765432 335688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC---cEEEe
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLS 234 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~ 234 (421)
.+.+..++||||+.|++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++ .+||+
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~ 173 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLA 173 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEe
Confidence 99999999999999999999996654 48999999999999999999995 4799999999999997654 59999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|||++........ ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......
T Consensus 174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------- 237 (362)
T 2bdw_A 174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------------- 237 (362)
T ss_dssp CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------
T ss_pred ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------------
Confidence 9999987654322 234689999999999999999999999999999999999999997643210
Q ss_pred chhhHhHhhhcccC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 315 DKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 315 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
....+...... ......++.++.+||.+||..||.+||++.++++.
T Consensus 238 ---~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 238 ---LYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---HHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111111111 11124567889999999999999999999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=349.71 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=212.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 57999999999999999999763 57899999986543 234568899999999999999999999987
Q ss_pred C--CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 160 G--ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 160 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
. ...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+..|+||||||+|||++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence 7 78899999999999999998766556999999999999999999999543339999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCc---cccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTT---KSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||.....
T Consensus 159 ~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------------- 216 (271)
T 3kmu_A 159 VKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------------- 216 (271)
T ss_dssp SCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---------------
T ss_pred ceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---------------
Confidence 8765322 2356899999999998766554 79999999999999999999975432
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
................+..++..+.++|.+||..||.+|||+.++++.|+++..
T Consensus 217 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 217 -MEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -HHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111222333334445566778899999999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=366.96 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=208.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..........+.+|+.+|+.++||||+++++++.+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 3589999999999999999997654 5789999999866544556788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC--CCcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA--EFNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~ 238 (421)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDlkp~NIll~~~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccchHHeEEecCCCCceEEEeccc
Confidence 99999999999999999986543 358999999999999999999995 47999999999999974 57799999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----------------~ 258 (387)
T 1kob_A 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------------T 258 (387)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----------------H
T ss_pred ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 98765432 2334579999999999999999999999999999999999999997643210 0
Q ss_pred HhHhhhc--ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+..+... .........++.++.+||.+||..||.+|||+.++++.
T Consensus 259 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 259 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111111 11122234567899999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=355.81 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=198.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--------------------------CHHHH
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--------------------------GHKEW 135 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~ 135 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CHH
T ss_pred cceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHH
Confidence 589999999999999999997654 5789999998754321 12467
Q ss_pred HHHHHHHhcCCCCCccceeeEEEe--CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCce
Q 014623 136 LTEVNYLGQLHHPNLVKLIGYCLE--GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQV 213 (421)
Q Consensus 136 ~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~i 213 (421)
.+|+++++.++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.|++.||.|||+ .||
T Consensus 84 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i 158 (298)
T 2zv2_A 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY--QKI 158 (298)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH--TTE
T ss_pred HHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCe
Confidence 899999999999999999999986 5688999999999999886532 358999999999999999999995 479
Q ss_pred eeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCC---CCccccchhhhHHHHHHHhC
Q 014623 214 IYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSG 290 (421)
Q Consensus 214 vHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg 290 (421)
+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999987544322 234467999999999997765 47789999999999999999
Q ss_pred CCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 291 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 291 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..||....... ....+............++.++.+||.+||..||.+||++.++++
T Consensus 237 ~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 237 QCPFMDERIMC----------------LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCSSCCSSHHH----------------HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCccHHH----------------HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99997643210 001111111111223456788999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=356.39 Aligned_cols=275 Identities=29% Similarity=0.395 Sum_probs=217.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. .+..+++.||+|++..... .....+.+|+++++.++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 568999999999999999997543 2344689999999975432 3446788999999999999999999999876
Q ss_pred --CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 --ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc--CCcccCCCchheEEEcCCCCEEECcccc
Confidence 66899999999999999996544 348999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh--hc
Q 014623 239 AKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL--SD 315 (421)
Q Consensus 239 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~--~~ 315 (421)
+......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+...... ......+.. ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccC
Confidence 9876543321 2233456888999999999999999999999999999999999987543211 111111111 11
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
...+...+........+..++..+.+||.+||..||.+|||+.++++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22233334444455566778899999999999999999999999999998864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=362.12 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=203.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|.... +++.||+|++...... ....+.+|..+++.+ +||||+++++++
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 579999999999999999997654 5889999999765332 234577899999887 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..|+||||+.||+|.+++.+.. .+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE--RGIIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999999999997664 38999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... ......
T Consensus 156 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------~~~~~~ 225 (345)
T 3a8x_A 156 MCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--------DQNTED 225 (345)
T ss_dssp GCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHH
T ss_pred ccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc--------ccccHH
Confidence 998643222 1234578999999999999999999999999999999999999999653211000 000111
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 357 (421)
.+.+.+.. ....++..++..+.+||.+||..||.+||++
T Consensus 226 ~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 226 YLFQVILE-KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHHc-CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11111111 1223556778899999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=365.50 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=206.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIG 155 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~ 155 (421)
..++|++.+.||+|+||.||+|.+.. +|+.||||+++... ......+..|..++..+ +||||+++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 45789999999999999999997654 58899999997532 13345677899999876 8999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
++.+.+..|+||||+.||+|.+++.+... +++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~g~vkL~D 161 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIAD 161 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCChhhEEECCCCCEEEeE
Confidence 99999999999999999999999977543 8999999999999999999995 4799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 162 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------------- 225 (345)
T 1xjd_A 162 FGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------------- 225 (345)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred ChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------------
Confidence 999986433221 2345789999999999999999999999999999999999999997643210
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS-EVL 361 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell 361 (421)
....+... ...++..++.++.+||.+||..||.+||++. +++
T Consensus 226 --~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 226 --LFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --HHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --HHHHHHhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01111111 1234556788999999999999999999987 665
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=353.49 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++ .
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecC------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 46899999999999999999987532 22467899999876432 2345688999999999999999999987 4
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHEEECCCCCEEECccccc
Confidence 567899999999999999997553 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~----------------- 225 (281)
T 1mp8_A 164 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----------------- 225 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------
T ss_pred cccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----------------
Confidence 876443221 1223456789999999999999999999999999999997 999997643211
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
....+........+..++..+.++|.+||..||.+||++.++++.|+++.
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11112222223445677889999999999999999999999999998874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=350.98 Aligned_cols=255 Identities=29% Similarity=0.552 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-------HHHHHHHHHHHhcCCCCCcccee
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-------HKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
++|++.+.||+|+||.||+|.+.. +++.||+|++....... .+.+.+|+++++.++||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 579999999999999999997654 47899999986543322 15688999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc----
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---- 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---- 230 (421)
+++.+.. ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+.+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~ 166 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPV 166 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCce
Confidence 9886554 79999999999999886544 4589999999999999999999954222999999999999988776
Q ss_pred -EEEeeccCcccCCCCCCcceeeccccccceecccccc--cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 231 -AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA--TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 231 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
+||+|||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 167 ~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----- 236 (287)
T 4f0f_A 167 CAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----- 236 (287)
T ss_dssp CEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----
T ss_pred eEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----
Confidence 99999999985432 234467999999999984 45678899999999999999999999976432211
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...............+..++..+.+||.+||..||.+|||+.++++.|+++
T Consensus 237 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 ---------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ---------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ---------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111122233334455667788999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=364.45 Aligned_cols=245 Identities=26% Similarity=0.341 Sum_probs=198.7
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 166 (421)
.+.||+|+||.||+|.+.. +|+.||+|+++.......+.+.+|+++|+.++||||+++++++...+..+||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999997654 5889999999877656667889999999999999999999999999999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe--CCCCcEEEeeccCcccCCC
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--DAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--~~~~~~kl~Dfg~a~~~~~ 244 (421)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++....
T Consensus 165 ~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ--MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 99999999999886543 348999999999999999999995 479999999999999 6778899999999987654
Q ss_pred CCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhh
Q 014623 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMD 324 (421)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (421)
... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..++.
T Consensus 242 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~i~~ 302 (373)
T 2x4f_A 242 REK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE----------------TLNNILA 302 (373)
T ss_dssp TCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHHHHH
T ss_pred ccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHHh
Confidence 332 234579999999999999999999999999999999999999997653211 1111111
Q ss_pred ccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 325 TKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 325 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .......++.++.+||.+||..||.+||++.++++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 303 CRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11112356788999999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=363.40 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=207.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 156 (421)
.++|++.+.||+|+||.||+|.... +++.||||+++... ......+..|..++..+ +||||++++++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~ 89 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 89 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence 4689999999999999999997654 57899999987532 13446678899999988 79999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+.+..|+||||+.||+|.+++.+... +++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+||
T Consensus 90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~vkL~DF 165 (353)
T 2i0e_A 90 FQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADF 165 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH--CCEEeccCCHHHEEEcCCCcEEEEeC
Confidence 9999999999999999999999977643 8999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+....
T Consensus 166 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---------------- 227 (353)
T 2i0e_A 166 GMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---------------- 227 (353)
T ss_dssp TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------
T ss_pred CcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----------------
Confidence 99986432221 234578999999999999999999999999999999999999999764321
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
.....+.... ..++..++.++.+||.+||..||.+||+ +.++++
T Consensus 228 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 228 ELFQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111222221 2345677889999999999999999995 466654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=360.80 Aligned_cols=276 Identities=28% Similarity=0.380 Sum_probs=222.1
Q ss_pred cCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCC
Q 014623 72 FTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPN 149 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~ 149 (421)
+....+....++|++.+.||+|+||.||+|.+... .+..+++.||||++...... ....+.+|+.+++.+ +|||
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 92 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence 34445555668999999999999999999976532 13346789999999765432 335688999999999 6999
Q ss_pred ccceeeEEEeCC-eEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCcee
Q 014623 150 LVKLIGYCLEGE-NRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVI 214 (421)
Q Consensus 150 iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~iv 214 (421)
|+++++++...+ ..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .||+
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~ 170 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCI 170 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH--TTCC
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh--CCcc
Confidence 999999988754 58999999999999999976542 127899999999999999999995 4799
Q ss_pred eccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCc
Q 014623 215 YRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCA 293 (421)
Q Consensus 215 HrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p 293 (421)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654443333445678999999999999999999999999999999998 9999
Q ss_pred cCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 294 VDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 294 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
|...... ......+........+..++..+.++|.+||..||.+|||+.++++.|+.+..
T Consensus 251 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 251 YPGVKID----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp STTCCCS----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Ccccchh----------------HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9764321 11112222222233455667889999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=360.93 Aligned_cols=268 Identities=25% Similarity=0.418 Sum_probs=217.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+..... ....++..||||++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 4689999999999999999998754211 2234578999999976532 2345688999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP--------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
..+..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVL 189 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCccceEE
Confidence 99999999999999999999976532 248899999999999999999995 47999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999999987654433222334567889999999999999999999999999999999 9999976432
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........+..++..+.++|.+||..||.+||++.++++.|+++..
T Consensus 266 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 -------------EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11122222223334456677899999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=353.14 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=210.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||++.+.. +..||+|++..... ..+++.+|+++++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETT----------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcC----------CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 4689999999999999999997653 66899999986543 346788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCccceEEEcCCCCEEEccccccc
Confidence 99999999999999999996633 348999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 169 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------------~~~ 230 (283)
T 3gen_A 169 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SET 230 (283)
T ss_dssp GBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHH
T ss_pred ccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------------hHH
Confidence 6543221 11223446788999999999999999999999999999998 9999976432 111
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
...+........+...+..+.+||.+||..||.+|||+.++++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 231 AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 2222223333445566788999999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=363.77 Aligned_cols=247 Identities=25% Similarity=0.345 Sum_probs=205.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 589999999999999999997643 58899999986432 122356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+ +|+|.+++..... +++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC--CeEecCCchhhEEEcCCCCEEEEEecc
Confidence 999999999999 7899999977653 89999999999999999999954 799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 155 s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------- 216 (336)
T 3h4j_B 155 SNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------------- 216 (336)
T ss_dssp TBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------
T ss_pred ceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------
Confidence 987654332 234689999999999988876 6899999999999999999999976432110
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+.+. ......+..++..+.+||.+||..||.+|||+.|+++.
T Consensus 217 --~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 --FKKVN-SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --BCCCC-SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --HHHHH-cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 01123345677889999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=359.75 Aligned_cols=261 Identities=20% Similarity=0.202 Sum_probs=208.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 76 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC 76 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence 4689999999999999999997543 588999999875532 24578999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-----EEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLS 234 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl~ 234 (421)
.+..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++. +||+
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~--~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 77 GKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred CCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 99999999999 99999999764 3459999999999999999999995 47999999999999999887 9999
Q ss_pred eccCcccCCCCCCcc-----eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
|||+++......... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.............
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i 232 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKI 232 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHH
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHH
Confidence 999998654332211 123578999999999999999999999999999999999999999865432111111100
Q ss_pred hhhhhchhhHhHhhhcccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
........ .....+ ++.+++..||..||.+||++.+|++.|+++...
T Consensus 233 -------------~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 233 -------------GDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp -------------HHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------HhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00000000 011234 899999999999999999999999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=349.61 Aligned_cols=252 Identities=31% Similarity=0.483 Sum_probs=198.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 57999999999999999999753 67899999875432 2346788999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCC-ceeeccCCCCcEEeCC--------C
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAES-QVIYRDFKASNILLDA--------E 228 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~-~ivHrDlkp~Nill~~--------~ 228 (421)
...+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+. +|+||||||+|||++. +
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred ecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999999999998853 348999999999999999999996421 2899999999999986 6
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 308 (421)
+.+||+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------- 220 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------- 220 (271)
T ss_dssp CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------
T ss_pred cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence 789999999998654322 22457899999999999999999999999999999999999999764321
Q ss_pred hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...............+..++..+.++|.+||..||.+|||+.++++.|+++
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 --------AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111222223333445567788999999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.91 Aligned_cols=271 Identities=25% Similarity=0.404 Sum_probs=217.4
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
....++|++.+.||+|+||.||+|.+... ....+++.||||.+..... .....+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 34457899999999999999999976531 1122467899999975432 233568899999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRG--------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
+.+.+..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAED 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCCccCCCccceEEEcCC
Confidence 999999999999999999999996532 1347899999999999999999995 479999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 307 (421)
+.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 247 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------- 247 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-------
Confidence 9999999999976543222222233567889999999999999999999999999999999 89999764321
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
.....+........+..++..+.+||.+||..||.+|||+.++++.|+++..+.
T Consensus 248 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 248 ----------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp ----------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 111111122222344567788999999999999999999999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=361.30 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=191.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 119 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET 119 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence 34689999999999999999997654 47899999997653 33567789999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~Df 236 (421)
.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE--NGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 999999999999999999996654 48999999999999999999995 47999999999999975 889999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------------- 258 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-------------- 258 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--------------
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--------------
Confidence 9998654322 23346799999999999999999999999999999999999999965432110
Q ss_pred hhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+..... .......++.++.+||.+||..||.+|||+.++++
T Consensus 259 -~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 259 -MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111111111 11223456788999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.92 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=198.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|+... ...+++.||+|+++.... .....+.+|+.+|+.++||||+++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVT------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECS------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEec------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 579999999999999999997642 223588999999976532 2334577899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..|+||||+.|++|.+++..... +++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQ--KGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHh--CCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 999999999999999999999976643 8899999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 167 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~ 228 (327)
T 3a62_A 167 LCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----------------K 228 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------H
T ss_pred cccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----------------H
Confidence 997543222 1234568999999999999999999999999999999999999999764321 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
....+... ....+..++.++.+||.+||..||.+|| ++.++++
T Consensus 229 ~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 229 TIDKILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111111 1234556788999999999999999999 6777775
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=375.66 Aligned_cols=258 Identities=30% Similarity=0.446 Sum_probs=210.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+++|+.++||||+++++++.+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 4678999999999999999997753 4579999998654 345678999999999999999999998865
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+|+|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChhhEEECCCCCEEECCCccce
Confidence 678999999999999999976444458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......++..|+|||++.++.++.++|||||||++|||++ |..||.+... ..+
T Consensus 329 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----------------~~~ 390 (452)
T 1fmk_A 329 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REV 390 (452)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHH
T ss_pred ecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 75433221 1223456789999999999999999999999999999999 9999976432 112
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+....+...+..++..+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus 391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 222333344455677888999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=365.54 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=196.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHH-HhcCCCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNY-LGQLHHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|.... +++.||||++...... ....+.+|..+ ++.++||||+++++++
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 579999999999999999997654 5789999999765332 23445667776 5778999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..|+||||+.||+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEECCCCCEEEeeCc
Confidence 99999999999999999999997754 38899999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...... .
T Consensus 185 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~ 246 (373)
T 2r5t_A 185 LCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------E 246 (373)
T ss_dssp BCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----------------H
T ss_pred cccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----------------H
Confidence 998632222 1234578999999999999999999999999999999999999999764321 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 360 (421)
....++... ..++..++..+.+||.+||..||.+||++.+.
T Consensus 247 ~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 247 MYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp HHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred HHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 111122221 23445678899999999999999999998543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=373.14 Aligned_cols=253 Identities=23% Similarity=0.259 Sum_probs=206.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
..++|++.+.||+|+||.||+|.... +++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 45689999999999999999997654 578999999864211 122347789999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+.+..||||||++||+|.+++... .+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+||
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999999654 38999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCC----CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR----LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|+++....... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+....
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------------ 279 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------------ 279 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------------
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------------
Confidence 99987544321 1234578999999999998765 889999999999999999999999764321
Q ss_pred hhchhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 313 LSDKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
.....++... ........++.++.+||.+||..+|.+ ||++.+|++.
T Consensus 280 ----~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 ----GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111111111 111222357789999999999999988 9999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.22 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=196.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||+||++.... +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 579999999999999999997654 588999999976543 3356889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc--EEEeeccCc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLA 239 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~a 239 (421)
..++||||+.+|+|.+++..... +++..++.++.|++.||.|||+ .||+||||||+|||++.++. +||+|||++
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a 165 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYS 165 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence 99999999999999999976553 8999999999999999999995 47999999999999987765 999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCcc-ccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTK-SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ...
T Consensus 166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------------~~~ 230 (361)
T 3uc3_A 166 KSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY------------RKT 230 (361)
T ss_dssp ------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH------------HHH
T ss_pred ccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH------------HHH
Confidence 7533222 2234679999999999988888765 89999999999999999999764321110 011
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+..+............++..+.+||.+||..||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111222222222223467889999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=362.05 Aligned_cols=266 Identities=27% Similarity=0.403 Sum_probs=216.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.... .......||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLG----KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCS----SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHceeeeEeccCCCcceEEEEecCCC----cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 468999999999999999999875431 122356899999976533 2345688999999999 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
..+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .||+||||||+|||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS--KNCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGCEEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc--CCcccCCcccceEEEC
Confidence 9999999999999999999996542 2457999999999999999999995 4799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~ 305 (421)
.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN----- 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-----
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-----
Confidence 999999999999986544333333344567889999999999999999999999999999998 99999764321
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
......+........+..++..+.+||.+||..||.+|||+.++++.|+++.
T Consensus 274 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 274 -----------SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp -----------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1122222233333445556788999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=353.45 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=200.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+. +++.||+|++...... ....+.+|+++++.++||||+++++++.
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 89 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH 89 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence 368999999999999999999763 2789999999754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 90 SERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ--HRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp CSSCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCchHhEEECCCCCEEEccCcC
Confidence 99999999999974 8888886543 458999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hhh---
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPY--- 312 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~-~~~--- 312 (421)
+........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... ...... .+.
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 987543221 2334678999999999876 56899999999999999999999999765432211 111100 000
Q ss_pred hhchhhHhHhhhcccC--CC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLG--GQ-----YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+............... .. ....++.++.+||.+||..||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000000000 00 11235678899999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=354.13 Aligned_cols=265 Identities=26% Similarity=0.446 Sum_probs=204.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+... ..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQE------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECT------TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEecc------CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 456899999999999999999977542 23467899999876533 2335688999999999999999999998
Q ss_pred EeCCe-----EEEEEEcCCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 158 LEGEN-----RLLVYEFMPKGSLENHLFRR----GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 158 ~~~~~-----~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
..... .++||||+.+++|.+++... ....+++..++.++.|++.||.||| ..||+||||||+|||++.+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDD 183 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCC
Confidence 87553 49999999999999998532 3356899999999999999999999 4579999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhh
Q 014623 229 FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~ 307 (421)
+.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------- 256 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------- 256 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------
Confidence 9999999999987654333223334567889999999999999999999999999999999 89999764321
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.....+........+..++..+.++|.+||..||.+||++.++++.|+++..
T Consensus 257 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 257 ----------EMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ----------GHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1112222222334556677899999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=375.18 Aligned_cols=258 Identities=21% Similarity=0.235 Sum_probs=207.4
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccce
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKL 153 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~ 153 (421)
+....++|++.+.||+|+||+||+|.+.. +++.||+|++..... .....+.+|..++..++||||+++
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 33445789999999999999999997654 578999999864211 122347789999999999999999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
++++.+.+..||||||+.||+|.+++.+.. ..+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeEcCCCCEEE
Confidence 999999999999999999999999997632 348999999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 308 (421)
+|||+++....... ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.....
T Consensus 217 ~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------- 288 (437)
T 4aw2_A 217 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------- 288 (437)
T ss_dssp CCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------
T ss_pred cchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------
Confidence 99999976544332 2234478999999999987 5679999999999999999999999997653211
Q ss_pred hhhhhhchhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKL--RPRMSEVLAI 363 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~ 363 (421)
....++.......+ ...++.++.+||.+||..+|++ |+++.++++.
T Consensus 289 ---------~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 ---------TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---------HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---------HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111111111111 2347889999999999888888 9999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=356.05 Aligned_cols=275 Identities=31% Similarity=0.446 Sum_probs=217.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG- 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 160 (421)
.|++.+.||+|+||+||++.+.. .+..+++.||||++..... ...+.+.+|+++++.++||||+++++++.+.
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HHhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 34999999999999999987654 3445789999999986532 2345688999999999999999999999874
Q ss_pred -CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 -ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
...++||||+++++|.+++.... +++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~--~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEEcCCCCEEECCcccc
Confidence 67899999999999999996653 8999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... .......|+..|+|||++.+..++.++|||||||++|+|++|..||......... ...+... ......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQG-QMTVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCH-HHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhccccc-chhHHH
Confidence 876543322 1233456888999999999999999999999999999999999999754221100 0000000 011122
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
+...+........+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 334444444555667788999999999999999999999999999988753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=350.00 Aligned_cols=266 Identities=24% Similarity=0.292 Sum_probs=202.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||+||+|.+.. +++.||||++....... ...+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 479999999999999999997654 57899999997654322 3668899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999965 6666665433 459999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh--hhhhh-hhhhhhc
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDW-AKPYLSD 315 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~-~~~~~~~ 315 (421)
........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... .+... ..+....
T Consensus 149 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~ 226 (292)
T 3o0g_A 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp EECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543222 233467899999999998766 899999999999999999988886433221111 01000 0000000
Q ss_pred hhhHhHhhh---------cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMD---------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
......... ..........++..+.+||.+||..||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000000000 00011122456788999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=356.89 Aligned_cols=264 Identities=25% Similarity=0.446 Sum_probs=207.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++.+.||+|+||.||+|.+... ....+..||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHhhcccEEecCCCeEEEEEEEecC-----CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 5788899999999999999987642 112345799999976532 2335688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 99999999999999999997643 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------------~~ 258 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------------HE 258 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HH
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----------------HH
Confidence 754332111 1122346788999999999999999999999999999999 9999965431 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
+...+........+..++..+.+||.+||..||.+||++.++++.|+++...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 259 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1222222223344556788999999999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=353.19 Aligned_cols=254 Identities=29% Similarity=0.469 Sum_probs=201.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||.||+|.+. ++.||||.+... ...+.+.+|+++++.++||||+++++++. +
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 57899999999999999999753 567999999754 34467889999999999999999999876 4
Q ss_pred eEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCC-CceeeccCCCCcEEeCCCCc-EEEeeccC
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAE-SQVIYRDFKASNILLDAEFN-AKLSDFGL 238 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~-~~ivHrDlkp~Nill~~~~~-~kl~Dfg~ 238 (421)
..++||||+++++|.+++..... ..++...++.++.|++.||.|||+.. .||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 57999999999999999976543 24788999999999999999999632 58999999999999988887 79999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~ 212 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------------R 212 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---------------H
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---------------H
Confidence 9764322 2235689999999999999999999999999999999999999975432110 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.............+..++..+.+||.+||..||.+|||+.++++.|+.+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 213 IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111112222334456778899999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.93 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=200.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCC--CCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHH--PNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--p~iv~~~~~ 156 (421)
.++|++.+.||+|+||.||++.+. +++.||||++...... ..+.+.+|+.+|+.++| +||++++++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 467999999999999999999653 3788999998755432 23568899999999976 999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+...+..++|||+ .+++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++ ++.+||+||
T Consensus 78 ~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~iiHrDikp~NIll~-~~~~kl~DF 151 (343)
T 3dbq_A 78 EITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIV-DGMLKLIDF 151 (343)
T ss_dssp EECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEE-TTEEEECCC
T ss_pred EeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEE-CCcEEEeec
Confidence 9999999999995 5889999997754 48999999999999999999995 4799999999999997 578999999
Q ss_pred cCcccCCCCCCcceeeccccccceeccccccc-----------CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 152 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------ 225 (343)
T 3dbq_A 152 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------ 225 (343)
T ss_dssp SSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------
T ss_pred ccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------
Confidence 99987654443333445789999999999865 6789999999999999999999999975322
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
....+...+.......++...+..+.+||.+||..||.+|||+.++++..
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 226 ---------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11122233333344445556667899999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.36 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=197.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+++|+.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3579999999999999999997654 5789999999754432 34678899999999999999999999865
Q ss_pred CC---------------------------------------------------------eEEEEEEcCCCCChHHHHhhc
Q 014623 160 GE---------------------------------------------------------NRLLVYEFMPKGSLENHLFRR 182 (421)
Q Consensus 160 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~ 182 (421)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 279999999999999999765
Q ss_pred CC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCc----------cee
Q 014623 183 GP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT----------HVS 251 (421)
Q Consensus 183 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~ 251 (421)
.. ....+..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++........ ...
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHHh--CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 43 235666789999999999999995 47999999999999999999999999999876543211 122
Q ss_pred eccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCC
Q 014623 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY 331 (421)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (421)
...+||+.|+|||++.+..++.++|||||||++|+|++|..|+.... ..............
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------------------~~~~~~~~~~~~~~ 294 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------------------RIITDVRNLKFPLL 294 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------------------HHHHHHHTTCCCHH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------------------HHHHHhhccCCCcc
Confidence 34579999999999999999999999999999999999876643210 00011111111111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 332 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 332 ~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+..+.+||.+||..||.+|||+.++++
T Consensus 295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 2355677899999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=365.37 Aligned_cols=272 Identities=19% Similarity=0.247 Sum_probs=205.0
Q ss_pred hcCCCCCceeccc--CceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 81 TRNFRPDSLLGEG--GFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.++|++.+.||+| +||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3689999999999 999999997654 588999999975432 223567789999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+.+..++||||+++++|.+++.......+++..+..++.||+.||.|||+ .||+||||||+||||+.++.+||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999999999999987755669999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCC-----cceeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh-hhh
Q 014623 237 GLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL-VDW 308 (421)
Q Consensus 237 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~-~~~ 308 (421)
|++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+......... ...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 98864322111 011123478999999999987 5799999999999999999999999976433211100 000
Q ss_pred hhhhhhchh------------------hHhHhh---------hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 309 AKPYLSDKR------------------KLFRIM---------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 309 ~~~~~~~~~------------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
..+...+.. .....+ ........+..++..+.+||.+||..||.+|||+.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000000000 000000 00001113345677899999999999999999999998
Q ss_pred HH
Q 014623 362 AI 363 (421)
Q Consensus 362 ~~ 363 (421)
+.
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 53
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=354.48 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=207.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+..... .....+..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3579999999999999999998764210 00011257999999776656667899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc--------EE
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--------AK 232 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--------~k 232 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++. +|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh--CCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999997653 348999999999999999999995 47999999999999988887 99
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCc-cCCCcccchhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCA-VDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p-f~~~~~~~~~~~~~~~~ 310 (421)
|+|||++..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..| |......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------- 225 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---------- 225 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH----------
Confidence 999999975432 223568999999999987 6799999999999999999996544 4432211
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCCCC
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNS 373 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~~~ 373 (421)
........ ....+...+.++.+||.+||..||.+|||+.++++.|+++..+..+
T Consensus 226 -------~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 226 -------RKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp -------HHHHHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred -------HHHHHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00111111 1122334466789999999999999999999999999998776544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.48 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=197.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++....... ...+.+|+++++.++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 4689999999999999999997643 57899999998654333 34678999999999999999999998
Q ss_pred EeCCe----EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 158 LEGEN----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 158 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
..... .|+||||++|++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEETTSCEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCCcCCCCHHHEEEcCCCCEEE
Confidence 76543 499999999999999997664 48999999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
+|||++......... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---------- 227 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---------- 227 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----------
Confidence 999999865433221 122346799999999999999999999999999999999999999976532110
Q ss_pred hhchhhHhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHH-HHHHHHhhc
Q 014623 313 LSDKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSE-VLAILERLE 368 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e-ll~~L~~~~ 368 (421)
........... .....++.++.+||.+||+.||.+||+..+ +...+.++.
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 228 ------AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ------HHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------HHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00111110000 001235778999999999999999996554 555666553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=348.77 Aligned_cols=260 Identities=29% Similarity=0.400 Sum_probs=209.9
Q ss_pred hcCCCCCc-eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDS-LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+ .||+|+||.||+|.+... .+++.||||++....... .+.+.+|+++++.++||||+++++++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35788888 999999999999966432 247889999997654322 46788999999999999999999998
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh--CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 6678899999999999999997754 38999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 238 LAKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 238 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------------- 226 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---------------- 226 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----------------
Confidence 998765433221 1122346788999999998899999999999999999999 9999976432
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........+..++..+.++|.+||..||.+||++.++++.|+++..
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 227 -SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp -HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11222222233334556778899999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=349.21 Aligned_cols=264 Identities=17% Similarity=0.189 Sum_probs=210.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++.... ....+.+|+.+++.+ +|+||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 4689999999999999999997543 58899999986543 224577899999999 79999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-----EEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLS 234 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~-----~kl~ 234 (421)
....++||||+ +++|.+++.... ..+++..++.++.|++.||.||| ..||+||||||+|||++.++. +||+
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 99999999999 999999997653 35899999999999999999999 558999999999999987776 9999
Q ss_pred eccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 235 DFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 235 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 99999865443221 1123467999999999999999999999999999999999999999875432211111100
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
. ..............++.++.+|+.+||..||.+||++.+|++.|+++..
T Consensus 234 ~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 234 G----------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp H----------HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred H----------hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 0 0000000000112456789999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=353.36 Aligned_cols=264 Identities=24% Similarity=0.371 Sum_probs=190.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 3579999999999999999996543 588999999975432 234678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRG----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
.+..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE--NKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999997 59999986542 2358999999999999999999995 4799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhh-h-
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAK-P- 311 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~-~- 311 (421)
||++........ .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........ +..... +
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999987543221 12346789999999998764 68999999999999999999999997654321110 111000 0
Q ss_pred --hhhchh---------------hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 --YLSDKR---------------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 --~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.... .+.+.+.. .....++.++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000 00000000 111235678999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=373.05 Aligned_cols=249 Identities=29% Similarity=0.353 Sum_probs=199.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 579999999999999999997654 58899999987532 223356778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+ ..||+||||||+||||+.++.+||+|||+
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence 9999999999999999999997664 48999999999999999999995 14799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .
T Consensus 296 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----------------~ 357 (446)
T 4ejn_A 296 CKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----------------L 357 (446)
T ss_dssp CCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------H
T ss_pred ceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----------------H
Confidence 98643322 12345789999999999999999999999999999999999999997643210 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
...+... ...++..++.++.+||.+||..||.+|| ++.++++
T Consensus 358 ~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 358 FELILME--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhC--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111111 1234556788999999999999999999 9999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=350.89 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=212.4
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+++++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC----------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 34689999999999999999997542 5689999997654 34577899999999999999999999876
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 4568999999999999999965433358999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----------------~ 218 (279)
T 1qpc_A 157 RLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----------------E 218 (279)
T ss_dssp EECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------H
T ss_pred ccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----------------H
Confidence 876543221 1223456789999999998999999999999999999999 99999764321 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....+........+..++..+.+|+.+||..||.+|||+.++++.|+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 112222223334455677899999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=363.96 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=200.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC--CCCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH--HPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~~~~~ 156 (421)
.++|++.+.||+|+||.||+|.+. .++.||||++..... ...+.+.+|+.+|+.+. |+||++++++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 356999999999999999999643 278899999975533 23466889999999996 5999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+...+..++||| +.+++|.+++.... .+++..++.++.||+.||.||| ..||+||||||+|||++ ++.+||+||
T Consensus 125 ~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 125 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEECCC
T ss_pred EecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEEec
Confidence 999999999999 55889999997764 4888899999999999999999 45799999999999995 578999999
Q ss_pred cCcccCCCCCCcceeeccccccceeccccccc-----------CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
|+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----- 273 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----- 273 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----
Confidence 99987654433333445789999999999865 46889999999999999999999999753211
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+..++........+...+.++.+||.+||..||.+||++.++++.
T Consensus 274 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 ----------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111223333333334444557789999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=349.31 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=199.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+. ++.||||++... ....+.+|.+++.. ++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 468999999999999999999753 678999998653 34455667777665 78999999999876
Q ss_pred eC----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCCCcEEeCCC
Q 014623 159 EG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 159 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~ 228 (421)
.. ...++||||+++|+|.+++... .+++..++.++.|++.||.|||.. ..||+||||||+|||++.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred cccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 43 4589999999999999999543 489999999999999999999932 3479999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCcc--eeeccccccceecccccccC------CCCccccchhhhHHHHHHHhC----------
Q 014623 229 FNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSG---------- 290 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg---------- 290 (421)
+.+||+|||+++......... .....+||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 999999999997543322211 12235799999999999876 455799999999999999999
Q ss_pred CCccCCCcccchhhhhhhhhhhhhchhhHhHhh-hcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 291 RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 291 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..||......... ........ ........ ...++..+.+||.+||..||.+|||+.+|++.|
T Consensus 230 ~~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 230 KPPFYDVVPNDPS------------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CCTTTTTSCSSCC------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccCCCCcc------------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 6777543211100 00111111 11111111 235788999999999999999999999999999
Q ss_pred Hhh
Q 014623 365 ERL 367 (421)
Q Consensus 365 ~~~ 367 (421)
+++
T Consensus 298 ~~i 300 (301)
T 3q4u_A 298 TKI 300 (301)
T ss_dssp HHH
T ss_pred hcc
Confidence 986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=370.28 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=207.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 579999999999999999997653 588999999865321 23457889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+.|++|.+++.+.. .+++..++.++.||+.||.||| ..||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~DFG~ 162 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGL 162 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEeccc
Confidence 9999999999999999999996554 4899999999999999999999 45899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---------------- 223 (476)
T 2y94_A 163 SNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---------------- 223 (476)
T ss_dssp CEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----------------
T ss_pred hhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----------------
Confidence 98765433 2335689999999999988776 689999999999999999999997643210
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+.... ...+..++.++.+||.+||..||.+|||+.++++
T Consensus 224 ~~~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 224 LFKKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 011111111 1234556788999999999999999999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=377.42 Aligned_cols=254 Identities=30% Similarity=0.442 Sum_probs=211.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.... +|+.||+|++.... ......+.+|+++|+.++||||+++++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 4679999999999999999997654 58899999986432 12345678999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..|+||||++||+|.+++.......+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~--~gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR--ERIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCEeccCCchheEEEeCCCCeEEEecc
Confidence 999999999999999999999987666669999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... .
T Consensus 332 la~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-------------~ 395 (576)
T 2acx_A 332 LAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-------------E 395 (576)
T ss_dssp TCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-------------H
T ss_pred cceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-------------H
Confidence 998765433 233468999999999999999999999999999999999999999765321110 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
.+...+. .....++..++.++.+||.+||..||.+|| ++.+|++
T Consensus 396 ~i~~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 396 EVERLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1111111 122344567788999999999999999999 6788875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=358.91 Aligned_cols=275 Identities=23% Similarity=0.257 Sum_probs=209.6
Q ss_pred cccCHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---
Q 014623 70 KAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH--- 146 (421)
Q Consensus 70 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--- 146 (421)
..+++.+.....++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+..|+.+++.+.
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~ 92 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDD 92 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCS
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccC
Confidence 344555555667899999999999999999997654 57899999997432 23355678999999886
Q ss_pred --CCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 147 --HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 147 --hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
||||+++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIl 169 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK--MSLTHTDLKPENIL 169 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCcccEE
Confidence 999999999999999999999999 9999999988766679999999999999999999995 47999999999999
Q ss_pred eCC-------------------------CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchh
Q 014623 225 LDA-------------------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYS 279 (421)
Q Consensus 225 l~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 279 (421)
++. ++.+||+|||++...... ....+||+.|+|||++.+..++.++||||
T Consensus 170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 975 788999999999864432 23467999999999999999999999999
Q ss_pred hhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhhchh------hHhHhhh-----cccCC----------------CC
Q 014623 280 FGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKR------KLFRIMD-----TKLGG----------------QY 331 (421)
Q Consensus 280 lG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~-----~~~~~----------------~~ 331 (421)
|||++|+|++|+.||............ ....+...... ....... ..... ..
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 999999999999999765432111111 00000000000 0000000 00000 00
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 332 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 332 ~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+..+.+||.+||+.||.+|||+.|+++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0111267889999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=354.85 Aligned_cols=265 Identities=25% Similarity=0.339 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
.++|++.+.||+|+||.||++.... +++.||||++........+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 4689999999999999999997643 578999999876555556778899999999999999999999873
Q ss_pred ---CCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 ---GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ---~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
....++||||+.+++|.+++... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEEC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCCCEEEE
Confidence 34789999999999999999753 33568999999999999999999995 479999999999999999999999
Q ss_pred eccCcccCCCCCCcc-------eeeccccccceecccccccCC---CCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 235 DFGLAKAGPTGDRTH-------VSTQVMGTHGYAAPEYVATGR---LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 252 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---- 252 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----
Confidence 999987543211000 011245799999999987654 688999999999999999999999532110
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...................++..+.+||.+||..||.+||++.++++.|+.+..+.
T Consensus 253 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 253 -----------GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -----------TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -----------cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00111111122222333566789999999999999999999999999999986543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=357.44 Aligned_cols=266 Identities=27% Similarity=0.401 Sum_probs=208.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... .+..++..||||.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 36899999999999999999975431 1334678999999975432 334568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGP-----QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNA 231 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 231 (421)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~--~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999976542 348899999999999999999995 47999999999999984 4469
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------- 251 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 251 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----------
Confidence 9999999875433222222334668999999999999999999999999999999998 9999975432
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........+..++..+.+||.+||..||.+||++.++++.|+.+..
T Consensus 252 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 252 ------QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11122222222333455677899999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=347.68 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=208.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+... ..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNH------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECT------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCC------CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35799999999999999999987542 22456799999976532 344678899999999999999999998764
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEECCCCcEEeCccCCC
Confidence 56789999999999999997654 348999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.......
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----------------- 222 (281)
T 3cc6_A 161 RYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----------------- 222 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-----------------
T ss_pred ccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-----------------
Confidence 875443221 1233457889999999999999999999999999999998 999997543211
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
....+........+..++..+.++|.+||..||.+||++.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 11122222223344567788999999999999999999999999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=382.61 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=207.7
Q ss_pred CCCCCc-eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 83 NFRPDS-LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+.+.+|+++|+.++||||+++++++..
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 344444 799999999999977532 2467899999986533 345789999999999999999999999875
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE--KNFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 5689999999999999999654 3458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
........ .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+... ..
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~ 547 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PE 547 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----------------HH
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------------HH
Confidence 76433221 11122345689999999999999999999999999999998 9999976432 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+...+........+..++.++.+||.+||..||.+||++.+|++.|+.+.
T Consensus 548 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 548 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22333334444566778899999999999999999999999999998864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=343.84 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=208.6
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++........+.+.+|+++++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34679999999999999999997654 478899999987655667889999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~Df 236 (421)
.+..++||||+.+++|.+++..... +++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999999999999977643 8999999999999999999995 479999999999999 78899999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.......
T Consensus 154 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------- 214 (277)
T 3f3z_A 154 GLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--------------- 214 (277)
T ss_dssp TTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------
T ss_pred ccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence 9998755433 22346799999999988654 8999999999999999999999997643211
Q ss_pred hhHhHhhhcccCCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHh
Q 014623 317 RKLFRIMDTKLGGQYPQ----KAAHTAATLALQCLNNEPKLRPRMSEVLA--ILER 366 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~ 366 (421)
....+..... ..+. .++..+.+||.+||..||.+||++.++++ .+++
T Consensus 215 -~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 215 -VMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -HHHHHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0111111111 1111 45778999999999999999999999985 4444
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=368.71 Aligned_cols=257 Identities=21% Similarity=0.226 Sum_probs=205.2
Q ss_pred HHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccc
Q 014623 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 76 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
+.....++|++.+.||+|+||.||+|.... +|+.||||++..... .....+.+|..++..++||||++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 333446789999999999999999997654 588999999864321 12234778999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
+++++.+.+..||||||++||+|.+++.+.+ ..+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+|
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeeecCCCCEE
Confidence 9999999999999999999999999997654 348999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccc-------cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
|+|||+++....... ......+||+.|+|||++. +..|+.++|||||||++|||++|+.||.......
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---- 277 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---- 277 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH----
Confidence 999999987644322 1223468999999999987 3568999999999999999999999997653211
Q ss_pred hhhhhhhhhchhhHhHhhhcc--c-CCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTK--L-GGQYPQKAAHTAATLALQCLNNEPKLR---PRMSEVLA 362 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell~ 362 (421)
....++... . ....+..++.++.+||.+||. +|.+| |++.++++
T Consensus 278 ------------~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 ------------TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ------------HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ------------HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 011111111 1 111224577899999999999 99998 58888875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=344.70 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=213.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred hhheeeeeEecCCCceeEEEEEecC----------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3579999999999999999997643 56899999986543 346788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEECCCCCEEEccccccc
Confidence 99999999999999999997653 358999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~~ 214 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EV 214 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----------------HH
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----------------HH
Confidence 653321 111223456788999999998999999999999999999999 89999754321 11
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
...+........+...+..+.+++.+||..||.+||++.++++.|+++..
T Consensus 215 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12222222333445667889999999999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=347.91 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=196.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+. ..+|+|+++.... ...+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred ccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 468999999999999999999653 2499999875533 2335688999999999999999999954
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.....++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccccCccceEEECCCCCEEEcccee
Confidence 5667899999999999999996543 458999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+................||+.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------------- 232 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------------- 232 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--------------
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--------------
Confidence 98654333233334567999999999986 5678889999999999999999999997643211
Q ss_pred hhhHhHhhhcc----cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 316 KRKLFRIMDTK----LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 316 ~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+...+... ........++..+.+||.+||..||.+||++.++++.|+++..
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 233 --QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111111111 1112234667899999999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.76 Aligned_cols=258 Identities=30% Similarity=0.442 Sum_probs=213.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.+.+|+++|+.|+|+||+++++++.+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3467788899999999999998753 4579999998654 345679999999999999999999998865
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..+|||||+.+|+|.+++.......+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 678999999999999999975444458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+... ..+
T Consensus 412 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----------------~~~ 473 (535)
T 2h8h_A 412 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------------REV 473 (535)
T ss_dssp TCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----------------HHH
T ss_pred ecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHH
Confidence 7543211 11223456789999999999999999999999999999999 9999976431 112
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+....+...+..++..+.+||.+||..||++|||+.+|++.|+.+...
T Consensus 474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 223333344455667888999999999999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=371.84 Aligned_cols=269 Identities=23% Similarity=0.293 Sum_probs=186.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+++.+|+++|+.++||||+++++++.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 122 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 3689999999999999999997654 578999999865422 23467889999999999999999999985
Q ss_pred eC-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
.. ...|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTCCEEE
T ss_pred cCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEECCCCCEee
Confidence 43 5689999998 679999986543 489999999999999999999954 7999999999999999999999
Q ss_pred eeccCcccCCCCCCc-------------------------ceeeccccccceeccccc-ccCCCCccccchhhhHHHHHH
Q 014623 234 SDFGLAKAGPTGDRT-------------------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLEL 287 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el 287 (421)
+|||+++........ ......+||++|+|||++ .+..|+.++||||||||||||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999875432211 123446789999999976 456799999999999999999
Q ss_pred Hh-----------CCCccCCCcccch------------------h---hhhhh-hhhhhhch-----hhHhHhh---hcc
Q 014623 288 LS-----------GRCAVDKTKVGIE------------------Q---SLVDW-AKPYLSDK-----RKLFRIM---DTK 326 (421)
Q Consensus 288 ~t-----------g~~pf~~~~~~~~------------------~---~~~~~-~~~~~~~~-----~~~~~~~---~~~ 326 (421)
++ |..+|.+...... + .+... ..+..... ......+ ...
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 5666654321000 0 00000 00000000 0000000 000
Q ss_pred cCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 327 LGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 327 ~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... ...+..+.++.+||.+||..||.+|||+.|+++.
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0113457889999999999999999999999873
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=349.11 Aligned_cols=268 Identities=26% Similarity=0.342 Sum_probs=201.0
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-----cCHHHHHHHHHHHhcCC---CCCcc
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-----QGHKEWLTEVNYLGQLH---HPNLV 151 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hp~iv 151 (421)
..++|++.+.||+|+||+||+|.+.. +++.||||++..... .....+.+|+.+++.+. ||||+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeE
Confidence 45789999999999999999996543 588999999864321 12245667777777664 99999
Q ss_pred ceeeEEEeCC-----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 152 KLIGYCLEGE-----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 152 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
++++++.... ..++||||+. ++|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA--NCIVHRDLKPENILVT 154 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCTTTEEEC
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEc
Confidence 9999998765 5799999996 599999987766669999999999999999999995 4799999999999999
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~ 305 (421)
.++.+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... .+
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231 (308)
T ss_dssp TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998754332 234568999999999999999999999999999999999999999765432111 01
Q ss_pred hhhhh-hhhhchhhHhHhhhcccCCC-------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 306 VDWAK-PYLSDKRKLFRIMDTKLGGQ-------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 306 ~~~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... +...............+... ....++..+.+||.+||..||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 00000000000000000000 11245678999999999999999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=385.77 Aligned_cols=252 Identities=29% Similarity=0.403 Sum_probs=205.4
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 165 (421)
+.||+|+||.||+|.+... ..++.||||+++.... ...+++.+|+++|+.++|||||++++++. .+..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 4799999999999976432 2468899999976433 23467899999999999999999999886 456899
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCC
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 245 (421)
||||+.+|+|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++.....
T Consensus 447 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~--~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred EEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999999999997654 48999999999999999999995 47999999999999999999999999999876443
Q ss_pred CCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 246 DRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 246 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... ..+...+
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----------------~~~~~~i 585 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAML 585 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHH
T ss_pred ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHH
Confidence 221 12233456889999999999999999999999999999998 9999976532 2233334
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
........+..++.++.+||.+||..||.+||++.+|++.|+++.
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 444445566778899999999999999999999999999998753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.49 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=203.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+++++.++||||+++++++.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 367999999999999999999653 6789999997653 456788999999999999999999987654
Q ss_pred -CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 161 -ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 161 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..++||||+++++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCcceEEEeCCCcEEEeecccc
Confidence 478999999999999999976544447889999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~ 222 (278)
T 1byg_A 165 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------D 222 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------G
T ss_pred ccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 7643321 23457889999999999999999999999999999998 99999764321 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
....+........+..++..+.++|.+||..||.+||++.++++.|+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 223 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112222223334556778899999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=346.72 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=211.6
Q ss_pred cCCCCCc-eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDS-LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|.+.+ .||+|+||.||+|.+... .++..||||+++.... ...+.+.+|+++++.++||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 4566666 999999999999976432 2478899999986532 3346788999999999999999999998 5
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCchheEEEcCCCCEEECcccce
Confidence 667999999999999999996443 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------------- 220 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----------------- 220 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-----------------
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----------------
Confidence 876433221 11223456889999999998899999999999999999998 99999764321
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+...+........+..++..+.++|.+||..||.+||++.++++.|+.+...
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11222222233345567788999999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=347.35 Aligned_cols=265 Identities=23% Similarity=0.342 Sum_probs=198.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+. +++.||+|++...... ....+.+|+++++.++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 47999999999999999999763 3788999999755332 23678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA 147 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEeECccc
Confidence 9999999999975 9999886543 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhhch
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~~~~~~ 316 (421)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....... ..... ..+.....
T Consensus 148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 76432211 12345789999999998764 5899999999999999999999999765421111 00000 00000000
Q ss_pred hhHhHh--hhcccC-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRI--MDTKLG-------GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~--~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...... ...... ......++.++.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000000 0112346788999999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=348.87 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=200.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 479999999999999999997643 478999999975432 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
..+..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIl~~~~~~~kl~Df 180 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDL 180 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCcHHHEEEcCCCCEEEEec
Confidence 99999999999999999999864 234558999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 181 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------ 246 (310)
T 2wqm_A 181 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL------------ 246 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH------------
T ss_pred cceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH------------
Confidence 99986543221 2234578999999999999999999999999999999999999997543211110
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
...+............++.++.+||.+||..||.+||++.++++.|+++.+.
T Consensus 247 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 247 --CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp --HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0111111111122345678899999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=344.30 Aligned_cols=254 Identities=25% Similarity=0.306 Sum_probs=206.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 3579999999999999999997653 478999999865432 334678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .||+||||||+||+++.++.+||+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 99999999999999999998654 348999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
................|++.|+|||++.+..+ +.++|||||||++|+|++|..||......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~------------- 218 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y------------- 218 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H-------------
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H-------------
Confidence 76543332222345679999999999987765 77999999999999999999999765321110 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...............++..+.+||.+||..||.+|||+.++++
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 219 -SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0111111111122456788999999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=352.16 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=205.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence 4579999999999999999997653 5789999998754322 356788999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----c
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----N 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~ 230 (421)
+++.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~--~~ivH~dikp~NIl~~~~~~~~~~ 157 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPH 157 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCTTSSSCC
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCChHHEEEecCCCCcCC
Confidence 99999999999999999999999997653 48999999999999999999995 4799999999999999888 7
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------- 226 (321)
T 2a2a_A 158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------- 226 (321)
T ss_dssp EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------
T ss_pred EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--------
Confidence 99999999987654321 2346799999999999999999999999999999999999999976432110
Q ss_pred hhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+..... .......++..+.+||.+||..||.+|||+.++++
T Consensus 227 --------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 227 --------LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --------HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --------HHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001110000 00011245678999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=359.05 Aligned_cols=274 Identities=17% Similarity=0.182 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH-----------HHHHHHHHHHhcCCCCC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-----------KEWLTEVNYLGQLHHPN 149 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hp~ 149 (421)
.++|++.+.||+|+||.||+|.+... .....++.||||++........ ..+..|+..++.++|||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 35899999999999999999987653 1223467899999876542111 22445667788889999
Q ss_pred ccceeeEEEeC----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 150 LVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 150 iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
|+++++++... ...+|||||+ |++|.+++.... ..+++..++.++.||+.||.|||+. ||+||||||+||||
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill 185 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLL 185 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEE
Confidence 99999998864 4589999999 999999997643 4599999999999999999999954 79999999999999
Q ss_pred C--CCCcEEEeeccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 226 D--AEFNAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 226 ~--~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
+ .++.+||+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999765432111 11133569999999999999999999999999999999999999998543
Q ss_pred ccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..... ....... ....+...+...+. ...++.++.+++..||..||.+||++.+|++.|+++..
T Consensus 266 ~~~~~--~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPKY--VRDSKIR--YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHHH--HHHHHHH--HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHHH--HHHHHHH--hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 22111 1000000 00111122221111 13446789999999999999999999999999988654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=357.26 Aligned_cols=263 Identities=23% Similarity=0.266 Sum_probs=203.7
Q ss_pred HHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC-----CccCHHHHHHHHHHHhcCCCCCccc
Q 014623 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-----GFQGHKEWLTEVNYLGQLHHPNLVK 152 (421)
Q Consensus 78 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~ 152 (421)
....++|++.+.||+|+||.||+|.+.. +++.||+|++... .....+.+.+|+++++.++||||++
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4456789999999999999999997654 5789999998643 2234467889999999999999999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcC--------------------------------------CCCCCHHHHHH
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRG--------------------------------------PQPLSWAVRMK 194 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~~~~~~~~~ 194 (421)
+++++.+.+..++||||++||+|.+++.... ...+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 9999999999999999999999999984210 11235677889
Q ss_pred HHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC--cEEEeeccCcccCCCCC--Ccceeeccccccceeccccccc--
Q 014623 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF--NAKLSDFGLAKAGPTGD--RTHVSTQVMGTHGYAAPEYVAT-- 268 (421)
Q Consensus 195 ~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-- 268 (421)
++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||++....... .........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 173 IMRQIFSALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHH--TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHH--CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 99999999999995 4799999999999998776 89999999997543211 1112335679999999999875
Q ss_pred CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCC--CCHHHHHHHHHHHHhc
Q 014623 269 GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQC 346 (421)
Q Consensus 269 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 346 (421)
..++.++|||||||++|+|++|..||...... ......+....... ....++..+.+||.+|
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA----------------DTISQVLNKKLCFENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcccccCCcccccCCHHHHHHHHHH
Confidence 67899999999999999999999999765321 11112222222111 1124678899999999
Q ss_pred cccCCCCCCCHHHHHH--HHHhh
Q 014623 347 LNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 347 l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
|..||.+||++.++++ .++++
T Consensus 315 l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHHHTT
T ss_pred cCCChhHCCCHHHHhcChhhccC
Confidence 9999999999999986 44443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=361.23 Aligned_cols=270 Identities=25% Similarity=0.340 Sum_probs=193.1
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCC-CCCccceee
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HPNLVKLIG 155 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 155 (421)
...++|++.+.||+|+||.||+|.+.. +|+.||||++.... .....++.+|+.+++.+. ||||+++++
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 345789999999999999999997654 58899999986532 233456789999999997 999999999
Q ss_pred EEEeCC--eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 156 YCLEGE--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 156 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
++...+ ..|+||||+. ++|.+++... .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEE
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHeEEcCCCCEEe
Confidence 998544 6899999996 5899988653 48999999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCC-------------------Ccceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCc
Q 014623 234 SDFGLAKAGPTGD-------------------RTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCA 293 (421)
Q Consensus 234 ~Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p 293 (421)
+|||+++...... ........+||++|+|||++.+ ..|+.++|||||||++|||++|+.|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999997653211 1112334689999999999987 6799999999999999999999999
Q ss_pred cCCCcccchhh-hhhh-hhhhhhc--------hhhHhHhhhc-------ccCC------------CCCHHHHHHHHHHHH
Q 014623 294 VDKTKVGIEQS-LVDW-AKPYLSD--------KRKLFRIMDT-------KLGG------------QYPQKAAHTAATLAL 344 (421)
Q Consensus 294 f~~~~~~~~~~-~~~~-~~~~~~~--------~~~~~~~~~~-------~~~~------------~~~~~~~~~l~~li~ 344 (421)
|.+........ +... ..|.... .......+.. .... .....++.++.+||.
T Consensus 231 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 98654321111 0000 0000000 0000000000 0000 011144678999999
Q ss_pred hccccCCCCCCCHHHHHHH
Q 014623 345 QCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 345 ~~l~~dP~~Rpt~~ell~~ 363 (421)
+||..||.+|||+.|+++.
T Consensus 311 ~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HhhccCcccCCCHHHHhCC
Confidence 9999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=347.42 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=202.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++....... .+.+.+|+.+++.++||||+++++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 103 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG 103 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 3689999999999999999997653 47899999997543322 35688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg 179 (309)
T 2h34_A 104 EIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA--AGATHRDVKPENILVSADDFAYLVDFG 179 (309)
T ss_dssp EETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSCC
T ss_pred eeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CcCCcCCCChHHEEEcCCCCEEEecCc
Confidence 99999999999999999999997764 48999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------- 242 (309)
T 2h34_A 180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---------------- 242 (309)
T ss_dssp C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----------------
T ss_pred cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----------------
Confidence 99765433211 2234678999999999999999999999999999999999999997643210
Q ss_pred hHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhcCCC
Q 014623 318 KLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLEAPK 371 (421)
Q Consensus 318 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~~~~~ 371 (421)
+...+.... ....+..++..+.++|.+||..||.+|| ++.++++.|+++....
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 243 -MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -HHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -HHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 011111110 1122345677899999999999999999 9999999999875543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.31 Aligned_cols=279 Identities=26% Similarity=0.379 Sum_probs=217.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. .+..+++.||||++........+.+.+|+++++.++||||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3579999999999999999997643 23346899999999876555567789999999999999999999988765
Q ss_pred C--eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 161 E--NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 161 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+ ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 4 6899999999999999997653 358999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 239 AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 239 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+.......... ......++..|+|||++.+..++.++|||||||++|+|++|..||.............. ........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~ 270 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVF 270 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT-CCTHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc-cchhhhHH
Confidence 98765433211 12234577889999999998999999999999999999999999864321110000000 00000011
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.+...+........+..++.++.+||.+||..||.+||++.+|++.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222333333334456677889999999999999999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=369.24 Aligned_cols=264 Identities=22% Similarity=0.264 Sum_probs=195.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|++.. +++.||||++.... ....+++.+|+.+|+.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 4689999999999999999997654 58899999997542 233466889999999999999999999997
Q ss_pred eC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.. ...|+||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+. ||+||||||+||||+.++.+|
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEEeCCCCEE
Confidence 54 357999999965 57776633 388999999999999999999954 799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~ 310 (421)
|+|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....... .+... ..
T Consensus 205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~ 281 (464)
T 3ttj_A 205 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281 (464)
T ss_dssp ECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999998754332 234578999999999999999999999999999999999999999875432111 01100 00
Q ss_pred hh---hhch-hhHhHhhhcc---------------cCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 PY---LSDK-RKLFRIMDTK---------------LGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~~---~~~~-~~~~~~~~~~---------------~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+. +... ......+... .... .....+.++.+||.+||..||.+|||+.|+++.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000 0000111100 0000 011237789999999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=355.14 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=204.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcCCCCCcc
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--------GHKEWLTEVNYLGQLHHPNLV 151 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv 151 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+++.++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 34689999999999999999997654 5889999999765321 223567899999999999999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 152 KLIGYCLEGENRLLVYEFMPKG-SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
++++++.+.+..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSC
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeEEeccCHHHEEEcCCCc
Confidence 9999999999999999998766 9999997654 38999999999999999999995 47999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
+||+|||++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99999999987654332 234679999999999988876 78999999999999999999999653210
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... ....+..++.++.+||.+||..||.+|||+.++++.
T Consensus 237 -------------~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -------------VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -------------TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -------------Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 112233467789999999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.52 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=209.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcE--EEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV--VAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
++|++.+.||+|+||.||+|.+.. ++.. +|+|.+.... ....+.+.+|+++++.+ +||||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 579999999999999999997754 3454 4999887532 23345688999999999 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NI 173 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNI 173 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCccceE
Confidence 99999999999999999999997643 2458999999999999999999995 4799999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccch
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIE 302 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~ 302 (421)
|++.++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-- 248 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 248 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred EEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--
Confidence 99999999999999997532211 1223456889999999999899999999999999999998 99999764321
Q ss_pred hhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 303 QSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
.+...+........+..++..+.+||.+||..||.+||++.++++.|+++....
T Consensus 249 ---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 249 ---------------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp ---------------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---------------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 112222222333445567789999999999999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=343.76 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=203.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 579999999999999999997654 478999999864321 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+++++|.+++..... +++..++.++.|++.||.||| ..||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 99999999999999999999977643 899999999999999999999 55899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------- 214 (279)
T 3fdn_A 156 SVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------- 214 (279)
T ss_dssp ESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----------------
T ss_pred cccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----------------
Confidence 86543322 234678999999999999999999999999999999999999997643211
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
....+ .......+..++..+.+||.+||..||.+||++.++++.
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 215 TYKRI-SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHH-HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHH-HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00111 111223445677889999999999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=356.18 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=202.8
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+|++++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 34679999999999999999997654 5889999999765433 34688888877 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC----CcEEEe
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLS 234 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~----~~~kl~ 234 (421)
+.+..|+||||+.||+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||+..+ +.+||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 9999999999999999999997654 48999999999999999999995 479999999999998443 349999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|||++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+
T Consensus 163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--------- 231 (342)
T 2qr7_A 163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI--------- 231 (342)
T ss_dssp CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---------
T ss_pred ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---------
Confidence 9999986543322 23456899999999999888899999999999999999999999975422111111
Q ss_pred chhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 315 DKRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 315 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+.... ........++.++.+||.+||..||.+||++.++++.
T Consensus 232 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 232 ----LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----HHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----HHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111 1122335678899999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=347.59 Aligned_cols=263 Identities=27% Similarity=0.416 Sum_probs=206.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEE-
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCL- 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~- 158 (421)
..+|++.+.||+|+||.||+|.+... ......+|+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDN------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ceehhhcceeeecCCceEEEEEEecC------CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 35789999999999999999986532 12345789999875432 33466889999999999999999999865
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCchheEEECCCCCEEECcccc
Confidence 4567899999999999999996533 458999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCc--ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--------------- 239 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------------- 239 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---------------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---------------
Confidence 9865432211 12233567889999999999999999999999999999999 55566543221
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.....+........+..++..+.+++.+||..||.+||++.++++.|+++..
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 240 --DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111112222233345567889999999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.59 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=209.3
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
.|++.+.||+|+||+||+|.+... ...+..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQ------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECS------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred EEccCceeccCCCceEEEEEEecC------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 566779999999999999986542 12345799999875433 23467889999999999999999999998766
Q ss_pred eE-EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 162 NR-LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 162 ~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
.. ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE--QKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 65 99999999999999996533 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCC--cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDR--THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
....... ........++..|+|||++.+..++.++|||||||++|+|++|..|+..... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----------------~~~ 236 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----------------PFD 236 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----------------GGG
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----------------HHH
Confidence 6543221 1112335678999999999999999999999999999999996555432211 111
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
....+........+..++..+.+|+.+||..||.+|||+.++++.|+++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 237 LTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2222223333344556778999999999999999999999999999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=347.59 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC--CCCCccc
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL--HHPNLVK 152 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hp~iv~ 152 (421)
.......++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++..+ +||||++
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~ 95 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILG 95 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeee
Confidence 333445678999999999999999999753 678999998643 234455666666554 8999999
Q ss_pred eeeEEEeC----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCCCc
Q 014623 153 LIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASN 222 (421)
Q Consensus 153 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~N 222 (421)
+++++... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+. ..||+||||||+|
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence 99999887 7889999999999999999654 389999999999999999999954 2289999999999
Q ss_pred EEeCCCCcEEEeeccCcccCCCCCCcc--eeeccccccceecccccccCCCCcc------ccchhhhHHHHHHHhCC---
Q 014623 223 ILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVATGRLTTK------SDVYSFGVVLLELLSGR--- 291 (421)
Q Consensus 223 ill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~el~tg~--- 291 (421)
||++.++.+||+|||++.......... .....+||+.|+|||++.+..+... +|||||||++|||++|.
T Consensus 173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999999999999997654332211 1124579999999999988776665 99999999999999994
Q ss_pred -------CccCCCcccchhhhhhhhhhhhhchhhHhHhh-hcccCCCCC-----HHHHHHHHHHHHhccccCCCCCCCHH
Q 014623 292 -------CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPRMS 358 (421)
Q Consensus 292 -------~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt~~ 358 (421)
.||........ ........+ ........+ ..++..+.+||.+||..||.+|||+.
T Consensus 253 ~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 320 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDP------------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320 (337)
T ss_dssp TBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred cccccccccHhhhcCCCC------------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH
Confidence 44433211100 001111111 112222222 37888999999999999999999999
Q ss_pred HHHHHHHhhcCC
Q 014623 359 EVLAILERLEAP 370 (421)
Q Consensus 359 ell~~L~~~~~~ 370 (421)
++++.|+++...
T Consensus 321 ell~~L~~l~~~ 332 (337)
T 3mdy_A 321 RVKKTLAKMSES 332 (337)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhh
Confidence 999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=342.19 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=206.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 4689999999999999999997654 578999999875432 23356789999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc---EEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~D 235 (421)
..+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++. +||+|
T Consensus 76 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 76 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 9999999999999999999987764 38999999999999999999995 47999999999999977655 99999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------------- 215 (284)
T 3kk8_A 152 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------------- 215 (284)
T ss_dssp CTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------
T ss_pred ceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------------
Confidence 999976544322 2346799999999999999999999999999999999999999976432110
Q ss_pred hhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 316 KRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
........ ........++.++.+||.+||..||.+|||+.++++.
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 216 ---YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---HHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 01111111 1111223567889999999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=346.57 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=205.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +|+.||+|++........+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 34689999999999999999997653 578999999986554445678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~Df 236 (421)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 999999999999999999997664 38999999999999999999995 479999999999999 78889999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|++....... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------- 214 (304)
T 2jam_A 154 GLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------------- 214 (304)
T ss_dssp STTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---------------
T ss_pred CcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---------------
Confidence 9997643321 234578999999999999999999999999999999999999997643210
Q ss_pred hhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+.... ........++..+.+||.+||..||.+||++.++++
T Consensus 215 -~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 215 -LFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -HHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -HHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111111 112233466789999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=352.93 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=179.9
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 165 (421)
.+.||+|+||.||+|.+.. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence 4889999999999997654 5789999999643 3456778999999997 9999999999999999999
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC---cEEEeeccCcccC
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF---NAKLSDFGLAKAG 242 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~---~~kl~Dfg~a~~~ 242 (421)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999999999997764 48999999999999999999995 4799999999999997765 7999999999865
Q ss_pred CCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 243 PTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .....+...
T Consensus 160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----------~~~~~~~~~ 227 (325)
T 3kn6_A 160 PPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC----------TSAVEIMKK 227 (325)
T ss_dssp CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C----------CCHHHHHHH
T ss_pred CCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc----------ccHHHHHHH
Confidence 43322 234567899999999999999999999999999999999999999764321100 000111111
Q ss_pred h-hcccCCC--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 323 M-DTKLGGQ--YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 323 ~-~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+ ....... ....++.++.+||.+||..||.+|||+.+++.
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1 1111101 11346789999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=358.13 Aligned_cols=272 Identities=18% Similarity=0.209 Sum_probs=201.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-----------CHHHHHHHHHHHhcCCCCCc
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-----------GHKEWLTEVNYLGQLHHPNL 150 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~i 150 (421)
++|++.+.||+|+||.||+|.+... ..++..+|||++...... ....+.+|+.+++.++||||
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNK------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSS------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred ceEEEEeeEeecCCeEEEEEEecCC------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 5799999999999999999987541 124678999998765321 11346678899999999999
Q ss_pred cceeeEEEe----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 151 VKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 151 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
+++++++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE--NEYVHGDIKAANLLLG 185 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEE
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCcCHHHEEEc
Confidence 999999988 67899999999 999999997655 58999999999999999999995 4799999999999998
Q ss_pred CCC--cEEEeeccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcc
Q 014623 227 AEF--NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299 (421)
Q Consensus 227 ~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 299 (421)
.++ .+||+|||+++........ .......||..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 9999999999765322111 111345799999999999999999999999999999999999999965322
Q ss_pred cchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
..... .......... +...+.... ....++.++.++|.+||..||.+||++.+|++.|+++..+.
T Consensus 266 ~~~~~-~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 266 DPVAV-QTAKTNLLDE---LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp CHHHH-HHHHHHHHHT---TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred ccHHH-HHHHHhhccc---ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 11110 0000000000 000000000 01145678999999999999999999999999998865433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=359.90 Aligned_cols=263 Identities=27% Similarity=0.405 Sum_probs=200.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
..|++.+.||+|+||.||+|.+...+ ..+..||+|.++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETT------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCC------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 35778899999999999999875321 1245789999875332 344678899999999999999999998764
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
++..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred CCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEecCccchheEEECCCCCEEEeecccc
Confidence 457899999999999999996543 458899999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcc--eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 240 KAGPTGDRTH--VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------------- 304 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------------- 304 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---------------
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---------------
Confidence 8654322111 1223457889999999999999999999999999999999 677776543211
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
....+........+..++..+.++|.+||..||.+||++.++++.|+++...
T Consensus 305 --~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 305 --ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111112222234456778899999999999999999999999999987643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=347.02 Aligned_cols=265 Identities=26% Similarity=0.276 Sum_probs=200.0
Q ss_pred cCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 82 RNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
++|++. +.||+|+||.||+|.+.. +++.||||++..........+.+|++++.++ +||||+++++++.+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 578874 789999999999996543 5789999999876656677889999999885 79999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc---EEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN---AKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~---~kl~Df 236 (421)
.+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++. +||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh--CCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 999999999999999999997764 48999999999999999999995 47999999999999988776 999999
Q ss_pred cCcccCCCCCC-----cceeeccccccceeccccccc-----CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh
Q 014623 237 GLAKAGPTGDR-----THVSTQVMGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306 (421)
Q Consensus 237 g~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 306 (421)
|++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99976532211 111223569999999999875 55889999999999999999999999765322100000
Q ss_pred hhhhhhhhchhhHhHhhhcccCCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 307 DWAKPYLSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .......+...+.... ...+ ..++..+.+||.+||..||.+|||+.++++
T Consensus 239 ~~~--~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 239 GEA--CPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp --C--CHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccc--chhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000 0000011111111111 1122 235678999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=349.21 Aligned_cols=246 Identities=26% Similarity=0.298 Sum_probs=194.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++...... ....+..|+..+..+ +|+||+++++++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~ 126 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 3579999999999999999997654 4789999998754322 223455566655554 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+++..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 127 EEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS--QGLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEccce
Confidence 9999999999999 779999887654 459999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..+|.....
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------ 260 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------ 260 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------
Confidence 998754332 2334569999999998876 799999999999999999999766643211
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+.........+..++.++.+||.+||..||.+|||+.++++
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 -WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111111111112345678999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=354.80 Aligned_cols=248 Identities=30% Similarity=0.412 Sum_probs=203.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+.+|+++++.++||||+++++++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 458999999999999999997543 5889999999754322 2356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
..+..++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999996 68888885443 458999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
+..... ....+||+.|+|||++. ++.++.++|||||||++|+|++|..||......
T Consensus 201 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--------------- 259 (348)
T 1u5q_A 201 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------------- 259 (348)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------------
T ss_pred ceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---------------
Confidence 986543 22467999999999885 567899999999999999999999999754321
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..+..+.........+..++..+.+||.+||..||.+|||+.++++..
T Consensus 260 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 260 -SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111112222222223345678899999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=352.15 Aligned_cols=263 Identities=20% Similarity=0.270 Sum_probs=209.9
Q ss_pred CHHHHHHHhcCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCC-CC
Q 014623 73 TFNELKTATRNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLH-HP 148 (421)
Q Consensus 73 ~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hp 148 (421)
.+.......++|.+. +.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+.+++.+. ||
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 89 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence 344555667788887 899999999999997654 57899999987543 234567889999999995 79
Q ss_pred CccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-
Q 014623 149 NLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA- 227 (421)
Q Consensus 149 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~- 227 (421)
||+++++++.+.+..++||||+.+++|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++.
T Consensus 90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~--~givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSI 167 (327)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESCB
T ss_pred CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH--CCeecCcCChHHEEEecC
Confidence 999999999999999999999999999999976655679999999999999999999995 47999999999999988
Q ss_pred --CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 228 --EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 228 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
++.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-- 242 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-- 242 (327)
T ss_dssp TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--
T ss_pred CCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH--
Confidence 7899999999998754332 123467999999999999999999999999999999999999999764321100
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.................++..+.+||.+||..||.+|||+.++++.
T Consensus 243 ------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 ------------LNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------------HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------------HHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0001111122223334677889999999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=371.27 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=208.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.... +|+.||+|++..... .....+.+|+.+|+.++||||+++++++.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 678999999999999999997654 588999999965322 23456889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
..+..|+||||++||+|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+||||+.+|.+||+||
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~--~gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ--RNIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH--cCCcccCCChHHEEEeCCCCEEEeec
Confidence 9999999999999999999997643 3458999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
|+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ .
T Consensus 334 Gla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-------------~ 398 (543)
T 3c4z_A 334 GLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------------N 398 (543)
T ss_dssp TTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-------------H
T ss_pred ceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-------------H
Confidence 99987654332 12346899999999999999999999999999999999999999976432111 0
Q ss_pred hhHh-HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014623 317 RKLF-RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA 362 (421)
Q Consensus 317 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~ 362 (421)
..+. .+... ...++..++..+.+||.+||..||.+||++ .+|+.
T Consensus 399 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 399 KELKQRVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111 11111 223556778899999999999999999975 56653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=345.55 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=199.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+++++.++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 579999999999999999997654 57899999986553322 3567899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHK--HNCIHRDVKPENILITKHSVIKLCDFGFA 149 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCChhhEEEcCCCCEEEeeCCCc
Confidence 999999999999999998886553 48999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-hhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 317 (421)
........ .....+||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... ...........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 150 RLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp EECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 87543221 2234678999999999876 56899999999999999999999999765432111111 00000000000
Q ss_pred hHhH---hhhc-ccCC--C------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFR---IMDT-KLGG--Q------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~---~~~~-~~~~--~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... .... .... . ....++..+.+||.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0000 0000 0 00245678999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=344.63 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=207.9
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
...+|++.+.||+|+||.||+|.+.. +++.||+|.+.... ..+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 45679999999999999999997653 47899999997543 346689999999999999999998864
Q ss_pred ----------------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcE
Q 014623 160 ----------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNI 223 (421)
Q Consensus 160 ----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Ni 223 (421)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Ni 153 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNI 153 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHE
Confidence 4457999999999999999977655569999999999999999999995 4799999999999
Q ss_pred EeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 224 LLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 224 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
|++.++.+||+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 225 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----- 225 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----
T ss_pred EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----
Confidence 999999999999999987544321 234568999999999999999999999999999999999998874211
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
........ ...+..++..+.+||.+||..||.+||++.++++.|..+....
T Consensus 226 -------------~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 -------------KFFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------------HHHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------------HHHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00001111 1223445678899999999999999999999999999886543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=342.49 Aligned_cols=251 Identities=27% Similarity=0.340 Sum_probs=198.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. ++..+|+|++..... ...+.+.+|+++++.++||||+++++++.+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 579999999999999999997654 478999999875432 3457788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEee
Q 014623 161 ENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSD 235 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 235 (421)
...++||||+.+++|.+++... ....+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 9999999999999999998543 23458999999999999999999995 479999999999999 4567899999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|..||.+............
T Consensus 171 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------- 239 (285)
T 3is5_A 171 FGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------- 239 (285)
T ss_dssp CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------
T ss_pred eecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-------
Confidence 99998654332 233467999999999875 5689999999999999999999999976532111100000
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 240 -------~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 240 -------KEPNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------CCccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0111224678899999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=357.38 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=207.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 3579999999999999999997654 578999999976532 234568899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+++++|.+++..... +++..+..++.+++.||.|||+. .||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999999999999977643 89999999999999999999953 26999999999999999999999999998
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh-----------
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW----------- 308 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----------- 308 (421)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 180 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 180 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 643211 12346799999999999999999999999999999999999999976543211111000
Q ss_pred ---------------hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 309 ---------------AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 309 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.......................++.++.+||.+||..||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000001111111122222222346778999999999999999999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=356.99 Aligned_cols=257 Identities=17% Similarity=0.172 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||+||+|.+... .+..+++.||||++... ...++.+|+++++.++ |+||+.+++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 46799999999999999999964331 12346889999999764 3456677888877776 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-------
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRR---GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA------- 227 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~------- 227 (421)
...+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+ .||+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC--
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999999652 33569999999999999999999994 57999999999999988
Q ss_pred ----CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 228 ----EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 228 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~ 294 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence 8999999999997543223333445678999999999999999999999999999999999999999643221100
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhc
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE 368 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~~ 368 (421)
+...+ ... ..++.+.+++..||+.+|.+|+ ++.++.+.|+++.
T Consensus 295 -------------------~~~~~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 -------------------PEGLF-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -------------------ECSCC-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -------------------echhc-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00000 011 2366788999999999999995 7888888887754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.65 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=203.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC----ccCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG----FQGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++.... ......+.+|+++++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4689999999999999999996543 57899999997532 1234678899999999999999999999
Q ss_pred EE--eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 157 CL--EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 157 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+. +....++||||+.++ |.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEcCCCcEEee
Confidence 85 445789999999775 8888877666679999999999999999999995 479999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCC--CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|||++................|+..|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------ 219 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------------ 219 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------------
Confidence 999998765433333344567999999999987654 477999999999999999999999764321
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.....+... ....+..++..+.+||.+||..||.+||++.++++.
T Consensus 220 -----~~~~~i~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 220 -----KLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----HHHHHHHHC-CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----HHHHHHhcC-CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111111 113345667889999999999999999999999964
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=348.71 Aligned_cols=275 Identities=21% Similarity=0.313 Sum_probs=200.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHH--HhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY--LGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+. ++.||||++... ....+..|.++ +..++|+||+++++.+..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEEC-----------CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccc
Confidence 58999999999999999999652 678999998643 23344455555 445899999999986542
Q ss_pred -----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------CCceeeccCCCCcEEeCC
Q 014623 160 -----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA-------ESQVIYRDFKASNILLDA 227 (421)
Q Consensus 160 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-------~~~ivHrDlkp~Nill~~ 227 (421)
....++||||+++|+|.+++.... .++..++.++.||+.||.|||+. ..||+||||||+||||+.
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 235789999999999999996654 58889999999999999999943 118999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCC------cceeeccccccceeccccccc-------CCCCccccchhhhHHHHHHHhCCCcc
Q 014623 228 EFNAKLSDFGLAKAGPTGDR------THVSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLSGRCAV 294 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~pf 294 (421)
++.+||+|||++........ .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999986543221 112234579999999999987 45677899999999999999998777
Q ss_pred CCCccc-chhhhhhhhhhhhhchhhHhHhh-hcccCCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 295 DKTKVG-IEQSLVDWAKPYLSDKRKLFRIM-DTKLGGQY------PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 295 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
...... ......................+ ........ ...++..+.+||.+||..||.+|||+.++++.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 433221 11100000000000001111111 11111222 23578899999999999999999999999999999
Q ss_pred hcCCCCC
Q 014623 367 LEAPKNS 373 (421)
Q Consensus 367 ~~~~~~~ 373 (421)
+......
T Consensus 316 ll~~~~~ 322 (336)
T 3g2f_A 316 LMMIWER 322 (336)
T ss_dssp HHHCCCC
T ss_pred HHHHHHh
Confidence 8766544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=361.46 Aligned_cols=276 Identities=20% Similarity=0.259 Sum_probs=213.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 3689999999999999999997654 578999999975432 345677899999999999999999999987
Q ss_pred CC--eEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe----CCCCcEE
Q 014623 160 GE--NRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DAEFNAK 232 (421)
Q Consensus 160 ~~--~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~~~~~k 232 (421)
.+ ..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH--CCEEECCcCHHHEEEeecCCCceeEE
Confidence 65 77999999999999999965432 338999999999999999999995 479999999999999 7788899
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc--------CCCCccccchhhhHHHHHHHhCCCccCCCcccc--h
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI--E 302 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~--~ 302 (421)
|+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~ 233 (396)
T 4eut_A 157 LTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233 (396)
T ss_dssp ECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred EecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence 99999998754432 2234679999999998865 567889999999999999999999996533211 1
Q ss_pred hhhhhhhhhhhh-chhhHhHhh--------hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 303 QSLVDWAKPYLS-DKRKLFRIM--------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 303 ~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
............ ......... ...........++..+.++|.+||..||++||++.++++.++.+...
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111111000000 000000000 00111234478899999999999999999999999999999887654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=340.74 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=206.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. ++..||+|++.... ......+.+|+++++.++||||+++++++.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 579999999999999999997654 47899999986432 123467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+++++|.+++.... .+++..++.++.|++.||.||| ..||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEecccc
Confidence 9999999999999999999997764 3899999999999999999999 55899999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||....... .
T Consensus 161 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~ 220 (284)
T 2vgo_A 161 SVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----------------T 220 (284)
T ss_dssp CEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred cccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----------------H
Confidence 87654322 234678999999999999999999999999999999999999997643210 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+... ....+..++..+.++|.+||..||.+||++.++++
T Consensus 221 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 221 HRRIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111111 12344567788999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=350.66 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=207.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||++.+.. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3689999999999999999997654 578999999875432 2345678999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCEecCCCchhEEEcCCCCEEEeecc
Confidence 99999999999999999999987654 48999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++........ ......||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------------- 248 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------- 248 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----------------
Confidence 9987543222 1234679999999999999999999999999999999999999997643210
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
....+... ....+..++..+.+||.+||..||.+||++.++++.
T Consensus 249 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 249 TYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHHHHHT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhcC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111111 112345667789999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=339.55 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=202.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCCe
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGEN 162 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 162 (421)
+|.....||+|+||.||+|.+.. ++..||||.+........+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 45556699999999999997654 578999999987665556788999999999999999999999999999
Q ss_pred EEEEEEcCCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCcEEEeeccCcc
Q 014623 163 RLLVYEFMPKGSLENHLFRRG-PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFNAKLSDFGLAK 240 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~~kl~Dfg~a~ 240 (421)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+|||++. ++.+||+|||++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD--NQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh--CCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999999997653 3456788999999999999999995 47999999999999987 8999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCC--CCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
....... ......|+..|+|||++.+.. ++.++|||||||++|+|++|..||........ .
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------------~ 234 (295)
T 2clq_A 172 RLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------------A 234 (295)
T ss_dssp ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---------------H
T ss_pred ccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---------------H
Confidence 6543221 123467899999999987654 88999999999999999999999964321110 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.............+..++.++.+||.+||..||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111112233445667889999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.04 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=204.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 74 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence 3579999999999999999997654 5789999998754322 356788999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----c
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----N 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~ 230 (421)
+++.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++ .
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 75 DIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSSSSCC
T ss_pred heecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCChHHEEEecCCCCCCc
Confidence 99999999999999999999999997654 48999999999999999999995 4799999999999998877 7
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------- 219 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------- 219 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--------
Confidence 99999999987543321 2345789999999999999999999999999999999999999976432110
Q ss_pred hhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 311 PYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
...+..... .......++..+.+||.+||..||.+||++.++++ .++.+
T Consensus 220 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 220 --------LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp --------HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --------HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 000000000 00011244678899999999999999999999996 45554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=379.24 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=208.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcC-CCCCccceee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQL-HHPNLVKLIG 155 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~ 155 (421)
..++|++++.||+|+||.||+|.+.. +++.||||+++... ......+..|..++..+ +||||+.+++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34689999999999999999997654 57899999987432 13345678899999988 6999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
++.+.+.+||||||+.||+|.+++..... +++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+|
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~--~gIiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TSEECCCCCSTTEEECSSSCEEECC
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHh--CCeEeccCChhhEEEcCCCcEEEee
Confidence 99999999999999999999999987653 8999999999999999999995 4799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+++....... .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+....
T Consensus 486 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------------- 548 (674)
T 3pfq_A 486 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------------- 548 (674)
T ss_dssp CTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---------------
T ss_pred cceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---------------
Confidence 999986433222 244578999999999999999999999999999999999999999765321
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM-----SEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~ 362 (421)
.....++.. ...++..++.++.+||.+||..||.+||++ .+|++
T Consensus 549 -~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 -ELFQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -HHHHHHHSS--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -HHHHHHHhC--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111122222 224566788999999999999999999987 66653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.92 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=193.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++....... ...+.+|+++++.++||||+++++++.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH 103 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence 3579999999999999999997654 58899999997554322 345779999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe-----CCCCcEEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL-----DAEFNAKL 233 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill-----~~~~~~kl 233 (421)
+.+..++||||+. ++|.+++..... +++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||
T Consensus 104 ~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~--~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 104 HNHRLHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred cCCEEEEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHh--CCEECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999999997 599999977654 8999999999999999999995 479999999999999 44556999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhh-hh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDW-AK 310 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~-~~ 310 (421)
+|||++........ .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .... ..
T Consensus 179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999976533221 23346789999999999875 48999999999999999999999997654321110 0000 00
Q ss_pred hhhhchhhHhHhh--h---cccCC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIM--D---TKLGG-----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~--~---~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+............ . ..... ..+..++.++.+||.+||..||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000000 0 00000 011225678899999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=350.05 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=195.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCH-HHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++........ ..+.+|+++++.++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 479999999999999999997654 578999999975432211 2345799999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 148 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR--QKVLHRDLKPQNLLINERGELKLADFGLAR 148 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEEESSCCGGGEEECTTCCEEECSSSEEE
T ss_pred CEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCcCHHHEEECCCCCEEEccCcccc
Confidence 99999999996 59999887654 358999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-hhh---hh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-KPY---LS 314 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~~~---~~ 314 (421)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........ +.... .+. +.
T Consensus 149 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 149 AKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp CC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 654322 12334578999999999876 568999999999999999999999997754321111 10000 000 00
Q ss_pred ---chhhHhHhhhcccCC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 ---DKRKLFRIMDTKLGG----QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ---~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
............... .....++.++.+||.+||..||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000000 011245678899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=342.58 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=208.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
+.|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 579999999999999999997643 578999999975543 3457788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCChheEEECCCCCEEEeecccce
Confidence 999999999999999999854 348999999999999999999995 479999999999999999999999999997
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----------------~~~ 228 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----------------KVL 228 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------HHH
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----------------HHH
Confidence 6543221 223467899999999999999999999999999999999999999754321 011
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 364 (421)
..+........+..++..+.+||.+||..||.+|||+.++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 229 FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 11111222233456677899999999999999999999998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=339.72 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=199.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 468889999999999999997654 578999999875432 234568899999999999999999999875
Q ss_pred ----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-CCCcEEEe
Q 014623 160 ----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLS 234 (421)
Q Consensus 160 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~ 234 (421)
....++||||+++++|.+++..... +++..++.++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 3568999999999999999977543 8999999999999999999995433399999999999997 78999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|||++....... .....||+.|+|||++. +.++.++|||||||++|+|++|..||.........
T Consensus 175 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----------- 238 (290)
T 1t4h_A 175 DLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 238 (290)
T ss_dssp CTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----------
T ss_pred eCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----------
Confidence 999997644322 23467999999999876 45999999999999999999999999754321100
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.............+...+.++.+||.+||..||.+|||+.++++
T Consensus 239 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 239 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----HHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111111111122344568999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=362.22 Aligned_cols=268 Identities=22% Similarity=0.306 Sum_probs=197.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+++.+|+++|+.++||||+++++++.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4689999999999999999997654 588999999975422 23467889999999999999999999987
Q ss_pred eC-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
.. ...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEE
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEECCCCCEEE
Confidence 66 57899999995 6999999654 3489999999999999999999954 7999999999999999999999
Q ss_pred eeccCcccCCCCCCc--------------------ceeeccccccceeccccc-ccCCCCccccchhhhHHHHHHHhCCC
Q 014623 234 SDFGLAKAGPTGDRT--------------------HVSTQVMGTHGYAAPEYV-ATGRLTTKSDVYSFGVVLLELLSGRC 292 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~ 292 (421)
+|||+++........ ......+||++|+|||++ .+..|+.++||||||||+|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876433211 123457899999999986 55669999999999999999998655
Q ss_pred ccCCCcccc--------------------------hhh---hhh-hhhhhhh-----chhhHhHhhhcc-cCCCC-----
Q 014623 293 AVDKTKVGI--------------------------EQS---LVD-WAKPYLS-----DKRKLFRIMDTK-LGGQY----- 331 (421)
Q Consensus 293 pf~~~~~~~--------------------------~~~---~~~-~~~~~~~-----~~~~~~~~~~~~-~~~~~----- 331 (421)
||.....+. .+. +.. ...+... ........+... .....
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 553221100 000 000 0000000 000111111100 00000
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 332 PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 332 ~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.++.++.+||.+||..||.+|||+.|+++
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1346788999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=345.06 Aligned_cols=263 Identities=28% Similarity=0.434 Sum_probs=201.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+... .+.+..||||+++.... ...+.+.+|+++++.++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHeeeeeeecCCCceeEEEEEeccC------CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 5799999999999999999976532 12234789999875432 23467889999999999999999999987
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
... .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh--CCcccCCCchheEEEcCCCCEEEccccc
Confidence 654 899999999999999997643 348899999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 239 AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 239 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------------- 231 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---------------- 231 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----------------
Confidence 98765433221 1223557889999999999899999999999999999999 99999764321
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.....+.........+..++..+.++|.+||..||.+||++.++++.|+++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 111112222222334456788999999999999999999999999999988654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=365.73 Aligned_cols=250 Identities=27% Similarity=0.349 Sum_probs=203.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC--ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG--FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ......+.+|+++++.++||||+++++++.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 4679999999999999999997653 57899999986432 234567889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC---CCCcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~D 235 (421)
+....++||||+.+++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++ .++.+||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 167 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIID 167 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCchHHEEEecCCCCCCEEEEE
Confidence 9999999999999999999997764 38999999999999999999995 4799999999999995 456799999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....
T Consensus 168 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------- 229 (486)
T 3mwu_A 168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------------- 229 (486)
T ss_dssp CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred CCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence 99998654432 2334679999999998875 59999999999999999999999997653211
Q ss_pred hhhHhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 316 KRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 316 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+..+....... .....++.++.+||.+||..||.+|||+.++++.
T Consensus 230 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 230 --ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --HHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --HHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111111 1124567889999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=339.56 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=207.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +++.+|+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 3689999999999999999997654 578999999865432 2345678899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg 160 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR--NRVIHRDLKLGNLFLNEDLEVKIGDFG 160 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEcCCCCEEEEecc
Confidence 99999999999999999999987654 48999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------- 222 (294)
T 2rku_A 161 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---------------- 222 (294)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------
T ss_pred CceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------
Confidence 9987543222 1234678999999999999899999999999999999999999997643211
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
........ ....+..++..+.+||.+||..||.+||++.++++.
T Consensus 223 ~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 223 TYLRIKKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHhhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111111 123345667889999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.20 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=191.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEE-
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCL- 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~- 158 (421)
..+|++.+.||+|+||.||+|.+.. +++.||||++..........+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 3589999999999999999997654 57899999987665555667889999999996 999999999984
Q ss_pred -------eCCeEEEEEEcCCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 159 -------EGENRLLVYEFMPKGSLENHLFR-RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 159 -------~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
.....++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+.+.+|+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3345799999995 699998865 2334599999999999999999999954223999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcc----------eeeccccccceeccccc---ccCCCCccccchhhhHHHHHHHhCCCccCCC
Q 014623 231 AKLSDFGLAKAGPTGDRTH----------VSTQVMGTHGYAAPEYV---ATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
+||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998754432211 11135689999999998 5667899999999999999999999999653
Q ss_pred cccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
... ..+............+..+.+||.+||+.||.+||++.++++.|+.+...
T Consensus 257 ~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 257 AKL--------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHH--------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 211 11111111222233445688999999999999999999999999988643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=365.20 Aligned_cols=264 Identities=22% Similarity=0.261 Sum_probs=206.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC-CCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+++++.|.| ++|..+..++..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~ 74 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE 74 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 4689999999999999999997654 4789999998755332 357789999999986 566666667778
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~Df 236 (421)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||| +.++.+||+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDIKP~NILl~~~~~~~~vkL~DF 150 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCcceEEEecCCCCCeEEEEeC
Confidence 88899999999 999999997543 359999999999999999999995 479999999999999 58899999999
Q ss_pred cCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 237 GLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 237 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
|+++........ ......+||..|+|||++.+..++.++|||||||+||+|++|+.||.+...............
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh
Confidence 999875543221 112256799999999999999999999999999999999999999987543222111111000
Q ss_pred hhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
......+. .....++.++.+||.+||..||++||++.+|++.|+.+..
T Consensus 231 -----~~~~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 231 -----KKVATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -----HHHHSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----ccccccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00000000 0112346789999999999999999999999999988743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=361.35 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=192.8
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCCCCCc
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--------QGHKEWLTEVNYLGQLHHPNL 150 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~i 150 (421)
...++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+|+.++||||
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 202 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence 456799999999999999999997654 578999999875321 112347799999999999999
Q ss_pred cceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-
Q 014623 151 VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF- 229 (421)
Q Consensus 151 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~- 229 (421)
+++++++. .+..++||||+.+++|.+++.... .+++..++.++.|++.||+|||+ .||+||||||+|||++.++
T Consensus 203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCCC
Confidence 99999874 566899999999999999886554 48999999999999999999995 4799999999999997544
Q ss_pred --cEEEeeccCcccCCCCCCcceeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 230 --NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 230 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
.+||+|||+++...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||........
T Consensus 278 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-- 352 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 352 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred cceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence 59999999998764322 2345789999999999863 5688899999999999999999999975432111
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+...+........ ...++..+.+||.+||..||.+||++.++++
T Consensus 353 --------------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 353 --------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --------------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --------------HHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0111111110001 1235778999999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=366.90 Aligned_cols=254 Identities=27% Similarity=0.373 Sum_probs=208.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.... +++.||||++..... .....+.+|+.+++.++||||+++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 95 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999997653 588999999865432 3456788999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEe
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLS 234 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~ 234 (421)
.+.+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 96 EDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence 99999999999999999999997654 48999999999999999999995 479999999999999 567899999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|||++........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....
T Consensus 172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------------- 234 (484)
T 3nyv_A 172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------------- 234 (484)
T ss_dssp CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------
T ss_pred eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------------
Confidence 9999987544332 234679999999998866 69999999999999999999999997653211
Q ss_pred chhhHhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 315 DKRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
.+..+....... .....++..+.+||.+||..||.+|||+.++++ .+...
T Consensus 235 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 235 ---ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 111111111111 112457789999999999999999999999996 44443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=344.20 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=206.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3579999999999999999997654 578999999976543 23456889999999999999999999886
Q ss_pred e--CCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC---CceeeccCCCCcEEeCCCCcE
Q 014623 159 E--GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 159 ~--~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~ 231 (421)
+ ....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~ 155 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence 4 56889999999999999999653 2345899999999999999999999642 129999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
||+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------- 222 (279)
T 2w5a_A 156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----------- 222 (279)
T ss_dssp EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------
T ss_pred EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-----------
Confidence 9999999986543221 123457899999999999999999999999999999999999999764321
Q ss_pred hhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 014623 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 366 (421)
.+...+........+..++.++.++|.+||..||.+||++.++++.+..
T Consensus 223 ------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 223 ------ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1111112222223455677899999999999999999999999986643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=365.06 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=199.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|.+.. ++..||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3579999999999999999997654 578999999876432 33467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC---CcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl~D 235 (421)
+....++|||||.+|+|.+++..... +++..++.++.||+.||.|||+ .||+||||||+|||++.. +.+||+|
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCceeccCChhhEEEeCCCCCCcEEEEE
Confidence 99999999999999999999977643 8999999999999999999995 479999999999999764 4599999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+.....
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------- 244 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------------- 244 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Confidence 99998765432 234467999999999876 569999999999999999999999997653211
Q ss_pred hhhHhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+....... .....++..+.+||.+||..||.+|||+.++++
T Consensus 245 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 245 --ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --HHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 011111111111 111356788999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=339.57 Aligned_cols=249 Identities=29% Similarity=0.411 Sum_probs=184.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 579999999999999999997643 578999999864321 23467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 9999999999999999999996543 458999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------- 220 (278)
T 3cok_A 159 ATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------------- 220 (278)
T ss_dssp CEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------
T ss_pred eeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------
Confidence 986543221 12346789999999999998999999999999999999999999976432110
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....... ....+..++.++.+||.+||..||.+||++.++++
T Consensus 221 ~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 LNKVVLA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCSS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhhc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000001 11234456778999999999999999999999885
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=349.75 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=199.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 45789999999999999999997653 47899999987543 3346788999999998 7999999999998
Q ss_pred e------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 E------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
. .+..++||||+.+++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCEE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCcHHHEEEcCCCCEE
Confidence 7 4678999999999999999987654568999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
|+|||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||......
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------- 240 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------
Confidence 999999986543211 123467999999999987 567899999999999999999999999654321
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+............++..+.+||.+||..||.+||++.++++
T Consensus 241 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 ---------RALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ---------HHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---------HHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111111111111223456778999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=341.13 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=202.9
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEE-E
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC-L 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~ 158 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+++++.++|++++..+.++ .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 45789999999999999999997543 5789999987654322 3577899999999988877766655 5
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---CCCCcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL---DAEFNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill---~~~~~~kl~D 235 (421)
..+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeeeeccCCCCeEEEec
Confidence 677889999999 999999997543 348999999999999999999995 479999999999999 7889999999
Q ss_pred ccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 236 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--- 228 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE--- 228 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH---
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh---
Confidence 9999875443221 11234679999999999999999999999999999999999999997643321111110
Q ss_pred hhhhchhhHhHhhhcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 311 PYLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
......... .....++.++.+||.+||+.||.+||++.++++.|+++...
T Consensus 229 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 229 ----------RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ----------HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----------hhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 000000000 01123467899999999999999999999999999987643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=364.55 Aligned_cols=255 Identities=25% Similarity=0.326 Sum_probs=204.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-------------cCHHHHHHHHHHHhcCC
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-------------QGHKEWLTEVNYLGQLH 146 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~ 146 (421)
..++|++.+.||+|+||+||+|.... ++..||||++..... ...+.+.+|+.+|+.++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 104 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD 104 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence 45789999999999999999997654 578999999875432 23456889999999999
Q ss_pred CCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 147 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
||||+++++++.+....++|||||.||+|.+++..... +++..++.++.||+.||.|||+ .||+||||||+|||++
T Consensus 105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHK--HNIVHRDIKPENILLE 180 (504)
T ss_dssp CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEES
T ss_pred CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCcHHHEEEe
Confidence 99999999999999999999999999999999977643 8999999999999999999995 4799999999999998
Q ss_pred CCC---cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 227 AEF---NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 227 ~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
.++ .+||+|||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||.+......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~- 255 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI- 255 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred cCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 776 69999999998765432 233467999999999876 5699999999999999999999999976532110
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
+..+......... ...++.++.+||.+||..||.+|||+.++++ .+.+.
T Consensus 256 ---------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 256 ---------------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ---------------HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ---------------HHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 1111111111000 1245778999999999999999999999985 44443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=350.47 Aligned_cols=269 Identities=26% Similarity=0.303 Sum_probs=197.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-----HHHHHHHHHHHhcCCCCCcccee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-----HKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
..++|++.+.||+|+||.||+|.+.. +|+.||||++....... ...+.+|+++++.++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 45789999999999999999996543 58899999987543221 24678999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
+++.+.+..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLA 154 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEEcCCCCEEEE
Confidence 999999999999999975 8988886543 457888999999999999999995 479999999999999999999999
Q ss_pred eccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKP 311 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~ 311 (421)
|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....... .+... ..+
T Consensus 155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999987643322 23346789999999998764 5899999999999999999999999765421110 00000 000
Q ss_pred hhh---chhhHhHhhhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 312 YLS---DKRKLFRIMDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 312 ~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... +.......+........ ...++.++.+||.+||..||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00000000000000000 13456789999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=344.56 Aligned_cols=269 Identities=24% Similarity=0.358 Sum_probs=210.2
Q ss_pred CHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc--CCCCCc
Q 014623 73 TFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ--LHHPNL 150 (421)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hp~i 150 (421)
.+.......++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|++++.. ++||||
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni 98 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENI 98 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTB
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcE
Confidence 34444566789999999999999999999752 678999999643 34567788888877 789999
Q ss_pred cceeeEEEeCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCC
Q 014623 151 VKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKA 220 (421)
Q Consensus 151 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp 220 (421)
+++++++.... ..++||||+.+|+|.+++.+. .+++..++.++.|++.||.|||.. ..||+||||||
T Consensus 99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 175 (342)
T 1b6c_B 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175 (342)
T ss_dssp CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG
T ss_pred EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH
Confidence 99999998776 789999999999999999764 389999999999999999999932 34799999999
Q ss_pred CcEEeCCCCcEEEeeccCcccCCCCCCcc--eeeccccccceecccccccC------CCCccccchhhhHHHHHHHhC--
Q 014623 221 SNILLDAEFNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVATG------RLTTKSDVYSFGVVLLELLSG-- 290 (421)
Q Consensus 221 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg-- 290 (421)
+|||++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999997654332211 12345799999999998776 234689999999999999999
Q ss_pred --------CCccCCCcccchhhhhhhhhhhhhchhhHhHh-hhcccCCCCC-----HHHHHHHHHHHHhccccCCCCCCC
Q 014623 291 --------RCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI-MDTKLGGQYP-----QKAAHTAATLALQCLNNEPKLRPR 356 (421)
Q Consensus 291 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~dP~~Rpt 356 (421)
..||........ ....+... .........+ ..++..+.+||.+||..||.+|||
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDP------------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSC------------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred cCCcccccccCccccCcCcc------------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 667754322110 00111111 1122222222 367789999999999999999999
Q ss_pred HHHHHHHHHhhcCC
Q 014623 357 MSEVLAILERLEAP 370 (421)
Q Consensus 357 ~~ell~~L~~~~~~ 370 (421)
+.+|++.|+++...
T Consensus 324 ~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 324 ALRIKKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999988643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=353.67 Aligned_cols=258 Identities=28% Similarity=0.345 Sum_probs=205.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcC-CCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~ 156 (421)
++|++.+.||+|+||.||+|.... ...+++.||||+++.... ...+.+.+|+++++.+ .||||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcc------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 579999999999999999997642 123588999999875321 2334566899999999 69999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+...+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+||
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCcEEEeeC
Confidence 999999999999999999999997764 38999999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccC--CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|+++....... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----------- 271 (355)
T 1vzo_A 204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----------- 271 (355)
T ss_dssp SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-----------
T ss_pred CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-----------
Confidence 99986543221 223356899999999999863 4788999999999999999999999754321110
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLAIL 364 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~L 364 (421)
..+...+. .....++..++..+.+||.+||..||.+|| ++.++++..
T Consensus 272 --~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 272 --AEISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --HHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --HHHHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00111111 112234566778899999999999999999 899988644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.18 Aligned_cols=262 Identities=22% Similarity=0.253 Sum_probs=206.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEE-Ee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYC-LE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+|+.+++.++|++++..+.++ ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 4689999999999999999997543 588999999876533 24678999999999988876666555 56
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC---CCCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~Df 236 (421)
.+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++ .++.+||+||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 77889999999 999999996443 458999999999999999999995 4799999999999994 7889999999
Q ss_pred cCcccCCCCCCcc-----eeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 237 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
|++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---- 228 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE---- 228 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH----
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh----
Confidence 9998654432211 1234679999999999999999999999999999999999999997643221111110
Q ss_pred hhhchhhHhHhhhcccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 312 YLSDKRKLFRIMDTKLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+....... .....++..+.+||.+||+.||.+||++.++++.|+++...
T Consensus 229 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 229 ---------RISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp ---------HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------hhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 000000000 01134567899999999999999999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=347.98 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=206.2
Q ss_pred HHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--------CHHHHHHHHHHHhcC
Q 014623 74 FNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--------GHKEWLTEVNYLGQL 145 (421)
Q Consensus 74 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l 145 (421)
+.......++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.+
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 156 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHh
Confidence 33445556789999999999999999997653 4889999998754321 134577899999999
Q ss_pred -CCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 146 -HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 146 -~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
+||||+++++++......++||||+.|++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 157 ~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENIL 232 (365)
T ss_dssp TTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEE
T ss_pred cCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence 79999999999999999999999999999999997654 38999999999999999999995 47999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc------CCCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
++.+|.+||+|||++........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999987654332 234689999999998864 358889999999999999999999997543
Q ss_pred ccchhhhhhhhhhhhhchhhHhHhhhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 299 VGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ...+......... ...++..+.+||.+||..||.+||++.++++
T Consensus 310 ~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 QILM----------------LRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH----------------HHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHH----------------HHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2100 0011111110000 0234567999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=338.73 Aligned_cols=245 Identities=19% Similarity=0.260 Sum_probs=200.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC-CCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQL-HHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++..+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~ 80 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 4679999999999999999997654 478999999876433 2345678899999998 899999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-------
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRG--PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------- 228 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 228 (421)
.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEC---------
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeecCCCHHHEEEcCCCCCcccc
Confidence 99999999999999999999997642 1458999999999999999999995 479999999999999844
Q ss_pred ------------CcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccC
Q 014623 229 ------------FNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 229 ------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
..+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|+|++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 479999999998754322 24589999999999876 56789999999999999999987764
Q ss_pred CCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 296 KTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... . ..+........+..++..+.+||.+||..||.+|||+.++++
T Consensus 233 ~~~~-------------------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 233 NGDQ-------------------W-HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SSHH-------------------H-HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhH-------------------H-HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 3210 0 111112223345567789999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.78 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=196.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+++.+|+++|+.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 4689999999999999999997654 588999999865432 22356889999999999999999999998
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
... ..|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCHHHEEEcCCCCEE
Confidence 653 469999999 88999998663 48999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA- 309 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~- 309 (421)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .+....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999875432 234678999999999887 67999999999999999999999999865432110 111100
Q ss_pred hhhhh------c--hhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPYLS------D--KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~~~------~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+... . .......+..... .......+..+.+||.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000 0 0000000000000 0122356788999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=340.17 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=202.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
..++|++.+.||+|+||.||+|.+.. +|+.||||.+.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34689999999999999999997654 57899999997653 34678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 172 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVA 172 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999996433 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
........ ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 173 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~ 234 (314)
T 3com_A 173 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA----------------I 234 (314)
T ss_dssp EECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------H
T ss_pred hhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH----------------H
Confidence 76543221 22346789999999999999999999999999999999999999975432100 0
Q ss_pred hHhhh-cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... .......+..++..+.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 235 FMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000 01111234456788999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.95 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=174.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC------CCCCccce
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL------HHPNLVKL 153 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~ 153 (421)
...+|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+|+++++.+ +|+||+++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 34679999999999999999997654 57899999997542 2234566788877766 57899999
Q ss_pred eeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc--E
Q 014623 154 IGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--A 231 (421)
Q Consensus 154 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--~ 231 (421)
++++...+..++||||+. ++|.+++.......+++..+..++.||+.||+|||+. ||+||||||+||||+.++. +
T Consensus 165 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp EEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCE
T ss_pred EeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcce
Confidence 999999999999999995 6999999887766799999999999999999999964 7999999999999999887 9
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcc
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 299 (421)
||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999764332 2346799999999999999999999999999999999999999977543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=346.83 Aligned_cols=266 Identities=26% Similarity=0.392 Sum_probs=199.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++....... .+.+.+|+.+++.++||||+++++++.+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 579999999999999999997654 57899999986543322 3457799999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH--CCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 999999999999988888775443 48999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhhhhhhhchh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 317 (421)
........ ......||..|+|||++.+. .++.++|||||||++|+|++|..||.......... .............
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 76543221 23346789999999998875 68999999999999999999999997654321111 0000000000000
Q ss_pred hHhHh-------hhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 KLFRI-------MDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ~~~~~-------~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... ......... ...++..+.+||.+||..||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000000 1245788999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.61 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=198.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 80 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 4689999999999999999997653 57899999986432 23345788999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
...+..++||||+.+++|.+++..... +++..++.++.|++.||.|||+. ||+|+||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 81 STPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH--CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChhhEEECCCCCEEEeecc
Confidence 999999999999999999999977643 89999999999999999999954 79999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------------- 218 (276)
T 2h6d_A 157 LSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------------- 218 (276)
T ss_dssp GGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------
T ss_pred cccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---------------
Confidence 998764432 1234578999999999988765 679999999999999999999997543210
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+.+... ....+..++..+.++|.+||..||.+|||+.++++.
T Consensus 219 --~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 219 --LFKKIRGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --HHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HHHHhhcC-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111111 112344567789999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=348.66 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=192.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 3689999999999999999997654 578999999975432 23356789999999999999999999998
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
..+ ..++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp SCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEE
T ss_pred cccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH--CCeecccCCHHHEEEcCCCCEE
Confidence 654 7899999996 478888852 38899999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~ 310 (421)
|+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... .+... ..
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998654322 233467999999999999999999999999999999999999999765431110 00000 00
Q ss_pred h---hhhch-hhHhHhhhc---------------ccCC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 311 P---YLSDK-RKLFRIMDT---------------KLGG---QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 311 ~---~~~~~-~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+ +.... ......... .... ......+..+.+||.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 00000 000000000 0000 0112447889999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=344.97 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=199.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++...... ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 87 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence 579999999999999999997654 5789999998654332 23567899999999999999999999887
Q ss_pred --------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 --------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.+..++||||+.+ +|.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 88 KASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp C--------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCE
T ss_pred cccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCHHHEEEcCCCCE
Confidence 4468999999965 8887775543 348999999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCC--cceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-h
Q 014623 232 KLSDFGLAKAGPTGDR--THVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-D 307 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~ 307 (421)
||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... .
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999986542221 112234678999999998876 45899999999999999999999999875432111111 0
Q ss_pred hhhh----hhhchh--hHhHhhhcccCCCC--CH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 308 WAKP----YLSDKR--KLFRIMDTKLGGQY--PQ-----KAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 308 ~~~~----~~~~~~--~~~~~~~~~~~~~~--~~-----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.... ...... .....+........ .. ..+..+.+||.+||..||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000 000000 00000000000000 00 124578899999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=352.72 Aligned_cols=274 Identities=17% Similarity=0.178 Sum_probs=206.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccc--------
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVK-------- 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~-------- 152 (421)
.++|++.+.||+|+||.||+|.+...... .....++.||||++... +.+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 36899999999999999999987642100 01113788999998754 45778999999999999988
Q ss_pred -------eeeEEEe-CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 153 -------LIGYCLE-GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 153 -------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
+++++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dikp~NIl 191 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE--NEYVHGNVTAENIF 191 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCCGGGEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh--CCccCCCCCHHHEE
Confidence 6777776 67889999999 9999999987644569999999999999999999995 47999999999999
Q ss_pred eCCCC--cEEEeeccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCC
Q 014623 225 LDAEF--NAKLSDFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT 297 (421)
Q Consensus 225 l~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 297 (421)
++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999765432211 1123357999999999999999999999999999999999999999764
Q ss_pred cccchhhhhhhhhhhhhchhhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 298 KVGIEQSLVDWAKPYLSDKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
...... ...... .......... .......++..+.+||.+||..||.+||++.+|++.|+++....
T Consensus 272 ~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNTED-IMKQKQ-------KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTCHHH-HHHHHH-------HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcCHHH-HHHHHH-------hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 321111 000000 0000000000 00011245688999999999999999999999999999876443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=341.56 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=200.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 4689999999999999999997654 5789999999877666778899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .|++||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc--CCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 99999999999999999886543 348999999999999999999995 479999999999999999999999999875
Q ss_pred cCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
..... ........|+..|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 166 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------- 229 (302)
T 2j7t_A 166 KNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------------- 229 (302)
T ss_dssp HHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------------
T ss_pred ccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------------
Confidence 32110 11123357899999999883 6678999999999999999999999997643210
Q ss_pred hhhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......... ....+..++..+.+||.+||..||.+|||+.++++
T Consensus 230 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 230 --VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --HHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111111111 11234566788999999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.83 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=204.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC--------CCCccc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH--------HPNLVK 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hp~iv~ 152 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||++.... ...+.+.+|+.+++.++ |+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 4689999999999999999997654 57899999997542 33456789999999885 788999
Q ss_pred eeeEEE----eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC
Q 014623 153 LIGYCL----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 153 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~ 228 (421)
+++++. .....++||||+ +++|.+++.......+++..++.++.||+.||.|||+. .||+||||||+||||+.+
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCC
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEecc
Confidence 999988 456789999999 67888888766556699999999999999999999953 279999999999999877
Q ss_pred C-------------------------------------------------cEEEeeccCcccCCCCCCcceeeccccccc
Q 014623 229 F-------------------------------------------------NAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259 (421)
Q Consensus 229 ~-------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 259 (421)
+ .+||+|||++...... ....+||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~ 258 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence 5 7999999999865432 234578999
Q ss_pred eecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-------hhhhhhhhh--------------hhchh-
Q 014623 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-------SLVDWAKPY--------------LSDKR- 317 (421)
Q Consensus 260 y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~~~~--------------~~~~~- 317 (421)
|+|||++.+..++.++|||||||++|+|++|..||......... ......... .....
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 99999999999999999999999999999999999754422110 000000000 00000
Q ss_pred ----------hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 318 ----------KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 318 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+.. ....+...+..+.+||.+||..||.+|||+.++++
T Consensus 339 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp BSSCCCCCCCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccCCcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 11345778899999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=342.15 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=200.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEe-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLE- 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 159 (421)
++|++.+.||+|+||.||+|.+.. +++.||||+++.. ..+.+.+|+.+++.++ ||||+++++++.+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 679999999999999999997654 5789999999753 3467889999999997 9999999999987
Q ss_pred -CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeecc
Q 014623 160 -GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFG 237 (421)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg 237 (421)
....++||||+.+++|.+++.. +++..+..++.|++.||.|||+ .||+||||||+|||++.++ .+||+|||
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 6678999999999999998842 7889999999999999999995 4799999999999999776 89999999
Q ss_pred CcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh--hhhh-hhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAK-PYL 313 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~~~~-~~~ 313 (421)
+++....... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ .... +..
T Consensus 177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 9986544332 234678999999999877 67899999999999999999999999654322111100 0000 000
Q ss_pred h---------chhhHhHhhh--------cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 S---------DKRKLFRIMD--------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~---------~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .......... ..........++.++.+||.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000000000 01111223346889999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=359.53 Aligned_cols=247 Identities=15% Similarity=0.147 Sum_probs=191.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC---CccCHHHHHHHHH---HHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE---GFQGHKEWLTEVN---YLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~hp~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++... .....+.+.+|+. +++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 4679999999999999999996543 5889999999743 2234467889994 55556799999998
Q ss_pred -------eEEEeCC-----------------eEEEEEEcCCCCChHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHH
Q 014623 155 -------GYCLEGE-----------------NRLLVYEFMPKGSLENHLFRRGPQ-----PLSWAVRMKVAIGAAKGLTF 205 (421)
Q Consensus 155 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~ 205 (421)
+++...+ ..||||||+ +|+|.+++...... .+++..++.++.||+.||+|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence 6666553 278999999 68999999764321 12347888899999999999
Q ss_pred hhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-----------CCCcc
Q 014623 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-----------RLTTK 274 (421)
Q Consensus 206 lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 274 (421)
||+ .||+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.+
T Consensus 222 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHh--CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 995 4799999999999999999999999999986332 2345678 999999999887 89999
Q ss_pred ccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCC
Q 014623 275 SDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLR 354 (421)
Q Consensus 275 ~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 354 (421)
+|||||||++|+|++|+.||......... ..+. .....++.++.+||.+||..||.+|
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~-----------------~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R 351 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGS-----------------EWIF-----RSCKNIPQPVRALLEGFLRYPKEDR 351 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCS-----------------GGGG-----SSCCCCCHHHHHHHHHHTCSSGGGC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccch-----------------hhhh-----hhccCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999999999999754321100 0000 0113456789999999999999999
Q ss_pred CCHHHHHH--HHHhh
Q 014623 355 PRMSEVLA--ILERL 367 (421)
Q Consensus 355 pt~~ell~--~L~~~ 367 (421)
|++.++++ .++.+
T Consensus 352 pt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 352 LLPLQAMETPEYEQL 366 (377)
T ss_dssp CCHHHHHTSHHHHHH
T ss_pred CCHHHHhhChHHHHH
Confidence 99999985 44443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=337.71 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=190.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-H-HHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-H-KEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++....... . ..+.++...++.++||||+++++++.
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 4689999999999999999997654 58899999997653222 2 23344555688889999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 159 EGENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+..++||||+. ++|.+++.. .....+++..++.++.|++.||.|||+. .||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred ccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999996 588887754 2335699999999999999999999953 27999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceeccccc----ccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......
T Consensus 155 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------ 219 (290)
T 3fme_A 155 GISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------------ 219 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------------
T ss_pred CCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------------
Confidence 9998654332 12335789999999996 5567899999999999999999999999753221
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+...............++.++.+||.+||..||.+|||+.++++
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 220 ---FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11122222222222333456788999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=351.26 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=196.7
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
...++|++.+.||+|+||+||+|.+.. +|+.||||++...... ..+|+++|+.++||||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheee
Confidence 345789999999999999999997654 5889999998654322 237999999999999999999985
Q ss_pred eC--------------------------------------CeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHH
Q 014623 159 EG--------------------------------------ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIG 198 (421)
Q Consensus 159 ~~--------------------------------------~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~ 198 (421)
.. ...++||||+. ++|.+.+.. .....+++..+..++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 43 34789999997 588877754 23356999999999999
Q ss_pred HHHHHHHhhhCCCceeeccCCCCcEEeC-CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCC-CCcccc
Q 014623 199 AAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSD 276 (421)
Q Consensus 199 i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~D 276 (421)
|+.||.||| ..||+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|
T Consensus 150 i~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 150 LFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchh
Confidence 999999999 55899999999999997 688999999999986544332 23467899999999987754 899999
Q ss_pred chhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhhchhhHh----Hhh-----hcccCCCCCHHHHHHHHHHHHh
Q 014623 277 VYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDKRKLF----RIM-----DTKLGGQYPQKAAHTAATLALQ 345 (421)
Q Consensus 277 iwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~~~~~~~~~~----~~~-----~~~~~~~~~~~~~~~l~~li~~ 345 (421)
||||||++|+|++|+.||.+....... .+... ..+......... ... ........+..++.++.+||.+
T Consensus 225 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 999999999999999999865422111 11100 000000000000 000 0000001234567789999999
Q ss_pred ccccCCCCCCCHHHHHH
Q 014623 346 CLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 346 ~l~~dP~~Rpt~~ell~ 362 (421)
||..||.+|||+.|+++
T Consensus 305 ~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HCCSSGGGSCCHHHHHT
T ss_pred HccCChhhCCCHHHHhc
Confidence 99999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=344.82 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=196.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCCCCCcc
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--------QGHKEWLTEVNYLGQLHHPNLV 151 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv 151 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+++++.++||||+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 78 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBC
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCc
Confidence 44689999999999999999997654 578999999875432 1223477999999999999999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc-
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN- 230 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~- 230 (421)
++++++...+ .++||||+.+++|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 79 KIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp CEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSSS
T ss_pred eEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEecCCCC
Confidence 9999987654 899999999999999986543 48999999999999999999995 47999999999999987665
Q ss_pred --EEEeeccCcccCCCCCCcceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 231 --AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 231 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--- 227 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--- 227 (322)
T ss_dssp CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---
T ss_pred CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---
Confidence 9999999998754321 223467999999999874 46789999999999999999999999975432111
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQY---PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+...+........ ...++..+.+||.+||..||.+||++.++++
T Consensus 228 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 -------------LKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -------------HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------------HHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000000000000 1235678999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=335.42 Aligned_cols=250 Identities=28% Similarity=0.365 Sum_probs=204.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---------cCHHHHHHHHHHHhcCC-CCCc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---------QGHKEWLTEVNYLGQLH-HPNL 150 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hp~i 150 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.+++++. ||||
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999997654 578999999975531 11345778999999995 9999
Q ss_pred cceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 151 VKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 151 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
+++++++...+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEcCCCc
Confidence 999999999999999999999999999997654 48999999999999999999995 47999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccc------cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA------TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
+||+|||++........ .....|++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 236 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--- 236 (298)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred EEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---
Confidence 99999999987554322 23467899999999885 4568899999999999999999999997543210
Q ss_pred hhhhhhhhhhchhhHhHhhhcccC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+...... ......++..+.+||.+||..||.+||++.++++
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 -------------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -------------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -------------HHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 01111111111 1122466788999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=346.70 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 4689999999999999999997654 578999999975432 233678899999999999999999999875
Q ss_pred C-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 G-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
. ...++||||+. ++|.+++... .+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEEC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChHhEEECCCCCEEEE
Confidence 5 36899999996 5999988654 38999999999999999999995 479999999999999999999999
Q ss_pred eccCcccCCCCCCc-ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhhhh-h
Q 014623 235 DFGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVDWA-K 310 (421)
Q Consensus 235 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~-~ 310 (421)
|||++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+........ +.... .
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999865432211 11234689999999998754 458999999999999999999999997654322111 11000 0
Q ss_pred hhhhchh-----hHhHhhh-cccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKR-----KLFRIMD-TKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~-----~~~~~~~-~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+...... ....... ....... ...++.++.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 0000000 0000011 1345678999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=340.16 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=205.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC------Ccccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP------NLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------~iv~~~ 154 (421)
.++|++.+.||+|+||.||+|.+.. .+++.||||+++... ...+.+.+|+++++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHK--------AGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecC--------CCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 4689999999999999999997633 247899999997542 3345677899998888655 599999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-------
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA------- 227 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~------- 227 (421)
+++...+..++||||+ +++|.+++.......+++..++.++.|++.||+|||+ .||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESCCCEEEEE
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEEecccccccc
Confidence 9999999999999999 8899999988776678999999999999999999995 47999999999999987
Q ss_pred ------------CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 228 ------------EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 228 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 668999999999864332 234678999999999999999999999999999999999999997
Q ss_pred CCcccchhhhhh-hhhhhhh--------------------chhhHhHhhhc-----ccCCCCCHHHHHHHHHHHHhcccc
Q 014623 296 KTKVGIEQSLVD-WAKPYLS--------------------DKRKLFRIMDT-----KLGGQYPQKAAHTAATLALQCLNN 349 (421)
Q Consensus 296 ~~~~~~~~~~~~-~~~~~~~--------------------~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~ 349 (421)
............ ...+... ........... ..........+..+.+||.+||..
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 654321111110 0000000 00000000000 001122346788999999999999
Q ss_pred CCCCCCCHHHHHH
Q 014623 350 EPKLRPRMSEVLA 362 (421)
Q Consensus 350 dP~~Rpt~~ell~ 362 (421)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=370.08 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=210.4
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
...++|++.+.||+|+||.||+|.+... ...+..||||.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSP------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCS------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecC------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456899999999999999999987542 12467899999875432 2336788999999999999999999988
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
. .+..++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~--~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchHhEEEeCCCCEEEEecC
Confidence 4 567899999999999999997543 458999999999999999999995 479999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---------------- 599 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---------------- 599 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------
T ss_pred CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----------------
Confidence 99876443321 2233457889999999999999999999999999999997 99999764321
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.....+........+..++..+.+||.+||..||.+||++.++++.|+++.
T Consensus 600 -~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 600 -DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111222222233455677889999999999999999999999999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=347.95 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=174.5
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CC-----Cccc
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HP-----NLVK 152 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~iv~ 152 (421)
...++|++.+.||+|+||+||+|.+.. +++.||||+++... .....+.+|+.+++.++ |+ +|++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 345789999999999999999997654 57899999997542 22355677888888775 44 4999
Q ss_pred eeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC--CCCc
Q 014623 153 LIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFN 230 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~ 230 (421)
+++++...+..++||||+. ++|.+++.......+++..+..++.|++.||.|||+++.||+||||||+||||+ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 9999999999999999995 599999987765669999999999999999999997667899999999999994 4778
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCc
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 298 (421)
+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999875432 234678999999999999999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=350.93 Aligned_cols=264 Identities=25% Similarity=0.340 Sum_probs=196.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG- 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~- 160 (421)
.+|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+|+++|+.++||||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 469999999999999999997654 578999999865432 223799999999999999999988642
Q ss_pred -----CeEEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-CcEE
Q 014623 161 -----ENRLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAK 232 (421)
Q Consensus 161 -----~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~-~~~k 232 (421)
..+++||||+.+ +|.+++.. .....+++..++.++.||+.||.||| ..||+||||||+||||+.+ +.+|
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEE
Confidence 236799999965 77766643 23456999999999999999999999 4579999999999999865 5689
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhh-hh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVD-WA 309 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~-~~ 309 (421)
|+|||+++....... ....+||+.|+|||++.+. .|+.++||||||||+|||++|+.||.+....... .+.. ..
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 198 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp ECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999987544322 2346789999999998765 7999999999999999999999999875421110 0110 00
Q ss_pred hhhhhchhhHhHhhhcccC-C------------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhhc
Q 014623 310 KPYLSDKRKLFRIMDTKLG-G------------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLE 368 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~~ 368 (421)
.+.. ..+.. +..... . .++...+.++.+||.+||..||.+||++.|+++ .++.+.
T Consensus 275 ~p~~---~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 275 TPTR---EQIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCH---HHHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCCH---HHHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0100 00000 010000 0 012345788999999999999999999999985 444443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=344.87 Aligned_cols=266 Identities=18% Similarity=0.239 Sum_probs=204.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-----------------HHHHHHHHHHHh
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-----------------HKEWLTEVNYLG 143 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~ 143 (421)
.++|++.+.||+|+||.||+|.+ +++.||||++....... .+.+.+|+.+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 98 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence 36899999999999999999976 37899999986432211 167889999999
Q ss_pred cCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeecc
Q 014623 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH------LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217 (421)
Q Consensus 144 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 217 (421)
.++||||+++++++.+.+..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ ..||+|||
T Consensus 99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~d 177 (348)
T 2pml_X 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRD 177 (348)
T ss_dssp TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCC
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecC
Confidence 99999999999999999999999999999999998 655445679999999999999999999995 15799999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCc-cccchhhhHHHHHHHhCCCccC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTT-KSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~tg~~pf~ 295 (421)
|||+|||++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++|||||||++|+|++|..||.
T Consensus 178 l~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 253 (348)
T 2pml_X 178 VKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253 (348)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875432 23456799999999999887 6766 9999999999999999999997
Q ss_pred CCcccchh--hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 296 KTKVGIEQ--SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 296 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
........ .+......+......................++..+.+||.+||..||.+||++.++++
T Consensus 254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 65431100 00000000000000000000000000111456788999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.38 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=184.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... ...+++.+|+++++.++||||+++++++.
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4689999999999999999997543 588999999975432 23457889999999999999999999987
Q ss_pred eC------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EG------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.. ...++|||++ +++|.+++.. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEECCCCCEE
Confidence 54 5679999999 7899998854 348999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-h
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-A 309 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~ 309 (421)
|+|||+++..... ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....... .+... .
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999864322 234679999999999887 67999999999999999999999999765432111 01110 0
Q ss_pred hhhhh---c--hhhHhHhhhcccC-CCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KPYLS---D--KRKLFRIMDTKLG-GQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~~~~---~--~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+... . .......+..... ... ....+..+.+||.+||..||.+|||+.++++.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 0 0000011110000 000 12346789999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=338.37 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=198.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCC--CCCccceee
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLH--HPNLVKLIG 155 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hp~iv~~~~ 155 (421)
..++|++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|+.+++.+. |+||+++++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 4568999999999999999999653 378899999975433 23466889999999997 599999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
++...+..++||| +.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||+++ +.+||+|
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEEET-TEEEECC
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEEEC-CeEEEee
Confidence 9999999999999 55889999997654 48999999999999999999995 47999999999999964 7999999
Q ss_pred ccCcccCCCCCCcceeeccccccceeccccccc-----------CCCCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-----------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 999987654333223345679999999999875 46888999999999999999999999754221
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.......+........+...+..+.+||.+||..||.+||++.++++.
T Consensus 246 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 -----------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111222233333334445557789999999999999999999999964
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=344.36 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=200.2
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 35789999999999999999997642 389999875432 2234567899999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++ ++.+||+|||
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChhhEEEe-CCCEEEeecC
Confidence 99999999999999999999996543 458899999999999999999995 4799999999999998 6799999999
Q ss_pred CcccCCCCC---Ccceeeccccccceeccccccc---------CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 238 LAKAGPTGD---RTHVSTQVMGTHGYAAPEYVAT---------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 238 ~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
++....... .........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---- 250 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---- 250 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH----
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 987543211 1111223568999999999864 357889999999999999999999997643211
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.................++.++.++|.+||..||.+|||+.++++.|+++...
T Consensus 251 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 251 ------------IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ------------HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ------------HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 01111111111112234567899999999999999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=340.73 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=186.8
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
...++|++.+.||+|+||.||+|.+.. +++.||||.+..... ...+.+.+|+.+++.++||||+++++++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 345789999999999999999996543 478999999875432 2345678999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRR------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
...+..++||||+.+++|.+++... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--NGQIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEECTTCCE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCCCCChhhEEEcCCCCE
Confidence 9999999999999999999998641 23458999999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCC---cceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhh
Q 014623 232 KLSDFGLAKAGPTGDR---THVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD 307 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 307 (421)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~- 239 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT- 239 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-
Confidence 9999999876543221 112234679999999999876 56899999999999999999999999765322111000
Q ss_pred hhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 308 WAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... ..... ............++..+.+||.+||..||.+||++.++++
T Consensus 240 -~~~---~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 240 -LQN---DPPSL---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -HTS---SCCCT---TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -hcc---CCCcc---ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 00000 0000001122345678999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=348.26 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=184.5
Q ss_pred cCCCC-CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 82 RNFRP-DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 82 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
+.|.+ +++||+|+||.||+|.+... .+++.||||++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 45666 56899999999999976431 2478899999976533 3567899999999999999999999965
Q ss_pred -CCeEEEEEEcCCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe----CC
Q 014623 160 -GENRLLVYEFMPKGSLENHLFRR-------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL----DA 227 (421)
Q Consensus 160 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill----~~ 227 (421)
....++||||+. ++|.+++... ....+++..++.++.||+.||.|||+ .||+||||||+|||| +.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECCSSTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh--CCEeCCCcCHHHeEEecCCCC
Confidence 678999999995 5888887532 12348999999999999999999995 479999999999999 67
Q ss_pred CCcEEEeeccCcccCCCCCC-cceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccch---
Q 014623 228 EFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIE--- 302 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--- 302 (421)
++.+||+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 78999999999987543221 1123346899999999999874 589999999999999999999999975543210
Q ss_pred ----hh---hhhh-hhhhhh---------chhhHhHhhhcccCCC---------CCHHHHHHHHHHHHhccccCCCCCCC
Q 014623 303 ----QS---LVDW-AKPYLS---------DKRKLFRIMDTKLGGQ---------YPQKAAHTAATLALQCLNNEPKLRPR 356 (421)
Q Consensus 303 ----~~---~~~~-~~~~~~---------~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt 356 (421)
.. +... ..+... ........+....... .....+..+.+||.+||..||.+|||
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 00 0000 000000 0000000000000000 00112567889999999999999999
Q ss_pred HHHHHHH
Q 014623 357 MSEVLAI 363 (421)
Q Consensus 357 ~~ell~~ 363 (421)
+.|+++.
T Consensus 328 a~e~L~h 334 (405)
T 3rgf_A 328 SEQAMQD 334 (405)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.51 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=206.0
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
...++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+++++.++||||++++++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 345689999999999999999997653 478999999865432 345678899999999999999999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC---CcEEE
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE---FNAKL 233 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~---~~~kl 233 (421)
+.+.+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++.+ +.+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dl~p~NIlv~~~~~~~~~kL 165 (287)
T 2wei_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKI 165 (287)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred EeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChhhEEEecCCCcccEEE
Confidence 999999999999999999999987664 38999999999999999999995 479999999999999764 46999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+|||++........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 166 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------------ 229 (287)
T 2wei_A 166 IDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------------ 229 (287)
T ss_dssp CSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------------
T ss_pred eccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------------
Confidence 99999986543321 233568999999998865 48999999999999999999999997643211
Q ss_pred hchhhHhHhhhcccCCCC--CHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 314 SDKRKLFRIMDTKLGGQY--PQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
....+......... ...++.++.++|.+||..||.+|||+.++++ .+++.
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 230 ----ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp ----HHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred ----HHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 01111111111111 1346778999999999999999999999997 44443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=340.45 Aligned_cols=271 Identities=24% Similarity=0.313 Sum_probs=191.5
Q ss_pred HHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceee
Q 014623 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 76 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 155 (421)
......++|++.+.||+|+||.||+|.+.. +|+.||||++.... .....+.+|++.+..++||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEE
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHH
Confidence 344556799999999999999999997654 57899999986543 22345678888889999999999999
Q ss_pred EEEeCCe-------EEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 156 YCLEGEN-------RLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 156 ~~~~~~~-------~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
++..... .++||||+.+ +|.+.+.. .....+++..+..++.|++.||.|||.+..||+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~ 165 (360)
T 3e3p_A 87 YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN 165 (360)
T ss_dssp EEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE
T ss_pred hhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe
Confidence 9876433 7899999976 66555432 233458899999999999999999995556899999999999998
Q ss_pred C-CCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchhh
Q 014623 227 A-EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304 (421)
Q Consensus 227 ~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 304 (421)
. ++.+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~- 241 (360)
T 3e3p_A 166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL- 241 (360)
T ss_dssp TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-
T ss_pred CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH-
Confidence 6 89999999999987654332 23467899999999987654 899999999999999999999999765432111
Q ss_pred hhhhhhhhhhchhhHhHhhhc----------------ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 305 LVDWAKPYLSDKRKLFRIMDT----------------KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.................+.. ..........+.++.+||.+||+.||.+|||+.++++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 242 -HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp -HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11000000000000000000 0011122336789999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=340.51 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=175.7
Q ss_pred hcCCCCCc-eecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHH-HHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDS-LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEV-NYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+ +||+|+||.||+|.+.. +++.||||++... ....+|+ ..++.+.||||+++++++.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHh
Confidence 36788854 69999999999997654 5789999998643 2222333 3456678999999999987
Q ss_pred e----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcE
Q 014623 159 E----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNA 231 (421)
Q Consensus 159 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~ 231 (421)
. ....++||||+++|+|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEESCSSTTCCE
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEEecCCCceE
Confidence 6 4558999999999999999987766679999999999999999999995 47999999999999976 4559
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 311 (421)
||+|||++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------- 239 (336)
T 3fhr_A 171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP------- 239 (336)
T ss_dssp EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-------
Confidence 999999998654322 234678999999999988899999999999999999999999996543211100
Q ss_pred hhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 YLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....................++.++.+||.+||..||.+|||+.++++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 240 ---GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000000111111222456788999999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=342.44 Aligned_cols=273 Identities=23% Similarity=0.317 Sum_probs=198.6
Q ss_pred CHHHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-----------HHHHHHHHHH
Q 014623 73 TFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-----------HKEWLTEVNY 141 (421)
Q Consensus 73 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~ 141 (421)
.+.++....++|++.+.||+|+||.||+|.+. .|..||||++....... .+.+.+|+++
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 82 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence 35567778899999999999999999999643 27899999986432211 2678899999
Q ss_pred HhcCCCCCccceeeEEEeC-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeec
Q 014623 142 LGQLHHPNLVKLIGYCLEG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216 (421)
Q Consensus 142 l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHr 216 (421)
++.++||||+++++++... ...++||||+. |+|.+++.... ..+++..++.++.||+.||.|||+ .||+||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~ 158 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE--AGVVHR 158 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CcCEec
Confidence 9999999999999998643 36799999996 68888886443 458999999999999999999995 479999
Q ss_pred cCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccC
Q 014623 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 217 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
||||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 999999999999999999999997543322 2334678999999999877 678999999999999999999999997
Q ss_pred CCcccchh-hhhhhh-hhhhh-----chhhHhHhhhcccCCC-------CCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 296 KTKVGIEQ-SLVDWA-KPYLS-----DKRKLFRIMDTKLGGQ-------YPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 296 ~~~~~~~~-~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
+....... ...... .+... ........+....... .....+..+.+||.+||..||.+|||+.+++
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 65421111 111100 00000 0000111111111100 1124467899999999999999999999998
Q ss_pred H
Q 014623 362 A 362 (421)
Q Consensus 362 ~ 362 (421)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=349.43 Aligned_cols=253 Identities=14% Similarity=0.024 Sum_probs=182.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHH---HHHhcCCCCCcccee-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEV---NYLGQLHHPNLVKLI- 154 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hp~iv~~~- 154 (421)
..|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+ ++|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~ 131 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR 131 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence 458999999999999999997654 5789999999875432 234566774 45555 799987754
Q ss_pred ------eEEEeC-----------------CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHH
Q 014623 155 ------GYCLEG-----------------ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR------MKVAIGAAKGLTF 205 (421)
Q Consensus 155 ------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------~~~~~~i~~~l~~ 205 (421)
+++... ...|+||||+. ++|.+++..... .+.+..+ +.++.||+.||+|
T Consensus 132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 555433 34799999998 899999976432 2344445 6777999999999
Q ss_pred hhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc--CCCCccccchhhhHH
Q 014623 206 LHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVV 283 (421)
Q Consensus 206 lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~i 283 (421)
||+ .||+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+
T Consensus 210 LH~--~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 210 LQS--KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HHH--TTEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HHH--CCCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 995 4799999999999999999999999999986532 1224567799999999987 679999999999999
Q ss_pred HHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 284 LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 284 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+|+|++|+.||............. ..................++..+.+||.+||..||.+|||+.++++
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHhCCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999999997653221110000 0000000111111222466889999999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=335.68 Aligned_cols=272 Identities=23% Similarity=0.312 Sum_probs=197.3
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEE--
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCL-- 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-- 158 (421)
.++|++.+.||+|+||.||+|.+.. +++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4689999999999999999997654 57899999998665555677889999999999999999999873
Q ss_pred ------------eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 159 ------------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 159 ------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
+....++||||+. ++|.+++.. ..+++..++.++.|++.||+|||+ .||+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFIN 154 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEE
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEc
Confidence 3467899999997 599999854 348999999999999999999995 4799999999999996
Q ss_pred -CCCcEEEeeccCcccCCCCCC-cceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh
Q 014623 227 -AEFNAKLSDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ 303 (421)
Q Consensus 227 -~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 303 (421)
.++.+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 234 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 567999999999987543211 111234567999999998865 67899999999999999999999999865432111
Q ss_pred hhhhhhhhhhh--chhhHh----HhhhcccCCC------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 304 SLVDWAKPYLS--DKRKLF----RIMDTKLGGQ------YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 304 ~~~~~~~~~~~--~~~~~~----~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
.......+... ....+. ..+....... ....++.++.+||.+||..||.+|||+.++++ .+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 10000000000 000000 0000000000 11345788999999999999999999999986 44443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=337.20 Aligned_cols=268 Identities=25% Similarity=0.334 Sum_probs=201.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC---CCCCccceee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQL---HHPNLVKLIG 155 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hp~iv~~~~ 155 (421)
.++|++.+.||+|+||.||+|.+.. .+++.||+|++..... .....+.+|+.+++.+ .||||+++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~ 81 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLK--------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred hhceeeeeeecccccEEEEEEEecC--------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeee
Confidence 4689999999999999999997642 2478999999864321 1123456777776665 8999999999
Q ss_pred EEE-----eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc
Q 014623 156 YCL-----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN 230 (421)
Q Consensus 156 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~ 230 (421)
++. .....++||||+. ++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 82 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCC
T ss_pred eeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHHHeEEcCCCC
Confidence 987 4567899999997 699999987766669999999999999999999995 47999999999999999999
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW- 308 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~- 308 (421)
+||+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.+....... .+...
T Consensus 159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999998654321 233467899999999999999999999999999999999999999765431110 00000
Q ss_pred hhhhhhchh---hH-hHhhh---cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 309 AKPYLSDKR---KL-FRIMD---TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 309 ~~~~~~~~~---~~-~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+...... .. ..... ..........++..+.+||.+||..||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000 00 00000 00001122456788999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=343.94 Aligned_cols=262 Identities=16% Similarity=0.238 Sum_probs=201.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----------CCCc
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----------HPNL 150 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~i 150 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++.... .....+.+|+++++.+. |+||
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 589999999999999999997643 57899999997542 23456778999988876 8999
Q ss_pred cceeeEEEeCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 151 VKLIGYCLEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 151 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
+++++++...+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. .||+||||||+||||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLME 166 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChHHeEEe
Confidence 99999988654 789999999 89999999876666699999999999999999999953 2799999999999994
Q ss_pred ------CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 227 ------AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 227 ------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 4457999999999865432 23357899999999999999999999999999999999999999754321
Q ss_pred ch----hh---hhhhhhhh----hhchh---------------------hHhHhhhcccCCCCCHHHHHHHHHHHHhccc
Q 014623 301 IE----QS---LVDWAKPY----LSDKR---------------------KLFRIMDTKLGGQYPQKAAHTAATLALQCLN 348 (421)
Q Consensus 301 ~~----~~---~~~~~~~~----~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 348 (421)
.. .. +....... ..... .....+. .....+..++.++.+||.+||.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~ 319 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQ 319 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhc
Confidence 10 00 00000000 00000 0001111 1123567889999999999999
Q ss_pred cCCCCCCCHHHHHH
Q 014623 349 NEPKLRPRMSEVLA 362 (421)
Q Consensus 349 ~dP~~Rpt~~ell~ 362 (421)
.||.+|||+.++++
T Consensus 320 ~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 320 LDPRKRADAGGLVN 333 (373)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred cCccccCCHHHHhh
Confidence 99999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.02 Aligned_cols=265 Identities=22% Similarity=0.245 Sum_probs=202.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC------cccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN------LVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~------iv~~~ 154 (421)
.++|++.+.||+|+||+||+|.+... .+..||+|+++... ...+.+.+|+.+++.+.|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 46899999999999999999976542 24689999997532 33456778999999887655 89999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe---------
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL--------- 225 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill--------- 225 (421)
+++...+..++||||+ +++|.+++.......+++..++.++.||+.||.||| ..||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecccccccc
Confidence 9999999999999999 778888887766567999999999999999999999 4589999999999999
Q ss_pred ----------CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 226 ----------DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 226 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
+.++.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 56788999999999864332 234679999999999999999999999999999999999999997
Q ss_pred CCcccchhhhh-hhhhhhhh--------------------chhhHhHhhhc-----ccCCCCCHHHHHHHHHHHHhcccc
Q 014623 296 KTKVGIEQSLV-DWAKPYLS--------------------DKRKLFRIMDT-----KLGGQYPQKAAHTAATLALQCLNN 349 (421)
Q Consensus 296 ~~~~~~~~~~~-~~~~~~~~--------------------~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~ 349 (421)
........... ....+... ........... ..........+..+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 65432111100 00000000 00000000000 000112345677899999999999
Q ss_pred CCCCCCCHHHHHH
Q 014623 350 EPKLRPRMSEVLA 362 (421)
Q Consensus 350 dP~~Rpt~~ell~ 362 (421)
||.+|||+.++++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.56 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=193.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
.++|++.+.||+|+||.||+|.+.. +++.||||++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred cccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 4679999999999999999997643 5789999998643 2334668899999999999999999998865
Q ss_pred ------------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 160 ------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 160 ------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~--~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECT
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh--CCeecccCCHHhEEEcC
Confidence 356799999999999999997643 347888999999999999999995 47999999999999999
Q ss_pred CCcEEEeeccCcccCCCCCC------------cceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCcc
Q 014623 228 EFNAKLSDFGLAKAGPTGDR------------THVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAV 294 (421)
Q Consensus 228 ~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf 294 (421)
++.+||+|||++........ ........|+..|+|||++.+. .++.++|||||||++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999986542210 1112346789999999998765 68999999999999999998 55
Q ss_pred CCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 295 DKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...... ... ...............+...+..+.+||.+||..||.+|||+.++++
T Consensus 229 ~~~~~~--~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 229 STGMER--VNI-----------LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SSHHHH--HHH-----------HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhH--HHH-----------HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 321100 000 0000111112223344566778999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.54 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=196.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 111 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 111 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence 4689999999999999999997654 5889999999764332 2356889999999999999999999998
Q ss_pred eCCeE------EEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGENR------LLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
..+.. ++||||+. ++|.+++. ..+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+|
T Consensus 112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp SCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEE
T ss_pred ccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCcCHHHeEECCCCCEE
Confidence 77654 99999996 58888773 238999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWAK 310 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~ 310 (421)
|+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... .......
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999865332 234678999999999887 67899999999999999999999999765422111 0000000
Q ss_pred -h---h---hhc--hhhHhHhhhcccCCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 -P---Y---LSD--KRKLFRIMDTKLGGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 -~---~---~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+ . ... .......+....... ....++..+.+||.+||..||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0 000 000000000000000 11245788999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.25 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=192.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..+|++.+.||+|+||+||+|.+.. +..+|+|++...... ..+|+++++.++||||+++++++...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~----------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE----------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC----------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEec
Confidence 3579999999999999999997654 334888877543221 23699999999999999999998654
Q ss_pred Ce------EEEEEEcCCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-CCCcE
Q 014623 161 EN------RLLVYEFMPKGSLENHLFR--RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNA 231 (421)
Q Consensus 161 ~~------~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~ 231 (421)
.. .++||||+.+ ++...+.. .....+++..+..++.||+.||+|||+ .||+||||||+||||+ .++.+
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~ 181 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVL 181 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCccCCCCCHHHEEEcCCCCcE
Confidence 33 7899999976 44444422 223458999999999999999999995 4799999999999998 79999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW- 308 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~- 308 (421)
||+|||+++....... ....+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+....... .+...
T Consensus 182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999987544332 2346789999999998765 5899999999999999999999999875432111 01110
Q ss_pred hhhhhhchhhHh-HhhhcccCC--------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 309 AKPYLSDKRKLF-RIMDTKLGG--------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 309 ~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+......... ......+.. .++..++.++.+||.+||..||.+|||+.++++.
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000 000000000 1123467799999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.12 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=199.6
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 4689999999999999999997654 578999999975432 223567899999999999999999998775
Q ss_pred C-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEe
Q 014623 160 G-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLS 234 (421)
Q Consensus 160 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~ 234 (421)
. ...++||||+. ++|.+++... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++.+||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~Dlkp~Nil~~~~~~~kl~ 154 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVC 154 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEEC
T ss_pred cccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEEcCCCcEEEE
Confidence 4 67899999996 6999988663 48999999999999999999995 479999999999999999999999
Q ss_pred eccCcccCCCCCCcc--------eeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 235 DFGLAKAGPTGDRTH--------VSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
|||++.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999998654322111 1223578999999998765 6789999999999999999999999986543211100
Q ss_pred h-hh-hhhhhh------chhhHhHhhhcccCC------CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 306 V-DW-AKPYLS------DKRKLFRIMDTKLGG------QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 306 ~-~~-~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
. .. ..+... ........+...... .....++.++.+||.+||..||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00 000000 000001111100000 011356778999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=335.49 Aligned_cols=244 Identities=26% Similarity=0.432 Sum_probs=193.8
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcC----CCC
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQL----HHP 148 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hp 148 (421)
...++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+++.+ +|+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~ 98 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence 345789999999999999999996543 5789999999765432 122345788888888 899
Q ss_pred CccceeeEEEeCCeEEEEEEc-CCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-
Q 014623 149 NLVKLIGYCLEGENRLLVYEF-MPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD- 226 (421)
Q Consensus 149 ~iv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~- 226 (421)
||+++++++...+..++|||+ +.+++|.+++.... .+++..++.++.|++.||.|||+. ||+||||||+|||++
T Consensus 99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~ 174 (312)
T 2iwi_A 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDL 174 (312)
T ss_dssp SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEET
T ss_pred CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeC
Confidence 999999999999999999999 78999999997764 389999999999999999999954 799999999999998
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCC-ccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLT-TKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
.++.+||+|||++....... .....|+..|+|||++.+..+. .++|||||||++|+|++|+.||.....
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 244 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ 244 (312)
T ss_dssp TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------
Confidence 88999999999998765432 2346789999999999877764 589999999999999999999964311
Q ss_pred hhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.... ....+..++..+.+||.+||..||.+||++.++++.
T Consensus 245 ----------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ----------------ILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------------HHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------------Hhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 112345567789999999999999999999999863
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=338.41 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=200.3
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCC--CCCcc
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLH--HPNLV 151 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~iv 151 (421)
..++|++.+.||+|+||.||+|.+.. +++.||||++...... ....+.+|+.+++.+. |+||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 45689999999999999999997654 5789999998754322 1234567999999996 59999
Q ss_pred ceeeEEEeCCeEEEEEEcCCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-CCC
Q 014623 152 KLIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEF 229 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~ 229 (421)
++++++...+..++|||++.+ ++|.+++.... .+++..++.++.|++.||.|||+ .||+||||||+|||++ .++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEeCCCC
Confidence 999999999999999999976 89999997754 48999999999999999999995 4799999999999998 788
Q ss_pred cEEEeeccCcccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhh
Q 014623 230 NAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDW 308 (421)
Q Consensus 230 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 308 (421)
.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------- 254 (320)
T ss_dssp EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------
Confidence 99999999998764322 234679999999999987766 6789999999999999999999965311
Q ss_pred hhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 309 AKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.... ....+..++.++.+||.+||..||.+||++.++++
T Consensus 255 -------------~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -------------IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------------HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------hhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01223456678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=334.53 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=179.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHH-HHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVN-YLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+..|+. +++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 689999999999999999997654 578999999976532 22344556666 6778899999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFR---RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
.+..++||||+.+ +|.+++.. .....+++..+..++.|++.||.|||+. .||+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccC
Confidence 9999999999975 88877753 2245689999999999999999999953 17999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceeccccc----ccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----ATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||......... .
T Consensus 171 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~------- 239 (327)
T 3aln_A 171 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-L------- 239 (327)
T ss_dssp SSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------
T ss_pred CCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-H-------
Confidence 9998754322 12334789999999998 4567899999999999999999999999754211000 0
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..........+.......++..+.+||.+||..||.+||++.++++
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 ----TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000000001111122356778999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=335.37 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=197.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 93 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT 93 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence 4689999999999999999997654 5889999999764322 2356789999999999999999999998
Q ss_pred eCCe------EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGEN------RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
.... .++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSSCCGGGEEECTTCCEE
T ss_pred cccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEeECCCCcEE
Confidence 7654 499999996 588887632 38999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA- 309 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~- 309 (421)
|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....... ......
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999864322 234678999999999877 67899999999999999999999999865431110 000000
Q ss_pred hhh------hhc--hhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPY------LSD--KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~------~~~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+. ..+ .......+..... ......++.++.+||.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 000 0000011111101 1123456889999999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.93 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=180.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-H-HHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-H-KEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||.||+|.+.. +|+.||||++....... . +.+.++..+++.++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 579999999999999999997654 47899999997654322 2 233445557888899999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+ ++.+..++... ...+++..++.++.|++.||.|||+. .||+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999999 55555554432 34589999999999999999999952 27999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
....... ......|++.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------- 236 (318)
T 2dyl_A 173 GRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------------- 236 (318)
T ss_dssp -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------------
T ss_pred hhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-------------
Confidence 7654322 123457899999999984 4568899999999999999999999997532210
Q ss_pred chhhHhHhhhccc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 315 DKRKLFRIMDTKL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+........ .......++.++.+||.+||..||.+||++.++++
T Consensus 237 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 237 --EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01111111110 01111346778999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=340.81 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=186.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 160 (421)
+.|.+.+.||+|+||+||.+... +|+.||||++... ..+.+.+|+++++.+ +||||+++++++.+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 81 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD 81 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 45677899999999999865322 3789999998653 235677899999876 899999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCC-----CHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC-------
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPL-----SWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE------- 228 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~------- 228 (421)
+..++||||+. |+|.+++........ .+..++.++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEECCHHHHSCC
T ss_pred CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH--CCccccCCChHhEEEecCccccccc
Confidence 99999999995 699999976543211 223456799999999999995 479999999999999654
Q ss_pred ------CcEEEeeccCcccCCCCCCcc--eeeccccccceeccccccc-------CCCCccccchhhhHHHHHHHh-CCC
Q 014623 229 ------FNAKLSDFGLAKAGPTGDRTH--VSTQVMGTHGYAAPEYVAT-------GRLTTKSDVYSFGVVLLELLS-GRC 292 (421)
Q Consensus 229 ------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t-g~~ 292 (421)
+.+||+|||++.......... .....+||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 479999999998765433211 1234679999999999876 568999999999999999999 999
Q ss_pred ccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 293 AVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 293 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
||........ ...... .............++.++.+||.+||..||.+|||+.++++
T Consensus 239 Pf~~~~~~~~-~i~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 239 PFGDKYSRES-NIIRGI------------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTCSTTTHHH-HHHHTC------------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCchhhHH-HHhcCC------------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9965422110 000000 00001111224578899999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=320.11 Aligned_cols=231 Identities=15% Similarity=0.137 Sum_probs=184.7
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.+.. +++.||||++....... .+.+.+|+.++..++||||+++++++.
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 579999999999999999997654 57899999998664432 367889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+||||++|++|.+++... .....+..++.|++.||.|||+ .||+||||||+||||+.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~--~givH~Dikp~NIll~~~g~~kl~~~~- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR--AGVALSIDHPSRVRVSIDGDVVLAYPA- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH--CCCccCCCCcccEEEcCCCCEEEEecc-
Confidence 999999999999999999999432 3556788899999999999995 479999999999999999999998553
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|++ .++.++|||||||++|+|++|+.||.+..........
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------ 214 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ 214 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------
Confidence 222 3688999999999999999999999865431100000
Q ss_pred HhHhhhcccC--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 319 LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 319 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+.+..... ......++.++.+||.+||+.||.+| |+.++++.|+++...
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 215 -ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp -CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred -HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000000000 00123467789999999999999999 999999999997653
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=336.80 Aligned_cols=247 Identities=25% Similarity=0.353 Sum_probs=185.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcC-CCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~ 160 (421)
.+|.+.+.||+|+||+||..... +++.||||++...... .+.+|+++|+.+ +||||+++++++.+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred EEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 46889999999999996543221 3788999999765433 345799999999 799999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-----CCcEEEee
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLSD 235 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl~D 235 (421)
...|+||||+. |+|.+++..... ......++.++.||+.||.|||+ .||+||||||+||||+. ...+||+|
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlKp~NIll~~~~~~~~~~~kL~D 166 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS--LNIVHRDLKPHNILISMPNAHGKIKAMISD 166 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH--TTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred CEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH--CcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence 99999999995 599999976542 24444567899999999999995 47999999999999953 23588999
Q ss_pred ccCcccCCCCCCc-ceeeccccccceecccccc---cCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVA---TGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 236 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~ 310 (421)
||+++........ ......+||+.|+|||++. +..++.++|||||||++|+|++ |..||.........
T Consensus 167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~------- 239 (432)
T 3p23_A 167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN------- 239 (432)
T ss_dssp TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------
T ss_pred ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------
Confidence 9999876533211 1233467999999999997 4567889999999999999999 99999653221100
Q ss_pred hhhhchhhHhHhhhc-cc-CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDT-KL-GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..... .. ........+..+.+||.+||..||.+|||+.++++
T Consensus 240 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 240 ----------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----------HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 00 01122456777899999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.71 Aligned_cols=270 Identities=23% Similarity=0.318 Sum_probs=202.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
++|++.+.||+|+||.||+|.+ ..+|+.||||++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~---------~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIH---------QDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCC---------TTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEE---------CCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 6899999999999999999854 34688999999876422 334568899999999999999999998765
Q ss_pred -----CCeEEEEEEcCCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCc---
Q 014623 160 -----GENRLLVYEFMPKGSLENHLFRRGP-QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFN--- 230 (421)
Q Consensus 160 -----~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~--- 230 (421)
++..++||||++|++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs--~gIVHrDLKP~NILl~~~g~~~~ 162 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE--NRIIHRDLKPENIVLQPGPQRLI 162 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH--TTBCCCCCCSTTEEEECCSSSCE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHeEeecCCCcee
Confidence 6678999999999999999976432 358888999999999999999995 47999999999999987765
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..|..
T Consensus 163 vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~ 234 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHG 234 (676)
T ss_dssp EEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSST
T ss_pred EEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhh
Confidence 99999999987654332 23467999999999999999999999999999999999999999754211 00100
Q ss_pred hhhhchh---hHhHhhh--------cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHH-----HHHHHHhhcCC
Q 014623 311 PYLSDKR---KLFRIMD--------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE-----VLAILERLEAP 370 (421)
Q Consensus 311 ~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e-----ll~~L~~~~~~ 370 (421)
....... ....... ..........++..+.+||.+||..||.+|||+.+ +...++.+...
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 0000000 0000000 01112244568899999999999999999999988 44566665543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.80 Aligned_cols=228 Identities=21% Similarity=0.300 Sum_probs=180.6
Q ss_pred cCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHH-hcCCCCCccceeeEEEe
Q 014623 82 RNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL-GQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hp~iv~~~~~~~~ 159 (421)
++|.+. +.||+|+||.||+|.+.. +++.||+|++.. ...+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 467776 789999999999997654 578999999863 24567888887 66689999999999887
Q ss_pred ----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEE
Q 014623 160 ----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAK 232 (421)
Q Consensus 160 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k 232 (421)
....++||||+++++|.+++.......+++..++.++.|++.||.|||+ .||+||||||+|||++. ++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESSSSTTCCEE
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEecCCCCCcEE
Confidence 6778999999999999999988766679999999999999999999995 47999999999999988 78899
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|+|||++.... +..++.++|||||||++|+|++|..||..........
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------- 208 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------- 208 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------
Confidence 99999986422 2457889999999999999999999996543211000
Q ss_pred hhchhhHhHhhhcccCCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYP----QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.....+.. .....+ ..++.++.+||.+||..||.+|||+.++++.
T Consensus 209 -----~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 209 -----GMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -----CSCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 000111 2457789999999999999999999999973
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.31 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=193.5
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
..++|++.+.||+|+||.||+|.+... +++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 347899999999999999999987542 378899999875432 33456789999999999999999999998
Q ss_pred eCCe-----EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EGEN-----RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
..+. .||||||++|++|.+++.. .+++..++.++.||+.||.|||+ .||+||||||+|||++.+ .+||
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS--IGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSS-CEEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH--CCCeecccChHHeEEeCC-cEEE
Confidence 7665 7999999999999987743 48999999999999999999995 479999999999999886 8999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
+|||+++..... ...+||+.|+|||++.++ ++.++|||||||++|+|++|..||.+......
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------- 284 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------- 284 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence 999999875432 346799999999988765 48899999999999999999988865321100
Q ss_pred hchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhh
Q 014623 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERL 367 (421)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~ 367 (421)
.. .......+..+.+||.+||..||.+|| ++.++...|..+
T Consensus 285 ~~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PE-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CT-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cc-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 000123456789999999999999999 466666666554
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=334.41 Aligned_cols=241 Identities=16% Similarity=0.135 Sum_probs=180.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCC-CCccc-----
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHH-PNLVK----- 152 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-p~iv~----- 152 (421)
+.|++.+.||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+.+++.+.| .|+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~ 148 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHT
T ss_pred eeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhc
Confidence 457888999999999999997654 578999999884332 234678899999999976 32111
Q ss_pred ----eee------------EEEe-----CCeEEEEEEcCCCCChHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHh
Q 014623 153 ----LIG------------YCLE-----GENRLLVYEFMPKGSLENHLF-----RRGPQPLSWAVRMKVAIGAAKGLTFL 206 (421)
Q Consensus 153 ----~~~------------~~~~-----~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~~~i~~~l~~l 206 (421)
.++ ++.. ....+++|+++ +++|.+++. ......+++..++.++.|++.||+||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 227 (413)
T 3dzo_A 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227 (413)
T ss_dssp CBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 111 1111 12357778876 689999884 22234477888899999999999999
Q ss_pred hhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccc----------ccCCCCcccc
Q 014623 207 HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYV----------ATGRLTTKSD 276 (421)
Q Consensus 207 H~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~D 276 (421)
|+ .||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|
T Consensus 228 H~--~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 228 HH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp HH--TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred Hh--CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 95 47999999999999999999999999998864322 344678 999999999 5556888999
Q ss_pred chhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 014623 277 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR 356 (421)
Q Consensus 277 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 356 (421)
||||||++|+|++|+.||........ ....+. ....++..+.+||.+||..||.+||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~----------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGG----------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhh----------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999976432110 000011 01134578999999999999999999
Q ss_pred HHHHHH
Q 014623 357 MSEVLA 362 (421)
Q Consensus 357 ~~ell~ 362 (421)
+.++++
T Consensus 358 ~~~~l~ 363 (413)
T 3dzo_A 358 PLQAME 363 (413)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 887764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=320.21 Aligned_cols=240 Identities=17% Similarity=0.168 Sum_probs=182.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--------cCHHHHHHHHHHHhcCC------
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--------QGHKEWLTEVNYLGQLH------ 146 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------ 146 (421)
.++|++.+.||+|+||+||+|.+ +|+.||||++..... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~ 87 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence 35799999999999999999975 268999999976532 23367888999888875
Q ss_pred ---CCCccceeeEEE-----------------e-------------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHH
Q 014623 147 ---HPNLVKLIGYCL-----------------E-------------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 193 (421)
Q Consensus 147 ---hp~iv~~~~~~~-----------------~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 193 (421)
||||+++++++. + .+..||||||+.+|++.+.+.+ ..+++..+.
T Consensus 88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~ 164 (336)
T 2vuw_A 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAK 164 (336)
T ss_dssp SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHH
T ss_pred cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHH
Confidence 777777666543 2 6789999999999987777643 348999999
Q ss_pred HHHHHHHHHHHHhh-hCCCceeeccCCCCcEEeCCCC--------------------cEEEeeccCcccCCCCCCcceee
Q 014623 194 KVAIGAAKGLTFLH-DAESQVIYRDFKASNILLDAEF--------------------NAKLSDFGLAKAGPTGDRTHVST 252 (421)
Q Consensus 194 ~~~~~i~~~l~~lH-~~~~~ivHrDlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~ 252 (421)
.++.||+.||.||| +. ||+||||||+||||+.++ .+||+|||+++.... .
T Consensus 165 ~i~~qi~~aL~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~ 235 (336)
T 2vuw_A 165 SILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred HHHHHHHHHHHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence 99999999999999 65 699999999999999887 899999999986532 1
Q ss_pred ccccccceecccccccCCCCccccchhhhHH-HHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhc--ccCC
Q 014623 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVV-LLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDT--KLGG 329 (421)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 329 (421)
..+||+.|+|||++.+.. +.++||||||++ .+++++|..||.... |... ....+...... ....
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~---~~~~~~~~~~~~~~~~~ 302 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHY---LTDKMLKQMTFKTKCNT 302 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHH---HHHHHHHTCCCSSCCCS
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhH---HHHhhhhhhccCcccch
Confidence 357999999999998766 889999998777 788888998885310 0000 00000000000 0011
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 014623 330 QYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361 (421)
Q Consensus 330 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 361 (421)
.....++.++.+||.+||..| |+.|++
T Consensus 303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 123478999999999999977 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.90 Aligned_cols=170 Identities=18% Similarity=0.114 Sum_probs=127.3
Q ss_pred CCcEEEEEEecCCCc----------cCHHHHHHHHHHHhcC-CCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcC
Q 014623 115 SGMVVAVKKLKPEGF----------QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG 183 (421)
Q Consensus 115 ~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 183 (421)
.|+.+++|++..... ...++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.+.+
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~ 337 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE 337 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence 477899999975432 1234688999999999 69999999999999999999999999999999997765
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecc
Q 014623 184 PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263 (421)
Q Consensus 184 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 263 (421)
. ++.. .|+.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+....... ...+.+||+.|+||
T Consensus 338 ~--l~~~---~I~~QIl~AL~ylH~--~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAP 408 (569)
T 4azs_A 338 E--IDRE---KILGSLLRSLAALEK--QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVN 408 (569)
T ss_dssp C--CCHH---HHHHHHHHHHHHHHH--TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHH
T ss_pred C--CCHH---HHHHHHHHHHHHHHH--CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccH
Confidence 4 5554 478999999999995 5799999999999999999999999999987644322 23467899999999
Q ss_pred cccccCCCCccccchhhhHHHHHHHhCCCcc
Q 014623 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAV 294 (421)
Q Consensus 264 E~~~~~~~~~~~DiwslG~il~el~tg~~pf 294 (421)
|++.+ .+..++|+|++|+++++|.++..+|
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHC------------------CCCCTTHHHH
T ss_pred HHhCC-CCCCcccccccccchhhhccccchh
Confidence 98865 4677899999999998887765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-30 Score=259.04 Aligned_cols=186 Identities=17% Similarity=0.242 Sum_probs=143.1
Q ss_pred CCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC--------HHHHHHHHHHHhcCCCCCccceee
Q 014623 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--------HKEWLTEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 84 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~ 155 (421)
+...+.||+|+||.||+|... +..+++|......... .+++.+|+++|++++||||+++..
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 406 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYI 406 (540)
T ss_dssp ----------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCE
T ss_pred CCCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEE
Confidence 345678999999999999432 5678999865433221 244789999999999999996666
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
++...+..||||||++|++|.+++.. +..++.|++.||.|||+ .||+||||||+|||++. .+||+|
T Consensus 407 ~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~--~gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 407 FDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK--NDVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp EEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH--TTEECTTCCTTSEEESS--SEEECC
T ss_pred EEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH--CcCccCCCCHHHEEECC--eEEEEE
Confidence 66677888999999999999999854 45889999999999995 47999999999999998 999999
Q ss_pred ccCcccCCCCCCcc-----eeeccccccceeccccccc--CCCCccccchhhhHHHHHHHhCCCcc
Q 014623 236 FGLAKAGPTGDRTH-----VSTQVMGTHGYAAPEYVAT--GRLTTKSDVYSFGVVLLELLSGRCAV 294 (421)
Q Consensus 236 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~pf 294 (421)
||+++......... ....++||+.|+|||++.. ..|+..+|+|+..+-..+.+.++-+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999765432111 1235789999999999987 66888999999998888887776554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-26 Score=212.57 Aligned_cols=151 Identities=15% Similarity=0.069 Sum_probs=117.8
Q ss_pred HHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------------------CHHHHHHH
Q 014623 77 LKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------------------GHKEWLTE 138 (421)
Q Consensus 77 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E 138 (421)
+......|.+++.||+|+||.||+|.+ . +|+.||||+++..... ....+.+|
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E 154 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 154 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHH
Confidence 334455677789999999999999976 2 4789999999643211 23457899
Q ss_pred HHHHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccC
Q 014623 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218 (421)
Q Consensus 139 ~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDl 218 (421)
+.+|+.++ | +++++++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+ .||+||||
T Consensus 155 ~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~--~giiHrDl 219 (282)
T 1zar_A 155 FRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH--RGIVHGDL 219 (282)
T ss_dssp HHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH--TTEECSCC
T ss_pred HHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH--CCCEeCCC
Confidence 99999998 5 666665543 56699999999999988 421 1234689999999999995 47999999
Q ss_pred CCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceeccccccc
Q 014623 219 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT 268 (421)
Q Consensus 219 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 268 (421)
||+|||++ ++.+||+|||+++. +..|+|||++..
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999 99999999999863 345788887743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-21 Score=177.45 Aligned_cols=138 Identities=17% Similarity=0.073 Sum_probs=104.0
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcE--EEEEEecCCCccC------------------------HHHHH
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMV--VAVKKLKPEGFQG------------------------HKEWL 136 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~ 136 (421)
-|.+.+.||+|+||.||+|.+.. +|+. ||||+++...... ...+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 36788999999999999997632 3778 9999976432110 12577
Q ss_pred HHHHHHhcCCCCCc--cceeeEEEeCCeEEEEEEcCCC-C----ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-h
Q 014623 137 TEVNYLGQLHHPNL--VKLIGYCLEGENRLLVYEFMPK-G----SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLH-D 208 (421)
Q Consensus 137 ~E~~~l~~l~hp~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~ 208 (421)
+|+.+|..+.|++| ..++++ +..+|||||+.+ | +|.+++.. .++..+..++.|++.+|.||| .
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH
Confidence 89999999988764 334432 356899999932 3 66665532 123456788999999999999 6
Q ss_pred CCCceeeccCCCCcEEeCCCCcEEEeeccCcccC
Q 014623 209 AESQVIYRDFKASNILLDAEFNAKLSDFGLAKAG 242 (421)
Q Consensus 209 ~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~ 242 (421)
. ||+||||||+|||++. .++|+|||+|...
T Consensus 190 ~--givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 A--ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp S--CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred C--CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 4 7999999999999988 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.3e-19 Score=169.76 Aligned_cols=138 Identities=12% Similarity=0.055 Sum_probs=97.0
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--------------cCHHH--------HHHHHH
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--------------QGHKE--------WLTEVN 140 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~ 140 (421)
-|++++.||.|+||.||+|... +|+.||||+++.... ..... ..+|..
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 4899999999999999999643 488999999764211 00111 134666
Q ss_pred HHhcCCCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCC
Q 014623 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKA 220 (421)
Q Consensus 141 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp 220 (421)
.|.+|.+.++.-..-+.. ...+|||||+.|++|..+.. . .....++.|++.+|.+||. .|||||||||
T Consensus 166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~--~gIVHrDLKp 233 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAK--HGLIHGDFNE 233 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHH--TTEECSCCST
T ss_pred HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHH--CCCcCCCCCH
Confidence 666664444322211212 23479999999988865431 1 1234678999999999995 5799999999
Q ss_pred CcEEeCCCC----------cEEEeeccCcccC
Q 014623 221 SNILLDAEF----------NAKLSDFGLAKAG 242 (421)
Q Consensus 221 ~Nill~~~~----------~~kl~Dfg~a~~~ 242 (421)
.||||+++| .+.|+||+-+...
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999998776 3899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=5.8e-14 Score=128.21 Aligned_cols=144 Identities=13% Similarity=-0.032 Sum_probs=110.8
Q ss_pred HHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEE
Q 014623 79 TATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYC 157 (421)
Q Consensus 79 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~ 157 (421)
.....|++...++.|+++.||++.. .+..+++|+...........+.+|+.+++.|. +..+.++++++
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~ 79 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 3446798889999999999999842 25689999987532122345778999999884 67788999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC---------------------------
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE--------------------------- 210 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--------------------------- 210 (421)
...+..|+||||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 80 ~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 80 RHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred ecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 988899999999999999876411 1123467788899999999710
Q ss_pred ------------------------------CceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 211 ------------------------------SQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 211 ------------------------------~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=115.97 Aligned_cols=135 Identities=16% Similarity=0.049 Sum_probs=95.4
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC--ccceeeEEEeC
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN--LVKLIGYCLEG 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~--iv~~~~~~~~~ 160 (421)
.|.+..+.+.|..+.||++... +|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++...+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 3444333345666999998432 35679999976542 234668999988885434 55688888877
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCC------------------------------
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAE------------------------------ 210 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~------------------------------ 210 (421)
+..++||||++|.+|. ... ... ..++.+++..|..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred CCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 8899999999998884 211 121 245667777788887532
Q ss_pred --------------------------CceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 211 --------------------------SQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 211 --------------------------~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
.+++|+|++|.|||++.++.+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 139999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.27 E-value=2.3e-11 Score=116.23 Aligned_cols=141 Identities=13% Similarity=0.168 Sum_probs=103.9
Q ss_pred CCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEec--CCCc-cCHHHHHHHHHHHhcCC--CCCccceeeEEEeC
Q 014623 86 PDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLK--PEGF-QGHKEWLTEVNYLGQLH--HPNLVKLIGYCLEG 160 (421)
Q Consensus 86 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hp~iv~~~~~~~~~ 160 (421)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+.
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 4567999999999998532 3568888775 3221 22345778999999886 45678888887766
Q ss_pred ---CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC----------------------------
Q 014623 161 ---ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA---------------------------- 209 (421)
Q Consensus 161 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---------------------------- 209 (421)
+..|+||||++|..+.+.. ...++......++.+++..|+.||..
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 3489999999998875421 12367778888999999999999962
Q ss_pred ----------------------------CCceeeccCCCCcEEeCCCCc--EEEeeccCccc
Q 014623 210 ----------------------------ESQVIYRDFKASNILLDAEFN--AKLSDFGLAKA 241 (421)
Q Consensus 210 ----------------------------~~~ivHrDlkp~Nill~~~~~--~kl~Dfg~a~~ 241 (421)
..+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=7.4e-12 Score=116.83 Aligned_cols=183 Identities=20% Similarity=0.208 Sum_probs=118.4
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCC--ccceeeEEEeCC--
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPN--LVKLIGYCLEGE-- 161 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~--iv~~~~~~~~~~-- 161 (421)
.+.++.|.+..||+. +..+++|+.... .....+.+|+.+|+.+. +.. +..++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 467899999999985 245889986533 23456788999998873 333 334444433332
Q ss_pred -eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------------------------------
Q 014623 162 -NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------------------------------- 209 (421)
Q Consensus 162 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------------- 209 (421)
..|+||++++|.+|.+.... .++......++.+++..|+.||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 34789999999888754322 256666677777777777777741
Q ss_pred -------------------------CCceeeccCCCCcEEeCC--CCcEEEeeccCcccCCCCCCcceeeccccccce--
Q 014623 210 -------------------------ESQVIYRDFKASNILLDA--EFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY-- 260 (421)
Q Consensus 210 -------------------------~~~ivHrDlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y-- 260 (421)
...++|+|+++.||+++. ++.+.|+||+.+....... .......+
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~ 238 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDE 238 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTT
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhcc
Confidence 135899999999999988 4568899999886532110 00001111
Q ss_pred -eccccccc-----CCC---------CccccchhhhHHHHHHHhCCCccC
Q 014623 261 -AAPEYVAT-----GRL---------TTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 261 -~aPE~~~~-----~~~---------~~~~DiwslG~il~el~tg~~pf~ 295 (421)
..|+.... +.. ....+.|++|.++|.+.+|..+|.
T Consensus 239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 12221110 111 122589999999999999987663
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=3.3e-08 Score=92.01 Aligned_cols=135 Identities=19% Similarity=0.147 Sum_probs=89.3
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC---CccceeeEEE-eCCe
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP---NLVKLIGYCL-EGEN 162 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---~iv~~~~~~~-~~~~ 162 (421)
.+.++.|....||+. |..+++|+.... .....+.+|+.+|+.|.+. .|.+++.+.. ..+.
T Consensus 24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~ 87 (306)
T 3tdw_A 24 VESLGEGFRNYAILV--------------NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN 87 (306)
T ss_dssp EEEEEECSSEEEEEE--------------TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred eeecCCCcceeEEEE--------------CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence 456888988999986 345888885321 2345678999999998642 3556666654 3456
Q ss_pred EEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------
Q 014623 163 RLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHD---------------------------------- 208 (421)
Q Consensus 163 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---------------------------------- 208 (421)
.++||||++|.+|.+.... .++......++.+++..|+.||+
T Consensus 88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 7899999999888763211 12333333344444444444442
Q ss_pred ------------------------CCCceeeccCCCCcEEeCC---CCc-EEEeeccCccc
Q 014623 209 ------------------------AESQVIYRDFKASNILLDA---EFN-AKLSDFGLAKA 241 (421)
Q Consensus 209 ------------------------~~~~ivHrDlkp~Nill~~---~~~-~kl~Dfg~a~~ 241 (421)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=8.2e-08 Score=87.50 Aligned_cols=134 Identities=18% Similarity=0.104 Sum_probs=92.4
Q ss_pred eecccCce-eEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEEE
Q 014623 89 LLGEGGFG-FVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLV 166 (421)
Q Consensus 89 ~lg~G~~g-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv 166 (421)
.+..|..+ .||+..... .+..+++|+-... ....+.+|..+|+.|. +--+.++++++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 45556555 688864322 3567889986532 2345778999988874 33467788888899999999
Q ss_pred EEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------------------------------------
Q 014623 167 YEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------------------------------------- 209 (421)
Q Consensus 167 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------------------- 209 (421)
||+++|.++.+...... .....+..+++..|..||..
T Consensus 99 me~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 99999988877653321 11223445555556666621
Q ss_pred -------------------CCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 210 -------------------ESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 210 -------------------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999987777899998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.3e-07 Score=89.99 Aligned_cols=87 Identities=3% Similarity=-0.109 Sum_probs=53.9
Q ss_pred Ccee-cccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCC-C--CCccceeeEEEe
Q 014623 87 DSLL-GEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLH-H--PNLVKLIGYCLE 159 (421)
Q Consensus 87 ~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--p~iv~~~~~~~~ 159 (421)
.+.| +.|....+|+....... .....+..+++|+..... ......+.+|+.+++.|. + -.+.+++.++.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3567 88888999987542000 000014578889865432 111234667888888774 3 356777777655
Q ss_pred C---CeEEEEEEcCCCCChH
Q 014623 160 G---ENRLLVYEFMPKGSLE 176 (421)
Q Consensus 160 ~---~~~~lv~e~~~~~~L~ 176 (421)
. ...++||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.2e-06 Score=84.56 Aligned_cols=76 Identities=14% Similarity=0.164 Sum_probs=49.0
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-------cCHHHHHHHHHHHhcCCC--CC-ccceeeE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-------QGHKEWLTEVNYLGQLHH--PN-LVKLIGY 156 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p~-iv~~~~~ 156 (421)
.+.||.|.++.||++.... .++.++||....... ....++..|.++|+.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4679999999999985432 356799998653211 123456778888887742 33 4455543
Q ss_pred EEeCCeEEEEEEcCCCC
Q 014623 157 CLEGENRLLVYEFMPKG 173 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~ 173 (421)
+.+..++||||+.+.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.36 E-value=4.4e-06 Score=78.56 Aligned_cols=32 Identities=16% Similarity=0.201 Sum_probs=28.2
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 45799999999999998888999999997753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.17 E-value=1.3e-05 Score=74.50 Aligned_cols=136 Identities=15% Similarity=0.094 Sum_probs=89.2
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC---CCCccceeeEEEeCCeE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH---HPNLVKLIGYCLEGENR 163 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hp~iv~~~~~~~~~~~~ 163 (421)
.+.|+.|.+..+|+... .+..+++|+.... ....+..|+..|+.|. ...+.+++.+....+..
T Consensus 41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 45789999999999753 2457888987542 2456778988888874 35688888888878889
Q ss_pred EEEEEcCCCCChHH-----------HHhhcCC-C-------------------CCCHHHHHH---HH-------------
Q 014623 164 LLVYEFMPKGSLEN-----------HLFRRGP-Q-------------------PLSWAVRMK---VA------------- 196 (421)
Q Consensus 164 ~lv~e~~~~~~L~~-----------~l~~~~~-~-------------------~~~~~~~~~---~~------------- 196 (421)
++||||++|..+.. .|+.... . .-+|..... +.
T Consensus 107 ~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~ 186 (312)
T 3jr1_A 107 FLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIF 186 (312)
T ss_dssp EEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCC
T ss_pred EEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCCh
Confidence 99999999876521 1222211 0 123433210 11
Q ss_pred ---HHHHHHH-HHh--hhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 197 ---IGAAKGL-TFL--HDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 197 ---~~i~~~l-~~l--H~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
..++..+ ..| |.....+||+|+.+.||+++.++ +.|+||.
T Consensus 187 ~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 187 GNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp SCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111112 233 22245799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.3e-05 Score=71.93 Aligned_cols=80 Identities=18% Similarity=0.183 Sum_probs=55.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC---CCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH---PNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---p~iv~~~~~~~ 158 (421)
....-.+.+|.|..+.||+.... +|+.+++|+...........+..|+..|+.|.- --+.+++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-- 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-- 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--
T ss_pred CCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--
Confidence 34455678999999999998654 378899998765443444457789998888742 234445543
Q ss_pred eCCeEEEEEEcCCCCCh
Q 014623 159 EGENRLLVYEFMPKGSL 175 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L 175 (421)
+ ..++||||++++..
T Consensus 83 ~--~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 D--DRTLAMEWVDERPP 97 (288)
T ss_dssp E--TTEEEEECCCCCCC
T ss_pred c--CceEEEEeecccCC
Confidence 2 34789999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.92 E-value=6.2e-05 Score=73.00 Aligned_cols=78 Identities=18% Similarity=0.192 Sum_probs=48.2
Q ss_pred CCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeecccc--ccceecccccccC---CCCccccchhhhHHH
Q 014623 210 ESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG--THGYAAPEYVATG---RLTTKSDVYSFGVVL 284 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il 284 (421)
...++|+|+++.|||++.++ ++|+||+.+....... . ...... ...|.+|+..... .-....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45799999999999998876 9999999886522100 0 000111 1346666544311 112234556778888
Q ss_pred HHHHhCC
Q 014623 285 LELLSGR 291 (421)
Q Consensus 285 ~el~tg~ 291 (421)
|+++++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8887754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.91 E-value=3.1e-05 Score=72.08 Aligned_cols=156 Identities=15% Similarity=0.115 Sum_probs=83.6
Q ss_pred cCHHHHHHHhcCCCCC-----ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC
Q 014623 72 FTFNELKTATRNFRPD-----SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH 146 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 146 (421)
.+..++...-.+|.+. +.|+.|....+|+....+ | .+++|+..... ....+..|+.+++.|.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~ 73 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLA 73 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHH
Confidence 3445555555667663 346678888999875421 3 58899887531 1234456777766653
Q ss_pred -----CCCcccee-e--EEEeCCeEEEEEEcCCCCChHH--------------HHhhcC-C--CC----CC---HHHHHH
Q 014623 147 -----HPNLVKLI-G--YCLEGENRLLVYEFMPKGSLEN--------------HLFRRG-P--QP----LS---WAVRMK 194 (421)
Q Consensus 147 -----hp~iv~~~-~--~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~-~--~~----~~---~~~~~~ 194 (421)
-|.++... + +....+..+++|+|++|..+.. .++... . .+ .. |...+.
T Consensus 74 ~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~ 153 (322)
T 2ppq_A 74 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD 153 (322)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred HCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHH
Confidence 23333211 1 1223456789999998865421 111110 0 00 11 111000
Q ss_pred ------------HHHHHHHHHHHhhh-----CCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 195 ------------VAIGAAKGLTFLHD-----AESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 195 ------------~~~~i~~~l~~lH~-----~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+...+...+.+++. ...+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 154 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00013334444442 13469999999999999887656899998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.79 E-value=0.0001 Score=63.55 Aligned_cols=140 Identities=15% Similarity=0.061 Sum_probs=90.6
Q ss_pred ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeec
Q 014623 174 SLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253 (421)
Q Consensus 174 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 253 (421)
+|.+.|...+ .++++.++|.++.|.+.+|.-+-... .-..+=+.|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 7889887665 67999999999999999887762111 111333457899999999988874 1110
Q ss_pred cccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCH
Q 014623 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQ 333 (421)
Q Consensus 254 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (421)
.....+.+||... ...+.+.=|||||+++|..+--..|= ..+.
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e-----------------------------------~eE~ 140 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE-----------------------------------NEER 140 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------------------TEEE
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------------------ccch
Confidence 1133567888653 34567788999999999988533221 1123
Q ss_pred HHHHHHHHHHHhcccc-------------------------CCCCCCCHHHHHHHHHh
Q 014623 334 KAAHTAATLALQCLNN-------------------------EPKLRPRMSEVLAILER 366 (421)
Q Consensus 334 ~~~~~l~~li~~~l~~-------------------------dP~~Rpt~~ell~~L~~ 366 (421)
.+++.|..||..|... .+..|.++.+|++.-..
T Consensus 141 eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 141 ELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp CCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred hhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 4566777777777655 34688899999987765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00014 Score=67.05 Aligned_cols=71 Identities=6% Similarity=0.008 Sum_probs=43.9
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~l 165 (421)
.+.|+.|....+|+. ..+++|+........ ....+|+.+++.+..-++ .+++++ +.+..++
T Consensus 23 i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~ 84 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVM 84 (301)
T ss_dssp CEEEESCSSEEEEEE---------------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred eeEcCCcccccccee---------------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence 688999999999997 138888876432111 112357777776642223 355543 3444679
Q ss_pred EEEcC-CCCCh
Q 014623 166 VYEFM-PKGSL 175 (421)
Q Consensus 166 v~e~~-~~~~L 175 (421)
|+||+ +|.+|
T Consensus 85 v~e~i~~g~~l 95 (301)
T 3dxq_A 85 VTRYIAGAQTM 95 (301)
T ss_dssp EEECCTTCEEC
T ss_pred EEeecCCCccC
Confidence 99999 66555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00033 Score=65.44 Aligned_cols=32 Identities=34% Similarity=0.400 Sum_probs=27.6
Q ss_pred CCceeeccCCCCcEEeCCC----CcEEEeeccCccc
Q 014623 210 ESQVIYRDFKASNILLDAE----FNAKLSDFGLAKA 241 (421)
Q Consensus 210 ~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~a~~ 241 (421)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6799999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00014 Score=69.25 Aligned_cols=147 Identities=15% Similarity=0.129 Sum_probs=81.5
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 165 (421)
.+.|..|-...+|++....... .....+..+++|+.... ........+|.++++.|. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4567778888899986532100 01123578999986432 234455668999998875 3333556665432 29
Q ss_pred EEEcCCCCChHH--------------HH---hhcC---CCCCC--HHHHHHHHHHHHH-------------------HHH
Q 014623 166 VYEFMPKGSLEN--------------HL---FRRG---PQPLS--WAVRMKVAIGAAK-------------------GLT 204 (421)
Q Consensus 166 v~e~~~~~~L~~--------------~l---~~~~---~~~~~--~~~~~~~~~~i~~-------------------~l~ 204 (421)
||||++|.+|.. .| +... ..... +..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865531 11 1110 11122 3444444433321 122
Q ss_pred Hhh----h--CCCceeeccCCCCcEEeCCC----CcEEEeeccCcc
Q 014623 205 FLH----D--AESQVIYRDFKASNILLDAE----FNAKLSDFGLAK 240 (421)
Q Consensus 205 ~lH----~--~~~~ivHrDlkp~Nill~~~----~~~kl~Dfg~a~ 240 (421)
.|. . ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 1 12358999999999999876 789999998774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0012 Score=61.43 Aligned_cols=140 Identities=16% Similarity=0.123 Sum_probs=77.9
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCC--CccceeeE-----EEeC
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHP--NLVKLIGY-----CLEG 160 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--~iv~~~~~-----~~~~ 160 (421)
+.|+ |....||+.... +|+.+++|+...... ....+..|..+++.|... .+.+++.. ....
T Consensus 32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ 99 (328)
T ss_dssp EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence 4577 888899986322 255799999864322 344566788877776421 23334332 2234
Q ss_pred CeEEEEEEcCCCCChH----H-------H---Hhhc----C---CCCCCHHHH----------------------HHHHH
Q 014623 161 ENRLLVYEFMPKGSLE----N-------H---LFRR----G---PQPLSWAVR----------------------MKVAI 197 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~----~-------~---l~~~----~---~~~~~~~~~----------------------~~~~~ 197 (421)
+..++||+|++|..+. + . ++.. . ....+.... ...+.
T Consensus 100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 179 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD 179 (328)
T ss_dssp TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence 5668899999875432 0 1 1110 0 001121110 01111
Q ss_pred HHHHHHHHhh--hCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 198 GAAKGLTFLH--DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 198 ~i~~~l~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
.++..+..+- .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1222222111 0234689999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00015 Score=70.47 Aligned_cols=81 Identities=14% Similarity=0.069 Sum_probs=50.0
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 165 (421)
.+.|+.|....||++....... .....+..+++|+.... .....+.+|+.+++.|...+ ..++++.+. + .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence 4568888889999986532100 01112568999988432 12245668999988885333 356666543 2 38
Q ss_pred EEEcCCCCCh
Q 014623 166 VYEFMPKGSL 175 (421)
Q Consensus 166 v~e~~~~~~L 175 (421)
||||++|.+|
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0003 Score=66.87 Aligned_cols=83 Identities=7% Similarity=-0.009 Sum_probs=43.6
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-ccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-LVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 165 (421)
.+.|+.|....+|+......... .....+..+++|+..... ........|..+++.|...+ +.++++.+ . .++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 35677888889999864320000 000113578889875432 11112346788887775333 44666543 2 378
Q ss_pred EEEcCCCCCh
Q 014623 166 VYEFMPKGSL 175 (421)
Q Consensus 166 v~e~~~~~~L 175 (421)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00091 Score=65.35 Aligned_cols=74 Identities=15% Similarity=0.032 Sum_probs=45.1
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEeCCeEEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLEGENRLLV 166 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~~~~~~lv 166 (421)
+.|+.|-...+|++.... .+..+++|+......... .-.+|+.+++.|...++ .++++++ .+ .+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v 179 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRI 179 (458)
T ss_dssp EEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEE
T ss_pred EEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEE
Confidence 467788889999985432 236788998754321111 11478888888864444 5666665 22 359
Q ss_pred EEcCCCCCh
Q 014623 167 YEFMPKGSL 175 (421)
Q Consensus 167 ~e~~~~~~L 175 (421)
|||++|.+|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0021 Score=60.27 Aligned_cols=31 Identities=19% Similarity=0.201 Sum_probs=27.4
Q ss_pred CceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 211 SQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 211 ~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.012 Score=56.72 Aligned_cols=82 Identities=11% Similarity=-0.065 Sum_probs=46.9
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 165 (421)
.+.|..|-...+|+........ .....+..+++|+........ -...+|..+++.|. +.-..++++.+ . .++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence 3567778888899986542110 001115779999865432111 12246888887774 33344555433 2 378
Q ss_pred EEEcCCCCCh
Q 014623 166 VYEFMPKGSL 175 (421)
Q Consensus 166 v~e~~~~~~L 175 (421)
||||++|..|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.10 E-value=0.061 Score=51.41 Aligned_cols=29 Identities=28% Similarity=0.332 Sum_probs=24.6
Q ss_pred ceeeccCCCCcEEe------CCCCcEEEeeccCcc
Q 014623 212 QVIYRDFKASNILL------DAEFNAKLSDFGLAK 240 (421)
Q Consensus 212 ~ivHrDlkp~Nill------~~~~~~kl~Dfg~a~ 240 (421)
.++|+|+.+.|||+ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36799999999999 456679999998875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.19 E-value=0.71 Score=39.70 Aligned_cols=115 Identities=10% Similarity=0.105 Sum_probs=76.4
Q ss_pred CCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhhCCCceeeccCCCCcEE
Q 014623 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT-FLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 146 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~ivHrDlkp~Nil 224 (421)
.||++ -..+-.+++.+.+.++.-+++.=+..+. .++....++++.+|+.... +++ .-+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEE
Confidence 57887 3444566777777777654443344442 2678888999999887776 555 2678899999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
++.++.++|.-.|+-.. ++|.- .+..-=+-.+=|++..++.++..|+
T Consensus 117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998776432 22221 1211123346677788888876664
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.59 E-value=0.78 Score=39.31 Aligned_cols=116 Identities=6% Similarity=0.083 Sum_probs=77.4
Q ss_pred CCCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 146 HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 146 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
.||+++.. .+-...+.+.+.++.-..+.=+..+ ..++....++++.+|+....+++. -+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 58888876 4556667666666654322222223 226788899999999887766652 5788999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccC
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVD 295 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 295 (421)
+.++.++|.-.|+-..+ +|. .++...=+-.+=|++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987764321 121 11222223456778888899888774
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.77 E-value=0.16 Score=49.52 Aligned_cols=62 Identities=10% Similarity=0.092 Sum_probs=17.9
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEE------EEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeE
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAV------KKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGY 156 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~ 156 (421)
.+.+.|| ||.||+|.+... ...||+ |..+.... .....+.+|..+++.++|+|+++.+++
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~---------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK---------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred cccccCC---chhhhccccccc---------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence 4556776 999999977532 235777 66554322 223467889999999999999999887
Q ss_pred EE
Q 014623 157 CL 158 (421)
Q Consensus 157 ~~ 158 (421)
..
T Consensus 213 ~~ 214 (463)
T 3cxl_A 213 KV 214 (463)
T ss_dssp EE
T ss_pred EE
Confidence 65
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 421 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-73 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-69 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-67 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-67 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-62 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-60 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 4e-73
Identities = 73/296 (24%), Positives = 115/296 (38%), Gaps = 35/296 (11%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
+G G FG VYKG VAVK L Q + + EV
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD------------VAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L + H N++ +GY +V ++ SL +HL + +A A
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTA 114
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+G+ +LH +I+RD K++NI L + K+ DFGLA +H Q+ G+ +
Sbjct: 115 QGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 261 AAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317
APE + + +SDVY+FG+VL EL++G+ + D +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGY 226
Query: 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA--PK 371
+ L +CL + RP ++LA +E L PK
Sbjct: 227 LSPDLSK------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 218 bits (555), Expect = 8e-69
Identities = 75/318 (23%), Positives = 134/318 (42%), Gaps = 40/318 (12%)
Query: 72 FTFNELKTATRNF---------RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVK 122
FTF + A R F + + ++G G FG V G + + VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60
Query: 123 KLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFR 181
LK + +++L+E + +GQ HPN++ L G + +++ EFM GSL+ R
Sbjct: 61 TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLR 119
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241
+ + + + G A G+ +L D ++RD A NIL+++ K+SDFGL++
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 242 GPTGDRTHVSTQV---MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTK 298
T + APE + + T+ SDV+S+G+V+ E++S
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------ 231
Query: 299 VGIEQSLVDWAKPYLSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
+PY + + ++ P L L C + RP+
Sbjct: 232 -----------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 358 SEVLAILERLEAPKNSAK 375
+++ L+++ NS K
Sbjct: 281 GQIVNTLDKMIRNPNSLK 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (552), Expect = 2e-68
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 29/285 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+ LG G +G VY+G + VAVK LK + + +E+L E +
Sbjct: 18 DITMKHKLGGGQYGEVYEGV---------WKKYSLTVAVKTLKEDTMEV-EEFLKEAAVM 67
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
++ HPNLV+L+G C ++ EFM G+L ++L Q +S V + +A +
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+ +L + I+RD A N L+ K++DFGL++ GD + A
Sbjct: 128 MEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 184
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE +A + + KSDV++FGV+L E+ + + D +++ +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYEL 228
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
++ + P+ L C P RP +E+ E +
Sbjct: 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 4e-68
Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 39/289 (13%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
+ + +G+G FG V G G VAVK +K + + +L E +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASV 53
Query: 142 LGQLHHPNLVKLIGYCLEGENRL-LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
+ QL H NLV+L+G +E + L +V E+M KGSL ++L RG L +K ++
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+ + +L + ++RD A N+L+ + AK+SDFGL K + + +
Sbjct: 114 EAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKW 166
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKL 319
APE + + +TKSDV+SFG++L E+ S PY + +
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLKDV 209
Query: 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368
++ P + C + + +RP ++ LE ++
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (547), Expect = 1e-67
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 49/310 (15%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNY 141
N +GEG FG V++ + +VAVK LK E ++ E
Sbjct: 14 NIEYVRDIGEGAFGRVFQA----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 69
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRG------------------ 183
+ + +PN+VKL+G C G+ L++E+M G L L
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 184 ----PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
P PLS A ++ +A A G+ +L E + ++RD N L+ K++DFGL+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
+ + D + PE + R TT+SDV+++GVVL E+ S
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL------- 240
Query: 300 GIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRM 357
+PY ++ + ++ + D + P+ L C + P RP
Sbjct: 241 ----------QPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSF 289
Query: 358 SEVLAILERL 367
+ IL+R+
Sbjct: 290 CSIHRILQRM 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-67
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+ LG G FG V+ G+ + VAVK LK +G +L E N +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLK-QGSMSPDAFLAEANLM 62
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
QL H LV+L + E ++ E+M GSL + L L+ + +A A+G
Sbjct: 63 KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+ F+ E I+RD +A+NIL+ + K++DFGLA+ + + A
Sbjct: 122 MAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 178
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + G T KSDV+SFG++L E+++ ++ +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----------------TNPEVIQN 222
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
++ P L C P+ RP + ++LE
Sbjct: 223 LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-67
Identities = 63/287 (21%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNY 141
++ LG G FG V G VA+K +K EG E++ E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIK-EGSMSEDEFIEEAKV 52
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ L H LV+L G C + ++ E+M G L N+L +++ +
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 111
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
+ +L Q ++RD A N L++ + K+SDFGL++ D S ++
Sbjct: 112 AMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWS 168
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLF 320
PE + + ++KSD+++FGV++ E+ S PY +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETA 211
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ L P A+ T+ C + + RP +L+ + +
Sbjct: 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 7e-67
Identities = 81/308 (26%), Positives = 136/308 (44%), Gaps = 29/308 (9%)
Query: 64 LSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK 123
L+ ++A + ++ + ++G G FG VY G + + G + AVK
Sbjct: 9 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKS 62
Query: 124 LKPEGFQGH-KEWLTEVNYLGQLHHPNLVKLIGYCLEGENR-LLVYEFMPKGSLENHLFR 181
L G ++LTE + HPN++ L+G CL E L+V +M G L N +
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 182 RGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK- 240
P + + + AKG+ FL + ++RD A N +LD +F K++DFGLA+
Sbjct: 123 ETHNP-TVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 241 -AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKV 299
D H T + A E + T + TTKSDV+SFGV+L EL++
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--- 236
Query: 300 GIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSE 359
+ + D L +R L P+ + L+C + + ++RP SE
Sbjct: 237 --DVNTFDITVYLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSE 283
Query: 360 VLAILERL 367
+++ + +
Sbjct: 284 LVSRISAI 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 8e-67
Identities = 73/314 (23%), Positives = 127/314 (40%), Gaps = 45/314 (14%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKE 134
ELK +F S LG G G V+K SG+V+A K + E +
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVS---------HKPSGLVMARKLIHLEIKPAIRNQ 50
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
+ E+ L + + P +V G + E M GSL+ L + G + + K
Sbjct: 51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGK 108
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
V+I KGLT+L + + ++++RD K SNIL+++ KL DFG++ ++
Sbjct: 109 VSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR----------------CAVDKTK 298
+GT Y +PE + + +SD++S G+ L+E+ GR C V+
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
Query: 299 VGIEQSLVDWAKPYLSD------KRKLFRIMDTKLGGQYPQKAAHT----AATLALQCLN 348
+P S +F ++D + P+ + +CL
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283
Query: 349 NEPKLRPRMSEVLA 362
P R + +++
Sbjct: 284 KNPAERADLKQLMV 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-66
Identities = 76/303 (25%), Positives = 118/303 (38%), Gaps = 39/303 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNY 141
LG G FG V + + K + M VAVK LKP +E ++E+
Sbjct: 24 RLSFGKTLGAGAFGKVVEA----TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 142 LGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQ--------------- 185
L L +H N+V L+G C G L++ E+ G L N L R+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 186 -PLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244
L + + AKG+ FL I+RD A NILL K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 245 GDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS 304
V + APE + T +SDV+S+G+ L EL S +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--------- 248
Query: 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
P + K ++++ P+ A + C + +P RP +++ ++
Sbjct: 249 ------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 365 ERL 367
E+
Sbjct: 303 EKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-65
Identities = 74/340 (21%), Positives = 127/340 (37%), Gaps = 49/340 (14%)
Query: 52 ESLPTPKSEGEILSSSNLKAFTFNELKTATR-NFRPDSLLGEGGFGFVYKGWIDQHSLSP 110
+ + S + + + ++ R N +LG G FG V +
Sbjct: 6 QMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA----TAYGI 61
Query: 111 AKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYE 168
+K G + VAVK LK + +E ++E+ + QL H N+V L+G C L++E
Sbjct: 62 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121
Query: 169 FMPKGSLENHLFRRGPQ---------------------PLSWAVRMKVAIGAAKGLTFLH 207
+ G L N+L + + L++ + A AKG+ FL
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 208 DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVA 267
++RD A N+L+ K+ DFGLA+ + V + APE +
Sbjct: 182 --FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
Query: 268 TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRKLFRIMDT 325
G T KSDV+S+G++L E+ S PY + ++++
Sbjct: 240 EGIYTIKSDVWSYGILLWEIFSLGV-----------------NPYPGIPVDANFYKLIQN 282
Query: 326 KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
P A + C + + RP + + L
Sbjct: 283 GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-64
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 31/285 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+G G FG V+ G+ + VA+K ++ EG ++++ E +
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVM 54
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+L HP LV+L G CLE LV+EFM G L ++ R + + + + +G
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEG 113
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+ +L E+ VI+RD A N L+ K+SDFG+ + D+ ST +A+
Sbjct: 114 MAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWAS 170
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322
PE + R ++KSDV+SFGV++ E+ S + + ++
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVED 214
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
+ T P+ A+ + C P+ RP S +L L +
Sbjct: 215 ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-63
Identities = 70/298 (23%), Positives = 134/298 (44%), Gaps = 27/298 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNY 141
++G G FG VYKG + S P VA+K LK + + ++L E
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+GQ H N+++L G + + +++ E+M G+ + R S + + G A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGTHGY 260
G+ +L ++RD A NIL+++ K+SDFGL++ + T+ ++ +
Sbjct: 122 GMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE ++ + T+ SDV+SFG+V+ E+++ + ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYG----------------ERPYWELSNHEVM 223
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL-EAPKNSAKLS 377
+ ++ P L +QC E RP+ +++++IL++L AP + L+
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-63
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 33/293 (11%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTE 138
++ R LG+G FG V +G D S G + VAVK LKP+ + +++ E
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
VN + L H NL++L G L + +V E P GSL + L + + A+
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQ 119
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV-STQVMGT 257
A+G+ +L + I+RD A N+LL K+ DFGL +A P D +V
Sbjct: 120 VAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 258 HGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSD 315
+ APE + T + SD + FGV L E+ + +P+ L+
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG-----------------QEPWIGLNG 220
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368
+ L +I P+ + +QC ++P+ RP + L +
Sbjct: 221 SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-63
Identities = 64/287 (22%), Positives = 105/287 (36%), Gaps = 38/287 (13%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEV 139
R + D +G G F VYKG + + VA +L+ + + E
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGL---------DTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 140 NYLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
L L HPN+V+ + +LV E M G+L+ +L R + V
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSW 117
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQV 254
KGL FLH +I+RD K NI + + K+ D GLA R + V
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAV 173
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
+GT + APE + DVY+FG+ +LE+ + + + +
Sbjct: 174 IGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------- 221
Query: 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
R+ + + A + C+ R + ++L
Sbjct: 222 ----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-63
Identities = 79/306 (25%), Positives = 124/306 (40%), Gaps = 43/306 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+ R + LG+G FG V+ G + VA+K LKP G + +L E +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWN----------GTTRVAIKTLKP-GTMSPEAFLQEAQVM 66
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
+L H LV+L E +V E+M KGSL + L + L + +A A G
Sbjct: 67 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAA 262
+ ++ ++RD +A+NIL+ K++DFGLA+ + + A
Sbjct: 126 MAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 182
Query: 263 PEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK--RKLF 320
PE GR T KSDV+SFG++L EL + + R++
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKG------------------RVPYPGMVNREVL 224
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPKNSAKLSQSE 380
++ P + + L QC EP+ RP + A LE + +E
Sbjct: 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY--------FTSTE 276
Query: 381 PHRQTG 386
P Q G
Sbjct: 277 PQYQPG 282
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-63
Identities = 78/283 (27%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVNYLGQ 144
D LG G FG V KG+ VAVK LK E E L E N + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 145 LHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLT 204
L +P +V++IG C E E+ +LV E G L +L + + +++ + G+
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMK 121
Query: 205 FLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG-DRTHVSTQVMGTHGYAAP 263
+L + S ++RD A N+LL + AK+SDFGL+KA + T + AP
Sbjct: 122 YLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 264 EYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLFRI 322
E + + ++KSDV+SFGV++ E S KPY K ++ +
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYG-----------------QKPYRGMKGSEVTAM 222
Query: 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
++ P L C + + RP + V L
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 9e-63
Identities = 76/314 (24%), Positives = 126/314 (40%), Gaps = 36/314 (11%)
Query: 76 ELKTATRNFRPDSL-LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-K 133
+L N + LG G FG V +G + VA+K LK + +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTE 54
Query: 134 EWLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 193
E + E + QL +P +V+LIG C + E +LV E G L L + + + +
Sbjct: 55 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVA 112
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA-GPTGDRTHVST 252
++ + G+ +L + ++RD A N+LL AK+SDFGL+KA G +
Sbjct: 113 ELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 253 QVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312
+ APE + + +++SDV+S+GV + E LS KPY
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG-----------------QKPY 213
Query: 313 LSDK-RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371
K ++ ++ + P + L C + + RP V +R+ A
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV---EQRMRACY 270
Query: 372 NS-AKLSQSEPHRQ 384
S A + H
Sbjct: 271 YSLASKVEGHHHHH 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-63
Identities = 82/318 (25%), Positives = 130/318 (40%), Gaps = 47/318 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNY 141
+ + ++GEG FG V K I K G M A+K++K H+++ E+
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 142 LGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QP 186
L +L HHPN++ L+G C L E+ P G+L + L +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 187 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246
LS + A A+G+ +L + Q I+RD A NIL+ + AK++DFGL++
Sbjct: 124 LSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
+ T + A E + TT SDV+S+GV+L E++S
Sbjct: 182 KK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---------------- 222
Query: 307 DWAKPYLSDKR-KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
PY +L+ + + P L QC +P RP +++L L
Sbjct: 223 -GGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 366 R-LEAPKNSAKLSQSEPH 382
R LE K + E
Sbjct: 282 RMLEERKTYVNTTLYEKF 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 5e-62
Identities = 69/290 (23%), Positives = 117/290 (40%), Gaps = 41/290 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
++ +G G +G K + G ++ K+L + ++EVN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIR---------RKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLL--VYEFMPKGSLENHLFR--RGPQPLSWAVRMKVA 196
L +L HPN+V+ ++ N L V E+ G L + + + + Q L ++V
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 197 IGAAKGLTFLH---DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
L H D V++RD K +N+ LD + N KL DFGLA+ T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY- 312
+GT Y +PE + KSD++S G +L EL + P+
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPFT 215
Query: 313 -LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
S K +I + K + P + + + + LN + RP + E+L
Sbjct: 216 AFSQKELAGKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-61
Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 30/287 (10%)
Query: 84 FRPDSLLGEGGFGFVYKG-WIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNY 141
F+ +LG G FG VYKG WI + VA+K+L+ + +KE L E
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYV 64
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ + +P++ +L+G CL +L + + MP G L +++ + + AK
Sbjct: 65 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAK 122
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
G+ +L D ++++RD A N+L+ + K++DFGLAK ++ + + +
Sbjct: 123 GMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK-RKLF 320
A E + T +SDV+S+GV + EL++ +KPY ++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFG-----------------SKPYDGIPASEIS 223
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
I++ P + ++C + RP+ E++ ++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-61
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 46/296 (15%)
Query: 81 TRNFRPD------SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE 134
TR+ P+ LG+G FG VYK + ++ A K + + + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQ---------NKETSVLAAAKVIDTKSEEELED 55
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
++ E++ L HPN+VKL+ N ++ EF G+++ + +PL+ +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 114
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
V L +LH ++++I+RD KA NIL + + KL+DFG++ +
Sbjct: 115 VCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170
Query: 255 MGTHGYAAPEYVAT-----GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309
+GT + APE V K+DV+S G+ L+E+
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------------------ 212
Query: 310 KPY--LSDKRKLFRIMDTKLGG-QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
P+ L+ R L +I ++ P + + +CL R S++L
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-61
Identities = 65/303 (21%), Positives = 111/303 (36%), Gaps = 43/303 (14%)
Query: 90 LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWL--TEVNYLGQLHH 147
+G+G FG V++G G VAVK + + W E+ L H
Sbjct: 11 IGKGRFGEVWRGKWR-----------GEEVAVKIFSS---REERSWFREAEIYQTVMLRH 56
Query: 148 PNLVKLIGYCLEGENRL----LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
N++ I + LV ++ GSL ++L R ++ +K+A+ A GL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGL 113
Query: 204 TFLH------DAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRT--HVSTQVM 255
LH + + +RD K+ NIL+ ++D GLA + T +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 256 GTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309
GT Y APE + ++D+Y+ G+V E+ C++ + D
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLV 232
Query: 310 KPYLSDKRKLFRIMDTKLGGQYPQK-----AAHTAATLALQCLNNEPKLRPRMSEVLAIL 364
S + + + KL P + A A + +C R + L
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
Query: 365 ERL 367
+L
Sbjct: 293 SQL 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-61
Identities = 70/284 (24%), Positives = 111/284 (39%), Gaps = 42/284 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEV 139
+F LG+G FG VY + S ++A+K L + EV
Sbjct: 7 DFEIGRPLGKGKFGNVYLAR---------EKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L HPN+++L GY + L+ E+ P G++ L +
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITEL 115
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
A L++ H +VI+RD K N+LL + K++DFG + P+ RT + GT
Sbjct: 116 ANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLD 169
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK- 318
Y PE + K D++S GV+ E L G+ P+ ++ +
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPFEANTYQE 211
Query: 319 -LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
RI + +P A L + L + P RP + EVL
Sbjct: 212 TYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 65/281 (23%), Positives = 104/281 (37%), Gaps = 30/281 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNY 141
++ LGEG +G V + VAVK + + + E+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAV---------NRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L+H N+VK G+ EG + L E+ G L + + + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 114
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
G+ +LH + +RD K N+LLD N K+SDFGLA +R + ++ GT Y
Sbjct: 115 GVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 262 APEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE + DV+S G+VL +L+G D+ Q DW +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLN---- 227
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
+K L + L P R + ++
Sbjct: 228 ----------PWKKIDSAPLALLHKILVENPSARITIPDIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (498), Expect = 3e-60
Identities = 73/289 (25%), Positives = 110/289 (38%), Gaps = 45/289 (15%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LT 137
+ F +G G FG VY + VVA+KK+ G Q +++W +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFAR---------DVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
EV +L +L HPN ++ G L LV E+ + + + PL V
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
GA +GL +LH +I+RD KA NILL KL DFG A + +GT
Sbjct: 123 GALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGT 174
Query: 258 HGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY-- 312
+ APE + G+ K DV+S G+ +EL + P
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------------------PPLFN 216
Query: 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
++ L+ I + + CL P+ RP +L
Sbjct: 217 MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-59
Identities = 71/297 (23%), Positives = 130/297 (43%), Gaps = 31/297 (10%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHK-EWLTEVNY 141
LG+G FG VY+G K VA+K + + E+L E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------QPLSWAVRM 193
+ + + ++V+L+G +G+ L++ E M +G L+++L P P S + +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
++A A G+ +L+ ++ ++RD A N ++ +F K+ DFG+ + D +
Sbjct: 137 QMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ + +PE + G TT SDV+SFGVVL E+ + + L
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---------------EQPYQGL 239
Query: 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370
S+++ L +M+ L P L C PK+RP E+++ ++ P
Sbjct: 240 SNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-58
Identities = 74/304 (24%), Positives = 125/304 (41%), Gaps = 38/304 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEVNY 141
LGEG FG V L KP VAVK LK + + + ++E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71
Query: 142 LGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGP--------------QP 186
+ + H N++ L+G C + ++ E+ KG+L +L R P +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 187 LSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGD 246
LS + A A+G+ +L + I+RD A N+L+ + K++DFGLA+ D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
+T + APE + T +SDV+SFGV+L E+ + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 307 DWAKPYL-SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365
PY +LF+++ P + + C + P RP +++ L+
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 366 RLEA 369
R+ A
Sbjct: 293 RIVA 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-58
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 28/286 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNY 141
+GEG FG V++G + + VA+K K +E +L E
Sbjct: 8 RIELGRCIGEGQFGDVHQGIY------MSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 142 LGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
+ Q HP++VKLIG E ++ E G L + L R L A + A +
Sbjct: 62 MRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 119
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYA 261
L +L + ++RD A N+L+ + KL DFGL++ + +++ +
Sbjct: 120 ALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWM 176
Query: 262 APEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321
APE + R T+ SDV+ FGV + E+L + + + R
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGV---------------KPFQGVKNNDVIGR 221
Query: 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367
I + + P T +L +C +P RPR +E+ A L +
Sbjct: 222 IENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-57
Identities = 80/331 (24%), Positives = 121/331 (36%), Gaps = 54/331 (16%)
Query: 54 LPTPKSEGEILSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKP 113
LP S+ E + LG G FG V + + K
Sbjct: 1 LPYDASKWEFPRD----------------RLKLGKPLGRGAFGQVIEA----DAFGIDKT 40
Query: 114 GSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQ-LHHPNLVKLIGYCLEGENRL-LVYEFM 170
+ VAVK LK H+ ++E+ L HH N+V L+G C + L ++ EF
Sbjct: 41 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 100
Query: 171 PKGSLENHLFRRGPQ--------------PLSWAVRMKVAIGAAKGLTFLHDAESQVIYR 216
G+L +L + + L+ + + AKG+ FL + I+R
Sbjct: 101 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHR 158
Query: 217 DFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSD 276
D A NILL + K+ DFGLA+ + APE + T +SD
Sbjct: 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 218
Query: 277 VYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAA 336
V+SFGV+L E+ S + P + + R + + P
Sbjct: 219 VWSFGVLLWEIFSLGASPY---------------PGVKIDEEFCRRLKEGTRMRAPDYTT 263
Query: 337 HTAATLALQCLNNEPKLRPRMSEVLAILERL 367
L C + EP RP SE++ L L
Sbjct: 264 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-57
Identities = 58/298 (19%), Positives = 105/298 (35%), Gaps = 38/298 (12%)
Query: 78 KTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKE 134
K +F+ +LGEG F V + + A+K L+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLAR---------ELATSREYAIKILEKRHIIKENKVPY 54
Query: 135 WLTEVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
E + + +L HP VKL + E + G L ++ + G
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRF 112
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
L +LH +I+RD K NILL+ + + +++DFG AK + +
Sbjct: 113 YTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314
+GT Y +PE + SD+++ G ++ +L++G P+ +
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRA 212
Query: 315 DKRK--LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370
+I+ + +P+K A L + L + R E+ P
Sbjct: 213 GNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-56
Identities = 64/284 (22%), Positives = 116/284 (40%), Gaps = 37/284 (13%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVN 140
+ + +G+G G VY +G VA++++ + + + E+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAM---------DVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
+ + +PN+V + L G+ +V E++ GSL + + V
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECL 126
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+ L FLH +QVI+RD K+ NILL + + KL+DFG + ++GT +
Sbjct: 127 QALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYW 182
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
APE V K D++S G++ +E++ G PY + R
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLNENPLRA 224
Query: 319 LFRI-MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVL 361
L+ I + Q P+K + +CL+ + + R E+L
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 184 bits (469), Expect = 2e-55
Identities = 68/341 (19%), Positives = 114/341 (33%), Gaps = 41/341 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
++ LG G FG V++ + +G A K + + E+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVT---------ERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
L HP LV L + +++YEFM G L + +S ++ KG
Sbjct: 78 SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKG 136
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFN--AKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
L +H+ ++ D K NI+ + + KL DFGL GT +
Sbjct: 137 LCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEF 191
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
AAPE + +D++S GV+ LLSG P+ +D
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------------------SPFGGENDDET 233
Query: 319 LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEAPKNSA 374
L + + + L +P R + + L L AP +
Sbjct: 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 375 KLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHR 415
++ S + + + + PL S L HR
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHR 334
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 2e-52
Identities = 66/337 (19%), Positives = 116/337 (34%), Gaps = 49/337 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+ LG G FG V++ + +G V K + E++ +
Sbjct: 30 YYDILEELGSGAFGVVHRCV---------EKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
QLHHP L+ L + +L+ EF+ G L + + +S A + A +G
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEG 139
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
L +H E +++ D K NI+ + + + K+ DFGLA + T +
Sbjct: 140 LKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKRK 318
AAPE V + +D+++ GV+ LLSG P+ D
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------------------SPFAGEDDLET 236
Query: 319 LFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA----------ILER 366
L + D + + A L EP+ R + + L + R
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 367 LEAPKNSAKLSQSEPHRQTGPVTVRKSPMRQQRSPLN 403
+ + + + + + P S L
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLR 333
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-51
Identities = 65/345 (18%), Positives = 129/345 (37%), Gaps = 46/345 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+ LG G FG V++ + S K +K +G E++ L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCV---------ETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
H N++ L E ++++EF+ + + L+ + +
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEA 114
Query: 203 LTFLHDAESQVIYRDFKASNILLDAEFNA--KLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
L FLH + + D + NI+ ++ K+ +FG A+ GD + + Y
Sbjct: 115 LQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK-- 318
APE ++T +D++S G ++ LLSG P+L++ +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------------------NPFLAETNQQI 211
Query: 319 LFRIMDTKLG--GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNS 373
+ IM+ + + ++ + A + L E K R SE L + +++E + S
Sbjct: 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE--RVS 269
Query: 374 AKLSQSEPHRQTGPVTVRKSPMRQQRSPLNMTPTASPLPSHRQSP 418
K+ ++ HR+ T+ K + S ++ + S
Sbjct: 270 TKVIRTLKHRRYYH-TLIKKDLNMVVSAARISCGGAIRSQKGVSV 313
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (428), Expect = 4e-50
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 54/300 (18%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---------QGHK 133
N+ P +LG G V + + AVK + G + +
Sbjct: 4 NYEPKEILGRGVSSVVRRCI---------HKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54
Query: 134 EWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVR 192
L EV+ L ++ HPN+++L LV++ M KG L ++L + LS
Sbjct: 55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 112
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVST 252
K+ + + LH +++RD K NILLD + N KL+DFG + G++
Sbjct: 113 RKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 167
Query: 253 QVMGTHGYAAPEYVATGRL------TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
+V GT Y APE + + D++S GV++ LL+G
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--------------- 212
Query: 307 DWAKPYLSDKRK--LFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
P+ K+ L IM + + G + T L + L +P+ R E LA
Sbjct: 213 ---PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (425), Expect = 9e-50
Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 44/297 (14%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVN 140
+ +LG GG V+ VAVK L+ + + + + E
Sbjct: 9 YELGEILGFGGMSEVHLAR---------DLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59
Query: 141 YLGQLHHPNLVKLIGYCLE----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
L+HP +V + G +V E++ +L + + GP ++ ++V
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI 117
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVM 255
A + L F H ++ +I+RD K +NI++ A K+ DFG+A+ +G+ + V+
Sbjct: 118 ADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 256 GTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--L 313
GT Y +PE + +SDVYS G VL E+L+G P+
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------------------PPFTGD 217
Query: 314 SDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-MSEVLAILERL 367
S ++ + D + + + L+ L P+ R + +E+ A L R+
Sbjct: 218 SPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 5e-49
Identities = 69/287 (24%), Positives = 106/287 (36%), Gaps = 39/287 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEV 139
+F ++G GGFG VY K +G + A+K L + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGCR---------KADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 140 N---YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVA 196
+ P +V + + + + M G L HL + G +
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 115
Query: 197 IGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMG 256
I GL +H V+YRD K +NILLD + ++SD GLA +G
Sbjct: 116 I--ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 167
Query: 257 THGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315
THGY APE + G + +D +S G +L +LL G + + D
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--------------FRQHKTKD 213
Query: 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
K ++ R+ T + P + +L L + R A
Sbjct: 214 KHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-49
Identities = 71/277 (25%), Positives = 103/277 (37%), Gaps = 37/277 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F +LG+G FG V+ + A+K LK + + + E
Sbjct: 3 DFILHKMLGKGSFGKVFLAE---------FKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53
Query: 140 NYLG-QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
L HP L + EN V E++ G L H+ LS A A
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAE 111
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
GL FLH ++YRD K NILLD + + K++DFG+ K GD GT
Sbjct: 112 IILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTP 167
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318
Y APE + + D +SFGV+L E+L G+ P+ +
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEE 209
Query: 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP 355
YP+ A L ++ EP+ R
Sbjct: 210 ELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 5e-48
Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 42/287 (14%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-WLTEVNYL 142
+ +LG G F V + +VA+K + + +G + E+ L
Sbjct: 11 YDFRDVLGTGAFSEVILAE---------DKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 143 GQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKG 202
++ HPN+V L G + L+ + + G L + + +G + ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDA 119
Query: 203 LTFLHDAESQVIYRDFKASNILL---DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
+ +LH + +++RD K N+L D + +SDFGL+K D V + GT G
Sbjct: 120 VKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPG 174
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR 317
Y APE +A + D +S GV+ LL G P+ +D +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------------------PPFYDENDAK 216
Query: 318 KLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+I+ + + Y + +A + +P+ R + L
Sbjct: 217 LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 2e-47
Identities = 62/291 (21%), Positives = 105/291 (36%), Gaps = 44/291 (15%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW------LT 137
+ LG G F V K + +G+ A K +K + +
Sbjct: 12 YDTGEELGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
EV+ L ++ HPN++ L + +L+ E + G L + L + A
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LK 120
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAE----FNAKLSDFGLAKAGPTGDRTHVSTQ 253
G+ +LH Q+ + D K NI+L K+ DFGLA G+
Sbjct: 121 QILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 175
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
+ GT + APE V L ++D++S GV+ LLSG
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---------------- 219
Query: 314 SDKRKLFRIM--DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ + L + + + +Y + A + L +PK R + + L
Sbjct: 220 TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 5e-46
Identities = 66/286 (23%), Positives = 113/286 (39%), Gaps = 43/286 (15%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE---WLTE 138
++F+ LG G FG V+ +G A+K LK E K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR---------SRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 139 VNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIG 198
L + HP ++++ G + + ++ +++ G L + L + P A +
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV- 113
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
L +LH +IYRD K NILLD + K++DFG AK P T GT
Sbjct: 114 -CLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTP 165
Query: 259 GYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDK 316
Y APE V+T D +SFG+++ E+L+G P+ +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------------------TPFYDSNTM 207
Query: 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ +I++ +L ++P L + + + R +
Sbjct: 208 KTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGT 251
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-46
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 28/299 (9%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGH-KEWLTEV 139
+ S +GEG +G V + + + VA+KK+ P Q + + L E+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRR-GPQPLSWAVRMKVAIG 198
L + H N++ + + ++ + L++ Q LS
Sbjct: 58 KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117
Query: 199 AAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK-AGPTGDRTHVSTQVMGT 257
+GL ++H + V++RD K SN+LL+ + K+ DFGLA+ A P D T T+ + T
Sbjct: 118 ILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 258 HGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRC--AVDKTKVGIEQSLVDWAKPYLS 314
Y APE + + TKS D++S G +L E+LS R + L P
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 315 DKRKLFRIMDTKLGGQYPQK-----------AAHTAATLALQCLNNEPKLRPRMSEVLA 362
D + + P K A A L + L P R + + LA
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-46
Identities = 68/290 (23%), Positives = 107/290 (36%), Gaps = 31/290 (10%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE-----WLTEVNYLG 143
LGEG F VYK + +VA+KK+K K+ L E+ L
Sbjct: 5 FLGEGQFATVYKAR---------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 144 QLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
+L HPN++ L+ N LV++FM S + +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY--MLMTLQGL 113
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAP 263
+LH + +++RD K +N+LLD KL+DFGLAK+ + +R + T + T Y AP
Sbjct: 114 EYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAP 169
Query: 264 EYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAKPY 312
E + R+ D+++ G +L ELL + + + W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
F+ A L P R ++ L
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-46
Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 33/302 (10%)
Query: 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLT 137
A + + + +GEG +G V+K G VA+K+++ + + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKAR--------DLKNGGRFVALKRVRVQTGEEGMPLSTIR 56
Query: 138 EVN---YLGQLHHPNLVKLIGYCL----EGENRLLVYEFMPKGSLENHLFRRGPQPLSWA 190
EV +L HPN+V+L C + E +L + L +L + +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116
Query: 191 VRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHV 250
+ +GL FLH +V++RD K NIL+ + KL+DFGLA+
Sbjct: 117 TIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMA 171
Query: 251 STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVG 300
T V+ T Y APE + T D++S G + E+ + + V
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 301 IEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEV 360
DW + + R+ F + ++ L L+CL P R
Sbjct: 232 GLPGEEDWPRDV-ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
Query: 361 LA 362
L+
Sbjct: 291 LS 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 6e-46
Identities = 59/301 (19%), Positives = 95/301 (31%), Gaps = 35/301 (11%)
Query: 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW 135
EL+ R +R +G G FG +Y G +G VA+K + H +
Sbjct: 2 ELRVGNR-YRLGRKIGSGSFGDIYLGT---------DIAAGEEVAIKLECVK--TKHPQL 49
Query: 136 LTEVNYLGQLHHPNLVKLIGYCL-EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
E + + I +C EG+ ++V E + + F S +
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLL 107
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNIL---LDAEFNAKLSDFGLAKA-----GPTGD 246
+A + ++H I+RD K N L + DFGLAK
Sbjct: 108 LADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 247 RTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV 306
+ + GT YA+ + + D+ S G VL+ G K
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA------A 219
Query: 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILER 366
+ Y K L YP + A C + +P S + +
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFAT----YLNFCRSLRFDDKPDYSYLRQLFRN 275
Query: 367 L 367
L
Sbjct: 276 L 276
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-46
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 26/293 (8%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
NF+ +GEG +G VYK +G VVA+KK++ + + E++
Sbjct: 3 NFQKVEKIGEGTYGVVYKAR---------NKLTGEVVALKKIRLDTETEGVPSTAIREIS 53
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L +L+HPN+VKL+ LV+EF+ + L+ + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+GL F H +V++RD K N+L++ E KL+DFGLA+A RT+ + +V+
Sbjct: 113 QGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYR 169
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRC----------AVDKTKVGIEQSLVDWAK 310
A + +T D++S G + E+++ R + V W
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 311 PY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ D + F + + +L Q L+ +P R LA
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 158 bits (399), Expect = 8e-46
Identities = 47/299 (15%), Positives = 89/299 (29%), Gaps = 42/299 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+++ +GEG FG +++G + VA+K + E
Sbjct: 6 HYKVGRRIGEGSFGVIFEGT---------NLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54
Query: 143 GQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAK 201
L + + + EG + +LV + + G L + S A
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112
Query: 202 GLTFLHDAESQVIYRDFKASNILLDAEFN-----AKLSDFGLAK-----AGPTGDRTHVS 251
+ +H E ++YRD K N L+ + + DFG+ K
Sbjct: 113 RVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 252 TQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKP 311
+ GT Y + + + D+ + G V + L G
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL-------------PWQGLK 217
Query: 312 YLSDKRKLFRIMDTKLGGQYPQKAAHT---AATLALQCLNNEPKLRPRMSEVLAILERL 367
++K+K RI + K + A N P + + ++
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (394), Expect = 3e-45
Identities = 59/293 (20%), Positives = 115/293 (39%), Gaps = 28/293 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
+ +GEG +G VYK A+ G A+KK++ E + E++
Sbjct: 3 KYHGLEKIGEGTYGVVYK----------AQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L +L H N+VKL + +LV+E + + + G L +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLL 110
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
G+ + HD +V++RD K N+L++ E K++DFGLA+A R + +++
Sbjct: 111 NGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYR 167
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKT----------KVGIEQSLVDWAK 310
A + + + +T D++S G + E+++G ++ + +W
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 311 PY-LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
L F + + + + + L + L +P R + L
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-44
Identities = 56/301 (18%), Positives = 108/301 (35%), Gaps = 40/301 (13%)
Query: 89 LLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQL-HH 147
+LG G G V + + + A+K L+ + EV +
Sbjct: 19 VLGLGINGKVLQIF---------NKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64
Query: 148 PNLVKLIGYC----LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGL 203
P++V+++ + L+V E + G L + + RG Q + ++ + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 204 TFLHDAESQVIYRDFKASNILLDAEFN---AKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
+LH + +RD K N+L ++ KL+DFG AK + + T Y
Sbjct: 125 QYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYY 179
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320
APE + + D++S GV++ LL G + +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS----------NHGLAISPGMKTRI 229
Query: 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA---ILERLEAPKNSAKLS 377
R+ + + + L L EP R ++E + I++ + P+ S
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 378 Q 378
+
Sbjct: 290 R 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-44
Identities = 62/305 (20%), Positives = 114/305 (37%), Gaps = 52/305 (17%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKE------WLT 137
++ LLG GGFG VY G + + VA+K ++ + E
Sbjct: 6 YQVGPLLGSGGFGSVYSGI---------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 138 EVNYLGQLH--HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKV 195
EV L ++ +++L+ + ++ +L+ E L +
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSF 115
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQV 254
+ + H V++RD K NIL+D KL DFG + V T
Sbjct: 116 FWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 169
Query: 255 MGTHGYAAPEYVATGRLTTKS-DVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313
GT Y+ PE++ R +S V+S G++L +++ G P+
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------IPFE 211
Query: 314 SDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEAPK 371
D+ I+ ++ + Q+ + L CL P RP E+ ++ + P+
Sbjct: 212 HDE----EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
Query: 372 NSAKL 376
+A++
Sbjct: 266 ETAEI 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 71/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEV 139
+F LLG+G FG V + +G A+K L+ E E +TE
Sbjct: 6 DFDYLKLLGKGTFGKVILVR---------EKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 140 NYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L HP L L + V E+ G L HL R + +
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEI 114
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHG 259
L +LH V+YRD K N++LD + + K++DFGL K G + T GT
Sbjct: 115 VSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPE 170
Query: 260 YAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY--LSDKR 317
Y APE + D + GVV+ E++ GR P+ +R
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------------------LPFYNQDHER 212
Query: 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
I+ ++ ++P+ + A +L L +PK R A
Sbjct: 213 LFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-41
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 36/299 (12%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
++ ++G G FG VY+ SG +VA+KK+ + + E+ +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAK---------LCDSGELVAIKKVLQD----KRFKNRELQIM 67
Query: 143 GQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHL-FRRGPQPLSWAVRMKV 195
+L H N+V+L + + LV +++P+ + R Q L
Sbjct: 68 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127
Query: 196 AIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRTHVSTQV 254
+ L ++H + +RD K N+LLD + KL DFG AK G+ + +
Sbjct: 128 MYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYI 183
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-----CAVDKTKVGIEQSLVDWA 309
+ A T+ DV+S G VL ELL G+ + V I + L
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 310 KPYLSD------KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ + + + K +I + + A L + L P R E A
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-41
Identities = 65/307 (21%), Positives = 112/307 (36%), Gaps = 40/307 (13%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG--HKEWLTEVN 140
+ + +G+G FG V+K +G VA+KK+ E + L E+
Sbjct: 11 KYEKLAKIGQGTFGEVFKAR---------HRKTGQKVALKKVLMENEKEGFPITALREIK 61
Query: 141 YLGQLHHPNLVKLIGYCLEGENR--------LLVYEFMPKGSLENHLFRRGPQPLSWAVR 192
L L H N+V LI C + LV++F LS R
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121
Query: 193 MKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVS- 251
V GL ++H +++++RD KA+N+L+ + KL+DFGLA+A + +
Sbjct: 122 --VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 252 -TQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGR-------------CAVDK 296
T + T Y PE + R D++ G ++ E+ +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAAT-LALQCLNNEPKLRP 355
+ + L +K +L + K+ + A L + L +P R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 356 RMSEVLA 362
+ L
Sbjct: 298 DSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 28/294 (9%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVN 140
+ +GEG +G V+K + +VA+K+++ + L E+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK---------NRETHEIVALKRVRLDDDDEGVPSSALREIC 53
Query: 141 YLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAA 200
L +L H N+V+L + LV+EF + + G +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLL 111
Query: 201 KGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGY 260
KGL F H V++RD K N+L++ KL++FGLA+A R + S +V+
Sbjct: 112 KGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYR 168
Query: 261 AAPEYVATGRLTTKSDVYSFGVVLLELLSGR---CAVDKTKVGIEQSLVDWAKPYLSDKR 317
+T D++S G + EL + + +++ P
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 318 KLFRIMDTKLGGQYPQ---------KAAHTAATLALQCLNNEPKLRPRMSEVLA 362
+ ++ D K YP K T L L P R E L
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-38
Identities = 62/316 (19%), Positives = 110/316 (34%), Gaps = 44/316 (13%)
Query: 72 FTFNELKTAT----RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE 127
F E+ +R +G G +G V +G VA+KKL
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV---------DGRTGAKVAIKKLYRP 54
Query: 128 GF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENR------LLVYEFMPKGSLENHL 179
K E+ L + H N++ L+ E LV FM G+ L
Sbjct: 55 FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL 112
Query: 180 FRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239
+ L + KGL ++H + +I+RD K N+ ++ + K+ DFGLA
Sbjct: 113 MKHEK--LGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-------- 291
+ + ++ V+ A + R T D++S G ++ E+++G+
Sbjct: 169 RQA----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 292 -----CAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQC 346
+ T + + + K ++ K A+ A L +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 347 LNNEPKLRPRMSEVLA 362
L + + R E LA
Sbjct: 285 LVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 1e-36
Identities = 72/317 (22%), Positives = 114/317 (35%), Gaps = 46/317 (14%)
Query: 49 GNSESLPTP---KSEGEILSSS---NLKAFTFNELKTATRN-FRPDSLLGEGGFGFVYKG 101
GN+ + +S E L+ + LK + TA + F LG G FG V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 102 WIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEW---LTEVNYLGQLHHPNLVKLIGYCL 158
SG A+K L + K+ L E L ++ P LVKL
Sbjct: 61 K---------HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDF 218
+ N +V E++ G + +HL R G S A +LH +IYRD
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDL 167
Query: 219 KASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVY 278
K N+L+D + +++DFG AK T + GT APE + + D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWW 222
Query: 279 SFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT 338
+ GV++ E+ +G P+ +D+ ++P +
Sbjct: 223 ALGVLIYEMAAGYP------------------PFFADQPIQIYEKIVSGKVRFPSHFSSD 264
Query: 339 AATLALQCLNNEPKLRP 355
L L + R
Sbjct: 265 LKDLLRNLLQVDLTKRF 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 81/310 (26%), Positives = 117/310 (37%), Gaps = 43/310 (13%)
Query: 64 LSSSNLKAFTFNELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKK 123
L ++NL T + K NF +LG G +G V+ + +G + A+K
Sbjct: 9 LRTANL---TGHAEKVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKV 59
Query: 124 LKPEGF----QGHKEWLTEVNYLGQL-HHPNLVKLIGYCLEGENRLLVYEFMPKGSLENH 178
LK + + TE L + P LV L L+ +++ G L H
Sbjct: 60 LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119
Query: 179 LFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238
L +R I L LH +IYRD K NILLD+ + L+DFGL
Sbjct: 120 LSQRERFTEHEVQIYVGEI--VLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGL 175
Query: 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR--LTTKSDVYSFGVVLLELLSGRCAVDK 296
+K D T + GT Y AP+ V G D +S GV++ ELL+G
Sbjct: 176 SKE-FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA----- 229
Query: 297 TKVGIEQSLVDWAKPY--LSDKRKLFRIMDTKLGGQ--YPQKAAHTAATLALQCLNNEPK 352
P+ +K I L + YPQ+ + A L + L +PK
Sbjct: 230 -------------SPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPK 276
Query: 353 LRPRMSEVLA 362
R A
Sbjct: 277 KRLGCGPRDA 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 5e-36
Identities = 54/305 (17%), Positives = 106/305 (34%), Gaps = 47/305 (15%)
Query: 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYL 142
+++ LG G + V++ + V VK LKP K+ E+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAI---------NITNNEKVVVKILKPVK---KKKIKREIKIL 83
Query: 143 GQL-HHPNLVKLIGYCLEGENRL--LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGA 199
L PN++ L + +R LV+E + + Q L+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEI 138
Query: 200 AKGLTFLHDAESQVIYRDFKASNILLDAEFN-AKLSDFGLAKAGPTGDRTHVSTQVMGTH 258
K L + H +++RD K N+++D E +L D+GLA+ G + +
Sbjct: 139 LKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASR 193
Query: 259 GYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-----------SLV 306
+ PE + ++ D++S G +L ++ + +Q L
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
Query: 307 DWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHT---------AATLALQCLNNEPKLRPRM 357
D+ Y + F + + + ++ H+ A + L + + R
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
Query: 358 SEVLA 362
E +
Sbjct: 314 REAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-31
Identities = 58/313 (18%), Positives = 107/313 (34%), Gaps = 51/313 (16%)
Query: 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEV 139
+ ++ +G G G V + VA+KKL K E+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 140 NYLGQLHHPNLVKLIGYCL------EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRM 193
+ ++H N++ L+ E ++ LV E M +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122
Query: 194 KVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQ 253
+ G+ LH + +I+RD K SNI++ ++ K+ DFGLA+ T T
Sbjct: 123 YLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TP 177
Query: 254 VMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC----------------AVDKT 297
+ T Y APE + D++S G ++ E++ + +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 298 KVGIEQSLVDWAKPYLSDK--------RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNN 349
+ L + Y+ ++ KLF ++ + A A L + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 350 EPKLRPRMSEVLA 362
+P R + + L
Sbjct: 298 DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-31
Identities = 58/301 (19%), Positives = 105/301 (34%), Gaps = 36/301 (11%)
Query: 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTE 138
++ S +G G +G V + +G+ VAVKKL K E
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67
Query: 139 VNYLGQLHHPNLVKLIGYCLEG----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMK 194
+ L + H N++ L+ E + G+ N++ + L+
Sbjct: 68 LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQF 125
Query: 195 VAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 254
+ +GL ++H + +I+RD K SN+ ++ + K+ DFGLA+ ++ V
Sbjct: 126 LIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYV 179
Query: 255 MGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRC-----AVDKTKVGIEQSLVDWA 309
A + D++S G ++ ELL+GR I + +
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 310 KPYLSDKRKLFRIMDTKLGGQYPQK--------AAHTAATLALQCLNNEPKLRPRMSEVL 361
L + Q P+ A A L + L + R ++ L
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 362 A 362
A
Sbjct: 300 A 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 3e-27
Identities = 42/324 (12%), Positives = 98/324 (30%), Gaps = 56/324 (17%)
Query: 84 FRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLG 143
+ LG G F V+ + VA+K ++ + + E+ L
Sbjct: 15 YILVRKLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQ 64
Query: 144 QLHHPNLVKLIGYCLEGENRLL-VYEFMPKGSLENHLF-------------RRGPQPLSW 189
+++ + K +LL + + + + + +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 190 AVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE-FNAKLSDFGLAKAGPTGDRT 248
+++ GL ++H +I+ D K N+L++ L +A G
Sbjct: 125 IYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 249 HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVD- 307
T + T Y +PE + +D++S ++ EL++G + + D
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 308 --------------------WAKPYLSDKRKLFRIMDTKL---------GGQYPQKAAHT 338
+ + + + + L I K ++ + A
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 339 AATLALQCLNNEPKLRPRMSEVLA 362
+ L +P+ R ++
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 8e-17
Identities = 22/163 (13%), Positives = 42/163 (25%), Gaps = 28/163 (17%)
Query: 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG----------FQGHKEWLT 137
L+GEG V+ VK K G +
Sbjct: 6 KLMGEGKESAVFN----------CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV 55
Query: 138 EVNYLGQLHHPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAI 197
+ L KL G + Y + L + + + +V
Sbjct: 56 LAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLD 110
Query: 198 GAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240
+ + + +++ D N+L+ E + DF +
Sbjct: 111 MILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 421 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.18 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=422.90 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||+||+|.+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 479999999999999999996543 58899999998766666778999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..|||||||+||+|.+++.+. .+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH--CCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 999999999999999988654 38999999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..+..
T Consensus 166 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~ 227 (293)
T d1yhwa1 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----------------RALYL 227 (293)
T ss_dssp CCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHHHH
T ss_pred eccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----------------HHHHH
Confidence 644332 234578999999999999999999999999999999999999999764321 11111
Q ss_pred hhh-cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 322 IMD-TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 322 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
... .......+..++.++.+||.+||..||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11122345677889999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=424.36 Aligned_cols=253 Identities=25% Similarity=0.304 Sum_probs=207.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 579999999999999999997654 588999999976533 2335688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+|+
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~--~~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH--cCCccCcccHHHEEECCCCCEEEccchhhe
Confidence 99999999999999999996543 49999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---------------~ 216 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------Y 216 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH---------------H
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH---------------H
Confidence 7654443334456789999999999988876 57899999999999999999999765321111 1
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...............++.++.+||.+||+.||.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111112223466789999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-58 Score=423.94 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=222.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||+||+|.+.. +++.||||+++... ...+++.+|+++|+.++|||||++++++.++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 4578999999999999999998765 47899999997654 4457799999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++|||||++|+|.+++.......+++..+..++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH--CCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999988777779999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... .......|++.|+|||++.++.|+.++|||||||++|||++|..||.... +...+.
T Consensus 164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~----------------~~~~~~ 226 (287)
T d1opja_ 164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVY 226 (287)
T ss_dssp TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC----------------CHHHHH
T ss_pred ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc----------------hHHHHH
Confidence 7654332 22334568999999999999999999999999999999999777664322 122233
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
+.+........+..++.++.+||.+||..||.+|||+.+|++.|+.+..
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4444555556677888999999999999999999999999999988743
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=414.33 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=209.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||+||+|.+.. +++.||+|++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 76 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence 469999999999999999997654 58899999986432 234467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+++..|+|||||++|+|.+++.+... +++..+..++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 77 DATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred ECCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHH--CCeeeeeeccccceecCCCCEeecccce
Confidence 99999999999999999999977654 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|....... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..... .
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~ 212 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------T 212 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------H
Confidence 98754432 335789999999999999999999999999999999999999997643211 0
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+... ....+..+++++.+||.+||..||.+|||+.|+++
T Consensus 213 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 213 YKRISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111111 12345667889999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=417.38 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=204.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|.++ ..||||+++.... ...+.|.+|+.+|++++|||||++++++.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~ 74 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe
Confidence 468999999999999999999643 2599999875432 33467889999999999999999999864
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
.+..++|||||++|+|.+++.... ..+++..+..++.||+.||+|||+ +|||||||||+||||+.++.+||+|||+
T Consensus 75 -~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 75 -APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp -SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred -ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc--CCEeccccCHHHEEEcCCCCEEEccccc
Confidence 467899999999999999996544 358999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccC---CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATG---RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|+...............||+.|+|||++.+. .|+.++|||||||+||||+||+.||.+.....
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-------------- 216 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------------- 216 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------------
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--------------
Confidence 9876544433344567899999999998643 58999999999999999999999997643211
Q ss_pred hhhHhHhhhcccC----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 316 KRKLFRIMDTKLG----GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 316 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+...+..... ...+..+++++.+||.+||..||++|||+.+|++.|+.+.+
T Consensus 217 --~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 217 --QIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp --HHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111111111 12345667899999999999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=416.33 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+++|++++|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 579999999999999999997654 5889999999765433 23568899999999999999999999865
Q ss_pred --CCeEEEEEEcCCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhCC---CceeeccCCCCcEEeCCCCcEE
Q 014623 160 --GENRLLVYEFMPKGSLENHLFRR--GPQPLSWAVRMKVAIGAAKGLTFLHDAE---SQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 160 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~ivHrDlkp~Nill~~~~~~k 232 (421)
.+.+|+|||||+||+|.+++.+. ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.++.+|
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 45689999999999999998653 2356999999999999999999999743 3599999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....
T Consensus 155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------------ 220 (269)
T d2java1 155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------------ 220 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------------
T ss_pred EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------------
Confidence 999999987654322 234578999999999999999999999999999999999999999764321
Q ss_pred hhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 313 LSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+...+........+..+++++.+||.+||..||.+|||+.|+++
T Consensus 221 -----~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 -----ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111112222222345667889999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=418.94 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=207.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 78 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence 579999999999999999997654 58899999986432 234467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|||||||+||+|.+++...+. +++..+..++.|++.||+|||+ .||+||||||+|||++.+|.+||+|||+
T Consensus 79 ~~~~~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 79 DDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ECCEEEEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhcc--ccEEcCcCCccccccCCCceEEeccccc
Confidence 99999999999999999999977654 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+..............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.... ..
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----------------~~ 218 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----------------LI 218 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----------------HH
Confidence 98765444333445678999999999999999999999999999999999999999764321 01
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
...+... ...++..+++++.+||.+||+.||.+|||+.|++..
T Consensus 219 ~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 219 FQKIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHHHHTT--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHHHHcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1111111 123456778899999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-56 Score=417.59 Aligned_cols=264 Identities=24% Similarity=0.438 Sum_probs=207.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
++|++.+.||+|+||+||+|.+.... .....||||.+..... ...++|.+|+++|++++|||||++++++.+.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 56888899999999999999875421 1234689999876433 3346789999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+++
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh--CCCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999999999886543 358999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcce---eeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 241 AGPTGDRTHV---STQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 241 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
.......... .....||+.|+|||++.++.|+.++|||||||++|||+| |..||.+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----------------- 239 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----------------- 239 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----------------
Confidence 7654332211 122457999999999999999999999999999999998 8999976432
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
..+...+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+++...+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 240 QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 1222333334444566778899999999999999999999999999999876543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=410.12 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=204.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||+||+|.+.+ +..||||+++... ...+++.+|++++++++|||||++++++...+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN----------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT----------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC----------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 578999999999999999997653 5689999997643 44578999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||+.++.+||+|||+++.
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred ceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc--cceeecccchhheeecCCCCeEecccchhee
Confidence 9999999999999999986543 458899999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhC-CCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......||..|+|||++.+..|+.++|||||||++|||+|+ ..||.... ...+.
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-----------------~~~~~ 212 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----------------NSEVV 212 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-----------------HHHHH
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-----------------HHHHH
Confidence 6543322 22346789999999999999999999999999999999995 55554322 11222
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+.+........+..++.++.+||.+||+.||++|||+++|++.|+++.
T Consensus 213 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 213 EDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 333333444556677889999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=415.49 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=209.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+.|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+++|+.++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 468999999999999999997654 58899999998766666678899999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..+||||||+||+|.+++.+.. ..+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~--~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD--NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEEeecChhheeECCCCCEEEEechhhhc
Confidence 9999999999999999986543 359999999999999999999995 4799999999999999999999999999975
Q ss_pred CCCCCCcceeeccccccceecccccc-----cCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhch
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVA-----TGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
.... .......+||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.....
T Consensus 160 ~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------------- 222 (288)
T d2jfla1 160 NTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------------- 222 (288)
T ss_dssp CHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---------------
T ss_pred cCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---------------
Confidence 4321 11223578999999999984 4568999999999999999999999997653211
Q ss_pred hhHhHhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 317 RKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 317 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+..+.... .....+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 223 -~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 223 -VLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111 122334677889999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=407.46 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=199.8
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe-
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE- 159 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 159 (421)
.|++.+.||+|+||+||+|.+.. +++.||+|++..... ...+.+.+|+++|++++|||||++++++.+
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 34777899999999999997654 578999999875432 234568899999999999999999999875
Q ss_pred ---CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC-CCCcEEEee
Q 014623 160 ---GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD-AEFNAKLSD 235 (421)
Q Consensus 160 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~-~~~~~kl~D 235 (421)
...+|+|||||++|+|.+++.+.. .+++..+..++.||+.||+|||+.+.+|+||||||+||||+ .++.+||+|
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence 346799999999999999997764 38999999999999999999996434499999999999996 578999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+....
T Consensus 159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--------------- 218 (270)
T d1t4ha_ 159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--------------- 218 (270)
T ss_dssp TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------------
T ss_pred cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---------------
Confidence 9999864332 2345789999999998865 5999999999999999999999999754321
Q ss_pred hhhHhHhhhcc-cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTK-LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+.+.+... .....+...++++.+||.+||..||++|||+.|+++
T Consensus 219 -~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 219 -AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -HHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111111111 111223345678999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=421.13 Aligned_cols=263 Identities=27% Similarity=0.402 Sum_probs=217.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|.+.... .......||+|.+..... .....+.+|+.+|.++ +|||||++++++.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCC----cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 367999999999999999999876531 222345799999865432 3345788999999998 8999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhCCCceeecc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGP---------------------QPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 217 (421)
+.+..++|||||++|+|.++|..... ..+++..++.++.||+.||+|||+ +||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~--~~IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH--TTEEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecc
Confidence 99999999999999999999975432 348899999999999999999995 4799999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDK 296 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~ 296 (421)
|||+|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655444444456778999999999999999999999999999999998 8999976
Q ss_pred CcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014623 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILE 365 (421)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 365 (421)
... ...+.+.+....+...+..+++++.+||.+||+.||++|||+.||++.|.
T Consensus 270 ~~~----------------~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPV----------------DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCC----------------SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCH----------------HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 432 12233444455555667788899999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=413.15 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=212.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++.+.||+|+||+||+|.++. +..||||+++... ...+.+.+|+++|++++|||||++++++. .
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 3579999999999999999997642 6789999997653 44577999999999999999999999775 4
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+|+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~--~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--RNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCccchhheeeecccceeeccccceE
Confidence 667999999999999998866555568999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... .......||+.|+|||++.++.|+.++|||||||++|||+||..|+..... ...+.
T Consensus 158 ~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~----------------~~~~~ 220 (272)
T d1qpca_ 158 LIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT----------------NPEVI 220 (272)
T ss_dssp ECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHH
T ss_pred EccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC----------------HHHHH
Confidence 7654332 223346789999999999999999999999999999999996555433211 11222
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
+.+....+...+..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus 221 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 33334444455677888999999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-56 Score=418.81 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=194.1
Q ss_pred HhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 80 ATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 80 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.+.|++.+.||+|+||+||+|.+.. +|+.||||++...... ....+.+|+.+|+.++|||||++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 45679999999999999999997654 5889999999765433 2345778999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC---CCCcEEEee
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD---AEFNAKLSD 235 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~---~~~~~kl~D 235 (421)
+++..|||||||+||+|.+++.+.+ .+++..+..++.||+.||+|||+ .||+||||||+|||+. .++.+||+|
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~--~~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHD--LGIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred ECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhh--ceeeeEEecccceeecccCCCceEEEec
Confidence 9999999999999999999997654 49999999999999999999995 4799999999999994 578999999
Q ss_pred ccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------------- 216 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------------- 216 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------------
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------------
Confidence 99998754432 2345789999999999999999999999999999999999999997643211
Q ss_pred hhhHhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
....+.... ........+++++.+||.+||..||++|||+.|+++
T Consensus 217 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 217 --LFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --HHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111111 122334567889999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=422.64 Aligned_cols=271 Identities=25% Similarity=0.366 Sum_probs=210.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-HHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-HKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||+||+|.+.. +|+.||+|+++...... ...+.+|+.+|+.++|||||+++++|.+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4689999999999999999997654 58999999997653332 4578899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..|+||||++||+|.+++.+.+. +++..+..++.|++.||.|||+. +||+||||||+||||+.+|.+||+|||+|
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 9999999999999999999987654 89999999999999999999963 36999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh----------
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA---------- 309 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~---------- 309 (421)
+..... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.............
T Consensus 153 ~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 153 GQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred cccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 864321 234578999999999999999999999999999999999999999765432211100000
Q ss_pred ----------------hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhh
Q 014623 310 ----------------KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERL 367 (421)
Q Consensus 310 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~ 367 (421)
.+........................+.++.+||.+||..||.+|||+.|+++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000000000111111111111235678999999999999999999999987 45543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-55 Score=400.23 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=216.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++.+.||+|+||+||+|.++ ++..||||+++.... ..+++++|+.++++++||||+++++++.+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 58999999999999999999864 267899999986543 4568999999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred ceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhhee
Confidence 9999999999999999976544 348899999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHh
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLF 320 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (421)
....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... ..+.
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----------------~~~~ 211 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETA 211 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHH
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----------------HHHH
Confidence 6543322 2334678999999999999999999999999999999998 8999976532 1222
Q ss_pred HhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 321 RIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
..+....+...+..++.++.+||.+||+.||++|||+.+|++.|.++
T Consensus 212 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 212 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 33333444556677888999999999999999999999999998653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=406.20 Aligned_cols=251 Identities=29% Similarity=0.409 Sum_probs=205.2
Q ss_pred ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEeCCeEEE
Q 014623 88 SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 88 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 165 (421)
+.||+|+||+||+|.+... .+++.||||+++..... ..+++.+|+++|++++|||||++++++. .+..+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEE
T ss_pred CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEE
Confidence 5799999999999986532 24678999999754332 2457899999999999999999999885 456789
Q ss_pred EEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCCC
Q 014623 166 VYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTG 245 (421)
Q Consensus 166 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 245 (421)
||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++.....
T Consensus 85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~--~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh--CCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 999999999999997654 38999999999999999999995 47999999999999999999999999999876543
Q ss_pred CCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhHhHhh
Q 014623 246 DRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRIM 323 (421)
Q Consensus 246 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (421)
... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+... ..+...+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----------------~~~~~~i 223 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAML 223 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------------HHHHHHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----------------HHHHHHH
Confidence 322 22234578999999999999999999999999999999998 8999976431 1223333
Q ss_pred hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 324 DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 324 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
....+...+..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 34444556677889999999999999999999999999888764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-55 Score=418.04 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=211.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+.+|+.|+|||||++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3589999999999999999997654 5889999999877666667788999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC--CCCcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~ 238 (421)
+..|||||||+||+|.+++.+.. ..+++..+..++.||+.||.|||+ .|||||||||+|||++ .++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE--NNYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeeeeechhHeeeccCCCCeEEEeecch
Confidence 99999999999999999985443 349999999999999999999995 4799999999999995 467899999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++...... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..
T Consensus 173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----------------~~ 233 (350)
T d1koaa2 173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----------------ET 233 (350)
T ss_dssp CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 98765433 234578999999999999999999999999999999999999999765321 11
Q ss_pred HhHhhhcc--cCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 319 LFRIMDTK--LGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 319 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
+..+.... ........+++++.+||.+||..||.+|||+.|+++.
T Consensus 234 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 234 LRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111 1112234677899999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-55 Score=407.25 Aligned_cols=258 Identities=27% Similarity=0.385 Sum_probs=211.9
Q ss_pred cCCCCCce-ecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSL-LGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~-lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|.+.+. ||+|+||+||+|.+... .++..||||+++.... ...++|.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45667774 99999999999976532 2456899999976533 334678999999999999999999998864
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
+..|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~--~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE--KNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCcCchhheeeccCCceeeccchhh
Confidence 56899999999999999885433 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 240 KAGPTGDRT-HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 240 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----------------~ 219 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------P 219 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----------------H
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----------------H
Confidence 876543322 22234568999999999999999999999999999999998 9999976432 1
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
.+...+....+...+..++.++.+||.+||..||++|||+.+|++.|+.+
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12233333444556778889999999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-55 Score=417.31 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=211.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++++.||+|+||+||+|.+.. +|+.||||++........+.+.+|+++|+.|+|||||++++++.+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 579999999999999999997653 58999999998766555667889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC--CCCcEEEeeccCc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD--AEFNAKLSDFGLA 239 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~--~~~~~kl~Dfg~a 239 (421)
.+|||||||+||+|.+++.+.. ..+++..++.++.||+.||.|||+ .||+||||||+||||+ .++.+||+|||+|
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccc
Confidence 9999999999999999885543 458999999999999999999995 4799999999999997 6789999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..+
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----------------~~~ 237 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----------------ETL 237 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----------------HHH
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHH
Confidence 8865433 234578999999999999999999999999999999999999999764321 111
Q ss_pred hHhhhc--ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 320 FRIMDT--KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 320 ~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
..+... .........++.++.+||.+||..||.+|||+.|+++
T Consensus 238 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 1222334567889999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-55 Score=410.30 Aligned_cols=246 Identities=29% Similarity=0.410 Sum_probs=205.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc---CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ---GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
+.|++++.||+|+||+||+|.+.. +|+.||||++...... ..+.+.+|+++|+.|+|||||++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 359999999999999999997654 5889999999765433 2356889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+|||||.+|+|..++.... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~--~~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred ECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCCCcceEEECCCCCEEEeeccc
Confidence 9999999999999999977665543 48999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceeccccccc---CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhc
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVAT---GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSD 315 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 315 (421)
|..... ....+||+.|+|||++.+ +.|+.++|||||||++|||++|..||.+...
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---------------- 219 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------------- 219 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------------
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----------------
Confidence 986533 234689999999999864 4589999999999999999999999975431
Q ss_pred hhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+..+.........+..+++++.+||.+||..||.+|||+.++++
T Consensus 220 ~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11122223333333334567889999999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=404.88 Aligned_cols=265 Identities=25% Similarity=0.427 Sum_probs=209.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
..|++.++||+|+||+||+|.++... ......||||.+...... ...+|.+|+++|++++|||||++++++.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSS-----GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCC-----CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 46888999999999999999876521 122357999999754333 235688999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~--~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc--cccccCccccceEEECCCCeEEEcccchhh
Confidence 99999999999999998886544 458999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCC-cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDR-THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
....... ........||+.|+|||++.++.++.++|||||||++|||++|..||..... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----------------~~~~ 222 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------NHEV 222 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----------------HHHH
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----------------HHHH
Confidence 7644322 2223345689999999999999999999999999999999997666543211 1223
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
.+.+....+...+..++..+.+||.+||..||++|||+.+|++.|+++...
T Consensus 223 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 334444555566677889999999999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=409.20 Aligned_cols=248 Identities=28% Similarity=0.376 Sum_probs=210.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||.||+|+... +|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 75 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence 479999999999999999997654 58999999997532 234567889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+.+|+|||||+||+|.+++.+... +++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+
T Consensus 76 ~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~--~~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 76 THDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH--TTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhh--cCccccccCHHHeEecCCCCEEEeeccc
Confidence 99999999999999999999987654 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.... .
T Consensus 152 a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-----------------~ 212 (337)
T d1o6la_ 152 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------R 212 (337)
T ss_dssp CBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----------------H
T ss_pred ccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-----------------H
Confidence 987543222 234578999999999999999999999999999999999999999865421 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
+.+.+.. ....++..++.++.+||.+||+.||.+|++ +.++++
T Consensus 213 ~~~~i~~-~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 213 LFELILM-EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHH-CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhc-CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1111111 123456678889999999999999999995 778775
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=404.88 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=207.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc------cCHHHHHHHHHHHhcCCCCCcccee
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF------QGHKEWLTEVNYLGQLHHPNLVKLI 154 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~ 154 (421)
.++|++++.||+|+||+||+|++.. +|+.||||+++.... ...+.+.+|+++|+.++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3689999999999999999997654 588999999865332 2356789999999999999999999
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC----c
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF----N 230 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~----~ 230 (421)
+++.+.+..|||||||+||+|.++|.... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++ .
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~--~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh--cceeecccccceEEEecCCCcccc
Confidence 99999999999999999999999997765 49999999999999999999995 4799999999999998776 4
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 310 (421)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------- 223 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 223 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---------
Confidence 99999999987654332 335679999999999999999999999999999999999999998653211
Q ss_pred hhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+..+..... ....+..++.++.+||.+||..||.+|||+.|+++
T Consensus 224 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 224 -------TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -------HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111111 00112345778999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=401.03 Aligned_cols=257 Identities=29% Similarity=0.422 Sum_probs=208.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
++|++++.||+|+||+||+|.+++ +..||||+++... ...+.|.+|+.+|++++|||||++++++. .+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred HHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 579999999999999999998754 4579999997654 44578999999999999999999999885 46
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..++||||+++|+|..++.......+++..++.++.||+.||+|||+ .||+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~--~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh--hheecccccceEEEECCCCcEEEcccchhhh
Confidence 68999999999999999876554569999999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhH
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFR 321 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (421)
...... .......||+.|+|||++.++.++.++|||||||++|||++|..||..... ...+..
T Consensus 163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~----------------~~~~~~ 225 (285)
T d1fmka3 163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV----------------NREVLD 225 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC----------------HHHHHH
T ss_pred ccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC----------------HHHHHH
Confidence 644332 223346789999999999999999999999999999999997666543221 122233
Q ss_pred hhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 322 IMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 322 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
.+........+..++.++.+||.+||+.||++||++.+|++.|+.+-.
T Consensus 226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 333444455677888999999999999999999999999999988643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-54 Score=402.83 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=208.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||+||+|++.. +|+.||||+++... ....+.+.+|+.+|+.++|||||++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 469999999999999999997654 58899999986432 234567889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+.+..|+|||||.||+|..++..... +++..+..++.||+.||+||| .+||+||||||+||||+.+|.+||+|||+
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCcc
Confidence 99999999999999999999877654 788888999999999999999 45799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..
T Consensus 151 a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~ 209 (316)
T d1fota_ 151 AKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KT 209 (316)
T ss_dssp CEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HH
T ss_pred ceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----------------HH
Confidence 9876432 23478999999999999999999999999999999999999999764321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
..++.... ...+..++.++.++|.+||..||.+|+ |++++++
T Consensus 210 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 210 YEKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11222222 245567788999999999999999996 8999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=396.60 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=203.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++++.||+|+||.||+|.+... ...+..||||.++..... ..+.+.+|+++|++++|||||++++++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSP------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecC------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 35799999999999999999987542 224567999998754333 3456889999999999999999999885
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc--cCeeccccchhheeecCCCcEEEccchhh
Confidence 567899999999999999876543 458999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
+....... .......||+.|+|||++.+..|+.++|||||||++|||++ |..||...... .
T Consensus 156 ~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----------------~ 217 (273)
T d1mp8a_ 156 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------D 217 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------G
T ss_pred eeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----------------H
Confidence 87554332 22344678999999999999999999999999999999998 89999765321 1
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
+...+........+..+++++.+||.+||..||.+|||+.+|++.|+.+.
T Consensus 218 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 218 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22222233334566778899999999999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=395.60 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=205.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEe-C
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-G 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 160 (421)
++|++++.||+|+||.||+|.++ |..||||+++... ..+.+.+|++++++++||||+++++++.+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56889999999999999999763 5789999997653 44678999999999999999999999865 4
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
+.+++||||+++|+|.+++.++....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc--CceeccccchHhheecCCCCEeecccccce
Confidence 568999999999999999976654558999999999999999999995 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
..... .....++..|+|||++.++.++.++|||||||++|||+| |+.||..... ..+
T Consensus 152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----------------~~~ 209 (262)
T d1byga_ 152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------------KDV 209 (262)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------------GGH
T ss_pred ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------------HHH
Confidence 64332 233568999999999999999999999999999999998 7888765432 122
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
...+....+...+..+++++.+||.+||..||.+|||+.+|++.|+++.
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2333344455667778889999999999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-54 Score=401.85 Aligned_cols=265 Identities=27% Similarity=0.396 Sum_probs=216.9
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|++.+.||+|+||+||+|.+... .+..+++.||||+++..... ..+++.+|+++|+.++||||+++++++..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 46799999999999999999987542 23345778999999765433 34678999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeecc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRG----------------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 217 (421)
.+..++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+ .+|||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~--~~ivHrD 165 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRD 165 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc--CCeEeeE
Confidence 999999999999999999996532 2347889999999999999999995 4799999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCC-CccCC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDK 296 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~pf~~ 296 (421)
|||+||||+.++.+||+|||+++...............|++.|+|||++.+..|+.++|||||||++|||++|. .||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999998654443333445577899999999999999999999999999999999986 56765
Q ss_pred CcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
... ..+...+........+..++.++.+||.+||+.||++|||+.||++.|+++.
T Consensus 246 ~~~-----------------~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 246 MAH-----------------EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp SCH-----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCH-----------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 421 1122222233334456677889999999999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=403.49 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=211.3
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.+|++++.||+|+||+||+|.+..+. ......||+|.++... ....+++.+|+++|++++|||||++++++.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEG-----EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCC-----CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 46999999999999999999875421 1123468999986533 34567899999999999999999999998764
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
..+++|||+.+++|.+++.... ..+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~--~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH--cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 5678889999999999886654 458999999999999999999996 479999999999999999999999999998
Q ss_pred cCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhchhhH
Q 014623 241 AGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDKRKL 319 (421)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (421)
...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.+... ..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----------------~~~ 222 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEI 222 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----------------GGH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----------------HHH
Confidence 7655444434445678999999999999999999999999999999998 8889876432 122
Q ss_pred hHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 320 FRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
...+....+...+..++..+.+||.+||..||.+|||+.+|++.|.++..
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 33334444455667788999999999999999999999999999988643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=402.70 Aligned_cols=272 Identities=28% Similarity=0.369 Sum_probs=210.3
Q ss_pred HHHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcC-CCCCccc
Q 014623 75 NELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQL-HHPNLVK 152 (421)
Q Consensus 75 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~ 152 (421)
.+++...++|++++.||+|+||.||+|.+... .+..+++.||||+++.... ...+.+.+|..++.++ +|+||+.
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 33434457899999999999999999987643 2334578999999975433 2345677888888776 6899999
Q ss_pred eeeEEEeC-CeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeecc
Q 014623 153 LIGYCLEG-ENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRD 217 (421)
Q Consensus 153 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrD 217 (421)
+++++... ...++|||||++|+|.++|.... ...+++..+..++.||+.||.|||+ .||+|||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~--~~ivHrD 159 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRD 159 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH--TTCCCSC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh--CCCcCCc
Confidence 99987764 46899999999999999996542 2348899999999999999999995 4799999
Q ss_pred CCCCcEEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhC-CCccCC
Q 014623 218 FKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSG-RCAVDK 296 (421)
Q Consensus 218 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~pf~~ 296 (421)
|||+||||+.++.+||+|||+|+..............+||+.|+|||++.++.++.++|||||||++|||++| ..||.+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544433344457899999999999999999999999999999999986 457765
Q ss_pred CcccchhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 297 TKVGIEQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
... ...+...+........+..+++++.+||.+||+.||++|||+.+|++.|+++.
T Consensus 240 ~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 240 VKI----------------DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CCC----------------SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCH----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 432 11222333334444566678889999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-53 Score=393.33 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=204.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---HHHHHHHHHHHhcCCCCCccceeeEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---HKEWLTEVNYLGQLHHPNLVKLIGYC 157 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~ 157 (421)
.++|++.+.||+|+||+||+|.+.. +|+.||||+++...... ...+.+|+++|+.++||||+++++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4689999999999999999997654 58899999998654433 34688999999999999999999998
Q ss_pred EeCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 158 LEGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 158 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
...+ ..||||||++|++|.+++...+. +++..+..++.||+.||+|||+ .||+||||||+||||+.++.++|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTSCEEE
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHh--CCccCccccCcccccCcccccee
Confidence 8654 37899999999999999977654 8999999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCCC-cceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 234 SDFGLAKAGPTGDR-THVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
+|||.+........ .......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.....
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----------- 221 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----------- 221 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----------
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----------
Confidence 99999875433221 223345689999999999999999999999999999999999999997643211
Q ss_pred hhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhc
Q 014623 313 LSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRP-RMSEVLAILERLE 368 (421)
Q Consensus 313 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~L~~~~ 368 (421)
...+.+.... .......+++++.+||.+||..||.+|| |++++++.|.++.
T Consensus 222 -----~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 222 -----VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111111 0112345678999999999999999999 8999999998875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-53 Score=403.98 Aligned_cols=245 Identities=25% Similarity=0.307 Sum_probs=208.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++++.||+|+||+||+|.+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 579999999999999999997654 58899999986432 234467889999999999999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+....++||||+.||+|.+++.+... +++..+..++.||+.||.|||+ .|||||||||+||||+.+|.+||+|||+
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~--~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHh--CCEecCcCCHHHcccCCCCCEEeeecee
Confidence 99999999999999999999977654 8999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
|+..... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ..
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~ 246 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QI 246 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----------------HH
Confidence 9876432 23478999999999999999999999999999999999999999764321 11
Q ss_pred HhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014623 319 LFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRP-----RMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~ 362 (421)
...+.... ...+..++.++.+||.+||..||.+|+ |+.++++
T Consensus 247 ~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 247 YEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11122221 234566788999999999999999994 8999885
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=394.41 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=204.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
++|++.+.||+|+||.||+|.++.. .+....||||+++.... ...++|.+|+++|+.++||||+++++++.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~------~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAP------SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECT------TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECC------CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 5799999999999999999987542 12345789999875432 23467899999999999999999999996
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccC
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGL 238 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~ 238 (421)
+ ...++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~--~~iiHrDikp~NIll~~~~~vkl~DfGl 157 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGL 157 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred e-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh--CCEeeeeecHHHhccccccceeeccchh
Confidence 5 56789999999999999886654 348999999999999999999995 4799999999999999999999999999
Q ss_pred cccCCCCCCcc-eeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchhhhhhhhhhhhhch
Q 014623 239 AKAGPTGDRTH-VSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQSLVDWAKPYLSDK 316 (421)
Q Consensus 239 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 316 (421)
++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----------------~ 221 (273)
T d1u46a_ 158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----------------S 221 (273)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------H
T ss_pred hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----------------H
Confidence 99765443322 2234567889999999999999999999999999999998 8999976432 1
Q ss_pred hhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 317 RKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
.....+.....+...+..++.++.+||.+||..||++|||+.+|++.|++.+
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 1122333334444556677889999999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-53 Score=403.75 Aligned_cols=249 Identities=27% Similarity=0.380 Sum_probs=202.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc---cCHHHHH---HHHHHHhcCCCCCccceee
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF---QGHKEWL---TEVNYLGQLHHPNLVKLIG 155 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hp~iv~~~~ 155 (421)
++|++.+.||+|+||.||+|++.. +|+.||||++..... .....+. +|+.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 579999999999999999997654 588999999864321 1222333 4577788889999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 156 YCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 156 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
++.+.+..|||||||+||+|.++|.+... +++..++.++.||+.||.|||+ .|||||||||+||||+.+|.+||+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~--~~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECSSSCEEECC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHH--CCccceeeccceeEEcCCCcEEEee
Confidence 99999999999999999999999977654 8899999999999999999995 4799999999999999999999999
Q ss_pred ccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 236 FGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 236 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
||+|+...... ....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||..........
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---------- 216 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---------- 216 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----------
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----------
Confidence 99998765432 234689999999999875 568999999999999999999999997654321111
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
+.+. ........+..+++++.+||.+||..||.+||| ++++++
T Consensus 217 ----~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 ----IDRM-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----HHHH-SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----HHHh-cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111 111222345567889999999999999999998 688875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=396.19 Aligned_cols=268 Identities=27% Similarity=0.403 Sum_probs=216.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||.||+|.....+. ....++..||||+++..... ...++.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCc--ccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3579999999999999999998755321 12234568999999765432 346688899998888 7999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEE
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG--------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNIL 224 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nil 224 (421)
+++..++||||+++|+|.++|.... ...+++..++.++.||+.||+|||+ .+||||||||+|||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~--~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh--CCEEeeeeccccee
Confidence 9999999999999999999997553 2358999999999999999999995 47999999999999
Q ss_pred eCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccchh
Q 014623 225 LDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGIEQ 303 (421)
Q Consensus 225 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~ 303 (421)
++.++.+||+|||+++...............|++.|+|||++.++.|+.++|||||||++|||++ |..||.+...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999999987655444444455779999999999999999999999999999999998 7888875432
Q ss_pred hhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 304 SLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+........+..+++++.+||.+||+.||.+|||+.||++.|+++.+
T Consensus 244 -------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 -------------EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -------------HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 12233344444556667788899999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9e-53 Score=387.15 Aligned_cols=249 Identities=29% Similarity=0.375 Sum_probs=207.5
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC---------HHHHHHHHHHHhcCC-CCCcc
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG---------HKEWLTEVNYLGQLH-HPNLV 151 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hp~iv 151 (421)
++|++.+.||+|+||+||+|+... +|+.||||++....... .+.+.+|+.+|++++ ||||+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv 73 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence 589999999999999999997654 58899999997654321 235789999999997 99999
Q ss_pred ceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 152 KLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
++++++.+++..|||||||+||+|.++|..++ .+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+
T Consensus 74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEECTTCCE
T ss_pred EEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEEcCCCCe
Confidence 99999999999999999999999999997765 48999999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceeccccccc------CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT------GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSL 305 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 305 (421)
||+|||+++....... ....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~----- 221 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----- 221 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH-----
Confidence 9999999987654332 344789999999999863 34788999999999999999999999865321
Q ss_pred hhhhhhhhhchhhHhHhhhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 306 VDWAKPYLSDKRKLFRIMDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.....+..... .......+++++.+||.+||..||.+|||+.||++
T Consensus 222 -----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 -----------LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -----------HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----------HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111222221 22233578899999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=396.40 Aligned_cols=250 Identities=22% Similarity=0.237 Sum_probs=207.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG 160 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 160 (421)
.++|++++.||+|+||+||+|.+.. +|+.||||+++.... ....+.+|+++|+.++|||||++++++.+.
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4689999999999999999997654 588999999986543 234578999999999999999999999999
Q ss_pred CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCC--CcEEEeeccC
Q 014623 161 ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAE--FNAKLSDFGL 238 (421)
Q Consensus 161 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~--~~~kl~Dfg~ 238 (421)
+.+|||||||.||+|.++|.... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.+ +.+||+|||+
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccch
Confidence 99999999999999999996543 358999999999999999999995 479999999999999754 4799999999
Q ss_pred cccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhh
Q 014623 239 AKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRK 318 (421)
Q Consensus 239 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 318 (421)
++...... .....+||+.|+|||.+.+..|+.++|||||||++|+|++|..||....... .
T Consensus 151 ~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----------------~ 211 (321)
T d1tkia_ 151 ARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----------------I 211 (321)
T ss_dssp CEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------H
T ss_pred hhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 98764433 2345779999999999999999999999999999999999999997653211 1
Q ss_pred HhHhhhcccCC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 319 LFRIMDTKLGG--QYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 319 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
...+....... .....++.++.+||.+||..||.+|||+.|+++
T Consensus 212 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111110 011245778999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=395.46 Aligned_cols=265 Identities=29% Similarity=0.432 Sum_probs=222.2
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc-CHHHHHHHHHHHhcC-CCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ-GHKEWLTEVNYLGQL-HHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||.||+|.+... .+..+++.||||+++..... ....+.+|+.+++.+ +|||||++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 36899999999999999999987542 23346889999999865433 345688999999999 6999999999999
Q ss_pred eCCeEEEEEEcCCCCChHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCc
Q 014623 159 EGENRLLVYEFMPKGSLENHLFRRG----------------PQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASN 222 (421)
Q Consensus 159 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~N 222 (421)
+.+..++|||||++|+|.+++.+.. ...+++..+..++.||+.||+|||+. |+|||||||+|
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLKp~N 175 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARN 175 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--Ceeeccccccc
Confidence 9999999999999999999997643 23588999999999999999999954 79999999999
Q ss_pred EEeCCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHh-CCCccCCCcccc
Q 014623 223 ILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLS-GRCAVDKTKVGI 301 (421)
Q Consensus 223 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~ 301 (421)
||++.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||++|||+| |..||.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-- 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999998766555555556789999999999999999999999999999999999 5555544321
Q ss_pred hhhhhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 014623 302 EQSLVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERL 367 (421)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~ 367 (421)
...+.+.+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+++
T Consensus 254 --------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 254 --------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1223344455555566677889999999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=396.58 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=205.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC---ccCHHHHHHHHHHHh-cCCCCCccceeeEE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG---FQGHKEWLTEVNYLG-QLHHPNLVKLIGYC 157 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 157 (421)
++|++++.||+|+||+||+|.+.. +|+.||||+++... ....+.+..|..++. .++|||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 579999999999999999997654 58999999996432 133455667777665 68999999999999
Q ss_pred EeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeecc
Q 014623 158 LEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFG 237 (421)
Q Consensus 158 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg 237 (421)
.+++..||||||+++|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~--~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC--CeeeccCcccceeecCCCceeccccc
Confidence 999999999999999999999977654 88999999999999999999964 79999999999999999999999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKR 317 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 317 (421)
+++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.....
T Consensus 149 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---------------- 210 (320)
T d1xjda_ 149 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---------------- 210 (320)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----------------
T ss_pred hhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----------------
Confidence 9986543322 2345789999999999999999999999999999999999999998653211
Q ss_pred hHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 014623 318 KLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMS-EVLA 362 (421)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~ 362 (421)
....+... ....+..++.++.+||.+||..||.+||++. ++++
T Consensus 211 ~~~~i~~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 211 LFHSIRMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHcC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 01111111 2245567788999999999999999999985 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=399.19 Aligned_cols=250 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred cCCCCC-ceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhc-CCCCCccceeeEEEe
Q 014623 82 RNFRPD-SLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQ-LHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hp~iv~~~~~~~~ 159 (421)
++|.+. +.||+|+||+||+|.+.. +++.||||+++. ...+.+|+.++.+ ++|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 578876 569999999999997654 588999999863 3567789998655 589999999999875
Q ss_pred ----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEE
Q 014623 160 ----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAK 232 (421)
Q Consensus 160 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~k 232 (421)
+..+|||||||+||+|.++|.+.+...+++..+..++.||+.||+|||+ .||+||||||+|||++. ++.+|
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEE
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCcccccccccccccccccccccc
Confidence 4568999999999999999987766679999999999999999999995 47999999999999975 56799
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhh
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPY 312 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 312 (421)
|+|||+|+....... ....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.......
T Consensus 155 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--------- 222 (335)
T d2ozaa1 155 LTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--------- 222 (335)
T ss_dssp ECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred ccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---------
Confidence 999999987654332 34578999999999999999999999999999999999999999754321100
Q ss_pred hhchhhHhHh-hhccc--CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 313 LSDKRKLFRI-MDTKL--GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 313 ~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
..+... ..... .......+++++.+||.+||..||++|||+.|+++.
T Consensus 223 ----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 223 ----PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ---------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000 00000 011123567899999999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=391.76 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=209.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCC-ccCHHHHHHHHHHHhcC-CCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEG-FQGHKEWLTEVNYLGQL-HHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 159 (421)
++|++.++||+|+||+||+|.+.... ....||||.+.... ....+.+.+|+++|.++ +|||||++++++.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence 57899999999999999999876521 12357888875432 23446789999999998 79999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRR--------------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILL 225 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill 225 (421)
++..++||||+++|+|.++|.+. ....+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~--~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV 160 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE
T ss_pred CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc--CCccccccccceEEE
Confidence 99999999999999999999654 23568999999999999999999995 479999999999999
Q ss_pred CCCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCC-CccCCCcccchhh
Q 014623 226 DAEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQS 304 (421)
Q Consensus 226 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~pf~~~~~~~~~~ 304 (421)
+.++.+||+|||+++...... ......||..|+|||.+.++.|+.++|||||||++|||++|. .||.+...
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~----- 232 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----- 232 (309)
T ss_dssp CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----
T ss_pred cCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----
Confidence 999999999999998644322 123456899999999999999999999999999999999975 46654321
Q ss_pred hhhhhhhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 305 LVDWAKPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
..+...+....+...+..+++++.+||.+||..||++|||+.+|++.|+++..
T Consensus 233 ------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 233 ------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 12223333334445667788999999999999999999999999999998764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=391.76 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=218.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
.++|.+++.||+|+||+||+|.+... .+..++..||||+++.... .....+.+|++++++++||||+++++++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 46889999999999999999987532 1222357899999975432 233468899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 GENRLLVYEFMPKGSLENHLFRR--------GPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.+..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||||+.++.+
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~--~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTCBCSCCSGGGEEECTTCCE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeeceEcCCceeecCCceE
Confidence 99999999999999999998643 12347889999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCC-CccCCCcccchhhhhhhhh
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGR-CAVDKTKVGIEQSLVDWAK 310 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~pf~~~~~~~~~~~~~~~~ 310 (421)
||+|||+++..............+||+.|+|||.+.++.++.++|||||||++|||+||. .||.+...
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----------- 241 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----------- 241 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----------
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 999999998765444333344567899999999999999999999999999999999984 66755321
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCCC
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAPK 371 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~~ 371 (421)
......+........+..++..+.+||.+||+.||++|||+.+|++.|++...+.
T Consensus 242 ------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 242 ------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ------HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1122222233334456677889999999999999999999999999998875543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=388.23 Aligned_cols=261 Identities=26% Similarity=0.270 Sum_probs=193.8
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccC-----HHHHHHHHHHHhcCCCCCccceeeEEEeCC
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQG-----HKEWLTEVNYLGQLHHPNLVKLIGYCLEGE 161 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 161 (421)
+++||+|+||+||+|.+.. +|+.||||+++...... .+.+.+|+++|+.++|||||++++++.+++
T Consensus 3 l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp EEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 5789999999999996543 68899999987543221 246889999999999999999999999999
Q ss_pred eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 162 NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 162 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
..||||||+.++++..++... ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~--~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ--HWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc--cceecccCCcceEEecCCCccccccCccccc
Confidence 999999999887776655433 448888999999999999999995 4799999999999999999999999999987
Q ss_pred CCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-hhhhh---c
Q 014623 242 GPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA-KPYLS---D 315 (421)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~-~~~~~---~ 315 (421)
...... .....+||+.|+|||++.+. .|+.++|||||||++|||++|..||.+....... .+.... .+... +
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 654332 23346899999999988754 5899999999999999999999999765432110 000000 00000 0
Q ss_pred hhhHhHhhhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
................ ....++++.+||.+||..||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000000000 1245678999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=384.32 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=206.9
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCC-CccCHHHHHHHHHHHhcCCCCCccceeeEEEe-CCeEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPE-GFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLE-GENRL 164 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 164 (421)
.++||+|+||+||+|.+...+ .+...||||.++.. .....++|.+|+++|++++||||+++++++.. +...+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEECCC------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 578999999999999875421 23457899999753 33344679999999999999999999999876 45889
Q ss_pred EEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCcccCCC
Q 014623 165 LVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPT 244 (421)
Q Consensus 165 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~~~~ 244 (421)
+|||||++|+|.+++.... ....+..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++....
T Consensus 106 lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~--~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH--TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc--cCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999999886544 457888899999999999999995 4799999999999999999999999999987544
Q ss_pred CCCc--ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhhchhhHhHh
Q 014623 245 GDRT--HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLSDKRKLFRI 322 (421)
Q Consensus 245 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (421)
.... .......||..|+|||.+.++.++.++||||||+++|||++|..||...... ..+...
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----------------~~~~~~ 246 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----------------FDITVY 246 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------------CHHH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----------------HHHHHH
Confidence 3221 1222356899999999999999999999999999999999988887643211 111122
Q ss_pred hhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcCC
Q 014623 323 MDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEAP 370 (421)
Q Consensus 323 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~~ 370 (421)
+....+...+..+++++.+||.+||..||++||++.||++.|+++...
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 222233345567788999999999999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=384.07 Aligned_cols=268 Identities=26% Similarity=0.356 Sum_probs=202.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|.+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 579999999999999999997654 5889999999754332 34678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..|+||||+.+ ++.+++.......+++..+..++.|++.||.|||+ .|||||||||+|||++.++.+||+|||+|
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~--~~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc--CCEEccccCchheeecccCcceeccCCcc
Confidence 9999999999954 66666666555679999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhhhhhch
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKPYLSDK 316 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~~~~~~ 316 (421)
+....... .....+||+.|+|||++.... ++.++|||||||++|+|++|+.||.+......- ..... ..+.....
T Consensus 150 ~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 76543222 233467999999999887766 578999999999999999999999765321100 00000 00000000
Q ss_pred hhHhHhhh--ccc----CCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 317 RKLFRIMD--TKL----GGQ---YPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 317 ~~~~~~~~--~~~----~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
........ ... ... ....++.++.+||.+||..||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000 000 012456789999999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=386.02 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=199.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------CHHHHHHHHHHHhcCC--CCCccc
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------GHKEWLTEVNYLGQLH--HPNLVK 152 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hp~iv~ 152 (421)
.++|++++.||+|+||+||+|.+.. +|+.||||++...... ...++.+|+.+|++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 3589999999999999999997654 5889999998754221 1234568999999986 899999
Q ss_pred eeeEEEeCCeEEEEEEcCCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-CCc
Q 014623 153 LIGYCLEGENRLLVYEFMPK-GSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-EFN 230 (421)
Q Consensus 153 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-~~~ 230 (421)
+++++.+.+..++||||+.+ +++.+++.+.. .+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEEETTTTE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH--CCCccccCcccceEEecCCCe
Confidence 99999999999999999976 57888887654 38999999999999999999995 47999999999999985 478
Q ss_pred EEEeeccCcccCCCCCCcceeeccccccceecccccccCCC-CccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 231 AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRL-TTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 231 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
+||+|||+|+...... ..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....
T Consensus 150 vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------- 215 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 215 (273)
T ss_dssp EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred EEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----------
Confidence 9999999998654322 345789999999999987765 5679999999999999999999975311
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+... ...++..++.++.+||.+||..||.+|||+.|+++
T Consensus 216 ------------i~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ------------IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------------HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------Hhhc--ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011 11234456789999999999999999999999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=382.49 Aligned_cols=270 Identities=23% Similarity=0.326 Sum_probs=201.4
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHH--HHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTE--VNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|.+.+.||+|+||.||+|.++ |+.||||+++.. ..+.+.+| +..+..++|||||++++++.
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~ 67 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEE
Confidence 357889999999999999999753 678999999754 23344444 44556789999999999998
Q ss_pred eCC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC------CCceeeccCCCCcEEeCCC
Q 014623 159 EGE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------ESQVIYRDFKASNILLDAE 228 (421)
Q Consensus 159 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------~~~ivHrDlkp~Nill~~~ 228 (421)
+.+ ..|+||||+++|+|.++|.+. .+++..++.++.+++.||+|||+. .+||+||||||+||||+.+
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~ 144 (303)
T d1vjya_ 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 144 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred eCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC
Confidence 654 579999999999999999765 389999999999999999999963 3589999999999999999
Q ss_pred CcEEEeeccCcccCCCCCCc--ceeeccccccceecccccccCC------CCccccchhhhHHHHHHHhCCCccCCCccc
Q 014623 229 FNAKLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATGR------LTTKSDVYSFGVVLLELLSGRCAVDKTKVG 300 (421)
Q Consensus 229 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~tg~~pf~~~~~~ 300 (421)
+.+||+|||+++........ ......+||+.|+|||++.+.. ++.++|||||||+||||+||..||......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 99999999999865433221 1233567999999999987643 677899999999999999999888543322
Q ss_pred chhhhhhhhhhhhhchhhHhH-hhhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhcC
Q 014623 301 IEQSLVDWAKPYLSDKRKLFR-IMDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLEA 369 (421)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~~ 369 (421)
...... .. ........+.. ......+... .......+.+|+.+||+.||.+|||+.||++.|+++..
T Consensus 225 ~~~~~~-~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 225 QLPYYD-LV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCTTTT-TS-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhh-cc-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111000 00 00001111111 1122222222 23456779999999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=376.80 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=197.9
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcC---CCCCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQL---HHPNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hp~iv~~~~~ 156 (421)
++|++++.||+|+||+||+|.+... +++.||||+++.... .....+.+|+.+|+.| +||||++++++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 78 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeee
Confidence 6899999999999999999976432 367899999864322 1223456777776665 79999999999
Q ss_pred EEe-----CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 157 CLE-----GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 157 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
|.. ....+++|||+.++.+.... ......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~--~~ivHrDiKp~NILi~~~~~~ 155 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQI 155 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCE
T ss_pred ecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecCCCccEEEEcCCCCe
Confidence 863 34678999999876655443 4444568999999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhhh-
Q 014623 232 KLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDWA- 309 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~- 309 (421)
||+|||++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....... .+....
T Consensus 156 kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 156 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp EECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 99999999864332 2334578999999999999999999999999999999999999999865432111 010000
Q ss_pred hhhhhc---hhh-HhHhhhc---ccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 310 KPYLSD---KRK-LFRIMDT---KLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 310 ~~~~~~---~~~-~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+.... ... ....... .........+++.+.+||.+||..||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 000 0000000 0011123456788999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-50 Score=372.05 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++.+.||+|+||+||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999764 378999999976543 224678999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
.+..+++|||+.++.+..+.... ..+++..+..++.||+.||.|||+ .|||||||||+||||+.++.+||+|||++
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLINREGELKIADFGLA 147 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred CCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeEcCCCCEEecccccc
Confidence 99999999999776666555433 459999999999999999999995 47999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhh-hhhhh---h
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD-WAKPY---L 313 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~-~~~~~---~ 313 (421)
........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+........ ... ...+. .
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 148 RAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 76543221 23345789999999998764 56899999999999999999999997654221110 000 00000 0
Q ss_pred hchhhHhHhh------hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SDKRKLFRIM------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.......... ...........++..+.+||.+||..||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000001122456778999999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=375.51 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=195.5
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|.+.. +|+.||||+++..... ..+.+.+|+++|+.++|||||+++++|.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~ 87 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence 4689999999999999999997654 5899999999764332 2356889999999999999999999998
Q ss_pred eCC------eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEE
Q 014623 159 EGE------NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAK 232 (421)
Q Consensus 159 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~k 232 (421)
..+ .+|+||||+ +.+|..++... .+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEE
T ss_pred cCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCcchhhcccccccc
Confidence 654 469999999 66777776443 39999999999999999999995 4799999999999999999999
Q ss_pred EeeccCcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-hhh-
Q 014623 233 LSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWA- 309 (421)
Q Consensus 233 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~- 309 (421)
|+|||+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.......... ...
T Consensus 162 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 9999999875432 2346799999999998764 5688999999999999999999999765432111000 000
Q ss_pred hh-------hhhc-hhhHhHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 310 KP-------YLSD-KRKLFRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 310 ~~-------~~~~-~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
.+ .... ............. ......+++++.+||.+||..||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 0000000000000 11223567789999999999999999999999873
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-48 Score=363.59 Aligned_cols=263 Identities=17% Similarity=0.176 Sum_probs=206.7
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC-CCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH-PNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 159 (421)
.++|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+|+++++.|.| +||+.+++++..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 4689999999999999999997654 588999999865432 2346788999998865 899999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC-----CCcEEEe
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA-----EFNAKLS 234 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~-----~~~~kl~ 234 (421)
+...++||||+ +++|.+++.... ..++...+..++.|++.||+||| ..||+||||||+|||++. ++.+||+
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred CCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceEEc
Confidence 99999999999 789999886554 45899999999999999999999 557999999999999964 5789999
Q ss_pred eccCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhh
Q 014623 235 DFGLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWA 309 (421)
Q Consensus 235 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 309 (421)
|||+|+........ ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 99999875432211 1233568999999999999999999999999999999999999999865433221111100
Q ss_pred hhhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 310 KPYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
...............+++++.+++..|+..+|++||+++.+.+.|+++.
T Consensus 229 ----------~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 229 ----------GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp ----------HHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ----------HhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0000000000011235678999999999999999999999988887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=371.35 Aligned_cols=269 Identities=23% Similarity=0.282 Sum_probs=197.1
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc-cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF-QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
+.+|++++.||+|+||+||+|.+.. +|+.||||++..... ...+.+++|+.+|+.|+||||+++++++..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~ 77 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence 4579999999999999999997654 588999999975433 234578899999999999999999999875
Q ss_pred CC----eEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEee
Q 014623 160 GE----NRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSD 235 (421)
Q Consensus 160 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~D 235 (421)
.. ..+++|+++.+|+|.+++... .+++..+..++.|++.||+|||+ +|||||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~--~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 78 PTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp SSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCCcCCCCCcceEEECCCCCEEEcc
Confidence 43 234555566799999999654 38999999999999999999995 4799999999999999999999999
Q ss_pred ccCcccCCCCCCc-ceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhh
Q 014623 236 FGLAKAGPTGDRT-HVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYL 313 (421)
Q Consensus 236 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 313 (421)
||++......... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||...................
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999765432211 12244679999999999854 567899999999999999999999997654321111110000000
Q ss_pred hch--------hhHhHhhhcccCCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 314 SDK--------RKLFRIMDTKLGGQY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 314 ~~~--------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
... ............... ...++.++.+||.+||..||.+|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000000000011 12445689999999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=372.65 Aligned_cols=256 Identities=28% Similarity=0.340 Sum_probs=205.6
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc----cCHHHHHHHHHHHhcCCC-CCccceeeE
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF----QGHKEWLTEVNYLGQLHH-PNLVKLIGY 156 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-p~iv~~~~~ 156 (421)
++|++++.||+|+||+||+|+... ...+|+.||||+++.... ...+.+.+|+++|++++| |||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKIS------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECS------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECc------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence 569999999999999999997642 234689999999875322 234567789999999976 899999999
Q ss_pred EEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeec
Q 014623 157 CLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDF 236 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Df 236 (421)
+.+....++||||+.+|+|.+++..... +.+..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceeecCCCCEEEeec
Confidence 9999999999999999999999987764 7788999999999999999995 47999999999999999999999999
Q ss_pred cCcccCCCCCCcceeeccccccceecccccccC--CCCccccchhhhHHHHHHHhCCCccCCCcccchhhhhhhhhhhhh
Q 014623 237 GLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG--RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLVDWAKPYLS 314 (421)
Q Consensus 237 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 314 (421)
|+++.+...... ......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.......
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~----------- 241 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----------- 241 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-----------
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----------
Confidence 999876443322 23457799999999998765 4678999999999999999999999765422110
Q ss_pred chhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014623 315 DKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPR-----MSEVLA 362 (421)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~ 362 (421)
..+.+. ........+..++.++.+||.+||..||.+||+ ++|+++
T Consensus 242 --~~i~~~-~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 242 --AEISRR-ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHHHH-HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --HHHHHh-cccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111 111122345678899999999999999999994 778774
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-49 Score=365.59 Aligned_cols=262 Identities=20% Similarity=0.186 Sum_probs=199.8
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCc-cceeeEEEe
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNL-VKLIGYCLE 159 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-v~~~~~~~~ 159 (421)
.++|++.+.||+|+||+||+|.+.. +|+.||||++...... .++.+|+++++.++|+|+ +.+.+++.+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 3579999999999999999997654 5789999998765332 457789999999987665 555566678
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC---CCcEEEeec
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA---EFNAKLSDF 236 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~---~~~~kl~Df 236 (421)
++..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+ .||+||||||+|||++. +..+||+||
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred CCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH--CCeeeccCCHhhccccccCCCceeeeecc
Confidence 88899999999 667777665433 458999999999999999999995 47999999999999854 457999999
Q ss_pred cCcccCCCCCCc-----ceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-hhhh
Q 014623 237 GLAKAGPTGDRT-----HVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DWAK 310 (421)
Q Consensus 237 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~~~ 310 (421)
|+|+........ ......+||+.|+|||++.+..++.++|||||||++|||++|..||............ ....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 999876543321 1234568999999999999999999999999999999999999999765432211111 0000
Q ss_pred hhhhchhhHhHhhhcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhc
Q 014623 311 PYLSDKRKLFRIMDTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLAILERLE 368 (421)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~~~ 368 (421)
... ... .......++.++.++|.+||..||++||++.++.+.|+.+.
T Consensus 231 ~~~----------~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 231 KKM----------STP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHH----------HSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ccC----------CCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 000 000 00012345678999999999999999999999988888753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=366.67 Aligned_cols=269 Identities=22% Similarity=0.270 Sum_probs=194.2
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|++.. +|+.||||++..... ....++.+|+++|+.++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 689999999999999999997654 588999999865432 234678899999999999999999998865
Q ss_pred --------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcE
Q 014623 160 --------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNA 231 (421)
Q Consensus 160 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~ 231 (421)
.+..|+||||+.++.+..+.. ....+.+..+..++.||+.||.|||+ .||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp ----------CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEECTTSCE
T ss_pred ccccccccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheeecCCCcE
Confidence 345799999997765554432 33458899999999999999999995 479999999999999999999
Q ss_pred EEeeccCcccCCCCCCc--ceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh-hhh
Q 014623 232 KLSDFGLAKAGPTGDRT--HVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS-LVD 307 (421)
Q Consensus 232 kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~ 307 (421)
||+|||+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+........ ...
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999765432221 122346799999999998765 68999999999999999999999997654321111 111
Q ss_pred hhhhhhh----c--hhhHhHhhhcccCCCCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014623 308 WAKPYLS----D--KRKLFRIMDTKLGGQYP-------QKAAHTAATLALQCLNNEPKLRPRMSEVLAI 363 (421)
Q Consensus 308 ~~~~~~~----~--~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 363 (421)
....... . ................. ...+..+.+||.+||..||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1000000 0 00000000000000000 1224577899999999999999999999863
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=370.54 Aligned_cols=269 Identities=25% Similarity=0.336 Sum_probs=197.6
Q ss_pred CCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCCccceeeEEEeC--
Q 014623 83 NFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPNLVKLIGYCLEG-- 160 (421)
Q Consensus 83 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 160 (421)
+|+..++||+|+||+||+|.+.. +|+.||||++...... ..+|+++|++++||||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 58889999999999999997654 5889999999765322 23799999999999999999998643
Q ss_pred ----CeEEEEEEcCCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEe
Q 014623 161 ----ENRLLVYEFMPKGSLENHLF-RRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLS 234 (421)
Q Consensus 161 ----~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~ 234 (421)
...+||||||.++.+..+.. ......+++..+..++.||+.||+||| .+||+||||||+||||+.++ .+||+
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl~ 165 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLC 165 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeEe
Confidence 34789999997654333332 233456999999999999999999999 45899999999999999775 89999
Q ss_pred eccCcccCCCCCCcceeeccccccceeccccccc-CCCCccccchhhhHHHHHHHhCCCccCCCcccchh-hhhhh-hhh
Q 014623 235 DFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVAT-GRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ-SLVDW-AKP 311 (421)
Q Consensus 235 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~-~~~ 311 (421)
|||+++....... ..+.+||..|+|||++.+ ..|+.++|||||||++|||++|+.||......... ..... ..+
T Consensus 166 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 166 DFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp CCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999987654332 334689999999998875 46899999999999999999999999765432111 00000 000
Q ss_pred hhhchhhHh-Hhhhccc--------CCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhhcC
Q 014623 312 YLSDKRKLF-RIMDTKL--------GGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA--ILERLEA 369 (421)
Q Consensus 312 ~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~--~L~~~~~ 369 (421)
......... ......+ ........++++.+||.+||..||.+|||+.|+++ .++++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000000000 0000000 01122356778999999999999999999999986 4555544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=360.67 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=205.0
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|.+.. +++.||||+++..... ...++.+|+.+|+.++||||+++++++.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 579999999999999999997654 5889999999755432 34678899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEEeeccCc
Q 014623 160 GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKLSDFGLA 239 (421)
Q Consensus 160 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a 239 (421)
....++|||++.+++|..++.... .+++..+..++.|++.||+|||+ .||+||||||+|||++.++.+||+|||.+
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCcccccccCCceeeeecchh
Confidence 999999999999988888776543 48899999999999999999995 57999999999999999999999999999
Q ss_pred ccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchh--hhhhhhh-hhhhc
Q 014623 240 KAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQ--SLVDWAK-PYLSD 315 (421)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~--~~~~~~~-~~~~~ 315 (421)
+........ .....++..|+|||++.+.. ++.++|||||||++|||++|+.||......... .+..... +....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (292)
T d1unla_ 149 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226 (292)
T ss_dssp EECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred hcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhh
Confidence 876543322 23356788999999887765 689999999999999999999997543321111 0111000 00000
Q ss_pred hhhHhHhhh---------cccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 316 KRKLFRIMD---------TKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 316 ~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
......... ...........+..+.+||.+||+.||.+|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 01111233466788999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-48 Score=365.62 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=199.1
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeC
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEG 160 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~ 160 (421)
++|++++.||+|+||+||+|++.. +|+.||||+++.. ..+++.+|+++|+.++ ||||+++++++...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 579999999999999999997654 5899999999754 3467889999999995 99999999998843
Q ss_pred --CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCC-cEEEeecc
Q 014623 161 --ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEF-NAKLSDFG 237 (421)
Q Consensus 161 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~-~~kl~Dfg 237 (421)
...++|||||.+++|..+. ..+++..+..++.||+.||.|||+ .||+||||||+||||+.++ .+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~--~gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh--cccccccccccceEEcCCCCeeeecccc
Confidence 5689999999999997754 348999999999999999999995 4799999999999998655 59999999
Q ss_pred CcccCCCCCCcceeeccccccceecccccccC-CCCccccchhhhHHHHHHHhCCCccCCCcccchhh--hhhhh-hhhh
Q 014623 238 LAKAGPTGDRTHVSTQVMGTHGYAAPEYVATG-RLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQS--LVDWA-KPYL 313 (421)
Q Consensus 238 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~~~~~-~~~~ 313 (421)
+|+....... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... +.... .+..
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9987654332 3456799999999998765 47999999999999999999999997654322111 00000 0000
Q ss_pred hc---------hhhHhHhh--------hcccCCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 314 SD---------KRKLFRIM--------DTKLGGQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 314 ~~---------~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
.+ ........ ...........++.++.+||.+||..||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000 001111223456788999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=364.51 Aligned_cols=262 Identities=22% Similarity=0.272 Sum_probs=190.4
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc--CHHHHHHHHHHHhcCCCCCccceeeEEEe
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ--GHKEWLTEVNYLGQLHHPNLVKLIGYCLE 159 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 159 (421)
++|++++.||+|+||+||+|++.. +|+.||||++...... ..+++.+|+.+|+.++||||++++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~ 87 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence 689999999999999999997654 5899999999765432 23568899999999999999999999864
Q ss_pred ------CCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 160 ------GENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 160 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
....|+|||||.+ ++.+.+. ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 88 QKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEECTTCCEEE
T ss_pred ccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCccccccccccceee
Confidence 3678999999965 4555453 238899999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccchhhhh--hhhhh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV--DWAKP 311 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--~~~~~ 311 (421)
+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......... ....+
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999988654332 234567999999999999999999999999999999999999999765432111000 00000
Q ss_pred ---hhhch-hhH---------------hHhhhcccC---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 312 ---YLSDK-RKL---------------FRIMDTKLG---GQYPQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 312 ---~~~~~-~~~---------------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
++... ... ......... .......+.++.+||.+||..||++|||++|+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 000 000000000 0112356889999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=364.82 Aligned_cols=263 Identities=24% Similarity=0.295 Sum_probs=196.0
Q ss_pred hcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCc--cCHHHHHHHHHHHhcCCCCCccceeeEEE
Q 014623 81 TRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGF--QGHKEWLTEVNYLGQLHHPNLVKLIGYCL 158 (421)
Q Consensus 81 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 158 (421)
.++|++++.||+|+||+||+|++.. +|+.||||++..... ...+++.+|+++|+.++|||||++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4689999999999999999997654 589999999976533 23356889999999999999999999986
Q ss_pred eC-----CeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCCCCcEEE
Q 014623 159 EG-----ENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDAEFNAKL 233 (421)
Q Consensus 159 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~~~~~kl 233 (421)
.. ...+++|+|+.||+|.+++..+ .+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+|+
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~--~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEECTTCCEEE
T ss_pred eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh--CCCcccccCCccccccccccccc
Confidence 43 3446677778899999998543 49999999999999999999995 47999999999999999999999
Q ss_pred eeccCcccCCCCCCcceeeccccccceecccccccCC-CCccccchhhhHHHHHHHhCCCccCCCcccchhhhh-hh-hh
Q 014623 234 SDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGR-LTTKSDVYSFGVVLLELLSGRCAVDKTKVGIEQSLV-DW-AK 310 (421)
Q Consensus 234 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-~~-~~ 310 (421)
+|||++..... ......|+..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.......... .. ..
T Consensus 163 ~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 163 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237 (348)
T ss_dssp CCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999976432 233467999999999877654 688999999999999999999999765432111110 00 00
Q ss_pred hh---hh--chhhHhHhhhcccCC-CC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014623 311 PY---LS--DKRKLFRIMDTKLGG-QY-----PQKAAHTAATLALQCLNNEPKLRPRMSEVLA 362 (421)
Q Consensus 311 ~~---~~--~~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 362 (421)
+. .. ............... .. ...++.++.+||.+||..||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 00 000000000000000 00 1245678999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-42 Score=331.29 Aligned_cols=265 Identities=16% Similarity=0.201 Sum_probs=191.8
Q ss_pred cCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-----------CCCc
Q 014623 82 RNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-----------HPNL 150 (421)
Q Consensus 82 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~i 150 (421)
.+|++++.||+|+||+||+|++.. +|+.||||+++.... ..+.+.+|+++++.++ |+||
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 369999999999999999997654 588999999986532 2356678888888775 5789
Q ss_pred cceeeEEEe--CCeEEEEEEcCCCCCh-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeCC
Q 014623 151 VKLIGYCLE--GENRLLVYEFMPKGSL-ENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLDA 227 (421)
Q Consensus 151 v~~~~~~~~--~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~~ 227 (421)
+++++++.. ....+++|+++..+.. ...........+.+..+..++.||+.||.|||+ ..||+||||||+||||+.
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeec
Confidence 999998764 3456677777655443 333444455668999999999999999999996 358999999999999976
Q ss_pred CCc------EEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhHHHHHHHhCCCccCCCcccc
Q 014623 228 EFN------AKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGVVLLELLSGRCAVDKTKVGI 301 (421)
Q Consensus 228 ~~~------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 301 (421)
++. ++|+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.......
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~ 236 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence 653 999999999764332 234679999999999999999999999999999999999999997543211
Q ss_pred hh----hhhhhhhh------hhh-chhhHhHhhh-------------------cccCCCCCHHHHHHHHHHHHhccccCC
Q 014623 302 EQ----SLVDWAKP------YLS-DKRKLFRIMD-------------------TKLGGQYPQKAAHTAATLALQCLNNEP 351 (421)
Q Consensus 302 ~~----~~~~~~~~------~~~-~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~l~~dP 351 (421)
.. .......- ... .......... ...........+.++.+||.+||..||
T Consensus 237 ~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 11 00000000 000 0000000000 001223456788999999999999999
Q ss_pred CCCCCHHHHHH
Q 014623 352 KLRPRMSEVLA 362 (421)
Q Consensus 352 ~~Rpt~~ell~ 362 (421)
.+|||++|+|+
T Consensus 317 ~~Rpta~e~L~ 327 (362)
T d1q8ya_ 317 RKRADAGGLVN 327 (362)
T ss_dssp TTCBCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4e-26 Score=197.22 Aligned_cols=167 Identities=14% Similarity=0.079 Sum_probs=116.4
Q ss_pred CCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCcc------------------CHHHHHHHHHHHhcCC
Q 014623 85 RPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQ------------------GHKEWLTEVNYLGQLH 146 (421)
Q Consensus 85 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~ 146 (421)
.+++.||+|+||+||+|.+. +|+.||||+++..... .......|...+.++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 72 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred hhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc
Confidence 46789999999999999754 3789999987632110 0122346888999999
Q ss_pred CCCccceeeEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhCCCceeeccCCCCcEEeC
Q 014623 147 HPNLVKLIGYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDAESQVIYRDFKASNILLD 226 (421)
Q Consensus 147 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ivHrDlkp~Nill~ 226 (421)
|.+++..+++. ..+++|||+.+..+.+ +.......++.|++.+|.|||+ .||+||||||+|||++
T Consensus 73 ~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~ 137 (191)
T d1zara2 73 GLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS 137 (191)
T ss_dssp TSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE
T ss_pred CCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeee
Confidence 99999887653 2379999998765543 2334456789999999999995 4799999999999998
Q ss_pred CCCcEEEeeccCcccCCCCCCcceeeccccccceecccccccCCCCccccchhhhH
Q 014623 227 AEFNAKLSDFGLAKAGPTGDRTHVSTQVMGTHGYAAPEYVATGRLTTKSDVYSFGV 282 (421)
Q Consensus 227 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 282 (421)
++ .++|+|||+|...............+.. -.+ +....|+.++|+||+.-
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAID 187 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHH
Confidence 66 4999999999765432211100000000 001 11356888999999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=3.1e-09 Score=94.40 Aligned_cols=147 Identities=16% Similarity=0.010 Sum_probs=98.1
Q ss_pred HHHHHhcCCCCCceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCcccee
Q 014623 76 ELKTATRNFRPDSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLI 154 (421)
Q Consensus 76 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~ 154 (421)
+++.....|++.+..+.++.+.||+... .+..+++|+...........+.+|...++.|. +--+.+++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl 76 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEE
Confidence 4555566788777766566678998743 24567888876544333345667888877764 43467778
Q ss_pred eEEEeCCeEEEEEEcCCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhC-------------------------
Q 014623 155 GYCLEGENRLLVYEFMPKGSLENHLFRRGPQPLSWAVRMKVAIGAAKGLTFLHDA------------------------- 209 (421)
Q Consensus 155 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~------------------------- 209 (421)
.+..+++..++||++++|.++.+..... .. ...++.+++..++.||+.
T Consensus 77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T d1j7la_ 77 HFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred EEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence 8888888999999999998776543211 11 112333444444444421
Q ss_pred --------------------------------CCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 210 --------------------------------ESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 210 --------------------------------~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
...++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=1.3e-06 Score=76.33 Aligned_cols=75 Identities=17% Similarity=0.081 Sum_probs=50.7
Q ss_pred eecccCc-eeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCC--CCccceeeEEEeCCeEEE
Q 014623 89 LLGEGGF-GFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHH--PNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 89 ~lg~G~~-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p~iv~~~~~~~~~~~~~l 165 (421)
.+..|.. +.||+.... .+..+++|........ .+..|+..++.|.. -.+.+++.+..+.+..++
T Consensus 17 ~~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 3445543 678987533 3566888987655433 34567777776642 336677888888888999
Q ss_pred EEEcCCCCChH
Q 014623 166 VYEFMPKGSLE 176 (421)
Q Consensus 166 v~e~~~~~~L~ 176 (421)
||++++|.++.
T Consensus 84 v~~~i~G~~~~ 94 (255)
T d1nd4a_ 84 LLGEVPGQDLL 94 (255)
T ss_dssp EEECCSSEETT
T ss_pred EEEeeeccccc
Confidence 99999887653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.21 E-value=5.1e-06 Score=77.62 Aligned_cols=78 Identities=15% Similarity=0.196 Sum_probs=49.0
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecC------CCc-cCHHHHHHHHHHHhcCC-C--CCccceeeE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKP------EGF-QGHKEWLTEVNYLGQLH-H--PNLVKLIGY 156 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~-h--p~iv~~~~~ 156 (421)
.+.||.|....||++.... +++.++||.-.. +.. ....+...|++.|+.+. + ..+.+++.
T Consensus 31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~- 100 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY- 100 (392)
T ss_dssp EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence 4578999999999985432 367899997432 111 12345567888887663 2 34555554
Q ss_pred EEeCCeEEEEEEcCCCCCh
Q 014623 157 CLEGENRLLVYEFMPKGSL 175 (421)
Q Consensus 157 ~~~~~~~~lv~e~~~~~~L 175 (421)
.+.+..++|||++.+..+
T Consensus 101 -~d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 101 -SDTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp -EETTTTEEEECCCTTSEE
T ss_pred -EcCCCCEEEEeccCCccc
Confidence 355667899999977544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.00044 Score=62.22 Aligned_cols=134 Identities=19% Similarity=0.099 Sum_probs=74.7
Q ss_pred ceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCCCCC-----ccce--eeEEEeCCeEEEEE
Q 014623 95 FGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLHHPN-----LVKL--IGYCLEGENRLLVY 167 (421)
Q Consensus 95 ~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp~-----iv~~--~~~~~~~~~~~lv~ 167 (421)
--.||++... +|..+++|+.+... ...+++..|...+..|...+ .+.. -..+..+...+.++
T Consensus 35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 3579997543 47889999987653 34466777888877764221 1121 11234566778999
Q ss_pred EcCCCCChHH-----------HH---hh----c---CCCCCC----------------------HHHHHHHHHHHHHHHH
Q 014623 168 EFMPKGSLEN-----------HL---FR----R---GPQPLS----------------------WAVRMKVAIGAAKGLT 204 (421)
Q Consensus 168 e~~~~~~L~~-----------~l---~~----~---~~~~~~----------------------~~~~~~~~~~i~~~l~ 204 (421)
+++.|..+.. .+ +. . .....+ .......+..+...+.
T Consensus 104 ~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 183 (325)
T d1zyla1 104 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 183 (325)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred eecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9997743310 01 00 0 000111 1111222333333332
Q ss_pred Hh--hhCCCceeeccCCCCcEEeCCCCcEEEeeccCccc
Q 014623 205 FL--HDAESQVIYRDFKASNILLDAEFNAKLSDFGLAKA 241 (421)
Q Consensus 205 ~l--H~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~~ 241 (421)
-+ .....++||+|+.+.|||++++ ..++||+-+..
T Consensus 184 ~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 184 AHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 22 1123579999999999999743 56899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.26 E-value=0.00056 Score=63.35 Aligned_cols=81 Identities=14% Similarity=0.051 Sum_probs=51.9
Q ss_pred CceecccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC-CCCccceeeEEEeCCeEEE
Q 014623 87 DSLLGEGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH-HPNLVKLIGYCLEGENRLL 165 (421)
Q Consensus 87 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l 165 (421)
++.|+.|-.-.+|++....... ........|.+++.... .......+|..+++.+. +.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3578888888999987654321 12233567888877532 22334557899988885 4334567776532 68
Q ss_pred EEEcCCCCCh
Q 014623 166 VYEFMPKGSL 175 (421)
Q Consensus 166 v~e~~~~~~L 175 (421)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.18 E-value=0.002 Score=57.28 Aligned_cols=156 Identities=15% Similarity=0.032 Sum_probs=82.1
Q ss_pred cCHHHHHHHhcCCCCCceec-----ccCceeEEEEEecCCCCCCCCCCCCcEEEEEEecCCCccCHHHHHHHHHHHhcCC
Q 014623 72 FTFNELKTATRNFRPDSLLG-----EGGFGFVYKGWIDQHSLSPAKPGSGMVVAVKKLKPEGFQGHKEWLTEVNYLGQLH 146 (421)
Q Consensus 72 ~~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~ 146 (421)
.+..++.....+|.+++... .|---+.|+....+ | .+++|++.... ..+++..|++++..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~----------g-~yVLri~~~~~--~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC----------C-cEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence 35567777778898876543 55557789875442 3 48999986532 2234445666666653
Q ss_pred -----CCCccceee---EEEeCCeEEEEEEcCCCCChHH--------------HHhhc---CC----CCCC---------
Q 014623 147 -----HPNLVKLIG---YCLEGENRLLVYEFMPKGSLEN--------------HLFRR---GP----QPLS--------- 188 (421)
Q Consensus 147 -----hp~iv~~~~---~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~---~~----~~~~--------- 188 (421)
.|..+...+ +.........++.++.+..... .++.. .. ....
T Consensus 70 ~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (316)
T d2ppqa1 70 AKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWD 149 (316)
T ss_dssp HTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHH
T ss_pred hccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhh
Confidence 233322211 1223445667777776643311 00000 00 0000
Q ss_pred ---------HHHHHHHHHHHHHHHHHhh--hCCCceeeccCCCCcEEeCCCCcEEEeeccCcc
Q 014623 189 ---------WAVRMKVAIGAAKGLTFLH--DAESQVIYRDFKASNILLDAEFNAKLSDFGLAK 240 (421)
Q Consensus 189 ---------~~~~~~~~~~i~~~l~~lH--~~~~~ivHrDlkp~Nill~~~~~~kl~Dfg~a~ 240 (421)
.......+..+...+...+ ....|+||+|+.++||+++.+...-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 150 KSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0001111222222222222 124579999999999999988777899999874
|